Citrus Sinensis ID: 006886
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LVM0 | 654 | Probable inactive recepto | yes | no | 0.945 | 0.906 | 0.608 | 0.0 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.972 | 0.953 | 0.593 | 0.0 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.968 | 0.948 | 0.571 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.942 | 0.898 | 0.520 | 1e-164 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.920 | 0.904 | 0.477 | 1e-158 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.904 | 0.965 | 0.450 | 1e-139 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.915 | 0.876 | 0.447 | 1e-138 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.912 | 0.951 | 0.442 | 1e-137 | |
| Q9FL63 | 614 | Inactive leucine-rich rep | no | no | 0.933 | 0.952 | 0.428 | 1e-136 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.909 | 0.850 | 0.459 | 1e-132 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/605 (60%), Positives = 458/605 (75%), Gaps = 12/605 (1%)
Query: 12 FLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRV 71
FLF +ADLNSD+QALL FA +VPH R+LNWN+ +C SW+GVTC + + V
Sbjct: 30 FLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSV 89
Query: 72 IGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS 131
+ LPGIG GPIP N++GKL++L+ILSLRSN L+G LP DI S+ SL Y+YLQ+N FS
Sbjct: 90 HALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFS 149
Query: 132 GVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKIL 191
G +P+F S QLN LDLSFN+FTG IP FQNL +L L+LQNN +SG +P L+ L+ L
Sbjct: 150 GEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRL 209
Query: 192 NFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTIS----- 246
N SNN+LNGSIP +L FP+SSF GN++LCGLPL PC+T S P PS P IS
Sbjct: 210 NLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSS----PPPSLTPHISTPPLP 265
Query: 247 --PHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKGTAEKP 304
PHK S++KL+ +II IA GG A+L L+ + CC+KK D++ ++K K EK
Sbjct: 266 PFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTLTEKA 325
Query: 305 K-DFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVV 363
K +FGSGVQE EKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+LE+ TTVVV
Sbjct: 326 KQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVV 385
Query: 364 KRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHR 423
KRL+EVAA KREFEQQME++ +G H +VVP+RAYYYSKDEKL+V Y PAG+L LLH
Sbjct: 386 KRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHG 445
Query: 424 NRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483
NR T LDW+SR+KI L A+GIA +H+ GG KF+HGNIKSSNV++ Q+ + CISD G
Sbjct: 446 NRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFG 505
Query: 484 LAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV 543
L L+ P R GYRAPEV ETRK + KSDVYSFGVL+LEMLTGK+P+Q DD+V
Sbjct: 506 LTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMV 565
Query: 544 DLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
DLPRWV+SVVREEWT+EVFD+EL+++Q++EEEMVQMLQIA++CVA+VP+ RP MDDVVRM
Sbjct: 566 DLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRM 625
Query: 604 IEQIQ 608
IE+I+
Sbjct: 626 IEEIR 630
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/627 (59%), Positives = 467/627 (74%), Gaps = 17/627 (2%)
Query: 8 VVPIFLFTVLPIFPT--VVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCN 65
++ FLF ++ F + + AD+ SDKQALL+FA VPH+RKLNWN+ P+C+SW G+TC+
Sbjct: 4 IIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCS 63
Query: 66 VNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYL 125
N +RV + LPG G GP+P + KLDAL+I+SLRSN+L G +PS I S+ ++ +Y
Sbjct: 64 KNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYF 123
Query: 126 QNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNL 185
N FSG +P S +L LDLS N+ +GNIP QNLT+L L+LQNNS+SG IP L
Sbjct: 124 HENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP- 182
Query: 186 PRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTI 245
PRLK LN S NNLNGS+P S+++FP SSF GNS+LCG PLTPC +++PSPSP+
Sbjct: 183 PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEG 242
Query: 246 SPHKNASR----KKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLD--RQGSGVLKGK- 298
N R K L++G+I+ IAVGG +LF++LA+ LCC KK D + + V K K
Sbjct: 243 PGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKP 302
Query: 299 GTAE-KPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILED 357
G ++ K ++FGSGVQEAEKNKL F +GS +NFDLEDLLRASAEVLGKGSYG+TYKAILE+
Sbjct: 303 GRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE 362
Query: 358 GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417
GTTVVVKRL+EVAA KREFEQQME VG I H NV P+RAYY+SKDEKL+VY Y G+
Sbjct: 363 GTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNF 422
Query: 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477
MLLH N G ALDW +R++I L ARGI+ IHS GAK HGNIKS NVLLTQ+L+
Sbjct: 423 SMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHV 482
Query: 478 CISDVGLAHLINFPT-TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
C+SD G+A L++ T +R++GYRAPE ETRK +QKSDVYSFGVLLLEMLTGKA +
Sbjct: 483 CVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKT 542
Query: 537 SGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ-DVEEEMVQMLQIALSCVAKVPDSRP 595
+GH++VVDLP+WV+SVVREEWT EVFDVEL+K Q +VEEEMVQMLQIA++CV+K PDSRP
Sbjct: 543 TGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRP 602
Query: 596 KMDDVVRMIEQIQQ----PELRNRASS 618
M++VV M+E+I+ P NRASS
Sbjct: 603 SMEEVVNMMEEIRPSGSGPGSGNRASS 629
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 700 bits (1806), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/644 (57%), Positives = 463/644 (71%), Gaps = 37/644 (5%)
Query: 6 SMVVPIFLFTVLPIFPTVV-ADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTC 64
+ V F F +L +V ADL SD+QALL+FA +VPH KLNWN +CSSWIG+TC
Sbjct: 7 AFVAASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITC 66
Query: 65 NVNR--SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQY 122
+ + SRV+ + LPG+G G IP ++GKLDALK+LSLRSN L GTLPSDI S+ SL+Y
Sbjct: 67 DESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEY 126
Query: 123 VYLQNNYFSG-----VLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS 177
+YLQ+N FSG LP+ S QL LDLS+N+ +GNIP G +NL+++ +L LQNNS
Sbjct: 127 LYLQHNNFSGELTTNSLPSI-SKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFD 185
Query: 178 GAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPS- 236
G I L+LP +K++N S NNL+G IP+ L+ P SF+GNS+LCG PL CS + SPS
Sbjct: 186 GPIDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSS 245
Query: 237 --PSPSYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCL----KKLDRQ 290
P P ++ + + R++ + IIAI VG C+V L L + FL CL KK +
Sbjct: 246 NLPRP-----LTENLHPVRRRQSKAYIIAIVVG-CSVAVLFLGIVFLVCLVKKTKKEEGG 299
Query: 291 GSGVLKGKG--TAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYG 348
G GV G ++KP+DFGSGVQ+ EKNKL F + NFDLEDLL+ASAEVLGKGS+G
Sbjct: 300 GEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFG 359
Query: 349 STYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408
+ YKA+LED T VVVKRLREV A+K+EFEQQME+VG I +HSN VP+ AYYYSKDEKL+V
Sbjct: 360 TAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLV 419
Query: 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSN 468
Y YM GSLF ++H NR D G +DW +RMKIA GT++ I+++HS KF HG+IKSSN
Sbjct: 420 YKYMTKGSLFGIMHGNRGDRG--VDWETRMKIATGTSKAISYLHS---LKFVHGDIKSSN 474
Query: 469 VLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528
+LLT+DL C+SD L L N PT RTIGY APEV ETR+ SQ+SDVYSFGV++LEML
Sbjct: 475 ILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEML 534
Query: 529 TGKAPLQHSGHDD---VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALS 585
TGK PL G +D V+DLPRWVRSVVREEWTAEVFDVELLK+Q++EEEMVQMLQ+AL+
Sbjct: 535 TGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALA 594
Query: 586 CVAKVPDSRPKMDDVVRMIEQIQ-----QPELRNRASSGTESNV 624
CVA+ P+SRPKM++V RMIE ++ Q +NR SS SNV
Sbjct: 595 CVARNPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSEATSNV 638
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 577 bits (1488), Expect = e-164, Method: Compositional matrix adjust.
Identities = 323/621 (52%), Positives = 418/621 (67%), Gaps = 30/621 (4%)
Query: 13 LFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRVI 72
LF++L + V ++ ++KQALL F +PH +L WN + C+ W+GV CN N+S +
Sbjct: 11 LFSILLLTQRVNSESTAEKQALLTFLQQIPHENRLQWNESDSACN-WVGVECNSNQSSIH 69
Query: 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSG 132
+ LPG G G IP+ S+G+L L++LSLRSN L+G +PSD ++++ L+ +YLQ+N FSG
Sbjct: 70 SLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSG 129
Query: 133 VLP-AFRSLQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKI 190
P +F L L LD+S N FTG+IP NLT L L L NN SG +P ++L L
Sbjct: 130 EFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL-GLVD 188
Query: 191 LNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTISPHKN 250
N SNNNLNGSIP SL F SF GN LCG PL PC + SPSPSPS S +
Sbjct: 189 FNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLI-NPSNRLS 247
Query: 251 ASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK-----GTAEKPK 305
+ + KL+ +I+AI V V LLLAL CL+K R+GS + K G A +
Sbjct: 248 SKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRK--RRGSNEARTKQPKPAGVATRNV 305
Query: 306 DFGSGVQ---------------EAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGST 350
D G E E+NKL F +G ++FDLEDLLRASAEVLGKGS G++
Sbjct: 306 DLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTS 365
Query: 351 YKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410
YKA+LE+GTTVVVKRL++V A+K+EFE QMEVVG I KH NV+P+RAYYYSKDEKL+V+
Sbjct: 366 YKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFD 424
Query: 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVL 470
+MP GSL LLH +R G T LDW++RM+IA+ ARG+A +H AK HGNIK+SN+L
Sbjct: 425 FMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS--AKLVHGNIKASNIL 482
Query: 471 LTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG 530
L + + C+SD GL L + + R GY APEV ETRK + KSDVYSFGVLLLE+LTG
Sbjct: 483 LHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTG 542
Query: 531 KAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKV 590
K+P Q S ++ +DLPRWV SVVREEWTAEVFDVEL++Y ++EEEMVQ+LQIA++CV+ V
Sbjct: 543 KSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTV 602
Query: 591 PDSRPKMDDVVRMIEQIQQPE 611
PD RP M +V+RMIE + + E
Sbjct: 603 PDQRPVMQEVLRMIEDVNRSE 623
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1441), Expect = e-158, Method: Compositional matrix adjust.
Identities = 300/628 (47%), Positives = 409/628 (65%), Gaps = 51/628 (8%)
Query: 30 DKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANS 89
DK+ALL+F + R LNWN + VC+ W GVTCN + SR+I + LPG+G G IP N+
Sbjct: 29 DKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQIPPNT 88
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL--QLNALDL 147
I +L AL++LSLRSN ++G P D + L ++YLQ+N SG LP S+ L +++L
Sbjct: 89 ISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNLTSVNL 148
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLN-LPRLKILNFSNN-NLNGSIPDS 205
S N F G IP L R+ LNL NN++SG IP L+ L L+ ++ SNN +L G IPD
Sbjct: 149 SNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAGPIPDW 208
Query: 206 LQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTISPHKNASRKKLNSGSIIAIA 265
L+ FP SS+ G+ + P + +P P P+ H+ S+ +
Sbjct: 209 LRRFPFSSY------TGIDIIPPGGNYTLVTPPP---PSEQTHQKPSKARF--------- 250
Query: 266 VGGCAVLFLLL----------ALFFL---CCLKKLDRQGSGVLKGKGTAEK----PKDFG 308
+G +FLL+ AL F+ C +++ R+G GV+ +K P+ F
Sbjct: 251 LGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMSPEKFV 310
Query: 309 SGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLRE 368
S +++ N+L F +G ++FDLEDLLRASAEVLGKG++G+TYKA+LED T+V VKRL++
Sbjct: 311 SRMEDV-NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKD 369
Query: 369 VAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG 428
VAA KR+FEQQME++G I KH NVV ++AYYYSKDEKL+VY Y GS+ LLH NR +
Sbjct: 370 VAAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGEN 428
Query: 429 GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488
LDW +RMKIA+G A+GIA IH E K HGNIKSSN+ L + NGC+SD+GL ++
Sbjct: 429 RIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVM 488
Query: 489 N-FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547
+ +R GYRAPEVT+TRK+SQ SDVYSFGV+LLE+LTGK+P+ + D+++ L R
Sbjct: 489 SPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVR 548
Query: 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
WV SVVREEWTAEVFD+ELL+Y ++EEEMV+MLQIA+SCV K D RPKM D+VR+IE +
Sbjct: 549 WVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENV 608
Query: 608 --------QQPELRNRASSGTESNVQTP 627
+PEL+ ++ +G S TP
Sbjct: 609 GNRRTSIEPEPELKPKSENGA-SETSTP 635
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 278/617 (45%), Positives = 382/617 (61%), Gaps = 50/617 (8%)
Query: 7 MVVPIFLFTVLPIFPTVVAD-LNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCN 65
M + +F F+++ F + + L DK+ALL F + +R L+WN ++ VC SW GVTCN
Sbjct: 1 MQIFLFFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCN 59
Query: 66 VNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYL 125
N R++ + LP +GF G IP +I +L +LK LSLR N+ G PSD T++ SL ++YL
Sbjct: 60 ENGDRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYL 119
Query: 126 QNNYFSG-VLPAFRSLQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL 183
Q+N+ SG +L F L+ L LDLS N F G+IP LT L +LNL NNS SG IP L
Sbjct: 120 QHNHLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNL 179
Query: 184 NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFP 243
+LP+L +N SNN L G+IP SLQ F +S+F GN++
Sbjct: 180 HLPKLSQINLSNNKLIGTIPKSLQRFQSSAFSGNNL------------------------ 215
Query: 244 TISPHKNASRKK---LNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKGT 300
+ RK L+ + + I C + L+ + C K + SG L+ + +
Sbjct: 216 ---TERKKQRKTPFGLSQLAFLLILSAACVLCVSGLSFIMITCFGK--TRISGKLRKRDS 270
Query: 301 AEKPKDFGSGVQEAEKN-KLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGT 359
+ P ++ S E+ K+ F G FDL+DLL +SAEVLGKG++G+TYK +ED +
Sbjct: 271 SSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMS 330
Query: 360 TVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFM 419
TVVVKRL+EV +REFEQQME++G I +H NV ++AYYYSKD+KL VYSY GSLF
Sbjct: 331 TVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYSYYNHGSLFE 389
Query: 420 LLHRNRSD-GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478
+LH NR LDW++R++IA G ARG+A IH EG KF HGNIKSSN+ L GC
Sbjct: 390 ILHGNRGRYHRVPLDWDARLRIATGAARGLAKIH-EG--KFIHGNIKSSNIFLDSQCYGC 446
Query: 479 ISDVGLAHLI-NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQH- 536
I DVGL ++ + P T T GY APE+T+TR+++Q SDVYSFGV+LLE+LTGK+P+
Sbjct: 447 IGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQA 506
Query: 537 ----SGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ-DVEEEMVQMLQIALSCVAKVP 591
+G ++ +DL W+RSVV +EWT EVFD+E+L EEEMV+MLQI L+CVA
Sbjct: 507 ELVPTGGEN-MDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQ 565
Query: 592 DSRPKMDDVVRMIEQIQ 608
RP + V+++IE I+
Sbjct: 566 QERPHIAQVLKLIEDIR 582
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1266), Expect = e-138, Method: Compositional matrix adjust.
Identities = 278/621 (44%), Positives = 384/621 (61%), Gaps = 47/621 (7%)
Query: 26 DLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPI 85
DLN+D+ ALL AV R WN +W GV C NR V + LPG+ +G I
Sbjct: 32 DLNADRTALLSLRSAV-GGRTFRWNIKQTSPCNWAGVKCESNR--VTALRLPGVALSGDI 88
Query: 86 PANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSLQLN 143
P G L L+ LSLR N L+G+LP D+++ S+L+++YLQ N FSG +P F L
Sbjct: 89 PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLV 148
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
L+L+ N+FTG I GF NLT+L L L+NN +SG+IP L+LP ++ N SNN+LNGSIP
Sbjct: 149 RLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLVQ-FNVSNNSLNGSIP 207
Query: 204 DSLQTFPNSSFVGNSMLCGLPLTPC---STVSSSPSPSPSYFP-TISPHKNASRKKLNSG 259
+LQ F + SF+ S LCG PL C TV S P+ + P ++ + +K SG
Sbjct: 208 KNLQRFESDSFLQTS-LCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSG 266
Query: 260 SIIAIAVGGCAVLFLLLALFFLC-CLKKLDRQGSGVLKGKGTAEKPKDFGSGVQEAEKN- 317
IA V GC V F L+ L + C KK +++ V ++P+ G +EA N
Sbjct: 267 GAIAGIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGD--KEAVDNG 324
Query: 318 ----------------------------KLCFLDGSYFNFDLEDLLRASAEVLGKGSYGS 349
KL F + FDLEDLLRASAEVLGKG++G+
Sbjct: 325 NVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGT 384
Query: 350 TYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409
YKA+L+ T V VKRL++V +EF++++E+VG + H N+VP+RAYY+S+DEKL+VY
Sbjct: 385 AYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAM-DHENLVPLRAYYFSRDEKLLVY 443
Query: 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469
+MP GSL LLH NR G + L+W+ R +IA+G ARG+ ++HS+G + +HGNIKSSN+
Sbjct: 444 DFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTST-SHGNIKSSNI 502
Query: 470 LLTQDLNGCISDVGLAHLI-NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528
LLT+ + +SD GLA L+ + T R GYRAPEVT+ ++ SQK DVYSFGV+LLE++
Sbjct: 503 LLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELI 562
Query: 529 TGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMV-QMLQIALSCV 587
TGKAP +++ VDLPRWV+SV R+EW EVFD ELL EEEM+ +M+Q+ L C
Sbjct: 563 TGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECT 622
Query: 588 AKVPDSRPKMDDVVRMIEQIQ 608
++ PD RP+M +VVR +E ++
Sbjct: 623 SQHPDQRPEMSEVVRKMENLR 643
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1255), Expect = e-137, Method: Compositional matrix adjust.
Identities = 282/638 (44%), Positives = 383/638 (60%), Gaps = 66/638 (10%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MK Q+ +++ + +F V T+ DK LL F + + H+ LNW+ + +C+ W
Sbjct: 1 MKCQVVLILIVVIFNVCIEAETI----KEDKHTLLQFVNNINHSHSLNWSPSLSICTKWT 56
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
GVTCN + S V +HL G G I + I +L L+ L L SN ++GT P+ + ++ +L
Sbjct: 57 GVTCNSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNL 116
Query: 121 QYVYLQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG 178
+ L N FSG LP+ S +L LDLS N F G+IP LT LH LNL N SG
Sbjct: 117 TELKLDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSG 176
Query: 179 AIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPS 238
IP L++P LK+LN ++NNL G++P SLQ FP S+FVGN +L +P
Sbjct: 177 EIPDLHIPGLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKVL---------------APV 221
Query: 239 PSYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK 298
S + H N ++ IA+ C + LLA+ + + + Q +
Sbjct: 222 HSSLRKHTKHHNHV--------VLGIALSVCFAILALLAILLVIIIHNREEQR------R 267
Query: 299 GTAEKP----KDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI 354
+ +KP KD V E + NK+ F +G FDLEDLLRASAEVLGKG +G+TYK
Sbjct: 268 SSKDKPSKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVD 326
Query: 355 LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414
LED T+VVKR++EV+ +REFEQQ+E +G+I KH NV +R Y+YSKDEKLVVY Y
Sbjct: 327 LEDSATIVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEH 385
Query: 415 GSLFMLLH-----RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469
GSL LLH R+R L+W +R+ + GTARG+A IHS+ G K HGNIKSSN+
Sbjct: 386 GSLSTLLHGQKGLRDRK----RLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNI 441
Query: 470 LLTQDLNGCISDVGLAHLIN-FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528
L GCIS G+A L++ P A +GYRAPE+T+TRK +Q SDVYSFG+L+ E+L
Sbjct: 442 FLNGKGYGCISGTGMATLMHSLPRHA---VGYRAPEITDTRKGTQPSDVYSFGILIFEVL 498
Query: 529 TGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVA 588
TGK+ +V +L RWV SVVREEWT EVFD ELL+ VEEEMV+MLQ+ + C A
Sbjct: 499 TGKS--------EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTA 550
Query: 589 KVPDSRPKMDDVVRMIEQIQQPELRNRASSGTESNVQT 626
++P+ RP M +VVRM+E+I +PE + +SG S V T
Sbjct: 551 RLPEKRPNMIEVVRMVEEI-RPE---KLASGYRSEVST 584
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 268/626 (42%), Positives = 378/626 (60%), Gaps = 41/626 (6%)
Query: 5 ISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTC 64
I V F ++ V DL D+QALLDF + + H R L WN ++PVC++W GVTC
Sbjct: 8 IFYFVLFLFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTC 67
Query: 65 NVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVY 124
+++ +RV +HLPG G IP +I +L L+ILSLRSN L G P D + L+ +
Sbjct: 68 DIDGTRVTALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAIS 127
Query: 125 LQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP 182
L NN FSG LP+ + L LDL N F G+IP GF NLT L LNL NS SG IP
Sbjct: 128 LGNNRFSGPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPD 187
Query: 183 LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYF 242
LNLP L+ LNFSNNNL GSIP+SL+ F NS+F GN+++ +P P+
Sbjct: 188 LNLPGLRRLNFSNNNLTGSIPNSLKRFGNSAFSGNNLVF------------ENAPPPAVV 235
Query: 243 PTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSG-------VL 295
KN ++ +I+ IA+ C V+F ++A+ + C K R+ L
Sbjct: 236 SFKEQKKNGIY--ISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKL 293
Query: 296 KGKGTAE-------KPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYG 348
K +E K K+ ++E NK+ F +GS F+LEDLL ASAE LGKG +G
Sbjct: 294 AKKMPSEKEVSKLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFG 353
Query: 349 STYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408
TYKA+LED + VKRL+++ ++++F+ QME+VG I KH NV P+RAY SK+EKL+V
Sbjct: 354 MTYKAVLEDSKVIAVKRLKDIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMV 412
Query: 409 YSYMPAGSLFMLLH-RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSS 467
Y Y GSL + LH +N +G L+W +R++ +G A+G+ IH++ A HGNIKSS
Sbjct: 413 YDYDSNGSLSLRLHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQNLA---HGNIKSS 469
Query: 468 NVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVL 523
NV + + GCIS+ GL L N ++A + YRAPEVT+TR+++ +SD+YSFG+L
Sbjct: 470 NVFMNSEGYGCISEAGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGIL 529
Query: 524 LLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIA 583
+LE LTG++ + + +DL WV V+ ++WT EVFD+EL+K +VE +++QMLQ+
Sbjct: 530 MLETLTGRSIMDD--RKEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLG 587
Query: 584 LSCVAKVPDSRPKMDDVVRMIEQIQQ 609
SC A VP RP M VV +E+I++
Sbjct: 588 TSCTAMVPAKRPDMVKVVETLEEIER 613
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 284/618 (45%), Positives = 393/618 (63%), Gaps = 48/618 (7%)
Query: 29 SDKQALLDFADAVPHARKLN-WNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPA 87
+D + LL+F KLN WN C W GV+CN R+RV + L I TG I +
Sbjct: 30 TDSETLLNFKLTADSTGKLNSWNTTTNPCQ-WTGVSCN--RNRVTRLVLEDINLTGSISS 86
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNAL 145
+ L +L++LSL+ N L+G +P +++++++L+ ++L NN FSG P + SL +L L
Sbjct: 87 LT--SLTSLRVLSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRL 143
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDS 205
DLSFN F+G IPP +LT L L L++N SG IP +NL L+ N S NN NG IP+S
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203
Query: 206 LQTFPNSSFVGNSMLCGLPLTPCSTVSSSPS---------PSPSYFPTISP--------- 247
L FP S F N LCG PL C+ +SS P+ SP P P
Sbjct: 204 LSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGG 263
Query: 248 HKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKL---DRQGSGVLKGKGTAEKP 304
K+ + ++++ S+IAI +G +L + L + C ++ ++ S +L+G+
Sbjct: 264 DKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSS 323
Query: 305 KDFGSGVQE--------AEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILE 356
+ + Q +K K+ F +G+ F+LEDLLRASAE+LGKG +G+ YKA+LE
Sbjct: 324 NPYPTSTQNNNNQNQQVGDKGKMVFFEGTR-RFELEDLLRASAEMLGKGGFGTAYKAVLE 382
Query: 357 DGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414
DG V VKRL++ A K+EFEQQMEV+G + +H+N+V ++AYY++++EKL+VY YMP
Sbjct: 383 DGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPN 441
Query: 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA-KFTHGNIKSSNVLLTQ 473
GSLF LLH NR G T LDW +R+KIA G ARG+AFIH K THG+IKS+NVLL +
Sbjct: 442 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDR 501
Query: 474 DLNGCISDVGLAHLINFPT-TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKA 532
N +SD GL+ I P+ T ++ GYRAPE+ + RK +QKSDVYSFGVLLLE+LTGK
Sbjct: 502 SGNARVSDFGLS--IFAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKC 559
Query: 533 P-LQHSGHDD-VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKV 590
P + +GH VDLPRWV+SVVREEWTAEVFD+EL++Y+D+EEEMV +LQIA++C A
Sbjct: 560 PNMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVA 619
Query: 591 PDSRPKMDDVVRMIEQIQ 608
D RPKM VV++IE I+
Sbjct: 620 ADHRPKMGHVVKLIEDIR 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | ||||||
| 224127864 | 630 | predicted protein [Populus trichocarpa] | 1.0 | 0.995 | 0.720 | 0.0 | |
| 224145409 | 636 | predicted protein [Populus trichocarpa] | 0.998 | 0.984 | 0.667 | 0.0 | |
| 359478866 | 637 | PREDICTED: probable inactive receptor ki | 1.0 | 0.984 | 0.660 | 0.0 | |
| 297745748 | 656 | unnamed protein product [Vitis vinifera] | 1.0 | 0.955 | 0.660 | 0.0 | |
| 224126989 | 635 | predicted protein [Populus trichocarpa] | 0.998 | 0.985 | 0.649 | 0.0 | |
| 356537708 | 664 | PREDICTED: probable inactive receptor ki | 0.990 | 0.935 | 0.649 | 0.0 | |
| 255586379 | 635 | Nodulation receptor kinase precursor, pu | 0.979 | 0.966 | 0.666 | 0.0 | |
| 356500954 | 654 | PREDICTED: probable inactive receptor ki | 0.977 | 0.937 | 0.651 | 0.0 | |
| 356570023 | 631 | PREDICTED: probable inactive receptor ki | 0.976 | 0.969 | 0.660 | 0.0 | |
| 356516211 | 642 | PREDICTED: probable inactive receptor ki | 1.0 | 0.976 | 0.645 | 0.0 |
| >gi|224127864|ref|XP_002329196.1| predicted protein [Populus trichocarpa] gi|222870977|gb|EEF08108.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2366), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/630 (72%), Positives = 525/630 (83%), Gaps = 3/630 (0%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MKL S+ +FLF +LP+ P ++ADLNSD+QALLDFA AVPH RKLNWNA+ VC+SW+
Sbjct: 1 MKLLSSISTVVFLFFILPVVPQIIADLNSDRQALLDFAAAVPHIRKLNWNASTSVCTSWV 60
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
G+TCN N + V+ +HLPG+G GPIPAN+IG+L++LKILSLRSN LNG LPSDI S+ SL
Sbjct: 61 GITCNTNGTGVVAVHLPGVGLYGPIPANTIGRLNSLKILSLRSNSLNGKLPSDIPSLPSL 120
Query: 121 QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180
Q++YLQ N FSGV PA SLQLN LDLSFN+FTG+IPP QNLT+L L LQNNSISGAI
Sbjct: 121 QHLYLQQNNFSGVFPALLSLQLNVLDLSFNSFTGSIPPTIQNLTQLTALYLQNNSISGAI 180
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPS 240
P +NLPRLK LN S N NG+IP S Q F SFVGNS+LCGLPL C T+SSSPSPSP+
Sbjct: 181 PDINLPRLKALNLSFNYFNGTIPSSFQKFSYYSFVGNSLLCGLPLKRCPTISSSPSPSPN 240
Query: 241 YF---PTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKG 297
F PT AS KKL S SIIAIA+GG AVLFL++ + F+C LK+ D + VLKG
Sbjct: 241 DFLNPPTKPQSHTASNKKLGSNSIIAIAIGGSAVLFLIIMVIFVCFLKRKDGARNTVLKG 300
Query: 298 KGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILED 357
K +EKPKDFGSGVQEAEKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+LED
Sbjct: 301 KAESEKPKDFGSGVQEAEKNKLFFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLED 360
Query: 358 GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417
GT+VVVKRL+EVAA K+EFEQQMEV+G +G+H N+VP+RAYYYSKDEKL+V++YM AGSL
Sbjct: 361 GTSVVVKRLKEVAAGKKEFEQQMEVIGRVGQHPNIVPLRAYYYSKDEKLLVHNYMSAGSL 420
Query: 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477
LH NR+ G T+LDWN+R+KI LGTARGIA IHSEGGAKF HGNIK+SNVLLT DL+G
Sbjct: 421 SAFLHGNRAGGRTSLDWNARVKICLGTARGIARIHSEGGAKFFHGNIKASNVLLTPDLDG 480
Query: 478 CISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537
CISDVGLA L+NFPTT RTIGYRAPEV ETRKASQKSDVYSFGVLLLEMLTGKAPLQ
Sbjct: 481 CISDVGLAPLMNFPTTMYRTIGYRAPEVIETRKASQKSDVYSFGVLLLEMLTGKAPLQVP 540
Query: 538 GHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKM 597
GHD VVDLPRWVRSVVREEWTAEVFDVEL+++Q++EEEMVQMLQIAL+CVAK PD RPKM
Sbjct: 541 GHDSVVDLPRWVRSVVREEWTAEVFDVELVRHQNIEEEMVQMLQIALACVAKAPDMRPKM 600
Query: 598 DDVVRMIEQIQQPELRNRASSGTESNVQTP 627
D+VVRMIE+IQ + +NR+SS ESNVQTP
Sbjct: 601 DEVVRMIEEIQHSDSKNRSSSDAESNVQTP 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145409|ref|XP_002325632.1| predicted protein [Populus trichocarpa] gi|222862507|gb|EEF00014.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/637 (66%), Positives = 502/637 (78%), Gaps = 11/637 (1%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MK+ + V+ F+ + IFP ADL SDKQALLDFA AVPH RKLNWN A+ VC+SW+
Sbjct: 1 MKIFLGSVIYFFIILTI-IFPFAFADLKSDKQALLDFATAVPHLRKLNWNPASSVCNSWV 59
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
GVTCN NR+RV + LPG+G G IP N++GKLDAL++LSLRSN L G LPSDITS+ SL
Sbjct: 60 GVTCNSNRTRVSQLRLPGVGLVGHIPPNTLGKLDALRVLSLRSNVLEGDLPSDITSLPSL 119
Query: 121 QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180
++LQ+N FSG +P SLQLN LDLSFN+FTGNIP NLT+L L+LQNN++SG I
Sbjct: 120 TNLFLQHNNFSGGIPTSFSLQLNVLDLSFNSFTGNIPQTLANLTQLIGLSLQNNTLSGPI 179
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPS 240
P LN R+K LN S N+LNGSIP SLQ FPNSSF+GNS+LCG PL PCS V PSPSP+
Sbjct: 180 PDLNHTRIKRLNLSYNHLNGSIPVSLQNFPNSSFIGNSLLCGPPLNPCSPVIRPPSPSPA 239
Query: 241 YFPTIS-PHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK- 298
Y P + P K +S+ KL G+IIAIAVGG AVLFL++ CCLKK D GS VLKGK
Sbjct: 240 YIPPPTVPRKRSSKVKLTMGAIIAIAVGGSAVLFLVVLTILCCCLKKKDNGGSSVLKGKA 299
Query: 299 ---GTAEKPKD-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI 354
G EKPK+ FGSGVQE EKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+
Sbjct: 300 VSSGRGEKPKEEFGSGVQEHEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 359
Query: 355 LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414
LE+ TTVVVKRLREV KR+FEQQME VG +G+H N+VP+RAYYYSKDEKL+VY Y+P
Sbjct: 360 LEESTTVVVKRLREVVMGKRDFEQQMENVGRVGQHPNIVPLRAYYYSKDEKLLVYDYIPG 419
Query: 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474
GSL LLH NR G T LDW+SR+KIALGTARGI+ +HS GG KFTHGNIKS+NVLL+QD
Sbjct: 420 GSLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSVGGPKFTHGNIKSTNVLLSQD 479
Query: 475 LNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+GCISD GL L+N P T++R+ GYRAPEV ETRK + KSDVYSFGV+LLEMLTGKAP+
Sbjct: 480 HDGCISDFGLTPLMNVPATSSRSAGYRAPEVIETRKHTHKSDVYSFGVVLLEMLTGKAPI 539
Query: 535 QHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR 594
Q G DD+VDLPRWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQI ++CVAKVPD R
Sbjct: 540 QSPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMR 599
Query: 595 PKMDDVVRMIEQIQQPELRNRASS----GTESNVQTP 627
P M++VVRMIE+I+Q + NR SS +SNVQTP
Sbjct: 600 PNMEEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 636
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478866|ref|XP_002276162.2| PREDICTED: probable inactive receptor kinase At5g58300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/637 (66%), Positives = 500/637 (78%), Gaps = 10/637 (1%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MKL + +V +FLF + + P +ADL++DKQALLDFADAVPH RKLNWN++ PVC+SW+
Sbjct: 1 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 60
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
G+ C + SRV + LPGIG TG IPA ++GKLDAL+ILSLRSN L G LPSDI S+ SL
Sbjct: 61 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 120
Query: 121 QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180
QY++LQ+N FSG +PA S QL LDLSFN+FTGNIP NLT+L LNLQNNS+SGAI
Sbjct: 121 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 180
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCS-TVSSSPSPSP 239
P +N +LK LN S NNLNGSIP SLQ FPNSSFVGNS+LCG PL CS T S
Sbjct: 181 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 240
Query: 240 SYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK- 298
P ++ K S+KKL+ G IIAIAVGG VLFL++ + FLCCL+K D +GSGV KGK
Sbjct: 241 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 300
Query: 299 ---GTAEKPKD-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI 354
G +EKPK+ FGSGVQE +KNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+
Sbjct: 301 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 360
Query: 355 LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414
LE+ TTVVVKRL+EV KR+FEQQM++VG +G+H NVVP+RAYYYSKDEKL+VY Y+
Sbjct: 361 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 420
Query: 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474
GSL LLH NR G + LDWN+R+KI+LG ARGI IHS GG KFTHGNIKSSNVLL QD
Sbjct: 421 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 480
Query: 475 LNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
GCISD GL L+NFP T++R GYRAPEV E+RK + KSDVYSFGVLLLEMLTGKAPL
Sbjct: 481 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 540
Query: 535 QHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR 594
Q G DD+VDLPRWV+SVVREEWTAEVFD+EL++YQ++EEEMVQMLQ+A++CVAKVPD R
Sbjct: 541 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 600
Query: 595 PKMDDVVRMIEQIQQPELRNRASS----GTESNVQTP 627
P MD+VVRMIE+I+Q + NR SS +SNVQTP
Sbjct: 601 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745748|emb|CBI15804.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/637 (66%), Positives = 500/637 (78%), Gaps = 10/637 (1%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MKL + +V +FLF + + P +ADL++DKQALLDFADAVPH RKLNWN++ PVC+SW+
Sbjct: 20 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 79
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
G+ C + SRV + LPGIG TG IPA ++GKLDAL+ILSLRSN L G LPSDI S+ SL
Sbjct: 80 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 139
Query: 121 QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180
QY++LQ+N FSG +PA S QL LDLSFN+FTGNIP NLT+L LNLQNNS+SGAI
Sbjct: 140 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 199
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCS-TVSSSPSPSP 239
P +N +LK LN S NNLNGSIP SLQ FPNSSFVGNS+LCG PL CS T S
Sbjct: 200 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 259
Query: 240 SYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK- 298
P ++ K S+KKL+ G IIAIAVGG VLFL++ + FLCCL+K D +GSGV KGK
Sbjct: 260 FPSPPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAKGKA 319
Query: 299 ---GTAEKPKD-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI 354
G +EKPK+ FGSGVQE +KNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+
Sbjct: 320 SGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 379
Query: 355 LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414
LE+ TTVVVKRL+EV KR+FEQQM++VG +G+H NVVP+RAYYYSKDEKL+VY Y+
Sbjct: 380 LEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDYVSG 439
Query: 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474
GSL LLH NR G + LDWN+R+KI+LG ARGI IHS GG KFTHGNIKSSNVLL QD
Sbjct: 440 GSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLLNQD 499
Query: 475 LNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
GCISD GL L+NFP T++R GYRAPEV E+RK + KSDVYSFGVLLLEMLTGKAPL
Sbjct: 500 FEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGKAPL 559
Query: 535 QHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR 594
Q G DD+VDLPRWV+SVVREEWTAEVFD+EL++YQ++EEEMVQMLQ+A++CVAKVPD R
Sbjct: 560 QSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVPDMR 619
Query: 595 PKMDDVVRMIEQIQQPELRNRASS----GTESNVQTP 627
P MD+VVRMIE+I+Q + NR SS +SNVQTP
Sbjct: 620 PSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 656
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126989|ref|XP_002319979.1| predicted protein [Populus trichocarpa] gi|222858355|gb|EEE95902.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/636 (64%), Positives = 496/636 (77%), Gaps = 10/636 (1%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWI 60
MK + V+ +F+ + IFP ++DL SDKQALLDFA VPH+RKLNWN A+ VC SW+
Sbjct: 1 MKFFRASVIHLFIILTI-IFPFAISDLKSDKQALLDFAAVVPHSRKLNWNPASLVCKSWV 59
Query: 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL 120
GVTCN N +RV+ + LPG+G G +P N++GKLDAL LSLRSN L G LPSD+TS+ SL
Sbjct: 60 GVTCNSNDTRVVELRLPGVGLLGHVPPNTLGKLDALNTLSLRSNVLEGDLPSDVTSLPSL 119
Query: 121 QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180
Q ++LQ+N FSG +P SL+LN LDLSFN+FTGNIP NLT+L L+LQNN++SG I
Sbjct: 120 QNLFLQHNNFSGGVPTSFSLKLNVLDLSFNSFTGNIPQTIANLTQLTGLSLQNNALSGPI 179
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPS 240
P LN R+K LN S N+LNGSIP SLQ FPNSSF+GNS+LCG PL PCS V P
Sbjct: 180 PDLNHTRIKHLNLSYNHLNGSIPVSLQKFPNSSFIGNSLLCGPPLNPCSIVLPPPPSPAY 239
Query: 241 YFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK-- 298
P + HK +S+ KL G+IIAIAVGG AVLFL++ + F CCLKK D +G GVLKGK
Sbjct: 240 TPPPATSHKRSSKLKLTMGAIIAIAVGGSAVLFLVVLIVFCCCLKKKDNEGPGVLKGKAV 299
Query: 299 --GTAEKPK-DFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAIL 355
G EKPK DFGSGVQE+EKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+L
Sbjct: 300 SSGRGEKPKEDFGSGVQESEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVL 359
Query: 356 EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415
E+ TTVVVKRL+EV KR+FEQQME+ G +G+H NVVP+RAYYYSKDE+L+VY Y+P G
Sbjct: 360 EESTTVVVKRLKEVVVGKRDFEQQMEIAGRVGQHPNVVPLRAYYYSKDERLLVYDYIPGG 419
Query: 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL 475
SL LLH NR G T LDW+SR+KIALGTARGI+ +HS GG KFTHGNIKSSNVLL+QD
Sbjct: 420 SLSTLLHANRGAGRTPLDWDSRVKIALGTARGISHLHSAGGPKFTHGNIKSSNVLLSQDH 479
Query: 476 NGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
+GCISD GL L+N P +++R+ GYRAPEV ET K S KSDVYSFGV+LLEMLTGKAP+Q
Sbjct: 480 DGCISDFGLTPLMNVPASSSRSAGYRAPEVIETSKHSHKSDVYSFGVILLEMLTGKAPIQ 539
Query: 536 HSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP 595
DD+VDLPRWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQI ++CVAKVPD RP
Sbjct: 540 SPRRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMRP 599
Query: 596 KMDDVVRMIEQIQQPELRNRASS----GTESNVQTP 627
M++VVRMIE+I+Q + NR SS +SNV TP
Sbjct: 600 NMEEVVRMIEEIRQSDSENRPSSEGNKSKDSNVHTP 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/631 (64%), Positives = 501/631 (79%), Gaps = 10/631 (1%)
Query: 6 SMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCN 65
S V FLF ++ FP +ADL+SDKQALL+FA+AVPH R L WN + VCSSW+G+TCN
Sbjct: 35 STSVASFLFVIVIFFPLAIADLSSDKQALLNFANAVPHRRNLMWNPSTSVCSSWVGITCN 94
Query: 66 VNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYL 125
NR+RV+ + LPG+G G IP+N++GKLDA+KI+SLRSN L+G LP+DI S+ SLQY+YL
Sbjct: 95 ENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLLSGNLPADIGSLPSLQYLYL 154
Query: 126 QNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNL 185
Q+N SG +PA S QL LDLS+N+FTG IP FQN++ L LNLQNNS+SG IP LN+
Sbjct: 155 QHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVLTSLNLQNNSLSGQIPNLNV 214
Query: 186 PRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTI 245
LK+LN S N+LNGSIP +L+ FPNSSF GNS+LCG PL PCS V +PSP+ + P+
Sbjct: 215 TLLKLLNLSYNHLNGSIPKALEIFPNSSFEGNSLLCGPPLKPCSAVPPTPSPASTPPPST 274
Query: 246 SPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKGTA---- 301
+ + +S+ KL+ +II IAVGG VLF + +F +CCLKK D +GS V+KGKG +
Sbjct: 275 T-GRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKEDNRGSNVIKGKGPSGGRG 333
Query: 302 EKPKD-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTT 360
EKPK+ FGSGVQE EKNKL F +GS +NFDLEDLLRASAEVLGKGSYG+ YKAILE+ T
Sbjct: 334 EKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILEESMT 393
Query: 361 VVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML 420
VVVKRL+EV K++FEQQME++G +G+H+NVVP+RAYYYSKDEKL+VY Y+P G+L L
Sbjct: 394 VVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGNLHTL 453
Query: 421 LHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480
LH R+ G T LDW+SR+KI+LGTA+G+A IHS GG KFTHGNIKSSNVLL QD +GCIS
Sbjct: 454 LHGGRTGGRTPLDWDSRIKISLGTAKGLAHIHSVGGPKFTHGNIKSSNVLLNQDNDGCIS 513
Query: 481 DVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
D GLA L+N P T +R GYRAPEV ETRK S KSDVYSFGVLLLEMLTGKAPLQ G D
Sbjct: 514 DFGLAPLMNVPATPSRAAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQSPGRD 573
Query: 541 DVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
D+VDLPRWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQIA++CVAK+PD RP MD+
Sbjct: 574 DMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPSMDEA 633
Query: 601 VRMIEQIQQPELRNRASS----GTESNVQTP 627
VRMIE+I+Q + NR SS +SNVQTP
Sbjct: 634 VRMIEEIRQSDSENRPSSEENKSKDSNVQTP 664
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586379|ref|XP_002533837.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223526229|gb|EEF28551.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/627 (66%), Positives = 495/627 (78%), Gaps = 13/627 (2%)
Query: 11 IFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSR 70
I LFT +F +ADLNSDKQALL+F+ A+PH R LNWN A+ +C SW+GVTCN +++R
Sbjct: 12 IVLFT---LFSLAIADLNSDKQALLNFSAAIPHYRLLNWNPASSICKSWVGVTCNPSQTR 68
Query: 71 VIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYF 130
V+ + LPG+GF G IPAN++GKLDAL++LSLRSN L G LPSD+TS+ SL+ +YLQ+N F
Sbjct: 69 VLELRLPGVGFIGQIPANTLGKLDALRVLSLRSNLLYGNLPSDVTSLPSLRNLYLQHNNF 128
Query: 131 SGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKI 190
S +P S QLN LDLSFN+F+G+IP NLT+L L+LQNN++SGAIP LN RL+
Sbjct: 129 SSTIPTSFSSQLNVLDLSFNSFSGSIPQTIANLTQLTGLSLQNNTLSGAIPDLNQSRLRH 188
Query: 191 LNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTISP-HK 249
LN S N+LNGS+P SLQ FPNSSF GNS+LCGLPL PCS + S PSPSP+ P HK
Sbjct: 189 LNLSYNHLNGSVPFSLQKFPNSSFTGNSLLCGLPLNPCSPILSPPSPSPASSPPPEMPHK 248
Query: 250 NASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGK----GTAEKPK 305
S+ KL G+IIAIAVGG AVLFL++ + CCLKK D GS VLKGK G EKPK
Sbjct: 249 KGSKAKLTLGAIIAIAVGGFAVLFLIVVIILCCCLKKKDNGGSSVLKGKAVSSGRGEKPK 308
Query: 306 D-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVK 364
+ FGSGVQE EKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+LE+ TTVVVK
Sbjct: 309 EEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVK 368
Query: 365 RLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRN 424
RL+EV KREFEQQME+VG +G+H NVVP+RAYYYSKDEKL+VY Y+ GSL LLH N
Sbjct: 369 RLKEVVVGKREFEQQMEIVGRVGQHQNVVPLRAYYYSKDEKLLVYDYIQGGSLSTLLHGN 428
Query: 425 RSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484
R G T LDW++R+KIALGTARGIA +HS GG KFTHGNIKSSNVLL QD +GCISD GL
Sbjct: 429 RQAGRTPLDWDNRVKIALGTARGIAHLHSAGGPKFTHGNIKSSNVLLNQDHDGCISDFGL 488
Query: 485 AHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
L+N P T +R+ GYRAPEV ETRK + KSDVYSFGVLLLEMLTGKAPLQ DD+VD
Sbjct: 489 TPLMNVPATPSRSAGYRAPEVIETRKHTHKSDVYSFGVLLLEMLTGKAPLQSPSRDDMVD 548
Query: 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
LPRWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQI ++CVAKVPD RP MD+VVRMI
Sbjct: 549 LPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVVRMI 608
Query: 605 EQIQQPELRNRASS----GTESNVQTP 627
E+I+Q + NR SS +SNVQTP
Sbjct: 609 EEIRQSDSENRPSSEENKSKDSNVQTP 635
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500954|ref|XP_003519295.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/626 (65%), Positives = 493/626 (78%), Gaps = 13/626 (2%)
Query: 12 FLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRV 71
FLF ++ +FP +ADL+SDKQALLDFA AVPH R L WN A P+CSSW+G+TCN N +RV
Sbjct: 32 FLFIIVILFPLAIADLSSDKQALLDFAAAVPHRRNLKWNPATPICSSWVGITCNPNGTRV 91
Query: 72 IGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS 131
+ + LPGIG G IPAN++GK+D+L+ +SLR+N L+G+LP DITS+ SLQY+YLQ+N S
Sbjct: 92 VSVRLPGIGLVGTIPANTLGKIDSLRNISLRANLLSGSLPPDITSLPSLQYLYLQHNNLS 151
Query: 132 GVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKIL 191
G +P S +LN LDLS+N+F+G IP QN+T+L LNLQNNS+SG IP LN+ +L+ L
Sbjct: 152 GSVPTSLSTRLNVLDLSYNSFSGAIPKTLQNITQLIKLNLQNNSLSGQIPNLNVTKLRHL 211
Query: 192 NFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTISPHKNA 251
N S N+LNGSIPD+LQ FPNSSF GNS LCGLPL CS VSS+P PS P+ +P +++
Sbjct: 212 NLSYNHLNGSIPDALQIFPNSSFEGNS-LCGLPLKSCSVVSSTP-PSTPVSPS-TPARHS 268
Query: 252 SRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKG----TAEKPKD- 306
S+ KL+ +IIAIAVGG +L L+ + LCCLKK D + V KGKG +EKPK+
Sbjct: 269 SKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCLKKKDDRSPSVTKGKGPSGGRSEKPKEE 328
Query: 307 FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRL 366
FGSGVQE EKNKL F +GS +NFDLEDLLRASAEVLGKGSYG+ YKAILE+ TTVVVKRL
Sbjct: 329 FGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILEESTTVVVKRL 388
Query: 367 REVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS 426
+EV KREFEQQME+VG +G H NVVP+RAYYYSKDEKL+VY Y+P+G+L LLH NR+
Sbjct: 389 KEVVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSKDEKLLVYDYIPSGNLSTLLHGNRA 448
Query: 427 DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486
G T LDWNSR+KI++G ARGIA IHS GG KFTHGN+KSSNVLL D +GCISD GL
Sbjct: 449 SGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFTHGNVKSSNVLLNHDNDGCISDFGLTP 508
Query: 487 LINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP 546
L+N P T +R GYRAPEV ETRK + KSDVYSFG+LLLEMLTGKAP Q G DD+VDLP
Sbjct: 509 LMNVPATPSRAAGYRAPEVIETRKHTHKSDVYSFGILLLEMLTGKAPQQSPGRDDMVDLP 568
Query: 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606
RWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQIA++CVAKVPD RP MD+VVRMIE+
Sbjct: 569 RWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKVPDMRPSMDEVVRMIEE 628
Query: 607 IQQPELRNRAS-----SGTESNVQTP 627
I+ + NR S S ES QTP
Sbjct: 629 IRLSDSENRPSSEENRSKEESAAQTP 654
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570023|ref|XP_003553192.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/618 (66%), Positives = 495/618 (80%), Gaps = 6/618 (0%)
Query: 6 SMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCN 65
S V FLF ++ +FP +ADL+SDKQALLDFA+AVPH R L WN + VC+SW+G+TCN
Sbjct: 5 STSVASFLFVIVILFPLAIADLSSDKQALLDFANAVPHRRNLMWNPSTSVCTSWVGITCN 64
Query: 66 VNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYL 125
NR+RV+ + LPG+G G IP+N++GKL A+KI+SLRSN L+G LP+DI S+ SLQY+YL
Sbjct: 65 ENRTRVVKVRLPGVGLVGTIPSNTLGKLGAVKIISLRSNLLSGNLPADIGSLPSLQYLYL 124
Query: 126 QNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNL 185
Q+N SG +PA SLQL LDLS+N+FTG IP FQNL+ L LNLQNNS+SG IP LN+
Sbjct: 125 QHNNLSGDIPASLSLQLVVLDLSYNSFTGVIPTTFQNLSELTSLNLQNNSLSGQIPNLNV 184
Query: 186 PRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTI 245
LK+LN S N LNGSIP +LQ FPNSSF GNS+LCG PL PCS V +PSPS + +
Sbjct: 185 NLLKLLNLSYNQLNGSIPKALQIFPNSSFEGNSLLCGPPLKPCSVVPPTPSPSSTPPQST 244
Query: 246 SPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKGTA---- 301
+ +S+ KL+ +IIAIAVGG VLF + +FF+CCLKK D +GS V+KGKG +
Sbjct: 245 P-GRQSSKNKLSKIAIIAIAVGGAVVLFFVALVFFICCLKKEDDRGSNVIKGKGPSGGRG 303
Query: 302 EKPKD-FGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTT 360
EKPK+ FGSGVQE EKNKL F +GS +NFDLEDLLRASAEVLGKGSYG+ YKAILE+ T
Sbjct: 304 EKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILEESMT 363
Query: 361 VVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML 420
VVVKRL+EV K++FEQQME++G +G+H+NVVP+RAYYYSKDEKL+VY Y+P G+L L
Sbjct: 364 VVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGGNLHTL 423
Query: 421 LHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480
LH R+ G T LDW+SR+KI+LGTA+G+A +HS GG KFTHGNIKSSNVLL QD +GCIS
Sbjct: 424 LHGGRTGGRTPLDWDSRIKISLGTAKGLAHVHSVGGPKFTHGNIKSSNVLLNQDNDGCIS 483
Query: 481 DVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
D GLA L+N P T +RT GYRAPEV E RK S KSDVYSFGVLLLEMLTGKAPLQ G D
Sbjct: 484 DFGLAPLMNVPATPSRTAGYRAPEVIEARKHSHKSDVYSFGVLLLEMLTGKAPLQSPGRD 543
Query: 541 DVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
D+VDLPRWV+SVVREEWTAEVFDVEL++YQ++EEEMVQMLQIA++CVAK+PD RP MD+V
Sbjct: 544 DMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRPSMDEV 603
Query: 601 VRMIEQIQQPELRNRASS 618
VRMIE+I+Q + NR SS
Sbjct: 604 VRMIEEIRQSDSENRPSS 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516211|ref|XP_003526789.1| PREDICTED: probable inactive receptor kinase At5g58300-like isoform 1 [Glycine max] gi|356516213|ref|XP_003526790.1| PREDICTED: probable inactive receptor kinase At5g58300-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/640 (64%), Positives = 505/640 (78%), Gaps = 13/640 (2%)
Query: 1 MKLQISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNA-AAPVCSSW 59
MK+Q S+V + L + L + +VADLNSD+QALL+FA +VPHA +LNW + +C+SW
Sbjct: 1 MKVQFSIVALVLLGSTLCLSGLIVADLNSDQQALLEFASSVPHAPRLNWKKDSVSICTSW 60
Query: 60 IGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISS 119
+GVTCN N +RV+G+HLPG+G G IP NSIGKLDAL++LSL SN L G+LPS+I SI S
Sbjct: 61 VGVTCNSNGTRVVGLHLPGMGLIGTIPENSIGKLDALRVLSLHSNGLIGSLPSNILSIPS 120
Query: 120 LQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA 179
LQ+ YLQ+N FSG++P+ + +L ALD+SFN F+G+IPP FQNL RL L LQNNSISGA
Sbjct: 121 LQFAYLQHNGFSGIIPSPVTPKLMALDISFNNFSGSIPPAFQNLRRLTWLYLQNNSISGA 180
Query: 180 IPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSP 239
IP NLP LK LN SNNNLNGSIP+S++TFP +SFVGNS+LCG PL CST+S SPSP+
Sbjct: 181 IPDFNLPSLKHLNLSNNNLNGSIPNSIKTFPYTSFVGNSLLCGPPLNHCSTISPSPSPAT 240
Query: 240 SYFPTISP---HKNASRKKLNSG--SIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGS-G 293
Y P P ++NA+ K N G +I+A+ +G A + L++ + + CLKK S G
Sbjct: 241 DYQPLTPPTTQNQNATHHKKNFGLATILALVIGVIAFISLIVVVICVFCLKKKKNSKSSG 300
Query: 294 VLKGK----GTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGS 349
+LKGK G E K FGSGVQ AEKNKL F +GS +FDLEDLL+ASAEVLGKGSYG+
Sbjct: 301 ILKGKASCAGKTEVSKSFGSGVQGAEKNKLFFFEGSSHSFDLEDLLKASAEVLGKGSYGT 360
Query: 350 TYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409
YKA+LE+GTTVVVKRL+EV K+EFEQQ+E+VG +G H NV+P+RAYYYSKDEKL+VY
Sbjct: 361 AYKAVLEEGTTVVVKRLKEVVVGKKEFEQQLEIVGRVGSHPNVMPLRAYYYSKDEKLLVY 420
Query: 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469
+YMP GSLF LLH NR G T LDW+SR+KI LG A+GIAFIHSEGG KF HGNIKS+NV
Sbjct: 421 NYMPGGSLFFLLHGNRGAGRTPLDWDSRVKILLGAAKGIAFIHSEGGPKFAHGNIKSTNV 480
Query: 470 LLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT 529
L+ Q+L+GCISDVGL L+N P T +R GYRAPEVT+++K + KSDVYSFGVLLLEMLT
Sbjct: 481 LINQELDGCISDVGLPPLMNTPATMSRANGYRAPEVTDSKKITHKSDVYSFGVLLLEMLT 540
Query: 530 GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAK 589
GK PL++ G++DVVDLPRWVRSVVREEWTAEVFD ELL+ Q VEEEMVQMLQIAL+CVAK
Sbjct: 541 GKTPLRYPGYEDVVDLPRWVRSVVREEWTAEVFDEELLRGQYVEEEMVQMLQIALACVAK 600
Query: 590 VPDSRPKMDDVVRMIEQIQQPELRN--RASSGTESNVQTP 627
PD RP+MD VVRM+E+I+ PEL+N R SS +ESNVQTP
Sbjct: 601 GPDQRPRMDQVVRMLEEIKHPELKNYHRQSSESESNVQTP 640
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | ||||||
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.985 | 0.944 | 0.561 | 5.5e-180 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.972 | 0.953 | 0.553 | 3.8e-172 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.974 | 0.954 | 0.545 | 1e-169 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.497 | 0.474 | 0.604 | 7.7e-146 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.535 | 0.526 | 0.559 | 6.9e-145 | |
| TAIR|locus:2024517 | 587 | AT1G64210 [Arabidopsis thalian | 0.497 | 0.531 | 0.518 | 5.4e-130 | |
| TAIR|locus:2154227 | 601 | AT5G53320 [Arabidopsis thalian | 0.494 | 0.515 | 0.529 | 5.5e-128 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.497 | 0.465 | 0.560 | 2.4e-125 | |
| TAIR|locus:2178712 | 614 | AT5G24100 [Arabidopsis thalian | 0.480 | 0.490 | 0.461 | 2.4e-123 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.491 | 0.470 | 0.510 | 5.1e-123 |
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1747 (620.0 bits), Expect = 5.5e-180, P = 5.5e-180
Identities = 350/623 (56%), Positives = 438/623 (70%)
Query: 5 ISMVVPIFLFTVLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTC 64
+S + FLF +ADLNSD+QALL FA +VPH R+LNWN+ +C SW+GVTC
Sbjct: 23 LSTCLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTC 82
Query: 65 NVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVY 124
+ + V + LPGIG GPIP N++GKL++L+ILSLRSN L+G LP DI S+ SL Y+Y
Sbjct: 83 TSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIY 142
Query: 125 LQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLN 184
LQ+N FSG +P+F S QLN LDLSFN+FTG IP FQNL +L L+LQNN +SG +P L+
Sbjct: 143 LQHNNFSGEVPSFVSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLD 202
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLXXXXXXXXX---XXXXXXXXX 241
L+ LN SNN+LNGSIP +L FP+SSF GN++LCGL
Sbjct: 203 TVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTP 262
Query: 242 XXXXXXHKNASRKKLNSGSIIAIXXXXXXXXXXXXXXXXXXXXXXXDRQGSGVLKGKGTA 301
HK S++KL+ +II I D++ ++K K
Sbjct: 263 PLPPFPHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTLT 322
Query: 302 EKPK-DFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTT 360
EK K +FGSGVQE EKNKL F +G +NFDLEDLLRASAEVLGKGSYG+ YKA+LE+ TT
Sbjct: 323 EKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTT 382
Query: 361 VVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML 420
VVVKRL+EVAA KREFEQQME++ +G H +VVP+RAYYYSKDEKL+V Y PAG+L L
Sbjct: 383 VVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSL 442
Query: 421 LHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480
LH NR T LDW+SR+KI L A+GIA +H+ GG KF+HGNIKSSNV++ Q+ + CIS
Sbjct: 443 LHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACIS 502
Query: 481 DVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
D GL L+ P R GYRAPEV ETRK + KSDVYSFGVL+LEMLTGK+P+Q D
Sbjct: 503 DFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRD 562
Query: 541 DVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
D+VDLPRWV+SVVREEWT+EVFD+EL+++Q++EEEMVQMLQIA++CVA+VP+ RP MDDV
Sbjct: 563 DMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDV 622
Query: 601 VRMIEQIQQPELRN-RASSGTES 622
VRMIE+I+ + R SS S
Sbjct: 623 VRMIEEIRVSDSETTRPSSDDNS 645
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1673 (594.0 bits), Expect = 3.8e-172, P = 3.8e-172
Identities = 347/627 (55%), Positives = 437/627 (69%)
Query: 8 VVPIFLFTVLPIFPT--VVADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCN 65
++ FLF ++ F + + AD+ SDKQALL+FA VPH+RKLNWN+ P+C+SW G+TC+
Sbjct: 4 IIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCS 63
Query: 66 VNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYL 125
N +RV + LPG G GP+P + KLDAL+I+SLRSN+L G +PS I S+ ++ +Y
Sbjct: 64 KNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYF 123
Query: 126 QNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNL 185
N FSG +P S +L LDLS N+ +GNIP QNLT+L L+LQNNS+SG IP L
Sbjct: 124 HENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLP- 182
Query: 186 PRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLXXX----XXXXXXXXXXXXXXX 241
PRLK LN S NNLNGS+P S+++FP SSF GNS+LCG
Sbjct: 183 PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEG 242
Query: 242 XXXXXXHKNASRKKLNSGSIIAIXXXXXXXXXXXXXXXXXXXXXXXD--RQGSGVLKGK- 298
+ ++K L++G+I+ I D + + V K K
Sbjct: 243 PGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKP 302
Query: 299 GTAE-KPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILED 357
G ++ K ++FGSGVQEAEKNKL F +GS +NFDLEDLLRASAEVLGKGSYG+TYKAILE+
Sbjct: 303 GRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE 362
Query: 358 GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417
GTTVVVKRL+EVAA KREFEQQME VG I H NV P+RAYY+SKDEKL+VY Y G+
Sbjct: 363 GTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNF 422
Query: 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477
MLLH N G ALDW +R++I L ARGI+ IHS GAK HGNIKS NVLLTQ+L+
Sbjct: 423 SMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHV 482
Query: 478 CISDVGLAHLINFPTTA-TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
C+SD G+A L++ T +R++GYRAPE ETRK +QKSDVYSFGVLLLEMLTGKA +
Sbjct: 483 CVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKT 542
Query: 537 SGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ-DVEEEMVQMLQIALSCVAKVPDSRP 595
+GH++VVDLP+WV+SVVREEWT EVFDVEL+K Q +VEEEMVQMLQIA++CV+K PDSRP
Sbjct: 543 TGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRP 602
Query: 596 KMDDVVRMIEQIQQ----PELRNRASS 618
M++VV M+E+I+ P NRASS
Sbjct: 603 SMEEVVNMMEEIRPSGSGPGSGNRASS 629
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1650 (585.9 bits), Expect = 1.0e-169, P = 1.0e-169
Identities = 349/640 (54%), Positives = 438/640 (68%)
Query: 6 SMVVPIFLFTVLPIFPTVV-ADLNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTC 64
+ V F F +L +V ADL SD+QALL+FA +VPH KLNWN +CSSWIG+TC
Sbjct: 7 AFVAASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITC 66
Query: 65 NVNR--SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQY 122
+ + SRV+ + LPG+G G IP ++GKLDALK+LSLRSN L GTLPSDI S+ SL+Y
Sbjct: 67 DESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEY 126
Query: 123 VYLQNNYFSGVL-----PAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS 177
+YLQ+N FSG L P+ S QL LDLS+N+ +GNIP G +NL+++ +L LQNNS
Sbjct: 127 LYLQHNNFSGELTTNSLPSI-SKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFD 185
Query: 178 GAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLXXXXXXXXXXXXXX 237
G I L+LP +K++N S NNL+G IP+ L+ P SF+GNS+LCG
Sbjct: 186 GPIDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSS 245
Query: 238 XXXXXXXXXXHKNASRKKLNSGSIIAIXXXXXXXXXXXXXXXXXXXXXXXDRQ---GSGV 294
H R++ + IIAI ++ G GV
Sbjct: 246 NLPRPLTENLHP--VRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGV 303
Query: 295 LKGKG--TAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYK 352
G ++KP+DFGSGVQ+ EKNKL F + NFDLEDLL+ASAEVLGKGS+G+ YK
Sbjct: 304 RTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYK 363
Query: 353 AILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412
A+LED T VVVKRLREV A+K+EFEQQME+VG I +HSN VP+ AYYYSKDEKL+VY YM
Sbjct: 364 AVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYM 423
Query: 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472
GSLF ++H NR D G +DW +RMKIA GT++ I+++HS KF HG+IKSSN+LLT
Sbjct: 424 TKGSLFGIMHGNRGDRG--VDWETRMKIATGTSKAISYLHS---LKFVHGDIKSSNILLT 478
Query: 473 QDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKA 532
+DL C+SD L L N PT RTIGY APEV ETR+ SQ+SDVYSFGV++LEMLTGK
Sbjct: 479 EDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKT 538
Query: 533 PLQHSGHDD---VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAK 589
PL G +D V+DLPRWVRSVVREEWTAEVFDVELLK+Q++EEEMVQMLQ+AL+CVA+
Sbjct: 539 PLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVAR 598
Query: 590 VPDSRPKMDDVVRMIEQI----QQPELR-NRASSGTESNV 624
P+SRPKM++V RMIE + Q +L+ NR SS SNV
Sbjct: 599 NPESRPKMEEVARMIEDVRRLDQSQQLQQNRTSSEATSNV 638
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.7e-146, Sum P(2) = 7.7e-146
Identities = 194/321 (60%), Positives = 246/321 (76%)
Query: 313 EAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT 372
E E+NKL F +G ++FDLEDLLRASAEVLGKGS G++YKA+LE+GTTVVVKRL++V A+
Sbjct: 328 ETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMAS 387
Query: 373 KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTAL 432
K+EFE QMEVVG I KH NV+P+RAYYYSKDEKL+V+ +MP GSL LLH +R G T L
Sbjct: 388 KKEFETQMEVVGKI-KHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPL 446
Query: 433 DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492
DW++RM+IA+ ARG+A +H AK HGNIK+SN+LL + + C+SD GL L + +
Sbjct: 447 DWDNRMRIAITAARGLAHLHVS--AKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSS 504
Query: 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
R GY APEV ETRK + KSDVYSFGVLLLE+LTGK+P Q S ++ +DLPRWV SV
Sbjct: 505 PPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSV 564
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE- 611
VREEWTAEVFDVEL++Y ++EEEMVQ+LQIA++CV+ VPD RP M +V+RMIE + + E
Sbjct: 565 VREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRSET 624
Query: 612 ----LRNRASSGTE-SNVQTP 627
LR + ++ S QTP
Sbjct: 625 TDDGLRQSSDDPSKGSEGQTP 645
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 6.9e-145, Sum P(2) = 6.9e-145
Identities = 197/352 (55%), Positives = 258/352 (73%)
Query: 289 RQGSGVLKGKGTAEK----PKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGK 344
R+G GV+ +K P+ F S +++ N+L F +G ++FDLEDLLRASAEVLGK
Sbjct: 287 RRGDGVISDNKLQKKGGMSPEKFVSRMEDVN-NRLSFFEGCNYSFDLEDLLRASAEVLGK 345
Query: 345 GSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE 404
G++G+TYKA+LED T+V VKRL++VAA KR+FEQQME++G I KH NVV ++AYYYSKDE
Sbjct: 346 GTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDE 404
Query: 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI 464
KL+VY Y GS+ LLH NR + LDW +RMKIA+G A+GIA IH E K HGNI
Sbjct: 405 KLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNI 464
Query: 465 KSSNVLLTQDLNGCISDVGLAHLIN-FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVL 523
KSSN+ L + NGC+SD+GL +++ +R GYRAPEVT+TRK+SQ SDVYSFGV+
Sbjct: 465 KSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVV 524
Query: 524 LLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIA 583
LLE+LTGK+P+ + D+++ L RWV SVVREEWTAEVFD+ELL+Y ++EEEMV+MLQIA
Sbjct: 525 LLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIA 584
Query: 584 LSCVAKVPDSRPKMDDVVRMIEQI--------QQPELRNRASSGTESNVQTP 627
+SCV K D RPKM D+VR+IE + +PEL+ ++ +G S TP
Sbjct: 585 MSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGA-SETSTP 635
|
|
| TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 801 (287.0 bits), Expect = 5.4e-130, Sum P(2) = 5.4e-130
Identities = 169/326 (51%), Positives = 226/326 (69%)
Query: 292 SGVLKGKGTAEKPKDFGSGVQEAEKN-KLCFLDGSYFNFDLEDLLRASAEVLGKGSYGST 350
SG L+ + ++ P ++ S E+ K+ F G FDL+DLL +SAEVLGKG++G+T
Sbjct: 262 SGKLRKRDSSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTT 321
Query: 351 YKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410
YK +ED +TVVVKRL+EV +REFEQQME++G I +H NV ++AYYYSKD+KL VYS
Sbjct: 322 YKVTMEDMSTVVVKRLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYS 380
Query: 411 YMPAGSLFMLLHRNRSD-GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469
Y GSLF +LH NR LDW++R++IA G ARG+A IH EG KF HGNIKSSN+
Sbjct: 381 YYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLAKIH-EG--KFIHGNIKSSNI 437
Query: 470 LLTQDLNGCISDVGLAHLI-NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528
L GCI DVGL ++ + P T T GY APE+T+TR+++Q SDVYSFGV+LLE+L
Sbjct: 438 FLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELL 497
Query: 529 TGKAPLQHS-----GHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD-VEEEMVQMLQI 582
TGK+P+ + G +++ DL W+RSVV +EWT EVFD+E+L EEEMV+MLQI
Sbjct: 498 TGKSPVSQAELVPTGGENM-DLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQI 556
Query: 583 ALSCVAKVPDSRPKMDDVVRMIEQIQ 608
L+CVA RP + V+++IE I+
Sbjct: 557 GLACVALKQQERPHIAQVLKLIEDIR 582
|
|
| TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 5.5e-128, Sum P(2) = 5.5e-128
Identities = 173/327 (52%), Positives = 226/327 (69%)
Query: 301 AEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTT 360
+++ KD V E + NK+ F +G FDLEDLLRASAEVLGKG +G+TYK LED T
Sbjct: 274 SKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSAT 332
Query: 361 VVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML 420
+VVKR++EV+ +REFEQQ+E +G+I KH NV +R Y+YSKDEKLVVY Y GSL L
Sbjct: 333 IVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEHGSLSTL 391
Query: 421 LHRNRS-DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479
LH + L+W +R+ + GTARG+A IHS+ G K HGNIKSSN+ L GCI
Sbjct: 392 LHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCI 451
Query: 480 SDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539
S G+A L++ + +GYRAPE+T+TRK +Q SDVYSFG+L+ E+LTGK+
Sbjct: 452 SGTGMATLMH--SLPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS------- 502
Query: 540 DDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599
+V +L RWV SVVREEWT EVFD ELL+ VEEEMV+MLQ+ + C A++P+ RP M +
Sbjct: 503 -EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIE 561
Query: 600 VVRMIEQIQQPELRNRASSGTESNVQT 626
VVRM+E+I+ PE + +SG S V T
Sbjct: 562 VVRMVEEIR-PE---KLASGYRSEVST 584
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 2.4e-125, Sum P(2) = 2.4e-125
Identities = 181/323 (56%), Positives = 237/323 (73%)
Query: 312 QEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVA- 370
Q +K K+ F +G+ F+LEDLLRASAE+LGKG +G+ YKA+LEDG V VKRL++
Sbjct: 339 QVGDKGKMVFFEGTR-RFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVT 397
Query: 371 -ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG 429
A K+EFEQQMEV+G + +H+N+V ++AYY++++EKL+VY YMP GSLF LLH NR G
Sbjct: 398 VAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGR 456
Query: 430 TALDWNSRMKIALGTARGIAFIHSEGGA-KFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488
T LDW +R+KIA G ARG+AFIH K THG+IKS+NVLL + N +SD GL+ I
Sbjct: 457 TPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLS--I 514
Query: 489 NFPT-TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP-LQHSGHDD-VVDL 545
P+ T ++ GYRAPE+ + RK +QKSDVYSFGVLLLE+LTGK P + +GH VDL
Sbjct: 515 FAPSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDL 574
Query: 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
PRWV+SVVREEWTAEVFD+EL++Y+D+EEEMV +LQIA++C A D RPKM VV++IE
Sbjct: 575 PRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIE 634
Query: 606 QIQQPELR-NRASSGTESNVQTP 627
I+ + + G S V +P
Sbjct: 635 DIRGGGSEASPCNDGINSAVDSP 657
|
|
| TAIR|locus:2178712 AT5G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 717 (257.5 bits), Expect = 2.4e-123, Sum P(2) = 2.4e-123
Identities = 144/312 (46%), Positives = 210/312 (67%)
Query: 303 KPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVV 362
K K+ ++E NK+ F +GS F+LEDLL ASAE LGKG +G TYKA+LED +
Sbjct: 308 KEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSKVIA 367
Query: 363 VKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLH 422
VKRL+++ ++++F+ QME+VG I KH NV P+RAY SK+EKL+VY Y GSL + LH
Sbjct: 368 VKRLKDIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLRLH 426
Query: 423 -RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481
+N +G L+W +R++ +G A+G+ IH++ A HGNIKSSNV + + GCIS+
Sbjct: 427 GKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQNLA---HGNIKSSNVFMNSEGYGCISE 483
Query: 482 VGLAHLIN----FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537
GL L N ++A + YRAPEVT+TR+++ +SD+YSFG+L+LE LTG++ +
Sbjct: 484 AGLPLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMDD- 542
Query: 538 GHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKM 597
+ +DL WV V+ ++WT EVFD+EL+K +VE +++QMLQ+ SC A VP RP M
Sbjct: 543 -RKEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPDM 601
Query: 598 DDVVRMIEQIQQ 609
VV +E+I++
Sbjct: 602 VKVVETLEEIER 613
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 5.1e-123, Sum P(2) = 5.1e-123
Identities = 163/319 (51%), Positives = 227/319 (71%)
Query: 292 SGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTY 351
+ + G G A + G+G A K KL F + FDLEDLLRASAEVLGKG++G+ Y
Sbjct: 334 AAAMTGNGKASE----GNG--PATK-KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAY 386
Query: 352 KAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411
KA+L+ T V VKRL++V +EF++++E+VG + H N+VP+RAYY+S+DEKL+VY +
Sbjct: 387 KAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMD-HENLVPLRAYYFSRDEKLLVYDF 445
Query: 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471
MP GSL LLH NR G + L+W+ R +IA+G ARG+ ++HS+G + +HGNIKSSN+LL
Sbjct: 446 MPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTST-SHGNIKSSNILL 504
Query: 472 TQDLNGCISDVGLAHLI-NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG 530
T+ + +SD GLA L+ + T R GYRAPEVT+ ++ SQK DVYSFGV+LLE++TG
Sbjct: 505 TKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITG 564
Query: 531 KAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMV-QMLQIALSCVAK 589
KAP +++ VDLPRWV+SV R+EW EVFD ELL EEEM+ +M+Q+ L C ++
Sbjct: 565 KAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQ 624
Query: 590 VPDSRPKMDDVVRMIEQIQ 608
PD RP+M +VVR +E ++
Sbjct: 625 HPDQRPEMSEVVRKMENLR 643
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVM0 | Y5830_ARATH | No assigned EC number | 0.6082 | 0.9457 | 0.9067 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01250078 | SubName- Full=Putative uncharacterized protein; (630 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 627 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-40
Identities = 150/546 (27%), Positives = 246/546 (45%), Gaps = 81/546 (14%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
F G +P +S G L+ L L N +G +P + S+S L + L N SG +P S
Sbjct: 464 FFGGLP-DSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS 521
Query: 141 --QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKIL---NFSN 195
+L +LDLS N +G IP F + L L+L N +SG IP NL ++ L N S+
Sbjct: 522 CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK-NLGNVESLVQVNISH 580
Query: 196 NNLNGSIPDS--LQTFPNSSFVGNSMLC------GLPLTPCSTVSSSPSPSPSYFPTISP 247
N+L+GS+P + S+ GN LC GLP PC V +PS +F
Sbjct: 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP--PCKRVRKTPS---WWF----- 630
Query: 248 HKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKKLDRQGSGVLKGKGTAEKPKDF 307
I +G A L L L F ++ R + + +
Sbjct: 631 -------------YITCTLG--AFLVLALVAFGFVFIRG--RNNLELKRVE--------- 664
Query: 308 GSGVQEAEKNKLCFLDGSYF-NFDLEDLLRASAE--VLGKGSYGSTYKA-ILEDGTTVVV 363
E +L F D + + D+L + E V+ +G G++YK +++G VV
Sbjct: 665 ----NEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVV 720
Query: 364 KRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHR 423
K + +V + M + +H N+V + S+ +++ Y+ +L +L R
Sbjct: 721 KEINDVNSIPSSEIADMGKL----QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-R 775
Query: 424 NRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL-TQDLNGCISDV 482
N L W R KIA+G A+ + F+H GN+ +++ +D +
Sbjct: 776 N-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--L 826
Query: 483 GLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP--LQHSGHD 540
L L+ T + Y APE ET+ ++KSD+Y FG++L+E+LTGK+P + H
Sbjct: 827 SLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 541 DVVDLPRWVRSVVR-EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599
+V+ R+ S + W ++ Q+ E+V+++ +AL C A P +RP +D
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCAND 943
Query: 600 VVRMIE 605
V++ +E
Sbjct: 944 VLKTLE 949
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 76/265 (28%), Positives = 111/265 (41%), Gaps = 29/265 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQ---MEVVGTIGKHSNVVPV 395
LG GS+G+ YKA G V VK L++ + ++ + + ++ + H N+V +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPNIVRL 63
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ KD +V Y G LF L R L + KIAL RG+ ++HS G
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-----LSEDEAKKIALQILRGLEYLHSNG 118
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYRAPEVT-ETRK 510
H ++K N+LL ++ I+D GLA + TT T Y APEV
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570
K DV+S GV+L E+LTGK P D ++R + E
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILD-------QLQLIRRILGPPLEFDEPKWSS 228
Query: 571 DVEEEMVQMLQIALSCVAKVPDSRP 595
EE + C+ K P RP
Sbjct: 229 GSEE----AKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-37
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLR------EVAATKREFEQQMEVVGTIGKHSNVVP 394
LG+G +G+ Y A + G V +K ++ + RE E ++ H N+V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-----NHPNIVK 55
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + ++ +V Y GSL LL N L + ++I L G+ ++HS
Sbjct: 56 LYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSN 111
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLIN----FPTTATRTIGYRAPEV-TET 508
G H ++K N+LL D ++D GL+ L+ T T Y APEV
Sbjct: 112 G---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 509 RKASQKSDVYSFGVLLLEM 527
S+KSD++S GV+L E+
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 31/271 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK---HSNVVPV 395
E LG+GS+G Y A + G V +K +++ K E+ I K H N+V +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREI--KILKKLKHPNIVRL 62
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ +D+ +V Y G LF LL + L + + ++HS+G
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQILSALEYLHSKG 117
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG---YRAPEVTETRKAS 512
H ++K N+LL +D + ++D GLA ++ T +G Y APEV +
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572
+ D++S GV+L E+LTGK P + + + + + D+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLEL-----FKKIGKPKPP------FPPPEWDI 223
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
E +++ + K P+ R ++ ++
Sbjct: 224 SPEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
+ LG+G++G YK L+ T V VK L+E A +++F ++ V+ +G H NVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR----SDGGTALDWNSRMKIALGTARGIA 449
+ ++ +V YM G L L ++R S + L + A+ A+G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRT---IGYRAP 503
++ S+ KF H ++ + N L+ +DL ISD GL+ + ++ T I + AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562
E + + KSDV+SFGVLL E+ T G P + G + ++ ++R R
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSN-EEVLEYLRKGYR-------- 225
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
L K + +E + ++ LSC P+ RP ++V +E
Sbjct: 226 ---LPKPEYCPDE---LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 340 EVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+ LG+G++G YK L T V VK L+E A + EF ++ ++ + H N+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + + +V YMP G L L ++ L +++AL A+G+ ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-NFPTTATRTIGYR-----APEVT 506
S+ F H ++ + N L+T++L ISD GL+ I R G APE
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEV 561
+ K + KSDV+SFGVLL E+ T G+ P ++ + R E E+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLELLEDGYRLPRPENCPDEL 233
Query: 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
+++ MLQ C A P+ RP ++V +
Sbjct: 234 YEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 39/279 (13%)
Query: 340 EVLGKGSYGSTYKAILEDG-----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+ LG+G++G YK L+ V VK L+E A EF ++ ++ + H N+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + ++ ++V YMP G L L R + L + + AL ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDL---LDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG----YR--APEVT 506
S+ F H ++ + N L+ ++L ISD GL+ + + + G R APE
Sbjct: 121 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAPESL 176
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565
+ K + KSDV+SFGVLL E+ T G+ P + G + ++ +++ R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMSN-AEVLEYLKKGYR----------- 222
Query: 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
L K + E+ ++ L C A+ P+ RP ++V ++
Sbjct: 223 LPKPPNCPPELY---KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 40/279 (14%)
Query: 340 EVLGKGSYGSTYKAILED-----GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+ LG+G++G YK L+ V VK L+E A EF ++ ++ + H NV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + ++ +V YM G L L +NR L + + AL ARG+ ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLE 119
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG----YR--APEVT 506
S+ F H ++ + N L+ ++L ISD GL+ + + R G R APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYRKRGGKLPIRWMAPESL 175
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565
+ K + KSDV+SFGVLL E+ T G+ P + G + ++ ++++ R
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSN-EEVLEYLKNGYR----------- 221
Query: 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
L + + E+ + L C A+ P+ RP ++V ++
Sbjct: 222 LPQPPNCPPELY---DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 73/202 (36%), Positives = 109/202 (53%), Gaps = 8/202 (3%)
Query: 10 PIFLFTVLPIFPTVVADLNSDKQALLDFADAV--PHARKLNWNAAAPVCSSWIGVTCNVN 67
P +F + +F + + LL F ++ P NWN++A VC W G+TCN N
Sbjct: 10 PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL-WQGITCN-N 67
Query: 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQ 126
SRV+ I L G +G I + +I +L ++ ++L +N L+G +P DI T+ SSL+Y+ L
Sbjct: 68 SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 127 NNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LN 184
NN F+G +P L LDLS N +G IP + + L +L+L N + G IP N
Sbjct: 127 NNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186
Query: 185 LPRLKILNFSNNNLNGSIPDSL 206
L L+ L ++N L G IP L
Sbjct: 187 LTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-25
Identities = 65/280 (23%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE----FEQQMEVVGTIGKHSNVVPV 395
LG+GS+G Y A D V +K L + +K + F ++++++ ++ N+V +
Sbjct: 6 RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
++ + +V Y+ GSL LL + G + + + + ++HS+G
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHSKG 121
Query: 456 GAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLI----------NFPTTATRTIGYRAPE 504
H +IK N+LL +D + D GLA L+ P+T+ T GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 505 V---TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561
V AS SD++S G+ L E+LTG P + G + + ++ ++ +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTPSLA 236
Query: 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601
+ + + + +L+ +AK P +R +
Sbjct: 237 SPLSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 51/232 (21%)
Query: 340 EVLGKGSYGSTYKAILED-GTTVVVKRLR-------EVAATKREFE--QQMEVVGTIGKH 389
E+LG+GS+GS Y A+ +D G + VK + E+ A +RE + +H
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-------QH 58
Query: 390 SNVVPVRAYYYSK-DEKLVVYS----YMPAGSLFMLLHRNRSDGGTALDWN-----SRMK 439
N+V YY S+ DE+ + Y+ GSL LL + L +R
Sbjct: 59 PNIV---RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQ- 109
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG 499
G+A++HS G H +IK +N+L+ D ++D G A + T T
Sbjct: 110 ----ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 500 YR------APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
R APEV + + +D++S G ++EM TGK P S + +
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMAA 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +GKG +G YKA G V +K ++ + K+E + KH N+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK------IALGTARGIAFIH 452
Y KDE +V + GSL LL N + + +G+ ++H
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLK----------STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR--TIGYRAPEVTETR 509
S G H +IK++N+LLT D + D GL+ L + T T + APEV +
Sbjct: 116 SNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPL 534
K+D++S G+ +E+ GK P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 62/281 (22%), Positives = 124/281 (44%), Gaps = 46/281 (16%)
Query: 340 EVLGKGSYGSTYKA-ILEDGTTVVVKR--LREVAATKREF-EQQMEVVGTIGKHSNVVPV 395
+ +GKGS+G Y DG V+K L ++ +RE +++++ + H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKY 64
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-----TALDWNSRMKIALGTARGIAF 450
+ K + +V Y G L + + + +G LDW ++ +AL +
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL------KY 118
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVT 506
+HS K H +IK N+ LT + + D G++ +++ +T +G Y +PE+
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA--EVFDV 564
+ + + KSD++S G +L E+ T K P + +L +++ ++ +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQYPPIPSQYSS 229
Query: 565 ELLKYQDVEEEMV-QMLQIALSCVAKVPDSRPKMDDVVRMI 604
EL +V +LQ K P+ RP + +++
Sbjct: 230 EL-------RNLVSSLLQ-------KDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+GKG +G G V VK L++ + + F + V+ T+ +H N+V +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV 69
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ +V YM GSL L RS G + ++ AL G+ ++ + F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-TIGYRAPEVTETRKASQKSDVY 518
H ++ + NVL+++DL +SD GLA + + + + + APE +K S KSDV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 519 SFGVLLLEMLT-GKAPLQHSGHDDVVD 544
SFG+LL E+ + G+ P DVV
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVV 393
+++G+G++G YK + LE G V +K++ K + E ++ I KH N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQIS---LEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA---RGIAF 450
+ D ++ Y GSL ++ + G +A+ +G+A+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKF---GPF-----PESLVAVYVYQVLQGLAY 114
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYRAPEVT 506
+H +G H +IK++N+L T+D ++D G+A +N + T + APEV
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAP 533
E AS SD++S G ++E+LTG P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-21
Identities = 54/133 (40%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 76 LPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP 135
L G G IP NS+ L +L+ L+L SN L G +P ++ + SL+++YL N SG +P
Sbjct: 171 LGGNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
Query: 136 A--FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKIL 191
LN LDL +N TG IP NL L L L N +SG IPP +L +L L
Sbjct: 230 YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL 289
Query: 192 NFSNNNLNGSIPD 204
+ S+N+L+G IP+
Sbjct: 290 DLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVR 396
+GKGS+G +K + + D +K++ +RE E+ ++ + K S ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--- 62
Query: 397 AYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
YY S KL +V Y G L LL R G L + + + G+A +HS
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETR 509
+ K H +IKS N+ L N I D+G+A L++ T TI Y +PE+ E +
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 510 KASQKSDVYSFGVLLLEMLTGKAP 533
++KSDV++ GV+L E TGK P
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 70/302 (23%), Positives = 125/302 (41%), Gaps = 66/302 (21%)
Query: 342 LGKGSYGSTYKA---ILEDGTT--VVVKRLR--EVAATKREFEQQMEVVGTIGKHSNVVP 394
LG+G +G L D T V VK L + +FE+++E++ T+ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVK 70
Query: 395 VRAYYYSKDEK--LVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + ++ Y+P+GSL ++ HR++ + L + +G+ +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL------LFSSQICKGMDY 124
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------------FPTTATRT 497
+ S+ ++ H ++ + N+L+ + ISD GLA ++ P
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP------ 175
Query: 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557
I + APE T K S SDV+SFGV L E+ T P Q ++R + +
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP-------PAEFLRMIGIAQG 228
Query: 558 TAEVFD-VELLKY-----------QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
V +ELLK +V + M C P RP D++ +++
Sbjct: 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVD 281
Query: 606 QI 607
++
Sbjct: 282 RL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 14/241 (5%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + + T V VK L+ + + F ++ ++ T+ +H +V + A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK 72
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
++ ++ YM GSL L +SD G + + + A G+A+I + + H
Sbjct: 73 EEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIH 126
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKSD 516
+++++NVL+++ L I+D GLA +I R I + APE + KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDV-VDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
V+SFG+LL E++T GK P + DV L R R E E++D+ +++ E
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAE 246
Query: 575 E 575
E
Sbjct: 247 E 247
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 44/270 (16%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + T V VK L+ + F Q+ +++ + +H +V + A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE 72
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
++ +V YM GSL L +S G L + +A A G+A++ S + H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLI-----------NFPTTATRTIGYRAPEVTETRK 510
++ + N+L+ ++L I+D GLA LI FP I + APE +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP------IKWTAPEAANYGR 180
Query: 511 ASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD-LPRWVRSVVREEWTAEVFDVELLK 568
+ KSDV+SFG+LL E++T G+ P + +V++ + R R E++D+
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL---- 236
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMD 598
MLQ C K P+ RP +
Sbjct: 237 ----------MLQ----CWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 64/257 (24%), Positives = 118/257 (45%), Gaps = 43/257 (16%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
E LG+G++G YK L T+V +K L+E A ++EF Q+ E++ + +H N
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPN 69
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSD---------GGTALDWNSRMKI 440
+V + + +++ Y+ G L F++ + SD ++LD + + I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------NFPTTA 494
A+ A G+ ++ S F H ++ + N L+ + L ISD GL+ I + +
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV---------- 543
+ + PE K + +SD++SFGV+L E+ + G P + +V+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 544 ---DLPRWVRSVVREEW 557
D P V +++ E W
Sbjct: 247 CPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 32/272 (11%)
Query: 332 EDLLRASAEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV--AATKREFEQQMEVVGTIGK 388
DL R VLG+GS G YK G +K++ +++ ++++ + +
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL-RSCE 57
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
VV +Y + E +V YM GSL LL + L IA +G+
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGL 112
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-----TIGYRAP 503
++H++ H +IK SN+L+ I+D G++ ++ T T+ Y +P
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSP 169
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
E + S +D++S G+ LLE GK P G +L ++++
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP------- 219
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRP 595
L ++ E + C+ K P RP
Sbjct: 220 PPSLPAEEFSPEFRDFISA---CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 62/238 (26%), Positives = 115/238 (48%), Gaps = 26/238 (10%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRL-REVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
LG G +G ++ + ++ V +K L + +++F+++++ + + +H +++ + A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCS 72
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
+ ++ M GSL L RS G L S + +A A G+A++ +
Sbjct: 73 VGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFP--TTATRTIGYR--APEVTETRKASQKSD 516
H ++ + N+L+ +DL ++D GLA LI ++ + I Y+ APE S KSD
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDVVDL-------------PRWVRSVVREEWTAE 560
V+SFG+LL EM T G+ P + +V D P+ + ++ E W AE
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 49/134 (36%), Positives = 70/134 (52%), Gaps = 4/134 (2%)
Query: 80 GFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFR 138
F+G +P+ KL + L + +N L G + S + SLQ + L N F G LP +F
Sbjct: 415 SFSGELPSE-FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNN 196
S +L LDLS N F+G +P +L+ L L L N +SG IP + +L L+ S+N
Sbjct: 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 197 NLNGSIPDSLQTFP 210
L+G IP S P
Sbjct: 534 QLSGQIPASFSEMP 547
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVRAY 398
LGKGSYGS YK L D +K + + +++E E + + + H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ ++ +V Y P G L + R + +I + RG+ +H + K
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRTIGYRAPEVTETRKASQKSD 516
H ++KS+N+LL + I D+G++ ++ N T T Y APEV + R S KSD
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 517 VYSFGVLLLEMLTGKAPLQ 535
++S G LL EM T P +
Sbjct: 184 IWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 15/243 (6%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ LG G +G + T V +K L++ + + F + ++ + +H +V + A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV 70
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+++ ++ YM GSL L ++ G L N + +A A G+AFI + +
Sbjct: 71 -TQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQK 514
H +++++N+L+++ L I+D GLA LI R I + APE + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVV-DLPRWVRSVVREEWTAEVFDVELLKYQDV 572
SDV+SFG+LL E++T G+ P + +V+ +L R R + E++++ L +++
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEK 243
Query: 573 EEE 575
EE
Sbjct: 244 PEE 246
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 47/258 (18%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
LG+G++G + D V VK L+E A +++FE++ E++ H N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HEN 69
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL----------FMLLHRNRSDGGTALDWNSRMKIA 441
+V D ++V+ YM G L L S G L + ++IA
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIA 128
Query: 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR 501
+ A G+ ++ S+ F H ++ + N L+ DL I D G++ + + T R G+
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHT 184
Query: 502 -------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAP-LQHSGHDDVV--------- 543
PE RK + +SDV+SFGV+L E+ T GK P S +V+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECITQGRLL 243
Query: 544 ----DLPRWVRSVVREEW 557
P V ++ W
Sbjct: 244 QRPRTCPSEVYDIMLGCW 261
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 342 LGKGSYGSTYKA-ILEDGTTVVVKRLR--------EVAATKREFEQQMEVVGTIGKHSNV 392
LGKGS+G + G +K L+ EV T E + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-----NHPFI 55
Query: 393 VPVRAYYYSKD-EKL-VVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIA 449
V + +Y + EKL +V Y P G LF L + A + + + +AL
Sbjct: 56 V--KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------ 107
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTAT---RTIGYRAPEV 505
++HS G + ++K N+LL D + ++D GLA L + + T Y APEV
Sbjct: 108 YLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV 164
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+ + D +S GVLL EMLTGK P ++ +
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-16
Identities = 75/281 (26%), Positives = 107/281 (38%), Gaps = 79/281 (28%)
Query: 16 VLPIFPTVVADLNSDKQALLDFADAVPHARKLNWNA--AAPVCSSWIGVTCNVNRSR--- 70
V I L + AL ++ + WN P W G C + ++
Sbjct: 359 VFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKW 418
Query: 71 -VIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNY 129
+ G+ L G G IP N I KL L+ ++L N + G +P + SI+SL+
Sbjct: 419 FIDGLGLDNQGLRGFIP-NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-------- 469
Query: 130 FSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRL- 188
LDLS+N+F G+IP LT L +LNL NS+SG +P RL
Sbjct: 470 --------------VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
Query: 189 --KILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLP-LTPCSTVSSSPSPSPSYFPTI 245
NF++ N+ LCG+P L C
Sbjct: 516 HRASFNFTD---------------------NAGLCGIPGLRAC----------------- 537
Query: 246 SPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCLKK 286
PH L+ G+ I IA G V FL L + +C K+
Sbjct: 538 GPH-------LSVGAKIGIAFGVS-VAFLFLVICAMCWWKR 570
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 36/271 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVVPVRA 397
E +GKG++G YK +L+ T V VK R KR+F Q+ E++ H N+V +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
K +V +P GSL L + L ++++L A G+ ++ S+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESK--- 112
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGL----AHLINFPTTATRTI--GYRAPEVTETRKA 511
H ++ + N L+ ++ ISD G+ I + + I + APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 512 SQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570
+ +SDV+S+G+LL E + G P P RE +E
Sbjct: 173 TSESDVWSYGILLWETFSLGDTP-----------YPGMSNQQTRER-------IESGYRM 214
Query: 571 DVEEEM-VQMLQIALSCVAKVPDSRPKMDDV 600
+ ++ ++ L C A P++RP ++
Sbjct: 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 342 LGKGSYGSTYKAIL----EDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPV 395
+G+GS+G KAIL EDG V+K + + +E E+ + V + KH N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS---DGGTALDWNSRMKIALGTARGIAFIH 452
+ + +V Y G L+ ++ R LDW ++ +AL +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVTET 508
K H +IKS N+ LT+D + D G+A ++N RT IG Y +PE+ E
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 509 RKASQKSDVYSFGVLLLEMLTGK 531
R + KSD+++ G +L EM T K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--LREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
EV+G G+ Y AI L + V +KR L + + E ++++ + H NVV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVV--- 62
Query: 397 AYYYS---KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
YY S DE +V Y+ GSL ++ + GG LD + +G+ ++HS
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYLHS 120
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--------TIGYRAPEV 505
G H +IK+ N+LL +D + I+D G++ + TR T + APEV
Sbjct: 121 NG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 506 TETRKA-SQKSDVYSFGVLLLEMLTGKAPLQH 536
E K+D++SFG+ +E+ TG AP
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + T V VK L+ + F ++ +++ + +H +V + A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVV-S 71
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDG-GTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
++ +V YM GSL L DG G AL + + +A A G+A+I +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKS 515
H +++S+N+L+ L I+D GLA LI R I + APE + + KS
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 516 DVYSFGVLLLEMLT-GKAP 533
DV+SFG+LL E++T G+ P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG+G +G + T V +K L+ F Q+ +++ + +H +VP+ A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV-S 71
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
++ +V +M GSL L + G L + +A A G+A+I + H
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKSD 516
+++++N+L+ +L I+D GLA LI R I + APE + + KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575
V+SFG+LL E++T G+ P P V V E+ + Q E
Sbjct: 186 VWSFGILLTELVTKGRVP-----------YPGMVNREVLEQVER---GYRMPCPQGCPES 231
Query: 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
+ +++++ C K PD RP + + +E
Sbjct: 232 LHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLR---EVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
+G G++G Y A+ L+ G + VK +R T +E +M+V+ + KH N+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK--- 63
Query: 398 YYYS---KDEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
YY EK+ ++ Y G+L LL G LD + L G+A++HS
Sbjct: 64 -YYGVEVHREKVYIFMEYCSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTIG--------YRAP 503
G H +IK +N+ L D NG I D G A + TT Y AP
Sbjct: 118 HG---IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 504 EVTETRKASQK---SDVYSFGVLLLEMLTGKAP 533
EV K +D++S G ++LEM TGK P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E LG+GSYGS YKAI E G V +K + V +E +++ ++ +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQC-DSPYIVKYYGS 66
Query: 399 YYSKDEKLVVYSYMPAGSLF-MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
Y+ + +V Y AGS+ ++ N++ L I T +G+ ++HS
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHSN--- 118
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRT--IG---YRAPEVTETRKA 511
K H +IK+ N+LL ++ ++D G++ L + T A R IG + APEV +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQH 536
+ K+D++S G+ +EM GK P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 58/284 (20%)
Query: 341 VLGKGSYGSTYKAIL----EDGTTVVVKR--LREVAATKREFEQQMEVVGTIGKHSNVVP 394
VLGKG++G A L ED + VV K L ++ +R V+ ++ +H N++
Sbjct: 7 VLGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII- 62
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL-----------G 443
AYY +M +L + + ++GGT D R K L
Sbjct: 63 --AYYNH---------FMDDNTLLIEMEY--ANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG--- 499
+++IH G H +IK+ N+ LT+ + D G++ ++ + T +G
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559
Y +PE+ + K + KSD+++ G +L E+LT K D + V +V+ +T
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTP 220
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
V E++ ++ S + + P+ RP D+V+
Sbjct: 221 VV--------SVYSSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHS 390
+ LG+G++G KA + +TV VK L++ AT+++ +ME++ IGKH
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHK 76
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-----------GTALDWNSRMK 439
N++ + + VV Y G+L L R G L +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINF--PTTA 494
A ARG+ F+ S+ K H ++ + NVL+T+D I+D GLA H I++ TT
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 495 TR-TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + APE R + +SDV+SFGVLL E+ T G +P
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 15/241 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG+G +G + T V +K L+ + F Q+ +V+ + +H +V + A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV-S 71
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
++ +V YM GSL L + + G L + +A A G+A++ + H
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKSD 516
+++++N+L+ ++L ++D GLA LI R I + APE + + KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDVVD-LPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
V+SFG+LL E+ T G+ P + +V+D + R R E + D+ ++ E
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 245
Query: 575 E 575
E
Sbjct: 246 E 246
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G ++ + + T V VK L+ ++F + +++ + +H ++ + A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL 72
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
++ +V M GSL L G AL + +A A G+A++ ++ + H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKSD 516
++ + NVL+ ++ ++D GLA +I R I + APE + S KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 517 VYSFGVLLLEMLT-GKAP 533
V+SFG+LL E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 340 EVLGKGSYGSTYKAILED--GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
+ +GKG +G +L D G V VK ++ AT + F + V+ + +HSN+V +
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQLLG 66
Query: 398 YYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ L +V YM GSL L RS G + L + +K +L + ++ +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-FPTTATRTIGYRAPEVTETRKASQKS 515
F H ++ + NVL+++D +SD GL + T + + APE +K S KS
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 516 DVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPR 547
DV+SFG+LL E+ + G+ P DVV PR
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVV--PR 211
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 49/134 (36%), Positives = 77/134 (57%), Gaps = 5/134 (3%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRS 139
G IP +G++ +LK + L N L+G +P +I ++SL ++ L N +G +P + +
Sbjct: 200 LVGQIPR-ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 140 LQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNN 196
L+ L L L N +G IPP +L +L L+L +NS+SG IP L L L+IL+ +N
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN 318
Query: 197 NLNGSIPDSLQTFP 210
N G IP +L + P
Sbjct: 319 NFTGKIPVALTSLP 332
|
Length = 968 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVG--TIGKHSNVVPVR 396
+ LG G++GS Y A E G V +K++++ + E EV + +H N+V ++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ DE V+ YM G+L+ L+ + G + I +G+A IH G
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFP--TTATRTIGYRAPEVT-ETRKAS 512
F H ++K N+L++ I+D GLA + + P T T YRAPE+ + S
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 513 QKSDVYSFGVLLLEMLTGKAPL 534
D+++ G ++ E+ T + PL
Sbjct: 178 SPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
LG G YG Y+ + + TV VK L+E EF ++ V+ I KH N+V +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
+ ++ +M G+L L R ++ + +A + + ++ + F
Sbjct: 73 REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLI-----NFPTTATRTIGYRAPEVTETRKASQKS 515
H ++ + N L+ ++ ++D GL+ L+ A I + APE K S KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 516 DVYSFGVLLLEMLT-GKAP 533
DV++FGVLL E+ T G +P
Sbjct: 187 DVWAFGVLLWEIATYGMSP 205
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 57/224 (25%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVA-------ATKREFE--QQMEVVGTIGKHSN 391
+G+G+YG YKA + G V +K++R RE + Q++ +H N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-------RHPN 59
Query: 392 VVPVRAYYYSKDEKLV--VYSYMP---AGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+V ++ SK + + V+ YM G LL +K +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSP------------EVKFTESQIK 103
Query: 447 --------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493
G+ ++HS H +IK SN+L+ D ++D GLA T
Sbjct: 104 CYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 494 ATRTIGYRAPEVT--ETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
T+ YR PE+ TR + D++S G +L E+ GK Q
Sbjct: 161 RVITLWYRPPELLLGATRYGP-EVDMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 47/219 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK--RLREVAATKREFEQQMEVVGTIG-----KHSN 391
+ +G G+YG YKA + G V +K +L +FE + I +H N
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFE---IIQQEISMLKECRHPN 61
Query: 392 VVPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL---GTA 445
+V AY+ Y + +KL +V Y GSL + R L S ++IA T
Sbjct: 62 IV---AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR----GPL---SELQIAYVCRETL 111
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRT--IG-- 499
+G+A++H G H +IK +N+LLT+D G + +D G++ + T A R IG
Sbjct: 112 KGLAYLHETGK---IHRDIKGANILLTED--GDVKLADFGVSAQL-TATIAKRKSFIGTP 165
Query: 500 -YRAPEVTETRKAS---QKSDVYSFGVLLLEMLTGKAPL 534
+ APEV + K D+++ G+ +E+ + P+
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 39/222 (17%)
Query: 340 EVLGKGSYGSTYKAILE-DGT--TVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVVP 394
+V+G+G++G +A+++ DG +K L+E A+ R+F ++EV+ +G H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 395 V------RAYYYSKDEKLVVYSYMPAGSLFMLLHRNR---------SDGGTALDWNSR-- 437
+ R Y Y + Y P G+L L ++R + GTA S+
Sbjct: 68 LLGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 438 MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT 497
++ A A G+ ++ + +F H ++ + NVL+ ++L I+D GL+ +T
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT 176
Query: 498 IG-----YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
+G + A E + KSDV+SFGVLL E+++ G P
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 24/266 (9%)
Query: 340 EVLGKGSYGSTYKAILE-DG--TTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVVP 394
+V+G+G++G KA ++ DG +KR++E A+ R+F ++EV+ +G H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR---------SDGGTALDWNSR--MKIALG 443
+ + + Y P G+L L ++R TA +S+ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINFPTTATRTIGY 500
ARG+ ++ + +F H ++ + N+L+ ++ I+D GL+ + T + +
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD-LPRWVRSVVREEWT 558
A E + SDV+S+GVLL E+++ G P ++ + LP+ R
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 559 AEVFDVELLKYQDVEEEMVQMLQIAL 584
EV+D+ +++ E QI +
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQILV 263
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/241 (26%), Positives = 117/241 (48%), Gaps = 15/241 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + A T V VK ++ + + F + V+ T+ +H +V + A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV-T 71
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
K+ ++ +M GSL L +SD G+ + + A G+AFI + H
Sbjct: 72 KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQKSD 516
+++++N+L++ L I+D GLA +I R I + APE + KSD
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDVV-DLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
V+SFG+LL+E++T G+ P + +V+ L R R E E++++ + +++ E
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPE 245
Query: 575 E 575
E
Sbjct: 246 E 246
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 51/209 (24%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
+G G +G + + V +K +RE A ++ +F ++ +V+ + H +V +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE 70
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
+ +V+ +M G L L R + + + L G+A++ S + H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRT---IGYRAPEVTETRKASQKSD 516
++ + N L+ ++ +SD G+ + + T++T T + + +PEV K S KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 517 VYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544
V+SFGVL+ E+ + GK P ++ + +VV+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 341 VLGKGSYGSTYKAI-LEDGTT----VVVKRLREVAATK--REFEQQMEVVGTIGKHSNVV 393
VLG G++G+ YK + + +G V +K LRE + K +E + V+ ++ H +VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVV 72
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFI 451
+ S +L+ MP G L + ++ + G L+W + A+G++++
Sbjct: 73 RLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-----FPTTATRT-IGYRAPEV 505
+ H ++ + NVL+ + I+D GLA L++ + + I + A E
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
R + KSDV+S+GV + E++T G P + ++ DL
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQ-MEVVGT-IG-----KHSNV 392
E +G+G+ G YKA +EVA K +Q E++ I KH N+
Sbjct: 25 EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 393 VPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK------IALG 443
V YY Y ++L VV YM GSL ++ +N RM +
Sbjct: 78 V---DYYDSYLVGDELWVVMEYMDGGSLTDIITQN----------FVRMNEPQIAYVCRE 124
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI-G--- 499
+G+ ++HS+ H +IKS N+LL++D + ++D G A + + ++ G
Sbjct: 125 VLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ APEV + + K D++S G++ +EM G+ P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 342 LGKGSYGSTYKAI---LED--GTTVVVKRLREVAATK-REFEQQMEVVGTIGKHSNVVPV 395
LGKG++GS L+D G V VK+L+ A R+FE+++E++ ++ +H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKY 70
Query: 396 RAYYYS--KDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ YS + +V Y+P GSL ++ HR R D L + S++ +G+ ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYL 124
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPE 504
G ++ H ++ + N+L+ + I D GL ++ + I + APE
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT 529
K S SDV+SFGV+L E+ T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR------EVAATKRE--FEQQMEVVGTIGKHS 390
E++G+G+YG+ Y+ + G V +K + +V+ +RE Q+ + S
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL-------RQS 59
Query: 391 NVVPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG 447
+ YY Y K +L ++ Y GS+ L+ + I
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK------AGPIAEKYISVIIREVLVA 113
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----TATRTIGYRAP 503
+ +IH G H +IK++N+L+T N + D G+A L+N + T T + AP
Sbjct: 114 LKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
Query: 504 EV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
EV TE + K+D++S G+ + EM TG P +S D
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP--YSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 50/289 (17%)
Query: 342 LGKGSYGSTYKAILEDGTT---VVVKRLREVAATKRE--FEQQMEVVGTIGKHSNVVPVR 396
+G G +G G + VVVK LR A + F Q+++ + H NV+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCL 61
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
L+V + P G L L NR + ++A A G+ ++H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPEVTETR 509
A F H ++ N LT DL+ I D GLA +P T + + APE+ E R
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 510 -------KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561
++KS+++S GV + E+ T P + V ++ VVRE+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQ----- 226
Query: 562 FDVEL------LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
D++L LKY D E++Q + P++RP ++V ++
Sbjct: 227 -DIKLPKPQLDLKYSDRWYEVMQFCWLD-------PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 20/216 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVR 396
E +GKGS+G+ K DG +V K + T++E +Q + V + KH N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 397 AYYYSKD---EKLVVYSYMP---AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
YY + +Y M G L L+ + + + ++ +I +
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYE 120
Query: 451 IH--SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYRAPE 504
H S+ G H ++K +N+ L + N + D GLA ++ F T T Y +PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
+KSD++S G L+ E+ P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 61/294 (20%)
Query: 342 LGKGSYGSTYKAIL------EDGTTVVVKRLREVAAT--KREFEQQ---------MEVVG 384
LG+GS+G Y+ + E T V +K + E A+ + EF + VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSD-----GGTALDWNSRMK 439
+G S P LVV M G L L R + G ++
Sbjct: 74 LLGVVSTGQPT----------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG 499
+A A G+A++ ++ KF H ++ + N ++ +DL I D G+ I + T R G
Sbjct: 124 MAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGG 179
Query: 500 YR-------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRS 551
APE + + KSDV+SFGV+L EM T + P Q +++V+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF------ 233
Query: 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
V D L + + +L++ C P RP ++V ++
Sbjct: 234 ---------VIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 62/186 (33%), Positives = 82/186 (44%), Gaps = 32/186 (17%)
Query: 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNY 129
++I + L +G IP + +L L+IL L SN G +P +TS+ LQ + L +N
Sbjct: 285 KLISLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 130 FSGVLPAFRSLQ--LNALDLSFNAFTGNIPPGF---QNLTRLHLLN-------------- 170
FSG +P L LDLS N TG IP G NL +L L +
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 171 -------LQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDSLQTFPN---SSFVGNS 218
LQ+NS SG +P LP + L+ SNNNL G I P+ S N
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 219 MLCGLP 224
GLP
Sbjct: 464 FFGGLP 469
|
Length = 968 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 342 LGKGSYGSTYKAIL------EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVP 394
LG+G++G + A +D V VK L+E + + +++F+++ E++ T+ +H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL-TVLQHQHIVR 71
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTA-------------LDWNSRMKIA 441
L+V+ YM G L L RS G A L + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFL---RSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRT- 497
A G+ ++ F H ++ + N L+ Q L I D G++ I ++ RT
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 498 --IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
I + PE RK + +SD++SFGV+L E+ T GK P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVV 393
+V+G G +G + L + V +K L+ ++ K +F + ++G H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNII 68
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ YM GSL L N + + G A G+ ++ S
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL-S 123
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG------YRAPEVTE 507
E + H ++ + N+L+ +L +SD GL+ + T G + APE
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 508 TRKASQKSDVYSFGVLLLEMLT-GKAP 533
RK + SDV+SFG+++ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 49/229 (21%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
+++G+GS+ + A E +K + ++V K E EV+ + H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE----KEVLTRLNGHP 62
Query: 391 NVVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
++ + YY +DE+ + V Y P G L + + S LD A +
Sbjct: 63 GII--KLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-----LDEKCTRFYAAEILLAL 115
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---------HLINFPTTATRTIG 499
++HS+G H ++K N+LL +D++ I+D G A T +
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 500 ---------------YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
Y +PE+ + A + SD+++ G ++ +MLTGK P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 33/271 (12%)
Query: 341 VLGKGSYGS-TYKAILEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNVVPVR 396
V+GKGSYG + DG V+K+L A++RE EQ+ +++ + KH N+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYR 65
Query: 397 AYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ +D L +V + G L+ H+ + G L N ++ + A + ++H +
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK- 121
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-NFPTTATRTIG---YRAPEVTETRKA 511
H ++K+ NV LT+ + D+G+A ++ N A+ IG Y +PE+ +
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571
+ KSDV++ G + EM T L+H+ + D+ V ++ + +D
Sbjct: 180 NYKSDVWALGCCVYEMAT----LKHAF--NAKDMNSLVYRIIEGKLPP--------MPKD 225
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
E+ +++ LS K P+ RP + ++R
Sbjct: 226 YSPELGELIATMLS---KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 68/287 (23%), Positives = 132/287 (45%), Gaps = 47/287 (16%)
Query: 340 EVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNV 392
E LG+ ++G YK L + V +K L+++ ++ EF+Q+ ++ + H N+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNI 69
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGG----------TALDWNSRMKI 440
V + + +++ Y+ G L F+++ SD G ++LD + I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRT 497
A+ A G+ ++ S F H ++ + N+L+ + L+ ISD+GL+ I ++ ++
Sbjct: 130 AIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 498 ---IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553
I + PE K S SD++SFGV+L E+ + G P + +V+++ V
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-------V 239
Query: 554 REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
R+ +LL E+ +M + C + P RP+ D+
Sbjct: 240 RKR--------QLLPCS--EDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
E++G+G +G+ + G V VK ++ T + F ++ V+ + H N+V +
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKL-HHKNLVRLLGVI 68
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+V+ M G+L L R+ G + ++ +L A G+ ++ S+ K
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-TIGYRAPEVTETRKASQKSDVY 518
H ++ + N+L+++D +SD GLA + + ++ + + APE + +K S KSDV+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 519 SFGVLLLEMLT-GKAP 533
S+GVLL E+ + G+AP
Sbjct: 182 SYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G+G+ G+ Y AI + G V +K++ K+E +V KH N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
Y DE VV Y+ GSL ++ T +D + + + F+HS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKASQ 513
H +IKS N+LL D + ++D G I P + R+ +G + APEV +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 514 KSDVYSFGVLLLEMLTGKAP 533
K D++S G++ +EM+ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 3e-13
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVG 384
E LG+G+YG YKA + G V +K+ LRE++ K E
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLK-EL-------- 55
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
KH N+V + +++ + +V+ Y L L + L N I
Sbjct: 56 ---KHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGP----LSPNLIKSIMYQL 107
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTI 498
RG+A+ HS + H ++K N+L+ + +G ++D GLA P T T+
Sbjct: 108 LRGLAYCHS---HRILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTYTHEVVTL 162
Query: 499 GYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ ++ S D++S G + EM+TGK PL
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK-PL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 43/285 (15%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVAATKREFEQQMEVVGTIGK---HSNV 392
V+GKG +G Y L D VK L + + E EQ ++ G I K H NV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-EVEQFLKE-GIIMKDFSHPNV 58
Query: 393 VPVRAYYYSKD-EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ + + LVV YM G L + R+ + T D + L A+G+ ++
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDL---IGFGLQVAKGMEYL 114
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--------HLINFPTTATRTIGYRAP 503
S+ KF H ++ + N +L + ++D GLA + ++ T A + + A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562
E +T+K + KSDV+SFGVLL E++T G P D+ R +++ E+ +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD-- 229
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ ++ LSC P+ RP ++V IEQI
Sbjct: 230 ---------------PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 73/275 (26%), Positives = 110/275 (40%), Gaps = 38/275 (13%)
Query: 341 VLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQME---VVGTIGKHSNVVPVRA 397
VLGKG+YG Y A D +T V ++E+ + Q + + + KH N+V
Sbjct: 15 VLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI-ALGTARGIAFIHSEGG 456
+ +P GSL LL RS G D + G+ ++H
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 457 AKFTHGNIKSSNVLLTQDLNGC-ISDVG----LAHLINFPTTATRTIGYRAPEVTE--TR 509
+ H +IK NVL+ ISD G LA + T T T+ Y APEV + R
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK- 568
+D++S G ++EM TGK P G E A +F V + K
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELG-----------------EPQAAMFKVGMFKI 229
Query: 569 YQDVEEEM-VQMLQIALSCVAKVPDSRPKMDDVVR 602
+ ++ E + + L C PD R D+++
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 48/225 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
EV+G+G+YG YKA + G V +K + + + E +++ ++ H N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 399 YYSK------DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK------IALGTAR 446
+ K D+ +V GS+ L+ R+K I T R
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKG-------LRKKGKRLKEEWIAYILRETLR 124
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA--TRTIGYR--- 501
G+A++H K H +IK N+LLT++ L++F +A T+G R
Sbjct: 125 GLAYLHEN---KVIHRDIKGQNILLTKN--------AEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 502 -------APEVT---ETRKAS--QKSDVYSFGVLLLEMLTGKAPL 534
APEV E AS +SDV+S G+ +E+ GK PL
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 342 LGKGSYGSTYKA----ILED----GTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
LG+G +G A I +D TV VK L++ A K + +ME++ IGKH N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-----------GTALDWNSRMKI 440
++ + V+ Y G+L L R G L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINF--PTTAT 495
A ARG+ ++ S+ K H ++ + NVL+T+D I+D GLA H I++ TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 496 R-TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + APE R + +SDV+SFGVLL E+ T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK 388
D E+L E +GKGS+G +K I VV ++ ++ + E E Q E+ T+
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI--TVLS 57
Query: 389 HSNVVPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+ V YY Y KD KL ++ Y+ GS LL LD I
Sbjct: 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREIL 111
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTIG---YR 501
+G+ ++HSE K H +IK++NVLL++ ++D G+A L + +G +
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
APEV + K+D++S G+ +E+ G+ P
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 32/268 (11%)
Query: 342 LGKGSYGSTYKA------ILEDGTTVVVKRLRE-VAATKREFEQQMEVVGTIGKHSNVVP 394
LG+G++G + A +D V VK L++ A +++F+++ E++ + +H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR-----------MKIALG 443
D ++V+ YM G L L + D +D R + IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT------ 497
A G+ ++ S+ F H ++ + N L+ +L I D G++ + + T R
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 187
Query: 498 -IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVRE 555
I + PE RK + +SDV+SFGV+L E+ T GK P + +V++ R + R
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 556 E-WTAEVFDVELLKYQDVEEEMVQMLQI 582
EV+D+ L +Q ++ + + +I
Sbjct: 248 RVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK------REFEQQMEVVGTIGKHSNV 392
E+LG GS+GS Y+ + L+DG VK + + ++ EQ++ ++ + +H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNI 64
Query: 393 VPVRAYYYSK--DEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
V Y ++ ++ L ++ +P GSL LL + S + +R + G+
Sbjct: 65 V---QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLE 116
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTIG---YRAPE 504
++H H +IK +N+L+ D NG + +D G+A + + A G + APE
Sbjct: 117 YLHDRN---TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 505 V-TETRKASQKSDVYSFGVLLLEMLTGKAP 533
V + +D++S G +LEM TGK P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 72/292 (24%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQ---MEVVGT 385
DL+DL +G+G++G+ K + + GT + VKR+R +T E EQ+ M++
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR---STVDEKEQKRLLMDL-DV 55
Query: 386 IGKHSNVVPVRAYY---YSKDEKLVVYSYMPAG--SLFMLLHRNRSDGGTALDWNSRMKI 440
+ + S+ + +Y + + + + M + ++ + + KI
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEV---LKSVIPEEILGKI 112
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS--DVGLA-HLINFPTTATRT 497
A+ T + + ++ E K H ++K SN+LL D NG I D G++ L++ TR
Sbjct: 113 AVATVKALNYLKEE--LKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVD-SIAKTRD 167
Query: 498 IG---YRAPE--VTETRKASQ-KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS 551
G Y APE R +SDV+S G+ L E+ TGK P + + V D +
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP--YPKWNSVFD---QLTQ 222
Query: 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
VV+ D +L + E + C+ K RPK +++
Sbjct: 223 VVKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-EVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
E +GKGS+G YKAI V +K + E A + E QQ E+ S +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-EIQFLSQCRS--PYITK 63
Query: 398 YY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
YY + K KL ++ Y GS LL + LD I G+ ++H E
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHEE 117
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVTETRK 510
G K H +IK++N+LL+++ + ++D G++ + + T +G + APEV +
Sbjct: 118 G--KI-HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQH 536
+K+D++S G+ +E+ G+ PL
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQME-VVGTIG-----KHSNV 392
+ LG G++ S Y+A ++ GT + VK++ V T E E+ +E + I H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + + +M GS+ LL G A + RG++++H
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYG-AFKEAVIINYTEQLLRGLSYLH 120
Query: 453 SEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATR--------TIGYR 501
+ H ++K +N+L+ Q L I+D G A + T TI +
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPL---QHSGH 539
APEV + + DV+S G +++EM T K P +HS H
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 65/275 (23%), Positives = 121/275 (44%), Gaps = 41/275 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVVPVRA 397
E+LGKG++G +K L+D T V VK +E K +F + ++ H N+V +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIG 59
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
+ +V +P G L + + + L +K AL A G+A++ S+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLESK--- 112
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---FPTTATRT--IGYRAPEVTETRKAS 512
H ++ + N L+ ++ ISD G++ + + ++ + I + APE + S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 513 QKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE----LL 567
+SDV+S+G+LL E + G P P RE+ VE +
Sbjct: 173 SESDVWSYGILLWETFSLGVCP-----------YPGMTNQQAREQ-------VEKGYRMS 214
Query: 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
Q +++ +++Q C P++RPK ++ +
Sbjct: 215 CPQKCPDDVYKVMQ---RCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 342 LGKGSYGSTY--KAILEDG------TTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
LG+G +G +AI D T V VK L+ A K + +ME++ IGKH N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-----------GTALDWNSRMKI 440
++ + V+ Y G+L L R G L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINF--PTTAT 495
A ARG+ ++ S+ K H ++ + NVL+T+D I+D GLA H I++ TT
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 496 R-TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + APE R + +SDV+SFGVLL E+ T G +P
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G+G+ G+ Y AI + G V +K++ K+E +V K+ N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
Y DE VV Y+ GSL ++ T +D + + + F+HS +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN---Q 135
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKASQ 513
H +IKS N+LL D + ++D G I P + R+ +G + APEV +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 514 KSDVYSFGVLLLEMLTGKAP 533
K D++S G++ +EM+ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRL----REVAATKREFEQQMEVVGTIG--KHSNVV 393
EVLGKG+YG+ Y + G + VK++ V A ++E+E+ E V + KH N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ + ++P GS+ +L+R L K G+A++H+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN 120
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCIS--DVGLAHLI----------NFPTTATRTIGYR 501
H +IK +NV+L NG I D G A + N + T +
Sbjct: 121 NC---VVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
APEV +KSD++S G + EM TGK PL
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 341 VLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQMEVVGTIGKHSNVVPV 395
V+G+GS+G +A+L +K +R +++ E ++ V+ KH N+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSD---GGTALDWNSRMKIALGTARGIAFIH 452
+ + + +V Y G L + R T L W +M + G+ IH
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH 117
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVG----LAHLINFPTTATRTIGYRAPEVTET 508
+ + H +IKS N+ LTQ+ + D G L + T T Y PE+ E
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQ 535
+ KSD++S G +L E+ T K P Q
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G+G+ G+ Y A+ + G V ++++ K+E +V K+ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
Y DE VV Y+ GSL ++ T +D + + + F+HS +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN---Q 136
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKASQ 513
H +IKS N+LL D + ++D G I P + R+ +G + APEV +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 514 KSDVYSFGVLLLEMLTGKAP 533
K D++S G++ +EM+ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 340 EVLGKGSYGSTYKA-ILEDGTTV--VVKRLREVAATK--REFEQQMEVVGTIGKHSNVVP 394
+V+G+G++G KA I +DG + +KR++E A+ R+F ++EV+ +G H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 395 V------RAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-----------SDGGTALDWNSR 437
+ R Y Y + Y P G+L L ++R + + L
Sbjct: 73 LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 438 MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT 497
+ A ARG+ ++ + +F H ++ + N+L+ ++ I+D GL+ +T
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 181
Query: 498 IG-----YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
+G + A E + SDV+S+GVLL E+++ G P
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 342 LGKGSYGSTYKAIL--------EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
LG+G +G +A + TV VK L++ A K + +ME++ IGKH N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG------GTA-----LDWNSRMKI 440
++ + + V+ Y G+L L R G T L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINF--PTTAT 495
A ARG+ ++ S + H ++ + NVL+T+D I+D GLA H I++ T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 496 RT-IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + APE R + +SDV+SFG+L+ E+ T G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 44/131 (33%), Positives = 73/131 (55%), Gaps = 9/131 (6%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP----A 136
F+G IP N +GK + L +L L +N L G +P + S +L + L +N G +P A
Sbjct: 344 FSGEIPKN-LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 137 FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI--PPLNLPRLKILNFS 194
RSL+ + L N+F+G +P F L ++ L++ NN++ G I ++P L++L+ +
Sbjct: 403 CRSLR--RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460
Query: 195 NNNLNGSIPDS 205
N G +PDS
Sbjct: 461 RNKFFGGLPDS 471
|
Length = 968 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 28/226 (12%)
Query: 342 LGKGSYGSTYKAIL------EDGTTVVVKRLREVAATKR-EFEQQMEVVGTIGKHSNVVP 394
LG+G++G + A +D V VK L++ + R +F ++ E++ + +H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG--------GTALDWNSRMKIALGTAR 446
D ++V+ YM G L L + D L + + IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG------- 499
G+ ++ S+ F H ++ + N L+ ++L I D G++ + + T R G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIR 187
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544
+ PE RK + +SDV+S GV+L E+ T GK P +++V++
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 35/210 (16%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--------KHSNV 392
+G+G+YG YKA G V +K++ K FE + + H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-IALGTARGIAFI 451
+ + + K + +V+ +M L+ L+ + L S +K +G+AF
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ----RGLP-ESLIKSYLYQLLQGLAFC 114
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTT---ATRTIGYRAPEV 505
HS G H ++K N+L+ + ++D GLA P T TR YRAPE+
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--YRAPEL 169
Query: 506 TET-RKASQKSDVYSFGVLLLEMLTGKAPL 534
+ S D++S G + E+L+ + PL
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAAT--KREFEQQMEVVGTIG--------- 387
E++GKG+YG Y A+ + G + VK++ E+ AT R +Q ++V +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQV-ELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG 447
H N+V + +++ + Y+P GS+ L R+ G + G
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYG--RFEEQLVRFFTEQVLEG 120
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH-----LINFPTTATR-TIGYR 501
+A++HS+G H ++K+ N+L+ D ISD G++ N + + ++ +
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 502 APEVTET--RKASQKSDVYSFGVLLLEMLTGKAP 533
APEV + + S K D++S G ++LEM G+ P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKR--LREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
+ +G+GS+G Y A + D V+K L ++ ++E ++ ++ KH N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
A + +V Y G L ++R R G + + + + G+ IH
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR-- 120
Query: 457 AKFTHGNIKSSNVLLTQDLNGCIS---DVGLAHLIN----FPTTATRTIGYRAPEVTETR 509
K H +IKS N+ L++ NG ++ D G+A +N T T Y +PE+ + R
Sbjct: 121 -KILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQ 535
+ K+D++S G +L E+ T K P +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 71/248 (28%), Positives = 108/248 (43%), Gaps = 44/248 (17%)
Query: 341 VLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFE-------QQMEVVGTIGKHSNV 392
VLGKG +G + G K+L + KR+ E Q +E V +S
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRF 61
Query: 393 VPVRAYYY-SKDEKLVVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V AY Y +KD +V + M G L F + H G + + A G+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLED 117
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR--TIGYRAPEVTE 507
+H E + + ++K N+LL + ISD+GLA H+ T R T+GY APEV +
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567
+ + D ++ G LL EM+ G++P Q + + REE VE L
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRK-----------KKIKREE-------VERL 216
Query: 568 KYQDVEEE 575
++V+EE
Sbjct: 217 -VKEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 46/281 (16%)
Query: 342 LGKGSYGSTY----KAILEDGT---TVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNV 392
LG G++G Y IL G+ V VK LR+ A K+EF ++ ++ H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLH--RNRSDGGTALDWNSRMKIALGTARGIAF 450
V + + + ++ M G L L R G L + I L A+G +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC-----ISDVGLAHLINFPTTATRTIGYR---- 501
+ F H ++ + N L+++ I D GLA I + + R G
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPV 177
Query: 502 ---APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557
APE K + +SDV+SFGVL+ E+LT G+ P + ++ ++ + V + R
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNN-QEVLQHVTAGGR--- 231
Query: 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMD 598
L K ++ +++ Q++ +C A+ P RP D
Sbjct: 232 --------LQKPENCPDKIYQLMT---NCWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 342 LGKGSYGSTYKAIL--------EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
LG+G +G A ++ TV VK L++ A K + +ME++ IGKH N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-----------GTALDWNSRMKI 440
++ + V+ Y G+L L R G + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-----PTTAT 495
ARG+ ++ S+ K H ++ + NVL+T++ I+D GLA +N TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 496 R-TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + APE R + +SDV+SFGVL+ E+ T G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 341 VLGKGSYGST----YKAILEDGTTVVVKRLREVAATKREFEQ-QMEVVGT-IGKHSNVVP 394
++GK K T V VK++ + +K + + Q E++ + +H N++P
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL---GTARGIAFI 451
+ E VV M GS LL + +G + IA + +I
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG------LPELAIAFILKDVLNALDYI 117
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------------FPTTATRTI 498
HS+G F H ++K+S++LL+ D +S GL + ++ FP ++ + +
Sbjct: 118 HSKG---FIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 499 GYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQ 535
+ +PEV + + ++KSD+YS G+ E+ G P +
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 341 VLGKGSYGSTYKAILEDGTTV-VVKRLR-EVAATKREFEQQM---EVVGTIGKHSNVVPV 395
VLGKGS+G A L+ +K L+ +V + E M V+ +H + +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 396 RAYYYSKDEKLVVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ +K+ V Y+ G L F + R D A + + + L F+H +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGL------QFLHKK 115
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL-INFPTTATRTIG---YRAPEVTETRK 510
G + ++K NVLL +D + I+D G+ +N A+ G Y APE+ + +K
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD--------LPRWV 549
++ D +SFGVLL EML G++P D++ D PRW+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 64/258 (24%), Positives = 108/258 (41%), Gaps = 43/258 (16%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
E LG+ +G YK L E V +K L++ A + EF+ + + + +H N
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPN 69
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGT---------ALDWNSRMKI 440
+V + + +++SY L F+++ SD G+ L+ + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL------AHLINFPTTA 494
A G+ F+ S H ++ + NVL+ LN ISD+GL A +
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV---------- 543
I + +PE K S SD++S+GV+L E+ + G P + DV+
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 544 ---DLPRWVRSVVREEWT 558
D P WV +++ E W
Sbjct: 247 CPDDCPAWVYTLMLECWN 264
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK 388
D E+L E +GKGS+G +K I VV ++ ++ + E E Q E+ T+
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI--TVLS 57
Query: 389 HSNVVPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+ V YY Y K KL ++ Y+ GS LL D + +K L
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEIL--- 111
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTIG---YR 501
+G+ ++HSE K H +IK++NVLL++ + ++D G+A L + +G +
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
APEV + K+D++S G+ +E+ G+ P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLR-EVAATKREFEQQM---EVVGTIGKHSNVVP 394
+VLGKGS+G A L+ G VK L+ +V + E M V+ ++ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ + +K+ V ++ G L F + + R D A + + + G+ F+HS
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC------GLQFLHS 114
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL----INFPTTATRTIGYRAPEVTETR 509
+G + ++K NV+L +D + I+D G+ N +T T Y APE+ +
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-----VDLPRWVRSVVRE 555
K + D +SFGVLL EML G++P D++ VD P + R + +E
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTV----VVKRLREVAATKR--EFEQQMEVVGTIGKHSNV 392
+VLG G++G+ YK I + +G TV +K L E K EF + ++ ++ H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 71
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + S +LV MP G L +H ++ + G+ L N ++IA +G+ ++
Sbjct: 72 VRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA----KGMMYLE 126
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAP------EVT 506
+ H ++ + NVL+ + I+D GLA L+ G + P E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 507 ETRKASQKSDVYSFGVLLLEMLT 529
RK + +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 23/228 (10%)
Query: 340 EVLGKGSYGSTYKAIL--EDGTT--VVVKRLREVAATKREFEQQMEVVGTIGK--HSNVV 393
++LG+G +GS + L +DG+ V VK ++ T E E+ + + H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 394 PVRAYYYSKDEK------LVVYSYMPAGSLFMLLHRNRSDGGTA-LDWNSRMKIALGTAR 446
+ + +V+ +M G L L +R G L + +K + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT------TATRTIGY 500
G+ ++ + F H ++ + N +L +D+ C++D GL+ I A + +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPR 547
A E R + KSDV++FGV + E+ T G+ P + ++ D R
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRL---REVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG+G+ GS K L++ + + +++ +++E+ + K +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGA 67
Query: 399 YYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRM--KIALGTARGIAFIHSE 454
+ + + Y GSL + + + GG ++ KIA +G++++HS
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI---GEKVLGKIAESVLKGLSYLHSR 124
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYRAPEVTETRKAS 512
K H +IK SN+LLT+ + D G++ L+N T T T Y APE + + S
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYS 181
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSG 538
SDV+S G+ LLE+ + P G
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + V +K +RE A ++ +F ++ +V+ + H N+V +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK 70
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
+ +V YM G L L + GT + + + ++ S G F H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAMEYLESNG---FIH 123
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLI-----------NFPTTATRTIGYRAPEVTETRK 510
++ + N L+ +D +SD GLA + FP + + PEV + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP------VKWAPPEVFDYSR 177
Query: 511 ASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544
S KSDV+SFGVL+ E+ + GK P + + +VV+
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 31/232 (13%)
Query: 344 KGSYGSTYKA------------ILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN 391
KG++GS Y A +L+ + ++ V A + Q G+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-------GESPY 58
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
V + + SKD +V Y+ G L+ ++ GG DW ++ IA G+ +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIA-EVVLGVEDL 113
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKA 511
H G H +IK N+L+ Q + ++D GL+ T Y APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
+ SD +S G ++ E L G P D V D + + W EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD--NILSRRI--NWPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 62/285 (21%), Positives = 127/285 (44%), Gaps = 45/285 (15%)
Query: 340 EVLGKGSYGSTYKAILE----DGTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNVV 393
+V+G G +G ++ IL+ V +K L+ K+ +F + ++G H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNII 69
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL--GTARGIAFI 451
+ +++ YM G+L L + DG +++S + + G A G+ ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDH--DG----EFSSYQLVGMLRGIAAGMKYL 123
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPE 504
+ H ++ + N+L+ +L +SD GL+ ++ T T I + APE
Sbjct: 124 SD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPL-QHSGHDDVVDLPRWVRSVVREEWTAEVF 562
RK + SDV+SFG+++ E+++ G+ P S H+ V + + +
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------VMKAINDGF----- 227
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
L D + Q++ L C + RP+ D+V +++++
Sbjct: 228 --RLPAPMDCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
EV+G G+YG YK ++ G +K + + E + ++ ++ H N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 399 YYSK------DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ K D+ +V + AGS+ L+ + G AL + I RG+A +H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLH 138
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR----------A 502
+ K H +IK NVLLT++ + D G++ ++ RT+G R A
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRNTFIGTPYWMA 189
Query: 503 PEVT---ETRKASQ--KSDVYSFGVLLLEMLTGKAPL 534
PEV E A+ +SD++S G+ +EM G PL
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 59/271 (21%), Positives = 112/271 (41%), Gaps = 33/271 (12%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G V +K ++E + ++ EF ++ +V+ + H +V +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK 70
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
+ +V YM G L L + G + +++ G+A++ S+ +F H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG------YRAPEVTETRKASQKS 515
++ + N L+ +SD GL+ + T ++G + PEV K S KS
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 516 DVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
DV++FGVL+ E+ + GK P + + + V+ + R +E
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE-------------- 228
Query: 575 EMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
++ I SC + + RP ++ IE
Sbjct: 229 ---KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLR---EVAATKRE-------FEQQMEVVGTIGKHS 390
+GKG + YKAI L DG V +K+++ + A R+ +Q++ H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-------HP 62
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALD---WNSRMKIALGTARG 447
NV+ A + +E +V AG L ++ + + W +++
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SA 118
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAP 503
+ +HS+ + H +IK +NV +T + D+GL + TTA + +G Y +P
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---AE 560
E + KSD++S G LL EM A LQ + D ++L + + + ++ A+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
+ EL ++V C+ P+ RP + V+++ +++
Sbjct: 232 HYSEEL-------RDLVSR------CINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
+G+GS G A + G V VK++ +RE V+ H NVV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
DE VV ++ G+L ++ R ++ + L R ++++H++G
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRKASQKSD 516
H +IKS ++LLT D +SD G ++ +++ + APEV + D
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 517 VYSFGVLLLEMLTGKAP 533
++S G++++EM+ G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E++G G+YG YK ++ G +K + + E +Q++ ++ H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 399 YYSK------DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ K D+ +V + AGS+ L+ + G L I RG++ +H
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH 128
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR----------A 502
K H +IK NVLLT++ + D G++ ++ RT+G R A
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRNTFIGTPYWMA 179
Query: 503 PEVT---ETRKASQ--KSDVYSFGVLLLEMLTGKAPL 534
PEV E A+ KSD++S G+ +EM G PL
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 27/226 (11%)
Query: 341 VLGKGSYGSTYKAILEDGTTVV--VKRLR-EVAATKREFEQQM---EVVGTIGKHSNVVP 394
VLGKGS+G A L+ GT + VK L+ +V + E M V+ GKH +
Sbjct: 2 VLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + + +KD V Y+ G L + R+ D A G+ F+H
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-----FDEPRARFYAAEIVLGLQFLHER 115
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTETRK 510
G + ++K NVLL + + I+D G+ ++ TT+T T Y APE+ +
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--------VDLPRW 548
D ++ GVLL EML G++P + D++ V PRW
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 342 LGKGSYGSTYKAI--LEDGT--TVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVVPV 395
LG G++GS K + ++ G V VK L++ +AA K+EF ++ V+ + H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV-- 59
Query: 396 RAYYYSKDEKLV-VYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
R K E L+ V P G L ++ R + A A G+A++
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVS-DLKEL------AHQVAMGMAYLE 112
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF------PTTATR-TIGYRAPEV 505
S+ F H ++ + NVLL ISD G++ + TTA R + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAP 533
K S KSDV+S+GV L E + G P
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
+G+GS G A ++ G V VK++ +RE V+ +H NVV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
DE VV ++ G+L ++ R ++ + L + ++ +H++G
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRKASQKSD 516
H +IKS ++LLT D +SD G ++ +++ + APE+ + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 517 VYSFGVLLLEMLTGKAP 533
++S G++++EM+ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 35/244 (14%)
Query: 373 KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TA 431
+R+F + ++G H N++ + ++V YM GSL L ++ DG T
Sbjct: 49 RRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH--DGQFTV 105
Query: 432 LDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-NF 490
+ ++ G A G+ ++ G + H ++ + N+L+ +L +SD GL+ ++ +
Sbjct: 106 IQLVGMLR---GIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
Query: 491 PTTATRTIG------YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
P A T G + APE RK + SDV+S+G+++ E+++ G+ P + DV+
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
Query: 544 DLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
+ E + L D + Q++ L C K + RPK + +V +
Sbjct: 220 -------KAIEEGY-------RLPAPMDCPAALHQLM---LDCWQKDRNERPKFEQIVSI 262
Query: 604 IEQI 607
++++
Sbjct: 263 LDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGKHSNVVPVRAY 398
E +GKGS+G YK I VV ++ ++ + E E Q E+ T+ + + Y
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEI--TVLSQCDSPYITRY 67
Query: 399 Y--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y Y K KL ++ Y+ GS LL L+ I +G+ ++HSE
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSE- 120
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTIG---YRAPEVTETRKA 511
+ H +IK++NVLL++ + ++D G+A L + +G + APEV +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 512 SQKSDVYSFGVLLLEMLTGKAP 533
K+D++S G+ +E+ G+ P
Sbjct: 179 DFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 311 VQEAEKNKLCFLDGSYFNFDLE-DLLRASAE---VLGKGSYG-----STYKAILEDGT-T 360
++ N+ ++D + +DL+ + R + LG G++G + Y D
Sbjct: 8 IESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK 67
Query: 361 VVVKRLREVA-ATKRE-FEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418
V VK L+ A +++RE +++++ +G H N+V + LV+ Y G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478
L R R + L + + A+G+AF+ S+ H ++ + NVLLT
Sbjct: 128 NFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181
Query: 479 ISDVGLAHLI----NFPT--TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT 529
I D GLA I N+ A + + APE + +SDV+S+G+LL E+ +
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 358 GTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415
G V V+R+ A T F Q V + H N+VP RA + + +E VV S+M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL 475
S L+ + DG + L + I G + + +IH G + H ++K+S++L++ D
Sbjct: 85 SAKDLICTHFMDGMSEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDG 138
Query: 476 NGCISDVGLAH-LIN----------FPTTATRTIGYRAPEVTET--RKASQKSDVYSFGV 522
+S + +IN FP + + + + +PEV + + KSD+YS G+
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198
Query: 523 LLLEMLTGKAPLQ 535
E+ G P +
Sbjct: 199 TACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFEQ---QMEVVGT 385
DLE L LG G+ G K G + VK +R + + +Q +++++
Sbjct: 2 DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHK 55
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+V +Y+ + + YM GSL +L G KIA+
Sbjct: 56 C-NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILG--KIAVAVL 110
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYRAP 503
+G+ ++H + K H ++K SN+L+ + D G++ L+N T T Y AP
Sbjct: 111 KGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAP 168
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
E + S KSD++S G+ L+E+ TG+ P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREV---------AATKREFEQQMEVVGTIGKHS 390
E LG+G+Y + YK + TT + L+E+ + RE E+ KH
Sbjct: 6 EKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-----KHE 58
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
N+V + +++++ ++V+ YM L +M H R ALD N+ +GI
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGI 113
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPE 504
AF H + H ++K N+L+ + ++D GLA P + T+ YRAP+
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPD 170
Query: 505 V-TETRKASQKSDVYSFGVLLLEMLTGKA 532
V +R S D++S G ++ EM+TG+
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 43/275 (15%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401
LG G +G + V +K + E A ++ +F ++ +V+ + H +V +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ 70
Query: 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTH 461
+ +V +M G L L + + L + + + G+ ++ F H
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 462 GNIKSSNVLLTQDLNGCISDVGLAHLI-----------NFPTTATRTIGYRAPEVTETRK 510
++ + N L++ +SD G+ + FP + + PEV K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP------VKWSPPEVFNFSK 177
Query: 511 ASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569
S KSDV+SFGVL+ E+ T GK P + + +VV++ + R + L
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK----------LAS 227
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
V E M SC + P+ RP +++R I
Sbjct: 228 MTVYEVM-------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 338 SAEVLGKGSYGSTYKAILEDGTT-----VVVKRLREVAATKREFEQQMEVVGTIG----- 387
+++L +G++G + IL D V VK +++ A+ E Q+ ++
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-----EIQVTLLLQESCLLYG 64
Query: 388 -KHSNVVPV-RAYYYSKDEKLVVYSYMPAGSLFMLLHRNR---SDGGTALDWNSRMKIAL 442
H N++P+ + V+Y YM G+L + L + R ++ AL + +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-------TAT 495
A G++++H G H +I + N ++ ++L I+D L+ + FP
Sbjct: 125 QIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL-FPMDYHCLGDNEN 180
Query: 496 RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + + A E ++ S SDV+SFGVLL E++T G+ P
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G+G+ G+ + AI + G V +K++ K+E +V K+ N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ DE VV Y+ GSL ++ T +D + + + F+H+ +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN---Q 135
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKASQ 513
H +IKS NVLL D + ++D G I P + R+ +G + APEV +
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 514 KSDVYSFGVLLLEMLTGKAP 533
K D++S G++ +EM+ G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 340 EVLGKGSYGSTYKAIL------EDGT--TVVVKRL-REVAATKRE-FEQQMEVVGTIGKH 389
VLG+G +G K L DGT V VK L RE +++++ ++ T+ H
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 390 SNVVPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG 447
N+V + + K ++ Y+P GSL L +++ L+ + A G
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK------LNLAQLLLFAQQICEG 119
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---------TATRTI 498
+A++HS+ + H ++ + NVLL D I D GLA + P +
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPV 174
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT 529
+ A E + K S SDV+SFGV L E+LT
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 69/291 (23%), Positives = 126/291 (43%), Gaps = 55/291 (18%)
Query: 340 EVLGKGSYGSTYKAILE----DGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVV 393
EV+G G +G + L+ V +K L+ +R+F + ++G H N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL-GTARGIAFIH 452
+ +++ +M G+L L +N DG + I L G RGIA
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQFTV-------IQLVGMLRGIA--- 116
Query: 453 SEGGAK------FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---TATRTIG---- 499
G K + H ++ + N+L+ +L +SD GL+ + T T T ++G
Sbjct: 117 --AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 500 --YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREE 556
+ APE RK + SDV+S+G+++ E+++ G+ P + DV++
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN------------ 222
Query: 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
A D L D + Q++ L C K ++RPK +V ++++
Sbjct: 223 --AIEQDYRLPPPMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 337 ASAEVLGKGSYGSTYKAILEDGTT---VVVKRLREVAATKREFEQQMEVVGTIGK--HSN 391
A + LG+G +GS + L + V VK ++ T+ E E + + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 392 VVPVRAYYYSKDEK------LVVYSYMPAGSLF-MLLHRNRSDGGTALDWNSRMKIALGT 444
V+ + E +V+ +M G L LL+ D L +K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------NFPTTATRTI 498
A G+ ++ S+ F H ++ + N +L +++N C++D GL+ I A +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557
+ A E R + KSDV+SFGV + E+ T G+ P + ++ D ++R R +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD---YLRQGNRLKQ 235
Query: 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ D + + SC P RP + + +E+
Sbjct: 236 PPDCLD--------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEV-VGTIGKHSNVVPVRA 397
V+G+G++G + D V++K++ TK E Q E V + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 398 YYYS--KDEKL-VVYSYMPAGSLFMLLHRNRS---DGGTALDWNSRMKIALGTARGIAFI 451
YY + +D+ L +V Y P G+L + + + D T L + ++ +AL +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHV 117
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFPTTATRTIG---YRAPEVTE 507
H++ H ++K+ N+LL + I D G++ +++ + A +G Y +PE+ E
Sbjct: 118 HTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174
Query: 508 TRKASQKSDVYSFGVLLLEMLTGK 531
+ +QKSD+++ G +L E+ + K
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 340 EVLGKGSYGSTYK-AILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +GKG+YG YK +DG+ VK L ++ E E + ++ ++ H NVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 399 YYSKDEKL-----VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+Y D+ + +V GS+ L+ + G LD I G G+ +H+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV-KGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGL-AHLINFPTTATRTIG---YRAPEVTETR 509
+ H ++K +N+LLT + + D G+ A L + ++G + APEV
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 510 KASQKS-----DVYSFGVLLLEMLTGKAPL 534
+ S DV+S G+ +E+ G PL
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 32/234 (13%)
Query: 334 LLRASAEVLGKGSYGSTYKAIL--EDGTT----VVVKRLREVAATKREFEQQMEVVGTIG 387
LLRA LG G++G Y+ + DG V VK L E + + E + ME + +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-IMS 64
Query: 388 K--HSNVVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALG 443
K H N+V + + + + ++ M G L F+ +R R + ++L + A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG---CISDVGLAHLINFPTTATRTIGY 500
A+G ++ F H +I + N LLT G I+D G+A I + + R G
Sbjct: 125 VAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYR-KGG 179
Query: 501 RA--------PEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
RA PE + K+DV+SFGVLL E+ + G P + +V++
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVRAY 398
LGKG +G ++ G K+L + KR+ EQ I + S + AY
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 399 -YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI-ALGTARGIAFIHSEGG 456
+ +KD+ +V + M G L + + G +R A G+ +H
Sbjct: 61 AFETKDDLCLVMTLMNGGDL----KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR--TIGYRAPEVTETRKASQ 513
+ ++K NVLL N ISD+GLA L R T GY APEV +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSG 538
D ++ G L EM+ G++P +
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTT----VVVKRLREVAA--TKREFEQQMEVVGTIGKHSNV 392
++LG G +G+ +K I + +G + V +K +++ + T +E M +G++ H+ +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYI 71
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + +LV P GSL + ++R N ++IA +G+ ++
Sbjct: 72 VRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA----KGMYYLE 126
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN------FPTTATRTIGYRAPEVT 506
H N+ + N+LL D I+D G+A L+ F + I + A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
+ + +SDV+S+GV + EM++ G P +V DL
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 346 SYGSTYKAILEDGTTVVV-----KRLREVAATKREFEQQM-------EVVGTIGK---HS 390
SY + I E T +V R+VA K + +Q EVV I + H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV--IMRDYQHP 76
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
N+V + + Y DE VV ++ G+L ++ R ++ + L + ++F
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLAVLKALSF 130
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEVT 506
+H++G H +IKS ++LLT D +SD G ++ + T + APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+ D++S G++++EM+ G+ P
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLR-EVAATKREFEQQM---EVVGTIGKHSNVVP 394
++LGKGS+G + A L+ +K L+ +V + E M V+ +H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLL---HRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ + +K+ V Y+ G L + H+ D A G+ F+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--------FDLPRATFYAAEIICGLQFL 112
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTAT--RTIGYRAPEVTE 507
HS+G + ++K N+LL D + I+D G+ +++ T T T Y APE+
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
+K + D +SFGVLL EML G++P GHD+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFH--GHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 341 VLGKGSYGSTY----KAILEDG--TTVVVKRL--REVAATKREFEQQMEVVGTIGKHSNV 392
LG+G +G + K I E+G T V+VK L + + EF +++++ + H NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNV 70
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGT--ARGI 448
V + + ++ Y G L F+ +++ + +++ K+AL T A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---------HLINFPTTATRTIG 499
+ + A+F H ++ + N L++ +S + L+ L N A +
Sbjct: 131 DHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN----ALIPLR 183
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
+ APE + S KSDV+SFGVL+ E+ T G+ P ++V+
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 341 VLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFE-------QQMEVVGTIGKHSNV 392
VLGKG +G + G K+L + KR+ E Q +E V + V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR----FV 62
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + Y +KD +V + M G L ++ N + G D + A G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR--TIGYRAPEVTETR 509
E + + ++K N+LL + ISD+GLA + T R T+GY APEV +
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQ 535
+ + D + G L+ EM+ GK+P +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 341 VLGKGSYGSTYKAI-LEDGTT----VVVKRLREVAATK--REFEQQMEVVGTIGKHSNVV 393
VLG G++G+ YK I + DG V +K LRE + K +E + V+ +G V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVC 72
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTA--LDWNSRMKIALGTARGIAFI 451
+ + +LV MP G L + N+ G+ L+W + A+G++++
Sbjct: 73 RLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAP------EV 505
+ H ++ + NVL+ + I+D GLA L++ T G + P E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
R+ + +SDV+S+GV + E++T G P ++ DL
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 62/276 (22%), Positives = 121/276 (43%), Gaps = 28/276 (10%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVR 396
+G+G + Y+A L DG V +K+++ A + + ++++++ + H NV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYY 68
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
A + +E +V AG L ++ ++ + + K + + +HS
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-- 125
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRKAS 512
+ H +IK +NV +T + D+GL + TTA ++ Y +PE +
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572
KSD++S G LL EM A LQ + D ++L + + E D L
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHY 233
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
EE+ Q++ + C+ P+ RP + V + +++
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKRL--------------REVAATKREFEQQMEVVGT 385
++G GS+GS Y + G + VK++ + A RE E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL--- 63
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+H N+V D + Y+P GS+ LL + A +
Sbjct: 64 --QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL-----NNYGAFEETLVRNFVRQIL 116
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR---- 501
+G+ ++H+ G H +IK +N+L+ ISD G++ + + +T+T G R
Sbjct: 117 KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 502 ------APEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
APEV + ++K+D++S G L++EMLTGK P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRL---REVAATKRE---FEQQMEVVGTIGKHSNVVP 394
LG+G++G Y ++ G + VK++ + TK+E E +++++ + +H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIV- 67
Query: 395 VRAYY--YSKDEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
YY DE L ++ YMP GS+ L ++ G AL K G+ ++
Sbjct: 68 --QYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYG--ALTETVTRKYTRQILEGVEYL 120
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------FPTTATRTIGYRAPE 504
HS H +IK +N+L N + D G + + + T T + +PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAP 533
V +K+DV+S G ++EMLT K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +GKG+YG +K + ++G+ VK L + E E + ++ + H NVV
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDW-------NSRMKIALGTARGIAFI 451
YY KD K L+++L +GG+ D RM+ + IA+I
Sbjct: 84 YYKKDVK-------NGDQLWLVLE--LCNGGSVTDLVKGFLKRGERMEEPI-----IAYI 129
Query: 452 HSEG--------GAKFTHGNIKSSNVLLTQDLNGCISDVGL-AHLINFPTTATRTIG--- 499
E K H ++K +N+LLT + + D G+ A L + ++G
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 500 YRAPEVTETRKA-----SQKSDVYSFGVLLLEMLTGKAPL 534
+ APEV + + DV+S G+ +E+ G PL
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLR-EVAATKREFEQQM---EVVGTIGKHSNVVP 394
VLGKGS+G A L E G VK L+ +V + E M ++ H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIHS 453
+ + + D V ++ G L + ++R D A + + + AL F+H
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL------MFLHD 114
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTETR 509
+G + ++K NVLL + + ++D G+ + N TT+T T Y APE+ +
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
D ++ GVLL EML G AP + DD+ +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 68/297 (22%), Positives = 128/297 (43%), Gaps = 39/297 (13%)
Query: 326 YFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT-KREFEQQMEVVG 384
+F D E L E+ G GS+G+ Y A D T V +++++ + K+ E+ +++
Sbjct: 18 FFKEDPEKLFTDLREI-GHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 74
Query: 385 TIG-----KHSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRM 438
+ KH N + + Y + +V Y + + S + +H+ L
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIA 128
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
I G +G+A++HS H +IK+ N+LLT+ ++D G A + + + T
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTP 185
Query: 499 GYRAPEVTETRKASQ---KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555
+ APEV Q K DV+S G+ +E+ K PL + S +
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------AMSALYH 235
Query: 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPE 611
E ++ ++ D V SC+ K+P RP +++++ + + ++PE
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVD------SCLQKIPQDRPTSEELLKHMFVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
+G G+YG YKA + G +K ++ QQ ++ KHSN+V Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
+D+ + + GSL + H + + + SR T +G+ ++HS+G
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE-----TLQGLYYLHSKGK---M 128
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKA---S 512
H +IK +N+LLT + + ++D G++ I T A R IG + APEV + +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 513 QKSDVYSFGVLLLEMLTGKAPL 534
Q D+++ G+ +E+ + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
+G G+YG YKA L G VK ++ QQ + KH N+V Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
S+++ + Y GSL + H + + R T +G+A++HS+G
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-----TLQGLAYLHSKGK---M 128
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKA---S 512
H +IK +N+LLT + + ++D G+A I T A R IG + APEV K +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 513 QKSDVYSFGVLLLEMLTGKAPL 534
Q D+++ G+ +E+ + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 69/294 (23%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 342 LGKGSYGSTYKAILED------GTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNVV 393
LG+GS+G Y+ D T V VK + E A+ + EF + V+ H +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSD-----GGTALDWNSRMKIALGTARGI 448
+ LVV M G L L R + G +++A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG-------YR 501
A+++++ KF H ++ + N ++ D I D G+ I + T R G +
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWM 188
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560
APE + + SD++SFGV+L E+ + + P Q ++ V+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--------------- 233
Query: 561 VFDVELLKYQD-VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELR 613
V D L D E + ++++ C P RP ++V +++ P
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 33/184 (17%)
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-----FPT 492
KIA+ G+ ++++ + H +IK SN+L+ + D G++ LIN F
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164
Query: 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD--------VVD 544
T+T Y +PE + K + KSDV+S G+ ++E+ GK P S DD ++D
Sbjct: 165 TST----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
L ++ +V+E L D E++ + C+ K P RP + M
Sbjct: 221 L---LQQIVQEP-------PPRLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMP 267
Query: 605 EQIQ 608
IQ
Sbjct: 268 PFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 341 VLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN---VVPVR 396
VLGKG +G + G KRL + KR+ E I + N VV +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
Y +KD +V + M G L ++ + G + + A G+ +H E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLEDLHREN- 122
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT-----RTIGYRAPEVTETRKA 511
+ ++K N+LL + ISD+GLA + P + T+GY APEV ++
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQ 535
+ D + G L+ EM+ G++P +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 48/284 (16%)
Query: 340 EVLGKGSYGS----TYKAILEDGTTVVVKRLR--EVAATKREFEQQMEVVGTIGKHSNVV 393
+ LG GS+G + V VK L+ +++ +F ++ ++ ++ H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLI 59
Query: 394 PVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDG---GTALDWNSRMKIALGTARGIA 449
R Y L +V P GSL L ++ T D+ A+ A G+
Sbjct: 60 --RLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMR 111
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-----NFPTTATRT--IGYRA 502
++ S+ +F H ++ + N+LL D I D GL + ++ + A
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561
PE TR S SDV+ FGV L EM T G+ P + ++ + +E
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEG----- 217
Query: 562 FDVELL-KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
E L + + +++ ++ L C A P RP + +
Sbjct: 218 ---ERLERPEACPQDIYNVM---LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 41/214 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-------REFEQQMEVVGTIGKHSN 391
E +G+G+YG YKA G V +K++R T+ RE E+ H N
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPN 60
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR----- 446
+V + +++++ +V+ ++ D +D + I L +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL------------HQDLKKFMDASPLSGIPLPLIKSYLFQ 108
Query: 447 ---GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIG 499
G+AF HS + H ++K N+L+ + ++D GLA P T T+
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 165
Query: 500 YRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKA 532
YRAPE+ + S D++S G + EM+T +A
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 340 EVLGKGSYGSTYKAILED---GTTVVVKRLREVAATKREFEQQMEVVGTIG--------- 387
E +G+G+YG YKA D T+ +K++R EQ+ E V +
Sbjct: 8 EKIGEGTYGVVYKA--RDRVTNETIALKKIR--------LEQEDEGVPSTAIREISLLKE 57
Query: 388 -KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM-KIAL-GT 444
+H N+V ++ +S+ +V+ Y+ L + D N R+ K L
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLD------LDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFP----TTATRTIG 499
RGIA+ HS + H ++K N+L+ + N ++D GLA P T T+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ +R S D++S G + EM+ K PL
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL 203
|
Length = 294 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-09
Identities = 16/42 (38%), Positives = 23/42 (54%), Gaps = 3/42 (7%)
Query: 27 LNSDKQALLDFADAV---PHARKLNWNAAAPVCSSWIGVTCN 65
LN D+ ALL F ++ P +WN ++ SW GVTC+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVV--VKRLR-EVAATKREFEQQM---EVVGTIGKHSNVV 393
+VLGKGS+G A L+ GT V +K L+ +V + + M ++ KH +
Sbjct: 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIH 452
+ + +KD V Y+ G L + R+R D + + + + +AL F+H
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLH 113
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTET 508
G + ++K N+LL + + ++D G+ ++N TT T T Y APE+ +
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
+ D ++ GVL+ EM+ G+ P + DD+ +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 54/222 (24%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR------EVAATK-REFEQQMEVVGTIGKHSN 391
E +G+G+YG YKA G V +K++R V +T RE E+ H N
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-----NHPN 59
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM----KIALGTA-- 445
+V + +S + KL Y+ +F L LD M L
Sbjct: 60 IVRLLDVVHS-ENKL----YL----VFEFLD---------LDLKKYMDSSPLTGLDPPLI 101
Query: 446 --------RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493
+GIA+ HS + H ++K N+L+ ++ ++D GLA P T
Sbjct: 102 KSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 494 ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+ YRAPE+ +R+ S D++S G + EM+ + PL
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLR--EVAATK--------RE--FEQQMEVVGTIGK 388
LG+G+Y YKA E G V +K+++ E K RE Q++ K
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-------K 60
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H N++ + + K +V+ +M L ++ +++S T D S M + L RG+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI-KDKSIVLTPADIKSYMLMTL---RGL 115
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTIGYRA 502
++HS H ++K +N+L+ D G ++D GLA P T T YRA
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASD--GVLKLADFGLARSFGSPNRKMTHQVVTRWYRA 170
Query: 503 PEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
PE+ R D++S G + E+L L G D+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP--GDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 342 LGKGSYGSTYKAIL------EDGTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNVV 393
LG+GS+G Y+ I E T V +K + E A+ + EF + V+ H +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSD----GGTALDWNSRM-KIALGTARGI 448
+ LV+ M G L L R + A +M ++A A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG-------YR 501
A++++ KF H ++ + N ++ +D I D G+ I + T R G +
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWM 188
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
+PE + + SDV+SFGV+L E+ T + P Q ++ V+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 61/287 (21%), Positives = 117/287 (40%), Gaps = 47/287 (16%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ--------------QMEVVGT 385
E LG G++G YK ++ ++ L+E+ F + ++ ++
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLA-LKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYM---PAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
+H N+V + D +V + P G F L + WN +++ L
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---FPTTATRTIG 499
+ ++H E + H ++ +N++L +D I+D GLA T+ TI
Sbjct: 125 A----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559
Y PE+ + +K+DV++FG +L +M T + P + +++ L +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLATKI---------- 225
Query: 560 EVFDVELLKYQDVEEEMV--QMLQIALSCVAKVPDSRPKMDDVVRMI 604
VE Y+ + E M + + SC+ ++RP + V MI
Sbjct: 226 ----VE-AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 46/218 (21%)
Query: 341 VLGKGSYGSTYKAILEDGT-------------TVVVKRLREVAATKREFEQQMEVVGTIG 387
VLGKG YG ++ G +V+ ++ A TK E +E V
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAE-RNILEAV---- 57
Query: 388 KHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDG----GTALDWNSRMKIAL 442
KH +V + Y + KL ++ Y+ G LFM L R +G TA + S + +AL
Sbjct: 58 KHPFIVDL-IYAFQTGGKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSEISLAL 113
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLA--HLINFPTTAT--R 496
+H +G + ++K N+LL D G + +D GL + T T
Sbjct: 114 E------HLHQQG---IIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGTVTHTFCG 162
Query: 497 TIGYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGKAP 533
TI Y APE+ R K+ D +S G L+ +MLTG P
Sbjct: 163 TIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 70/305 (22%), Positives = 120/305 (39%), Gaps = 63/305 (20%)
Query: 341 VLGKGSYGSTYKAI------LEDGTTVVVKRLREVAATKR------EFEQQMEVVGTIGK 388
LG+G +G KA TTV VK L+E A++ EF +V
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-----N 61
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-------------------SDGG 429
H +V+ + L++ Y GSL L +R +
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 430 TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489
AL + A +RG+ ++ +E K H ++ + NVL+ + ISD GL+ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYL-AE--MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 490 FPTTATR------TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDV 542
+ + + + A E + +SDV+SFGVLL E++T G P + +
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 543 VDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+L + + R E +E +M + L+C + PD RP D+ +
Sbjct: 239 FNLLKTGYRMERPENCSE-----------------EMYNLMLTCWKQEPDKRPTFADISK 281
Query: 603 MIEQI 607
+E++
Sbjct: 282 ELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 340 EVLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVR 396
V+G+G+YG K G V +K+ +E + + + V + +H N+V ++
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ K +V+ Y+ +L LL + L ++ + IA+ HS
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT-------ATRTIGYRAPEV---- 505
H +IK N+L+++ + D G A + ATR YRAPE+
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW--YRAPELLVGD 176
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T K DV++ G ++ E+L G+ PL
Sbjct: 177 TNYGKP---VDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQMEVVGTIG--KHSNV 392
++LGKG++G K IL G +K L+ EV K E + + +H +
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR--SDGGTALDWNSRMKIALGTARGIAF 450
++ + +KD V Y+ G LF L R R S+ T + + + AL +
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALD------Y 110
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVT 506
+HS K + ++K N++L +D + I+D GL + + T T T Y APEV
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
E + D + GV++ EM+ G+ P + H+ + +L
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400
+G+GS G A + G V VK + +RE V+ +H NVV + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
+E V+ ++ G+L ++ + R L+ + + + ++HS+G
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRKASQKSD 516
H +IKS ++LLT D +SD G I+ +++ + APEV + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 517 VYSFGVLLLEMLTGKAP 533
++S G++++EM+ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 340 EVLGKGSYGSTY---KAILEDGTTV----VVKR----LREVAATKREFEQQMEVVGTIGK 388
+VLG+GS+G + K D + V+K+ +R+ TK E + EV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----N 56
Query: 389 HSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT-AR 446
H +V + Y + + KL ++ ++ G LF L + + +K L A
Sbjct: 57 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELAL 109
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR---TIGYRA 502
+ +HS G + ++K N+LL ++ + ++D GL+ I+ A T+ Y A
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
PEV R +Q +D +SFGVL+ EMLTG P Q
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 32/211 (15%)
Query: 337 ASAEVLGKGSYGSTYKAI-LEDGTTVVVKRL-----REVAATKREFEQ-----QMEVVGT 385
S + +G G+YGS AI G V +K+L E+ A KR + + M
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA-KRAYRELTLLKHM----- 71
Query: 386 IGKHSNVVPVRAYYYSK---DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
+H NV+ + + S DE Y MP + L + G L + +
Sbjct: 72 --QHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIM---GHPLSEDKVQYLVY 124
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA-TRTIGYR 501
G+ +IHS G H ++K N+ + +D I D GLA + T T YR
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR 181
Query: 502 APEVTET-RKASQKSDVYSFGVLLLEMLTGK 531
APEV +Q D++S G ++ EMLTGK
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 62/234 (26%), Positives = 88/234 (37%), Gaps = 61/234 (26%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVGTI 386
LG+G++G YKA ++ G V +K+ LRE+ K+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL----------- 64
Query: 387 GKHSNVVPV--RAYYYSKDE---KLVVYSYMP--AGSLFMLLHRNRSDGGTALDWNSRMK 439
KH NVVP+ A + VY P L LL N S T M
Sbjct: 65 -KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYML 122
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLI--------N 489
L GI ++H H +IK++N+L+ D G I+D GLA
Sbjct: 123 QLL---EGINYLHE---NHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPPNPKG 174
Query: 490 FPTTATR-------TIGYRAPE-VTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
TR T YR PE + R+ + D++ G + EM T + LQ
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 363 VKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV--VYSYMPAGSLFML 420
V RL++ E EV H ++ R ++ D++ + + Y+P G LF
Sbjct: 39 VIRLKQEQHVHNEKRVLKEV-----SHPFII--RLFWTEHDQRFLYMLMEYVPGGELFSY 91
Query: 421 LH-RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479
L R T L + S + A + ++HS+ + ++K N+LL ++ + +
Sbjct: 92 LRNSGRFSNSTGLFYASEIVCA------LEYLHSKE---IVYRDLKPENILLDKEGHIKL 142
Query: 480 SDVGLA-HLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
+D G A L + T T Y APEV +++ ++ D ++ G+L+ EML G P
Sbjct: 143 TDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 28/224 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVR 396
++G+GSYG K E G V +K+ E K + M + + + H N+V +
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ K +V+ ++ L L + G LD + K RGI F HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL---EKYPNG--LDESRVRKYLFQILRGIEFCHSH-- 119
Query: 457 AKFTHGNIKSSNVLLTQDLNGCIS--DVGLAHLINFPT------TATRTIGYRAPE--VT 506
H +IK N+L++Q +G + D G A + P ATR YRAPE V
Sbjct: 120 -NIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYTDYVATRW--YRAPELLVG 174
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550
+T K + D+++ G L+ EMLTG+ PL G D+ L ++
Sbjct: 175 DT-KYGRAVDIWAVGCLVTEMLTGE-PL-FPGDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 42/211 (19%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 349 STYKAILEDGTTVVVKRLRE----VAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE 404
S YK I + V+++ ++ E +++ + I +N++ + + +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD 92
Query: 405 KL----VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
L ++ Y G L +L + + L + +++ +A+ +G+ ++ K+T
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLY-----KYT 142
Query: 461 ---HGNIKSSNVLLTQDLNGCISDVGLAH-LINFPTTATRTIGYRAPEVTET--RKASQK 514
+ N+ S + L+T++ I GL L + P + Y + ++ + + K
Sbjct: 143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
D+YS GV+L E+ TGK P ++ ++ DL
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233
|
Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 40/101 (39%), Positives = 54/101 (53%), Gaps = 20/101 (19%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLL--TQDLNGCISDVGLAHLIN-------FPT--TA 494
RG+ +IHS A H ++K SN+LL DL C D GLA + + F T A
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKIC--DFGLARIADPEHDHTGFLTEYVA 171
Query: 495 TRTIGYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGKAPL 534
TR YRAPE+ K K+ D++S G +L EML+ + PL
Sbjct: 172 TRW--YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 63/224 (28%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLR-----EVAA--TKREFE--QQMEVVGTIGKH 389
+G G+YG A + G V +K+L + A T RE + M H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DH 73
Query: 390 SNVV---PVRAYYYSKDEKLV----VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK--- 439
NV+ V ++ L VY M D N+ +K
Sbjct: 74 ENVIGLLDV----FTPASSLEDFQDVYLVTH----LM-----------GADLNNIVKCQK 114
Query: 440 --------IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491
+ RG+ +IHS A H ++K SN+ + +D I D GLA +
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171
Query: 492 TT---ATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGK 531
T ATR YRAPE+ +Q D++S G ++ E+LTGK
Sbjct: 172 MTGYVATRW--YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 35/210 (16%)
Query: 341 VLGKGSYGSTYKAILEDGTTV----------VVKRLREVAATKREFE--QQMEVVGTIGK 388
V+GKG++G D + V++ V E Q++
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK-GSVRNVLNERRILQELN------- 58
Query: 389 HSNVVPVRAYYYSKDEKL-VVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTAR 446
H +V + Y + +E + +V + G L + L + + W +I L
Sbjct: 59 HPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC--EIVLA--- 112
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TIGYRAP 503
+ ++HS+G H +IK N+LL + + I+D +A + T T T GY AP
Sbjct: 113 -LEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
EV + S D +S GV E L GK P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 395 VRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V+ YY + +K + V Y+P G L LL + G +LD + + ++H
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGGDLASLLE---NVG--SLDEDVARIYIAEIVLALEYLH 110
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCI-------SDVGL----AHLINFPTTATRTIG-- 499
S G H ++K N+L+ NG + S VGL +L + R +G
Sbjct: 111 SNG---IIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 500 -YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
Y APEV + S+ D +S G +L E L G P H + +
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF----HGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 341 VLGKGSYGSTYKA-ILEDGTTVVVKRLREVAATKREFE-------QQMEVVGTIGKHSNV 392
VLGKG +G + G K+L + KR+ E + +E V + V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS----RFV 62
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + Y +KD +V + M G L ++ + G D + A G+ +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT-----RTIGYRAPEVTE 507
E + + ++K N+LL + ISD+GLA + P T T+GY APEV
Sbjct: 120 RE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVIN 174
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
K + D + G L+ EM+ G++P +
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTT----VVVKRLREVAATK--REFEQQMEVVGTIGKHSNV 392
+VLG G++G+ YK + + +G V +K LRE + K +E + V+ ++ + +V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 71
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + +L+ MP G L ++ H++ L+W + A+G+ +
Sbjct: 72 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 124
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAP------E 504
+ + H ++ + NVL+ + I+D GLA L+ G + P E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
R + +SDV+S+GV + E++T G P
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 38/235 (16%)
Query: 342 LGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVV 393
+G+G++G ++A E T V VK L+E A+ + +F+++ ++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIV 71
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRN---------------RSDGGTALDWN--S 436
+ +++ YM G L L R G L +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 437 RMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR 496
++ IA A G+A++ SE KF H ++ + N L+ +++ I+D GL+ I + +
Sbjct: 132 QLCIAKQVAAGMAYL-SE--RKFVHRDLATRNCLVGENMVVKIADFGLSRNI-YSADYYK 187
Query: 497 T-------IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
I + PE + + +SDV+++GV+L E+ + G P H++V+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 42/221 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQ----- 379
E +G+G+YG YKA G V +K+ LRE++ + E
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 380 MEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK 439
++V K+ K +V+ Y+ + L + N G L +
Sbjct: 67 LDVEHVEEKNG-----------KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFP----TTA 494
+G+A H G H ++K N+L+ + I+D+GL + P T
Sbjct: 115 FMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 495 TRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+ YRAPEV + S D++S G + EM K PL
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 342 LGKGSYGSTYKAILEDGTT---VVVKRLREVAATKREFEQQMEVVGTIG----------K 388
+G+G+YG Y+A D T+ V +K++R + + + + +
Sbjct: 15 IGEGTYGIVYRA--RDTTSGEIVALKKVR--------MDNERDGIPISSLREITLLLNLR 64
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR------MK-IA 441
H N+V ++ ++VV ++ S+F+++ D + LD +K +
Sbjct: 65 HPNIVELK--------EVVVGKHL--DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTAT 495
L RG+ ++H H ++K SN+LLT GC I+D GLA P T
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTD--KGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 496 RTIGYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGKAPL 534
T+ YRAPE+ + D+++ G +L E+L K PL
Sbjct: 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 326 YFNFDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVG 384
+F D E L + +G GS+G+ Y A + + V +K++ + K+ E+ +++
Sbjct: 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIK 64
Query: 385 TIG-----KHSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRM 438
+ +H N + R Y + +V Y + + S + +H+ L
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIA 118
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
+ G +G+A++HS H ++K+ N+LL++ + D G A ++ T
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175
Query: 499 GYRAPEVTETRKASQ---KSDVYSFGVLLLEMLTGKAPL 534
+ APEV Q K DV+S G+ +E+ K PL
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---ATRTIGYRA 502
RG+ ++HS G H ++K SN+L+ ++ + I D GLA + + T +TR YRA
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--YRA 173
Query: 503 PEVTET-RKASQKSDVYSFGVLLLEMLTGKAPL 534
PE+ T +K + D++S G + EML GK PL
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR------EVAATK-REFEQQMEVVGTIGKHSN 391
E +G+G+YG YK + G V +K++R V +T RE E+ +H N
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-----QHPN 60
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL-GTARGIAF 450
+V ++ + +++ ++ S+ + + + G +D +K L +GI F
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMD-AELVKSYLYQILQGILF 116
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFP----TTATRTIGYRAPE 504
HS + H ++K N+L+ D G I +D GLA P T T+ YRAPE
Sbjct: 117 CHSR---RVLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171
Query: 505 V-TETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
V + + S D++S G + EM T K PL H
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 341 VLGKGSYGSTYKAILED--GTT--VVVKRLR-EVAATKREFEQQM---EVVGTIGKHSNV 392
VLGKGS+G K +L + GT +K L+ +V + E M V+ GK +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHR-NRSDGGTALDWNSRMKIALGTARGIAFI 451
+ + + + D V Y+ G L + + R A+ + + + I G+ F+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFL 117
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTAT--RTIGYRAPEVTE 507
HS+G + ++K NV+L + + I+D G+ ++ + TT T T Y APE+
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
+ + D ++FGVLL EML G+AP + D++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 342 LGKGSYGSTYKAIL-EDGTTVVVKRLREVAAT-------KREFEQQMEVVGTIGKHSNVV 393
LG+G++ + YK +L +V +EV+ R+ E + + S+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 394 PVRAYYYS-KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V+ Y +DE ++V Y+ G L + LHR + +L W ++ +A A + ++
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREK--NNVSLHW--KLDVAKQLASALHYLE 118
Query: 453 SEGGAKFTHGNIKSSNVLLTQ-DLNGC------ISDVGLAHLINFPTTATRT------IG 499
+ K HGN+ N+L+ + LN +SD G+ P T I
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI------PITVLSREERVERIP 169
Query: 500 YRAPEVTETRKAS--QKSDVYSFGVLLLEMLT-GKAPLQ 535
+ APE +AS +D +SFG LLE+ + G+ PL
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 34/239 (14%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEV--------VGTIGKHSNV 392
+G+G YG + A +D G V +KR++ K + EV + T K +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK-----KSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 393 VPVRAYYYSKDEKLVVYS--YMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIA 449
V + Y +D++ + + Y+P G LL+ A + + M A +
Sbjct: 64 V--KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA------VD 115
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG---YRAPEVT 506
+H G + H ++K N L+ + ++D GL+ T A +G Y APEV
Sbjct: 116 ALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVL 170
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-VDLPRWVRSVVREEWTAEVFDV 564
+ D +S G +L E L G P S ++ +L W ++ R + F++
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 342 LGKGSYGSTYKAILEDG---TTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVR 396
+G G +G + G VVVK LR A+ + +F ++ + ++ +HSN++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCL 61
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
L+V + P G L L R D + ++A A G+ +H
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRT---IGYRAPEVTETRK 510
F H ++ N LLT DL I D GL+H ++ T + + + APE+ +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 511 A-------SQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREE 556
+++S+V+S GV + E+ G P +H + V+ VRE+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TVREQ 226
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 61/277 (22%), Positives = 121/277 (43%), Gaps = 30/277 (10%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVR 396
+G+G + Y+A L D V +K+++ A +++ ++++++ + H NV+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYL 68
Query: 397 AYYYSKDEKLVVYSYMPAGSLF-MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ +E +V AG L M+ + + + + K + + +HS
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLIPERTVWKYFVQLCSAVEHMHSR- 125
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRKA 511
+ H +IK +NV +T + D+GL + TTA ++ Y +PE
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571
+ KSD++S G LL EM A LQ + D ++L + + + ++ + Y +
Sbjct: 184 NFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKIEQCDYPP----LPTEHYSE 235
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
E+V M C+ PD RP + V ++ +Q+
Sbjct: 236 KLRELVSM------CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 45/226 (19%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG------------- 387
LG+G+YG KA G V +K+++ + + + ++VG G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 388 --KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
KH N++ + Y D +V M A L ++ R L + I L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK-----IRLTESQVKCILLQIL 129
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-------------- 491
G+ +H F H ++ +N+ + I+D GLA +P
Sbjct: 130 NGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 492 ----TTATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKA 532
T+ T+ YRAPE+ K D++S G + E+LTGK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 51/236 (21%), Positives = 86/236 (36%), Gaps = 78/236 (33%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATK--REFEQQMEVV 383
+G G+YG A+ G V +K+ LRE+ K R
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREI---KLLRHL------- 56
Query: 384 GTIGKHSNVVPVRAYYYSKD----EKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM 438
+H N++ + + +V M LH+ + +
Sbjct: 57 ----RHENIIGLLDILRPPSPEDFNDVYIVTELMETD-----LHK-------VI----KS 96
Query: 439 KIALGTA----------RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488
L RG+ ++HS A H ++K SN+L+ + + I D GLA +
Sbjct: 97 PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
Query: 489 NFPTT---------ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+ TR YRAPE+ + + ++ D++S G + E+LT K PL
Sbjct: 154 DPDEDEKGFLTEYVVTRW--YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 23/225 (10%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRL-REVAATKREFEQQM---EVVGTIGKHSNVVP 394
+V+GKGS+G A + DG VK L +++ ++E + M V+ KH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIHS 453
+ + + ++ V ++ G LF L R RS A + + + ALG ++HS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG------YLHS 114
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH----LINFPTTATRTIGYRAPEVTETR 509
+ ++K N+LL + ++D GL + TT T Y APEV +
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPL----QHSGHDDVVDLPRWVR 550
D + G +L EML G P +D+++ P +R
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 64/296 (21%), Positives = 120/296 (40%), Gaps = 56/296 (18%)
Query: 326 YFNFDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVG 384
+ D E L E+ G GS+G+ Y A + V +K++ + K+ E+ +++
Sbjct: 8 FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIK 64
Query: 385 TIG-----KHSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRM 438
+ +H N + + Y + +V Y + + S + +H+ L
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK------PLQEVEIA 118
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
I G +G+A++HS + H +IK+ N+LLT+ ++D G A L++ + T
Sbjct: 119 AICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTP 175
Query: 499 GYRAPEVTETRKASQ---KSDVYSFGVLLLEMLTGKAP---------LQHSGHDDVVDLP 546
+ APEV Q K DV+S G+ +E+ K P L H +D L
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS 235
Query: 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+W+ + + SC+ K+P RP +++++
Sbjct: 236 -------SNDWS---------------DYFRNFVD---SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GY 500
A G+ F+HS+G + ++K NV+L + + I+D G+ F TRT Y
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDY 167
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
APE+ + + D ++FGVLL EML G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 326 YFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVV-VKRLREVAATKREFEQQMEVVG 384
++ D E++ E+ G GS+G+ Y A VV VK++ + K+ E+ +++
Sbjct: 14 FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMS--YSGKQTNEKWQDIIK 70
Query: 385 TIG-----KHSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRM 438
+ KH N + + Y + +V Y + + S + +H+ L
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIA 124
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
I G +G+A++HS H +IK+ N+LLT+ ++D G A + + T
Sbjct: 125 AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP 181
Query: 499 GYRAPEVTETRKASQ---KSDVYSFGVLLLEMLTGKAPL 534
+ APEV Q K DV+S G+ +E+ K PL
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQ-----MEVVGTIGKHSNVVPV 395
LG G++G YKA E G K V TK E E + +E++ T V +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAK----VIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 396 RAYYYSKDEKL-VVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
A+Y+ D KL ++ + P G++ ++L +R L I + ++HS
Sbjct: 76 GAFYW--DGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHS 128
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVT-- 506
K H ++K+ NVLLT D + ++D G++ N T R IG + APEV
Sbjct: 129 M---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 507 ETRKASQ---KSDVYSFGVLLLEMLTGKAP 533
ET K + K+D++S G+ L+EM + P
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 341 VLGKGSYGSTYKAIL--EDGT--TVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVP 394
+LGKG +GS +A L EDG+ V VK L+ + + E+ + + + H NV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 395 VRAYYYSKDEK------LVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+ K +V+ +M G L F+L+ R + L + ++ + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------NFPTTATRTIGY 500
G+ ++ S+ F H ++ + N +L +++ C++D GL+ I + + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
A E + SDV++FGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 5/173 (2%)
Query: 87 ANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNAL 145
+ L L L L N ++ LP +I +S+L+ + L NN +L + +L L+ L
Sbjct: 179 PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGL 237
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDS 205
+LS N ++P NL+ L L+L NN IS +L L+ L+ S N+L+ ++P
Sbjct: 238 ELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLI 296
Query: 206 LQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFP-TISPHKNASRKKLN 257
+ N +L L S + + T SP + + LN
Sbjct: 297 ALLLLLLELLLNLLLTLKALEL-KLNSILLNNNILSNGETSSPEALSILESLN 348
|
Length = 394 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM----EVVGTIGKHSNVVPV 395
V+GKGS+G A DG VK L++ A K++ ++ + V+ KH +V +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ + D+ V Y+ G LF L R RS + +R A A + ++HS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARF-YAAEIASALGYLHS-- 114
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTETRKA 511
+ ++K N+LL + ++D GL + + TT+T T Y APEV +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
+ D + G +L EML G P ++ D
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 43/246 (17%)
Query: 342 LGKGSYGSTYKA--ILEDGTTVVVKRLREVA-------ATKREFE--QQMEVVGTIGKHS 390
+G+G+YG +KA + G V +KR+R +T RE + +E +H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHP 64
Query: 391 NVVPV----RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
NVV + ++ KL + L L + + G + M L R
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQL--LR 121
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TTATRTIGYRAP 503
G+ F+HS + H ++K N+L+T ++D GLA + +F T+ T+ YRAP
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD--------DVVDLPRWVRSVVRE 555
EV + D++S G + EM K PL D DV+ LP E
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPG------EE 231
Query: 556 EWTAEV 561
+W +V
Sbjct: 232 DWPRDV 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 43/215 (20%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKR----------EFEQQMEVVGTIGKHSN 391
LG G++G YKA K AA K +F +++++ KH N
Sbjct: 13 LGDGAFGKVYKA--------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPN 63
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FML-LHRNRSDGGTALDWNSRMKIALGTARGI 448
+V + Y+ +++ ++ + G+L ML L R ++ + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEAL 116
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAP 503
F+HS K H ++K+ N+LLT D + ++D G++ N T R IG + AP
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAP 172
Query: 504 EV--TETRKAS---QKSDVYSFGVLLLEMLTGKAP 533
EV ET K + K+D++S G+ L+E+ + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVK--RLREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
E LG+GSY + YK + +G V +K RL+E T ++ ++ + KH+N+V +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLH 69
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
++K+ +V+ Y+ + + ++ GG + N ++ + RG+++IH
Sbjct: 70 DIIHTKETLTLVFEYVHTD---LCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQR-- 122
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEV-TETRKA 511
H ++K N+L++ ++D GLA + P + T+ YR P+V + +
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
S D++ G + +EM+ G A G D+ D
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAF--PGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 21/124 (16%)
Query: 419 MLLHRNRSDGGTALDWNSRMKIALGTA--------RGIAFIHSEGGAKFTHGNIKSSNVL 470
M+L SD T L SR + + A G+ ++H + H ++K+ N+
Sbjct: 134 MVLPHYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIF 189
Query: 471 LTQDLNGCISDVGLAHLINFPTTATR------TIGYRAPEVTETRKASQKSDVYSFGVLL 524
+ CI D+G A FP A T+ APEV K + K+D++S G++L
Sbjct: 190 INDVDQVCIGDLGAAQ---FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVL 246
Query: 525 LEML 528
EML
Sbjct: 247 FEML 250
|
Length = 357 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 339 AEVLGKGSYGSTYKAILED-GTTVVVKRL------REVAATKREFEQQMEVVGTIGKHSN 391
++LG+G++G Y D G + VK++ +E + E +++++ + +H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDR 65
Query: 392 VVPVRAYYYS-----KDEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+V YY +++KL ++ YMP GS+ +++ AL N +
Sbjct: 66 IVQ----YYGCLRDPEEKKLSIFVEYMPGGSI-----KDQLKAYGALTENVTRRYTRQIL 116
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-------TTATRTI 498
+G++++HS H +IK +N+L N + D G + I + T T
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ +PEV +K+DV+S ++EMLT K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQM----EVVGTIGKHSNVVP 394
+V+GKGS+G A + DG+ VK L++ K++ + + V+ KH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 395 VRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ Y + EKL V Y+ G LF L R R L+ +R A A I ++HS
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARF-YAAEVASAIGYLHS 114
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETR 509
+ ++K N+LL + ++D GL P T T Y APEV
Sbjct: 115 L---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPL 534
+ D + G +L EML G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 60/224 (26%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATK----------------RE--FEQQMEVV 383
LGKG+YG +KAI D +R +EV A K RE F Q++
Sbjct: 15 LGKGAYGIVWKAI--D------RRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL--- 63
Query: 384 GTIGKHSNVVPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRN-RSDGGTALDWNSRMKI 440
G H N+V + ++++K +V+ YM LH R+ D + R I
Sbjct: 64 ---GDHPNIVKLLNVIKAENDKDIYLVFEYMETD-----LHAVIRA--NILEDVHKRY-I 112
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------FPT- 492
+ + +IHS H ++K SN+LL D ++D GLA ++ P
Sbjct: 113 MYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 493 ---TATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKA 532
ATR YRAPE+ + + ++ D++S G +L EML GK
Sbjct: 170 TDYVATRW--YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 3e-07
Identities = 26/62 (41%), Positives = 35/62 (56%), Gaps = 6/62 (9%)
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L +LDLS N T IP G F+ L L +L+L N+++ I P LP L+ L+ S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 197 NL 198
NL
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 341 VLGKGSYGSTYKAILE----DGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVP 394
+LG G +G + L+ V + LR + K+ E + T+G+ HSN+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL-TLGQFDHSNIVR 70
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + ++V YM G+L L ++ L M + G A G+ ++
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM 126
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG-----YRAPEVTETR 509
G + H + + VL+ DL IS T G + APE +
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 510 KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
S SDV+SFG+++ E+++ G+ P DV+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQM--EVVGTIGKHSNV 392
++LGKG++G K IL G +K L+ EV K E + V +H +
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFI 451
++ + + D V Y G LF L R R A + + + AL ++
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD------YL 111
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTE 507
HSE + ++K N++L +D + I+D GL + + T T T Y APEV E
Sbjct: 112 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+ D + GV++ EM+ G+ P + H+ + +L
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 46/214 (21%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVGTI 386
+G+GSYG +K E G V +K+ LRE+ K+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL----------- 57
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
KH N+V + + K + +V+ Y ++ L +N + + KI T +
Sbjct: 58 -KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPR----GVPEHLIKKIIWQTLQ 111
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT------ATRTIGY 500
+ F H H ++K N+L+T+ + D G A ++ P ATR Y
Sbjct: 112 AVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW--Y 166
Query: 501 RAPE--VTETRKASQKSDVYSFGVLLLEMLTGKA 532
RAPE V +T+ DV++ G + E+LTG+
Sbjct: 167 RAPELLVGDTQYGP-PVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQM----EVVGTIGKHSNVVP 394
+V+GKGS+G A + + VK L++ A K++ E+ + V+ KH +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + + D+ V Y+ G LF L R R L+ +R A A + ++HS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARF-YAAEIASALGYLHS- 114
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTETRK 510
+ ++K N+LL + ++D GL T T Y APEV +
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSG----HDDVVDLP 546
+ D + G +L EML G P +D++++ P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 33/176 (18%)
Query: 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-GTALDWNSRMKIALGTAR 446
+H N++ + + V+ +M GS LL +G AL N I G R
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALR 112
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL-------------INFPTT 493
G+ ++H G + H NIK+S++L++ D G +S GL+HL +FP
Sbjct: 113 GLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167
Query: 494 ATRTIGYRAPEV--TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547
+T + + +PE+ + + KSD+YS G+ E+ TG+ P Q D+ R
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ--------DMLR 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQMEVVGTIGKHSNVVP 394
+G+G +G Y+ + + V VK + + + RE Q + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ +++ +V P G L L N+ +LD S + + + +A++ S+
Sbjct: 72 LIGVI-TENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK 126
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--TATRT---IGYRAPEVTETR 509
+F H +I + NVL++ + D GL+ + + A++ I + APE R
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 510 KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
+ + SDV+ FGV + E+L G P Q ++DV+
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 33/225 (14%)
Query: 329 FDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRL----REVAATKREFEQQMEVV 383
FD+ + E +G G+YG AI G V +K++ KR ++++++
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKIL 58
Query: 384 GTIGKHSNVVPVRAYYYSKDEKL----VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK 439
KH N++ +R VV M L ++H SD + ++
Sbjct: 59 RHF-KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIH---SDQPLTEE---HIR 110
Query: 440 IALGTA-RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--------NF 490
L RG+ +IHS A H ++K SN+L+ +D I D G+A + F
Sbjct: 111 YFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 491 PTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPL 534
T T YRAPE+ + + + D++S G + EML G+ L
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATK------REFEQQMEVVGTIGKHSNVVPV 395
+G+G+YG YKA +DG L+++ T RE E+ KH NV+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-----KHPNVIAL 63
Query: 396 RAYYYSKDEKLV--VYSYMPAGSLFML-LHRNRSDGGTALDWNSRMKIAL--GTARGIAF 450
+ + S ++ V ++ Y ++ HR + M +L GI +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 451 IHSEGGAKFTHGNIKSSNVLLT----QDLNGCISDVGLAHLINFPTT-------ATRTIG 499
+H+ H ++K +N+L+ + I+D+G A L N P T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 500 YRAPE-VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
YRAPE + R ++ D+++ G + E+LT + P+ H +D+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 50/222 (22%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQ---MEVVGTIGKHSNVVPV 395
E LG+G+YG K GT + VKR+R AT EQ+ M++ I S P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIR---ATVNSQEQKRLLMDL--DISMRSVDCPY 61
Query: 396 RAYYYSKDEKLVVYSYMPAGSLF--------MLL--------HRNRSDGGTALDWNSRMK 439
+Y G+LF M + ++ D G + + K
Sbjct: 62 TVTFY--------------GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTI 498
IA+ + + ++HS+ H ++K SNVL+ ++ + D G++ +L++ T
Sbjct: 108 IAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTIDA 164
Query: 499 G---YRAPE-VTETRKASQ---KSDVYSFGVLLLEMLTGKAP 533
G Y APE + KSDV+S G+ ++E+ TG+ P
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL--INF---PTTATRTIGYR 501
GI +HS G H ++K SN+++ D I D GLA NF P TR YR
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY--YR 189
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
APEV + D++S G ++ E++ G Q + H D
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVR 396
E +G+G++G + L D T V VK RE K +F Q+ ++ H N+V +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 59
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
K +V + G L R++G L +++ A G+ ++ S+
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL---RTEG-PRLKVKELIQMVENAAAGMEYLESK-- 113
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHL----INFPTTATRTI--GYRAPEVTETRK 510
H ++ + N L+T+ ISD G++ + T + I + APE +
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 511 ASQKSDVYSFGVLLLEMLT-GKAP 533
S +SDV+SFG+LL E + G P
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLR---EVAATKRE---FEQQMEVVGTIGKHSN 391
++LG+G++G Y ++ G + K+++ E T +E E +++++ + +H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHER 65
Query: 392 VVPVRAYYYSKDEKL--VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V + EK + YMP GS+ +++ AL + K G++
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSV-----KDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINFPTTATRTIG----YRA 502
++H H +IK +N+L N + D G + I T R++ + +
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PEV +K+DV+S G ++EMLT K P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 27/213 (12%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQM----EVVGTIGKHSNVVPVR 396
LG G +G ++ T +K +++ + ++ + E++ H +V +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 397 AYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ KD+K + + Y G L+ +L G ++ +R IA ++H+
Sbjct: 60 RTF--KDKKYIYMLMEYCLGGELWTILRDR----GLFDEYTARFYIA-CVVLAFEYLHNR 112
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCIS--DVGLAHLINFPTTATRTI----GYRAPEVTET 508
G + ++K N+LL D NG + D G A + T T Y APE+
Sbjct: 113 G---IIYRDLKPENLLL--DSNGYVKLVDFGFAKKL-KSGQKTWTFCGTPEYVAPEIILN 166
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
+ D +S G+LL E+LTG+ P D
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 41/219 (18%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREV-----AATK--REFEQQMEVVGTIGKHSN 391
EV+GKGSYG AI G V +K++ +V AT+ RE + + + +H +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-----LLRLLRHPD 60
Query: 392 VVPVRAYYYSKDEK-----LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+V ++ + VV+ M + L ++ N D T + L R
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHHQFFLYQLL---R 114
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTT-------ATRT 497
+ +IH+ A H ++K N+L D I D GLA + PT ATR
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 498 IGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ + K + D++S G + E+LTGK PL
Sbjct: 172 --YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVK--RLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LGKG+YGS YK + G T+ +K RL + + +++++ H V P
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL-----HKAVSPYIVD 63
Query: 399 YYSK--DEKLVVY--SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+Y E V YM AGSL L + G + + +I +G+ F+ E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG--IPEDVLRRITYAVVKGLKFLKEE 121
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVTETRK 510
H ++K +NVL+ + + D G++ N + +T IG Y APE ++
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 511 ASQ------KSDVYSFGVLLLEMLTGKAP 533
+Q +SDV+S G+ +LEM G+ P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 32/270 (11%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN---VVPVRA 397
LGKG +G +++ G K+L + K+ E+ + I + N +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 398 YYYSKDEKLVVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ SK +V S M G L + + + G L+ + + GI +HS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV----GERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TIGYRAPEVTETRKASQ 513
+ ++K NVLL N +SD+GLA + T T+ T GY APE+ + S
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
D ++ G + EM+ G+ P + H + V R + +E E +Q+
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKD--HKEKVAKEELKRRTLEDEVKFE--------HQNFT 223
Query: 574 EEMVQMLQIALSCVAKVPD----SRPKMDD 599
EE + ++ L AK P+ SR K DD
Sbjct: 224 EESKDICRLFL---AKKPEDRLGSREKNDD 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 12/205 (5%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAATKRE-FEQQMEVVGTIGK-HSNVVPVRAY 398
LGKG +G + G K+L + KR+ +E M + K HS + AY
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 399 -YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
+ +K + +V + M G L ++ N + G+ +H
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEVTETRKASQ 513
+ + ++K NVLL D N ISD+GLA + + T+ T G+ APE+ + +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSG 538
D ++ GV L EM+ + P + G
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQMEVVGTI--GKHSNV 392
++LGKG++G K IL G +K LR EV K E + + +H +
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFI 451
++ + + D V Y G LF L R R A + + + AL ++
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL------EYL 111
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPEVTE 507
HS + +IK N++L +D + I+D GL + + T T T Y APEV E
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+ D + GV++ EM+ G+ P + H+ + +L
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 342 LGKGSYGSTYKAILE-DGTTVVVKRL--REVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+G G+ G+ YK I G +K + +R+ +++E++ + H NVV
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDM 140
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ E V+ +M GSL +G D +A GIA++H
Sbjct: 141 FDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQILSGIAYLHRR---H 188
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVG----LAHLINFPTTATRTIGYRAPEVTET-----R 509
H +IK SN+L+ N I+D G LA ++ ++ TI Y +PE T
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPL 534
D++S GV +LE G+ P
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 341 VLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQMEVVGTIGK 388
VLG+G +G K +L + G +K L+ EV + E ++ E +
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE-KRIFETANSER- 60
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H +V + A + ++D V Y G L M +H + A+ + + + + L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGL------ 114
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRAPE 504
++H + ++K N+LL + I+D GL + T+T T + APE
Sbjct: 115 QYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556
V ++ D + GVL+ EML G++P ++V D S+V +E
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDE 217
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRL----REVAATKREFEQQMEVVGTIGKHSNVV--- 393
+G G+YGS A + G V VK+L + + KR + +++ ++ + KH NV+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHM-KHENVIGLL 82
Query: 394 ----PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
P R+ D LV + M N L + + RG+
Sbjct: 83 DVFTPARSLEEFNDVYLVTH--------LMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTIGYRAPEVT-E 507
+IHS A H ++K SN+ + +D I D GLA H + T T YRAPE+
Sbjct: 135 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 191
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+Q D++S G ++ E+LTG+ + H D + L
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 56/232 (24%), Positives = 86/232 (37%), Gaps = 51/232 (21%)
Query: 342 LGKGSYGSTYKAILED---GTTVVVKRLRE----VAATKREFEQQMEVVGTIGKHSNVVP 394
+GKG G Y A D V +K++RE K+ F ++ ++ + H +VP
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVP 66
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALG 443
V Y + VY MP + L +S T++ + + I
Sbjct: 67 V---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV--GAFLSIFHK 121
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------------- 489
I ++HS+G H ++K N+LL I D G A
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 490 --------FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
P T Y APE AS+ +D+Y+ GV+L +MLT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 33/98 (33%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA-TRTIGYRAPE 504
+G+ +IH+ G H ++K N+ + +D I D GLA + T T YRAPE
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPE 185
Query: 505 VTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
V +Q D++S G ++ EMLTGK + H D
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVPVRA 397
E LG+GSY + YK I +G V +K + F E G KH+N+V +
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 398 YYYSKDEKLVVYSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
++K+ V+ YM + +M+ H GG L + RG+A+IH G
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQH----PGG--LHPYNVRLFMFQLLRGLAYIH---G 121
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEV-TETRKA 511
H ++K N+L++ ++D GLA + P ++ T+ YR P+V
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 512 SQKSDVYSFGVLLLEMLTGK 531
S D++ G + +EML G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 9/91 (9%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---ATRTIGYRA 502
RG+ +IHS G H ++K SNV + +D I D GLA + T ATR YRA
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW--YRA 183
Query: 503 PEVT-ETRKASQKSDVYSFGVLLLEMLTGKA 532
PE+ +Q D++S G ++ E+L GKA
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLL-TQDLNGCISDVGLAHLIN-------FPTTATRT 497
RG+ +IHS A H ++K +NV + T+DL I D GLA +++ + + T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 498 IGYRAPE-VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
YR+P + ++ D+++ G + EMLTGK PL H+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATKREFEQQMEVVGTI--------G 387
++LGKG++G K IL G +K L++ ++ EV T+
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKD-----EVAHTLTESRVLQNT 52
Query: 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR--SDGGTALDWNSRMKIALGTA 445
+H + ++ + + D V Y G LF L R R S+ + + + ALG
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALG-- 109
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL-INFPTTATRTIG---YR 501
++HS + ++K N++L +D + I+D GL I+ T G Y
Sbjct: 110 ----YLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
APEV E + D + GV++ EM+ G+ P + H+ + +L
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 36/223 (16%)
Query: 335 LRASAE------VLGKGSYGSTYKAILEDGTTVV--VKRLREVAATKRE----FEQQMEV 382
LR AE V+G+G++G + + T V +K L + KR F ++ ++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 383 VGTIGKHSNVVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
+ +S V V+ +Y +D++ + V YMP G L L+ A + + + +
Sbjct: 97 MAF--ANSPWV-VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TTAT 495
AL IHS G F H ++K N+LL + + ++D G +N TA
Sbjct: 154 ALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 496 RTIGYRAPEVTETRKAS----QKSDVYSFGVLLLEMLTGKAPL 534
T Y +PEV +++ ++ D +S GV L EML G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+YS E + +M GSL +L + + N KI++ RG+ ++ + K
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVLKKAGR-----IPENILGKISIAVLRGLTYLREK--HK 120
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYRAPEVTETRKASQKSD 516
H ++K SN+L+ + D G++ LI+ + T Y +PE + + +SD
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSD 180
Query: 517 VYSFGVLLLEMLTGKAPL 534
++S G+ L+EM G+ P+
Sbjct: 181 IWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 343 GKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIG-----KHSNVVPVR 396
G+G+YG YKA ++G +++ K ++ I KH NVV +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 397 AYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ +K V ++ Y L+ ++ +R ++ + + G+ ++HS
Sbjct: 69 EVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGC----ISDVGLAHLINFPTTA-------TRTIGYRAP 503
H ++K +N+L+ + I D+GLA L N P TI YRAP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184
Query: 504 EVTETRKASQKS-DVYSFGVLLLEMLT 529
E+ + K+ D+++ G + E+LT
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 51/243 (20%), Positives = 88/243 (36%), Gaps = 51/243 (20%)
Query: 340 EVLGKGSYGSTYKAILED-GTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
+ LG GS+G + G +K +L++V E + +H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-----RHP 61
Query: 391 NVVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR-- 446
+V Y +D+ + V Y+P G LF L ++ + AR
Sbjct: 62 FLV--NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------------RFPEPVARFY 106
Query: 447 ------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRTIG 499
+ ++HS + ++K N+LL D I+D G A + T T T
Sbjct: 107 AAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE 163
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--------VDLPRWVRS 551
Y APE+ ++ + D ++ G+L+ EML G P + V P +
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSP 223
Query: 552 VVR 554
+
Sbjct: 224 DAK 226
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 10/160 (6%)
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+ N + + + +++ Y+ G LF LL + L KI
Sbjct: 66 KDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVE 120
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFPTTATRTIGYRAPEV 505
+ +H H +IK NVL + + + D GL +I P+ T+ Y +PE
Sbjct: 121 ALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEK 177
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+ D ++ GVL E+LTGK P + D+ +DL
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 341 VLGKGSYGSTYKAILEDGTTV----VVKR--------LREVAATKREFEQQMEVVGTIGK 388
V+G+GSY L+ + VVK+ + V K FEQ +G
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARG 447
HS + + +V Y+ G L + R R A + + + IAL
Sbjct: 62 HS-------CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN---- 110
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAP 503
F+H G + ++K NVLL D + ++D G+ P T T Y AP
Sbjct: 111 --FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP 546
E+ + D ++ GVL+ EM+ G++P D + D P
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPF-----DIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATK------REFEQQMEVVGTIGKHSNVVPV 395
+G+G+YG YKA +DG L+++ T RE E+ KH NV+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-----KHPNVISL 63
Query: 396 RAYYYSKDEKLV--VYSYMPAGSLFML-LHRNRSDGGTALDWNSRMKIAL--GTARGIAF 450
+ + S ++ V ++ Y ++ HR + M +L GI +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 451 IHSEGGAKFTHGNIKSSNVLLT----QDLNGCISDVGLAHLINFPTT-------ATRTIG 499
+H+ H ++K +N+L+ + I+D+G A L N P T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 500 YRAPE-VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
YRAPE + R ++ D+++ G + E+LT + P+ H +D+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 341 VLGKGSYGSTY---KAILED-GTTVVVKRLREV-----AATKREFEQQMEVVGTIGKHSN 391
VLG G+YG + K D G +K L++ A T + +V+ + +
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 392 VVPVRAYYYSKDEKL-VVYSYMPAGSLFM-LLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V + Y + D KL ++ Y+ G LF L R + + + +AL +
Sbjct: 67 LVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR------TIGYRAP 503
I+ + IK N+LL + + ++D GL+ R TI Y AP
Sbjct: 126 IIYRD---------IKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYMAP 175
Query: 504 EV--TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538
EV + + D +S GVL E+LTG +P G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 30/176 (17%)
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT------I 498
ARG+ F+ S K H ++ + N+LL+++ I D GLA I R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDD--VVDLPRWVRSVVRE 555
+ APE + + +SDV+SFGVLL E+ + G +P D+ L R E
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE 299
Query: 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
T E++ I L C P+ RP ++V ++ + Q
Sbjct: 300 YATPEIY------------------SIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TTATRTIGY 500
RG+ ++HS A H +IK N+L+ + I D GLA + T T Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 501 RAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538
RAPE+ +R + D++S G + E+L + Q
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 341 VLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFE-------QQMEVVGTIGKHSNV 392
+G+G+YG YKA +D G V +K++R E E ++++++ + H N+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR----LDNEKEGFPITAIREIKILRQL-NHRNI 68
Query: 393 VPVRAYYYSKDEKL----------VVYSYMPAGSLFMLLHRNRSDGGTALDWN-----SR 437
V ++ K + L +V+ YM L LL + ++ S
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG------LVHFSEDHIKSF 121
Query: 438 MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----T 492
MK L G+ + H + F H +IK SN+LL ++D GLA L N T
Sbjct: 122 MKQLL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 493 TATRTIGYRAPEVT--ETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
T+ YR PE+ E R DV+S G +L E+ T K Q
Sbjct: 176 NKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 26/208 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-------REFEQQMEVVGTIGKHSN 391
E +G+G+YG+ +KA E V +KR+R + RE E+ KH N
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKN 60
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+V + +S + +V+ Y L + +D +G+AF
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEVTE 507
HS H ++K N+L+ ++ ++D GLA P + T+ YR P+V
Sbjct: 116 HSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 508 TRKASQKS-DVYSFGVLLLEMLTGKAPL 534
K S D++S G + E+ PL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 18/147 (12%)
Query: 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKS 466
+V Y AG L + ++R+ + + + + +HS+ H +IKS
Sbjct: 116 LVLDYANAGDLRQEI-KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKS 171
Query: 467 SNVLLTQDLNGCIS--DVGLAHLINFPTTATRTIG--------YRAPEVTETRKASQKSD 516
+N+LL NG + D G + + + T + +G Y APE+ + S+K+D
Sbjct: 172 ANILLCS--NGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227
Query: 517 VYSFGVLLLEMLTGKAPLQHSGHDDVV 543
++S GVLL E+LT K P ++V+
Sbjct: 228 MFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 42/246 (17%)
Query: 303 KPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYG----STYKAILEDG 358
K KD S + KNK+ + D FNF LG GS+G +TYK ED
Sbjct: 11 KKKDSDSTKEPKRKNKMKYED---FNF---------IRTLGTGSFGRVILATYKN--EDF 56
Query: 359 TTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVP----VRAYYYSKDEKLV--VYSYM 412
V +KR + K ++Q++ V + K N + V Y KDE + V ++
Sbjct: 57 PPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113
Query: 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALG---TARGIAFIHSEGGAKFTHGNIKSSNV 469
G F L RN+ R +G A+ + + ++K N+
Sbjct: 114 IGGEFFTFLRRNK-----------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162
Query: 470 LLTQDLNGCISDVGLAHLINFPT-TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528
LL +D ++D G A +++ T T T Y APE+ + +D ++ G+ + E+L
Sbjct: 163 LLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 529 TGKAPL 534
G P
Sbjct: 223 VGCPPF 228
|
Length = 340 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 44/212 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK--RLREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
E+LG G+ G+ YKA L + VK L +++ ++E++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL------------- 53
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNR-------SDGGTALDWNSRM------KIALG 443
Y D ++ Y G+ F+ NR DGG+ LD ++ +IA+
Sbjct: 54 ---YKCDSPYIIGFY---GAFFV---ENRISICTEFMDGGS-LDVYRKIPEHVLGRIAVA 103
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYR 501
+G+ ++ S K H ++K SN+L+ + D G++ L+N T T Y
Sbjct: 104 VVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYM 160
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
APE + SDV+S G+ +E+ G+ P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--------FPTTATRT 497
G+ +IHS A H ++K N+L+ D I D GLA + F T T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 498 IGYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGK 531
YRAPE+ + ++ K+ DV+S G +L E+L K
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVRAYY 399
LG G++G YKA ++ + ++ + ++ E E M + + H N+V + +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 400 YSKDEKLVVYSYMPAGSL-FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
Y ++ ++ + G++ ++L R L + T + ++H K
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR----------APEV--- 505
H ++K+ N+L T D + ++D G++ TRTI R APEV
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 506 --TETRKASQKSDVYSFGVLLLEMLTGKAP 533
++ R K+DV+S G+ L+EM + P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 51/232 (21%), Positives = 102/232 (43%), Gaps = 28/232 (12%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ--------QMEVVGTIGKHSN 391
E LG+G+Y + +K G + + + L + + E E+ ++ ++ + KH+N
Sbjct: 12 EKLGEGTYATVFK-----GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHAN 65
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+V + ++ +V+ Y+ L + D G + ++ RG+A+
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV-T 506
H K H ++K N+L+ + ++D GLA + PT T+ YR P+V
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP-RWVRSVVREEW 557
+ + S + D++ G + EM +G+ S +D + L R + + E W
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 46/206 (22%), Positives = 93/206 (45%), Gaps = 28/206 (13%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ--------QMEVVGTIGKHSNVV 393
LG+G+Y + YK G + + L + + E E+ ++ ++ + KH+N+V
Sbjct: 14 LGEGTYATVYK-----GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIV 67
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ +V+ Y+ L + D G +++ ++ RG+ + H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKD-----LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV-TET 508
K H ++K N+L+ + ++D GLA + PT T+ YR P++ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPL 534
S + D++ G + EM TG+ PL
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 6/132 (4%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQNNYFSGVLPAFRSL-QLNAL 145
+ + +L L L L +N + +P I S+L+ + L +N + R+L L L
Sbjct: 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNL 168
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPR-LKILNFSNNNLNGSIPD 204
DLSFN + ++P NL+ L+ L+L N IS P + L L+ L+ SNN++ +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLS 226
Query: 205 SLQTFPNSSFVG 216
SL N S +
Sbjct: 227 SLSNLKNLSGLE 238
|
Length = 394 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLR---EVAATKRE---FEQQMEVVGTIGKHSN 391
++LG+G++G Y D G + VK+++ E T +E E +++++ + H
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHER 65
Query: 392 VVPVRAYYYSKDEKL--VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V E+ + +MP GS+ +++ AL N K G++
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSI-----KDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA---HLINFPTTATRTIG----YRA 502
++HS H +IK +N+L N + D G + I T +++ + +
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PEV +K+D++S G ++EMLT K P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 356 EDGTTVVVKRLREVAATK----REFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL-VVYS 410
G V +K LR A + F ++ + + H N+V + + L V+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLDSGEAPPGLLFAVFE 59
Query: 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVL 470
Y+P +L +L +DG AL ++ L +A H++G H ++K N++
Sbjct: 60 YVPGRTLREVL---AADG--ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 471 LTQ-DLNGC--ISDVGLAHLI-----NFPTTATRT---IG---YRAPEVTETRKASQKSD 516
++Q + + D G+ L+ T TRT +G Y APE + SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 517 VYSFGVLLLEMLTGKAPLQHSGHDDV---------VDLPRWVRS 551
+Y++G++ LE LTG+ +Q + ++ V LP W+
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG G+ G K + ++ ++L + A + + ++++V+ +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+YS E + +M GSL +L + L K+++ RG+A++ + +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQ 124
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYRAPEVTETRKASQKSD 516
H ++K SN+L+ + D G++ LI+ + T Y +PE + S +SD
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 517 VYSFGVLLLEMLTGKAPL 534
++S G+ L+E+ G+ P+
Sbjct: 185 IWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 51/240 (21%)
Query: 338 SAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
S +V+G+G++G +D G +K LR+ ++E + I ++ + V
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 397 AYYYSKDEKLVVY---SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+YS +KL +Y ++P G + LL + T + ++ IA T I IH
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGL------AHLINF--------PTTAT---- 495
G F H +IK N+LL + +SD GL AH F P+ T
Sbjct: 120 LG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 496 ------------------RTIG---YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+G Y APEV ++ D +S GV++ EML G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 34/228 (14%)
Query: 342 LGKGSYGSTYKAILEDGTTV-VVKRLREVAATKREFEQQMEVVGTIGKHSN--------V 392
+GKGS+G + D + +K +R+ R EV T+ + + +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRN-RSDGGTALDWNSRMKIALGTARGIAFI 451
VP++ + S ++ +V +++ G LF L R R D A + + + AL I
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTE 507
+ + +K N+LL + + D GL L T T Y APE+
Sbjct: 116 YRD---------LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555
++ D ++ GVLL EMLTG P +D+ ++ R +++E
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPF----YDE--NVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHS---------- 390
+GKG++G Y+ +D +K L +K+E + EV TIG+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-----SKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 391 -NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V ++ + + + +V YM G LF L + G + ++ IA +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIA-ELVLALE 110
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL--AHLINFPTTAT--RTIGYRAPEV 505
+H + ++K N+LL + + D GL A+L + TT T T Y APEV
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
Query: 506 TETRKASQKS-DVYSFGVLLLEMLTGKAPL 534
K K D +S GVL+ EM G +P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTAT--RTIGY 500
+ G+ F+H G + ++K NV+L + + I+D G+ H+++ TT T T Y
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDY 167
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
APE+ + + D +++GVLL EML G+ P D++
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 61/233 (26%), Positives = 91/233 (39%), Gaps = 49/233 (21%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVP--VRA 397
V+G+G++G + + G +K LR+ KR + I ++ P V+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKL 66
Query: 398 YYYSKDEKLV--VYSYMPAGSLFMLL-HRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
YY +DE+ + V YMP G L LL ++ TA R IA + +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA-----RFYIAELVL-ALDSVHKL 120
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLA----------------HLINFPTTATR-- 496
G F H +IK N+L+ D + ++D GL H + F
Sbjct: 121 G---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 497 ------------TIG---YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+G Y APEV + D +S GV+L EML G P
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 341 VLGKGSYGSTYKAILED-GTTVVVKRL--REVAATKREF----EQQMEVVGTIGKHSNVV 393
++G+G +G Y D G +K L + + + E E+ M + + G +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ D+ + M G L H + S G + R A G+ +H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRF-YATEIILGLEHMHN 115
Query: 454 EGGAKFT-HGNIKSSNVLLTQDLNGCISDVGLAHLINF----PTTATRTIGYRAPEVTET 508
+F + ++K +N+LL + + ISD+GLA +F P + T GY APEV +
Sbjct: 116 ----RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 509 RKASQKS-DVYSFGVLLLEMLTGKAPL-QHSGHD 540
A S D +S G +L ++L G +P QH D
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 29/188 (15%)
Query: 358 GTTVVVKRLR------EVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE---KLVV 408
G V VK L+ +A K+E E + H N+V + KL++
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLY-----HENIVKYKGICTEDGGNGIKLIM 87
Query: 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSN 468
++P+GSL L RN++ ++ ++K A+ +G+ ++ G ++ H ++ + N
Sbjct: 88 -EFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARN 139
Query: 469 VLLTQDLNGCISDVGLAHLIN----FPTTAT---RTIGYRAPEVTETRKASQKSDVYSFG 521
VL+ + I D GL I + T + + APE K SDV+SFG
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFG 199
Query: 522 VLLLEMLT 529
V L E+LT
Sbjct: 200 VTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 9/115 (7%)
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLI----NF---PTTATRTIGYRAPEVTETRKA 511
F H ++ + NVLL ISD GL+ + N+ T + + APE K
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 512 SQKSDVYSFGVLLLEMLT-GKAP-LQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
S KSDV+SFGVL+ E + G+ P G++ + R + E++D+
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDL 230
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 15/97 (15%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYR 501
RG+ +IHS A H ++K SN+LL + + I D GLA + F T T YR
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 502 APEV----TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
APE+ +E A DV+S G + E+L K PL
Sbjct: 176 APELLLNCSEYTTA---IDVWSVGCIFAELLGRK-PL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 28/154 (18%)
Query: 395 VRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V+ +Y +D+K +V YMP G L L+ S+ W +R A + IH
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW-ARFYTA-EVVLALDAIH 159
Query: 453 SEGGAKFTHGNIKSSNVLLTQ-------DLNGCI--SDVGLAHLINFPTTATRTIGYRAP 503
S G F H ++K N+LL + D C+ G+ TA T Y +P
Sbjct: 160 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR----CDTAVGTPDYISP 212
Query: 504 EVTETRKAS----QKSDVYSFGVLLLEMLTGKAP 533
EV +++ ++ D +S GV L EML G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 53/242 (21%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
E LG GS+G A + G +K ++++V +E ME+ H
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-----SHP 78
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALD----WNSRMKIALGTAR 446
+V + + ++ + ++ G LF L R G D +++ + +A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLAF---- 131
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRTIGYRAPEV 505
++HS+ + ++K N+LL + ++D G A + T T T Y APEV
Sbjct: 132 --EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEV 186
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------------VDLPRWVRSVV 553
+++ + D ++ GVLL E + G P DD + P W
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPF----FDDTPFRIYEKILAGRLKFPNWFDGRA 242
Query: 554 RE 555
R+
Sbjct: 243 RD 244
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 341 VLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREF----------EQQMEVVGTIGKHS 390
V+G+GSY L+ +R+ + K+E + + V H
Sbjct: 2 VIGRGSYAKVLLVRLKK-----TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 56
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIA 449
+V + + + ++ V Y+ G L + R R A +++ + +AL
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------ 110
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV 505
++H G + ++K NVLL + + ++D G+ P T T Y APE+
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
D ++ GVL+ EM+ G++P G D D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 52/228 (22%), Positives = 88/228 (38%), Gaps = 44/228 (19%)
Query: 340 EVLGKGSYGSTY---------------KAILEDGTTVVVKRLREVAATKREFEQQMEVVG 384
+VLG G+YG + +L+ T V + E T+R+ + +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI---- 61
Query: 385 TIGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFM-LLHRNRSDGGTALDWNSRMKIAL 442
+ S + Y + D KL ++ Y+ G LF L R R ++ + +AL
Sbjct: 62 ---RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR------ 496
+ I+ + IK N+LL + + ++D GL+ F
Sbjct: 119 EHLHKLGIIYRD---------IKLENILLDSNGHVVLTDFGLSK--EFHEDEVERAYSFC 167
Query: 497 -TIGYRAPEVTETRKASQKS--DVYSFGVLLLEMLTGKAPLQHSGHDD 541
TI Y AP++ D +S GVL+ E+LTG +P G +
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--ATRTIG-----YRAPEVTET 508
G F H ++ + NVLL ISD GL+ + + R+ G + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 509 RKASQKSDVYSFGVLLLEMLT-GKAP 533
RK S +SDV+S+G+ + E + G+ P
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 45/212 (21%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVGTI 386
+G+G+YG+ YKA L G V +K+ LRE+A K+ E
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-LESF------- 58
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA- 445
+H N+V + + + L ++ D T L + + T
Sbjct: 59 -EHPNIVRLLDVCHGPR----TDREL---KLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 446 -------RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TTAT 495
RG+ F+HS + H ++K N+L+T D I+D GLA + +F T+
Sbjct: 111 DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167
Query: 496 RTIGYRAPEVTETRKASQKSDVYSFGVLLLEM 527
T+ YRAPEV + D++S G + E+
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 340 EVLGKGSYGSTY---KAILED-GTTVVVKRLREVAATKREFEQQ--------MEVVGTIG 387
+VLG G+YG + K D G +K L++ A ++ + +E V
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV---- 61
Query: 388 KHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFM-LLHRNRSDGGTALDWNSRMKIALGTA 445
+ S + Y + + KL ++ Y+ G +F L R+ ++ + +AL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL--- 118
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-------TI 498
+H G + +IK N+LL + + ++D GL+ F + TI
Sbjct: 119 ---EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK--EFLSEEKERTYSFCGTI 170
Query: 499 GYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGKAPLQHSG 538
Y APE+ + K+ D +S G+L+ E+LTG +P G
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 54/228 (23%)
Query: 345 GSYGSTYKAILEDGTTVVVKRLREVAATKR-EFEQQME--------VVGTI--GKHSNVV 393
G+YG Y+A K+ E+ A K+ + E++ E + + +H N+V
Sbjct: 16 GTYGVVYRA--------RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA-------- 445
V+ ++VV S + ++M++ D + ++ MK +
Sbjct: 68 TVK--------EVVVGSNL--DKIYMVMEYVEHDLKSLME---TMKQPFLQSEVKCLMLQ 114
Query: 446 --RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTA-TR---T 497
G+A +H H ++K+SN+LL G I D GLA P T+ T
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVT 169
Query: 498 IGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
+ YRAPE+ ++ S D++S G + E+LT K D ++
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLR-EVAATKR-EFEQQMEVVGTIGKHSNVVPVR 396
AE LG+G+ + +L V VK LR +V T R +F ++++++ + K+ N++ +
Sbjct: 30 AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRN-------RSDGGTALDWNSRMKIALGTARGIA 449
S D ++ YM G L L + ++ ++ + + +A+ A G+
Sbjct: 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------NFPTTATRTIGYRAP 503
++ S F H ++ + N L+ I+D G++ + A I + A
Sbjct: 144 YLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLT 529
E K + SDV++FGV L EM T
Sbjct: 201 ESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 340 EVLGKGSYGSTYKAILED--------GTTVVVKRLREVAATKREF-EQQMEVVGTIGK-- 388
E LG+G++ +K I + T V++K L + R + E E + +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD---KSHRNYSESFFEAASMMSQLS 57
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H ++V DE ++V Y+ GSL L +N++ + W ++++A A +
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS--W--KLEVAKQLAWAL 113
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--------ISDVGLAHLINFPTTATRTIGY 500
F+ +G THGN+ + NVLL ++ + +SD G++ + I +
Sbjct: 114 HFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW 170
Query: 501 RAPE-VTETRKASQKSDVYSFGVLLLEMLTG 530
PE + + S +D +SFG L E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 31/213 (14%)
Query: 362 VVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLL 421
+ KR++ + + E ++ +G + H N++ + S+ +YM L
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILRSEA-----NTYMITQKYDFDL 249
Query: 422 HRNRSDGGTALDWNSR---------MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472
+ D A DW R MK L + +IH + K H +IK N+ L
Sbjct: 250 YSFMYDE--AFDWKDRPLLKQTRAIMKQLLC---AVEYIHDK---KLIHRDIKLENIFLN 301
Query: 473 QDLNGCISDVGLAHLINFPTTATR-----TIGYRAPEVTETRKASQKSDVYSFGVLLLEM 527
D + D G A A T+ +PE+ + +D++S G++LL+M
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 528 LTGK-APLQHSGHDDVVDLPRWVR--SVVREEW 557
L+ P+ G L + + SV EE+
Sbjct: 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG G+ G +K + ++ ++L + A + + ++++V+ +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+YS E + +M GSL +L + L K+++ +G+ ++ + K
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK--HK 124
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLA-HLIN-FPTTATRTIGYRAPEVTETRKASQKSD 516
H ++K SN+L+ + D G++ LI+ + T Y +PE + S +SD
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 517 VYSFGVLLLEMLTGKAPL 534
++S G+ L+EM G+ P+
Sbjct: 185 IWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 463 NIKSSNVLLTQDLNGCISDVGLAHLINF----PTTATRTIGYRAPEVTETRKASQKS-DV 517
++K +N+LL + + ISD+GLA +F P + T GY APEV + A S D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 179
Query: 518 YSFGVLLLEMLTGKAPL-QHSGHD 540
+S G +L ++L G +P QH D
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 71/300 (23%), Positives = 122/300 (40%), Gaps = 73/300 (24%)
Query: 342 LGKGSYGSTYKAILED------GTTVVVKRLREVAATKR--EFEQQMEVVGTIGKHSNVV 393
+G G +G K +L + VVVK L+ A++K EF QQ + I +H N++
Sbjct: 3 IGNGWFG---KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPY-RILQHPNIL 58
Query: 394 P-----VRAYYYSKDEKLVVYSYMPAGSLFMLLHRN---RSDGGTALDWNSRMKIALGTA 445
V A Y L+V+ Y G L L + R + L ++A A
Sbjct: 59 QCLGQCVEAIPY-----LLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIA 109
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------I 498
G+ +H F H ++ N LT DL + D G+ + T +
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPL 165
Query: 499 GYRAPE-VTE------TRKASQKSDVYSFGVLLLEMLTGKA-PLQHSGHDDVVDLPRWVR 550
+ APE V E T + ++ S+V++ GV L E+ A P H +V++
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------ 219
Query: 551 SVVREEWTAEVFDVELLK------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604
V++++ V+L K Y + E++Q ++ P+ R ++V R++
Sbjct: 220 HVIKDQ------QVKLFKPQLELPYSERWYEVLQFCWLS-------PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 6e-05
Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 119 SLQYVYLQNNYFSGVLP-AFRSLQ-LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNS 175
+L+ + L NN + + AF+ L L LDLS N T I P F L L L+L N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
Query: 176 I 176
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 10/100 (10%)
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH-----LINFPTTATRTIGYR 501
GI +HS G H ++K SN+++ D I D GLA + P TR YR
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 192
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
APEV + D++S G ++ EM+ G + H D
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 25/201 (12%)
Query: 342 LGKGSYGSTY-----KAILEDGTTVV----VKRLREVAATKREFEQQMEVVGTIGK--HS 390
LGKGS+G+ Y KA+ E+ V+ V L + E Q+ + K H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL-----LSKLDHP 62
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+V A + +D ++ Y L L + G T L N + + G+ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHY 121
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI----NFPTTATRTIGYRAPEVT 506
+H + H ++K+ N+ L +L I D G++ L+ + TT T T Y +PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 507 ETRKASQKSDVYSFGVLLLEM 527
+ + KSD++S G +L EM
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 341 VLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQME----------VVGTIG 387
V+G+GSY K +L V +K+ R + A K+E E V T
Sbjct: 2 VIGRGSYA---KVLL-----VELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS 53
Query: 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTAR 446
H +V + + + ++ V ++ G L + R R A +++ + +AL
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH--LINFPTTAT--RTIGYRA 502
F+H G + ++K NVLL + + ++D G+ + TT+T T Y A
Sbjct: 111 ---FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
PE+ D ++ GVL+ EM+ G++P G D D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 26/187 (13%)
Query: 427 DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486
+ ALD + + A+G++F+ S+ H ++ + N+LLT I D GLA
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 262
Query: 487 LINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGH 539
I + A + + APE + +SDV+S+G+LL E+ + G +P + G
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGM 320
Query: 540 DDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599
VD + +++E + + E +M I SC P RP
Sbjct: 321 P--VDSKFY--KMIKEGY----------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366
Query: 600 VVRMIEQ 606
+V++IEQ
Sbjct: 367 IVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 28/148 (18%)
Query: 402 KDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+D+K +V YMP G L L+ A + + + +AL IHS G
Sbjct: 113 QDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG---L 163
Query: 460 THGNIKSSNVLLTQ-------DLNGCIS--DVGLAHLINFPTTATRTIGYRAPEVTETRK 510
H ++K N+LL + D C+ + G+ TA T Y +PEV +++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC----DTAVGTPDYISPEVLKSQG 219
Query: 511 AS----QKSDVYSFGVLLLEMLTGKAPL 534
++ D +S GV L EML G P
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 39/231 (16%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVKR-LREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
++G GS+G Y+AI ++ V +K+ L++ RE + H N++ ++ Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-----NHINIIFLKDY 127
Query: 399 YYS----KDEK----LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
YY+ K+EK VV ++P + H R++ L L R +A+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185
Query: 451 IHSEGGAKFT-HGNIKSSNVLL---TQDLNGCISDVGLAHLINFPTTATRTIG------Y 500
IHS KF H ++K N+L+ T L C D G A + R++ Y
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLC--DFGSAKNL---LAGQRSVSYICSRFY 236
Query: 501 RAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550
RAPE+ + D++S G ++ EM+ G P+ SG V L R ++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPI-FSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 31/118 (26%), Positives = 50/118 (42%), Gaps = 15/118 (12%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--------T 497
R I ++H + H +IK+ N+ + + C+ D G A FP T
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA---CFPVDINANKYYGWAGT 246
Query: 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL-QHSGHDDVVDLPRWVRSVVR 554
I APE+ D++S G++L EM T L + G D D R ++ ++R
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
|
Length = 391 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT------I 498
ARG+ F+ S K H ++ + N+LL+++ I D GLA I R +
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557
+ APE + + +SDV+SFGVLL E+ + G +P + + EE+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP--------------YPGVQINEEF 286
Query: 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ D ++ + ++ +I L+C P RP +V ++ + Q
Sbjct: 287 CQRLKDGTRMRAPENATP--EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 48/172 (27%), Positives = 71/172 (41%), Gaps = 25/172 (14%)
Query: 376 FEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDW 434
FE++ +++ +S +P Y + + L +V Y P G L LL NR + D
Sbjct: 48 FEEERDILSI--SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFDE 101
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLIN--- 489
+ A + IHS + H +IK NVL+ D G I +D G A +
Sbjct: 102 D---MAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANK 156
Query: 490 --FPTTATRTIGYRAPEVTETRKASQKS------DVYSFGVLLLEMLTGKAP 533
T Y APEV T K D +S GV+ EM+ G++P
Sbjct: 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 58/218 (26%), Positives = 86/218 (39%), Gaps = 44/218 (20%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLR--------------EVAATKR--EFEQQ----- 379
+G G+YG+ YKA G V +K +R EVA KR F+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 380 MEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK 439
M+V T + V + D+ L Y L + G A M+
Sbjct: 68 MDVCATS-RTDRETKVTLVFEHVDQDLRTY-----------LDKVPPPGLPAETIKDLMR 115
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TTATR 496
L RG+ F+H+ H ++K N+L+T ++D GLA + + T
Sbjct: 116 QFL---RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
Query: 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+ YRAPEV + D++S G + EM K PL
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-----FPTTATRTIGYR 501
GI +HS G H ++K SN+++ D I D GLA P TR YR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 184
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
APEV + D++S G ++ EM+ G + H D
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 11/82 (13%)
Query: 461 HGNIKSSNVLLTQDLNGCIS--DVGLAHLINFPTTATRTIG---YRAPEVTETRKASQK- 514
H ++K SN+LL D +G + D G++ + TR+ G Y APE + + K
Sbjct: 138 HRDVKPSNILL--DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195
Query: 515 ---SDVYSFGVLLLEMLTGKAP 533
+DV+S G+ L+E+ TG+ P
Sbjct: 196 DIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 340 EVLGKGSYGSTYKAIL-------EDGTT------VVVKRL----REVAATKREFEQQMEV 382
E LG+G+ Y IL +DG + V++K L R+++ E M
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 383 VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
V H ++V + E ++V ++ G L + +HR T W + K+A
Sbjct: 61 V----SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--W--KFKVAK 112
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD--LNGC-----ISDVGLAHLINFPTTAT 495
A ++++ + HGN+ + N+LL ++ C +SD G+ +
Sbjct: 113 QLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV 169
Query: 496 RTIGYRAPE-VTETRKASQKSDVYSFGVLLLEM-LTGKAPLQ 535
I + APE V +++ S +D +SFG L E+ G+ PL+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVPVRA 397
+ LG+GSY + YK + G V +K +R F E KH+N+V +
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 398 YYYSKDEKLVVYSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
++K +V+ Y+ +M D G L ++ RG+A+ H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYM------DDCGGGLSMHNVRLFLFQLLRGLAYCHQR-- 122
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV-TETRKA 511
+ H ++K N+L+++ ++D GLA + P+ T+ YR P+V + +
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
S D++ G + EM TG+ G DV D
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLF--PGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTV-VVKRLREVAATKRE----FEQQMEVVGTIGKHSNVVP 394
+V+G+G++G L++ V +K L + KR F ++ +V+ + + +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWIT 64
Query: 395 VRAYYYSKDEKL-VVYSYMPAGSLFMLLHR--NRSDGGTALDWNSRMKIALGTARGIAFI 451
Y + + L +V Y G L LL + +R A + + M IA+ + + ++
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-------PTTATRTIGYRAPE 504
H + IK N+L+ D+NG I + + A T Y +PE
Sbjct: 125 HRD---------IKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 505 VTETRKASQ-----KSDVYSFGVLLLEMLTGKAPL 534
+ + + + + D +S GV + EML G+ P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 44/203 (21%), Positives = 93/203 (45%), Gaps = 27/203 (13%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQ--------QMEVVGTIGKHSNVV 393
LG+G+Y + +K G + + + L + + E E+ ++ ++ + KH+N+V
Sbjct: 13 LGEGTYATVFK-----GRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIV 66
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ +V+ Y+ + L + + G + ++ RG+++ H
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSD-----LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV-TET 508
K H ++K N+L+ + ++D GLA + PT T+ YR P+V +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 509 RKASQKSDVYSFGVLLLEMLTGK 531
+ S D++ G +L EM TG+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT------I 498
A+G+ F+ S K H ++ + N+LL+++ I D GLA I R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557
+ APE R + +SDV+SFGVLL E+ + G +P D EE+
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEF 291
Query: 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ + ++ D +M Q L C P RP ++V + + Q
Sbjct: 292 CRRLKEGTRMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSN 468
Y + LL + S+G T LD + ARG+ F+ S+ H ++ + N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFLASK---NCVHRDLAARN 267
Query: 469 VLLTQDLNGCISDVGLA----HLINFPTTATR--TIGYRAPEVTETRKASQKSDVYSFGV 522
VLL Q I D GLA H N+ + + + + APE + SDV+S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 523 LLLEMLT 529
LL E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 17/36 (47%), Positives = 23/36 (63%), Gaps = 2/36 (5%)
Query: 164 TRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
T L L+L NN I+ +PPL NLP L+ L+ S N +
Sbjct: 1 TNLETLDLSNNQITD-LPPLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 51/240 (21%)
Query: 338 SAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
S +V+G+G++G +D G +K LR+ ++E + I ++ V
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 397 AYYYSKDEKLVVY---SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+YS +K +Y ++P G + LL + T + ++ IA T I IH
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIA-ETVLAIDAIHQ 119
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGL------AHLINF--------PTT------ 493
G F H +IK N+LL + +SD GL AH F P+
Sbjct: 120 LG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 494 ----------------ATRTIG---YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
A T+G Y APEV ++ D +S GV++ EML G P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 10/90 (11%)
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH-----LINFPTTATRTIGYR 501
GI +HS G H ++K SN+++ D I D GLA + P TR YR
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 185
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGK 531
APEV + D++S G ++ EM+ K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 53/235 (22%), Positives = 87/235 (37%), Gaps = 52/235 (22%)
Query: 358 GTTVVVKRLREVAATKREFEQQMEVVGTIGKHS--NVVPVRAYYYSKDEKLVVYSYMPAG 415
T ++K LR+ + RE TI H N+V + Y S+D +V + G
Sbjct: 18 QQTFILKGLRKSSEYSRERL-------TIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70
Query: 416 SLF-MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474
L+ + W + M +AL +H EG ++ +D
Sbjct: 71 KLWSHISKFLNIPEECVKRWAAEMVVALDA------LHREG--------------IVCRD 110
Query: 475 LNG---CISDVGLAHLINF-------PTTATRTIG--YRAPEVTETRKASQKSDVYSFGV 522
LN + D G L F + + Y APEV + ++ D +S G
Sbjct: 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGA 170
Query: 523 LLLEMLTGKAPLQ-HS---GHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
+L E+LTGK ++ H +++P WV R +LL++ E
Sbjct: 171 ILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQ------QLLQFNPTE 219
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 361 VVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418
V VK LR A + +F ++++++ + K N++ + +D ++ YM G L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 419 MLL-HRNRSDG-------------GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI 464
L + D A+ ++S + +AL A G+ ++ S F H ++
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164
Query: 465 KSSNVLLTQDLNGCISDVGLAHLI------NFPTTATRTIGYRAPEVTETRKASQKSDVY 518
+ N L+ ++L I+D G++ + A I + A E K + SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 519 SFGVLLLEML 528
+FGV L E+L
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 45/202 (22%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 361 VVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418
V VK LR A+ + +F ++++++ + N+ + ++ YM G L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 419 MLLHR------NRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472
L + + +L +++ + +A A G+ ++ S F H ++ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 473 QDLNGCISDVGLAHLINFPTTATRTIGYRAP--------EVTETRKASQKSDVYSFGVLL 524
++ I+D G++ N ++ + RAP E K + KSDV++FGV L
Sbjct: 165 KNYTIKIADFGMSR--NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222
Query: 525 LEMLT--GKAPLQHSGHDDVVD 544
E+LT + P +H V++
Sbjct: 223 WEILTLCREQPYEHLTDQQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 18/50 (36%), Positives = 26/50 (52%), Gaps = 4/50 (8%)
Query: 165 RLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L L+L NN ++ IP LP LK+L+ S NNL P++ P+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPS 49
|
Length = 60 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 67/251 (26%), Positives = 101/251 (40%), Gaps = 72/251 (28%)
Query: 338 SAEVLGKGSYGSTYKAILED-GTTVVVKRLR--------EVAATKREFEQQMEVVGTIGK 388
S +V+G+G++G +D G +K+LR +VA + E + E
Sbjct: 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA------ 58
Query: 389 HSNVVPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+ V V+ YY +DE ++ Y+P G + LL + T + +R IA T
Sbjct: 59 DNPWV-VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIA-ETIL 112
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGL------AHLINF-------- 490
I IH G + H +IK N+LL D G I SD GL +H F
Sbjct: 113 AIDSIHKLG---YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 491 ----------PTTATR---------------TIG---YRAPEVTETRKASQKSDVYSFGV 522
P ++ R T+G Y APEV +++ D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 523 LLLEMLTGKAP 533
++ EML G P
Sbjct: 228 IMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/91 (29%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL------INFPTTATRTIGYRAPE 504
+HS K H ++KS+N+ L + D G + ++ ++ T Y APE
Sbjct: 185 VHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
+ E ++ S+K+D++S GV+L E+LT P +
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--------TI 498
G+ +IH K H ++K++N+L+T+D ++D GLA + + T+
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 499 GYRAPEV-TETRKASQKSDVYSFGVLLLEMLT 529
YR PE+ R D++ G ++ EM T
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 33/215 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTV-VVKRLREVAATKRE----FEQQMEVVGTIGKHSNVVP 394
+V+G+G++G ++ + +K L + KR F ++ V+ + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNGDCQWIT 64
Query: 395 VRAYYYSKDEKL-VVYSYMPAGSLFMLLHR--NRSDGGTALDWNSRMKIALGTARGIAFI 451
Y + + L +V Y G L LL + +R A + + M +A I
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA---------I 115
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTT-----ATRTIGYRAPE 504
HS + H +IK NVLL D+NG I +D G +N T A T Y +PE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 505 VTETR-----KASQKSDVYSFGVLLLEMLTGKAPL 534
+ + K + D +S GV + EML G+ P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 10/109 (9%)
Query: 432 LDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--- 488
LD + ++ + A+G+ F+ S+ H ++ + NVLLT I D GLA I
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 489 -NFPT--TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAP 533
N+ A + + APE + +SDV+S+G+LL E+ + GK+P
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 22/104 (21%)
Query: 456 GAKFTHGNIKSSNVLLT-------------QDLNG----CISDVGLAHLINFPTTATRTI 498
G + H ++K N+ L+ +LNG I D GL+ I + A +
Sbjct: 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV 202
Query: 499 G---YRAPEVT--ETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537
G Y +PE+ ET+ KSD+++ G ++ E+ +GK P +
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 340 EVLGKGSYGS-----------------TYKAILEDGTTVVVKRLREVA--ATKREFEQQM 380
E LG+G +G + V VK LRE A + +F +++
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTA----LDW 434
+++ + K N++ + A + D ++ YM G L F+ H + A + +
Sbjct: 71 KIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------ 488
++ + +A A G+ ++ S F H ++ + N L+ ++ I+D G++ +
Sbjct: 130 STLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 489 NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT 529
A I + + E K + SDV++FGV L E+LT
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.51 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.39 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.28 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.17 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.07 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.06 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.04 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.03 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.99 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.78 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.72 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.68 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.32 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.26 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.25 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.22 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-60 Score=558.28 Aligned_cols=492 Identities=27% Similarity=0.448 Sum_probs=307.3
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~l 147 (627)
.+..|+|++|++++.+|. .+..+++|+.|+|++|.+.+.+|..+ .+++|+.|+|++|++++..|..+. .+|+.|+|
T Consensus 429 ~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L 506 (968)
T PLN00113 429 LVYFLDISNNNLQGRINS-RKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506 (968)
T ss_pred CCCEEECcCCcccCccCh-hhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEEC
Confidence 455666666666665554 45555555555555555555555433 235555555555555555443222 14555555
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCc------------
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSS------------ 213 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~------------ 213 (627)
++|++++.+|..+.++++|+.|+|++|+++|.+|.. .+++|+.|+|++|+++|.+|..+.+++.|+
T Consensus 507 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 507 SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred cCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 555555555555555555555555555555555443 455555555555555555555544444443
Q ss_pred --------------ccCCCcCCCCCCCCCCCCCCCCCCCCCCCCcCCCCCcccccccCccceeeeehhhHHHHHHHHHHH
Q 006886 214 --------------FVGNSMLCGLPLTPCSTVSSSPSPSPSYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALF 279 (627)
Q Consensus 214 --------------~~~n~~~~~~~~~~c~~~~~~~~p~~~~~~~~s~~~~~~~~~~~~~~ii~~~~~~~~~~~~l~~~~ 279 (627)
+.+|+.+|+.+.. ...++... ..+......++++++++ ++++++++++
T Consensus 587 ~p~~~~~~~~~~~~~~~n~~lc~~~~~----------------~~~~~c~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 648 (968)
T PLN00113 587 LPSTGAFLAINASAVAGNIDLCGGDTT----------------SGLPPCKR-VRKTPSWWFYITCTLGA-FLVLALVAFG 648 (968)
T ss_pred CCCcchhcccChhhhcCCccccCCccc----------------cCCCCCcc-ccccceeeeehhHHHHH-HHHHHHHHHH
Confidence 3444444432110 00001110 00111111222222222 2222222333
Q ss_pred HhhhhcccccCCCCcccCCCCCCCCCCCCCCccccccCceeeec-CCCCCCCHHHHHHHH--hcccCcCCceeEEEEEe-
Q 006886 280 FLCCLKKLDRQGSGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLD-GSYFNFDLEDLLRAS--AEVLGKGSYGSTYKAIL- 355 (627)
Q Consensus 280 ~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~lg~G~~g~Vy~~~~- 355 (627)
+++++||+...........+ .+ ...... .....++++++.... .+.||+|+||.||+|+.
T Consensus 649 ~~~~~~~~~~~~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~ 712 (968)
T PLN00113 649 FVFIRGRNNLELKRVENEDG------TW----------ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSI 712 (968)
T ss_pred HHHHHhhhcccccccccccc------cc----------cccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEEC
Confidence 33333322111111000000 00 000001 011224455554443 46899999999999996
Q ss_pred cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHH
Q 006886 356 EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWN 435 (627)
Q Consensus 356 ~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~ 435 (627)
.++..||||++...... ...|++.++++ +||||++++++|.+.+..++||||+++|+|.++++. ++|.
T Consensus 713 ~~~~~vavK~~~~~~~~---~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~ 780 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI---PSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWE 780 (968)
T ss_pred CCCcEEEEEEccCCccc---cHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHH
Confidence 47899999998654322 23457888888 999999999999999999999999999999999952 7999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCCCCccccCccccCCCCCCCcc
Q 006886 436 SRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKS 515 (627)
Q Consensus 436 ~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 515 (627)
.+.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+..........++..|+|||++.+..++.++
T Consensus 781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~s 859 (968)
T PLN00113 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859 (968)
T ss_pred HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCccc
Confidence 999999999999999997655679999999999999999998886 7766554444445678999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC-CChHHHHHHHHHHHHHcccCCCCCC
Q 006886 516 DVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY-QDVEEEMVQMLQIALSCVAKVPDSR 594 (627)
Q Consensus 516 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~~p~~R 594 (627)
|||||||++|||+||+.||+... .....+.+|.+...........+|+.+... ....++..++.+++.+||+.+|++|
T Consensus 860 Dv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 938 (968)
T PLN00113 860 DIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938 (968)
T ss_pred chhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhC
Confidence 99999999999999999996432 233466777765544444444455544221 2335667788999999999999999
Q ss_pred CCHHHHHHHHHhhcccc
Q 006886 595 PKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 595 Ps~~ev~~~L~~~~~~~ 611 (627)
|||+|+++.|+++....
T Consensus 939 Pt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 939 PCANDVLKTLESASRSS 955 (968)
T ss_pred cCHHHHHHHHHHhhccc
Confidence 99999999999986543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-54 Score=441.01 Aligned_cols=282 Identities=38% Similarity=0.677 Sum_probs=250.4
Q ss_pred CCCCCCHHHHHHHH-----hcccCcCCceeEEEEEecCCcEEEEEEecccccC-HHHHHHHHHHHHHhccCCCeeeeeeE
Q 006886 325 SYFNFDLEDLLRAS-----AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT-KREFEQQMEVVGTIGKHSNVVPVRAY 398 (627)
Q Consensus 325 ~~~~~~~~~l~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~ 398 (627)
....|+++|+..|| .+.||+|+||.||+|.+.+|+.||||++...... .++|..|++++.++ +|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEE
Confidence 34568999999998 4689999999999999999999999988776554 77799999999999 79999999999
Q ss_pred EeeCC-ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 399 YYSKD-EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 399 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||+|+++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99998 499999999999999999875321 78999999999999999999999998899999999999999999999
Q ss_pred EEeecccccccCC-CCC---C-CCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006886 478 CISDVGLAHLINF-PTT---A-TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 478 ki~DfG~a~~~~~-~~~---~-~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
||+|||+|+.... ... . .||.+|+|||++..+..++|+|||||||+|+|++||+.|.+.........+..|.+..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999977654 322 1 7899999999999999999999999999999999999998865545556699999999
Q ss_pred hhhcccccccchhhhcCCChH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 553 VREEWTAEVFDVELLKYQDVE-EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
+.+....+++|+.+....... +++..+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 988899999999987433333 7888999999999999999999999999999776544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=384.92 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=211.4
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-c
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-E 404 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~ 404 (627)
++.+++.. .+.||+|+||+||+|.++....||||++...... .++|.+|+.++.++ +|||||+++|+|.+.. .
T Consensus 38 i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCc
Confidence 44555533 4669999999999999985444999999765432 45899999999999 9999999999999887 7
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVG 483 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG 483 (627)
.++|||||++|+|.++++.. ....+++..++++|.|||+||.|||+++ + ||||||||+|||++.++ ++||+|||
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCc
Confidence 89999999999999999874 1357999999999999999999999987 3 99999999999999997 99999999
Q ss_pred cccccCC---CC-CCCCCccccCccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 484 LAHLINF---PT-TATRTIGYRAPEVTE--TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 484 ~a~~~~~---~~-~~~~t~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
+++.... .. ...||..|||||++. ...|+.|+|||||||++|||+||+.||..... ......+.....
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL 263 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC
Confidence 9987653 22 357899999999999 56999999999999999999999999986542 111111111111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
... ....+...+..++.+||..||+.||++.+++..|+.+.....
T Consensus 264 Rp~----------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 RPP----------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCC----------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 111 111244567778889999999999999999999998866433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=361.77 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=209.0
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccc--ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREV--AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE- 404 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~- 404 (627)
+...|+. ..+.||+|..|+|||++++ +++.+|.|.+... ....+++.+|++++... +||+||.++|.|+.+..
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 5566663 3588999999999999976 6888999999543 33567899999999999 99999999999999994
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++||||++|+|..++... ..+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++||||||
T Consensus 153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence 99999999999999999864 359999999999999999999996 55 9999999999999999999999999
Q ss_pred cccccCC--CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 484 LAHLINF--PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 484 ~a~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
.++.+.. ..+..||..|||||.+.+..|+.++||||||++++|+.+|+.||... ........+.+..++.+...
T Consensus 225 VS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~ppP--- 300 (364)
T KOG0581|consen 225 VSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDEPPP--- 300 (364)
T ss_pred ccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcCCCC---
Confidence 9987754 35778999999999999999999999999999999999999999764 12223334444433332211
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+.. . ....++.+++..|+++||.+||++.|++++
T Consensus 301 ---~lP~--~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 ---RLPE--G--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---CCCc--c--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 1 233456677779999999999999999885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=374.87 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=216.3
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
++-+++ ...+.||+|-||.||.|.++....||+|.++......+.|.+|+++|.++ +|+|||+++|+|..++..++|
T Consensus 203 i~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 203 IPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred ecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEE
Confidence 444444 45688999999999999999888999999998777888999999999999 999999999999998899999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
||||+.|+|.+||+.. ++..+...+.+.++.|||+|++||++++ +|||||.++|||++++..+||+|||+|+..
T Consensus 280 tE~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999862 3567899999999999999999999998 999999999999999999999999999965
Q ss_pred CCCCCCC-----CCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 489 NFPTTAT-----RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 489 ~~~~~~~-----~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.+..... -++.|.|||.+..+.++.|+|||||||+||||+| |+.||..+...+ -+..+-+...
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyR----- 422 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYR----- 422 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCc-----
Confidence 4432211 2467999999999999999999999999999999 999987664332 2222222211
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
+ +.++.+..++.++|..||+.+|++|||++.+...|+++....
T Consensus 423 ---l---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 423 ---L---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ---C---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 1 122345556778899999999999999999999999986654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=388.02 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=213.1
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|+.. +...||||.+++... ..++|++|++++..+ +|||||+++|.|.+++.+++|+|
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeEEEEE
Confidence 578999999999999843 356799999987654 467999999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 411 YMPAGSLFMLLHRNRSD-----G----GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
||..|||.+||...... + ..+++..+.+.||.|||.||.||-++. +|||||.++|+|+.++..+||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecc
Confidence 99999999999865321 1 233899999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCCCCCC------CCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 482 VGLAHLINFPTTAT------RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 482 fG~a~~~~~~~~~~------~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+++..-..+.+. -.++|||||.+..+++++++|||||||+|||+++ |+.||.+...++..+ .++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe-------~i~ 719 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE-------CIR 719 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-------HHH
Confidence 99999875443322 2578999999999999999999999999999999 999998776544222 122
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.+.. ....+.+..++.+||..||+..|.+||++.||-..|+......
T Consensus 720 ~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 AGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2211 2334566778899999999999999999999999999986554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=367.63 Aligned_cols=238 Identities=24% Similarity=0.432 Sum_probs=202.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.++||+|||+.||.++. ..|..||+|++.+. ....+...+|+++.+.+ +|||||+++++|++.++.|+|.|+|+
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecC
Confidence 57899999999999997 78999999999763 33567789999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
.++|.+++++. .++++.+++.++.||+.||.|||+.+ |+|||||-.|++++++.++||+|||+|..+..+
T Consensus 102 ~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 102 RGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999854 46999999999999999999999998 999999999999999999999999999988643
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+.+||+.|+|||++.....+..+||||+||+||-|+.|++||+... +.+-...+...+... .
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~~---------P 238 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYSM---------P 238 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCccc---------c
Confidence 56779999999999999999999999999999999999999998642 222222222221111 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... +..++|.++|+.+|.+|||+++|+.+
T Consensus 239 ~~ls~---~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 SHLSA---EAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccCH---HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11222 34467779999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=341.69 Aligned_cols=190 Identities=25% Similarity=0.395 Sum_probs=171.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
+.||+|+||+||+|+++ ++..||||.+.... ...+-...|+++++.+ +|||||.+++++..++..++|||||+||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45999999999999966 58999999987653 2345578999999999 8999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC------CCeEEeecccccccC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD------LNGCISDVGLAHLIN 489 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~------~~~ki~DfG~a~~~~ 489 (627)
||.+|++... .+++.....++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+|+.+.
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999753 5999999999999999999999998 9999999999999875 457999999999997
Q ss_pred CC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 490 FP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
.. .+.+|++-|||||++...+|+.|+|+||+|+++|+|++|+.||+..+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 64 46679999999999999999999999999999999999999998543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=349.18 Aligned_cols=243 Identities=24% Similarity=0.411 Sum_probs=195.8
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc--------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA--------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.|-+|.. ++|+.||||++.+... ......+|+++|+++ +|||||++.++++..+..|+|+
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEE
Confidence 57899999999999995 4799999999965321 223457999999999 9999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEeeccccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCISDVGLAH 486 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfG~a~ 486 (627)
||++||+|.+++-.++ .+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999998664 4777777889999999999999999 9999999999999876 788999999999
Q ss_pred ccCC---CCCCCCCccccCccccCCCCC---CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 487 LINF---PTTATRTIGYRAPEVTETRKA---SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 487 ~~~~---~~~~~~t~~y~aPE~~~~~~~---~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
..+. ..+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.+...+. .+ ..++...... .
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---~eQI~~G~y~-f 401 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---KEQILKGRYA-F 401 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---HHHHhcCccc-c
Confidence 8854 357789999999999976433 358899999999999999999998654332 11 1222222111 1
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
- .....+...+..++|.+|+..||++|||+.|++++
T Consensus 402 --~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 --G-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --c-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 01123334455677789999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=323.70 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=201.5
Q ss_pred HhcccCcCCceeEEEEE-ecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeE-EeeCCc-eEEEEec
Q 006886 338 SAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAY-YYSKDE-KLVVYSY 411 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~-~~lv~e~ 411 (627)
+.++||+|.||+||++. ..+|..||.|.++-.. ...+....|+.+++.+ +|||||+++++ +.++.+ .++||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHh
Confidence 35889999999999998 5689999999997543 2355688999999999 99999999984 444444 7899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--CeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA--KFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~--~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
+..|+|...++..+. +...+++...++++.|+++||..+|..- + .|+||||||.||+++.+|.+|++|||+++++.
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999987653 4578999999999999999999999943 3 39999999999999999999999999999987
Q ss_pred CCC----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 490 FPT----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 490 ~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
... +.+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. ++.+...++...+.. ...
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd~~-~~p--- 249 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGDYP-PLP--- 249 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCCCC-CCc---
Confidence 653 457999999999999999999999999999999999999999864 344444444433211 111
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.+-...++..++..|+..||+.||+.-.++.
T Consensus 250 ------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 250 ------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred ------HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 1234456778888999999999998544433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.14 Aligned_cols=260 Identities=28% Similarity=0.397 Sum_probs=199.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhc-cCCCeeeeeeEEeeCC----ceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVPVRAYYYSKD----EKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lv~e~~~ 413 (627)
.++||+|+||.||||.+. ++.||||++.. ..++.|..|-+++.... +|+||++++++-.... +++||++|.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 367999999999999997 59999999964 34677888888877543 8999999999876655 7899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG------GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
.|+|.+||..+ .++|....+|+..+++||+|||+.. .|+|+|||||++|||+..|+.+.|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999865 6999999999999999999999864 46899999999999999999999999999987
Q ss_pred cCCC------CCCCCCccccCccccCCCC------CCCcchhHHHHHHHHHHHhCCCCCCC--------CCCCCC---CC
Q 006886 488 INFP------TTATRTIGYRAPEVTETRK------ASQKSDVYSFGVLLLEMLTGKAPLQH--------SGHDDV---VD 544 (627)
Q Consensus 488 ~~~~------~~~~~t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg~~p~~~--------~~~~~~---~~ 544 (627)
+... ...+||.+|||||++.+.- .-.+.||||+|.|||||+++..-++. ..+.+. ..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 7542 2356899999999997642 22468999999999999996543321 111010 11
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
+-+.-..++++.....+.| .......+..+.+.+..||+.||+.|.|+.=+.+.+.++....-
T Consensus 446 ~e~mq~~VV~kK~RP~~p~-----~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPD-----AWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhccCCCChh-----hhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111112222222211111 11112456677889999999999999999999999999876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.51 Aligned_cols=238 Identities=23% Similarity=0.376 Sum_probs=196.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.++||+|+||+||.++.+ .++.+|+|++++... ..+...+|..++..+ +||.||++...|++.+.+|+|+||+.
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccC
Confidence 588999999999999965 588999999976532 346688899999998 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---- 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~---- 489 (627)
||.|..+|++. ..+++..+.-++..|+.||.|||+.+ ||||||||+|||+|.+|+++|+|||+++..-
T Consensus 109 GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999865 35899999999999999999999999 9999999999999999999999999998542
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+ ...+.+.+...... ...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~~--------~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKLP--------LPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcCC--------CCC
Confidence 2345689999999999999999999999999999999999999998643 33444444443311 011
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRP----KMDDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RP----s~~ev~~ 602 (627)
....++. .+++.+.+..+|++|- .+.+|.+
T Consensus 247 ~~ls~~a---rdll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 247 GYLSEEA---RDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ccCCHHH---HHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1133444 4455688899999995 4555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.24 Aligned_cols=247 Identities=23% Similarity=0.450 Sum_probs=211.0
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
+++||.|.||.||+|+++ ....||||.++... ..+.+|..|+.+|.++ .||||+++.|........++|+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhh
Confidence 689999999999999976 24579999998764 3567899999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|..||+.+. ..+.+.+...++.+||.|+.||-+++ +|||||.++|||++.+..+||+|||+++.+.++.
T Consensus 713 ENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999763 45999999999999999999999998 9999999999999999999999999999885543
Q ss_pred C----CCC---CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 493 T----ATR---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 493 ~----~~~---t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ..| .++|.|||.+..++++.++|||||||||||.++ |.+||.++...+.. +.+ ..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---kaI---e~gy-------- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---KAI---EQGY-------- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH---HHH---Hhcc--------
Confidence 1 112 368999999999999999999999999999888 99999877654321 111 1111
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
+.+...++...+.+||+.||++|-.+||.+.+|+..|+++...
T Consensus 852 ---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 852 ---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1123345667888999999999999999999999999998543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.02 Aligned_cols=264 Identities=25% Similarity=0.420 Sum_probs=207.8
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
..+.++|+ ...+.||+|.||+||+|++. ..||||++..... ..+.|..|+..+++= +|.||+-+.|||....
T Consensus 387 WeIp~~ev--~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 387 WEIPPEEV--LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP 461 (678)
T ss_pred cccCHHHh--hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc
Confidence 34445555 44689999999999999987 3699999976533 356799999999998 9999999999999887
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
. .+|+.+|+|-+|+.+++..+ ..++..+.+.||.|||+|+.|||.++ |||||||+.||++.+++.+||+|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred e-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 7 99999999999999999654 45888999999999999999999998 9999999999999999999999999
Q ss_pred cccccCC------CCCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 484 LAHLINF------PTTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 484 ~a~~~~~------~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
++..-.. -....+...|||||++.. ..|++.+||||||+|+|||++|..||.....+.+. .++-+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------fmVGr 607 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------FMVGR 607 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------EEecc
Confidence 9865422 123346778999999853 47899999999999999999999999843322211 11111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc--cccccCC
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ--PELRNRA 616 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~--~~~~~~~ 616 (627)
..... |.. .....+.+++.+|+..||+.++++||.+.+|+..|+++.. +.+..+.
T Consensus 608 G~l~p---d~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~ 664 (678)
T KOG0193|consen 608 GYLMP---DLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSA 664 (678)
T ss_pred cccCc---cch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCc
Confidence 11111 111 1123444566777789999999999999999999999877 4444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.98 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=196.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
..++|+|+||+|||++.+ +|+.||||++..... -++-.++|+++++++ +|+|+|.++..|......++|+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecch
Confidence 367999999999999977 599999999976543 356688999999999 999999999999999999999999977
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++.+-|.+.. ..++.....+++.|++.|+.|+|+++ +|||||||+|||++.++.+||||||+|+.+..+
T Consensus 86 -TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 86 -TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred -HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 5556665553 35888999999999999999999998 999999999999999999999999999988632
Q ss_pred -CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc--ccccc----
Q 006886 492 -TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT--AEVFD---- 563 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~d---- 563 (627)
..++.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|.+...-+ ++. .+...+.+-.. ..+|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD--QLy-~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID--QLY-LIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH--HHH-HHHHHHcccCHHHHHHhccCCc
Confidence 23457899999999876 789999999999999999999999887654322 211 11111110000 00000
Q ss_pred ---hhhhcCC-------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 ---VELLKYQ-------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ---~~l~~~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+.... ..+....-+++++..|++.||.+|++-+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000000 11122235688999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=340.28 Aligned_cols=239 Identities=21% Similarity=0.362 Sum_probs=197.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+|++||+|+.+ .++.||||++.+... ..+-...|-+.|..|.+||.|++++..|.++..+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 467999999999999954 689999999865422 223466788889999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++++.. .+++.....++.+|+.||+|||+.| ||||||||+|||+|+||++||+|||.|+.+...
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999763 5999999999999999999999999 999999999999999999999999999876321
Q ss_pred ---------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 492 ---------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 492 ---------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
.+++||..|++||++.....+..+|+|+|||++|+|+.|++||.+.++.-. +.+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------Fqk----- 298 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQK----- 298 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHH-----
Confidence 335689999999999999999999999999999999999999986543211 111
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+++....-.++.++. ..+|+.+.+..||.+|+|.++|.++
T Consensus 299 ----I~~l~y~fp~~fp~~---a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ----IQALDYEFPEGFPED---ARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----HHHhcccCCCCCCHH---HHHHHHHHHccCccccccHHHHhhC
Confidence 111111112233344 4456668889999999999999764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=334.25 Aligned_cols=257 Identities=16% Similarity=0.301 Sum_probs=205.6
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEecccccC----HHHHHHHHHHHHHhccCCCeeeeeeEEee-
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT----KREFEQQMEVVGTIGKHSNVVPVRAYYYS- 401 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 401 (627)
..++.+++.......||+|++|.||+|.+ +|+.||||+++..... .+.+.+|++++.++ +||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDI 90 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEec
Confidence 44566666555457899999999999998 4899999999765333 35678999999999 99999999999876
Q ss_pred ---CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCe
Q 006886 402 ---KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 402 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
....++||||+++|+|.+++... ..++|....+++.+++.||.|||+. + ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcE
Confidence 34678999999999999999754 3589999999999999999999985 5 7899999999999999999
Q ss_pred EEeecccccccCCC-CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 478 CISDVGLAHLINFP-TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 478 ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 163 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~ 236 (283)
T PHA02988 163 KIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIIN 236 (283)
T ss_pred EEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh
Confidence 99999999865443 33457889999999976 6889999999999999999999999975422 122222221
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
...... + . ......+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 237 ~~~~~~-~------~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 KNNSLK-L------P---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCCCC-C------C---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111100 0 0 1223356678889999999999999999999998763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=337.64 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=203.5
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceE
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 406 (627)
..+.++++.. .+-||.|+.|.||.|+++ ++.||||+++.. -+.+++-+++| +|+||+.+.|+|.....++
T Consensus 119 WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkL-kH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKL-KHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhc-cCcceeeEeeeecCCceeE
Confidence 3445555532 367999999999999998 689999988642 24567778889 9999999999999999999
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|||||+.|-|...|+.. ..+.-.....+..+||.|+.|||.+. |||||||+-||||+.+..+||+|||-++
T Consensus 189 IiMEfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred EeeeccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999864 45788888999999999999999987 9999999999999999999999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ..+.||..|||||++.....++|+||||||||||||+||..||..-+...+. .. +.
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----------wG------VG 324 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----------WG------VG 324 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----------Ee------cc
Confidence 77543 4567999999999999999999999999999999999999999754322110 00 01
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.+.....-...+..-|.=+++.||+..|..||++++++.+|+-....
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11112222344444555678899999999999999999999866543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=369.62 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=211.8
Q ss_pred hcccCcCCceeEEEEEecC--Cc----EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED--GT----TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
...||+|+||.||.|.+.+ +. .||||.+++.. ....+|.+|..+|+.+ +|||||+++|.|.+....++++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEeh
Confidence 5789999999999999653 43 49999998763 3567899999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 411 YMPAGSLFMLLHRNRSDG--GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
||++|+|..||++.+... ...+.....+.++.|||+|+.||++++ +|||||.++|+|++....+||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhh
Confidence 999999999999764322 456888999999999999999999998 999999999999999999999999999955
Q ss_pred CCCCCC------CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 489 NFPTTA------TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 489 ~~~~~~------~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
.....+ .-...|||||.+.++.++.|+|||||||+|||++| |..||......+... .+..++
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg----- 921 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG----- 921 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-----
Confidence 332211 12468999999999999999999999999999999 899998665433211 112222
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccccCCC
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRAS 617 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~~ 617 (627)
++ ...+.+...+.++|..||+.+|++||++..+++.+.++.+.-......
T Consensus 922 ---RL---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~ 971 (1025)
T KOG1095|consen 922 ---RL---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYG 971 (1025)
T ss_pred ---cc---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccc
Confidence 11 222345556779999999999999999999999999987766554443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=340.25 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=197.6
Q ss_pred hcccCcCCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 409 (627)
.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+..|++++..+.+||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 57899999999999974 2356799999875432 24568899999999988999999999887654 578999
Q ss_pred ecCCCCCHHHHhhhcCCC---------------------------------------------------------CCCCC
Q 006886 410 SYMPAGSLFMLLHRNRSD---------------------------------------------------------GGTAL 432 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~l 432 (627)
||+++|+|.+++...... ....+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999999753210 02357
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC------CCCCCccccCcccc
Q 006886 433 DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVT 506 (627)
Q Consensus 433 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~ 506 (627)
++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...++..|+|||++
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 88899999999999999999998 9999999999999999999999999998653221 22345789999999
Q ss_pred CCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHH
Q 006886 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALS 585 (627)
Q Consensus 507 ~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~ 585 (627)
.+..++.++||||||+++|||++ |..||......+ . ............ ........+.+++.+
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~----------~~~~~~~~l~~li~~ 312 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----E-FCQRLKDGTRMR----------APENATPEIYRIMLA 312 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----H-HHHHHhcCCCCC----------CCCCCCHHHHHHHHH
Confidence 98899999999999999999997 999997543211 1 111111111100 011123356788899
Q ss_pred cccCCCCCCCCHHHHHHHHHhhcc
Q 006886 586 CVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 586 Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
||+.+|++|||+.|+++.|+.+..
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=324.19 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=196.8
Q ss_pred HhcccCcCCceeEEEEEecC-CcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEecCC
Q 006886 338 SAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYSYMP 413 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~ 413 (627)
..+.||+|+||.||++...+ |...|||.+..... ..+.+++|+.++.++ +|||||+++|...... .+++.|||++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeeeeccC
Confidence 35789999999999999764 89999998865421 246689999999999 6999999999855555 5889999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~-- 490 (627)
+|+|.+++.+.. + .+++.....++.||++||.|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 100 GGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999998753 2 5999999999999999999999998 999999999999999 79999999999987652
Q ss_pred -----CCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 491 -----PTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 491 -----~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.....||+.|||||++..+ ....++||||+||++.||+||+.||... .....++-.+..+.....+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip-- 245 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP-- 245 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC--
Confidence 2245689999999999853 3345999999999999999999999753 11222222222222111111
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
...+++ ..+++.+|+..+|++||||.+++++.-.-.+.
T Consensus 246 -----~~ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 246 -----DSLSDE---AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -----cccCHH---HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 112333 44566699999999999999999976654433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.67 Aligned_cols=239 Identities=25% Similarity=0.389 Sum_probs=198.7
Q ss_pred cccCcCCceeEEEEE-ecCCcEEEEEEecccccC-HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAAT-KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
++||+|+.|.||.+. ..+++.||||++...... ++-+..|+.+|+.. +|+|||.++..|...++.++|||||+||+|
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 679999999999998 446889999999876554 45578999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----CCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----PTT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----~~~ 493 (627)
.+.+... .+++.+...|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.. ..+
T Consensus 358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 358 TDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999865 4899999999999999999999999 99999999999999999999999999987754 346
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..||+.|||||+.....|.+|+||||||++.+||+.|++||-... ....+..+...+ . +.+.......
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~------PlrAlyLIa~ng-~-----P~lk~~~klS 496 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRALYLIATNG-T-----PKLKNPEKLS 496 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC------hHHHHHHHhhcC-C-----CCcCCccccC
Confidence 679999999999999999999999999999999999999996421 111111111111 1 1222222223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+.+++.+||..|+++||++.|++++
T Consensus 497 ---~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 ---PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ---HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 345556669999999999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.26 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=205.4
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.++||+|-||.|..+....+..||||.++.... ...+|.+|+++|.++ +||||+.++|.|..++..++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 789999999999999998889999999987643 457899999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCC-
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT- 495 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~- 495 (627)
|.+|+.++... .+.-....+|+.|||.|++||.+.+ +|||||.++|+|++.++++||+|||+++-+-......
T Consensus 622 LnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 622 LNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999876421 2455566789999999999999988 9999999999999999999999999999664433322
Q ss_pred -----CCccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 496 -----RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 496 -----~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
-.++|||+|.+.-++++.++|||+||+++||+++ ...||.....++.. +-....+...-... -
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~~-------~ 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQV-------V 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcce-------e
Confidence 2578999999999999999999999999999877 77888765433211 11111111111100 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
......+...+.+++.+||+.+-++||+++++...|++.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112344556788999999999999999999999998864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.54 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=195.3
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.++||+|.||.||+|+ ..+|+.||+|+++... ..-....+|+.+++++ .||||+++.+...+. ...|+|+|||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecc
Confidence 3789999999999999 4579999999997653 2345678999999999 999999999999887 6899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
+. ||..++... +..++..+...++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 87 888888643 346899999999999999999999999 9999999999999999999999999999875543
Q ss_pred -----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHH-HHHHhhhcccc------
Q 006886 493 -----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRW-VRSVVREEWTA------ 559 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~------ 559 (627)
..+.|..|.|||.+.+ ..|+..+|+||.||||.||++|++.|++.++-+..+.+-. +.....+.|..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 2345889999999876 5799999999999999999999999998654332211110 00000111110
Q ss_pred cccchhhhcCC-ChHHH----HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 560 EVFDVELLKYQ-DVEEE----MVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 560 ~~~d~~l~~~~-~~~~~----~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+.+.- .+. ...|. ....++++..+|..||.+|.|+.++++
T Consensus 353 ~~~kp~~-~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQ-PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCC-cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111100 001 11111 123467777999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.64 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.2
Q ss_pred hcccCcCCceeEEEEEecC--C--cE-EEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILED--G--TT-VVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.++||+|+||.||+|.++. + .. ||||..+.. ....++|.+|+++|+.+ +|||||+++|++......++||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEE
Confidence 3889999999999999653 2 23 899988752 23467899999999999 9999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|+|+||+|.+||++.. ..++..++..++.++|.||+|||+++ ++||||-++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999764 25999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCC----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 490 FPT----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 490 ~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
... ...-...|+|||.+....|++++|||||||++||+++ |..||.+.... ++. ..+...+.....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~---~kI~~~~~r~~~--- 384 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVK---AKIVKNGYRMPI--- 384 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHH---HHHHhcCccCCC---
Confidence 211 1123578999999999999999999999999999999 88899865322 111 112122222111
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
....+. ++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 385 ----~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 ----PSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 112233 44556669999999999999999999999876544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=317.09 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=203.1
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||.|..++||+|+ .+.+..||||++.... ...+.+.+|+..|..+ +||||++++..|..+...|+||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCC
Confidence 5789999999999999 4567999999997553 3357899999999998 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
++.+.++....+ .+++..+..|..++++||.|||++| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999876543 4999999999999999999999999 999999999999999999999999987654221
Q ss_pred ----CCCCCCccccCccccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc---cccc
Q 006886 492 ----TTATRTIGYRAPEVTE--TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---AEVF 562 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~--~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 562 (627)
.+..||+.|||||++. ...|+.|+||||||++..||.+|..||.....-. -.-..+..... ....
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCCCcccccC
Confidence 4557899999999953 3579999999999999999999999997543211 11111111110 0011
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhccccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQIQQPEL 612 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~~~~~~~ 612 (627)
|.. ......+.+.+++..|+.+||.+|||+.++++ .++..+..+.
T Consensus 258 ~~d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 258 DKD-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred ChH-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 111 11112236778888999999999999999997 4555554443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=327.43 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=200.8
Q ss_pred HhcccCcCCceeEEEEE-ecCCcEEEEEEecccccCHHH--HHHHHHHHHHhccCCCeeeeeeEEeeCC-ceEEEEecCC
Q 006886 338 SAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE--FEQQMEVVGTIGKHSNVVPVRAYYYSKD-EKLVVYSYMP 413 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~--~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~e~~~ 413 (627)
+.++||.|.||.||+|+ ..+|..||||+++......++ -.+|++.+.++..||||+++...+.+.+ .+++|||||+
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 35789999999999999 446899999999876443333 4689999999966999999999999888 8999999995
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
.+|++.++.. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.+...
T Consensus 94 -~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 94 -CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred -hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC
Confidence 5999999865 368999999999999999999999999 999999999999999999999999999988654
Q ss_pred -CCCCCCccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh----ccc-----cc
Q 006886 492 -TTATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE----EWT-----AE 560 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-----~~ 560 (627)
..++.|..|+|||++ ..+.|+.+.|+||+|||++|+.+-++-|.+.++-| ++-+.+. ++.. .+. ..
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc~-VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKICE-VLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHHH-HhCCCccccchhHHHHHH
Confidence 334568899999996 56789999999999999999999999998765432 2221111 1110 110 00
Q ss_pred ccchhhhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+...+.... -.+....+.++++.+|++.||.+|||+.|++++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111000 012345677889999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.65 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=202.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhc-cCCCeeeeeeEEeeCC----ceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVPVRAYYYSKD----EKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~----~~~lv~e~~~ 413 (627)
.+.||+|.||.||+|.++ |+.||||++.. .+++.+.+|.++++.+. +|+||+.+++.-..+. +++||++|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 578999999999999998 89999999963 45666778888877532 9999999998866543 5789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-----GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
.|+|++||.++ .++....++++..+|.||++||.+ |.|.|.|||||+.|||+.+++.+.|+|+|+|...
T Consensus 293 ~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999864 589999999999999999999964 6789999999999999999999999999999665
Q ss_pred CC--------CCCCCCCccccCccccCCCC------CCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006886 489 NF--------PTTATRTIGYRAPEVTETRK------ASQKSDVYSFGVLLLEMLTG----------KAPLQHSGHDDVVD 544 (627)
Q Consensus 489 ~~--------~~~~~~t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~~~~ 544 (627)
.. .....||.+|||||++...- .-..+||||||+|+||+... +.||.+.-..+- +
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-S 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-C
Confidence 33 23456899999999986531 12569999999999999863 456654332221 1
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. +..++++.... +.|.........+.+..+.++|+.||..+|..|-|+-.+.+.|.++.+.
T Consensus 446 ~-eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 446 F-EEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred H-HHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 1 11112221111 2223333445578899999999999999999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.92 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.0
Q ss_pred HhcccCcCCceeEEEEEe-cCCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 338 SAEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
..+.+|+|.||.||+|+. ++|+.||||+++..... .....+|++.++.+ +|+||+.+++.|...+...+|+|||+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEecc
Confidence 357899999999999994 47999999999865332 45788999999999 89999999999999999999999997
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
. +|...++.. ...++-.....++.++++|++|+|++. |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 85 t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 85 T-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred c-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 6 899998754 357888999999999999999999998 99999999999999999999999999999865432
Q ss_pred ----CCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---hhcccc--cccc
Q 006886 494 ----ATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV---REEWTA--EVFD 563 (627)
Q Consensus 494 ----~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~d 563 (627)
.+.|..|.|||.+.| +.|+..+||||.|||+.||+-|.+-|.+.+ ++.++...++..- .+.|.. ...|
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s--DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS--DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc--hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 245889999999876 579999999999999999999988776543 3333322222111 111110 0111
Q ss_pred hh-hhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VE-LLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~-l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. +...+ -.+.+..+.++++..++..+|.+|+++.|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10 01011 123344566889999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=301.33 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=177.2
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
+.+++. .+...||.|+||+|..++.+ +|..+|+|++.+... ..+....|..+++.+ .||.++++.+.|.+.+
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCC
Confidence 445555 33578999999999999966 588999999976532 234567788999999 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++||||.+||.|..++++.+ .+++..++-+|.+|+.||+|||+.+ |++|||||+|||+|.+|.+||+|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999999753 5999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 484 LAHLINFP-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 484 ~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
+|+..... -+.+||+.|+|||++....+...+|+|||||++|||+.|.+||....
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 99987654 45679999999999999999999999999999999999999998654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=324.75 Aligned_cols=237 Identities=23% Similarity=0.400 Sum_probs=200.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCH---HHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATK---REFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|.||+||||+-+ +.+.||+|.+.+....+ +...+|+++++.+ +||||+.++++|+...+.++|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhhh
Confidence 467999999999999955 57899999997654433 4588999999999 999999999999999999999999977
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+|..++.... .+++..+..++.+++.||.|||+.+ |.|||+||.|||+++.+.+|+||||+|+.+....
T Consensus 86 -~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 86 -DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred -hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999998653 4999999999999999999999998 9999999999999999999999999999886543
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...||+-|||||...++.|+..+|.||+||++||+++|++||... .+...++.+..+...
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v~------------ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPVK------------ 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCCC------------
Confidence 345899999999999999999999999999999999999999743 233344444433211
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+..++...+.+||.+|.|-.+++.+
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112334466777778899999999999998763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=323.00 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=195.7
Q ss_pred hcccCcCCceeEEEEEecC-----------------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEE
Q 006886 339 AEVLGKGSYGSTYKAILED-----------------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYY 399 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 399 (627)
.+.||+|+||.||++.+++ +..||+|.+..... ...+|.+|++++.++ +||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 4679999999999998542 33699999875422 345789999999999 999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHhhhcCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 006886 400 YSKDEKLVVYSYMPAGSLFMLLHRNRS--------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIK 465 (627)
Q Consensus 400 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 465 (627)
...+..++||||+++|+|.+++..... .....++|...++++.|++.||.|||+.+ |+|||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcc
Confidence 999999999999999999999865321 11235788999999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 006886 466 SSNVLLTQDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHS 537 (627)
Q Consensus 466 ~~NILl~~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~ 537 (627)
|+|||++.++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999998653321 2234678999999988889999999999999999987 56677653
Q ss_pred CCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 538 GHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
... .....+.......... .. ....+.....+.+++.+||..+|++|||+.+|.+.|++
T Consensus 246 ~~~---~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDE---QVIENAGEFFRDQGRQ-VY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHH---HHHHHHHHHhhhcccc-cc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 221 1222222211111000 00 00111223467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=325.45 Aligned_cols=239 Identities=23% Similarity=0.383 Sum_probs=196.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc-----c-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV-----A-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-----~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|.||.|+.|... ++..||+|++... . ...+.+.+|+.+++++..||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 467999999999999854 6899999977553 1 23456678999999995599999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLIN- 489 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~- 489 (627)
+.+|+|.+++... ..+.+..+..++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 102 CSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred cCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 9999999999863 35888999999999999999999999 9999999999999999 999999999999872
Q ss_pred ---CCCCCCCCccccCccccCCCC-CC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 490 ---FPTTATRTIGYRAPEVTETRK-AS-QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 490 ---~~~~~~~t~~y~aPE~~~~~~-~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
...+..||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. ......+.+......
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~~~------ 241 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGEFK------ 241 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCCcc------
Confidence 245778999999999999877 85 7899999999999999999999862 223333332221110
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
-..... ..+...++.+|+..+|.+|+++.++++
T Consensus 242 ---~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 ---IPSYLL--SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 001110 345567888999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.80 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=206.7
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+.|.|-.|++ .+|+.+|||++.+.. .....+++|+-+|+.+ .|||++++++.|+++.++|+|.||++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEecC
Confidence 57799999999999995 479999999997652 2356789999999988 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|.|++++-.. .++.+.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|..-...
T Consensus 96 gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 96 GGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred CchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999764 46899999999999999999999998 999999999999999999999999999876443
Q ss_pred -CCCCCCccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKAS-QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+.+|++.|.|||++.+..|. .++||||.|||||-|+||+.||++. ++.....++.++...
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~f~----------- 230 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGVFE----------- 230 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCccc-----------
Confidence 467899999999999999985 7899999999999999999999842 444444443333221
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.......+..+++.+|+..||+.|.|++||+++-.-......
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 111222345567779999999999999999997665544443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=329.85 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEe------cCCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++..+.+||||++++++|...+..++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 58899999999999973 235689999987543 2345688999999999889999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC----------------------------------------------------------------
Q 006886 411 YMPAGSLFMLLHRNRS---------------------------------------------------------------- 426 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~---------------------------------------------------------------- 426 (627)
|+++|+|.++++....
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 9999999999975321
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC------C
Q 006886 427 ------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT------A 494 (627)
Q Consensus 427 ------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~------~ 494 (627)
.....++|..+.+++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 276 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence 01235789999999999999999999998 99999999999999999999999999986643221 2
Q ss_pred CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 495 ~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
.++..|+|||++.+..++.++||||||+++|||++ |..||....... .. ........... ...
T Consensus 277 ~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~~~-------~~~--- 340 (375)
T cd05104 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKMIKEGYRML-------SPE--- 340 (375)
T ss_pred CCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHHHHhCccCC-------CCC---
Confidence 23467999999999999999999999999999998 888986542211 11 11111111100 001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
....++.+++.+||+.+|++||++.||++.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1123567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.04 Aligned_cols=253 Identities=20% Similarity=0.337 Sum_probs=202.8
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e~ 411 (627)
.+.+|+|||+.||.+. ..++..+|+|++.-.. ...+..++|++..+++ +|||+++++++...+ ...|+++.|
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 4789999999999998 5678899999986554 4667889999999999 999999999887643 348999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
...|+|.+.+...+ .++..+++.+.++|+.++++||.+||+.. ++++||||||.|||+.+++.+++.|||.++.....
T Consensus 105 y~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 105 YKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 99999999998754 34678999999999999999999999987 78999999999999999999999999998765321
Q ss_pred -------------CCCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh
Q 006886 492 -------------TTATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555 (627)
Q Consensus 492 -------------~~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 555 (627)
....-|..|.|||.+. +...++++|||||||+||+|+.|..||+...+.+. .
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S----------- 250 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S----------- 250 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e-----------
Confidence 1122478899999985 44678999999999999999999999985432111 1
Q ss_pred cccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 556 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
....+....+ ..+........+.+++.+|++.||.+||++.+++..++.+.
T Consensus 251 -laLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 -LALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -EEEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111 11222224556778888999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.41 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++.. .+++.||+|.+.... .....+.+|++++..+ +|+|++++.+++.+++..++|+||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecC
Confidence 36799999999999996 478999999986432 1234577899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 84 GGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999998886432 235899999999999999999999998 999999999999999999999999999875432
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+........ . .
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~--------~---~ 223 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ--------E---E 223 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc--------c---c
Confidence 234578999999999999999999999999999999999999986433211 111111111100 0 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
.......++.+++.+||+.+|++||+ +++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00112235667888999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.01 Aligned_cols=240 Identities=21% Similarity=0.348 Sum_probs=191.5
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
+...||+|+||.||.++.+ +|..+|+|++++... .-+....|-.+|... .+|.||+++..|.+.+.+||||||+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEec
Confidence 3588999999999999966 589999999987632 335677888888885 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
+||++..+|.+. ..+++..+..++.+++.|+..+|+.| +|||||||+|+|||..|++||+|||++.-+..
T Consensus 224 PGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 224 PGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999864 46999999999999999999999999 99999999999999999999999999843200
Q ss_pred -----------------------C--------------------------CCCCCCccccCccccCCCCCCCcchhHHHH
Q 006886 491 -----------------------P--------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFG 521 (627)
Q Consensus 491 -----------------------~--------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~G 521 (627)
. ...+|||.|||||++.+..|+..+|+||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 012378999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCC-CCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC---H
Q 006886 522 VLLLEMLTGKAPLQHSGHDDV-VDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK---M 597 (627)
Q Consensus 522 vvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~ 597 (627)
||+|||+.|.+||...+..+. ..+..|-..+.. +...+...+..++|.+|+. ||++|-- +
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999987543321 122222211111 1111111345567778888 9999964 5
Q ss_pred HHHHH
Q 006886 598 DDVVR 602 (627)
Q Consensus 598 ~ev~~ 602 (627)
+||.+
T Consensus 440 ~EIK~ 444 (550)
T KOG0605|consen 440 EEIKK 444 (550)
T ss_pred HHHhc
Confidence 66544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.53 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=197.6
Q ss_pred HhcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 338 SAEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
..+.||+|+||.||+++.. ++..||+|+++.... ....+.+|+++++.+.+|+||++++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 3588999999999998842 245799999975432 23568889999999988999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCC---------------------------------------------------------------
Q 006886 410 SYMPAGSLFMLLHRNRS--------------------------------------------------------------- 426 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~--------------------------------------------------------------- 426 (627)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999865321
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC------CCCCCc
Q 006886 427 --DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT------TATRTI 498 (627)
Q Consensus 427 --~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~------~~~~t~ 498 (627)
.....+++...++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ...++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 01134788999999999999999999998 9999999999999999999999999997654322 112346
Q ss_pred cccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHH
Q 006886 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMV 577 (627)
Q Consensus 499 ~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 577 (627)
.|+|||++....++.++|||||||++|||++ |+.||....... . ............ . ... ...
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~--~-----~~~---~~~ 342 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS--R-----PDF---APP 342 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc--C-----CCC---CCH
Confidence 7999999988899999999999999999997 999997543211 0 111111111000 0 001 124
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 578 QMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 578 ~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
++.+++.+||+.+|++||++.++++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 5677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.15 Aligned_cols=232 Identities=24% Similarity=0.337 Sum_probs=193.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
..+||+|.||+|+++..+ +++.+|||++++... .-+..+.|..++....+||.++.++..|...++.+.||||..
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 578999999999999976 578999999987632 345677888888888789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---- 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~---- 489 (627)
||++..+.+. ..+++..+.-+|..|+.||+|||+++ |||||||-+|||+|.+|++||+|||+++..-
T Consensus 453 Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 453 GGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9996555442 35999999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...+.+||+.|||||++.+..|+..+|+|||||+||||+.|..||.+.++++. +..++.++..
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~~~----------- 586 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDEVR----------- 586 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCCC-----------
Confidence 34677899999999999999999999999999999999999999997655432 2222222111
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM 597 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 597 (627)
.......+.+.++.+.+.++|++|--+
T Consensus 587 -yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 -YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111223456677789999999999765
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=307.24 Aligned_cols=241 Identities=23% Similarity=0.404 Sum_probs=198.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++.++++..+|+|.+.......+++..|+++++++ +||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 467999999999999998888999999876655677899999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
++++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||.++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9987542 25899999999999999999999998 9999999999999999999999999987653321 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...+..+...... ..+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~---~~~-------- 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL---YRP-------- 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC---CCC--------
Confidence 123457999999988889999999999999999999 8999965421 1112222111110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
......+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11223577889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.97 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=197.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
+.||+|.||.||+|... .++.||+|++.... ...+++++|+.++... +++||.+++|.+..+..++++||||.||+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 67999999999999955 68899999997653 3456889999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----PT 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----~~ 492 (627)
+.+.+... ..+++....-|+.++..|+.|||+++ .+|||||+.|||+..+|.+|++|||.+..... ..
T Consensus 98 v~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 98 VLDLLKSG-----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhhccC-----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999754 34577778889999999999999998 99999999999999999999999999987643 36
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
++.||+.|||||++....|+.|+||||||++.+||.+|.+|+..........+ ..+-..|.+..
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~---- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG---- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc----
Confidence 77899999999999998999999999999999999999999986543211100 01111111111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++..|++++|+.||++.+++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 223345567779999999999999999873
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=293.47 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=205.6
Q ss_pred CCCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC
Q 006886 328 NFDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK 402 (627)
Q Consensus 328 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 402 (627)
.+.++++ ...+.||+|-||.||.|+.+ ++..||+|++.+.. ....++.+|+++...| +||||++++++|.+.
T Consensus 18 ~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 18 TWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS 94 (281)
T ss_pred ccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc
Confidence 3455555 33688999999999999955 67889999987653 3467889999999999 999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 403 DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 403 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
...|+++||.++|++...|+..+ ...+++.....+..|+|.|+.|+|..+ |+||||||+|+|++.++..||+||
T Consensus 95 ~riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999998543 246888889999999999999999988 999999999999999999999999
Q ss_pred ccccccC--CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 483 GLAHLIN--FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 483 G~a~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
|-+.... ...+.+||..|.|||...+..++..+|+|++|++.||++.|.+||+....++.. ..+. ..+
T Consensus 169 GwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY------krI~----k~~ 238 (281)
T KOG0580|consen 169 GWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY------KRIR----KVD 238 (281)
T ss_pred CceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH------HHHH----Hcc
Confidence 9886553 346778999999999999999999999999999999999999999875432211 1111 111
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
..++ ...+. ...++|.+|+.++|.+|.+..|++.+-.
T Consensus 239 ~~~p-----~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 239 LKFP-----STISG---GAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ccCC-----cccCh---hHHHHHHHHhccCccccccHHHHhhhHH
Confidence 1222 12222 3456778999999999999999987643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.75 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=206.0
Q ss_pred hcccCcCCceeEEEEEecCC-cEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeee-EEee------CCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILEDG-TTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRA-YYYS------KDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~------~~~~~lv~ 409 (627)
.++|.+|||+.||.|....+ ..||+|++... ....+...+|+++|+.|..|+|||.+++ .... ..+.+|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 57899999999999997765 99999998654 3345778999999999989999999998 3322 13578999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|||.+|.|-+++..... ..+++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||||||.|...-
T Consensus 122 EyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred hhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999986532 34999999999999999999999986 899999999999999999999999999986543
Q ss_pred CCC-------------CCCCCccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh
Q 006886 490 FPT-------------TATRTIGYRAPEVT---ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553 (627)
Q Consensus 490 ~~~-------------~~~~t~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 553 (627)
... ....|+.|+|||.+ .+...++|+|||+|||+||-|+....||++...-.
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------ 265 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------ 265 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------------
Confidence 221 12248899999986 56788999999999999999999999998653221
Q ss_pred hhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 554 REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 554 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
+++-.. ..+..+.....|.+||..||+.+|++||++-+|++.+.+|......-
T Consensus 266 -------Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 266 -------ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred -------EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 111111 12233566677888999999999999999999999999998766533
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.24 Aligned_cols=245 Identities=25% Similarity=0.454 Sum_probs=200.4
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|..+++..||+|.+.......+.+..|+.+++++ +|+||+++++.+...+..++++||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 478999999999999988888999999876555567899999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++...... .
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 9997542 345889999999999999999999988 9999999999999999999999999998764322 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++....++.++||||||+++|||++ |+.||...... ..... ........ ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~-~~~~~~~~-------~~--- 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSA-LQRGYRMP-------RM--- 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHH-HHcCCCCC-------CC---
Confidence 224567999999988889999999999999999998 99999653211 11111 11111100 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.....++.+++.+|+..+|++||+++++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.65 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=210.1
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..+||-|.||.||.|.|+. .-.||||.++.....-++|..|..+|+.+ +|||+|+++|.|.....+|+|+|||.+|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 5789999999999999874 56799999998888889999999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCC--
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT-- 495 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~-- 495 (627)
.+||++... ..++--..+.+|.||+.|+.||..++ +|||||.++|.|+.++..+||+|||+++++..+....
T Consensus 351 LdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 351 LDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred HHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 999997643 45677778899999999999999998 9999999999999999999999999999986443221
Q ss_pred C---CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 496 R---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 496 ~---t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
| .+.|.|||-+....++.|+|||+|||+|||+.| |..||.+.+- ..+..++..+.. +. .
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgyR-------M~---~ 487 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGYR-------MD---G 487 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhcccc-------cc---C
Confidence 2 467999999999999999999999999999998 8889876432 122222322221 11 2
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.+.|...+.++|+.||+..|.+||++.|+-+.++.|..+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 234555778899999999999999999999999998654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.97 Aligned_cols=248 Identities=26% Similarity=0.487 Sum_probs=198.3
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.... ...||+|.+..... ....+.+|++++..+ +||||+++++++...+..++++|
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEe
Confidence 5789999999999998643 25799998865432 345688999999999 99999999999998889999999
Q ss_pred cCCCCCHHHHhhhcCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 411 YMPAGSLFMLLHRNRSDGG-----------TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
|+++|+|.+++........ ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence 9999999999976432111 46889999999999999999999998 999999999999999999999
Q ss_pred eecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
+|||+++...... ...+++.|+|||++....++.++|||||||++|||++ |..||.+....+ + . ..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---~-~~ 238 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---I-EM 238 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HH
Confidence 9999987653221 2234678999999988899999999999999999998 999997543211 1 1 11
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
+....... .......++.+++.+||+.+|.+||++.||++.|+.+
T Consensus 239 i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111110 1122335677888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.52 Aligned_cols=244 Identities=22% Similarity=0.401 Sum_probs=196.1
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|.++ .+..||+|.++.... ..+.+.+|+..+..+ +||||+++++++..++..++||||+
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeC
Confidence 478999999999999854 356899999876532 235788999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999997542 35899999999999999999999998 9999999999999999999999999876543221
Q ss_pred -----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 -----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...++..|+|||++.+..++.++||||||+++||+++ |+.||...... ...... .+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~-~~~~~~------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAV-EDGFRL------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHH-HCCCCC-------
Confidence 1223568999999998999999999999999999875 99999754321 111111 111000
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.........+.+++.+||+.+|++||++.++.+.|.++
T Consensus 228 ---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122334567788899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.08 Aligned_cols=237 Identities=21% Similarity=0.309 Sum_probs=192.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +|+.||+|+++... .....+..|++++.++ +||||+++.+++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999864 68999999987542 1234577899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence 9999998754 35899999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+ ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~-------~~--p~ 216 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEI-------RF--PR 216 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCC-------CC--CC
Confidence 1234588999999999999999999999999999999999999975321 111111111110 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
. ...++.+++.+|+..||++|| ++.+++++
T Consensus 217 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 T---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 123456778899999999999 79998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.67 Aligned_cols=242 Identities=28% Similarity=0.508 Sum_probs=189.4
Q ss_pred hcccCcCCceeEEEEEec-----CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-----DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||.|.||.||+|.++ .+..|+||.++.... ..+.|.+|++.+.++ +||||++++|++...+..++|+||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccc
Confidence 367999999999999977 357899999965332 357899999999999 999999999999988889999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ...+++..+.+|+.|++.||.|||+.+ ++|+||+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999998752 246899999999999999999999998 999999999999999999999999999876321
Q ss_pred ------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
........|+|||.+.+..++.++||||||+++||+++ |+.||... ............... .
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~~~-~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQRL-P---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTEET-T----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccccc-e----
Confidence 22335678999999988889999999999999999999 78888643 222222222211111 1
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
........+.+++.+||+.+|++||++.++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111233567888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.17 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=190.4
Q ss_pred CHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceE
Q 006886 330 DLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 330 ~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 406 (627)
.++++. ..+.||+|+||.||+++.. +++.||||++..... ..+.+.+|++++..+ +|+||+++++++...+..+
T Consensus 72 ~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 72 SLSELE--RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CHHHHh--hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEE
Confidence 445552 3478999999999999965 689999999864322 346788999999999 9999999999999999999
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||+++|+|.... ..++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 149 lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 149 VLLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999985432 3566778899999999999999998 9999999999999999999999999998
Q ss_pred ccCCC----CCCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 487 LINFP----TTATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 487 ~~~~~----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
..... ....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+ .............
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 293 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQP 293 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccCC
Confidence 76432 23468899999998743 234568999999999999999999997432221 1111111110000
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
. ........++.+++.+||..+|++||++.|++++-
T Consensus 294 -~----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 -P----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -C----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 00112234567788899999999999999998853
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=304.02 Aligned_cols=239 Identities=23% Similarity=0.388 Sum_probs=202.7
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|.||.|-++.. ..|+.||||.+++... +.-.+.+|+++|..+ +||||+.++..|++.+...+||||..
T Consensus 58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEYaS 136 (668)
T KOG0611|consen 58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEYAS 136 (668)
T ss_pred HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEecC
Confidence 57899999999999995 6799999999987643 233578999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|.|++|+.+.. .+++.++..++.||..|+.|+|.++ ++|||||-+|||+|.|+++||+|||++..+...
T Consensus 137 ~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 137 GGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred CccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 999999998753 5999999999999999999999998 999999999999999999999999999887654
Q ss_pred -CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+++|++-|.+||+..+..| .+.+|-||+||+||.|+.|..||++.+ ....++++-..... +
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYr-E--------- 272 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYR-E--------- 272 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhccccc-C---------
Confidence 57889999999999999888 478999999999999999999998753 23334443332211 1
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
++......-+|++|+..+|++|.|..||..+-+
T Consensus 273 ---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 ---PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111123345778999999999999999988643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.74 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=193.5
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +++.||+|+++.... ..+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999965 688999999975421 2345778889998887899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 9999888654 35899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC--CCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD--VVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+........... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--------I 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC--------C
Confidence 223457899999999999999999999999999999999999997432221 111222222222211110 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPK------MDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs------~~ev~~~ 603 (627)
... ...++.+++.+|++.+|.+||+ +++++++
T Consensus 225 p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011 1234567888999999999997 6777653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.51 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=198.9
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|... .+..||||+++.... ..+.+.+|++++.++..||||++++++|.+.+..++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 578999999999999853 134699999965432 345789999999999669999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC---------------------------------------------------------------
Q 006886 411 YMPAGSLFMLLHRNRSD--------------------------------------------------------------- 427 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~--------------------------------------------------------------- 427 (627)
|+++|+|.++++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 99999999998754210
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 428 ----------------------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 428 ----------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEE
Confidence 1134788899999999999999999998 999999999999999999999
Q ss_pred eecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||....... .....
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~ 352 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNK 352 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHH
Confidence 9999998653221 2234678999999988899999999999999999997 999987542211 01111
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
....... .........+.+++.+||..+|++||++.+|.++|+++..
T Consensus 353 ~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111000 0111233467788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.20 Aligned_cols=234 Identities=21% Similarity=0.298 Sum_probs=189.3
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||.||+++.. +++.||+|++.... .....+..|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999975 57899999986532 2335677899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 80 LFHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 99999754 34899999999999999999999998 999999999999999999999999998764221 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............. .....
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~---------~~~~~- 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPL---------RFPDG- 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC---------CCCCc-
Confidence 3458899999999999999999999999999999999999997532 2222222222110 00011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPK---MDDVVR 602 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~~ 602 (627)
....+.+++.+||..+|++||+ +.|+++
T Consensus 216 --~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 --FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1234567788999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=307.04 Aligned_cols=245 Identities=25% Similarity=0.434 Sum_probs=201.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|++|.||+|..++++.||+|.++......+++.+|++++.++ +|+||+++++++...+..++|+||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 478999999999999988888999999976655677899999999999 8999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC--CCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--ATR 496 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~--~~~ 496 (627)
+++.... +..+++.....++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||+++....... ..+
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9997543 346899999999999999999999998 99999999999999999999999999987653211 112
Q ss_pred ---CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 497 ---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 497 ---t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+. ..... ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVLQQVD-QGYRM----------PCP 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCCC----------CCC
Confidence 347999999998899999999999999999999 99999753211 1111111 11000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
......+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12234677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.37 Aligned_cols=239 Identities=17% Similarity=0.254 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 467999999999999976 68899999986432 2345688899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 85 GGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 99999999754 35889999999999999999999998 999999999999999999999999999876443 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... + + ....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~-----~--~--~~~~ 221 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGKL-----E--F--PRHL 221 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCc-----C--C--CccC
Confidence 34588999999999988899999999999999999999999975421 111122111110 0 0 0011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRMI 604 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~L 604 (627)
...+.+++.+|+..||.+||+ ++|++++-
T Consensus 222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 224567888999999999995 88888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.36 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=199.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|..+ .++.||+|.+.......+++.+|++++..+ +|+||+++++++..++..++||||+++++|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 467999999999999965 588899999876555567899999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---- 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~---- 493 (627)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 99997542 245899999999999999999999998 99999999999999999999999999887643221
Q ss_pred -CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 494 -ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 494 -~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...+..|+|||++.+..++.++||||||+++|||++ |..||..... ........ ..... . .
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~-~~~~~-----~-----~ 226 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLE-KGYRM-----E-----R 226 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH-CCCCC-----C-----C
Confidence 123567999999998899999999999999999998 9999875321 11111111 11000 0 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
......++.+++.+|++.+|++||++.+++++|+.+
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011224577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.17 Aligned_cols=191 Identities=21% Similarity=0.331 Sum_probs=167.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+++.+ ++..||+|.+..... ..+.+.+|++++..+ +||||+++++++..++..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 468999999999999976 578899998865422 345789999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--CC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--TT 493 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~~ 493 (627)
+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 89 SLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 999999754 34889999999999999999999853 3999999999999999999999999998765432 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 45788999999999989999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.71 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=191.9
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +++.||+|+++.... ..+.+..|+.++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 578999999875421 2345677888888777899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 9999888654 35899999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC--CCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--VDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......... . +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-~------ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-I------ 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-C------
Confidence 1234578999999999999999999999999999999999999964322111 1112222222211110 0 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPK------MDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs------~~ev~~~ 603 (627)
. ......+.+++.+|+..||++||+ +.+++++
T Consensus 225 p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 P---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0 112234567888999999999998 4676554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.12 Aligned_cols=237 Identities=22% Similarity=0.331 Sum_probs=191.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +|+.||+|+++... .....+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36999999999999965 68999999987542 1234567889999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 80 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151 (323)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence 9999888754 35899999999999999999999998 999999999999999999999999998754221
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ........... . . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~~-----~--~--p~ 216 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI-----R--F--PR 216 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCC-----C--C--CC
Confidence 2345789999999999889999999999999999999999999754321 11111111110 0 0 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.. ..++.+++.+|++.+|++|| ++.+++++
T Consensus 217 ~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CC---CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11 23456778899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.09 Aligned_cols=241 Identities=24% Similarity=0.425 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..+|+|.+.........+.+|++++..+ +|+||+++++++...+..++|+||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 577999999999999988778899999876555667889999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC--C--
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--A-- 494 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~--~-- 494 (627)
+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++....... .
T Consensus 88 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 88 NYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9997542 25899999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred -CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 495 -TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 495 -~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
.++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ . ..... ... .. ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~-~~~-----~~-----~~~ 223 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VESVS-AGY-----RL-----YRP 223 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHHHH-cCC-----cC-----CCC
Confidence 12357999999998899999999999999999999 899987532211 1 11111 110 00 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....++.+++.+||..+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11234677888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.78 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=190.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.+ +++.||+|+++... .....+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 468999999999999965 68899999986432 2345678899999999 999999999999998899999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... +..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 88 DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 899888653 235789999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---cccccccc-hh-
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTAEVFD-VE- 565 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-~~- 565 (627)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ......... .......+ ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhccccchhh
Confidence 23346889999998865 56899999999999999999999999754322111 001000000 00000000 00
Q ss_pred ----hhcC--CC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 566 ----LLKY--QD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 566 ----l~~~--~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... .. .+....+..+++.+|+..||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00 00112345678889999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.59 Aligned_cols=248 Identities=22% Similarity=0.397 Sum_probs=196.8
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|.+. ++. .||+|.++... ...+++..|+.++..+ +||||++++++|... ..++|+||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cceeeeec
Confidence 378999999999999854 333 38999986542 2346788899999999 999999999998764 56799999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999998642 35889999999999999999999998 999999999999999999999999999876432
Q ss_pred CC------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 TT------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~~------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.. ...+..|+|||++....++.++||||||+++|||++ |+.||...... . ...........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~----- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL----- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC-----
Confidence 21 123567999999999999999999999999999998 99998753211 1 11111111100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.....+..++.+++.+||..+|++||++.+++..|.++.....
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0011123456788899999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.20 Aligned_cols=238 Identities=19% Similarity=0.276 Sum_probs=194.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||+|.+.... ...+.+.+|++++.++ +||||+++++++..++..++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 478999999999999976 58899999986532 2345688999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 102 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 102 GGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999754 34788899999999999999999998 999999999999999999999999999876443 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... . . . ....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~-~----~--~--p~~~ 238 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGR-L----K--F--PNWF 238 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCC-c----C--C--CCCC
Confidence 44688999999999998999999999999999999999999975321 11111111111 0 0 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
+ ..+.+++.+||+.||.+||+ +++++++
T Consensus 239 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 D---GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred C---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 24567888999999999997 6888764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.87 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=197.4
Q ss_pred HhcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEE
Q 006886 338 SAEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVV 408 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv 408 (627)
..+.||+|+||.||+|... .++.||+|+++.... ..+.+..|++++.++.+|+||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3588999999999999742 247899999875432 2345778999999998899999999988754 467889
Q ss_pred EecCCCCCHHHHhhhcCCC--------------------------------------------------------CCCCC
Q 006886 409 YSYMPAGSLFMLLHRNRSD--------------------------------------------------------GGTAL 432 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l 432 (627)
+||+++|+|.+++...... ....+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999998643210 01368
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC------CCCCCccccCcccc
Q 006886 433 DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVT 506 (627)
Q Consensus 433 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~ 506 (627)
+|..+.+++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ...++..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 99999999999999999999998 9999999999999999999999999998753221 22345679999999
Q ss_pred CCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHH
Q 006886 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALS 585 (627)
Q Consensus 507 ~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~ 585 (627)
.+..++.++|||||||++|||++ |+.||......+ ............ ........++.+++.+
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM----------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC----------CCCccCCHHHHHHHHH
Confidence 99999999999999999999998 999997532211 011111111100 0011223467788899
Q ss_pred cccCCCCCCCCHHHHHHHHHhhcc
Q 006886 586 CVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 586 Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
||+.+|++||++.|++++|+++.+
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=316.62 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=198.0
Q ss_pred cccCcCCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
..||.|+||.||.++. ++...||||++...- ..-.++..|+.++..+ +|||++.+.|+|..+...|+||||| -
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHHHHH-h
Confidence 5699999999999995 467889999986432 2346789999999999 9999999999999999999999999 5
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~ 494 (627)
|+-.+.+.-.+ .++.+.++..|+.+++.||+|||+++ .||||||+.|||+++.|.+|++|||.|....+..++
T Consensus 110 GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF 182 (948)
T KOG0577|consen 110 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF 182 (948)
T ss_pred ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence 57777776553 46888999999999999999999998 999999999999999999999999999999999999
Q ss_pred CCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 495 TRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 495 ~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
+|||.|||||++. .+.|+-++||||+|++..||...++|+..++. -..+..+...+ +....
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNe-------sPtLq--- 246 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-------SPTLQ--- 246 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcC-------CCCCC---
Confidence 9999999999974 57899999999999999999999999865431 11112222211 11111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+....|.+++..|+++-|.+|||.++++++
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23444456667779999999999999998764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.53 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=197.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..+|+|.+........++.+|+.++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 467999999999999988777899999876555677899999999999 8999999999999888899999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... ..+++..+++++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++...... .
T Consensus 88 ~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 88 NYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9997542 25899999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||+..+..++.++||||||+++|||++ |+.||...... ............. ..
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~-----------~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLRLY-----------RP 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCCCC-----------CC
Confidence 123467999999988889999999999999999998 99998643321 1111111111100 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
......+.+++.+||..+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112346778888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.04 Aligned_cols=246 Identities=18% Similarity=0.268 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+..|++++..+ +||||+++++++...+..++||||++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 478999999999999976 58899999987542 2345678899999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-CC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-PT 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-~~ 492 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 85 g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 85 GGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccC
Confidence 99999999754 35889999999999999999999998 99999999999999999999999999986644 23
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.... ..+...... ...
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~---~~~~~~~~~-~~~ 226 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWK---ETLQRPVYD-DPR 226 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcc---ccccCCCCC-ccc
Confidence 4568899999999998899999999999999999999999997543211 111111100 000000000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+|+..+|.+||++++++++
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1123356678889999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.41 Aligned_cols=239 Identities=20% Similarity=0.282 Sum_probs=190.6
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +++.||+|+++.... ..+.+..|+.++.++.+||||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 578999999975422 2345778888888887899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 9999988754 35899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+........... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--------IPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--------CCC
Confidence 223458899999999999999999999999999999999999997543332222223332222211100 001
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKM 597 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 597 (627)
.. ...+.+++.+|+..||++|+++
T Consensus 225 ~~---~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FL---SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC---CHHHHHHHHHHhccCHHHcCCC
Confidence 11 1345678889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.54 Aligned_cols=237 Identities=21% Similarity=0.341 Sum_probs=192.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +++.||+|++.... .....+..|+++++.+ +||||+++.+++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999965 68999999987542 2335678899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 80 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151 (328)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence 9999888754 35899999999999999999999998 999999999999999999999999998764221
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... .+ ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~~-------~~--p~ 216 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEDI-------KF--PR 216 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCCc-------cC--CC
Confidence 2345889999999999889999999999999999999999999753221 11111111110 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.. ..++.+++.+|+..+|++|| ++.|++++
T Consensus 217 ~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11 23456777899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=316.00 Aligned_cols=232 Identities=23% Similarity=0.328 Sum_probs=187.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +++.||+|++.... ...+.+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 58899999987532 23456677888888776899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 9999998754 34889999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~----~-----~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV----Y-----PT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCCC----C-----CC
Confidence 1234578999999999988999999999999999999999999975432 1222222211100 0 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKM 597 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 597 (627)
. ...++.+++.+|++.||++||++
T Consensus 218 ~---~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 W---LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C---CCHHHHHHHHHHcccCHHHCCCC
Confidence 1 12345678889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.79 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=188.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|+.+ +++.||+|+++... ...+.+..|..++....+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 47899999987542 23345667777777666999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999999753 35889999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... . .+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~-~--~~~------~ 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIRMDN-P--CYP------R 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C--CCC------c
Confidence 12345789999999999889999999999999999999999999754211 1111111110 0 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMD-DVVR 602 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~~ 602 (627)
....++.+++.+|++.+|++||++. ++.+
T Consensus 218 ---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 ---WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1123456778899999999999997 5644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.85 Aligned_cols=247 Identities=25% Similarity=0.434 Sum_probs=198.2
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|...+ +..||+|.+..... ..+.+.+|++++.++ +|+||+++++++......++|||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEEe
Confidence 4789999999999998643 47899999876533 346899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 411 YMPAGSLFMLLHRNRS---------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
|+++|+|.+++..... .....+++.....++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence 9999999999976421 12345889999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 482 VGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 482 fG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------~~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHH-
Confidence 9998764321 12234678999999999999999999999999999998 99998754321 1111111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
...... ........+.+++.+||..+|++||++.|+++.|++
T Consensus 239 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111000 001123456788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.09 Aligned_cols=256 Identities=17% Similarity=0.230 Sum_probs=192.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+++.+ +++.||+|++.... ...+.+.+|++++..+ +||||+++++++..++..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCC
Confidence 467999999999999976 57889999987542 2345678899999999 999999999999999999999999998
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
+.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 877655432 235899999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHH---------HHHHHHhhhccccc
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP---------RWVRSVVREEWTAE 560 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 560 (627)
....++..|+|||++.+..++.++|||||||++|||++|+.||......+..... .+............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 1235788999999999888999999999999999999999999764321110000 00000000000000
Q ss_pred ccchhhhcCCC-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQD-----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+....... .......+.+++.+|++.+|++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 01123457889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=315.69 Aligned_cols=238 Identities=22% Similarity=0.339 Sum_probs=191.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|+.+ +++.||+|++.... ...+.+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 57899999987542 22345677888888776899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 9999988754 34889999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~~----~-----p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDVL----Y-----PV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC----C-----CC
Confidence 12345789999999999889999999999999999999999999754321 112222211110 0 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-------KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-------s~~ev~~~ 603 (627)
. ...++.+++.+|+..+|++|| ++++++++
T Consensus 218 ~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 W---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 123566788899999999999 78888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.26 Aligned_cols=236 Identities=24% Similarity=0.329 Sum_probs=188.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +|+.||+|.++... ...+.+..|.+++....+||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999987542 23345667777777666899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 9999998753 35889999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.... +... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~~~~~-------~~~~--~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESIRVDT-------PHYP--R 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------CCCC--C
Confidence 2234578999999999999999999999999999999999999975321 11111111110 0000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMD-DVV 601 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~ 601 (627)
. ...++.+++.+|+..||++||++. ++.
T Consensus 218 ~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 W---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 123456788899999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.58 Aligned_cols=238 Identities=23% Similarity=0.373 Sum_probs=187.6
Q ss_pred cccCcCCceeEEEEEecC-------------CcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce
Q 006886 340 EVLGKGSYGSTYKAILED-------------GTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK 405 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 405 (627)
+.||+|+||.||+|...+ ...|++|.+.... .....+..|+.++..+ +||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2258888876542 2345678888888888 999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC-------eE
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN-------GC 478 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-------~k 478 (627)
++|+||+++|+|..++.... ..+++..+++++.|++.||+|||+.+ |+||||||+|||++.++. ++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999999887532 35899999999999999999999998 999999999999987664 89
Q ss_pred EeecccccccCCCCCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 479 ISDVGLAHLINFPTTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEML-TGKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 479 i~DfG~a~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
++|||++..........++..|+|||++. +..++.++||||||+++|||+ +|+.||......+ . .......
T Consensus 153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~----~~~~~~~ 225 (262)
T cd05077 153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---K----ERFYEGQ 225 (262)
T ss_pred eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---H----HHHHhcC
Confidence 99999998776555566788999999886 567899999999999999997 5888876432111 0 0000000
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
. . ...+...++.+++.+||+.||++||++.++++.+
T Consensus 226 -~-~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 -C-M----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -c-c----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0 0011123567788899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.54 Aligned_cols=244 Identities=27% Similarity=0.463 Sum_probs=198.0
Q ss_pred HhcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 338 SAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..+.||+|+||.||++..+++..+|+|.+.......+.+.+|++++.++ +|+|++++++++. ....+++|||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 3578999999999999988888999999977655677899999999999 9999999999875 4567899999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~----- 492 (627)
.++++... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||.+.......
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 99997542 245899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+.... .. ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~-~~----------~~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGY-RM----------PC 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-CC----------CC
Confidence 1223457999999988889999999999999999999 8999965321 11111111110 00 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223457788899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=292.51 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=196.9
Q ss_pred CHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEee--CC
Q 006886 330 DLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYS--KD 403 (627)
Q Consensus 330 ~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~ 403 (627)
+++|.. ..+.|++|.||.||+|+.+ +++.||+|+++..... .-...+|+.++.+. +|||||.+...... -+
T Consensus 74 sv~efe--~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 74 SVEEFE--KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cHHHHH--HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccc
Confidence 344442 2578999999999999965 6889999999754321 23468899999999 89999999887764 35
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..|+||||++. +|...++..+ .++...+..-++.|+++|++|||... |+|||||++|+|++..|.+||+|||
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccc
Confidence 78999999987 8999998764 46888999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCC----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh--hhc
Q 006886 484 LAHLINFPT----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV--REE 556 (627)
Q Consensus 484 ~a~~~~~~~----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~ 556 (627)
+|+.++.+. ..+.|..|.|||.+.+ ..|++..|+||+|||+.|++++++-|.+..+-+ ++...+...- .+.
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccc
Confidence 999987652 2346899999999876 569999999999999999999999998765432 2222221110 011
Q ss_pred ccccccchh------hh---------cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WTAEVFDVE------LL---------KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~~~~~d~~------l~---------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+....... +. .+.... -...-++++...+..||.+|.|+.|.+++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111110000 00 011000 11344567778999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.10 Aligned_cols=243 Identities=19% Similarity=0.273 Sum_probs=191.4
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||+||++..+ +++.||+|.+..... ..+.+..|+++++.+ +|+||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999865 688999999865322 224567899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|..++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9988864321 2346899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+++.|+|||++.+..++.++||||||+++|||++|+.||....... ............ .. ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~---------~~---~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILND---------SV---TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhccc---------CC---CCc
Confidence 2357889999999999999999999999999999999999997543211 111111111100 00 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
......+.+++.+|++.+|++|| ++++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11233566788899999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=317.29 Aligned_cols=238 Identities=18% Similarity=0.255 Sum_probs=192.9
Q ss_pred hcccCcCCceeEEEEEecC--CcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED--GTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|..++ +..||+|++.... ...+.+..|++++..+ +||||+++++++.+.+..++||||+
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCC
Confidence 4789999999999998653 3689999986532 2345678899999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 114 IGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999764 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... .+ ...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~---~~------p~~ 250 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGII---YF------PKF 250 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCC---CC------CCC
Confidence 3446889999999999888999999999999999999999999753211 11111111110 00 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
..+ .+.+++.+|++.+|++|+ ++++++++
T Consensus 251 ~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 122 345677899999999995 89988775
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.16 Aligned_cols=241 Identities=23% Similarity=0.372 Sum_probs=205.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-eEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-KLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~e~~~ 413 (627)
.+++|+|+||.++..+.+ +++.+|+|.+..... ..+...+|+.+++++ +|||||.+.+.|.+++. .++||+|++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecC
Confidence 478999999999999865 578899999876543 345678999999998 99999999999999988 899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
||++.+.+.+.+ +..+++....+++.|++.|+.|||+.. |+|||||+.||+++.++.+||+|||+|+.+...
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999998765 467899999999999999999999887 999999999999999999999999999998654
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+..||+.||.||.+.+..|..|+||||+||++|||++-+++|...+ ....+.++.+.. ++
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~~-----~~------ 224 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRGL-----YS------ 224 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhcc-----CC------
Confidence 35679999999999999999999999999999999999999998643 233333333322 11
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+-...+..++..++..|+..+|+.||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1123344567778889999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.02 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=193.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
+.||+|+||.||+|..+ +++.||+|.+.... .....+.+|+++++++ +||||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999965 68899999876432 2346789999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC---
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--- 493 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~--- 493 (627)
|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99999753 235899999999999999999999998 99999999999999999999999999876532211
Q ss_pred ---CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 494 ---ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 494 ---~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....... ...........
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC----------
Confidence 112356999999998889999999999999999998 888886432110 11111110000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.........+.+++.+|+..+|++||++.++.++|++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0111223467788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.30 Aligned_cols=237 Identities=21% Similarity=0.344 Sum_probs=191.0
Q ss_pred cccCcCCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILE----DGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
+.||+|+||.||+++.. +++.||+|.++... .....+..|++++..+ +||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 57999999999999853 57899999987532 2234577899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++... ..+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999998754 34788889999999999999999998 99999999999999999999999999875422
Q ss_pred C----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 491 P----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 491 ~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... +
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~~~---~---- 219 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGKLN---L---- 219 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC---C----
Confidence 1 233578999999999988899999999999999999999999975321 1112222211100 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
... ...++.+++.+|++.+|++|| ++++++++
T Consensus 220 --~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 --PPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011 123456788899999999999 78888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.43 Aligned_cols=246 Identities=24% Similarity=0.442 Sum_probs=201.5
Q ss_pred HhcccCcCCceeEEEEEecCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 338 SAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
..+.||+|+||.||+|..+++..+++|.+..... ....+..|+.++..+ +|+||+++++++...+..++||||+++|+
T Consensus 10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (261)
T cd05148 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGS 88 (261)
T ss_pred HhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCC
Confidence 3578999999999999988899999999876543 456789999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|.+++.... +..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 89 L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 89 LLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 999997542 346899999999999999999999998 9999999999999999999999999997664321
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||+.....++.++||||||+++|+|++ |+.||...... ....... .... ...
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~-~~~~----------~~~ 225 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQIT-AGYR----------MPC 225 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHH-hCCc----------CCC
Confidence 2234567999999988889999999999999999998 89999754311 1111111 1100 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.......+.+++.+|++.+|.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122234577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.99 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=194.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---------------CHHHHHHHHHHHHHhccCCCeeeeeeEEee-
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------------TKREFEQQMEVVGTIGKHSNVVPVRAYYYS- 401 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 401 (627)
.+.||+|.||.|-+|+.. +++.||||++.+... ..+...+|+.+|+++ +|||||+++.+..+
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCc
Confidence 467999999999999954 789999999854311 125788999999999 99999999999876
Q ss_pred -CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 402 -KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 402 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
.+..|+|+|||..|.+... .. ....++..++++++.++..||.|||.++ ||||||||+|+|++++|++||+
T Consensus 181 ~s~~~YlVley~s~G~v~w~----p~-d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWC----PP-DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ccCceEEEEEeccCCccccC----CC-CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 4578999999999886322 11 1223899999999999999999999999 9999999999999999999999
Q ss_pred ecccccccCCC---------CCCCCCccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH
Q 006886 481 DVGLAHLINFP---------TTATRTIGYRAPEVTETRK----ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547 (627)
Q Consensus 481 DfG~a~~~~~~---------~~~~~t~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 547 (627)
|||.+...... ....||+.|+|||.+.++. .+.+.||||+||+||+|+.|+.||-+... ..
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~~ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------LE 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------HH
Confidence 99998765211 2356899999999987633 35789999999999999999999975321 12
Q ss_pred HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
...++..+ .+ .++..++....+-+++.+++.+||++|.+..+|..+..-....+.
T Consensus 327 l~~KIvn~---------pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 327 LFDKIVND---------PL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHHHHhcC---------cc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 22222211 11 222333445566778889999999999999999988877665433
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.73 Aligned_cols=244 Identities=26% Similarity=0.429 Sum_probs=198.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|..+++..||+|++.......+.+.+|++++.++ +|+||+++++.+. .+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 478999999999999987777899999986555667899999999999 8999999998874 45678999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
++++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.++...... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9997532 245799999999999999999999988 9999999999999999999999999997664322 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||+..+..++.++||||||+++|||++ |+.||...... .......... .....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~-----------~~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY-----------RMPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC-----------CCCCc
Confidence 224567999999988889999999999999999999 88888643211 1111111100 00111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.+....+.+++.+|++.+|++||++.++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 23345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=300.16 Aligned_cols=249 Identities=22% Similarity=0.425 Sum_probs=195.9
Q ss_pred cccCcCCceeEEEEEecC-Cc--EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILED-GT--TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|..++ +. .+++|.+.... ...+.+..|++++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999754 33 46888876432 23457889999999998899999999999999999999999999
Q ss_pred CCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 415 GSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 415 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
|+|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999976432 11235789999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccc
Q 006886 484 LAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559 (627)
Q Consensus 484 ~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (627)
++...... .....+..|+|||++....++.++||||||+++|||++ |..||..... ......... ....
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~-~~~~ 230 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ-GYRL 230 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhC-CCCC
Confidence 98643211 11223567999999988889999999999999999997 9999965321 111111111 1000
Q ss_pred cccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 560 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
+ .......++.+++.+|+..+|.+|||+.+++..|+++.
T Consensus 231 ---~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ---E-------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---C-------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 00112235778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.04 Aligned_cols=237 Identities=24% Similarity=0.336 Sum_probs=187.5
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|+.+ +++.||+|.++... ...+.+..|.+++....+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57889999987542 22344566777776666899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 9999998754 24889999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~---~~~------~ 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDRP---HFP------R 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC---CCC------C
Confidence 1234578999999999998999999999999999999999999975432 111111111100 000 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMD-DVVR 602 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~~ 602 (627)
. ...++.+++.+||..+|++||++. ++++
T Consensus 218 ~---~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 W---ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 123456778899999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=298.69 Aligned_cols=244 Identities=26% Similarity=0.473 Sum_probs=198.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.++||+|+||.||+|..++++.||+|.+.......+.+.+|+++++++ +|+|++++++++. .+..++++||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 478999999999999988899999999987666678899999999999 8999999998864 55689999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... +..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 9987542 346899999999999999999999988 9999999999999999999999999997664221 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++||+++ |+.||..... ......... ..... ..
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~-~~~~~-------~~--- 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLER-GYRMP-------RP--- 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHc-CCCCC-------CC---
Confidence 234568999999988889999999999999999999 9999975431 111111111 10000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.....++.+++.+|++.+|++||+++++.+.|+.+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 11223577888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.93 Aligned_cols=191 Identities=21% Similarity=0.344 Sum_probs=167.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++..+ ++..+|+|.+..... ....+.+|++++..+ +|+||+++++++.+++..++||||+++|
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCC
Confidence 478999999999999976 578899998765422 245688999999999 8999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--CC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--TT 493 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~~ 493 (627)
+|.+++... ..+++.....++.+++.||.|||+.+ .|+||||||+|||++.++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 89 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 999999754 34888999999999999999999752 3999999999999999999999999998765332 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 45788999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.59 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=189.7
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||.||+++.+ +|+.||+|.+..... ..+.+..|++++.++ +||||+++.+++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999965 589999999864321 234556799999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---T 493 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---~ 493 (627)
|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 998886542 245899999999999999999999998 9999999999999999999999999987664322 2
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||+||++|||++|+.||....... ............. ... ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~-----~~~---~~~~-- 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE-----VKF---EHQN-- 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc-----ccc---cccc--
Confidence 457889999999988889999999999999999999999997532211 1111111111111 000 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
...++.+++.+||+.+|++||+++|+++
T Consensus 222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 222 -FTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 2234667888999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.20 Aligned_cols=243 Identities=20% Similarity=0.306 Sum_probs=191.0
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+++.. +++.||+|++.... ...+.+..|++++..+.+|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 478999999999998853 57899999986532 123467789999999977999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999754 34889999999999999999999998 9999999999999999999999999997653
Q ss_pred CC-----CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 490 FP-----TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 490 ~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ........... +
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~-------~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILKC-------D 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhcC-------C
Confidence 22 123578999999998765 478899999999999999999999975432211 11111111110 0
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
+.. .. .....+.+++.+|+..||++|| ++++++++
T Consensus 228 ~~~--~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF--PS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC--CC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 01 1123456778899999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.28 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=201.1
Q ss_pred HhcccCcCCceeEEEEEec--------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 338 SAEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
..+.||+|+||.||+++.. ++..||+|.+.... ...+++.+|+.++..+.+||||+++++++......++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 3578999999999999741 24579999886542 2346788999999999889999999999999999999
Q ss_pred EEecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC
Q 006886 408 VYSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN 476 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 476 (627)
||||+++|+|.+++...+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCc
Confidence 99999999999999864321 1245889999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006886 477 GCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 477 ~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 549 (627)
+||+|||+++...... ...++..|+|||++.+..++.++||||||+++||+++ |..||.... .....
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~ 249 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELF 249 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHHHH
Confidence 9999999998764321 1224567999999988889999999999999999998 788886432 12222
Q ss_pred HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 550 RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
... ....... ........+.+++.+||..+|++||++.|+++.|+++....
T Consensus 250 ~~~-~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 250 KLL-KEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHH-HcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 211 1111000 01122345677888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.54 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=194.9
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||+||++.. .++..||+|.++.... ..+.+.+|+++++++ +||||+++++++... ...++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEe
Confidence 47899999999988653 3578899999875432 456788999999999 999999999988754 3578999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999753 4899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCC-------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FPTT-------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.... ..++..|+|||.+.+..++.++||||||+++|||++|+.|+......- .................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 3211 123556999999988889999999999999999999999986432110 00000000000000000000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
+... ..........++.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 00011122356778889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.75 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=198.4
Q ss_pred HHhcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 337 ASAEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
...+.||+|+||.||+|+++ .+..||+|+++.... ..+.+..|++++.++..||||+++++++...+..++|
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv 119 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII 119 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence 34688999999999999864 246799999975432 2346889999999995599999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCC--------------------------------------------------------------
Q 006886 409 YSYMPAGSLFMLLHRNRS-------------------------------------------------------------- 426 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~-------------------------------------------------------------- 426 (627)
+||+++|+|.+++++.+.
T Consensus 120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (401)
T cd05107 120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV 199 (401)
T ss_pred EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence 999999999999976431
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC
Q 006886 427 -------------------------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL 475 (627)
Q Consensus 427 -------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 475 (627)
.....+++...+.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCC
Confidence 01134788889999999999999999987 99999999999999999
Q ss_pred CeEEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHH
Q 006886 476 NGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRW 548 (627)
Q Consensus 476 ~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~ 548 (627)
.+||+|||+++..... ....++..|+|||.+....++.++||||||+++|||++ |..||......+ .
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~ 350 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------Q 350 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------H
Confidence 9999999999765321 12235678999999988889999999999999999998 888986432111 1
Q ss_pred HHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 549 VRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 549 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
............ .. .....++.+++.+||..+|.+||+++||++.|+++.
T Consensus 351 ~~~~~~~~~~~~-------~p---~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRGYRMA-------KP---AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCCCC-------CC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111111000 01 112245677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=303.95 Aligned_cols=251 Identities=22% Similarity=0.431 Sum_probs=199.7
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++... ++..+|+|.+.... ...+.+..|++++.++ +||||+++++++...+..++|+||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEc
Confidence 467999999999999842 34568999886543 2356789999999999 899999999999999999999999
Q ss_pred CCCCCHHHHhhhcCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 412 MPAGSLFMLLHRNRS--------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCC
Confidence 999999999975431 12235899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 484 LAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 484 ~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
+++...... ...++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~i~~~~ 239 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECITQGR 239 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC
Confidence 997653221 1224568999999998899999999999999999998 89998654321 1111111111
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
... ... ....++.+++.+||+.+|.+|||+.++.+.|+++...
T Consensus 240 -~~~-------~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 -VLQ-------RPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -cCC-------CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 001 1223577888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.03 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=196.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..+|+|.+.......+.+.+|+++++++ +|+|++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 467999999999999988777899999876555667889999999999 9999999998875 45678999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
++++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.++...... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9997542 245899999999999999999999988 9999999999999999999999999997664322 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||+..+..++.++||||||+++|||++ |+.||...... ......... ... ...
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~-~~~----------~~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVERG-YRM----------PCP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC-CCC----------CCC
Confidence 224567999999988889999999999999999999 89998753211 111111111 000 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
......+.+++.+||..+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223456778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.98 Aligned_cols=238 Identities=26% Similarity=0.361 Sum_probs=191.6
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +++.||+|+++... .....+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 57899999997542 23445677888888887899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 9999988754 25899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 491 PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+ ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~~---~~------~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDEV---RY------PR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCC---CC------CC
Confidence 1223478899999999999999999999999999999999999975321 111111111110 00 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~~ 603 (627)
.....+.+++.+||..||.+||++ .+++++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112356678889999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=294.72 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=199.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCC-eeeeeeEEeeCC------ceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSN-VVPVRAYYYSKD------EKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~------~~~l 407 (627)
.++||+|.||+||+|+.+ +|+.||+|+++.... ......+|+.++.++ +|+| |+.+.+++...+ ..++
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEE
Confidence 366999999999999954 789999999976543 234568999999999 8999 999999999877 7889
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|+||++. +|..++......+ ..++-.....++.|+++||+|||+++ |+||||||.|||++++|.+||+|||+|+.
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHH
Confidence 9999965 9999998764321 34666889999999999999999999 99999999999999999999999999997
Q ss_pred cCCC----CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---hhcccc
Q 006886 488 INFP----TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV---REEWTA 559 (627)
Q Consensus 488 ~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 559 (627)
...+ ....+|..|.|||++.+. .|+...||||+||+++||++++.-|.+..+. .++...++..- .+.|..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcCCCCccCCCC
Confidence 7533 234578899999998776 7999999999999999999999989875431 11111111110 011211
Q ss_pred ccc----chhhhcCC---ChHHH----HHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 006886 560 EVF----DVELLKYQ---DVEEE----MVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQI 607 (627)
Q Consensus 560 ~~~----d~~l~~~~---~~~~~----~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~ 607 (627)
... +....... ..... ..+..+++.+|++.+|.+|.|++.++++ +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 110 11111111 11111 1367788899999999999999999886 5544
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.36 Aligned_cols=247 Identities=25% Similarity=0.430 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|.. .++..|++|.+..... ....+.+|+++++++ +||||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEc
Confidence 47899999999999984 2467899999875332 235788999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 412 MPAGSLFMLLHRNRS------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
+++|+|.+++..... .....+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEe
Confidence 999999999864321 11235789999999999999999999998 999999999999999999999
Q ss_pred eecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |..||.+.... .+ ...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~----~~~ 238 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EV----IEM 238 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHH
Confidence 999999765332 12234567999999988889999999999999999998 99998653211 11 111
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
........ ... .....+.+++.+|++.+|++||++.++.++|..
T Consensus 239 ~~~~~~~~-------~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLLP-------CSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCC-------CCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111100 011 122356678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=302.22 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=195.5
Q ss_pred HhcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 338 SAEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
..+.||+|+||.||+|...+ +..||+|++..... ..+.+.+|+.++..+ +||||+++++++...+..++++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEE
Confidence 35789999999999998642 47899999875432 235688899999999 9999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 410 SYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
||+++++|..++..... .....+++..+.+++.|++.||.|||+.+ |+||||||+||++++++.+|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceE
Confidence 99999999999853210 11235888999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHH
Q 006886 479 ISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRS 551 (627)
Q Consensus 479 i~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 551 (627)
|+|||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..+...
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~ 238 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVIEM 238 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 99999987653321 2234678999999988889999999999999999998 8888865321 122222
Q ss_pred HhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
+...... . ........+.+++.+||+.+|++||++.+|+..|+.
T Consensus 239 i~~~~~~-~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVL-P----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcC-C----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2211110 0 011223456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.97 Aligned_cols=244 Identities=22% Similarity=0.442 Sum_probs=197.0
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|.++. ...||||.++.... ...+|..|+.++..+ +||||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcC
Confidence 4789999999999999752 45799998865432 345788999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..+.+++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999997642 36899999999999999999999988 9999999999999999999999999998764211
Q ss_pred ------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 493 ------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ......
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~~------ 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAV-EDGYRL------ 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHH-HcCCCC------
Confidence 1123567999999998899999999999999999998 99998643211 111111 111000
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.........+.+++.+|++.+|++||++.|++++|+++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112234577888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.65 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=188.2
Q ss_pred ccCcCCceeEEEEEecC---CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILED---GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++.++ +||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998653 45789998865432 235688899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.++++..+.......++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999998654333345678888899999999999999998 9999999999999999999999999987543221
Q ss_pred ---CCCCCccccCccccCCC-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 493 ---TATRTIGYRAPEVTETR-------KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~-------~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
...++..|+|||++... .++.++||||||+++|||++ |+.||......+ .... ..... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhhcc-cCCC
Confidence 22356789999998542 35789999999999999996 999997543221 1000 11110 1111
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.++... .. ....+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~--~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK--LP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC--CC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111110 01 1223556777898 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.97 Aligned_cols=257 Identities=22% Similarity=0.413 Sum_probs=211.0
Q ss_pred CCCHHHHHHHHhcccCcCCceeEEEEEecC---C--cEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEe
Q 006886 328 NFDLEDLLRASAEVLGKGSYGSTYKAILED---G--TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYY 400 (627)
Q Consensus 328 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 400 (627)
++.+..-.....++||+|-||.||+|.+.+ | -.||||..+... ...+.|.+|..+|+.+ +||||++++|.|.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeee
Confidence 444433333457899999999999999643 2 358899887643 3567899999999999 9999999999987
Q ss_pred eCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 401 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
+. ..++|||.++.|.|.+||+.++ ..++......++.|++.||+|||+.. +|||||..+|||+.....+|++
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeec
Confidence 54 6789999999999999999875 35888899999999999999999988 9999999999999999999999
Q ss_pred ecccccccCCCCCCCC-----CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 481 DVGLAHLINFPTTATR-----TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 481 DfG~a~~~~~~~~~~~-----t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
|||+++.+.....+.. ++.|||||.+.-++++.++|||-|||.+||++. |..||++-...+.... +.
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iE 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IE 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ec
Confidence 9999999876544432 457999999999999999999999999999987 9999998655543211 00
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.+ .+.+..+.+...+..++.+||+.+|.+||++.|+...|.++.+.
T Consensus 607 nG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 607 NG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 00 11233345566777899999999999999999999999998663
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=316.00 Aligned_cols=250 Identities=18% Similarity=0.278 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++... +++.||+|... ...+.+|+++++++ +||||+++++++......++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 478999999999999965 68899999753 34578899999999 99999999999999999999999985 688
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-----PT 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-----~~ 492 (627)
..++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 170 ~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 170 YCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 8888653 34889999999999999999999998 99999999999999999999999999975422 12
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC-CCCHHHHHHHHhhh-c-----ccc---ccc
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD-VVDLPRWVRSVVRE-E-----WTA---EVF 562 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~-~-----~~~---~~~ 562 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+..+... + ... ..+
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 3458999999999998899999999999999999999998875432111 00000111111000 0 000 000
Q ss_pred c-------------hh-hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 D-------------VE-LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d-------------~~-l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ +. ........+...++.+++.+|++.||++|||++|++++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00 00000111233467788999999999999999999863
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.13 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=191.4
Q ss_pred ccCcCCceeEEEEEec---CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 341 VLGKGSYGSTYKAILE---DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.||+|+||.||+|.++ ++..+|+|+++.... ..+++..|+.++..+ +|+||+++++++. .+..++|+||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 5899999999999753 578899999865432 245788899999999 9999999999875 4567899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC-
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT- 493 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~- 493 (627)
|+|.+++... ..+++..+.+++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999753 35899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 494 ------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 494 ------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
..++..|+|||.+....++.++||||||+++|||++ |+.||...... ..... .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~-i~~~~~~~~----- 219 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQM-IESGERMEC----- 219 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHCCCCCCC-----
Confidence 122468999999988889999999999999999998 99999753221 11111 111111110
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
. .....++.+++.+||+.+|++||++.+|.+.|++.
T Consensus 220 --~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 --P---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --C---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 0 11223566788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=315.73 Aligned_cols=237 Identities=21% Similarity=0.317 Sum_probs=190.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +++.||+|++.... .....+..|++++..+ +||||+++.+++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999864 68899999987542 1234567788888888 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
|+|..++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 80 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 9999988754 358999999999999999999997 67 999999999999999999999999998754221
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... . + .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~~-----~--~--p 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-----R--F--P 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCCC-----C--C--C
Confidence 2345889999999999989999999999999999999999999754221 11111111100 0 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.. ...++.+++.+|++.||++|+ ++.+++++
T Consensus 217 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RT---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 123456778899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.07 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=199.8
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++... ++..+++|.+..... ..+.+.+|++.+.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEec
Confidence 367999999999999743 345688998865432 345788999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 412 MPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
+++++|.+++..... .....+++..+++++.|++.|++|||+.+ |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEEC
Confidence 999999999975431 11235899999999999999999999998 9999999999999999999999
Q ss_pred ecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHh
Q 006886 481 DVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553 (627)
Q Consensus 481 DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 553 (627)
|||++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ......
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~~- 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------EVIECI- 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-
Confidence 99999765332 12234678999999998899999999999999999999 99998654321 111111
Q ss_pred hhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 554 REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 554 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
........ .......+.+++.+||..+|++||++.+|+++|+++...
T Consensus 239 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111100 011234577888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=303.53 Aligned_cols=237 Identities=22% Similarity=0.345 Sum_probs=185.7
Q ss_pred ccCcCCceeEEEEEecC-------------------------CcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeee
Q 006886 341 VLGKGSYGSTYKAILED-------------------------GTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVP 394 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~ 394 (627)
.||+|+||.||+|.+.. ...|++|.+..... ....+..|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 59999999999997421 13588898865422 235677888888888 9999999
Q ss_pred eeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC
Q 006886 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474 (627)
Q Consensus 395 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~ 474 (627)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence 999999999999999999999999998753 235889999999999999999999988 9999999999999865
Q ss_pred C-------CeEEeecccccccCCCCCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCH
Q 006886 475 L-------NGCISDVGLAHLINFPTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEML-TGKAPLQHSGHDDVVDL 545 (627)
Q Consensus 475 ~-------~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~ 545 (627)
+ .+|++|||.+..........++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+ .
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---K 230 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---H
Confidence 4 379999999876544444557788999998865 56899999999999999995 6999987543211 1
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
... ...... . .......+.+++.+||+.+|++||++.++++.|
T Consensus 231 ~~~----~~~~~~-------~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERF----YEKKHR-------L-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHhccC-------C-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 111000 0 001123577888999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.21 Aligned_cols=250 Identities=21% Similarity=0.361 Sum_probs=189.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.+ +++.||+|++.... .....+.+|+++++.+ +||||+++++++..++..++||||++ +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 478999999999999976 68899999986542 2334677899999999 99999999999999999999999995 6
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 8888876542 35888999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---h----cccc----
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR---E----EWTA---- 559 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~----~~~~---- 559 (627)
....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .......... . .+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhccchhhc
Confidence 23456889999999865 4578999999999999999999999975321 1111111110 0 0000
Q ss_pred cccchh-h--hcCCChHH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 560 EVFDVE-L--LKYQDVEE------EMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 560 ~~~d~~-l--~~~~~~~~------~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+++. . ........ ....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0 00000110 1134567888999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=301.31 Aligned_cols=238 Identities=22% Similarity=0.403 Sum_probs=191.3
Q ss_pred cccCcCCceeEEEEEecCCc-----------EEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 340 EVLGKGSYGSTYKAILEDGT-----------TVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
+.||+|+||.||+|...+.. .+++|.+.........+.+|+.+++.+ +||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 478887765443467889999999999 89999999999988 778999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-------CeEEee
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-------NGCISD 481 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-------~~ki~D 481 (627)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999998643 25899999999999999999999988 99999999999999888 799999
Q ss_pred cccccccCCCCCCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 482 VGLAHLINFPTTATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 482 fG~a~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
||++..........++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+. ....
T Consensus 152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~---~~~~-- 223 (259)
T cd05037 152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY---QDQH-- 223 (259)
T ss_pred CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH---hcCC--
Confidence 9999877654455567789999998776 78999999999999999999 577776543211 11111 0000
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.. ... ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 224 -~~------~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -RL------PMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CC------CCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000 0156778889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.96 Aligned_cols=190 Identities=25% Similarity=0.358 Sum_probs=167.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||++..+ +++.||+|++.... .....+..|++++..+ +|+||+++++.+.+....++||||++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCC
Confidence 478999999999999865 58899999987532 1234677899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999754 35899999999999999999999998 999999999999999999999999998754211
Q ss_pred -------------------------------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 492 -------------------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 492 -------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1235889999999999989999999999999999999999999
Q ss_pred CCC
Q 006886 535 QHS 537 (627)
Q Consensus 535 ~~~ 537 (627)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.69 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=192.7
Q ss_pred hcccCcCCceeEEEEEecCC-c--EEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceE
Q 006886 339 AEVLGKGSYGSTYKAILEDG-T--TVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~-~--~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~ 406 (627)
.+.||+|+||.||+|...+. . .||+|.++... ...+.+..|++++..+ +|+||+++++++... ...+
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence 47799999999999997643 2 58999886542 2345688899999999 999999999987532 2468
Q ss_pred EEEecCCCCCHHHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
+++||+++|+|.+++...+. .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998854321 12345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+...... ...+++.|+|||+..+..++.++||||||+++|||++ |+.||..... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~-~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDY-LRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHcCCC
Confidence 8764321 1234567999999998899999999999999999999 8889865321 111111 111111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.. ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0111223567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.21 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=193.9
Q ss_pred cccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||+|.+.. +..+|+|.+..... ..+++..|+++++.+ .|+|++++++++. .+..++|+||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999998542 26899999876543 456788999999999 9999999999876 456789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999998642 5899999999999999999999998 99999999999999999999999999986643321
Q ss_pred C-------CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 494 A-------TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 494 ~-------~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
. .++..|+|||...+..++.++||||||+++||+++ |+.||...... .+..++ .......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~~~----- 218 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESGERLP----- 218 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcCCcCC-----
Confidence 1 12357999999988899999999999999999998 99999754211 111111 1111000
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
........+.+++.+|+..+|++||++.++++.|+++.
T Consensus 219 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -----RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112346678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=323.39 Aligned_cols=242 Identities=19% Similarity=0.238 Sum_probs=193.4
Q ss_pred hcccCcCCceeEEEEEec-C-CcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-D-GTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... + +..||+|.+.... .....+..|+++++.+ +||||+++++++...+..++||||+++|
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 478999999999999854 3 5778888764432 2334677899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.++++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998865321 2346889999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~-----~----- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYD-----P----- 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----C-----
Confidence 233588999999999999999999999999999999999999975321 1122222211110 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
........+.+++.+||..+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00112235677888999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.09 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=190.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-----ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-----EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 409 (627)
.+.||+|+||.||+|+.+ +++.||||++.... .....+.+|++++.++ +||||+++++++.... ..++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEE
Confidence 478999999999999965 68999999987432 2345688999999999 9999999999886432 478999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9995 6899888754 35899999999999999999999998 9999999999999999999999999997643
Q ss_pred CC-------CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh------
Q 006886 490 FP-------TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR------ 554 (627)
Q Consensus 490 ~~-------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 554 (627)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 21 12357889999999865 678999999999999999999999997543211 0000000000
Q ss_pred -----hcccccccchhhh-cCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhcc
Q 006886 555 -----EEWTAEVFDVELL-KYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQ 609 (627)
Q Consensus 555 -----~~~~~~~~d~~l~-~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~ 609 (627)
.......+..-.. ..... +.....+.+++.+||+.+|++|||++|++++ +..+..
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000000000 00000 0112346788889999999999999999975 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=304.74 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=194.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++..... ....+.+|++++.++ +||||+++++.+..++..++||||++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccC
Confidence 468999999999999964 688999999865321 234577899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999998886532 245899999999999999999999998 9999999999999999999999999998764322
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...++..|+|||++.+..++.++||||+|+++|||++|+.||....... ....+...+.... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-----------~~ 223 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ-----------EE 223 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc-----------cc
Confidence 2357889999999988889999999999999999999999997543211 1111111111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
........+.+++.+|+..||++|| ++++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111233566788899999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=304.17 Aligned_cols=253 Identities=23% Similarity=0.417 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEecC-Cc--EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILED-GT--TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|..++ +. .+++|.++... ...+.+..|++++.++.+||||+++++++...+..++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4679999999999999753 32 47888876432 2345788999999999789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 414 AGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 414 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+|+|.++++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence 99999999754311 1235889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 483 GLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 483 G~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
|++...... .....+..|+|||+..+..++.++|||||||++|||++ |..||..... ........... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~~~~~~-~ 236 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGY-R 236 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCC-C
Confidence 998654321 11122457999999988889999999999999999997 9999975432 11122111110 0
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.. .. ......+.+++.+|++.+|.+||+++++++.|+.+.+..
T Consensus 237 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 237 ME-------KP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00 112235677888999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.71 Aligned_cols=254 Identities=23% Similarity=0.424 Sum_probs=198.5
Q ss_pred hcccCcCCceeEEEEEec-CCc--EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT--TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|.++ ++. .+++|.++... ...+.+.+|++++.++.+|+||+++++++..++..++|+||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 478999999999999965 344 45777766432 2345788899999999889999999999999999999999999
Q ss_pred CCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 414 AGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 414 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+|+|.++++.... .....+++..++.++.|++.|++|||+.+ ++||||||+|||++.++.+||+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence 9999999976431 11235889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 483 GLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 483 G~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
|+++..... .....+..|+|||++.+..++.++||||||+++|||+| |..||...... ....... ....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~-~~~~ 241 (303)
T cd05088 169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP-QGYR 241 (303)
T ss_pred ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHHHh-cCCc
Confidence 998643221 11223567999999988889999999999999999998 99999654321 1111111 1100
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.. .. ......+.+++.+|++.+|++||+++++++.|+.+...+.
T Consensus 242 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 242 LE-------KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 00 1122356788889999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=296.30 Aligned_cols=241 Identities=25% Similarity=0.433 Sum_probs=195.0
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
++||+|+||.||+|..++++.+|+|.+..... ....+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999988899999999865432 244688999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~----- 492 (627)
.+++.... ..+++..+.+++.|++.||.|+|+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99986532 35789999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||++.+..++.++||||||+++||+++ |..||...... . ............ .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~-~~~~~~~~~~~~----------~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------Q-AREQVEKGYRMS----------C 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCCCCC----------C
Confidence 1123567999999998899999999999999999998 99999754211 1 111111111000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.......+.+++.+|+..+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112346778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=300.57 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=200.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||||.+.... .....+..|+++++.+ +|||++++++++...+..++|+||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecC
Confidence 467999999999999965 68999999875422 2235688899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++..... ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999998864322 2345788999999999999999999998 9999999999999999999999999988764322
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||..... +...+.......... .
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~--------- 227 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYP-P--------- 227 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCC-C---------
Confidence 23567889999999888899999999999999999999999864321 112222211111100 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
.........+.+++.+||..+|++||++.+|++.|++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 001223346778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.42 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=187.7
Q ss_pred hcccCcCCceeEEEEEec--CCcEEEEEEeccccc---CHHHHHHHHHHHHHhc--cCCCeeeeeeEEee-----CCceE
Q 006886 339 AEVLGKGSYGSTYKAILE--DGTTVVVKRLREVAA---TKREFEQQMEVVGTIG--KHSNVVPVRAYYYS-----KDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 406 (627)
.+.||+|+||.||+|+.. +++.||+|+++.... ....+.+|++++..+. +||||+++++++.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 467999999999999863 467899998864322 2345667887777664 69999999998852 34578
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 9999996 68999987543 235899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh----hhcccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV----REEWTA 559 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 559 (627)
..... ....+++.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.... .+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhchh
Confidence 66432 23457889999999988889999999999999999999999997643211 111111000 000000
Q ss_pred cc-cc-hhhh--cCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 560 EV-FD-VELL--KYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 560 ~~-~d-~~l~--~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.. .. ..+. ..... +.....+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00 0000 00000 111234567888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=301.59 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=194.4
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|..+ .+..||+|++..... ...++.+|+.+++.+ +|+||+++++++......++|+|
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEe
Confidence 478999999999999753 246799998864322 345688999999998 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRSD-----GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
|+++|+|.++++..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999999754321 1234688999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+...... ...++..|+|||++.+..++.++||||||+++|||++ |..||..... ........... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFVMEGG-L 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC-c
Confidence 7653321 1234678999999998899999999999999999999 7888865322 11111111111 0
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
... .......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 LDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 01122357788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.69 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=200.0
Q ss_pred hcccCcCCceeEEEEEec--------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||++... +...+|+|.++... ....++..|++++.++.+|+||+++++++...+..++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 578999999999999853 23569999987542 23456888999999998899999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 409 YSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
+||+++|+|.+++...+.. ....+++.++++++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcE
Confidence 9999999999999764321 1235899999999999999999999988 9999999999999999999
Q ss_pred EEeecccccccCCCC----C--CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFPT----T--ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~~----~--~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||.++...... . ..++..|+|||++.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~~~~~~ 253 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFK 253 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHH
Confidence 999999987654321 1 123467999999988889999999999999999998 888886432 111111
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
. .......+ .......++.+++.+|+..+|++||++.++++.|+++....
T Consensus 254 ~-~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 254 L-LKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred H-HHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11111100 11122346677888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=304.26 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=191.8
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|.+. +++ .+++|.+..... ...++..|+..+.++ +||||+++++++. ....++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEe
Confidence 478999999999999964 344 477787754322 235677777788888 9999999999875 4557789999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999997542 35899999999999999999999998 999999999999999999999999999765322
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...++..|+|||++.+..++.++||||||+++||+++ |+.||.+..... ............ .+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--QP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--CC
Confidence 1 2235668999999988899999999999999999998 999997542111 111111111100 00
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..+...+.+++.+||..+|++|||+.|+++.|..+..+
T Consensus 234 --------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 234 --------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 01223456788899999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=299.59 Aligned_cols=264 Identities=20% Similarity=0.314 Sum_probs=195.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----eEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-----KLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~e~~~ 413 (627)
+++|+|+||.||+|... +++.||||+.-.... --.+|+++|+.+ .|||||++..+|....+ ..+|+|||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 78999999999999965 578999998754322 234678889888 99999999988875432 357999998
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINFPT 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~~~ 492 (627)
. +|.++++... .....++.....-+..|+.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+....
T Consensus 106 ~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 106 E-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred H-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 7 8999988531 12345777778889999999999999988 9999999999999987 899999999999885543
Q ss_pred ---CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh--cc-----c--c
Q 006886 493 ---TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE--EW-----T--A 559 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-----~--~ 559 (627)
++.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+.. .++...++..-.. +. . .
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 3335778999999876 57999999999999999999999999875432 2333322211100 00 0 0
Q ss_pred cccchhhhcCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhccccccc
Q 006886 560 EVFDVELLKYQ----DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQIQQPELRN 614 (627)
Q Consensus 560 ~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~~~~~~~~~ 614 (627)
+...+.+.... .......+.++++.+++..+|.+|.++.|++. ...+++++..+-
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l 319 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKL 319 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccC
Confidence 11111111111 11223356778888999999999999999986 566676664433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=296.84 Aligned_cols=262 Identities=21% Similarity=0.337 Sum_probs=198.2
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEee-----CCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-----KDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~e 410 (627)
+.||+|+||.|+++..+ +|..||||++.... ...++..+|+++++.+ +|+||+.+...+.. -...|+|+|
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEehh
Confidence 77999999999999965 68999999997542 3456788999999999 79999999988865 356899999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
+| .-+|...++.+ ..++.....-++.|+++||.|+|+.+ |+||||||+|++++.+...||||||+|+....
T Consensus 107 lM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred HH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence 99 55899999864 34888888899999999999999999 99999999999999999999999999998853
Q ss_pred C------CCCCCCccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH--------HHhhh
Q 006886 491 P------TTATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR--------SVVRE 555 (627)
Q Consensus 491 ~------~~~~~t~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 555 (627)
. +....|..|.|||++ ....|+...||||.|||+.||++|++-|.+.+.-+...++..+- ..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 234568899999997 45789999999999999999999999998765433222111100 00000
Q ss_pred cccccccc-------hh-hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccccccc
Q 006886 556 EWTAEVFD-------VE-LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPELRN 614 (627)
Q Consensus 556 ~~~~~~~d-------~~-l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~~~~~ 614 (627)
......+. .. ...++... ...++++.+|+..||.+|+|++|.+++ |..+.+++-.+
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 00000000 00 00111222 345677779999999999999999883 56665554444
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=295.41 Aligned_cols=241 Identities=20% Similarity=0.353 Sum_probs=191.0
Q ss_pred ccCcCCceeEEEEEec---CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILE---DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||.||+|.+. ++..||+|.+..... ..+++.+|+++++++ +|+||+++++++. .+..++|+||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999864 355799998865432 245688999999999 9999999999875 45788999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC--
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT-- 493 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~-- 493 (627)
+|.+++.... ..+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999987532 35899999999999999999999998 99999999999999999999999999976533211
Q ss_pred -----CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 494 -----ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 494 -----~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
..++..|+|||++....++.++||||||+++||+++ |+.||...... ..... +.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~~~------- 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSF-IEQGKRLD------- 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HHCCCCCC-------
Confidence 112467999999988889999999999999999996 99999754221 11111 11111000
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 219 ---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 ---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0111234566788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=314.68 Aligned_cols=233 Identities=21% Similarity=0.339 Sum_probs=188.3
Q ss_pred cccCcCCceeEEEEEe----cCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
+.||+|+||.||+++. .+|+.||+|++..... ....+..|++++.++ +||||+++++++...+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999874 3578999999975432 334567899999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999998753 35899999999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...... .
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~~---------~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKLG---------M 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCCC---------C
Confidence 234578899999999988899999999999999999999999975321 1111111111100 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 599 (627)
... ....+.+++.+||+.||++||++.+
T Consensus 218 p~~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQF---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011 1234567888999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.78 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=198.6
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||++...+ ...+|+|.+..... ...++.+|++++.++.+|+||+++++++..++..+++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 4789999999999998642 35799998875422 234688899999999789999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 411 YMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
|+++|+|..+++.... .....+++..+++++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence 9999999999975321 22456899999999999999999999988 999999999999999999999
Q ss_pred eecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
+|||.++...... ...++..|+|||++.+..++.++|||||||++||+++ |..||...... .... .
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~-~ 246 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------ELFK-L 246 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH------HHHH-H
Confidence 9999998764321 1223567999999988899999999999999999998 99998643211 1111 1
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
....... .........+.+++.+|+..+|++|||+.|+++.|+.+.
T Consensus 247 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111000 011122346778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.45 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=192.7
Q ss_pred hcccCcCCceeEEEEEec-----CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-----DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e 410 (627)
.+.||+|+||.||++..+ ++..||+|++..... ..+.+.+|++++..+ +||||+++++++.. ....++|+|
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEE
Confidence 478999999999999743 578999999865432 345788999999999 99999999998754 346789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999997542 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCC-------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC---------CCHHHHHHHHhh
Q 006886 491 PTT-------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV---------VDLPRWVRSVVR 554 (627)
Q Consensus 491 ~~~-------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~---------~~~~~~~~~~~~ 554 (627)
... ..++..|+|||+..+..++.++||||||+++|||++|..|+......-. ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 1123459999999888899999999999999999998776543211000 000000000000
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
... ..........++.+++.+||..+|++|||+.|+++.|+.++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000 00011122345778888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.24 Aligned_cols=245 Identities=29% Similarity=0.476 Sum_probs=199.2
Q ss_pred cccCcCCceeEEEEEecC----CcEEEEEEecccccC--HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILED----GTTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||++.... +..|++|.+...... .+.+.+|++.+..+ +|+|++++++++......++|+||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999999764 788999998765433 57889999999999 69999999999999999999999999
Q ss_pred CCCHHHHhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 414 AGSLFMLLHRNRSD----GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
+++|.+++...... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999864211 1256899999999999999999999988 9999999999999999999999999998775
Q ss_pred CC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ....++..|+|||.+....++.++||||+|+++|||++ |..||..... ......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~~--- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRK-GYRL--- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCCC---
Confidence 43 22345778999999988889999999999999999999 6999975421 111111111 1000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
........++.+++.+|++.+|++|||+.|++++|+
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122346778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=286.61 Aligned_cols=244 Identities=22% Similarity=0.353 Sum_probs=195.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.+|+|..++|.++..+ +|..+|+|++..... ..+.-.+|+++++++..||+|+++.+.|+.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999888754 688999999854321 1234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+|.|+.|.|.++|... ..+++....+|+.|+..|++|||... ||||||||+|||+|++.++||+|||+|+.+
T Consensus 102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999864 46999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCC---CCCCCccccCccccCC------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc
Q 006886 489 NFPT---TATRTIGYRAPEVTET------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559 (627)
Q Consensus 489 ~~~~---~~~~t~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (627)
.... ..+||++|+|||.+.. ..|+..+|+|+.||++|.|+.|.+||.+..+- -..+.+. ++...
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------lMLR~Im-eGkyq 246 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------LMLRMIM-EGKYQ 246 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------HHHHHHH-hcccc
Confidence 7654 4579999999999853 36788999999999999999999999753210 0111111 11110
Q ss_pred cccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 560 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
-. .+.+.+.....-+++.+|+..||.+|.|++|++.+-
T Consensus 247 ----F~---speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 247 ----FR---SPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred ----cC---CcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 01 111223333455677799999999999999999853
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.52 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=188.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.. +++.||+|++.... ...+.+..|++++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 367999999999999864 57899999996532 1235688899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 85 GGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999754 34888999999999999999999998 99999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCccccCccccCCCCCCCcchhHHHHH
Q 006886 491 ------------------------------------------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGV 522 (627)
Q Consensus 491 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gv 522 (627)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 01235789999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 006886 523 LLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALS--CVAKVPDSRPKMDDV 600 (627)
Q Consensus 523 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~ev 600 (627)
++|||++|+.||......+ ....+....... ..........+.. +++.+ |+..+|..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~-----~~~~~~~~s~~~~---dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE------TQLKVINWENTL-----HIPPQVKLSPEAV---DLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH------HHHHHHcccccc-----CCCCCCCCCHHHH---HHHHHHccCcccccCCCCHHHH
Confidence 9999999999997543211 111111100000 0011112233333 44444 667777789999999
Q ss_pred HHH
Q 006886 601 VRM 603 (627)
Q Consensus 601 ~~~ 603 (627)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=310.00 Aligned_cols=238 Identities=24% Similarity=0.341 Sum_probs=189.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||+|++..... ..+.+..|.+++..+.+|++|+++.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 468999999999999966 578999999875421 234566777888877789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999998754 34889999999999999999999998 99999999999999999999999999875432
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... .+ .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~~~---~~------p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNV---AY------P 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---CC------C
Confidence 12345789999999999999999999999999999999999999754321 11111111110 00 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~ 602 (627)
.....++.+++.+|++.+|++|++. .++.+
T Consensus 222 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1122355678889999999999985 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.78 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=208.1
Q ss_pred HHHHHHhcccCcCCceeEEEEEe-cCC----cEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce
Q 006886 333 DLLRASAEVLGKGSYGSTYKAIL-EDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK 405 (627)
Q Consensus 333 ~l~~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 405 (627)
|.+....++||+|+||+||+|.+ ..| -+||||++.... ....++..|+.+|.++ +|||+++++|+|.... .
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence 33334468999999999999985 333 468999887653 3467899999999999 9999999999998776 7
Q ss_pred EEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
.+|++||+.|+|.+|++.++. .+--...+.+..|||+||.|||++. +|||||.++|||+..-..+||.|||++
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 799999999999999998753 5777889999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCC------CCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFPTTAT------RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~~~~~------~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+......... ..+.|||-|.+....|+.++|||||||++||++| |..|+++...+++.++ ++.+
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~g-- 916 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKG-- 916 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhcc--
Confidence 9886543221 2467999999999999999999999999999999 9999987654433221 1111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. +....+-+..++..++.+||..|+..||+++++...+.++..+
T Consensus 917 -----e---RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 -----E---RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----c---cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 0 1233455667788899999999999999999999999887544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.43 Aligned_cols=232 Identities=23% Similarity=0.324 Sum_probs=184.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHH-HHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEV-VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||+||+|+.+ +|+.||+|++..... ...++..|... ++.+ +||||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999975 689999999865321 22344555544 4556 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999998754 35889999999999999999999998 99999999999999999999999999875422
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~---------~~~ 216 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKPL---------RLK 216 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCCC---------CCC
Confidence 1233578999999999998999999999999999999999999975321 122222221110 001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMD 598 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 598 (627)
... ...+.+++.+|++.+|.+||++.
T Consensus 217 ~~~---~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNI---SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCC---CHHHHHHHHHHhhcCHHhCCCCC
Confidence 111 23466788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.59 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|... ....+++|.+..... ..+.+..|++++..+ +||||+++++.+..++..++|+|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEE
Confidence 478999999999999853 235688888765432 235688899999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 006886 411 YMPAGSLFMLLHRNRS-------------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 471 (627)
|+++|+|.+++...+. .....+++...+.++.|++.||.|||+.+ ++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 9999999999875321 11235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006886 472 TQDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 544 (627)
++++.+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 999999999999997653221 1224568999999988889999999999999999998 99998653211
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
. +........... .......++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 237 --~-~~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --R-LFNLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --H-HHHHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111111111000 011122457788899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.71 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=195.6
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc------e
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE------K 405 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~ 405 (627)
.+.||+|+||.||+|.... +..||+|+++..... ...+.+|++.+..+ +|+||+++++++..... .
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCccc
Confidence 4679999999999998642 367999998754322 35688899999999 99999999998876554 6
Q ss_pred EEEEecCCCCCHHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSD-GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
++++||+++|+|..++...+.. ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 8999999999999998654321 2346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCC------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 485 AHLINFPTT------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 485 a~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
++....... ...+..|+|||++.+..++.++||||||+++|||++ |..||.+.... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~- 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHGN- 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC-
Confidence 987643321 123567999999988889999999999999999999 88998653211 1111111111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.. ........++.+++.+||+.+|++||++.|+++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112334678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=311.54 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=196.8
Q ss_pred HHhcccCcCCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEE
Q 006886 337 ASAEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLV 407 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~l 407 (627)
...+.||+|+||.||+|.. .+++.||||+++.... ....+.+|++++.++.+|+||+++++++... ...++
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~l 89 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 89 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEE
Confidence 3468899999999999973 3467899999975432 2356888999999998899999999988654 45789
Q ss_pred EEecCCCCCHHHHhhhcCCC------------------------------------------------------------
Q 006886 408 VYSYMPAGSLFMLLHRNRSD------------------------------------------------------------ 427 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 427 (627)
|+||+++|+|.++++.....
T Consensus 90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T cd05103 90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE 169 (343)
T ss_pred EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence 99999999999998753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC------CCCCCcc
Q 006886 428 --GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT------TATRTIG 499 (627)
Q Consensus 428 --~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~------~~~~t~~ 499 (627)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ...++..
T Consensus 170 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 0124788899999999999999999998 9999999999999999999999999987653221 1224567
Q ss_pred ccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHH
Q 006886 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQ 578 (627)
Q Consensus 500 y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 578 (627)
|+|||.+.+..++.++||||||+++|||++ |..||....... .............. .. ....+
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~~---~~~~~ 310 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------PD---YTTPE 310 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCC-------CC---CCCHH
Confidence 999999988899999999999999999997 999986532110 11111111111000 00 11235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 579 MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 579 l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
+.+++.+||+.+|++||++.|++++|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 77888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=300.84 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=185.6
Q ss_pred ccCcCCceeEEEEEecC---CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILED---GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||.||+|...+ ...+++|.+..... ....+.+|++.++.+ +|+||+++++.+......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 34688887754322 235678899999988 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++...+.......++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999998754333344578888999999999999999998 999999999999999999999999998654221
Q ss_pred --CCCCCCccccCccccC-------CCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 492 --TTATRTIGYRAPEVTE-------TRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
....++..|+|||+.. ...++.++||||||+++|||++ |..||...... ........... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccC
Confidence 1223456799999864 2456889999999999999999 78888643211 11111111111 111
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.++.. .......+.+++..|+ .||++|||+++|++.|.
T Consensus 231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 1112234455667888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=308.74 Aligned_cols=238 Identities=24% Similarity=0.335 Sum_probs=188.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|..+ +++.||+|++.... ...+.+..|.+++..+.+|++|+.+.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 478999999999999966 47789999987542 2345677888888888556678899999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 85 GGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 99999998754 34889999999999999999999998 99999999999999999999999999875321
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.... . + . .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~-~----~--~--~ 221 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN-V----S--Y--P 221 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-C----C--C--C
Confidence 12335789999999999989999999999999999999999999754311 1111111110 0 0 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~ 602 (627)
.. ...++.+++.+|+..+|.+|++. +++.+
T Consensus 222 ~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 222 KS---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 12345678889999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=298.48 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=194.7
Q ss_pred cccCcCCceeEEEEEecC--C--cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILED--G--TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|++|.||+|.+.+ + ..||+|.+..... ..+.+..|++.+.++ +||||+++++.+.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999999653 2 3689999876543 356788999999999 99999999999988 88899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++..... ..++|.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999986431 46899999999999999999999998 9999999999999999999999999998764321
Q ss_pred ------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 493 ------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... ............
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~------- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGER------- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCc-------
Confidence 2235678999999998899999999999999999998 99999643221 111111111100
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
..........+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 ---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0001122346778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.69 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=194.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEe-eCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY-SKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++..+ +..||+|.++.. ...+.+..|+.+++++ +|+|++++++++. .++..++|+||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 478999999999999876 788999988643 3456788999999999 9999999999765 44568999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-CCCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATR 496 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~ 496 (627)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..... .....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 99997543 235899999999999999999999998 999999999999999999999999998765432 22334
Q ss_pred CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHH
Q 006886 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575 (627)
Q Consensus 497 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 575 (627)
+..|+|||+..+..++.++||||||+++|||++ |+.||.... ........ ........ ....
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~ 224 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMDA----------PDGC 224 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCCC----------CCCC
Confidence 568999999988889999999999999999998 999986432 11222111 11111110 0112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 576 ~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
...+.+++.+|++.+|++|||+.++++.|+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 34567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.71 Aligned_cols=241 Identities=21% Similarity=0.354 Sum_probs=194.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||+|++.... .....+..|++++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCC
Confidence 468999999999999976 68999999987542 2345688899999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 85 GGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999764 35899999999999999999999988 9999999999999999999999999997654322
Q ss_pred --------------------------------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 493 --------------------------------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 493 --------------------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 234788999999999999999999999999999999999999754311
Q ss_pred CCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 006886 541 DVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK-MDDVVRM 603 (627)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~ev~~~ 603 (627)
.....+.. +.... ....... ...++.+++.+|+. +|.+||+ +++++++
T Consensus 237 ------~~~~~i~~--~~~~~---~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ------ETYNKIIN--WKESL---RFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHhc--cCCcc---cCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111 00000 0000111 23355677779997 9999999 9999885
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.93 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.+.+ +..||+|.+..... ....|..|+.+++++ +|+||+++++++.+.+..++|+|
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEe
Confidence 4689999999999999753 56789998764432 345688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRSD--GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfG~a 485 (627)
|+++|+|.+++...+.. ....++|..+++++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccc
Confidence 99999999999765321 1235899999999999999999999998 99999999999998764 5899999999
Q ss_pred cccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||...... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~ 240 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEFVTGGGRL 240 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCCcC
Confidence 8763221 1122457999999998899999999999999999997 99999754321 111111111100
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
. ........+.+++.+|++.+|++||++.+|+++|++
T Consensus 241 -~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 241 -D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0 001122457788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.51 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=192.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~e~ 411 (627)
.+.||+|+||.||+|... +++.||+|.+........++..|+.++.++.+|+|++++.+++... ...++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 467999999999999965 5788999998766556678899999999987899999999998753 357899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++...+ ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999997642 246899999999999999999999998 999999999999999999999999998765332
Q ss_pred ----CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 ----TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... .... ... .......
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~-~~~-~~~~~~~- 236 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF-LIP-RNPAPRL- 236 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH-HHh-cCCCCCC-
Confidence 2345788899999985 345788999999999999999999999643211 0000 000 0000000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ....++.+++.+||..+|.+|||+.|++++
T Consensus 237 -----~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 237 -----KSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----CCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 001 122356778889999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.20 Aligned_cols=251 Identities=21% Similarity=0.372 Sum_probs=202.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... +|+.||+|.++... ...+.+.+|+++++++ +|+|++++++++...+..++||||++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCC
Confidence 367999999999999976 78999999886321 2256788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|..++..... ....+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999875422 2346899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... .+............ ....
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-~~~~-------- 228 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCD-YPPL-------- 228 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCC-CCCC--------
Confidence 2346788999999988889999999999999999999999986432 12222221111110 0000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
........+.+++.+||..+|++||++.+|+++|+++.
T Consensus 229 -~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 -PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01122345678888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.66 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=200.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++.. .+++.+|||.+.... ....++..|++++..+ +|+||+++++++..++..++++||++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecC
Confidence 46799999999999995 478999999876432 2235788899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+++|.+++..... ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999999875322 2346899999999999999999999998 9999999999999999999999999987664322
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...++..|+|||++.+..++.++||||||+++|||++|..||.....+ ............ .+..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~~--- 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCD------YPPL--- 228 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCC------CCCC---
Confidence 235678899999998888999999999999999999999999643211 111111111000 0000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
........+.+++.+||..+|++|||+.+|++.++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01122345677888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.49 Aligned_cols=244 Identities=27% Similarity=0.458 Sum_probs=200.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..||||.+.......+++.+|+++++++ +|+|++++++++......++|+||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 478999999999999988888999999987666678899999999999 8999999999999888999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... +..+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.+||+|||.++...... .
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 9997642 246899999999999999999999998 9999999999999999999999999987764321 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+..|+|||.+.+..++.++||||||+++||+++ |+.||...... ............ ...
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~-----------~~~ 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGYRM-----------PRP 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC-----------CCC
Confidence 223467999999998889999999999999999998 99999643211 111111111000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.....++.+++.+|+..+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113456788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.65 Aligned_cols=242 Identities=20% Similarity=0.313 Sum_probs=191.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|+++.... ..+.+..|++++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCC
Confidence 478999999999999965 688999999976432 345678888888888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999997642 35899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ----CCCCCccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 493 ----TATRTIGYRAPEVTE------TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 493 ----~~~~t~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
...+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~--- 228 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFL--- 228 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCcc---
Confidence 235788999999986 45678999999999999999999999975321 11122221111000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+........+.+++..|+. +|.+||++.+++++
T Consensus 229 -----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 -----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 011111122345667778997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.93 Aligned_cols=241 Identities=21% Similarity=0.425 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++.+.++..+|+|.+.........+.+|++++..+ +|||++++++++......++|+||+++|+|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 478999999999999987788999999876666677899999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... ..+++..+..++.+++.|+.|||+.+ ++||||||+||+++.++.+||+|||.++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 88 DYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9987542 35789999999999999999999998 9999999999999999999999999987653321 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ....... .... ....+.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~--~~~~~~------- 224 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETI-NAGF--RLYKPR------- 224 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHH-hCCC--CCCCCC-------
Confidence 223568999999998899999999999999999998 9999975321 1111111 1110 001111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....+.+++.+||..+|++||++.|+++.|
T Consensus 225 -~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 -LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1124677889999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.22 Aligned_cols=250 Identities=24% Similarity=0.428 Sum_probs=198.8
Q ss_pred hcccCcCCceeEEEEEecC-----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED-----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e 410 (627)
.+.||+|+||.||+|...+ +..|++|++..... ..+.+.+|+.++.++ +|+|++++++++.. +...++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEE
Confidence 4789999999999999765 68899998865422 345688899999999 99999999998876 467889999
Q ss_pred cCCCCCHHHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 411 YMPAGSLFMLLHRNRSD---GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|+++|+|.+++...+.. .+..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999999765321 1256899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 488 INFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 488 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
+.... ...++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..+ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~- 238 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY----LKDGYRL- 238 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHcCCCC-
Confidence 53221 2234667999999988889999999999999999999 99999753211 11111 1111000
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
........++.+++.+||..+|++|||+.++++.|+.+..
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 ---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122356788889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.37 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=200.6
Q ss_pred HhcccCcCCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 338 SAEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
..+.||+|+||.||++... .+..||+|.++.... ..+++.+|++++.++.+||||+++++++...+..++
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 95 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence 4678999999999999742 123689998875322 346788999999999889999999999999999999
Q ss_pred EEecCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC
Q 006886 408 VYSYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN 476 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 476 (627)
++||+++|+|.+++..... .....++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~ 172 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNV 172 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 9999999999999976431 12345889999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006886 477 GCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 477 ~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 549 (627)
+||+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||.... .....
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~ 246 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEELF 246 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence 9999999997654321 1123457999999998899999999999999999998 888886532 12222
Q ss_pred HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 550 RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
....... ... .......++.+++.+||+.+|++||++.|+++.|+++....
T Consensus 247 ~~~~~~~-~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 KLLKEGH-RMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHcCC-CCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 2221111 100 01122346778889999999999999999999999987444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=293.66 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=199.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++... |+.||+|.+.......+.+.+|+.++..+ +|+|++++++++...+..++|+||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 478999999999999976 78999999977655567899999999999 8999999999999989999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC-CCCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT-ATRT 497 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~-~~~t 497 (627)
+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++....... ...+
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 9997542 236899999999999999999999998 99999999999999999999999999987643322 2235
Q ss_pred ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHH
Q 006886 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEM 576 (627)
Q Consensus 498 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 576 (627)
..|+|||++.+..++.++||||||+++||+++ |..||...... .+........... ......
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~----------~~~~~~ 225 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRME----------APEGCP 225 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCC----------CccCCC
Confidence 67999999988889999999999999999997 99998643211 1111111111100 001123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 577 VQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 577 ~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
..+.+++.+|+..+|++||++.|++++|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 4567888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=309.97 Aligned_cols=235 Identities=22% Similarity=0.298 Sum_probs=183.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHH-HHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEV-VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||+++.+ +++.||+|++.... .....+..|... +..+ +|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999966 57889999986532 122344445443 4556 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 80 GGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 99999999753 24778888899999999999999998 99999999999999999999999999875422
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~---------~~~ 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL---------QLK 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCc---------CCC
Confidence 1234588999999999999999999999999999999999999975322 111222111110 001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 601 (627)
... ...+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~---~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNI---TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCC---CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 111 23456677899999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.28 Aligned_cols=239 Identities=24% Similarity=0.424 Sum_probs=187.8
Q ss_pred cccCcCCceeEEEEEecC--------CcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILED--------GTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
+.||+|+||.||+|..+. ...|++|.+.... ...+.+..|+.++..+ .|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998642 2347888775432 2345688889999988 89999999999999899999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC--------eEEeec
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN--------GCISDV 482 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~ki~Df 482 (627)
|+++|+|..+++... ..+++..+++++.|++.||.|||+.+ |+||||||+||+++.++. ++++||
T Consensus 80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999997642 35899999999999999999999998 999999999999988765 599999
Q ss_pred ccccccCCCCCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 483 GLAHLINFPTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGK-APLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 483 G~a~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
|.+..........++..|+|||++.+ ..++.++||||||+++|||++|. .||...... .... ..... ..
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~-~~~~~--~~ 223 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQ-FYEDR--HQ 223 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHH-HHHcc--cc
Confidence 99877665555667889999999976 45799999999999999999985 555432111 0000 00000 00
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
+ + .....++.+++.+||+.+|++|||++++++.|+
T Consensus 224 -~-------~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -L-------P--APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -C-------C--CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 111235678888999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.79 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=196.9
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||++... ++..||+|.++.... ..+.+.+|+++++++.+|+||+++++++...+..++|+|
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 578999999999999742 345799998875422 235688999999999789999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.++++... ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.++++|||+++....
T Consensus 120 ~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 120 YCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred cCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999997543 234899999999999999999999998 99999999999999999999999999986543
Q ss_pred CC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 491 PT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 491 ~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .............
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~--- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA--- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC---
Confidence 22 1234567999999988889999999999999999998 999987543211 1111111111000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
... ....++.+++.+|+..+|++||++.|+++.|+++
T Consensus 265 ----~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 ----QPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001 1123577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.60 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=196.3
Q ss_pred hcccCcCCceeEEEEEecC-----------------CcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEE
Q 006886 339 AEVLGKGSYGSTYKAILED-----------------GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYY 399 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~ 399 (627)
.+.||+|+||.||++...+ +..||+|.+.... ...+++.+|++++.++ +|||++++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence 4789999999999988542 2458999887543 2356788999999999 999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSD------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 400 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
..++..++|+||+++++|.+++...... ....+++...+.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence 9999999999999999999999865421 1236899999999999999999999998 999999999999999
Q ss_pred CCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCH
Q 006886 474 DLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDL 545 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~~~ 545 (627)
++.++|+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ +..||...... ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QV 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HH
Confidence 9999999999987653221 2234678999999988889999999999999999998 67777643211 11
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
................. ........++.+++.+|++.+|++|||+.||++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111110000000 0111122467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=298.54 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=195.1
Q ss_pred HhcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEE
Q 006886 338 SAEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVV 408 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv 408 (627)
..+.||+|+||.||++.+ .++..||+|.++.... ..+.+.+|+++++.+ +|||++++.+++... ...++|
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEEE
Confidence 357899999999999974 3578899999865432 345788999999999 999999999998875 567899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++++|.+++.... ..++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 87 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 87 MEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999997542 35899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC---------CCCCHHHHHHHH
Q 006886 489 NFPT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD---------DVVDLPRWVRSV 552 (627)
Q Consensus 489 ~~~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~---------~~~~~~~~~~~~ 552 (627)
.... ...++..|+|||++.+..++.++||||||+++|||++++.|+...... .......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV- 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-
Confidence 4322 223456799999998888999999999999999999987765321100 00011111111
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
...... ..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 239 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 001112334678889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.38 Aligned_cols=243 Identities=20% Similarity=0.322 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|.. .+++.||+|.+..... ..+++..|++++.++ +||||+++++++...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 47899999999999985 4688999999865422 245688999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--CC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--TT 493 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~~ 493 (627)
+|..+. .+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... ..
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 996542 3678888999999999999999998 999999999999999999999999999765432 33
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-CHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV-DLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... ............. . +.+ ..
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~-~~--- 222 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-P-----PVL-PV--- 222 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-C-----CCC-CC---
Confidence 45788999999999888999999999999999999999999753322111 1111111111000 0 000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....++.+++.+|++.+|++||+++|++++-
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 11223567788899999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.57 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=187.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++..+ +++.||||+++... ...+.+..|++++..+. +||||+++++++...+..++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 368999999999999965 68999999997542 12345666666554332 799999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
+++|+|..+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999988864 25899999999999999999999998 99999999999999999999999999875422
Q ss_pred ---CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 491 ---PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~--------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR--------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---------
Confidence 22345789999999999989999999999999999999999999754321 111111111100
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.... ....+.+++.+|+..||.+|| ++.+++++
T Consensus 220 ~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011 123456788899999999999 56776663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.36 Aligned_cols=247 Identities=23% Similarity=0.412 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||+||+|.+. ++. .||+|.++.... ..+++..|+.++..+ .|+||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCcEEEEEc
Confidence 478999999999999853 444 489998865422 345788889898888 99999999999875 456799999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.++++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999997542 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CC------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 TT------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~~------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.. ..++..|+|||...+..++.++||||||+++|||++ |..||+..... .+..+ ........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~---- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERLP---- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcCC----
Confidence 21 123567999999988899999999999999999998 89998643211 11111 11110000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.......++.+++.+||..+|++||++.++++.|+++....
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01122345678889999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.86 Aligned_cols=233 Identities=22% Similarity=0.319 Sum_probs=184.4
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHH-HHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEV-VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||+++.. +|+.||+|++.... .....+..|... ++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36999999999999965 68999999986542 123445556554 4455 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999888753 35899999999999999999999998 99999999999999999999999999875322
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~~---------~~~ 216 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKPL---------VLR 216 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCCc---------cCC
Confidence 2234578999999999999999999999999999999999999975321 111222221110 001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 599 (627)
.. ....+.+++.+|+..+|.+||++.+
T Consensus 217 ~~---~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PG---ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CC---CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11 2234567888999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.36 Aligned_cols=241 Identities=20% Similarity=0.292 Sum_probs=190.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|++.... ...+.+..|+++++.+ +||||+++++++.+.+..++||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCC
Confidence 478999999999999965 58899999986432 2334577899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999998743 3778888899999999999999998 999999999999999999999999999765432
Q ss_pred ---CCCCCCccccCccccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ---TTATRTIGYRAPEVTETR----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~----- 266 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL----- 266 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC-----
Confidence 234589999999998643 478999999999999999999999975421 11122222111000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDS--RPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~ 603 (627)
..+.......++.+++.+|+..+|.+ ||++.|++++
T Consensus 267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00111112235567778999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.63 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=198.8
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|..++ +..||+|.+..... ....+..|+.+++.+ +|+||+++++++...+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 4789999999999997542 45799998764432 234677899999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRS-----DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
|+++|+|.+++..... .+....++....+++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999975321 11234677888999999999999999998 999999999999999999999999998
Q ss_pred cccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||...... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 7653221 1223567999999988889999999999999999998 78888653221 111111111100
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
. ........+.+++.+|++.+|++|||+.++++.|++...+..++
T Consensus 241 -~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 -D----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred -C----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0 00112246778888999999999999999999999876654443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=301.67 Aligned_cols=194 Identities=23% Similarity=0.425 Sum_probs=159.5
Q ss_pred hcccCcCCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE---DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~ 413 (627)
...||+|+||.||+|+.+ +++.||+|.+.... ....+.+|++++.++ +||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999865 46789999986532 345578899999999 99999999998864 445789999985
Q ss_pred CCCHHHHhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----cCCCCeEEeecccc
Q 006886 414 AGSLFMLLHRNRS----DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL----TQDLNGCISDVGLA 485 (627)
Q Consensus 414 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfG~a 485 (627)
++|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 588888764321 11235889999999999999999999998 9999999999999 45678999999999
Q ss_pred cccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 486 HLINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 486 ~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
+..... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432 23356889999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.53 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=192.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--------ceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--------EKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 406 (627)
.+.||+|+||.||+++.. +++.||||++..... ....+.+|+..+..+ +|+|++++...+...+ ..+
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence 478999999999999854 689999999865432 234677888888888 9999999887765432 257
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+||||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999975432 2356899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCC------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 487 LINF------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 487 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+......... .
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~~~-~ 264 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGRYD-P 264 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCCCC-C
Confidence 6532 123458899999999999999999999999999999999999997532 22222222211110 0
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ . .....++.+++.+||..+|.+||++.+++++
T Consensus 265 -~------~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 265 -L------P---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -C------C---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0 1122356678889999999999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=313.64 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=190.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.. +++.||||++.... .....+.+|++++..+ +||||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCC
Confidence 478999999999999965 58899999997542 2234577899999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 85 GGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999753 35899999999999999999999998 999999999999999999999999998654211
Q ss_pred ----------------------------------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCC
Q 006886 492 ----------------------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGK 531 (627)
Q Consensus 492 ----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~ 531 (627)
....||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0134789999999999889999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006886 532 APLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK---MDDVVRM 603 (627)
Q Consensus 532 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~~~ 603 (627)
.||..... ......+.... ... .........+ .+.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~------~~~~~~i~~~~--~~~---~~~~~~~~s~---~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNP------QETYRKIINWK--ETL---QFPDEVPLSP---EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCH------HHHHHHHHcCC--Ccc---CCCCCCCCCH---HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99975431 11111111100 000 0001111223 34556668886 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=307.67 Aligned_cols=232 Identities=23% Similarity=0.320 Sum_probs=182.9
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHH-HHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQME-VVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||+++.. +++.||+|++..... ....+..|.. ++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999975 588999999865321 2334555554 45556 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 80 GGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99999888653 34788889999999999999999998 99999999999999999999999999875322
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+.... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~---------~~~~ 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP---------LQLP 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC---------CCCC
Confidence 123357889999999998899999999999999999999999997542 112222221111 0000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMD 598 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 598 (627)
......+.+++.+|++.+|.+||++.
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 ---GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223566788899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=293.78 Aligned_cols=244 Identities=21% Similarity=0.447 Sum_probs=196.2
Q ss_pred hcccCcCCceeEEEEEec-CCc---EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT---TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~---~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|..+ ++. .+|+|.+.... ...+++..|++++.++ +|+|++++.+++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcC
Confidence 478999999999999975 333 69999886542 2346788999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999997532 35899999999999999999999998 9999999999999999999999999987664321
Q ss_pred CC-------CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 493 TA-------TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 493 ~~-------~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.. ..+..|+|||++....++.++||||||+++||+++ |+.||..... ......+.....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~~------- 228 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGFR------- 228 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCCC-------
Confidence 11 12346999999988889999999999999999998 9999965321 112222211100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.+...+...++.+++.+||..+|++||++.+|++.|+++
T Consensus 229 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112334677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.55 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=198.6
Q ss_pred HhcccCcCCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 338 SAEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
..+.||+|+||.||++... +...+|+|.++.... ...++..|++++.++.+||||+++++++...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 3578999999999999742 245789998875432 245688899999999779999999999998889999
Q ss_pred EEecCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC
Q 006886 408 VYSYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN 476 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 476 (627)
|+||+++|+|.+++..... .....+++....+++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence 9999999999999976431 11245899999999999999999999998 999999999999999999
Q ss_pred eEEeecccccccCCCC----C--CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHH
Q 006886 477 GCISDVGLAHLINFPT----T--ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 477 ~ki~DfG~a~~~~~~~----~--~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~ 549 (627)
+||+|||.++...... . ..++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~~~ 246 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE------ELF 246 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 9999999998664321 1 123457999999988889999999999999999999 88898643211 111
Q ss_pred HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 550 RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.. ........ .......++.+++.+|+..+|++||++.|+++.|+++...
T Consensus 247 ~~-~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 247 KL-LREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HH-HHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 11111100 0111223566788899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.42 Aligned_cols=240 Identities=21% Similarity=0.390 Sum_probs=193.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecc-----cccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc--eEEEEec
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLRE-----VAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE--KLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~-----~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--~~lv~e~ 411 (627)
++||+|+|-+||+|.+. +|-.||--.++. .....+.|..|+++++.| +||||++++.+|.+... ..+|+|.
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeeec
Confidence 67999999999999965 477777433321 122347899999999999 99999999999998665 6789999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINF 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~ 490 (627)
+..|+|..|..+.+ .++......|+.||++||.|||++. |||||||||-+||+|+.+ |.+||+|.|+|+....
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999875 4788899999999999999999987 899999999999999876 8999999999998865
Q ss_pred C--CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 P--TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. ....|||.|||||.+. ..|++.+||||||+.++||+|+..||.+- .+..+..+++..+... .. +.+
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP-~s----l~k 267 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKP-AA----LSK 267 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCH-HH----hhc
Confidence 4 3356999999999997 68999999999999999999999999743 3334444443333222 11 111
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. .. ++.++|.+|+.. .++|||+.|+++.
T Consensus 268 V~--dP---evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VK--DP---EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cC--CH---HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11 12 455677799999 9999999999873
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=301.65 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=195.7
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|..++ +..||+|.+..... ....+.+|+.++..+ +|+||+++++++......++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEe
Confidence 4789999999999998653 36799999865432 245688899999998 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRSD-----GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
|+++|+|.+++...... ....++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence 99999999999754321 1235789999999999999999999988 999999999999999999999999998
Q ss_pred cccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+..... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ..... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------EVLKF-VIDGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH------HHHHH-HhcCCC
Confidence 765332 12234678999999988889999999999999999998 99998643221 11111 111111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
... ......++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 LDL----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 1112346778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.78 Aligned_cols=253 Identities=19% Similarity=0.335 Sum_probs=190.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.+ +++.||+|.++... .....+.+|++++.++ +||||+++++++..++..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 478999999999999965 57889999986442 2344677899999999 999999999999999999999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... +..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 89 DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 888887654 235889999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---cccc------cc
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTA------EV 561 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~------~~ 561 (627)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ....... .... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchhhh
Confidence 22346788999998864 5688999999999999999999999976543221110 0000000 0000 00
Q ss_pred cchhhhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 FDVELLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+....... .......++.+++.+|+..||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000 001112345678889999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.97 Aligned_cols=244 Identities=25% Similarity=0.464 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..+|+|.+.......+.+.+|+++++++ +|+|++++.+.+.. ...++++||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 478999999999999988788899998876554567789999999999 89999999999877 7789999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 9997642 345889999999999999999999988 9999999999999999999999999987654321 1
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++....++.++||||||+++|++++ |+.||...... .+..+ ....... ...
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~----------~~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRM----------PRP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCCC----------CCc
Confidence 223567999999988889999999999999999999 99999753211 11111 1111100 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.....++.+++.+|++.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 12234577888899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.59 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=192.0
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++..+ +||||+++++.+...+..++|+||+++++
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 47899999999999996 468899999986442 2345678899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.++++.. ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||+++..... .
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99998753 35889999999999999999999988 999999999999999999999999999865432 2
Q ss_pred CCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 TATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...++..|+|||.+. ...++.++||||||+++|||++|+.||......+... .. ....+.+. ..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~-----~~~~~~~~--~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-----SKSNFQPP--KL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee-----ecCCCCCC--CC
Confidence 334678899999874 3457889999999999999999999986432211100 00 00000000 00
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.........+.+++.+||..+|++||++++++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01112234667888899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=288.73 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=200.6
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
+.+..+ ...+.||+|.-|+||++++++ +..+|+|++.+... .....+.|.+|++.+ .||.+..+++.++.++
T Consensus 74 l~l~~f--~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 74 LGLRHF--RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDK 150 (459)
T ss_pred cCHHHH--HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccc
Confidence 445554 234789999999999999875 58899999977633 234677788999999 9999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++|||||+||+|....+++. +..+++..+..++.+|+-||+|||-.| ||+|||||+|||+.++|++.|+||.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence 9999999999999999988754 467999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCC-----------------------------------C-------------------------CCCCCCccccCc
Q 006886 484 LAHLINF-----------------------------------P-------------------------TTATRTIGYRAP 503 (627)
Q Consensus 484 ~a~~~~~-----------------------------------~-------------------------~~~~~t~~y~aP 503 (627)
++..... . ...+||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8643200 0 012367789999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHH
Q 006886 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIA 583 (627)
Q Consensus 504 E~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~ 583 (627)
|++.+...+.++|+|+|||++|||+.|+-||.+.+..... ..++... . .++..++......++|
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NIv~~~-------l---~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNIVGQP-------L---KFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHHhcCC-------C---cCCCCCcchhHHHHHH
Confidence 9999999999999999999999999999999987654321 1111111 1 1222223445666788
Q ss_pred HHcccCCCCCCCC----HHHHHH
Q 006886 584 LSCVAKVPDSRPK----MDDVVR 602 (627)
Q Consensus 584 ~~Cl~~~p~~RPs----~~ev~~ 602 (627)
++.+.+||.+|.- +.||.+
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhccChhhhhccccchHHhhc
Confidence 8999999999988 777765
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.22 Aligned_cols=241 Identities=25% Similarity=0.447 Sum_probs=195.1
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
++||+|+||.||++...+++.||+|.+..... ..+.+.+|+++++++ .|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999987799999998876433 346789999999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---- 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~---- 493 (627)
.+++.... ..+++.....++.+++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99997542 35789999999999999999999998 99999999999999999999999999876542111
Q ss_pred --CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 --ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 --~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ........ ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~-~~~~~~~~----------~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTR-ERIESGYR----------MP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHH-HHHhcCCC----------CC
Confidence 122456999999988899999999999999999999 88888654221 111 11111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
........+.+++.+|+..+|.+||++.|+++.|+
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01122346778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=293.19 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=189.1
Q ss_pred cccCcCCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAILE----DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~ 412 (627)
+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.+++.+ +|||++++++++.. ++..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999854 23579999885432 2345788899999998 99999999998764 55678999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
.+|+|.+++.... ...++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999997542 24678888999999999999999988 999999999999999999999999998755321
Q ss_pred -------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 -------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG-KAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....++..|+|||++.+..++.++||||||+++|||++| .+||.... ...............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~---- 222 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRLL---- 222 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCCC----
Confidence 112245679999999888899999999999999999995 55665321 111122111111000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.. ......+.+++.+||..+|++||++.|+++.|+++..
T Consensus 223 ----~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 223 ----QP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00 1112357788899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=298.60 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=192.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++... +++.||+|.+..... ..+.+..|+.++.++ +|++++.+.+.+...+..++||||+++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 67999999999999965 688999999865322 234567899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999986532 235899999999999999999999988 9999999999999999999999999987654322
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||++.+..++.++||||||+++|||++|+.||......... ......... ... .. .
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~-~~~-----~~--~-- 225 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE-VQE-----EY--S-- 225 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh-hhh-----hc--C--
Confidence 235788999999999889999999999999999999999999754321100 001110000 000 00 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
......+.+++.+||+.+|++||| ++|++++
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 226 -EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111234567888999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.81 Aligned_cols=243 Identities=24% Similarity=0.307 Sum_probs=192.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||+||++... +++.||+|.+..... ....+.+|++++.++ +|+|++.+.+.+..++..++|+||+++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEeccC
Confidence 67999999999999965 688999999865421 234567899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99998886532 235899999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....++..|+|||++.+..++.++|+||||+++|||++|+.||........ ............ ..+ .
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~~------~-- 225 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EVY------S-- 225 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--ccc------C--
Confidence 234578899999999888999999999999999999999999975422110 011111111100 000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
......+.+++.+|+..+|++||+ +.+++.+
T Consensus 226 -~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 -AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111234567888999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=294.83 Aligned_cols=244 Identities=23% Similarity=0.455 Sum_probs=195.0
Q ss_pred hcccCcCCceeEEEEEecC-C---cEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED-G---TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|..+. + ..||+|.+.... ...++|..|+.+++.+ +||||+++++++..+...++|+||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecC
Confidence 5789999999999999653 3 369999987542 2346799999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999997542 35899999999999999999999998 9999999999999999999999999987653321
Q ss_pred C---C---C---CCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 493 T---A---T---RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 493 ~---~---~---~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
. . . .+..|+|||++.+..++.++||||||+++||+++ |..||...... ....++ .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCc----
Confidence 1 1 1 1346999999998899999999999999999887 99999753211 111111 11100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.....+....+.+++.+||..+|.+||++++++..|+++
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001112234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=327.92 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=197.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+++..++||||++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 478999999999999965 588999999875422 245788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 414 AGSLFMLLHRNRS------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 414 ~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
+|+|.+++..... ......++..+++++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCccee
Confidence 9999999875321 11234677888999999999999999998 99999999999999999999999999976
Q ss_pred cCC----------------------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006886 488 INF----------------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545 (627)
Q Consensus 488 ~~~----------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 545 (627)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-- 240 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-- 240 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh--
Confidence 511 01134789999999999999999999999999999999999999753221110
Q ss_pred HHHHHHHhhhcccccccchh-hhcCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhccc
Q 006886 546 PRWVRSVVREEWTAEVFDVE-LLKYQDVEEEMVQMLQIALSCVAKVPDSRP-KMDDVVRMIEQIQQP 610 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~ev~~~L~~~~~~ 610 (627)
... ...++. .... .+....+.+++.+|++.+|++|| +++++.+.|+...+.
T Consensus 241 --------~~~---~i~~P~~~~p~---~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 --------YRD---VILSPIEVAPY---REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --------hhh---hccChhhcccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 000000 0001 12223466788899999999995 677788888887554
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=287.50 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=205.6
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
..++||+|+||.||++.++ .|+.+|||.+.- ..+.+++..|+.+|++- ..|++|+++|.|.....+++|||||-.|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 3678999999999999965 699999998754 44678899999999998 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----PT 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----~~ 492 (627)
+.+.++..+ .++++.+...++...+.||+|||... -+|||||+.|||++.+|.+|++|||.|..+.+ ..
T Consensus 115 iSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 115 ISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred HHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999998653 57999999999999999999999987 89999999999999999999999999987754 35
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc-chhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF-DVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~~~ 571 (627)
+..||+-|||||++..-.|+.++||||+|++..||..|++||.....-.. ..++ ...-..+..
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPPTFKK 251 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCCCCCC
Confidence 66799999999999999999999999999999999999999975432110 0011 011123445
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.++...++-+++++|+-++|++|-|+.++.++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 56777788899999999999999999988764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.79 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++..+ +|+||+++++++...+..++++||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEec
Confidence 478999999999999742 35678999876543 2356789999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 412 MPAGSLFMLLHRNRS----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
+++|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECC
Confidence 999999999976431 01135899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 482 VGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 482 fG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ........
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~ 239 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAIECITQ 239 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHHHHHHc
Confidence 99987553221 2224578999999998899999999999999999998 89998643221 11111111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.. ... .. ......+.+++.+||+.+|.+||++.||++.|++
T Consensus 240 ~~-~~~-------~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 GR-ELE-------RP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred Cc-cCC-------CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 10 000 00 1122346678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=290.84 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||++..+ +++.|++|.+... ....+.+..|+++++++ +|||++++++++...+..++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCC
Confidence 367999999999999965 6889999988643 23456788899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.++++... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 84 GDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999998642 246899999999999999999999988 9999999999999999999999999988664432
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+++.|+|||+..+..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~---------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRGV-FPP---------- 220 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-CCC----------
Confidence 234678899999999888999999999999999999999999754311 1111111111 000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 001233467788889999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.07 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=195.0
Q ss_pred hcccCcCCceeEEEEEec-----------------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEE
Q 006886 339 AEVLGKGSYGSTYKAILE-----------------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYY 399 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 399 (627)
.+.||+|+||.||++... ++..||+|++..... ...++.+|++++..+ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 467999999999998633 234689999875432 346789999999999 999999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSD------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 400 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
...+..++||||+++|+|.+++...... ....+++.....++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcC
Confidence 9999999999999999999999764321 1235788999999999999999999998 999999999999999
Q ss_pred CCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCH
Q 006886 474 DLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDL 545 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~~~ 545 (627)
++.++|+|||+++...... ....+..|+|||+..++.++.++||||||+++|||++ |..||......+ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~ 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---V 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---H
Confidence 9999999999997653321 1223567999999888889999999999999999998 778886432211 1
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
................. .....+...+.+++.+||+.+|++||++.||.+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111000000 0011123567788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=311.59 Aligned_cols=196 Identities=27% Similarity=0.419 Sum_probs=172.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccC-----CCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKH-----SNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-----~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.++||+|+||.|.+|... +++.||||+++....-..+...|+.++..+.+| -|+|+++++|...++.++|+|.+
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 578999999999999955 689999999988766667778899999999634 37999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC--CCeEEeecccccccCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD--LNGCISDVGLAHLINF 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfG~a~~~~~ 490 (627)
.. +|+++++.++. ..++......++.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|.....
T Consensus 271 ~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 271 ST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 55 99999998765 45999999999999999999999998 9999999999999764 4789999999988754
Q ss_pred C-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 006886 491 P-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541 (627)
Q Consensus 491 ~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~ 541 (627)
. .++..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+.++.+
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 3 35567788999999999999999999999999999999988887765443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.29 Aligned_cols=233 Identities=22% Similarity=0.306 Sum_probs=186.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.||+|++.... ...+.+..|.+++..+.+|++|+++.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 368999999999999965 68899999987542 2234577788888888677888899999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 99999998754 35899999999999999999999998 999999999999999999999999998754322
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...... . .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~~-------~--p 221 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNVS-------Y--P 221 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-------C--C
Confidence 2344789999999999889999999999999999999999999754221 111111111100 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM 597 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 597 (627)
.....++.+++.+|+..+|.+|++.
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ---KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1112345678889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.69 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=193.0
Q ss_pred hcccCcCCceeEEEEEecC---------------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEee
Q 006886 339 AEVLGKGSYGSTYKAILED---------------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~ 401 (627)
.+.||+|+||.||+++..+ ...||+|.++.... ....+.+|++++.++ +|+|++++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence 4679999999999987542 22589999875422 345688999999999 99999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC
Q 006886 402 KDEKLVVYSYMPAGSLFMLLHRNRSD-------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD 474 (627)
Q Consensus 402 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~ 474 (627)
.+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence 99999999999999999999653211 1124789999999999999999999998 9999999999999999
Q ss_pred CCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCHH
Q 006886 475 LNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDLP 546 (627)
Q Consensus 475 ~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t--g~~p~~~~~~~~~~~~~ 546 (627)
+.+||+|||+++...... ...++..|+|||+.....++.++||||||+++|||++ +..||....... ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence 999999999987653321 1223568999999988889999999999999999998 667776432211 11
Q ss_pred HHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
................. ..+.....+.+++.+|++.+|++||++.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000000 001122467888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=315.37 Aligned_cols=241 Identities=18% Similarity=0.282 Sum_probs=187.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.||||++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 478999999999999864 68899999986532 1235678899999998 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 85 GGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999754 35888999999999999999999998 999999999999999999999999998632110
Q ss_pred -------------------------------------------------CCCCCCccccCccccCCCCCCCcchhHHHHH
Q 006886 492 -------------------------------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFGV 522 (627)
Q Consensus 492 -------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gv 522 (627)
....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0134788999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCC---CCHHH
Q 006886 523 LLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR---PKMDD 599 (627)
Q Consensus 523 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~e 599 (627)
++|||++|+.||...... .....+.... ... .+....... .++.+++.+|+. +|.+| +++.|
T Consensus 237 il~elltG~~Pf~~~~~~------~~~~~i~~~~--~~~---~~p~~~~~s---~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSH------ETYRKIINWR--ETL---YFPDDIHLS---VEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHH------HHHHHHHccC--Ccc---CCCCCCCCC---HHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999754321 1111111100 000 000011112 345567778887 66665 69999
Q ss_pred HHHH
Q 006886 600 VVRM 603 (627)
Q Consensus 600 v~~~ 603 (627)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.52 Aligned_cols=190 Identities=25% Similarity=0.366 Sum_probs=165.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++..+ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999964 58899999986542 1235678899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++.+. ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 85 GGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999754 24788899999999999999999998 99999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCccccCccccCCCCCCCcchhHHHHH
Q 006886 491 ------------------------------------------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGV 522 (627)
Q Consensus 491 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gv 522 (627)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 01234788999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 006886 523 LLLEMLTGKAPLQHS 537 (627)
Q Consensus 523 vl~el~tg~~p~~~~ 537 (627)
++|||++|+.||...
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=281.35 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|.|+.||++.. .+|+.+|+|++... ....+++++|+.+-+.+ +||||+++...+.+....++|+|+|+|
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccc
Confidence 57799999999999874 46889999887533 33677889999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~ 491 (627)
|+|..-+-.. ...++..+-..+.||+.+|.|+|..+ |||||+||+|+++.. ..-+|++|||+|..++..
T Consensus 95 ~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 95 GELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred hHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9997766543 34788888999999999999999998 999999999999954 345799999999988743
Q ss_pred C---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 T---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. ...||++|||||+....+|+..+|||+.||+||-|+.|..||.+.+... ...++. ...+|.....
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~-----~g~yd~~~~~ 235 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIK-----AGAYDYPSPE 235 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHh-----ccccCCCCcc
Confidence 3 3568999999999999999999999999999999999999998643221 112222 2223333334
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
+....++.+. ++++|+..||.+|.|+.|.+++-+
T Consensus 236 w~~is~~Ak~---LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 236 WDTVTPEAKS---LIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred cCcCCHHHHH---HHHHHhccChhhhccHHHHhCCch
Confidence 4555666665 555999999999999999876543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=291.92 Aligned_cols=241 Identities=24% Similarity=0.394 Sum_probs=196.1
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|..++ ++.+++|.+..... .+++.+|+++++.+ +|+|++++++++......++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4679999999999999764 78999999865433 67899999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----C
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----T 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~----~ 493 (627)
.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99997532 46899999999999999999999998 9999999999999999999999999988764332 2
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||||+++|+|++|+.||......... .. .... .. . ......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~-~~----~---~~~~~~ 223 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNK-PP----P---TLSDPE 223 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccC-CC----C---CCCchh
Confidence 33678899999998889999999999999999999999999754321100 00 0000 00 0 001111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 222456778889999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.64 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|++++..+ +|+||+++++.+.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 478999999999999965 58899999986532 2345678899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 85 GGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999754 35788889999999999999999998 99999999999999999999999999753210
Q ss_pred --------------------------------------------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHH
Q 006886 491 --------------------------------------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLE 526 (627)
Q Consensus 491 --------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~e 526 (627)
.....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 012357889999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 006886 527 MLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP---KMDDVVRM 603 (627)
Q Consensus 527 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~ev~~~ 603 (627)
|++|+.||...... .....+.. +.... .......... ++.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~------~~~~~i~~--~~~~~---~~~~~~~~s~---~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPA------ETQLKVIN--WETTL---HIPSQAKLSR---EASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHH------HHHHHHhc--cCccc---cCCCCCCCCH---HHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999754321 11111110 00000 0001111222 3344555655 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.15 Aligned_cols=241 Identities=19% Similarity=0.279 Sum_probs=187.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|.+.... ...+.+..|++++..+ +||||+++++++.+++..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 468999999999999976 57899999986432 2344577888998888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999643 3788899999999999999999998 999999999999999999999999999876432
Q ss_pred ---CCCCCCccccCccccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ---TTATRTIGYRAPEVTETR----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.+..||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+........
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---- 267 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLN---- 267 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccC----
Confidence 244589999999998653 378899999999999999999999975421 111222221111000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPD--SRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPs~~ev~~~ 603 (627)
....... ...+.+++.+|+..++. .||++.|++++
T Consensus 268 -~p~~~~~---s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 -FPEDVEI---SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -CCCcccC---CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011111 23345566688875554 38999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.71 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=193.5
Q ss_pred ccCcCCceeEEEEEecC-------CcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 341 VLGKGSYGSTYKAILED-------GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.||+|+||.||+|..++ +..+|+|.+.... ....++.+|+++++.+ +||||+++++++...+..++|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998653 2578999876543 3456788999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-----CeEEeeccc
Q 006886 412 MPAGSLFMLLHRNRSD--GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-----NGCISDVGL 484 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-----~~ki~DfG~ 484 (627)
+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999754221 2245789999999999999999999988 99999999999999887 899999999
Q ss_pred ccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 485 AHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 485 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
++...... ....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHHhcCC-
Confidence 87653221 2234578999999998899999999999999999998 99998643211 1111111110
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.+ ... ......+.+++.+||..+|.+||++.++++.|++
T Consensus 231 ---~~----~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---RL----QKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---cc----CCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 001 1123456788889999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=295.90 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=198.3
Q ss_pred hcccCcCCceeEEEEEec-----CCcEEEEEEecccccC--HHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-----DGTTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~ 409 (627)
.+.||+|+||.||++.+. ++..||||.+...... .+.|..|+++++.+ .|+||+++++++.. ....++|+
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEE
Confidence 478999999999999854 3678999999765543 67899999999999 99999999999877 55789999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+....
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999997643 25899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCC-------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CHHHHHHHHhh
Q 006886 490 FPTT-------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV--------DLPRWVRSVVR 554 (627)
Q Consensus 490 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~ 554 (627)
.... ..++..|+|||...+..++.++||||||+++|||++|+.|+......... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3211 12345699999998889999999999999999999999998653221100 00001111111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
... ..........++.+++.+||..+|++|||+.||+++|+++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 100 0001112235678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=298.56 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=193.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.. +++.|++|.+.... ...+.+.+|++++..+ +|+|++++++.+......++|+||+++++
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 367999999999999954 68899999886543 3356788899999988 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++... .+++.+...++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... .
T Consensus 104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 99998642 4789999999999999999999998 999999999999999999999999998765332 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... .. .. ...
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~-----~~---~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TP-----EL---QNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CC-----CC---CCc
Confidence 2357789999999988889999999999999999999999997543211 111111110 00 00 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++||++.|++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1223456778889999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.55 Aligned_cols=247 Identities=22% Similarity=0.396 Sum_probs=195.6
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||++..+ ++..||+|.+..... ..+++.+|++++.++ +|||++++++++...+..++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEe
Confidence 467999999999999864 467899999875432 346788999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 411 YMPAGSLFMLLHRNRS-----------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
|+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecC
Confidence 9999999999975321 11235788999999999999999999998 999999999999999
Q ss_pred CCCeEEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHH
Q 006886 474 DLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLP 546 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~ 546 (627)
++.++|+|||++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||.+... .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------~ 239 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------E 239 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------H
Confidence 999999999998765322 12223567999999988899999999999999999998 8888864322 1
Q ss_pred HHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
+...... ...... .......++.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 ~~~~~~~-~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVR-DGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHh-cCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1121111 111100 001123467778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.57 Aligned_cols=240 Identities=21% Similarity=0.301 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|++|.||++... +++.||+|.+..... ..+.+.+|++++.++ +||||+++++++..++..++|+||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEE
Confidence 478999999999999864 689999998864321 124678899999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++++|.+++... ..+++....+++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 86 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999998754 34888999999999999999999998 999999999999999999999999998765321
Q ss_pred -------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 -------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~----- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNP----- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCC-----
Confidence 1234567899999999888999999999999999999999999643211 1111111110000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........+.+++.+||..+|.+|||+.|++++
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011223356678889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=296.53 Aligned_cols=245 Identities=27% Similarity=0.485 Sum_probs=193.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHH---HHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKR---EFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||++... +++.||+|.+........ ....|+.++.++ +||||+++++++......++||||+++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccccccccccccc
Confidence 478999999999999976 466899999976543332 234589999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----C
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----F 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~----~ 490 (627)
++|.+++... ..+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||.+.... .
T Consensus 83 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999843 35899999999999999999999998 9999999999999999999999999987531 1
Q ss_pred CCCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 PTTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....++..|+|||++. +..++.++||||+|+++|+|++|..||...... +............ .... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~-----~~~~---~ 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRP-----LPSS---S 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTH-----HHHH---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhccccc-----cccc---c
Confidence 23345788999999998 888999999999999999999999999854110 1111111111100 0000 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111112577888899999999999999999763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=292.85 Aligned_cols=244 Identities=23% Similarity=0.481 Sum_probs=195.2
Q ss_pred hcccCcCCceeEEEEEec-C---CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-D---GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|... + +..+|+|.++.... ..+.+..|++++.++ +||||+++++++..++..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcC
Confidence 478999999999999864 2 33799998865432 245788999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++++|.+++.... ..+++.+...++.|++.|+.|||+.+ ++||||||+||+++.++.++++|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999997542 35899999999999999999999998 9999999999999999999999999998764322
Q ss_pred C-------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 493 T-------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 493 ~-------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ..++..|+|||++.+..++.++||||||+++||+++ |+.||......+ . ..... +...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~~-~~~~------ 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKAIE-EGYR------ 227 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHHHh-CCCc------
Confidence 1 112457999999998889999999999999999887 999997543211 1 11111 1100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
..........+.+++.+|++.+|.+||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000111234567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.99 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=184.7
Q ss_pred ccCcCCceeEEEEEecCCc---EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILEDGT---TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~~~---~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||.||++...++. .+++|.+.... ...+.+.+|+.++..+ +||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999854433 45666665432 2346788999999998 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----- 490 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----- 490 (627)
+|.+++++.... ....++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999864321 234677788899999999999999988 99999999999999999999999999864321
Q ss_pred -CCCCCCCccccCccccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 491 -PTTATRTIGYRAPEVTET-------RKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .........+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-cccc
Confidence 123346788999998743 245789999999999999997 5677754321 22222222221 1122
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.++.+.. ... ..+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~--~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL--PYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC--CCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222211 112 34556777899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=299.38 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=194.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++... ++..+|+|.+..... ...++.+|++++.++ +||||+++++++..++..++|+||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 467999999999999965 578889998764322 235688899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--C
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--T 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~ 492 (627)
+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++...... .
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 999999754 3588999999999999999999974 5 999999999999999999999999998765332 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc-------------
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA------------- 559 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 559 (627)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+...........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCc
Confidence 3457889999999988889999999999999999999999986432111 111110000000000
Q ss_pred -------cccchhhhc-CCC--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 560 -------EVFDVELLK-YQD--VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 560 -------~~~d~~l~~-~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
+..+..... .+. ......++.+++.+|+..+|++||++.+++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000000000 000 0012235778889999999999999999988744
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.10 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=199.6
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
..+.||+|+||+||++... +++.||+|++.... ...+.+..|++++..+ +||||+++++++...+..++|+||+++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCC
Confidence 3578999999999999965 58889999876542 2356789999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
++|..++... ..+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 9999998753 358999999999999999999997 45 999999999999999999999999998755322
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-----CCHHHHHHHHhhhcccccccchhh
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-----VDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....++..|+|||++.+..++.++|||||||++||+++|+.||......+. ..+..+......+... .+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 233 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------RL 233 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC------CC
Confidence 234578899999999888899999999999999999999999985432211 1111222222111100 00
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
...+...++.+++.+|+..+|++|||+.|++++..-++
T Consensus 234 ----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 234 ----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01113345778888999999999999999998755544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=301.39 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=199.7
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|.||.||+++.+. |+.+|+|.+.+... ......+|+++|+++..||||+.+.+.|++.+..++|||++.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 679999999999999774 99999999976532 3468999999999996699999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC----CCeEEeecccccccCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD----LNGCISDVGLAHLINF 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~DfG~a~~~~~ 490 (627)
|.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++.....
T Consensus 121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999764 2899999999999999999999998 9999999999999654 4799999999998876
Q ss_pred C---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 491 P---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 ~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
. ....||+.|+|||++....|+..+||||+||++|.|+.|.+||.+....... ..+..... +....
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~~~~-----~f~~~ 260 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILRGDF-----DFTSE 260 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHcCCC-----CCCCC
Confidence 2 3456999999999999999999999999999999999999999875433211 12222211 11112
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+....+.+ -+++..|+..||.+|+|+.+++++
T Consensus 261 ~w~~is~~a---kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 261 PWDDISESA---KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CccccCHHH---HHHHHHhcccCcccCCCHHHHhcC
Confidence 233334444 456669999999999999999985
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.97 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=188.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++... .++.||||... ...+.+|+++++++ +|+||+++++++...+..++|+|++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 467999999999999976 47889999642 23467899999999 99999999999999999999999994 689
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC------
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP------ 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~------ 491 (627)
..++.... ..++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 88886532 36899999999999999999999998 999999999999999999999999999865322
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-CCCCHHHHHHHHhhhccc-cccc----chh
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD-DVVDLPRWVRSVVREEWT-AEVF----DVE 565 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~----d~~ 565 (627)
....||..|+|||++.+..++.++|||||||++|||++|..|+...... ........+..++..... ...+ ...
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 1235789999999999999999999999999999999988765432211 111111111111111000 0000 000
Q ss_pred h------------h-c--CCChH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 566 L------------L-K--YQDVE---EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 566 l------------~-~--~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ . . ..... .....+.+++.+||+.||.+|||+.|++++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 0 00000 111256678889999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.33 Aligned_cols=187 Identities=25% Similarity=0.366 Sum_probs=159.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||.||++... +|..||+|++.... .....+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEE
Confidence 478999999999999965 58899999986532 2345678899999999 9999999999986543 46899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999965 56666642 3788889999999999999999998 999999999999999999999999999765
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
... ....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 332 2345788999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.94 Aligned_cols=243 Identities=19% Similarity=0.303 Sum_probs=191.0
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
..+.||+|+||.||++... ++..+++|.+.... ...+.+..|++++..+ +|||++++++++...+..++|+||+++|
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 3577999999999999976 47788888886432 2345688899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 88 AVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999888653 236899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....++..|+|||++. +..++.++|||||||++|||++|+.||...... ............ . .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~-----~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP-T-----L 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCCC-C-----C
Confidence 2345788999999973 345788999999999999999999998753211 111111111100 0 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ...++.+++.+||..+|.+||++.+++++
T Consensus 229 ~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQPSR---WSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 12356678889999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=304.60 Aligned_cols=182 Identities=22% Similarity=0.348 Sum_probs=157.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|+.. ++..||+|..... ....|+.++.++ +|+||+++++++...+..++|+||+. |+|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 578999999999999976 4678999975432 235688899999 99999999999999999999999994 688
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---CCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TTA 494 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~~~ 494 (627)
..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 144 ~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 144 YTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 8888653 246899999999999999999999998 999999999999999999999999999754322 234
Q ss_pred CCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 495 ~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
.||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5789999999999999999999999999999999865554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=307.86 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=200.7
Q ss_pred HHhcccCcCCceeEEEEEec--CCc--EEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 337 ASAEVLGKGSYGSTYKAILE--DGT--TVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
...|+||+|.||.|++|.|. +|+ .||||.++.... ...+|.+|+.+|.++ +|+|+++++|...+ ....+|+|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhh
Confidence 44688999999999999976 343 589999987643 568899999999999 99999999999877 67789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
.++.|+|.+.|++.. ...+-......++.|||.||.||.+++ +|||||.++|+|+.....+||+|||+.+.+..
T Consensus 191 LaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999998732 356788888999999999999999998 99999999999999999999999999998865
Q ss_pred CCCC-------CCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 PTTA-------TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ~~~~-------~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.... .-...|.|||.+....++.++|||+|||++|||+| |+.||-+.....+ + +.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------L------~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------L------KNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------H------Hhc
Confidence 4321 12467999999999999999999999999999999 8889876432211 1 111
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
| .-........+.+++.++++.||..+|++|||+..|.+.+
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2 1112233456777899999999999999999999998543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=310.35 Aligned_cols=236 Identities=19% Similarity=0.255 Sum_probs=182.5
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
||+|+||+||+|+.+ +++.||+|++..... ....+..|..++.... +||||++++..+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 589999999864321 1223445666666554 799999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999998753 35899999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 PTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~-------~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKV-------RFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCC-------CCCC-
Confidence 1234588999999998754 479999999999999999999999975321 111111111110 0000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRP----KMDDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RP----s~~ev~~ 602 (627)
... ...+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~~~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVL---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccC---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 011 22445677899999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.93 Aligned_cols=253 Identities=17% Similarity=0.272 Sum_probs=185.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhc-----cCCCeeeeeeEEeeC-CceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVVPVRAYYYSK-DEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~-~~~~lv~e~ 411 (627)
.+.||+|+||+||+|... .++.||||+++......+++..|++++..+. .|.+++.+++++... ...++|+|+
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 468999999999999965 5788999999754444456677777777762 344588888888764 467888888
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCC---------------
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDL--------------- 475 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~--------------- 475 (627)
+ +++|.+++.+. ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 7 77898888754 3589999999999999999999984 7 99999999999998765
Q ss_pred -CeEEeecccccccCC-CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh
Q 006886 476 -NGCISDVGLAHLINF-PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553 (627)
Q Consensus 476 -~~ki~DfG~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 553 (627)
.+||+|||.+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+....
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~ 361 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL---HLMEKTL 361 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHc
Confidence 489999998865433 23456899999999999999999999999999999999999999764322111 1111100
Q ss_pred h---hccc--------ccc----------cchh-h---hcCCCh--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 554 R---EEWT--------AEV----------FDVE-L---LKYQDV--EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 554 ~---~~~~--------~~~----------~d~~-l---~~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ..+. .+. .++. + ...... ......+.+++.+||..||++|||++|++++
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0 0000 000 0000 0 000000 0112456789999999999999999999873
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=299.61 Aligned_cols=193 Identities=23% Similarity=0.425 Sum_probs=158.4
Q ss_pred cccCcCCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE---DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~ 414 (627)
..||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++..+ +||||+++++++.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999965 35689999886533 345678899999999 99999999998854 4567899999864
Q ss_pred CCHHHHhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----cCCCCeEEeeccccc
Q 006886 415 GSLFMLLHRNRS----DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL----TQDLNGCISDVGLAH 486 (627)
Q Consensus 415 g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfG~a~ 486 (627)
+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 78777753321 12235889999999999999999999998 9999999999999 566789999999998
Q ss_pred ccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 487 LINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 487 ~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
..... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76432 12346888999999876 457999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=313.13 Aligned_cols=258 Identities=19% Similarity=0.310 Sum_probs=185.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--------CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--------DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~lv~ 409 (627)
.+.||+|+||.||+|... +++.||||++... .....+|+.+++.+ +||||+++.+++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 478999999999999965 5889999988543 23345789999999 999999998887532 1356899
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeeccccccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLI 488 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~ 488 (627)
||+++ +|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 99975 77777654321 2346899999999999999999999998 99999999999999765 6999999999866
Q ss_pred CCC---CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc--cc
Q 006886 489 NFP---TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE--VF 562 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 562 (627)
... ....+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+ .+..... ......... ..
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~~~~~~~ 298 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTEDQLKEM 298 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCHHHHHHh
Confidence 432 23457889999999865 468999999999999999999999997643211 1111110 000000000 00
Q ss_pred chhh-----h--cCCCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhc
Q 006886 563 DVEL-----L--KYQDV-----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQ 608 (627)
Q Consensus 563 d~~l-----~--~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~ 608 (627)
.+.. . ..... .....++.+++.+||..+|.+|||+.|++++ +..+.
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000 0 00000 0112457788889999999999999999964 44443
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=294.98 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=191.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEe-----eCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYY-----SKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~-----~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||++..+ +++.+|+|.+........++..|+.++..+.+|+||+++++++. .++..++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 467999999999999865 57899999886544445678889999999977999999999884 345689999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.++++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998864321 2346889999999999999999999988 999999999999999999999999998765432
Q ss_pred ---CCCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 ---TTATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....++..|+|||++.. ..++.++|||||||++|||++|+.||....... . ..... ........+
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~~~-~~~~~~~~~ 251 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFKIP-RNPPPTLHQ 251 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhhcc-ccCCCcccC
Confidence 23357889999998753 457889999999999999999999997542211 0 00000 000000001
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
+ ......+.+++.+||+.+|++|||+.|++++.
T Consensus 252 ~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 252 P--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred C--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 11123577788899999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.22 Aligned_cols=192 Identities=25% Similarity=0.390 Sum_probs=161.6
Q ss_pred hcccCcC--CceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKG--SYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.++||+| +|++||++..+ +|+.||+|++..... ..+.+..|+++++.+ +||||+++++++..++..++|+||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 3679999 68899999864 689999999875432 234577788999888 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999975422 34899999999999999999999998 99999999999999999999999986543211
Q ss_pred ---------CCCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 491 ---------PTTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 491 ---------~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 112234667999999875 46899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=308.23 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-----ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-----EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 409 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++..+ +|+||+++++++...+ ..++|+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEe
Confidence 478999999999999964 68999999986532 2345688899999999 9999999999998766 789999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+. ++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9996 5788877543 35899999999999999999999998 9999999999999999999999999997654
Q ss_pred CC-----CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh--------
Q 006886 490 FP-----TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE-------- 555 (627)
Q Consensus 490 ~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 555 (627)
.. ....++..|+|||++.+. .++.++|||||||++|||++|+.||......+.. ..+......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHH
Confidence 32 123467889999998764 5789999999999999999999999765322111 000000000
Q ss_pred -------cccccccc-hhhhc-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 -------EWTAEVFD-VELLK-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 -------~~~~~~~d-~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........ +.... .....+...++.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 00000 00001113456788889999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=296.88 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeC-----CceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSK-----DEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~l 407 (627)
.+.||+|+||.||+|..+ +++.||+|.++... .....+.+|++++..+. +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 367999999999999965 68899999886432 12345667777777664 699999999988642 34789
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|+||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 9999974 8988887542 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---hhccccc-
Q 006886 488 INFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV---REEWTAE- 560 (627)
Q Consensus 488 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 560 (627)
.... ....++..|+|||++.+..++.++||||+||++|||++|++||......+ .+........ ...+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCcccc
Confidence 6432 23346888999999988899999999999999999999999996542211 1111110000 0000000
Q ss_pred -----ccchhhhc--CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 -----VFDVELLK--YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 -----~~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+.+.... ....++...++.+++.+|++.||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00001122356788889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=294.15 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=195.4
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|...+ ...|+||...... ...+.+..|+.+++++ +||||+++++++.+ +..++|+||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcC
Confidence 4789999999999998653 2468999876543 2345788999999999 89999999998865 4578999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999997542 35899999999999999999999988 9999999999999999999999999987654322
Q ss_pred C-----CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 T-----ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 ~-----~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
. ..++..|+|||.+....++.++||||||+++||+++ |+.||......+ . ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~~~~~~~-------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---IGRIENGERL-------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHcCCcC--------
Confidence 1 123457999999988889999999999999999986 999997543221 1 1111111100
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
... ......+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 PMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 001 122345777888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=289.13 Aligned_cols=246 Identities=22% Similarity=0.405 Sum_probs=196.2
Q ss_pred hcccCcCCceeEEEEEecC-Cc----EEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED-GT----TVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|..++ |. .+|+|.+..... ...++.+|++.++++ +|+|++++++++.. ...++|+||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEec
Confidence 4789999999999998653 33 589998865532 345788999999999 99999999999887 788999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.++.....
T Consensus 90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999997643 34899999999999999999999988 999999999999999999999999999876532
Q ss_pred CC------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 TT------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~~------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.. ..++..|+|||.+....++.++||||||+++||+++ |+.||...... ... ........ .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~-~~~~~~~~---~-- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIP-DLLEKGER---L-- 230 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHH-HHHhCCCC---C--
Confidence 21 112457999999988889999999999999999998 99999754211 111 11111100 0
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.....+...+.+++.+||..+|.+||++.++++.|+++...
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00011223567788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.28 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=187.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|++.... ...+.+..|++++..+ +||||+++++.+......++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 578999999999999976 57899999986432 2234577888888888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999998643 3788888999999999999999998 999999999999999999999999999866432
Q ss_pred ---CCCCCCccccCccccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ---TTATRTIGYRAPEVTETR----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
....||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---- 267 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT---- 267 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc----
Confidence 234589999999998653 378999999999999999999999975321 122222221111100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDS--RPKMDDVVRMI 604 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~L 604 (627)
....... ...+.+++.+|+...+.+ ||+++|++++.
T Consensus 268 -~~~~~~~---s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 -FPDDNDI---SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CCCcCCC---CHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111112 234456677888744433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.37 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=193.0
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||++.. .+++.||+|.+.... ...+.+..|+.+++.+ +|+|++++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 47799999999999996 468999999986543 3346678899999988 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99998642 4788999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+++.|+|||.+.+..++.++||||||+++|++++|+.||.......... ...... .+.. ...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~~---~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPEL---QNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCCC---CCc
Confidence 2346788999999998889999999999999999999999997543211100 000000 0000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122345678889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.30 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=189.8
Q ss_pred hcccCcCCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE---DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++... .+..||+|.+... +...+|++++..+ +||||+++++++......++|||++. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 478999999999999754 3577999987542 3456899999999 99999999999999999999999985 6
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 171 ~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 171 DLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 888888432 46899999999999999999999998 9999999999999999999999999997654321
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc--c-----c-
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA--E-----V- 561 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----~- 561 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.......... . .
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 2357899999999999999999999999999999999999997654322111111111000000000 0 0
Q ss_pred -----cchhhhcCCChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 562 -----FDVELLKYQDVE------EEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 562 -----~d~~l~~~~~~~------~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
+..........+ ....++.+++.+|+..+|++|||+.|++.+=
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000 0123456788899999999999999998863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=279.07 Aligned_cols=259 Identities=20% Similarity=0.364 Sum_probs=201.9
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEE-ecCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceE
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 406 (627)
-.++|+.+-+.+.||+|+|+.|-.+. +.+|..||||++.+.. .......+|++++..-+.|+||+.++.+|+++...|
T Consensus 73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 35788888889999999999999988 6789999999997653 346678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeecc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVG 483 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG 483 (627)
+|||-|.||.|..++++.+ .+++.++.++..+|+.||.|||.+| |.|||+||+|||-.+... +|||||.
T Consensus 153 LVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999998764 5999999999999999999999999 999999999999976544 6999999
Q ss_pred cccccCCC-----------CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC----
Q 006886 484 LAHLINFP-----------TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV---- 543 (627)
Q Consensus 484 ~a~~~~~~-----------~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---- 543 (627)
++...... .+..|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||.+.-..+..
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 87544211 2345777899999863 346899999999999999999999999875433221
Q ss_pred CHHHHH----HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 544 DLPRWV----RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 544 ~~~~~~----~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
....-. -.-++++.. +..| ..+....++.++++. ..+..|+.+|-++.+++.
T Consensus 305 e~Cr~CQ~~LFesIQEGkY-eFPd---kdWahIS~eakdlis---nLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKY-EFPD---KDWAHISSEAKDLIS---NLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhccCC-cCCh---hhhHHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence 111111 111222211 1111 122334455555444 566799999999999887
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.35 Aligned_cols=240 Identities=25% Similarity=0.372 Sum_probs=193.3
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||.|+||.||+|.. .+++.|++|.+.... ...+.+.+|+++++.+ +|+|++++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 36799999999999985 468999999886543 3456788899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|..++... .+++.++..++.+++.|+.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 103 LTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99988642 4899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .......... ... + ...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~-~~~-----~---~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG-TPE-----L---QNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-Ccc-----c---CCc
Confidence 234678899999999888999999999999999999999999754321 1111111000 000 0 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1122356678889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.72 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++... +++.+|+|.++... ...+.+..|++++..+ +|+|++++.+.+..++..++|+||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 478999999999999965 68899999886432 2346788899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.... ...+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.++.....
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999887532 245789999999999999999999998 999999999999999999999999998766432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ........... ... +
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~-~--------- 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS-YKP-L--------- 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC-CCC-C---------
Confidence 234577889999999988899999999999999999999999975321 11111111111 100 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122346678889999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=299.61 Aligned_cols=248 Identities=23% Similarity=0.414 Sum_probs=194.4
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|... ++. .||+|.+..... ...++.+|+.++..+ +||||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cceeeehh
Confidence 478999999999999864 343 478888765432 234688899999999 999999999998754 46789999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999987542 35889999999999999999999998 999999999999999999999999999865432
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...++..|+|||++.+..++.++||||||+++||+++ |+.||...... .. ......... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~---~-- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EI----PDLLEKGER---L-- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCC---C--
Confidence 1 1223568999999998899999999999999999998 89998653211 11 111111110 0
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.........+.+++.+||..+|++||++.++++.|+++.....
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 0011123456788899999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=282.76 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=200.6
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
..|+-++++. .+.||.|+||+|+|-.++ .|+..|||+++.... ..+++..|.+...+-.+.||||+++|.+..++
T Consensus 59 ~~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 3444444433 277999999999999865 699999999987643 45678888888777779999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++.||.|+- +|..+......-....+++...-+|+.....||.||.+.. .|||||+||+|||++..|.+|+||||
T Consensus 137 dcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 99999999954 7766554433333457899989999999999999998764 69999999999999999999999999
Q ss_pred cccccCCCC---CCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 484 LAHLINFPT---TATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 484 ~a~~~~~~~---~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
++..+..+- ...|-..|||||.+.. ..|+-++||||+|++|||+.||+.||..-+ ++-+.+.+++.....
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPP 288 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCC
Confidence 998775432 3346677999999853 458999999999999999999999997422 233333343333322
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.-..+ ...-+....+.+++.-|+.+|..+||...++.++
T Consensus 289 ~l~~~------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFD------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCc------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11111 1222344567788889999999999999998763
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.58 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=190.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.. +++.||+|.++.... ....+.+|+.++..+ +||||+++++.+...+..++|+||+++++
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 578999999999999864 688999999865432 334577899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++... ..+++.+...++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 93 LQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99998754 35899999999999999999999998 999999999999999999999999998755322 2
Q ss_pred CCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 TATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...++..|+|||++. ...++.++|||||||++|||++|+.||........ ............ .....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~----~~~~~ 234 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQPP----KLKDK 234 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCCC----ccccc
Confidence 345788999999874 45688999999999999999999999864332110 000011110000 00000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ....+.+++.+|+..+|++||++++++++
T Consensus 235 ~~---~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 235 MK---WSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CC---CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01 12245678889999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=293.04 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e~~ 412 (627)
.+.||+|+||.||++..+ +++.+|+|.+.........+.+|+.++.++.+|||++++++++... ...++|+||+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 367999999999999964 6889999998765445667888999999987899999999998754 3578999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.++++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99999999875321 2346899999999999999999999988 999999999999999999999999998765432
Q ss_pred ---CCCCCCccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 ---TTATRTIGYRAPEVTETR-----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....++..|+|||++... .++.++|||||||++|||++|+.||...... ..+..+.... ....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~~-- 253 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFKIPRNP-PPTL-- 253 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHHHhcCC-CCCC--
Confidence 234567889999997543 3689999999999999999999999753211 1111111110 0011
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+.....+.+++.+|+..+|++||++.|++++
T Consensus 254 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 ------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1112233457788899999999999999999764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=297.89 Aligned_cols=253 Identities=18% Similarity=0.310 Sum_probs=190.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.+ +++.||+|.+.... .....+.+|++++..+ +||||+++++++...+..++|+||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 367999999999999865 57899999986432 2345677899999999 99999999999999999999999997 5
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|..++.... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 8988887542 35889999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---hcccccccc----
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR---EEWTAEVFD---- 563 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d---- 563 (627)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+ .......... ........+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccccc
Confidence 12345788999998865 457889999999999999999999997543211 1111100000 000000000
Q ss_pred --hhhhcCC--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 --VELLKYQ--D----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 --~~l~~~~--~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... . .......+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0 00112345678889999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=306.53 Aligned_cols=190 Identities=25% Similarity=0.371 Sum_probs=167.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.||+|+++... .....+..|++++..+ +|+||+++++.+.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 378999999999999965 58899999986532 2345677899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 85 GGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999754 35899999999999999999999998 999999999999999999999999998654211
Q ss_pred -------------------------------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 492 -------------------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 492 -------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 1235789999999999999999999999999999999999999
Q ss_pred CCC
Q 006886 535 QHS 537 (627)
Q Consensus 535 ~~~ 537 (627)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.77 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=190.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee------CCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS------KDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|... +++.+|+|.+........++..|+.++.++.+|+|++++++++.. ....+++|||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 468999999999999964 688999998865544556788899999998789999999999853 4567899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
+++|+|.+++...+ ...+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999997643 235788889999999999999999998 99999999999999999999999999876532
Q ss_pred ---CCCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 ---PTTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ---~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||......... .... ....
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~-~~~~---- 243 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP-RNPP---- 243 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHh-hCCC----
Confidence 22345788899999875 346788999999999999999999999653211100 0000 0000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
... ........+.+++.+||..+|.+||++.|+++
T Consensus 244 -~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 -PKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -CCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 01122346778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.52 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=191.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|...+++.+|+|.+..... ..+.+.+|+++++++ +|+||+++++++.+.+..++|+||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEec
Confidence 467999999999999988899999998864321 124578899999999 899999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 84 VPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999753 24789999999999999999999988 99999999999999999999999999875421
Q ss_pred ---------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 491 ---------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 491 ---------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....... . ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~--- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGL--- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCC---
Confidence 112346788999999998889999999999999999999999997532110 0 0000000000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.+.. . .....++.+++.+|+..+|++||++.|+++
T Consensus 227 -~~~~--~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRL--P---DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC--C---CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0 112234567888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.27 Aligned_cols=238 Identities=23% Similarity=0.341 Sum_probs=192.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... ++..||+|.+.... ...+.+..|++++.++ +||||+++++.+..++..++|+||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCC
Confidence 467999999999999865 57889999886432 2345788999999999 8999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 88 SALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 99998863 24889999999999999999999988 9999999999999999999999999987654322
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||++.+..++.++||||||+++|||++|+.||........ .. ....... +. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~~~-----~~-----~ 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKNSP-----PT-----L 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcCCC-----CC-----C
Confidence 23467789999999988899999999999999999999999864322110 00 0111100 00 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+|++.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223456788889999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.10 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=187.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||++... .++.||||++..... ..+.+.+|+.+++.+ +||||+++++++... ...++|
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEE
Confidence 478999999999999864 588999999875422 235677899999999 999999999988643 246899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++ ++..++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 999965 67666643 3788899999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---------HHHH-------H
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD---------LPRW-------V 549 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~~-------~ 549 (627)
... ....+|..|+|||++.+..++.++|||||||++|||++|+.||.+....+... ...+ +
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 443 23457889999999999899999999999999999999999997543111000 0000 0
Q ss_pred HHHhhhcc-cccccchhh-----h-c-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 550 RSVVREEW-TAEVFDVEL-----L-K-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 550 ~~~~~~~~-~~~~~d~~l-----~-~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........ ......+.. . . .........++.+++.+|+..||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000000 0 0 00001123456788899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.85 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=190.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|+++++.+ +|+|++++++.+..+...++||||+++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 467999999999999975 48899999986543 2345688899999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|..++.+.. ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 96 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 96 VDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 988876532 35899999999999999999999988 999999999999999999999999998754322 2
Q ss_pred CCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 TATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ............ +..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~------~~~- 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP------PTL- 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCCC------ccC-
Confidence 334678899999984 34568899999999999999999999865321 111111111110 000
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........++.+++.+||..+|++||+++|++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111223356778889999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.04 Aligned_cols=187 Identities=24% Similarity=0.345 Sum_probs=160.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.+ +||||+++++++... ...++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence 478999999999999965 58899999987542 2345677899999999 999999999887643 346899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++ +|..++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 999965 67777643 3788899999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
... ....+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 543 2345788999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.58 Aligned_cols=240 Identities=26% Similarity=0.407 Sum_probs=192.3
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
-+||+|.||+||.|++.+ ...+|||.+... ....+-...|+.+-+++ +|.|||+++|.+.+++..-+.||-.+||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 479999999999999765 446899988654 23445678899999999 999999999999999998999999999999
Q ss_pred HHHhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccC----C
Q 006886 418 FMLLHRNRSDGGTAL--DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLIN----F 490 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~----~ 490 (627)
.++|+.... ++ ++...-.+..||++||.|||+.. |||||||-+|||++. .|.+||+|||-++.+. .
T Consensus 660 SsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 660 SSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred HHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999986532 34 67778888999999999999998 999999999999975 6899999999887653 2
Q ss_pred CCCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 PTTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
..++.||..|||||++.. +.|...+|||||||++.||.||++||.+...... .+++-+. +. ..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGm----yK---vH 797 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGM----YK---VH 797 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcc----ee---cC
Confidence 356789999999999965 4688999999999999999999999986543211 1111111 11 01
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.+-.++-..+...++.+|+.++|.+||++.++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1222333445666888999999999999999976
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=289.72 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=190.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||+|+.+ ++..||+|+++... ...+.+.+|++++..+ +|||++++++++..++..++|+||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 367999999999999965 68899999986432 2346788899999999 89999999999999999999999997
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 83 MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 689888865432 346899999999999999999999998 999999999999999999999999998765432
Q ss_pred -CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---hhccc--ccccc-
Q 006886 492 -TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV---REEWT--AEVFD- 563 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~d- 563 (627)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .......... ...+. ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHH
Confidence 22345788999998865 457899999999999999999999997542110 0000000000 00000 00000
Q ss_pred -hhhhc--CCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 -VELLK--YQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 -~~l~~--~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ... ......++.+++.+|+..||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000 00112355678889999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=284.02 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=196.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||.++.. +++.+++|.+.... ...+++.+|+++++++ +|+||+++++++.+.+..+++|||+++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 378999999999999854 68899999876432 2346788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
|+|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999997643 246899999999999999999999998 9999999999999999999999999987664332
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+++.|+|||+..+..++.++||||||+++|||++|+.||.... .......+.......
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~----------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQGNYTP----------- 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC-----------
Confidence 3457889999999988889999999999999999999999996532 122222222111110
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.......++.+++.+||..+|++||++.|+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0012234566788899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.09 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=186.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|++.... ...+.+..|+.++..+ +|+||+++++++.+++..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCC
Confidence 478999999999999965 58899999986432 2334578888888888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 85 GGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999753 235889999999999999999999998 9999999999999999999999999987653321
Q ss_pred ----CCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 493 ----TATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 493 ----~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .......+........ +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~-~~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQ-FP 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCccc-CC
Confidence 2347899999999863 457889999999999999999999997532 1122222221110000 00
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcc--cCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCV--AKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl--~~~p~~RPs~~ev~~~ 603 (627)
+ .....++... +++.+|+ ..++..||++++++++
T Consensus 231 ~---~~~~~~~~~~---~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 P---DVTDVSEEAK---DLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---ccCCCCHHHH---HHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0111233444 4444555 4444558899999886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.48 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=192.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++..+ ++..||+|.+..... ....+.+|++++.++ +|+||+++++.+...+..++|+||++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 578999999999999976 689999998865322 245788999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--C
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--T 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~ 492 (627)
+|..++..... ...+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+|||.+...... .
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 85 SLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999875321 23689999999999999999999974 5 999999999999999999999999998765332 2
Q ss_pred CCCCCccccCccccCCCC------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 TATRTIGYRAPEVTETRK------ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...++..|+|||++.+.. ++.++|||||||++|||++|+.||...... ........... ....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~-~~~~------- 228 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVD-GDPP------- 228 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhh-cCCC-------
Confidence 334678899999985543 478999999999999999999999753211 11111111111 0000
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........++.+++.+|+..+|++||++.+++.+
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0111233456678889999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=284.22 Aligned_cols=241 Identities=24% Similarity=0.436 Sum_probs=192.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++.++ +|||++++++++..+ ..++|+||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 57899999999999975 4788999998653 2456788999999999 999999999998654 578999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-CCCCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRT 497 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-~~~~t 497 (627)
+++.... ...+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... ....+
T Consensus 87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 9997542 245889999999999999999999988 9999999999999999999999999987654322 22335
Q ss_pred ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHH
Q 006886 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEM 576 (627)
Q Consensus 498 ~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 576 (627)
..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ...... + ......
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~---~-------~~~~~~ 223 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECV-EKGYRM---E-------PPEGCP 223 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHH-hCCCCC---C-------CCCcCC
Confidence 67999999988899999999999999999998 9999875422 1111111 111100 0 001123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 577 VQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 577 ~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
..+.+++.+||+.+|++||++.++++.|++
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 456678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=288.36 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=192.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|++++.++ +|+|++++++++......++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH 84 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCc
Confidence 367999999999999976 58899999886432 2345678999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|..+.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 85 TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 9888776532 34899999999999999999999988 9999999999999999999999999998764432
Q ss_pred --CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-HHHHHHHHhh--------hccccc
Q 006886 493 --TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD-LPRWVRSVVR--------EEWTAE 560 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~ 560 (627)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.+....+... +......... ......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 2346778999999865 567899999999999999999999997543221100 0000000000 000000
Q ss_pred ccchhhhcCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+........ ......+.+++.+||+.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000 1113456788899999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=287.97 Aligned_cols=241 Identities=25% Similarity=0.356 Sum_probs=188.2
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..||+|+||.||+|... ++..|++|.+.... ...+.+.+|++++..+ +|+||+++++++...+..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 57999999999999955 57789999886543 2456788999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCCC---
Q 006886 418 FMLLHRNRSDGGTAL--DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~~--- 491 (627)
.+++.... ..+ ++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||.+......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99997542 224 78888999999999999999998 999999999999986 679999999998765321
Q ss_pred -CCCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 -TTATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....++..|+|||++... .++.++||||||+++|+|++|+.||........ ..+....... .+..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-------~~~~-- 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI-------HPEI-- 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc-------CCCC--
Confidence 223467899999998654 378999999999999999999999975322110 0000000000 0000
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......++.+++.+||+.+|.+|||+.|++++
T Consensus 234 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 ---PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01122346678889999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.23 Aligned_cols=247 Identities=22% Similarity=0.384 Sum_probs=194.1
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccccC--HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|+.+ +...|++|.+...... .+++..|+++++++ +|+||+++++++.+.+..++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEE
Confidence 367999999999999964 2467999988654332 46789999999999 99999999999999889999999
Q ss_pred cCCCCCHHHHhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDG----GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
|+++|+|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999997654211 125899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCC-----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 487 LINFP-----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 487 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
..... ....++..|+|||.+.+..++.++||||||+++|++++ |..||...... ..+....... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~~~~~-~~~ 238 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRLQAGK-LEL 238 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHHHcCC-cCC
Confidence 54321 12234667999999988888999999999999999999 88888643211 1111111111 000
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.........+.+++.+|+..+|++||++.|++..|.
T Consensus 239 ---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 ---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000112235777888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.26 Aligned_cols=247 Identities=19% Similarity=0.339 Sum_probs=193.4
Q ss_pred hcccCcCCceeEEEEEecC--CcEEEEEEecccc-----------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce
Q 006886 339 AEVLGKGSYGSTYKAILED--GTTVVVKRLREVA-----------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK 405 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 405 (627)
.+.||+|+||.||+|..+. ++.+|+|.+.... ....++..|+.++.+..+||||+++++++..++..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999764 6789999875321 11244667888777655999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
++||||+++++|.+++..... ....+++..+++++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|||.
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999998864321 23468999999999999999999996 55 99999999999999999999999999
Q ss_pred ccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 485 AHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 485 a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
+...... ....++..|+|||...+..++.++||||||+++|||++|+.||.... .............. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEAVYE-PL 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhhccCC-cC
Confidence 9766443 23446788999999998889999999999999999999999986432 11111111111110 00
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
. .......+.+++.+||+.+|++||++.|+..+++
T Consensus 234 ------~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 ------P---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------C---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0012245677888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=286.74 Aligned_cols=238 Identities=23% Similarity=0.336 Sum_probs=194.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... ++..||+|.+.... .....+..|++++.++ .|+||+++++.+.++...++||||+++|
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 467999999999999965 58899999886432 2345788899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 88 SALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999998642 4788899999999999999999988 9999999999999999999999999997654322
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...++..|+|||++.+..++.++||||||+++|||++|+.||......... .. ...... ...
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~~~----------~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL-IPKNNP----------PTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh-hhcCCC----------CCC
Confidence 224677899999998888999999999999999999999999754321110 00 000000 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22344567788999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.64 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=192.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||++..+ ++..||+|.+.... ...+.+..|+++++++ +|+|++++++.+..+...++||||+++++
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 577999999999999975 68899999986542 2345788999999999 79999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 89 L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 89 LDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999987542 35899999999999999999999998 999999999999999999999999998665332 2
Q ss_pred CCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 TATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
...+++.|+|||++. +..++.++||||||+++|||++|+.||...... ........... +.+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~ 229 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEP------PTLD 229 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCC------CCcC
Confidence 234788899999874 345678999999999999999999999754211 11111111100 0000
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ......+.+++.+||+.+|.+||++.+++++
T Consensus 230 ~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 QP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01 1122356678889999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=288.94 Aligned_cols=239 Identities=22% Similarity=0.359 Sum_probs=194.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||.|+||.||+|... +++.||+|.+.... .....+.+|+++++.+ +|+|++++++++.++...++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 467999999999999965 58899999986543 2345688999999999 8999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... .+++.....++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999998753 5899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....++..|+|||++.+..++.++||||||+++|||++|+.||....... ... .......... .. ..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-~~~~~~~~~~-----~~-~~ 222 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-LIPKNNPPSL-----EG-NK 222 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-HhhhcCCCCC-----cc-cc
Confidence 23446778999999998889999999999999999999999997543111 111 1111111110 00 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+.+++.+|+..+|++||++++++++
T Consensus 223 ---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 ---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 22356678889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=288.37 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=188.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++..+ +|+.||+|+++.... ...++..|+....+..+|||++++++++..++..++|+||++ |
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 367999999999999975 689999999875432 344566677765555599999999999999999999999996 6
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+|.+++...... ...+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 888888754322 35689999999999999999999987 6 9999999999999999999999999998664322
Q ss_pred -CCCCCccccCccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 -TATRTIGYRAPEVTET----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
...++..|+|||++.+ ..++.++|+||||+++|||++|+.||...... ........... ... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-----~~ 229 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP-SPQ-----LP 229 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC-CCC-----CC
Confidence 2346788999998864 45688999999999999999999999642211 11111111110 000 00
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .....++.+++.+||..+|++||++.+++++
T Consensus 230 ~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 A----EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred c----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0122356778889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=284.28 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||++... +++.+++|.+.... ...+.+.+|+++++++ +||||+++++++...+..+++|||+++++
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 367999999999999965 57889999986542 2456788999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+...... .
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 87 LQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999987642 35889999999999999999999998 999999999999999999999999998765432 2
Q ss_pred CCCCCccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 TATRTIGYRAPEVTETR---KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...++..|+|||.+... .++.++||||||+++|||++|+.||....... -........ +.+. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~-----~~~~--~~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSN-----FPPP--KL 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc-----CCCc--cc
Confidence 33467789999998776 88999999999999999999999997532111 011111110 0000 00
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........++.+++.+||..+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1112233467788899999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.94 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~ 413 (627)
.+.||+|++|.||++..+ +++.||+|++.... ...+.+..|+++++++ +|+|++++++.+... ...++|+||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccC
Confidence 478999999999999965 57889999986532 2345688899999999 899999999887644 45789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++.... ...+++.++..++.+++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999997642 245899999999999999999999998 999999999999999999999999998766432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+++.|+|||+..+..++.++||||||++++||++|+.||.... .......... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~--------- 221 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIE-GKLPP--------- 221 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHh-cCCCC---------
Confidence 23346788999999998899999999999999999999999987432 1122222111 11100
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+.+++.+|++.+|++||++.+++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011223457788889999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.98 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=186.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||++... +++.||||++.... ...+.+.+|++++..+ +||||+++++++... ...+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEE
Confidence 478999999999999864 67899999986542 2345677899999999 999999999887543 346889
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
++++ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 99 TNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred eecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 9988 7899888753 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc---cccccc
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW---TAEVFD 563 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d 563 (627)
... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.... ....... ...+..
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIM-EVVGTPSPEVLKKISS 245 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCCHHHHHhcch
Confidence 443 33457889999999876 568999999999999999999999997542111 000000 0000000 000000
Q ss_pred -------hhhhcCC--Ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 -------VELLKYQ--DV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 -------~~l~~~~--~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+.... .. ......+.+++.+|+..||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00 0011245688899999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=294.06 Aligned_cols=244 Identities=19% Similarity=0.280 Sum_probs=186.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.+|+|++.... .....+..|+.++..+ +|++|+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~ 84 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYV 84 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccC
Confidence 478999999999999976 47789999986432 1234577888888888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999997632 35899999999999999999999998 999999999999999999999999998764322
Q ss_pred ---CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 ---TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+........ +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~-~p 230 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ-FP 230 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc-CC
Confidence 1245889999999985 3467899999999999999999999997532 1222222221110000 00
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAK--VPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~ev~~~ 603 (627)
. ......+ ++.+++.+|+.. ++..|+++.|++++
T Consensus 231 ~---~~~~~s~---~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 A---QVTDVSE---DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C---ccccCCH---HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0111223 344555666644 44457899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=285.61 Aligned_cols=238 Identities=22% Similarity=0.396 Sum_probs=190.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC----------HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT----------KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
...||+|+||.||+|... +++.||+|.+...... .+.+..|++++..+ +||||+++++++...+..++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEE
Confidence 367999999999999864 5789999988643221 24578899999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999754 34888999999999999999999998 99999999999999999999999999876
Q ss_pred cCCC----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 488 INFP----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 488 ~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIG-EN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHh-cc-
Confidence 6421 1223677899999998888999999999999999999999999753211 1111100 00
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+.. .......+.+++.+||+.+|.+||++.|+++
T Consensus 228 ----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 0112245667888999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=290.69 Aligned_cols=236 Identities=22% Similarity=0.308 Sum_probs=189.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
++||+||||.||-+..+ +|+.+|.|++.+.. ..+.....|-+++.++ +.+.||.+-.+|+..+.+++|+..|+|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecC
Confidence 67999999999999865 58999999886543 3445577888899999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.-+|.... ...+++..++.+|.+|+.||.+||+.. ||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus 270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999987653 357999999999999999999999998 999999999999999999999999999887543
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||.+|||||++....|+...|+||+||++|||+.|+.||....+... .+.+...+ ......-...
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---~eEvdrr~--------~~~~~ey~~k 412 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---REEVDRRT--------LEDPEEYSDK 412 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---HHHHHHHH--------hcchhhcccc
Confidence 234789999999999999999999999999999999999999974322110 00111111 1111011123
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPK 596 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs 596 (627)
..++.+.+.+ ..+.+||++|--
T Consensus 413 FS~eakslc~---~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 413 FSEEAKSLCE---GLLTKDPEKRLG 434 (591)
T ss_pred cCHHHHHHHH---HHHccCHHHhcc
Confidence 4566666666 456899998854
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=292.67 Aligned_cols=242 Identities=23% Similarity=0.363 Sum_probs=193.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... +++.||+|.+..... ..+++.+|++++..+ +|||++++.+++...+..++|+||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 377999999999999965 689999998864321 234688899999999 89999999999999999999999996
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
|++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++........
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 57777765432 35899999999999999999999998 99999999999999999999999999987766666
Q ss_pred CCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..++..|+|||++. ...++.++||||||+++|||++|+.||..... ........... ... .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~-~~~-----~---- 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-SPT-----L---- 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcCC-CCC-----C----
Confidence 67788999999874 45688999999999999999999999864321 11111111100 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
........+.+++.+||..+|++||++.+++.+..
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 01123346778888999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=271.99 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=195.6
Q ss_pred CCCCCCCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEe
Q 006886 324 GSYFNFDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYY 400 (627)
Q Consensus 324 ~~~~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 400 (627)
+..+..++.|+.. ...||.|..|.|++++.+ .|...|||.+..... ..+.+...+.++..--..|.||+.+|||.
T Consensus 84 g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 84 GQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred CcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 4445667788743 478999999999999976 488999999976543 23456666666655436899999999999
Q ss_pred eCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 401 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
.+...++.||.|.. -...++.+.+ .++++...-++...+..||.||.+++ .|+|||+||+|||+|+.|++|+|
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 99999999999854 4566665543 46888888899999999999998876 59999999999999999999999
Q ss_pred ecccccccCCCC---CCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 481 DVGLAHLINFPT---TATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 481 DfG~a~~~~~~~---~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
|||++..+-++. ...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.....+ .+. ...++.
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~---ltkvln 309 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEV---LTKVLN 309 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHH---HHHHHh
Confidence 999997765433 3346788999999853 47899999999999999999999999864321 111 111222
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
++ . +.+....+ -...+.+++..|+.+|+.+||...+++++
T Consensus 310 ~e-P-----P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EE-P-----PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cC-C-----CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 1 11111111 23456778889999999999999998764
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=293.32 Aligned_cols=239 Identities=21% Similarity=0.335 Sum_probs=192.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..+ +|||++++++++...+..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999865 68999999986432 3456688899999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 988754 24889999999999999999999998 999999999999999999999999998755332 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||||+++|||++|+.||...... ...... ...... .......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~~~-----~~~~~~~-- 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRL-RDSPPP-----KLKNAHK-- 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hccCCC-----CccccCC--
Confidence 34788999999998888999999999999999999999999743211 111111 111000 0001111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+.+++.+|++.+|++||++.+++++
T Consensus 243 -~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 -ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12346678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=286.16 Aligned_cols=248 Identities=22% Similarity=0.408 Sum_probs=192.6
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ce
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EK 405 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~ 405 (627)
.+.||+|+||.||+|.+. +++.||||.+..... ..+++.+|+++++.+ +||||+++++++.... ..
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccce
Confidence 467999999999999854 367899999865432 345688899999999 8999999999886532 23
Q ss_pred EEEEecCCCCCHHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSD-GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
+++++|+++|+|..++...+.. ....+++....+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence 6889999999999887643221 1235789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 485 AHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 485 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
++...... ...++..|++||.+....++.++||||||+++|||++ |+.||...... .+ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~---~~~~~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI---YNYLIKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH---HHHHHcCCc
Confidence 88654321 2224567999999988889999999999999999999 88888643211 11 111111110
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
.. ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 234 ~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK-----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0012234678889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=282.51 Aligned_cols=242 Identities=29% Similarity=0.500 Sum_probs=195.3
Q ss_pred hcccCcCCceeEEEEEecC-----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED-----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++...+ +..||+|.+..... ..+.+..|++++..+ +|+|++++++++.+.+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence 4679999999999999764 37899999976543 456889999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999976432 12899999999999999999999998 999999999999999999999999999776433
Q ss_pred CC-----CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 492 TT-----ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 492 ~~-----~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
.. ..++..|+|||...+..++.++||||+|+++|||++ |+.||..... ........... ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~-~~~----- 224 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGY-RLP----- 224 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC-CCC-----
Confidence 11 225678999999988889999999999999999998 7888865321 11111111111 000
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.......++.+++.+|+..+|++|||+.|+++.|
T Consensus 225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111334677788899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.91 Aligned_cols=244 Identities=19% Similarity=0.262 Sum_probs=186.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|.+.... .....+..|..++..+ +|+||+.+++++.+.+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 468999999999999965 57889999986532 1234477788888887 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999997632 35889999999999999999999998 9999999999999999999999999997664322
Q ss_pred ----CCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 493 ----TATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 493 ----~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
...|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+........ +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~-~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ-FP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc-CC
Confidence 2358899999999865 4678999999999999999999999975321 111222211110000 00
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDS--RPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~ 603 (627)
........++.+++.+|+...+.+ |+++++++++
T Consensus 231 ------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 ------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011111234555666777765543 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=293.30 Aligned_cols=240 Identities=21% Similarity=0.348 Sum_probs=191.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
...||+|+||.||++... ++..||||.+.... ...+.+..|+.++..+ +|+|++++++.+...+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 367999999999999864 58899999886432 2345688899999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++... .+++.....++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++...... .
T Consensus 106 L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 106 LTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99988532 4789999999999999999999998 999999999999999999999999998755322 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||+..+..++.++||||||+++|||++|+.||...... ..... .... +.......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~-----~~~~~~~~--- 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRR-IRDN-----LPPRVKDS--- 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhc-----CCCccccc---
Confidence 234678899999998888999999999999999999999999743211 11111 1111 01111011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+|+..+|.+|||++|++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122345667789999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=282.32 Aligned_cols=241 Identities=22% Similarity=0.404 Sum_probs=195.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++... +++.||+|.+.... ...+++.+|+++++++ +|+||+++.+++...+..++|+||+++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEG 83 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCC
Confidence 478999999999999854 68899999986432 2345788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++.... ...+++....+++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 84 GDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999987542 235789999999999999999999998 9999999999999999999999999997664322
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...++..|+|||+..+..++.++||||||+++++|++|+.||.... ....+..........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~----------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSYPP----------- 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCCCC-----------
Confidence 2346788999999988889999999999999999999999986432 222222222211100
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......++.+++.+|++.+|++||++.||+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223457778889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=287.07 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=193.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~e~ 411 (627)
.+.||+|+||.||+|..+ +++.+++|.+.......+.+..|++++.++.+|+||+++++++.... ..++||||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 478999999999999975 57889999987665566789999999999978999999999997644 47899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999999875431 1346899999999999999999999998 999999999999999999999999998765332
Q ss_pred ----CCCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 ----TTATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ......... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~--- 236 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPRN-PPP--- 236 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhcc-CCC---
Confidence 23346788999998753 34678999999999999999999999643211 111111110 000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...........+.+++.+|+..||++|||+.|++++
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 011112234467788889999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=288.88 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=188.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++.++..|+||+++++++...+..++++||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 478999999999999965 58999999986543 23456888999999996699999999999999899999999864
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++.++...........+++....+++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 555443221111124689999999999999999999975 6 999999999999999999999999998765332
Q ss_pred CCCCCCccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 TTATRTIGYRAPEVTETR---KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....++..|+|||++.+. .++.++||||||+++|||++|+.||.... .............. +.+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------~~~~- 232 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------PILS- 232 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------CcCC-
Confidence 233567889999998765 68999999999999999999999996432 11111111111100 0010
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........++.+++.+|+..+|++|||+++|+++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111233467788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.82 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=194.5
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~~ 414 (627)
+.||.|++|.||++..+ +++.+|+|.+..... ....+.+|+++++++ +||||+++++++... ...++||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 67999999999999975 578899998865432 356788999999999 899999999998654 367899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--C
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--T 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~ 492 (627)
++|.+++..... ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 999998765322 2345888999999999999999999998 999999999999999999999999998765432 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ....+......... ... +.... ...
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~-~~~~~---~~~ 235 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMP-NPE-LKDEP---GNG 235 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCC-chh-hccCC---CCC
Confidence 3346778999999998899999999999999999999999998653211 11111111111100 000 00000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++|||+.|++++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1123456788899999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=285.70 Aligned_cols=242 Identities=20% Similarity=0.252 Sum_probs=188.4
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|... +++.||+|.+..... ....+..|..++....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999965 588999999865321 1223455555555555899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~ 494 (627)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++........
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 9999999754 35889999999999999999999998 999999999999999999999999998876555555
Q ss_pred CCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHH
Q 006886 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574 (627)
Q Consensus 495 ~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 574 (627)
.++..|+|||.+.+..++.++||||||+++|||++|..||...... ............ ... .....
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---~~~-----~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRIN---WPE-----EVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccC---CCC-----ccccc
Confidence 6788999999998888899999999999999999999999753221 111111111000 000 00011
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 575 EMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 575 ~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+.+++.+||..+|++||++.++.+.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 23456788889999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.31 Aligned_cols=235 Identities=20% Similarity=0.293 Sum_probs=185.4
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHH
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML 420 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 420 (627)
||+|+||.||++..+ ++..+|+|.+....... .|+.....+.+|+|++++++.+...+..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999964 67889999886432221 1222222233799999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCCCCCCCCcc
Q 006886 421 LHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFPTTATRTIG 499 (627)
Q Consensus 421 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~~~~~~t~~ 499 (627)
+.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.........++..
T Consensus 100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 171 (267)
T PHA03390 100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD 171 (267)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCc
Confidence 97542 6899999999999999999999998 99999999999999998 999999999988776666678899
Q ss_pred ccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHH
Q 006886 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQM 579 (627)
Q Consensus 500 y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 579 (627)
|+|||++.+..++.++||||||+++|||++|+.||......+ .....+.... .. .. .........+
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~----~~--------~~~~~~~~~~ 237 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK----KL--------PFIKNVSKNA 237 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc----cC--------CcccccCHHH
Confidence 999999998889999999999999999999999998443221 1222222111 00 00 0011223356
Q ss_pred HHHHHHcccCCCCCCCC-HHHHHH
Q 006886 580 LQIALSCVAKVPDSRPK-MDDVVR 602 (627)
Q Consensus 580 ~~l~~~Cl~~~p~~RPs-~~ev~~ 602 (627)
.+++.+|++.+|.+||+ ++|+++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 67788999999999996 588875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=315.80 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=204.7
Q ss_pred HHhcccCcCCceeEEEEEec----C----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceE
Q 006886 337 ASAEVLGKGSYGSTYKAILE----D----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 406 (627)
+..+.+|+|.||.|++|... . ...||||.++.... ..+.+..|+++|..++.|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44569999999999999843 1 45799999986644 46789999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhhcC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC
Q 006886 407 VVYSYMPAGSLFMLLHRNR---------SDGG--TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL 475 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 475 (627)
+|.||+..|+|.++++..+ .... ..+.....+.++.|||.|++||++.. +|||||.++|||++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCC
Confidence 9999999999999999876 1111 23888999999999999999999987 99999999999999999
Q ss_pred CeEEeecccccccCCCCCC-----CC--CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHH
Q 006886 476 NGCISDVGLAHLINFPTTA-----TR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPR 547 (627)
Q Consensus 476 ~~ki~DfG~a~~~~~~~~~-----~~--t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~ 547 (627)
.+||+|||+|+........ .+ ...|||||.+....|+.++|||||||+|||++| |..||.+... ...
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----~~~ 530 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----TEE 530 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----HHH
Confidence 9999999999965443221 11 346999999999999999999999999999999 8889865211 111
Q ss_pred HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
. ...++++... .....+..++.++|+.||+.+|++||++.++.+.++...
T Consensus 531 l-~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 531 L-LEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred H-HHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1 1122222211 112233557788999999999999999999999999853
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=282.95 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=192.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|..+ ++..|++|.+..... ..+.+..|++++..+ +|+|++++++++......++|+||
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEe
Confidence 367999999999999976 789999998864321 235688899999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++++|.+++... ..+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 84 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 84 VPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999754 24889999999999999999999998 999999999999999999999999998765432
Q ss_pred ---CCCCCCccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ---TTATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............... +
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~-~----- 223 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP-I----- 223 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-c-----
Confidence 2344678899999987766 89999999999999999999999975321 111111111000000 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+||..+|++||++.+++++
T Consensus 224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01112345677889999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.92 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=195.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.. ++..||+|++..... ....+..|+++++.+ +|+|++++++++..++..++|+||++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 467999999999999964 688999999864321 234688899999999 89999999999999999999999996
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
|++.+++.... ..++|.++..++.+++.|+.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 109 -g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 -GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 47877775432 35899999999999999999999998 99999999999999999999999999887766666
Q ss_pred CCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..++..|+|||++. ...++.++||||||+++|||++|+.||...... ............. .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~~----------~ 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESPT----------L 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCCC----------C
Confidence 67888999999973 456889999999999999999999998643211 1111111111000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
........+.+++.+|++.+|.+||++.++++++..+.
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 11122335677888999999999999999998766543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.06 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=188.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+.. +|+.||+|+++... .....+.+|++++..+ +|+|++++++++.+....++|+||++
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCC-
Confidence 367999999999999975 68899999986432 1235677899999999 99999999999999999999999997
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 83 QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 57888776432 35899999999999999999999998 999999999999999999999999998865432
Q ss_pred -CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc-------c--ccc
Q 006886 492 -TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE-------W--TAE 560 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~--~~~ 560 (627)
....++..|+|||++.+. .++.++|||||||++|||++|+.|+...... ......+.... + ...
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHHhCCCChHHhHHhhh
Confidence 123457889999998664 4689999999999999999999986532211 11111110000 0 000
Q ss_pred ccch-hhhcCC-------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDV-ELLKYQ-------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~-~l~~~~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+. ...... ..+....++.+++.+|++.+|.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 000000 001122455678889999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.80 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=196.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
+.||+|++|.||++..+ ++..|++|++.......+.+..|++.+..+ +|+|++++++.+...+..++|+||+++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 67999999999999976 688999999876544567788999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTA 494 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~~ 494 (627)
+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 176 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence 9998653 36899999999999999999999988 999999999999999999999999988655332 233
Q ss_pred CCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHH
Q 006886 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574 (627)
Q Consensus 495 ~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 574 (627)
.++..|+|||++.+..++.++||||||+++|+|++|+.||...... .......... ... ......
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~--------~~~~~~ 241 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKG-IPP--------LKNPEK 241 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CCC--------Ccchhh
Confidence 4678899999998888999999999999999999999998643211 1111111111 000 001111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 575 EMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 575 ~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+.+++.+|++.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 23456778889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.65 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=196.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++..+ +++.+|+|.+.... ...+++.+|+++++++ +||||+++++.+......++++||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCC
Confidence 467999999999999976 68899999887543 2345788999999999 7999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--C
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--T 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~ 492 (627)
+|.+++.... ..+++....+++.|++.|+.|||+ .+ ++|+||||+||+++.++.++|+|||.+...... .
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999998643 468899999999999999999999 77 999999999999999999999999998765322 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||++.+..++.++||||||+++|+|++|+.||...... ................. .. ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~-~~---------~~ 226 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPP-RL---------PS 226 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCC-CC---------Ch
Confidence 255778899999999889999999999999999999999999754321 11222222222211100 00 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++|||+.+++.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1123456778889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=287.41 Aligned_cols=239 Identities=18% Similarity=0.317 Sum_probs=199.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
++.||+|.|+.|-.+++- .|..||||++.+... ....+.+|+.-|+.+ +|||||+++.........|+|.|.-++
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCC
Confidence 467999999999998843 799999999977643 456788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a~~~~~~-- 491 (627)
|+|++|+-++. ..+.+..+.+++.||..|+.|+|+.+ +|||||||+||.+- +-|-+|+.|||++..+.+.
T Consensus 102 GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 102 GDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred chHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999998764 46999999999999999999999988 99999999999875 5689999999999887654
Q ss_pred -CCCCCCccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKAS-QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+.+|+..|-|||++.+..|+ +++||||+|||||-|+.|+.||+..+..+... .++|-...-.
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKYtvP 239 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKYTVP 239 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccccCc
Confidence 466789999999999999886 68999999999999999999999776544322 1223222122
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+..++|.+|+..||.+|.+.+||+..
T Consensus 240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2223344567779999999999999999763
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=291.47 Aligned_cols=243 Identities=21% Similarity=0.372 Sum_probs=192.1
Q ss_pred HHhcccCcCCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 337 ASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
...++||+||.+.||++...+.+.||+|++.... .....|..|++.+.++..|.+||++++|-..++..|+||||-
T Consensus 364 eilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G- 442 (677)
T KOG0596|consen 364 EILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG- 442 (677)
T ss_pred hHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-
Confidence 3458899999999999998888999999876543 245679999999999999999999999999999999999987
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
..+|..+|++... ....| .+..+..|++.++.++|++| |||.||||.|+|+-+ |.+||+|||+|..+..+.
T Consensus 443 d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 443 DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 4599999987532 23345 77789999999999999999 999999999999964 789999999999887654
Q ss_pred -----CCCCCccccCccccCCC-----------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 493 -----TATRTIGYRAPEVTETR-----------KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
+..||+.||+||.+... +.++++||||+|||||+|+.|+.||.. +.....+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~aK----- 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIAK----- 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHHH-----
Confidence 35699999999987532 256899999999999999999999973 2211111
Q ss_pred ccccccchhh-hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WTAEVFDVEL-LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~~~~~d~~l-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+.|+.. ..++..++. .+++++|+.|+..||.+|||..+++++
T Consensus 582 -l~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -LHAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112223311 112221111 127889999999999999999999873
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.88 Aligned_cols=240 Identities=20% Similarity=0.288 Sum_probs=183.8
Q ss_pred ccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHh--ccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 341 VLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTI--GKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.||+|+||.||++... +++.+|+|.+..... ....+..|..++..+ .+|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999965 588999998865421 122344444333333 279999999999998899999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999998754 35899999999999999999999998 999999999999999999999999998755332
Q ss_pred CCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 TTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....++..|+|||.+. +..++.++|||||||++|||++|+.||........ ......... ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT------VNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc------CCcCC----
Confidence 2345788999999986 45689999999999999999999999975432211 111111100 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
......++.+++.+|+..+|++|| +++|++++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011223566778899999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.81 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=190.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----eEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-----KLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~ 409 (627)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++..+.+|+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 367999999999999965 688999998765422 235688899999999778999999999887665 79999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeeccccccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLI 488 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~ 488 (627)
||+++ +|.+++..........+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 8988887654322356899999999999999999999998 999999999999999 899999999998765
Q ss_pred CCC----CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc--ccc--
Q 006886 489 NFP----TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE--WTA-- 559 (627)
Q Consensus 489 ~~~----~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 559 (627)
... ....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLLHIFKLLGTPTEQV 235 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHhCCCChhh
Confidence 332 12235778999998865 45789999999999999999999999753211 1111111100 000
Q ss_pred --cccch-h---hhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 560 --EVFDV-E---LLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 560 --~~~d~-~---l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+. . ..... ..+....++.+++.+|+..+|.+||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0 00000 001123456788899999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=282.07 Aligned_cols=238 Identities=21% Similarity=0.335 Sum_probs=184.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||++... ++..|++|++..... ....+.+|+++++.+ +||||+++++++... ...++++
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEE
Confidence 478999999999999865 588999998864321 224578899999999 899999999988753 5678999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 86 EYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999999753 24789999999999999999999988 9999999999999999999999999987653
Q ss_pred CC-------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FP-------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 21 123467889999999988899999999999999999999999974321 111111111110
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.+.+ .......+.+++ +||..+|++||+++|+++
T Consensus 227 ~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 011122334444 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.85 Aligned_cols=244 Identities=18% Similarity=0.257 Sum_probs=190.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.|++|.+.... ...+.+.+|++++..+ +||||+++++.+..++..++||||++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 367999999999999965 57899999886542 1235677899999998 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 85 GGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999754 35899999999999999999999998 999999999999999999999999998642110
Q ss_pred -----------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 492 -----------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 492 -----------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
....++..|+|||++....++.++||||||+++||+++|+.||.+... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 112356789999999888899999999999999999999999974321 111211111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.... .+. ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 231 ~~~~----~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE----WPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC----CCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1100 000 000122346778889999999999996655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=283.51 Aligned_cols=244 Identities=23% Similarity=0.381 Sum_probs=190.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-----------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-----------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 406 (627)
.+.||+|+||.||+|... +++.||+|.++.... ..+.+..|++++..+ +|+|++++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceE
Confidence 468999999999999854 688999998753211 123577899999999 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999754 35899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCC------CCCCCCccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 487 LINFP------TTATRTIGYRAPEVTETRK--ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 487 ~~~~~------~~~~~t~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
..... ....++..|+|||++.... ++.++||||||+++||+++|..||..... ... ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~~-~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MFKLGNKR-S 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HHHhhccc-c
Confidence 65422 1234678899999987654 78999999999999999999999863221 111 11111000 0
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...++.. ...+....+.+++.+|+..+|++||++.+++++
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111 001223466778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=317.00 Aligned_cols=250 Identities=17% Similarity=0.314 Sum_probs=190.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|+||+||++... ++..||+|.+.... .....+..|+.++..+ +||||++++++|... ...++||||+
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 478999999999999965 46788999886432 2345688999999999 999999999988653 4688999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeEecC---------------
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG----AKFTHGNIKSSNVLLTQ--------------- 473 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dlk~~NILl~~--------------- 473 (627)
++|+|.+++..... ....+++..++.|+.||+.||.|||+.+. .+||||||||+|||++.
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999975422 12468999999999999999999998542 34999999999999964
Q ss_pred --CCCeEEeecccccccCCC---CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHH
Q 006886 474 --DLNGCISDVGLAHLINFP---TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP 546 (627)
Q Consensus 474 --~~~~ki~DfG~a~~~~~~---~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~ 546 (627)
...+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-----~~~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-----NFS 250 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-----cHH
Confidence 345899999999876432 23458899999999854 458899999999999999999999997432 111
Q ss_pred HHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 006886 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQI 607 (627)
Q Consensus 547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~~ 607 (627)
..+.. +.... + + .. .....++.+++..||..+|.+||++.|++. .+..+
T Consensus 251 qli~~-lk~~p-----~--l-pi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 251 QLISE-LKRGP-----D--L-PI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHH-HhcCC-----C--C-Cc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 11111 11110 0 0 00 111245677888999999999999999985 44433
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.52 Aligned_cols=243 Identities=23% Similarity=0.402 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|++|.||++..+ +++.|++|++..... ..+.+..|++.+.++ +|+|++++++++...+..++|+||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 478999999999999976 489999999876532 457799999999999 7999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+|.+++... ..+++...+.++.|+++|+.|||+ .+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999754 358999999999999999999999 88 9999999999999999999999999988764432
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ............ ... .+ .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~-~~~-~~------~ 225 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGP-PPS-LP------A 225 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCC-CCC-CC------c
Confidence 2346778999999998889999999999999999999999997654311 111111111111 000 00 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .....+.+++.+|+..+|++||++.|++++
T Consensus 226 ~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 E--EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred c--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 023467778889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.28 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=192.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|... +++.|++|.++.... ..+.+..|++++.++ +|+||+++++.+...+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCC
Confidence 468999999999999865 688999999876543 356788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++... ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||.+.......
T Consensus 84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998753 34788999999999999999999998 9999999999999999999999999987764322
Q ss_pred ------CCCCCccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 493 ------TATRTIGYRAPEVTETRK---ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
...++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......... .. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----C
Confidence 134567899999998766 889999999999999999999999753211 011111110 00 0
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
+.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111 111334567888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.99 Aligned_cols=243 Identities=21% Similarity=0.356 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+++++++ +|+|++++++++.+.+..++|+|
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEe
Confidence 36799999999999985 4689999999864321 235788999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLIN 489 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~ 489 (627)
|+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999753 35889999999999999999999998 99999999999998776 58999999987654
Q ss_pred CC--------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 490 FP--------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 490 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
.. ....++..|+|||++.+..++.++||||+|+++|+|++|+.||....... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~--- 229 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATTA--- 229 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCCC---
Confidence 32 12346778999999988889999999999999999999999996432211 11111111100000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........++.+++.+|+..+|++||++.|++++
T Consensus 230 -------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 -------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111233467778889999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=290.75 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=190.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|++++..+ +||||+++++++..++..++|+||+++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCc
Confidence 378999999999999976 588999998865422 245688899999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|..+.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 85 TVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 9988876542 24899999999999999999999998 9999999999999999999999999987654321
Q ss_pred --CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc--cccccc-----
Q 006886 493 --TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE--WTAEVF----- 562 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----- 562 (627)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ...........- .....+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchH
Confidence 2346778999999865 457889999999999999999999986432110 000000000000 000000
Q ss_pred -----chhhhcCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 -----DVELLKYQ----DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 -----d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+...... ..+.....+.+++.+||..+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000 001123457788899999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.81 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=195.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||.|+||+||+|... ++..+++|++.... ...+.+.+|++.++.+ +|+|++++++.+...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 467999999999999954 67889999986432 2456788999999998 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++..... ...+++.....++.|++.|+.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999976422 245899999999999999999999998 9999999999999999999999999987664322
Q ss_pred -----CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 -----TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...++..|+|||++... .++.++||||||+++|||++|+.||....... ........... ..
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~------~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDPP------SL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCCC------Cc
Confidence 22467889999998766 78999999999999999999999997543211 11111111100 00
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
............+.+++.+|+..+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0001011223456788889999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.96 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=192.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||++... ++..||+|.+... ....+.+..|+.++..+ +|||++++++.+...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 478999999999999854 6789999998643 23456788899999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99998743 4788999999999999999999998 9999999999999999999999999887654322
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+++.|+|||.+....++.++||||||+++|++++|+.||.......... ....... + .....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~---~~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------P---ELQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------C---CCCCc
Confidence 2346778999999988889999999999999999999999997543221110 0000000 0 00111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||..+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122356678889999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.61 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=191.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT------KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|... +++.||||.+...... ...+..|++++..+ +|+||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEcc
Confidence 367999999999999965 6899999998754322 34567899999999 899999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+ +|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9 999999997542 35899999999999999999999998 999999999999999999999999999876443
Q ss_pred C----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---hhcc-----c
Q 006886 492 T----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV---REEW-----T 558 (627)
Q Consensus 492 ~----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~-----~ 558 (627)
. ...++..|+|||.+.+ ..++.++||||||+++|||++|..||......+ .+........ ...+ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhcccc
Confidence 1 2235678999998854 467899999999999999999988776432211 1111100000 0000 0
Q ss_pred ccccchhhhcCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLKYQ----DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
............ ........+.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 011223567788999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=283.34 Aligned_cols=238 Identities=23% Similarity=0.363 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++.+.++ +||||+++++++..++..++|+||++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 467999999999999864 68899999876432 2345788899999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|..++... .+++.....++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999998642 4889999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....++..|+|||++.+..++.++||||||+++|+|++|..||...... .......... .. .+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~-~~--------- 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKNN-PP-TL--------- 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcCC-CC-CC---------
Confidence 1234677899999998888899999999999999999999999643211 1111111110 00 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+|+..+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01123456678889999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.40 Aligned_cols=240 Identities=23% Similarity=0.361 Sum_probs=191.9
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++... +++.||+|.+..... ..+.+..|++++..+ +|+||+++++.+...+..++||||+.+
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecCC
Confidence 67999999999999976 489999999875432 335688899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++.... ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999987542 246899999999999999999999998 9999999999999999999999999986542210
Q ss_pred -------------------------------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 006886 493 -------------------------------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541 (627)
Q Consensus 493 -------------------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~ 541 (627)
...|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1245778999999998889999999999999999999999997543211
Q ss_pred CCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 006886 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK----MDDVVR 602 (627)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~ev~~ 602 (627)
.......... ...........+.+++.+|+..+|++||+ ++|++.
T Consensus 240 ------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ------TFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------HHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0111111000 00111113346777888999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=283.89 Aligned_cols=240 Identities=21% Similarity=0.353 Sum_probs=191.7
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc--cCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|.. .+++.||+|.+.... ...+++.+|+++++.+. .|||++++++++..+...++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 36799999999999996 468999999986542 23467888999999984 49999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+++|.+++... .+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998642 5899999999999999999999998 9999999999999999999999999987664322
Q ss_pred ---CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 493 ---TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .... .... ..+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~-----~~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS-----KPPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC-----CCCCCCc
Confidence 2346788999998865 456899999999999999999999997542211 1100 0000 0011100
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+||..+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0123467788889999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=288.32 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=192.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +++.||+|+++... ...+.+.+|+++++++ +|+||+++++++..++..++|+||+++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 84 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVER 84 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCC
Confidence 467999999999999976 57899999886532 2346789999999999 899999999999999999999999998
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+.+..+.... ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 85 TLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 7776655432 34899999999999999999999998 9999999999999999999999999988765432
Q ss_pred ---CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh------------hc
Q 006886 493 ---TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR------------EE 556 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~~ 556 (627)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .......... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCc
Confidence 23457789999999887 88999999999999999999999997532111 0000000000 00
Q ss_pred cc-----ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WT-----AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~-----~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ....+..............++.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000000000000001124567888999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=284.47 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||+|+.+ +++.||||++..... ....+..|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccc-
Confidence 367999999999999965 688999998864322 235788999999999 99999999999999999999999996
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|..++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 68988887542 246899999999999999999999998 9999999999999999999999999987654321
Q ss_pred --CCCCCccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch-----
Q 006886 493 --TATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV----- 564 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~----- 564 (627)
...++..|+|||++.+.. ++.++||||||+++|||+||+.||......+ ......... ........+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~ 231 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTL---GTPDEVVWPGVTSL 231 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHh---CCCChhhhhhhhHH
Confidence 223577899999886644 5889999999999999999999997532111 111111000 000000000
Q ss_pred -----hhh--cCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 -----ELL--KYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 -----~l~--~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ..... .....++.+++.+|++.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 00000 0112345678889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.89 Aligned_cols=238 Identities=21% Similarity=0.354 Sum_probs=192.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.++..+ +|+|++++++++...+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 68999999999999954 68899999886433 2345678899999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
.+++... .+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9998752 4789999999999999999999998 999999999999999999999999988754322 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||...+..++.++||||||+++|||++|+.||..... .......... .... .... .
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~~~-----~~~~---~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LPPK-----LKNL---H 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CCCC-----Cccc---c
Confidence 3477889999999888899999999999999999999999864321 1112111111 1000 0000 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12235778888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.24 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=188.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|++|.||+|..+ +++.||+|.+..... ....+.+|+++++.+ +|+||+++++++.+++..++||||+++
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 368999999999999976 688999999865422 234567899999999 999999999999999999999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 88 DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9999887542 35889999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---ccccc-------
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTAE------- 560 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~------- 560 (627)
....++..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .+........... .....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12235778999999865 45789999999999999999999999754311 0000000000000 00000
Q ss_pred ------cc-chhhhc-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 561 ------VF-DVELLK-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 561 ------~~-d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.. ...+.. .... ....++.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000000 0000 01145678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=282.96 Aligned_cols=240 Identities=21% Similarity=0.289 Sum_probs=188.4
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||+||++..+ +|+.||+|.+.... .....+..|+++++.+ +|||++++.+.+...+..++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999855 68899999986432 2244567899999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TT 493 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~~ 493 (627)
|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 80 LKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 9999976432 35899999999999999999999998 999999999999999999999999998765432 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||||+++|+|++|+.||........ ... +.... ... ... .. .
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~----~~~--~~~--~~---~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKRRT----LEM--AVE--YP---D 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHhcc----ccc--ccc--CC---c
Confidence 3456789999999888899999999999999999999999975432111 000 10000 000 000 00 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRP-----KMDDVVR 602 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 602 (627)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1123456788899999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.70 Aligned_cols=253 Identities=17% Similarity=0.219 Sum_probs=189.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|..+ +++.||+|+++.... .......|+..+.++.+|+|++++++++.+. +..++|+||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 467999999999999965 688999999875422 2334557888888886799999999999987 88999999997
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
|+|.+++.... ..++|..+..++.|++.||.|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 58888876532 36899999999999999999999998 999999999999999 999999999998764322
Q ss_pred --CCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh-----------hccc
Q 006886 493 --TATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR-----------EEWT 558 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~ 558 (627)
...++..|+|||++. +..++.++|||||||++|||++|+.||...+..+ ...+...... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccccc
Confidence 234678899999764 4567899999999999999999999997543211 1111111110 0000
Q ss_pred ccccchhhhc---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLK---YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.... ..........+.+++.+|+..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 00011234677888999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=278.33 Aligned_cols=241 Identities=20% Similarity=0.392 Sum_probs=193.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++... +++.+|+|.+.... ...+.+..|+++++++ +|||++++++.+...+..++|+||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCC
Confidence 468999999999999864 68899999986542 2345788899999999 899999999999989999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCCCC-
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~~~- 492 (627)
++|.+++.... ...+++..+.+++.+++.|+.|||+.+ ++|+||||+||+++.+ +.+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999997642 345899999999999999999999998 9999999999999865 457999999998765432
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ............. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~-~~--------- 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGTFA-PI--------- 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcCCC-CC---------
Confidence 23467889999999988899999999999999999999999965321 1112211111100 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+||..+|++|||+.|++.+
T Consensus 222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01123356678889999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.47 Aligned_cols=196 Identities=23% Similarity=0.421 Sum_probs=164.5
Q ss_pred hcccCcCCceeEEEEEec---CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE---DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|++++..+ +||||+++++++... +..++||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEE
Confidence 367999999999999965 47899999987632 2345678899999999 999999999999988 7899999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC----CCCeEEeecccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ----DLNGCISDVGLA 485 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~ki~DfG~a 485 (627)
||+++ ++.+++..........+++.....++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99975 7777776544333347899999999999999999999998 999999999999999 899999999999
Q ss_pred cccCCCC-------CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 006886 486 HLINFPT-------TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539 (627)
Q Consensus 486 ~~~~~~~-------~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 539 (627)
+...... ...++..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 8764321 2245778999998765 4578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=281.25 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=186.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---c---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---A---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||++... ++..||+|.+.... . ..+.+.+|++++.++ +||||+++++++.+. ...++|+
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEE
Confidence 478999999999999965 58899999875321 1 134678899999999 999999999988764 4577899
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.++...
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 86 EHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998753 24788899999999999999999998 9999999999999999999999999987543
Q ss_pred C-------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 F-------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
. .....++..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC-----
Confidence 2 1223467889999999888899999999999999999999999964311 111111111100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ..........+.+++.+|+ .+|++||+++|++++
T Consensus 227 ~-----~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 N-----PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred C-----CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 0 0011222345566777888 499999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=284.53 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=186.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.+ +|+||+++.+++..++..++|+||+. +
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 367999999999999865 68899999986542 2234677899999999 99999999999999999999999995 6
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
++..++.... ..+.+.....++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 88 DLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 7877765432 34788889999999999999999998 999999999999999999999999998764322
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh----------------
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR---------------- 554 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------------- 554 (627)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||+..... .+.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhc
Confidence 22345788999999875 35788999999999999999999999753211 111111000
Q ss_pred hccccccc----chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 555 EEWTAEVF----DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 555 ~~~~~~~~----d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
........ ...+............+.+++.+|+..||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000000000011235667888999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=296.61 Aligned_cols=244 Identities=20% Similarity=0.330 Sum_probs=194.7
Q ss_pred HHhcccCcCCceeEEEEEecCCcE-EEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 337 ASAEVLGKGSYGSTYKAILEDGTT-VVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+...||.|+||.||++..++... .|.|++... ....++|.-|++++..- .||+||++++.|+..+.++++.|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCC
Confidence 345679999999999999775443 456666432 23457789999999998 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc----CC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI----NF 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~----~~ 490 (627)
|-....+-.. +.++.+.++.-++.+++.||.|||++. |||||||+.|||++-+|.++++|||.+... ..
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9998887654 357999999999999999999999998 999999999999999999999999998554 34
Q ss_pred CCCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 491 PTTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 491 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
.+++.||+.|||||+.. ..+|+.++||||||++|.||..+.+|-...+. -.-+-.+. ... .+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKia-KSe-----PPT 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSE-----PPT 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHh-hcC-----CCc
Confidence 57888999999999864 46899999999999999999999999654321 11111111 111 112
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+. ........|-+++.+|+.++|..||++.+++++
T Consensus 255 Ll---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 255 LL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 223445567778889999999999999998763
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=278.16 Aligned_cols=241 Identities=23% Similarity=0.403 Sum_probs=194.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++..+ +|..+|+|.+.... ...+.+.+|+++++.+ +|+|++++++.+......++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCC
Confidence 467999999999999976 58899999986532 2445788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCCC-
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFPT- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~~- 492 (627)
++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999997542 235799999999999999999999998 99999999999999885 46999999987764432
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
...+++.|+|||+..+..++.++||||||+++|||++|+.||.... ...+.......... ..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~-------- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGYFA-PI-------- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcccCC-CC--------
Confidence 2346788999999988889999999999999999999999986432 22233222221110 00
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+|+..+|++|||+.|++++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112356778889999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=280.30 Aligned_cols=242 Identities=21% Similarity=0.331 Sum_probs=192.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~ 413 (627)
+.||+|+||.||++... +++.||+|.+..... ..+.+..|+++++.+ +|+|++++++++.. ....++++||++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhcc
Confidence 67999999999999854 678999998865322 345678899999999 99999999998764 345789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH-----SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+++|.+++..... ....+++...+.++.+++.||.||| +.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999976432 2356899999999999999999999 655 999999999999999999999999999877
Q ss_pred CCCC----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 489 NFPT----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 489 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.... ...++..|+|||++.+..++.++||||||+++|+|++|+.||..... ...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~---- 229 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASK-IKEGKFRR---- 229 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHH-HhcCCCCC----
Confidence 5433 23568899999999988899999999999999999999999975431 111111 11111000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+.+++.+|+..+|++||++.+|+++
T Consensus 230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011223467788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=280.42 Aligned_cols=238 Identities=18% Similarity=0.279 Sum_probs=191.9
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||.||+++.. +++.||+|.+.... ...+.+..|++++..+ +||||+++++.+.++...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999976 48899999986532 2345788999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TT 493 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~~ 493 (627)
|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 80 LWTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 99999764 24889999999999999999999988 999999999999999999999999999876543 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||.....+ .............. .....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~----------~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGK----------LEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCC----------CCCCc
Confidence 34678899999998888999999999999999999999999754321 11222221110000 00011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPK-----MDDVVR 602 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~ 602 (627)
....++.+++.+||..+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11346778888999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=281.27 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=192.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++++++ +|||++++++++......++|+||+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEeccc-C
Confidence 467999999999999965 68999999987543 2346789999999999 7999999999999999999999999 9
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999987542 45899999999999999999999998 9999999999999999999999999988764432
Q ss_pred ---CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc----cc--cccc
Q 006886 493 ---TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE----WT--AEVF 562 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~ 562 (627)
...++..|+|||.+.+. .++.++||||+|+++|||++|.+||...... .....+....... +. .+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 33467889999998654 4689999999999999999998887643211 0011110000000 00 0000
Q ss_pred chhhh-----cC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELL-----KY----QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~-----~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.... .. ...++....+.+++.+|+..+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00 0001223567788899999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.67 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=191.9
Q ss_pred CCCHHHHHHHHhcccCcCCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc
Q 006886 328 NFDLEDLLRASAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE 404 (627)
Q Consensus 328 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~ 404 (627)
.++++++ ...+.||+|+||.||+|..++ ++.||||.++.... ...++..|++++.+...|+||+++++++.....
T Consensus 11 ~~~~~~~--~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDL--ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchh--eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3444444 335889999999999999874 88999999875432 345567777777777579999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
.++||||+. +++..+..... ..+++..+..++.|++.||.|||+. + |+||||+|+||++++++.+||+|||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 999999985 47777765432 3689999999999999999999974 6 9999999999999999999999999
Q ss_pred cccccCCCC---CCCCCccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 484 LAHLINFPT---TATRTIGYRAPEVTETRK----ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 484 ~a~~~~~~~---~~~~t~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
++....... ...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~ 235 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE 235 (296)
T ss_pred cchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC
Confidence 987654322 223567899999987554 789999999999999999999999642111 11111111111
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
. .. ..... ....++.+++.+||..+|++||++.+++++-.
T Consensus 236 ~-~~-----~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 236 P-PS-----LPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-CC-----CCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0 00 00000 12335677888999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=276.41 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++++..+ +|+|++++++.+......++++||+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 367999999999999976 688999999976543 567899999999999 79999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TT 493 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~~ 493 (627)
|.+++.... ..+++..+..++.+++.|+.|||+.+ ++||||+|+||++++++.++|+|||.+...... ..
T Consensus 84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccc
Confidence 999987642 35899999999999999999999988 999999999999999999999999998876543 34
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........ ...... ....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~--------~~~~ 221 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGL--------RNPE 221 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCc--------Cccc
Confidence 45678899999998888999999999999999999999998753211 11111111 000000 0001
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++.+|+..+|++|||+.|++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113457778889999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=281.31 Aligned_cols=239 Identities=20% Similarity=0.275 Sum_probs=194.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||.|+||.||++... +++.||+|.+.... ...+.+.+|+++++++ +||||+++++.+.+....++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 478999999999999976 58899999986542 2346788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|..++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999754 35889999999999999999999998 999999999999999999999999998776443
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....++..|+|||++.+..++.++|+||||+++|+|++|+.||...... ...+....... ... .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~---------~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADV---------L 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccc---------c
Confidence 2344677899999998888999999999999999999999999865432 11122111111 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKM--DDVV 601 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~ev~ 601 (627)
........+.+++.+||..+|.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122566778889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=285.08 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=189.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|..+ +++.+|+|.++.... ....+.+|++++.++ +||||+++.+++... ...++|+||+
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 478999999999999976 588999999865422 234567899999999 899999999998877 8899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
+ ++|.+++.... ..+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 89 ~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 89 E-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred C-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 7 49998887542 25899999999999999999999998 999999999999999999999999998876443
Q ss_pred ---CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh-----------h-
Q 006886 492 ---TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR-----------E- 555 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------~- 555 (627)
....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+. . ..+..... +
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--L-NKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCchHHHHHhhcc
Confidence 123457789999998654 468999999999999999999999975432110 0 00000000 0
Q ss_pred -----cccccccchhhhcCCChHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 -----EWTAEVFDVELLKYQDVEE--EMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 -----~~~~~~~d~~l~~~~~~~~--~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..........+. ...+. ....+.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhh--ccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000 00111 13456678889999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=282.96 Aligned_cols=238 Identities=19% Similarity=0.280 Sum_probs=192.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+++++++ +||||+++++.+...+..++||||++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVP 84 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCC
Confidence 468999999999999965 58999999986532 2345688899999999 79999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++...... .
T Consensus 85 ~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 85 GGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCC
Confidence 99999999764 35889999999999999999999988 999999999999999999999999999876443 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ........... . .+ ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~------~~--~~~~ 221 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK-V------RF--PSFF 221 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-c------cC--CccC
Confidence 33578899999999888889999999999999999999999975331 11111111110 0 00 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
...+.+++.+||..+|.+|| +++|++++
T Consensus 222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 23556788899999999999 77777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.39 Aligned_cols=260 Identities=17% Similarity=0.251 Sum_probs=180.2
Q ss_pred hcccCcCCceeEEEEEecC--CcEEEEE------------------EecccccCHHHHHHHHHHHHHhccCCCeeeeeeE
Q 006886 339 AEVLGKGSYGSTYKAILED--GTTVVVK------------------RLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~ 398 (627)
.+.||+|+||+||++..+. +..+++| .+.........+.+|++++.++ +|+||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEE
Confidence 4789999999999987542 2222222 1111122345688999999999 99999999999
Q ss_pred EeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 399 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
+...+..++|++++. ++|..++..................++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999984 57877776443222223345667789999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCC-----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCCCCCCCCHHHHHHHH
Q 006886 479 ISDVGLAHLINFPT-----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP-LQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 479 i~DfG~a~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p-~~~~~~~~~~~~~~~~~~~ 552 (627)
|+|||+++...... ...||..|+|||++.+..++.++|||||||++|||++|..+ +..........+...+...
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999998764321 24588999999999999999999999999999999998764 4322211111111111100
Q ss_pred h--hhcccc---cccch----hhh-cCCChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 553 V--REEWTA---EVFDV----ELL-KYQDVEEE------MVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 553 ~--~~~~~~---~~~d~----~l~-~~~~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .+.... ..++. ... .....+.. ..++.+++.+|++.||.+|||+.|++.+
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000 00000 000 00000111 1245667889999999999999999874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=280.26 Aligned_cols=238 Identities=20% Similarity=0.338 Sum_probs=189.6
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||.||+++.. +|+.+++|.+..... ..+.+.+|++++.++ +|+|++++++.+......++|+||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999976 489999999865432 345688889999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----- 491 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----- 491 (627)
|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999997542 5899999999999999999999998 999999999999999999999999998764322
Q ss_pred -------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 -------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 -------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
....++..|+|||......++.++||||||+++||+++|+.||..... ........... . .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~----~- 219 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGK-I----E- 219 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-c----C-
Confidence 122356789999999888899999999999999999999999975431 11111111100 0 0
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
..........+.+++.+|++.+|++|||+.++.+.|
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 ----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000000134567788899999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=285.04 Aligned_cols=245 Identities=22% Similarity=0.340 Sum_probs=193.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. ++..+|+|.+.... ...+++.+|+++++.+ +|+|++++.+++......++|+||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccC
Confidence 467999999999999965 57889999886421 1234677899999999 99999999999999999999999996
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
|++.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 -~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (308)
T cd06634 99 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170 (308)
T ss_pred -CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCccc
Confidence 68887775432 35889999999999999999999988 99999999999999999999999999987766666
Q ss_pred CCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..++..|+|||++. ...++.++|||||||++|||++|+.||...... .......... ... .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~---------~ 234 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPA---------L 234 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcC-CCC---------c
Confidence 67888999999974 356788999999999999999999998643211 1111111111 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
........+.+++.+||..+|++||++.+++++.....
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01122345667888999999999999999998755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=279.50 Aligned_cols=240 Identities=20% Similarity=0.291 Sum_probs=183.6
Q ss_pred ccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHh--ccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 341 VLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTI--GKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.||+|+||.||++... +++.||+|.+..... ....+..|..++..+ ..||+|+.+.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998865321 122244444333332 379999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999988643 35899999999999999999999988 999999999999999999999999998765332
Q ss_pred CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....++..|+|||++.++ .++.++||||+|+++|||++|+.||.......... ....... .+..+ .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~--~- 219 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVEL--P- 219 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCC--C-
Confidence 234578899999998754 68999999999999999999999997543221111 0000000 00000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.....++.+++.+|+..+|.+|| ++.+++++
T Consensus 220 --~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11134566788899999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=267.87 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=195.7
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYM 412 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~ 412 (627)
+.++||-|-.|.|-.+..+ +++.+|+|++... ....+|+++--+...|||||.+++.|.+ ...+++|||.|
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 3578999999999999865 6889999998643 3456777777777799999999999875 34578899999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLIN 489 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~ 489 (627)
+||.|.+.++... ...+++.++.+|+.||+.|+.|||+.+ |.||||||+|+|.+. |..+|++|||+|+...
T Consensus 142 eGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 142 EGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred cchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999998653 467999999999999999999999998 999999999999975 5678999999998775
Q ss_pred CC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 490 FP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
.. .+..-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||...... .+....+..++.+... ..+
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy~-FP~--- 288 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQYE-FPE--- 288 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCcc-CCC---
Confidence 43 3556789999999999999999999999999999999999999865432 1111222222221110 001
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
+.+....++.-++|+..++.+|.+|.|+++++.+=.-.+
T Consensus 289 ---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 289 ---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ---hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 112233344456777889999999999999987654433
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=283.58 Aligned_cols=239 Identities=21% Similarity=0.351 Sum_probs=191.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..||+|+||.||++..+ +++.||||++.... .....+..|+.++..+ +|+|++++++.+...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 67999999999999864 68899999885432 2345688899999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
.+++... .+++.....++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++...... ..
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9987532 4789999999999999999999998 999999999999999999999999988765332 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..++..|+|||++.+..++.++||||||+++|||++|+.||...... ..... ...... ..+... .
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~-~~~~~~-----~~~~~~---~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNLP-----PKLKNL---H 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhhCC-----cccCCc---c
Confidence 34678899999998888899999999999999999999998743211 11111 111110 011011 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++.+|+..+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 122345677889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.47 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=190.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||+|..+ +|..||+|++.... ...+.+..|+++++.+ +|+|++++++++.+.+..++++||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccC-
Confidence 467999999999999965 79999999986542 2345688899999999 89999999999999999999999995
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|.+++..... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 689999875431 35899999999999999999999988 999999999999999999999999999765422
Q ss_pred -CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---cccc--cccc-
Q 006886 492 -TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTA--EVFD- 563 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~d- 563 (627)
....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+....+..... .+.. ...+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 122357789999987654 56899999999999999999999997542110 111111100000 0000 0000
Q ss_pred -hhhhcC--CC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 -VELLKY--QD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 -~~l~~~--~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...... .. .+.....+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00 01112456788899999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=273.30 Aligned_cols=241 Identities=24% Similarity=0.381 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|++|.||+|..+ +++.|++|++.... ...+.+.+|++.++++ +|+||+++++.+... ...++|+||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 367999999999999976 68899999987654 2356788999999999 899999999999988 8899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 84 SGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999997642 6899999999999999999999988 9999999999999999999999999988765432
Q ss_pred ------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 ------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...++..|+|||...+...+.++||||||+++|+|++|+.||.... ................
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~------- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP------- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc-------
Confidence 2346788999999988889999999999999999999999997543 1111111111000000
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........+.+++.+|+..+|++||++.|++++
T Consensus 224 ---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 ---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0011123467778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=281.24 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|++|.||+|+.+ +|..||||.++... ...+.+..|+++++.+ +|+||+++++++...+..++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 368999999999999975 58899999987543 2345677899999999 999999999999999999999999985
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.....
T Consensus 83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 88888865432 245899999999999999999999998 999999999999999999999999999765332
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh--hcc-----cccccc
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR--EEW-----TAEVFD 563 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~d 563 (627)
....++..|++||++.+ ..++.++||||||+++|||++|+.||......+. .......... ... ....+.
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345788999998865 4568999999999999999999999976432211 0000000000 000 000000
Q ss_pred hhhhc------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 VELLK------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ~~l~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..... ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000122345678888999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=285.19 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=184.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--------ceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--------EKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 406 (627)
.+.||+|+||.||++..+ +++.||||.+..... ....+.+|+++++++ +||||+++++++...+ ..+
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEE
Confidence 478999999999999965 688999998864321 234567899999999 9999999999987654 348
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||+. ++|.+++... ...+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 96 lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 96 LVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 9999996 4788877643 235899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCC--------CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---
Q 006886 487 LINFPT--------TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR--- 554 (627)
Q Consensus 487 ~~~~~~--------~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 554 (627)
...... ...++..|+|||++.+. .++.++||||||+++|||++|+.||....... ....+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~ 244 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSIT 244 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 653321 12356789999988654 46889999999999999999999997543211 1111111110
Q ss_pred hccccc-----ccch-hhhcC--CChH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 555 EEWTAE-----VFDV-ELLKY--QDVE------EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 555 ~~~~~~-----~~d~-~l~~~--~~~~------~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...... ..+. ..... .... .....+.+++.+|+..+|++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000 00000 0000 012345689999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=282.69 Aligned_cols=246 Identities=16% Similarity=0.249 Sum_probs=171.9
Q ss_pred hcccCcCCceeEEEEEecCC----cEEEEEEecccccC---HH---------HHHHHHHHHHHhccCCCeeeeeeEEeeC
Q 006886 339 AEVLGKGSYGSTYKAILEDG----TTVVVKRLREVAAT---KR---------EFEQQMEVVGTIGKHSNVVPVRAYYYSK 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~~---~~---------~~~~e~~~l~~l~~h~niv~l~~~~~~~ 402 (627)
.+.||+|+||.||+|...++ ..+|+|+....... .. ....+...+..+ .|++++++++++...
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFK 95 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEe
Confidence 46899999999999997643 45566653221111 00 011112223344 799999999876654
Q ss_pred C----ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 403 D----EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 403 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
. ..++++|++. .++.+.+... ...++.....++.|++.||.|||+.+ |+||||||+|||++.++.++
T Consensus 96 ~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 96 RCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred cCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 3 3467777764 3666666542 23577888999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH
Q 006886 479 ISDVGLAHLINFP-----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547 (627)
Q Consensus 479 i~DfG~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 547 (627)
|+|||+++..... ....||+.|+|||+..+..++.++|||||||++|||++|+.||........ +..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~ 244 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIH 244 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHH
Confidence 9999999765311 123578999999999999999999999999999999999999986532211 111
Q ss_pred HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.... .....+..... .. ......+.+++..|+..+|++||++.++.+.+
T Consensus 245 ~~~~----~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC----DFIKRLHEGKI-KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH----HHHHHhhhhhh-cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 00000000000 11 12235577788899999999999999999876
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.64 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=194.0
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
.+.+++. ...+.||+|+||.||+|+.. ++..|++|++..... ..+.+..|+++++.+ +|||++++++++.+..
T Consensus 17 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 17 DDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEH 94 (313)
T ss_pred CCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence 3444442 22467999999999999964 688999999864322 234678899999999 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++|+||+. |++.+++.... ..+++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecC
Confidence 9999999995 57877776432 35899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 484 LAHLINFPTTATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 484 ~a~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
++..........++..|+|||++. ...++.++||||||+++|||++|..||..... ............. .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~ 239 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDSP-T 239 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-C
Confidence 987665555566788999999974 45688999999999999999999999865321 1111111111110 0
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. . ......+.+++.+|++.+|.+||++.+++.+
T Consensus 240 ~~------~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQ------S---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC------c---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 1112346678889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=281.54 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=190.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|+.. +++.+|+|++.... .....+.+|++++..+ +|+|++++++++... +..++|+||+
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEeccc
Confidence 367999999999999976 48899999997652 2345688899999999 899999999999988 7899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++ +|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 75 8888886432 36899999999999999999999998 9999999999999999999999999998765432
Q ss_pred -----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc---ccccccc
Q 006886 493 -----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE---WTAEVFD 563 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 563 (627)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...... ....+....... ......+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccccc
Confidence 2235678999997754 457899999999999999999999997543211 011110000000 0000000
Q ss_pred --------hhhhcCC----ChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 --------VELLKYQ----DVEE-EMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 --------~~l~~~~----~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... .... +...+.+++.+|+..+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 0001 24567889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=282.87 Aligned_cols=254 Identities=21% Similarity=0.257 Sum_probs=186.0
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
+.+|.|+++.||++.. +++.||+|++... ....+.+..|++++..+ +|+||+++++++..++..+++|||+++|+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 4455556666666555 5899999998654 22346789999999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----- 491 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----- 491 (627)
|.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999998643 235888999999999999999999998 999999999999999999999999988654211
Q ss_pred ------CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh----cc--
Q 006886 492 ------TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE----EW-- 557 (627)
Q Consensus 492 ------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~-- 557 (627)
....++..|+|||++.. ..++.++||||||+++|||++|+.||....... ...+........ ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 12235678999999865 357899999999999999999999997532111 000000000000 00
Q ss_pred -----ccc----ccchhh---hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 -----TAE----VFDVEL---LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 -----~~~----~~d~~l---~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ..+... ...........++.+++.+||..+|++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 000000 0000111223467788899999999999999999884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=281.67 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=191.3
Q ss_pred cccCcC--CceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKG--SYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+| +||+||++... +|+.||+|.+...... .+.+.+|+.++..+ +||||+++++++...+..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEeccc
Confidence 457776 89999999964 7899999998654322 35678888888888 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+.....
T Consensus 83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 83 YGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999999886532 35889999999999999999999988 99999999999999999999999985432211
Q ss_pred --------CCCCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH----------
Q 006886 491 --------PTTATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR---------- 550 (627)
Q Consensus 491 --------~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~---------- 550 (627)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccc
Confidence 0111234569999998763 478999999999999999999999975432110 000000
Q ss_pred ------HHh----------------hhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 006886 551 ------SVV----------------REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQ 606 (627)
Q Consensus 551 ------~~~----------------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~ 606 (627)
... .........+..+ ...........+.+++.+||..||++|||+.|+++ .+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000 0000000000000 11112234567888999999999999999999987 4444
Q ss_pred hccc
Q 006886 607 IQQP 610 (627)
Q Consensus 607 ~~~~ 610 (627)
++..
T Consensus 314 ~~~~ 317 (328)
T cd08226 314 VKEQ 317 (328)
T ss_pred HHHh
Confidence 5444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=280.86 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=193.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||++... +++.+++|.+..... ....+..|+++++++ +|+||+++++++...+..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCC
Confidence 367999999999999965 688999999865432 346788899999999 899999999999999999999999975
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 8888887532 36899999999999999999999998 9999999999999999999999999987765432
Q ss_pred --CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---cccccccc---
Q 006886 493 --TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTAEVFD--- 563 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d--- 563 (627)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+ ........... .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhh
Confidence 23356789999998776 78999999999999999999999997543211 00000000000 00000000
Q ss_pred ---hhhhc------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 ---VELLK------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ---~~l~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ....+....++.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 00112234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.00 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=179.0
Q ss_pred CCCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-
Q 006886 328 NFDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD- 403 (627)
Q Consensus 328 ~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~- 403 (627)
--+++|+ ++||+||||.||+++.+ ||+.||||++.... .....+.+|+..++++ +|||||+++..|.+..
T Consensus 478 ~~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 478 LNDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCC
Confidence 3456666 78999999999999976 89999999997653 3345688999999999 9999999886652110
Q ss_pred --------------------------------------------------------------------------------
Q 006886 404 -------------------------------------------------------------------------------- 403 (627)
Q Consensus 404 -------------------------------------------------------------------------------- 403 (627)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred --------------------------------------ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 006886 404 --------------------------------------EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445 (627)
Q Consensus 404 --------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia 445 (627)
..|+=||||+..++.++++++... -.....++++.+|+
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREIL 707 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHH
Confidence 024556777776666666654321 03567789999999
Q ss_pred HHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----------------------CCCCCCCCccccCc
Q 006886 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----------------------FPTTATRTIGYRAP 503 (627)
Q Consensus 446 ~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~----------------------~~~~~~~t~~y~aP 503 (627)
.||.|+|++| ||||||||.||++|++..+||+|||+|+... ......||.-|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999998721 01233578889999
Q ss_pred cccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHH
Q 006886 504 EVTETR---KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQML 580 (627)
Q Consensus 504 E~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~ 580 (627)
|++.+. .|+.|+|+||+|||++||+. ||....+ .... -..++......- .. ...+.+..=.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~i----L~~LR~g~iP~~--~~-----f~~~~~~~e~ 848 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASI----LTNLRKGSIPEP--AD-----FFDPEHPEEA 848 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHH----HHhcccCCCCCC--cc-----cccccchHHH
Confidence 998654 59999999999999999996 4653211 1111 111122111111 00 0122223334
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 006886 581 QIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 581 ~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
++|.++++.||.+|||+.|+++
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhh
Confidence 6788999999999999999976
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=288.22 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=189.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCH---------------HHHHHHHHHHHHhccCCCeeeeeeEEeeC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATK---------------REFEQQMEVVGTIGKHSNVVPVRAYYYSK 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 402 (627)
.+.||+|+||.||+|..+ +++.||||++....... ..+.+|++++..+ +|+||+++++++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence 467999999999999965 68999999986542211 2477899999999 999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 403 DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 403 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+..++||||++ |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 99999999996 6899988643 34889999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCC------------------CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 006886 483 GLAHLINFP------------------TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV 543 (627)
Q Consensus 483 G~a~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 543 (627)
|.++..... ....++..|+|||++.+. .++.++||||||+++|||++|+.||......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-- 241 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-- 241 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 998765410 112346789999998764 46899999999999999999999997543211
Q ss_pred CHHHHHHHHhhhc----ccccccchhhh-----cCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 544 DLPRWVRSVVREE----WTAEVFDVELL-----KYQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 544 ~~~~~~~~~~~~~----~~~~~~d~~l~-----~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
....+....... +......+... .... ......++.+++.+|++.+|++||+++|++.+-
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 111111111000 00000000000 0000 011234567888999999999999999998743
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=283.21 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=190.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.++.++.+|+||+++++++... ...++|+||+
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 478999999999999975 5889999988543 223455778999999998899999999998654 3578999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
+ ++|..++... .++|..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 7 5998888642 5789999999999999999999998 9999999999999999999999999997653321
Q ss_pred ---------CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh---------
Q 006886 493 ---------TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV--------- 553 (627)
Q Consensus 493 ---------~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 553 (627)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ........
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHH
Confidence 2246788999998754 5678999999999999999999999965332110 00000000
Q ss_pred --hhcccccccc----hhhhc-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccc
Q 006886 554 --REEWTAEVFD----VELLK-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQP 610 (627)
Q Consensus 554 --~~~~~~~~~d----~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~ 610 (627)
........++ ..... .........++.+++.+||+.+|++|||+.+++++ +..+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 0000000000 00000 00001123467788999999999999999999985 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=274.53 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=190.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCc-----eEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDE-----KLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~-----~~l 407 (627)
.+.||+|+||.||+|+.+ +++.||+|++..... ....+.+|++++.++. .|+|++++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 367999999999999976 489999999864322 2345667887777774 59999999999988776 899
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
+|||+++ +|.+++.... ...+++..+.+++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+..
T Consensus 84 ~~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred Eehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999974 8998887543 235899999999999999999999998 99999999999999999999999999877
Q ss_pred cCCCC---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc-------c
Q 006886 488 INFPT---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE-------W 557 (627)
Q Consensus 488 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~ 557 (627)
..... ...++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+.... +
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCChHhc
Confidence 64332 223577899999999888999999999999999999999998754321 1111111100 0
Q ss_pred cccc------cchhhhc--CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAEV------FDVELLK--YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~~------~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... +...... ....++....+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 0000000 00011223556788899999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=284.34 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=187.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|..+ +|+.||+|.++.... ....+.+|++++.++ +|+|++++++++... +..++|+||+
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecC
Confidence 367999999999999975 589999999864322 223466799999999 999999999998765 4679999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+.......
T Consensus 91 ~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 91 EQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred CC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 64 8888887542 45899999999999999999999998 9999999999999999999999999998765321
Q ss_pred ----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---ccc------
Q 006886 493 ----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWT------ 558 (627)
Q Consensus 493 ----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------ 558 (627)
...++..|+|||++.+ ..++.++||||+|+++|||++|+.||...+..+ ....+...... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhcc
Confidence 1224677999999865 457899999999999999999999997543211 11111110000 000
Q ss_pred --ccccchhhhcCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 --AEVFDVELLKYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 --~~~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+.......... .....++.+++.+|+..||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000000 1123456678889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=277.99 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=192.2
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+++.. +++.||||.++... ...+.+..|++++.++.+|+||+++.+.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 367999999999999843 57889999986432 234568889999999978999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999998753 35889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCC-----CCCCCccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FPT-----TATRTIGYRAPEVTETRK--ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~~-----~~~~t~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
... ...++..|+|||...+.. .+.++||||||+++|||++|..||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~----- 229 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSKP----- 229 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccCC-----
Confidence 322 234678899999987655 788999999999999999999999643211 111111111111100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
. .. ......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 230 --~--~~---~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 --P--FP---KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --C--CC---cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 00 1112345678889999999999999888776655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.57 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=186.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||+|..+ +++.||+|++.... ...+.+..|+++++++ +|+||+++++++......++|+||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~- 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLD- 84 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEeccc-
Confidence 367999999999999965 68899999886532 2235688899999999 99999999999999999999999996
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~~-- 491 (627)
++|.+++.... ...+++.....++.|++.||.|||+.+ ++||||+|+||+++. ++.+||+|||++......
T Consensus 85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 57888775432 234678888899999999999999998 999999999999985 457899999999765332
Q ss_pred --CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---cccccc---c
Q 006886 492 --TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTAEV---F 562 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~ 562 (627)
....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+ .+..... .... ...... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFR-ILGTPNEETWPGVTSLP 235 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCChhhccccccch
Confidence 22345788999998865 457899999999999999999999997542211 0110000 0000 000000 0
Q ss_pred chh--hhcC--CC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVE--LLKY--QD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~--l~~~--~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.. .... .. .+....++.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 00 01122346778889999999999999999873
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=277.25 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|++|.||+|+.. +++.|+||++..... ......+|+..+.++.+|+|++++++++..++..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999976 478899999865433 23345678888999944999999999999999999999999 88
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---C
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---T 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~ 492 (627)
+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+...... .
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 9999887643 246899999999999999999999998 999999999999999999999999999876432 2
Q ss_pred CCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC----------CHHHHHHHHhhhcccccc
Q 006886 493 TATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV----------DLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~ 561 (627)
...++..|+|||++. ...++.++|+||||++++||++|+.||......+.. .-..|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 234677899999874 456789999999999999999999999654321110 000011100000000000
Q ss_pred cchhhhc--CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 FDVELLK--YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+...... ....+.....+.+++.+||..+|++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00001113467789999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=288.24 Aligned_cols=257 Identities=19% Similarity=0.308 Sum_probs=191.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 409 (627)
.+.||+|+||.||+++.. +++.||||.+... ......+..|++++..+ +|+||+++++++... ...++|+
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEE
Confidence 368999999999999964 6899999998653 22345677899999999 999999999987654 3479999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 89 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 89 ELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred eCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 9995 6898888643 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CC----CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---------
Q 006886 490 FP----TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE--------- 555 (627)
Q Consensus 490 ~~----~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 555 (627)
.. ....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhc
Confidence 33 23346788999998764 56889999999999999999999999754211 000000000000
Q ss_pred --ccccc-------ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccc
Q 006886 556 --EWTAE-------VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQP 610 (627)
Q Consensus 556 --~~~~~-------~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~ 610 (627)
..... ..+..... ..+....++.+++.+|++.+|++|||++|++++ +..+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFAR--LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CchhhhHHHHhcCcccccCHHH--HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000 00000000 001223456788899999999999999999987 6665444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.76 Aligned_cols=239 Identities=25% Similarity=0.382 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
..+||.|.||.||.|. ..+|...|+|-++-. ....+.+..|+.++..+ +|||+|+++|.=...+..++.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhcc
Confidence 5689999999999999 456888999977543 23446788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
|+|.+.+...+ ..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|.+|||.|..+..+.
T Consensus 1319 GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred CcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 99999998653 3666777778899999999999999 9999999999999999999999999998876542
Q ss_pred ------CCCCCccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 493 ------TATRTIGYRAPEVTETR---KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
...||+.|||||++.+. ....+.||||+|||+.||+||+.||...+.+ |.- ++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI----------My~ 1453 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI----------MYH 1453 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH----------HhH
Confidence 23589999999999654 3467899999999999999999999865432 111 011
Q ss_pred hhhhcCCChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEE-EMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+..++ -..+-.+++.+|+..||++|.++.|++++
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111111111 22233456679999999999888877653
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=276.73 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=189.6
Q ss_pred hcccCcCCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL----EDGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+++. .+|..||+|++.... ...+.+..|++++.++.+|+||+++.+.+..+...++|+
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 36799999999999986 368899999986532 234667889999999978999999999999888999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999754 34788999999999999999999998 9999999999999999999999999987654
Q ss_pred CCC-----CCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FPT-----TATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~~-----~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
... ...++..|+|||.+... .++.++||||||+++|+|++|+.||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~----- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP----- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-----
Confidence 321 23467889999998653 4678999999999999999999999643211 111121111111100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
. ........+.+++.+|+..+|++|| ++++++.+
T Consensus 230 --~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 --P-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --C-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 0011223556788899999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=286.97 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=189.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-----ceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-----EKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~e 410 (627)
.+.||+|+||.||+|... +|+.||+|.+.... .....+.+|+.++.++ +|+||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEeh
Confidence 478999999999999854 68999999986432 2345678899999999 8999999998876443 4789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+.+ +|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 89 LMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred hccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9964 88777753 25899999999999999999999998 99999999999999999999999999876533
Q ss_pred CC-------CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc---c
Q 006886 491 PT-------TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---A 559 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 559 (627)
.. ...++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ............... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHH
Confidence 21 2346788999998654 56889999999999999999999999653211 001111111100000 0
Q ss_pred cccchh-------hhcCC--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhcc
Q 006886 560 EVFDVE-------LLKYQ--D----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQ 609 (627)
Q Consensus 560 ~~~d~~-------l~~~~--~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~ 609 (627)
.+.+.. ..... . .+....++.+++.+||+.+|++|||+.|++++ ++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 00000 0 01123457789999999999999999999886 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=285.56 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=187.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||++... +++.||+|++.... .....+.+|++++.++ +|+||+++++++... ...++|
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEE
Confidence 468999999999999965 68999999986432 2234677899999999 999999999988644 346899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+. ++|.+.+.. .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 99995 588887753 2788899999999999999999998 999999999999999999999999999876
Q ss_pred CCCC---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------CHHHHHHH-----
Q 006886 489 NFPT---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV---------DLPRWVRS----- 551 (627)
Q Consensus 489 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---------~~~~~~~~----- 551 (627)
.... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.. ....+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4432 234678899999999999999999999999999999999999754311000 00000000
Q ss_pred --Hhhhccc------ccccchhhhc---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 552 --VVREEWT------AEVFDVELLK---YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 552 --~~~~~~~------~~~~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... ...+...... ..........+.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000000 00011223456788999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=284.94 Aligned_cols=239 Identities=19% Similarity=0.342 Sum_probs=195.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
...||+|.|+.|..++.. .+..||||.+.+... ..+.+.+|+++|..+ +|||||+++.+.......|+||||+.+
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccC
Confidence 467999999999999955 689999999987643 234588999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|.+++|+.++. ......+..++.|+..|++|+|+++ |+|||||++|||++.+.++||+|||++..+...
T Consensus 140 ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 140 GELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred chhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccc
Confidence 99999998763 3555888899999999999999999 999999999999999999999999999988643
Q ss_pred CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.+..|++.|.|||++.+..| .+.+|+||+|+++|-|+.|..||++..-.+.. +. .+-..+.-..
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~r----vl~gk~rIp~ 276 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PR----VLRGKYRIPF 276 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------ch----heeeeecccc
Confidence 56789999999999998877 58999999999999999999999875422111 00 0000000111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.... +.-+++++++-.+|.+|++++++.+.-
T Consensus 277 ~ms~---dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 277 YMSC---DCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeec---hhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1122 233566788899999999999998743
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=270.69 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=196.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++..+ +++.+|+|.+.... ....++..|+++++++ +|+||+++.+++......++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCC
Confidence 467999999999999854 67899999987543 2345677899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--C
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--T 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--~ 492 (627)
++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+|++|||+++..... .
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 999999876322 2356899999999999999999999998 999999999999999999999999999776443 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||.+.+..++.++|+||||+++|||++|+.||...+.. ....... ..... ...
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~----------~~~ 222 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQ-RGKYP----------PIP 222 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCCC----------CCc
Confidence 234678899999999888999999999999999999999999754311 1111111 11000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1233567788899999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=269.26 Aligned_cols=238 Identities=24% Similarity=0.430 Sum_probs=193.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|++|.||++..+ +++.|++|.+..... ..+.+.+|++++.++ +|+|++++++++.+....++++||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 478999999999999865 578999999876543 346788999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC-
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT- 493 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~- 493 (627)
++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998754 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ---CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ---ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ---~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..++..|+|||...+..++.++||||+|+++|+|++|+.||..... ..... ...... ...+.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~~--~~~~~------- 220 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RIVQDD--HPPLP------- 220 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HHhccC--CCCCC-------
Confidence 3467889999999887889999999999999999999999974321 11111 111000 00000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
......+.+++.+|+..+|++||++.+++.
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 --EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111235667888999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=262.24 Aligned_cols=194 Identities=25% Similarity=0.445 Sum_probs=166.8
Q ss_pred hcccCcCCceeEEEEEec---C--CcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE---D--GTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~---~--~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~ 409 (627)
...||+|.||.||+|.-+ + ...+|+|+++.... -....-+|+.+++.+ +|||++.+...+.+ +...++++
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEe
Confidence 467999999999999633 2 23789999976532 234567899999999 99999999988877 77889999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC----CCeEEeecccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD----LNGCISDVGLA 485 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~ki~DfG~a 485 (627)
||.+. +|.+.++.++......++......|+.||+.|+.|||+.- |+||||||.|||+..+ |.+||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99987 8999998877766778999999999999999999999998 9999999999999988 99999999999
Q ss_pred cccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 486 HLINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 486 ~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
+.+..+ ...+.|+.|.|||.+.+ ..|+.+.||||.|||+.||+|-++-|.+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 988653 22345899999999876 46899999999999999999998888754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=287.69 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e 410 (627)
.+.||+|+||.||+|..+ ++..||+|++.... ...+.+..|++++.++ +||||+++.+++.. ....++|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEe
Confidence 367999999999999965 68999999987542 2345677899999999 89999999988763 346789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+. |+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 89 ~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 89 LME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 995 6898888643 34899999999999999999999998 99999999999999999999999999876532
Q ss_pred C--------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh-------
Q 006886 491 P--------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR------- 554 (627)
Q Consensus 491 ~--------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 554 (627)
. ....++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHhh
Confidence 2 12346778999998755 5688999999999999999999999975432111 000000000
Q ss_pred ----hcccccccch-hhhcCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 555 ----EEWTAEVFDV-ELLKYQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 555 ----~~~~~~~~d~-~l~~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+..+. ....... .+....++.+++.+|++.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0000000 01224567788899999999999999999884
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.15 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=205.7
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee-----CCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-----KDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~e~~ 412 (627)
.+.||.|.+|.||+++ .++++.+|+|++.......++++.|.++++.+..|||++.++|++.. ++.++||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 4789999999999999 45789999999988888889999999999999999999999999874 56899999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
.+|+..+.++... +..+.|....-|+..++.|+.+||... ++|||||-.|||+++++.+|++|||.+..++.
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 9999999998765 568999999999999999999999987 99999999999999999999999999987743
Q ss_pred --CCCCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 491 --PTTATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 491 --~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..+..||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+.++.... .+-.+. ....
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------aLF~Ip------RNPP 245 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP------RNPP 245 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------hhccCC------CCCC
Confidence 456779999999999854 357789999999999999999999997653211 111111 1111
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.+ .......++|.++|..|+.+|.++||++.+++++
T Consensus 246 PkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 246 PKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 222 2345566788889999999999999999998763
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=289.06 Aligned_cols=271 Identities=21% Similarity=0.318 Sum_probs=200.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~ 409 (627)
.+.||+|+||.||+|+. ..|+.||||.++... ...+...+|+++++++ +|+|||++++.=++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEE
Confidence 46799999999999994 479999999998753 3456788999999999 7999999998855433 467999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec--CCCC--eEEeecccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT--QDLN--GCISDVGLA 485 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~--~ki~DfG~a 485 (627)
|||.+|||...+.+-. ....+++.+.+.+..+++.||.|||+++ |+||||||.||++- .+|+ -||+|||.|
T Consensus 97 EyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred eecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999997543 3456999999999999999999999998 99999999999984 2333 599999999
Q ss_pred cccCCCC---CCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 486 HLINFPT---TATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 486 ~~~~~~~---~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
+.++... +..||..|.+||.+. .+.|+..+|.|||||++||++||..||..........-..|. .........+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKKPSGVA 249 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccCCCcee
Confidence 9987764 456999999999998 488999999999999999999999999754322111001111 1111111000
Q ss_pred --cch----------hhhcCCC-hHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHhhcccccccCCC
Q 006886 562 --FDV----------ELLKYQD-VEEEMVQMLQIALSCVAKVPDSRP--KMDDVVRMIEQIQQPELRNRAS 617 (627)
Q Consensus 562 --~d~----------~l~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RP--s~~ev~~~L~~~~~~~~~~~~~ 617 (627)
.+. .+..... .......+-+.+..++..+|++|- .+.+....+..|........++
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs 320 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFS 320 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEe
Confidence 010 0000000 112223344555677788888888 7788888887777665554443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=266.70 Aligned_cols=243 Identities=20% Similarity=0.376 Sum_probs=197.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++... ++..|++|++.... ...+.+..|++++..+ +|+|++++.+.+...+..++|+||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCC
Confidence 367999999999999965 68899999987543 3456788899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++..... ....+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 999999986431 2357899999999999999999999998 9999999999999999999999999987764432
Q ss_pred --CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 --TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+++.|+|||...+..++.++||||+|+++++|++|+.||.... ............ ... +
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~-----~---- 223 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQ-YPP-----I---- 223 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCC-CCC-----C----
Confidence 2346778999999988889999999999999999999999996542 112222211111 000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+||..+|++||++.|++++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01122456778889999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=285.42 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=189.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++..+ +|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEE
Confidence 478999999999999964 68999999986532 2245678899999999 9999999999987543 45899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+.. +|..+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 999964 7766542 24889999999999999999999998 999999999999999999999999998865
Q ss_pred CCCC-CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh-----------
Q 006886 489 NFPT-TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE----------- 555 (627)
Q Consensus 489 ~~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 555 (627)
.... ...++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+......
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCCHHHHHH
Confidence 4322 2346778999999865 468899999999999999999999997543111 01110000
Q ss_pred ---ccccccc-------chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhcccc
Q 006886 556 ---EWTAEVF-------DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPE 611 (627)
Q Consensus 556 ---~~~~~~~-------d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~~ 611 (627)
....... ...+.. ..+....++.+++.+|++.+|++||++.+++.+ ++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFST--LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred hcccchHHHHhhcCCcccchHHH--HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 0000000 000000 001122356788899999999999999999965 77776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=277.77 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=186.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC----------c
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD----------E 404 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----------~ 404 (627)
.+.||+|+||.||+|..+ +++.||+|+++... .....+.+|++++.++ +|||++++++++.+.. .
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCc
Confidence 478999999999999976 58899999986542 2345677899999999 9999999999987654 6
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
.++|+||+++ ++..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||.
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence 8899999976 677776543 235899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC-----CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 485 AHLINFPT-----TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 485 a~~~~~~~-----~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+....... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCP 239 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCh
Confidence 98764322 1234678999998754 45789999999999999999999999753211 111111111100000
Q ss_pred ---ccc--------cchhhhcC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 ---AEV--------FDVELLKY----QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ---~~~--------~d~~l~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+ .+...... .........+.+++.+||..+|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00000000 0000112456788889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.25 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=197.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-----ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-----EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 409 (627)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+++++.+ +|+||+++.+++...+ ..++|+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEe
Confidence 467999999999999975 48999999987543 2346788999999999 8999999999988765 789999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||++ ++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||.+....
T Consensus 84 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 84 ELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred cchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9997 5888888643 26899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCC-------CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc--cc-
Q 006886 490 FPT-------TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE--WT- 558 (627)
Q Consensus 490 ~~~-------~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~- 558 (627)
... ...++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ....+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~ 228 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID------QLNLIVEVLGTPSE 228 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHhcCCCCh
Confidence 432 23457789999999877 78999999999999999999999997653211 111111000 00
Q ss_pred -----------ccccchhhhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccccc
Q 006886 559 -----------AEVFDVELLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPEL 612 (627)
Q Consensus 559 -----------~~~~d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~~~ 612 (627)
...+. ...... ..+.....+.+++.+||+.+|++||++++++++ ++.++....
T Consensus 229 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 229 EDLKFITSEKARNYLK-SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred hHhhhccccchhhHHh-hcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 00000 000000 001123456788889999999999999999985 666665533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=265.93 Aligned_cols=231 Identities=24% Similarity=0.332 Sum_probs=187.9
Q ss_pred cCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 342 LGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
||+|+||.||++... +++.+|+|.+..... ....+..|+++++.+ +|+|++++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999975 588999999875432 345788899999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++.... .+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 999997542 5899999999999999999999988 999999999999999999999999998776432 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...++..|+|||...+...+.++|+||||+++||+++|+.||..... ............ ......
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------~~~~~~ 216 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL---------RFPEFL 216 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC---------CCCCCC
Confidence 33467889999999888889999999999999999999999965422 111111111100 000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDD 599 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e 599 (627)
...+.+++.+|+..+|++||++.+
T Consensus 217 ---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 235567888999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=280.03 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=184.6
Q ss_pred hcccCcCCceeEEEEEec-C--CcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC----CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-D--GTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK----DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~--~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~~~~lv 408 (627)
.+.||+|+||.||+++.. . +..||+|++.... ...+.+.+|++++.++.+||||+++++.+... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999965 3 6789999986532 22456788999999997799999999875432 356788
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+. ++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 88885 6898888643 35899999999999999999999998 999999999999999999999999999765
Q ss_pred CCC--------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC---------CHHHHHH
Q 006886 489 NFP--------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV---------DLPRWVR 550 (627)
Q Consensus 489 ~~~--------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---------~~~~~~~ 550 (627)
... ....++..|+|||+..+ ..++.++||||||+++|+|++|+.||......... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 12346788999998765 56899999999999999999999999754311000 0000000
Q ss_pred HHhhhccc------ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 551 SVVREEWT------AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 551 ~~~~~~~~------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
........ .......+.. ..+.....+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFES--IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHh--hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0000000000 00011346778889999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=269.03 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=186.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+++++++ +|+||+++++++.+. ...++|+
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEE
Confidence 478999999999999964 58899999874321 1234688899999999 999999999998764 4578999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999998753 24788999999999999999999998 9999999999999999999999999997653
Q ss_pred CC-------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FP-------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ....++..|+|||++.+..++.++||||||+++||+++|+.||..... ...+....... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 230 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQP-TKPML 230 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCC-CCCCC
Confidence 21 123467889999999888899999999999999999999999974321 11111111110 00001
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+.+++.+|+. +|..||++.+++.+
T Consensus 231 ---------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 ---------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122346667779998 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=276.40 Aligned_cols=238 Identities=21% Similarity=0.365 Sum_probs=191.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+..|++++.++.+|+||+++++.+..++..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 367999999999999965 68999999986532 2345678899999999449999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 86 ~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 86 NGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999764 25999999999999999999999998 9999999999999999999999999987654321
Q ss_pred -----------------------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH
Q 006886 493 -----------------------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 493 -----------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 549 (627)
...++..|+|||+..+..++.++||||||++++++++|+.||...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~ 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTF 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHH
Confidence 123567899999998888999999999999999999999999754311 001
Q ss_pred HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 006886 550 RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKM----DDVVR 602 (627)
Q Consensus 550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~ev~~ 602 (627)
.......+ .........+.+++.+|++.+|++||++ +++++
T Consensus 232 ~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111000 0001113456778889999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=280.74 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=190.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+..|++++..+ +|||++++.+++.. ....++|+||+
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 478999999999999855 78999999886432 2346788899999999 99999999998875 45788999998
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+++|..++... .+++.....++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||.+...... .
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 56898887632 4788888899999999999999998 999999999999999999999999998865433 2
Q ss_pred CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---------HHHHHHHHhhhccccccc
Q 006886 493 TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD---------LPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 562 (627)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..++........ ..+.+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-TLRFV 242 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-hHHHH
Confidence 3346778999998765 568999999999999999999999997543210000 000110000000 00000
Q ss_pred -chhhhcCCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccc
Q 006886 563 -DVELLKYQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQP 610 (627)
Q Consensus 563 -d~~l~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~ 610 (627)
........... .....+.+++.+|++.+|++||++.+++.+ ++..+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00000000001 112467788889999999999999999875 4444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-33 Score=271.69 Aligned_cols=245 Identities=21% Similarity=0.337 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccccCH--------HHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEE
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK--------REFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~--------~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv 408 (627)
..+||+|||+.||++. +...+.||||+-.....++ +...+|..+-+.+ .||.||++++++.- .+.++-|
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccccceee
Confidence 4689999999999998 4457889999865433322 3456788888889 99999999999975 4567889
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLA 485 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a 485 (627)
.||++|.+|.-||+.++ .+++.++..|+.||+.||.||.+.. +||||.||||.|||+-. -|.+||.|||++
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999999875 4899999999999999999999876 89999999999999954 478999999999
Q ss_pred cccCCCC-----------CCCCCccccCccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006886 486 HLINFPT-----------TATRTIGYRAPEVTET----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 486 ~~~~~~~-----------~~~~t~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 550 (627)
+.++..+ ...||.+|++||.+-- .+.+.|+||||.||++|.++.|+.||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 9886432 2347899999998742 357899999999999999999999997532110
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.++.+......-...+...+....+.+ .+|++|++..-++|....++..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHhhhchhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHHcc
Confidence 112222111111112222223334444 4566999999999998888765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=265.67 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEecccccC--HHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAAT--KREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~ 409 (627)
.-++-+|.||+||.|.+++ .+.|.+|.++..... -..+..|.-.+..+ .|||+.++.+.+.++ +..+++|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEE
Confidence 3467899999999997653 445667776654332 23466666666667 799999999998765 4568899
Q ss_pred ecCCCCCHHHHhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 410 SYMPAGSLFMLLHRNRS---DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
.++.-|+|..||...+. ...+.++-.+...++.|++.|++|||+++ +||.||.++|.+||+...+||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999985442 22456778889999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccc
Q 006886 487 LINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559 (627)
Q Consensus 487 ~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (627)
.+-+.+ ....+..||+||.+....|+..+|||||||+||||+| |+.||.+.+..+ +...+.++.
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkdGy-- 515 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKDGY-- 515 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhccc--
Confidence 775432 3345678999999999999999999999999999999 999998654332 222222221
Q ss_pred cccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 560 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
++. ..-.+..+++.+|..||+..|++||+++|++..|.++..
T Consensus 516 -----Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 516 -----RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -----eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111 223344567788889999999999999999999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=267.47 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=198.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCC-----CeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS-----NVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lv~e~~ 412 (627)
...+|+|.||.|-.+.++ .+..||+|+++....-.+..+.|+++++++.++. -++.+.++|...++.++|+|.+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 467999999999999865 4789999999887666777888999999995443 3788889999999999999998
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-------------------
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ------------------- 473 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~------------------- 473 (627)
|-++.+++..+. -.+++......|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 174 -G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 -GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred -ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 669999998764 357888999999999999999999998 999999999999842
Q ss_pred -CCCeEEeecccccccCCCC-CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH
Q 006886 474 -DLNGCISDVGLAHLINFPT-TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS 551 (627)
Q Consensus 474 -~~~~ki~DfG~a~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~ 551 (627)
+..++|+|||.|++..... +.+.|..|.|||++.+-.++.++||||+||||.|+.||..-|+..+..+.. .....
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL---aMMer 323 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL---AMMER 323 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH---HHHHH
Confidence 3457899999999876544 445688999999999999999999999999999999999999865422211 11111
Q ss_pred Hhh-----------------hc---ccc--------cccc---hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006886 552 VVR-----------------EE---WTA--------EVFD---VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600 (627)
Q Consensus 552 ~~~-----------------~~---~~~--------~~~d---~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 600 (627)
++. .+ |.. .+++ +.-.......++..++++++.+++..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 111 00 000 0000 0000111235667789999999999999999999999
Q ss_pred HHH
Q 006886 601 VRM 603 (627)
Q Consensus 601 ~~~ 603 (627)
+.+
T Consensus 404 L~H 406 (415)
T KOG0671|consen 404 LSH 406 (415)
T ss_pred hcC
Confidence 864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=263.67 Aligned_cols=193 Identities=25% Similarity=0.391 Sum_probs=169.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-CHHH---HHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-TKRE---FEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.++||+|.||.|-.++-+ .++.+|+|++++... .+.+ -..|-++++.- +||.+..+...|...+..+.||||..
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEcc
Confidence 478999999999999955 689999999987643 3333 34466777777 99999999888999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc----C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI----N 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~----~ 489 (627)
||.|.-+|.+. ..+++.....+-..|+.||.|||+.+ ||.||||-+|.|+|+||++||+|||+++.. .
T Consensus 252 GGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred CceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999764 35888888889999999999999988 999999999999999999999999998753 2
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
...+.+||+.|+|||++....|...+|+|.+|||+|||+.|+.||...+.+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 346788999999999999999999999999999999999999999876544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=270.29 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=192.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
+.||+|++|.||+|... +++.||+|.+.... ...+.+..|+++++.+ +|+|++++++++...+..++|+||++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 67999999999999966 58999999987642 2346778899999999 89999999999999999999999997 5
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||++++++.++|+|||.++......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 8999998642 35899999999999999999999998 9999999999999999999999999988764432
Q ss_pred -CCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc------cc--cc
Q 006886 493 -TATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT------AE--VF 562 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~ 562 (627)
...++..|+|||.+.+. .++.++||||||+++||+++|+.||......+ ....+......... .. ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 22346679999998766 78999999999999999999999996543111 00011000000000 00 00
Q ss_pred chhhhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+....... ..+.....+.+++.+|+..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 001113467888999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=281.00 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=184.7
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||++.. ++++.||+|++..... ..+.+.+|++++.++ +|+||+++.+++... ...+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEE
Confidence 36799999999999985 4688999999865422 245677899999999 999999999988643 335777
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 101 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 7776 7899888753 24899999999999999999999998 999999999999999999999999998866
Q ss_pred CCCC-CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh-c-----cccc
Q 006886 489 NFPT-TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE-E-----WTAE 560 (627)
Q Consensus 489 ~~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~ 560 (627)
.... ...++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........ . ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCCHHHHhh
Confidence 4432 3456788999999865 567899999999999999999999996532211 01110000 0 0000
Q ss_pred ccch-------hhhcCC--ChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDV-------ELLKYQ--DVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~-------~l~~~~--~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+. .+.... ... ....++.+++.+|+..+|.+||++.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 000000 000 112356788889999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=277.41 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=183.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--------ceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--------EKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 406 (627)
.+.||+|+||.||+|..+ +++.+|+|++..... ....+.+|++++..+ +|+||+++++++.... ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEE
Confidence 467999999999999965 688999998864322 234577899999999 9999999998875433 358
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||+.+ ++...+... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.++|+|||+++
T Consensus 92 lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 92 MVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence 99999965 677776543 235899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCC---------------CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006886 487 LINFPT---------------TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 487 ~~~~~~---------------~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 550 (627)
...... ...+++.|+|||.+.+ ..++.++||||||+++|||++|++||....... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~------~~~ 237 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID------QLH 237 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 653211 1124677999998765 457899999999999999999999997543211 111
Q ss_pred HHhhhcc------------cccccc-hhhhcC-CCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 551 SVVREEW------------TAEVFD-VELLKY-QDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 551 ~~~~~~~------------~~~~~d-~~l~~~-~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
....... .....+ ...... ... ......+.+++.+|+..+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000 000000 000000 000 111246778899999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=266.52 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEecccc------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVA------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||++.... +..+++|.++... .....+..|+.++.++ +|||++++++++.+....++|+||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence 4679999999999998653 4456666654321 1234566788889999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++++|..++..... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++. +.++|+|||.++.....
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999999875322 2356899999999999999999999998 999999999999975 56999999998765332
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....++..|+|||...+..++.++|+||||+++|+|++|..||.... ............ ..
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~-~~-------- 223 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEGP-TP-------- 223 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCC-CC--------
Confidence 23346788999999988888999999999999999999999986421 111111111110 00
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........++.+++.+|+..+|++||++.|++++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0012233467788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=263.33 Aligned_cols=219 Identities=17% Similarity=0.206 Sum_probs=172.9
Q ss_pred CCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhh
Q 006886 345 GSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHR 423 (627)
Q Consensus 345 G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 423 (627)
|.+|.||+++.+ +++.||+|++.... .+..|...+... .|||++++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 68899999986542 233444444444 799999999999999999999999999999999875
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-CCCCCCccccC
Q 006886 424 NRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATRTIGYRA 502 (627)
Q Consensus 424 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~t~~y~a 502 (627)
. ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++++|||.+...... ....++..|+|
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 4 24899999999999999999999998 999999999999999999999999987665432 23345677999
Q ss_pred ccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHH
Q 006886 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQI 582 (627)
Q Consensus 503 PE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l 582 (627)
||...+..++.++||||+|+++|||++|+.|+....... ... .. ++ . . ......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~--~~-~~--~--~---~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH--TT-LN--I--P---EWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc--cc-cC--C--c---ccCCHHHHHH
Confidence 999988889999999999999999999998875321100 000 00 00 0 0 0112345678
Q ss_pred HHHcccCCCCCCCCHH
Q 006886 583 ALSCVAKVPDSRPKMD 598 (627)
Q Consensus 583 ~~~Cl~~~p~~RPs~~ 598 (627)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=280.81 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=189.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||.||++... ++..||||++..... ..+.+..|++++..+ +||||+++++++..+. ..++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEE
Confidence 367999999999999854 689999999864322 235678899999999 9999999999887553 35899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 99 ~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 99 MPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 9998 7799888753 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCC-CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc-c-----ccc
Q 006886 489 NFPT-TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE-W-----TAE 560 (627)
Q Consensus 489 ~~~~-~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~ 560 (627)
.... ...+++.|+|||.+.+ ..++.++||||||+++|++++|+.||...... .......... . ...
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL------DQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHh
Confidence 4432 3356788999999865 45889999999999999999999999754211 1111100000 0 000
Q ss_pred ccc-------hhhhcCC--C----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhccc
Q 006886 561 VFD-------VELLKYQ--D----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQIQQP 610 (627)
Q Consensus 561 ~~d-------~~l~~~~--~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~~~~~ 610 (627)
... ..+.... . .......+.+++.+|+..+|++|||+.+++. .++.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000 0000000 0 0112235678889999999999999999994 45555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=278.93 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=187.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc------eEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE------KLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv 408 (627)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.+ +|+|++++.+++...+. .++|
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEE
Confidence 368999999999999975 57899999986432 2235577899999999 99999999988776554 8899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9998 6799998864 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc------cccc
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE------WTAE 560 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 560 (627)
... ....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...... ..+..+.... ....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI------DQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhcCCCCHHHHhh
Confidence 433 23456788999999755 46789999999999999999999999754221 1111111000 0000
Q ss_pred ccch---------hhhcCCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDV---------ELLKYQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~---------~l~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... ......... ....++.+++.+|+..+|++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 000000000 123467788999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=278.34 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=182.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--------------
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-------------- 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-------------- 402 (627)
.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+++++++ +||||+++++.+...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccccccccc
Confidence 367999999999999965 58899999886543 3346688899999999 999999998776543
Q ss_pred CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEee
Q 006886 403 DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISD 481 (627)
Q Consensus 403 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~D 481 (627)
...++|+||++ ++|.+++... .+++.....++.|++.||.|||+.+ |+||||||+||+++. ++.+|++|
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35689999997 5898887532 4889999999999999999999998 999999999999984 56789999
Q ss_pred cccccccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH-
Q 006886 482 VGLAHLINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV- 552 (627)
Q Consensus 482 fG~a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~- 552 (627)
||.++..... ....++..|+|||++.. ..++.++|||||||++|||++|+.||......+. ........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVP 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcC
Confidence 9998765321 11235778999998654 5678899999999999999999999975432110 00000000
Q ss_pred ---------hhhcccccccchhhhcCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 553 ---------VREEWTAEVFDVELLKYQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 553 ---------~~~~~~~~~~d~~l~~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
................... ......++.+++.+|+..+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000 0112245677888999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=295.36 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=191.2
Q ss_pred HhcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 338 SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 338 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
+.++||+|+||.|..++.+ .++.||.|++.+. ......|..|-.+|..- ..+=|+.+...|.++.++|+|||||
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEecc
Confidence 3588999999999999976 5788999999774 33456788888888776 7788999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
+||+|-.++.+.. .+++.++..++..|+-||.-+|+.| +|||||||+|||+|..|++|++|||.+-.+..
T Consensus 158 pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred cCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999998652 6899999999999999999999999 99999999999999999999999999877653
Q ss_pred ---CCCCCCCccccCccccC----C-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 ---PTTATRTIGYRAPEVTE----T-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ---~~~~~~t~~y~aPE~~~----~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+|||.|++||++. + +.|.+.+|+||+||++|||+.|.-||... .++.-...+..-. +.+
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk---~~l 300 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHK---ESL 300 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchh---hhc
Confidence 34567999999999984 3 57899999999999999999999999743 2222222222211 111
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK---MDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~~~ 603 (627)
. +......+++.+.++. +- --+|+.|.. ++|+..+
T Consensus 301 ~--FP~~~~VSeeakdLI~---~l-l~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 S--FPDETDVSEEAKDLIE---AL-LCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred C--CCcccccCHHHHHHHH---HH-hcChhhhcccccHHHHHhC
Confidence 1 0111234566666554 32 256777777 8887664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=295.96 Aligned_cols=139 Identities=19% Similarity=0.330 Sum_probs=124.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... +++.||||+++.... ....+..|+.++..+ +|+||+++++.+...+..++||||++
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 468999999999999976 688999999875422 235678888999888 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999754 24788999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=237.64 Aligned_cols=214 Identities=24% Similarity=0.360 Sum_probs=173.4
Q ss_pred CceeeecCCCCCCCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCee
Q 006886 317 NKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVV 393 (627)
Q Consensus 317 ~~~~~~~~~~~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv 393 (627)
..+.....+.+++.-+++ ...+.||+|++|.|-+.++. +|+..|+|++..... ..+....|+.+..+-..+|.+|
T Consensus 31 ~a~i~I~~~~~eV~ad~L--~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V 108 (282)
T KOG0984|consen 31 RALIYIGDRNFEVPADDL--VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTV 108 (282)
T ss_pred CceEEEecCccccchhhh--hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEE
Confidence 344444444444444444 44578999999999888854 799999999976543 3455677777766665899999
Q ss_pred eeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 394 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
.++|.+......++.||.|+. +|..+.++.- ..+..+++...-+||..|..||.|||++- .++|||+||+|||++.
T Consensus 109 ~FyGa~~regdvwIcME~M~t-Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 109 HFYGALFREGDVWICMELMDT-SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINY 184 (282)
T ss_pred EeehhhhccccEEEeHHHhhh-hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEcc
Confidence 999999999999999999965 7877766532 23567899999999999999999999974 6999999999999999
Q ss_pred CCCeEEeecccccccCCCCC---CCCCccccCccccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 006886 474 DLNGCISDVGLAHLINFPTT---ATRTIGYRAPEVTET----RKASQKSDVYSFGVLLLEMLTGKAPLQH 536 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~~~~~---~~~t~~y~aPE~~~~----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 536 (627)
+|++||||||++..+.++.. ..|-..|||||.+.. ..|+-++||||+|+++.||.+++.||+.
T Consensus 185 ~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 185 DGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred CCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99999999999988765432 346678999999853 4789999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.75 Aligned_cols=237 Identities=20% Similarity=0.287 Sum_probs=189.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
...+|.|+|+.|-.+... +++..++|++.+. ..+-.+|+.++.....||||+++.+.+.+..+.++|||.+.++-+
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 356999999999888854 6788999998654 233456777788888999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-cCCCCeEEeecccccccCCC-CCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL-TQDLNGCISDVGLAHLINFP-TTAT 495 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl-~~~~~~ki~DfG~a~~~~~~-~~~~ 495 (627)
.+.+...+. .. ..+..|+.+++.|+.|||++| +|||||||+|||+ +..++++|+|||.++..... .+..
T Consensus 404 l~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~ 474 (612)
T KOG0603|consen 404 LRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPA 474 (612)
T ss_pred HHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccc
Confidence 888876532 22 778889999999999999998 9999999999999 58899999999999988665 3445
Q ss_pred CCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHH
Q 006886 496 RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575 (627)
Q Consensus 496 ~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 575 (627)
-|..|.|||+.....|++++||||||++||+|++|+.||.....+ .++ ...+...... ...+++
T Consensus 475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~~~~s----------~~vS~~ 538 (612)
T KOG0603|consen 475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQMPKFS----------ECVSDE 538 (612)
T ss_pred hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcCCccc----------cccCHH
Confidence 688999999999999999999999999999999999999864332 111 1111111000 223344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 576 ~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
.+ +++..|++.||.+||+|.++..+-..
T Consensus 539 AK---dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 539 AK---DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HH---HHHHHhccCChhhCcChhhhccCcch
Confidence 44 45669999999999999999876555
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=265.55 Aligned_cols=194 Identities=26% Similarity=0.357 Sum_probs=168.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
..+||+|+||.|-.+.-+ ..+.+|||++++... +-+--+.|-++++.-++.|.++++..+|..-+.+|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 478999999999999866 356799999987632 223345566777777789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---- 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~---- 489 (627)
||+|--++++.. .+.+..+.-+|..||-||-+||+++ |+.||||-+|||+|.+|++||+|||+++.--
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999998887653 4778889999999999999999999 9999999999999999999999999987542
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
...+..||+.|+|||++....|...+|+|||||+||||+.|++||++.+++
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 234567999999999999999999999999999999999999999976543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=270.49 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=195.2
Q ss_pred CCHHHHHHHH-hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 329 FDLEDLLRAS-AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 329 ~~~~~l~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
.++..+.+.. +++||+|.||+||-|..+ +|+.||||++.+. ...+....+|+.+++.+ +||.||.+.-.|+..+
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPE 636 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCc
Confidence 3444444333 689999999999999965 7999999998765 33556789999999999 9999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEe
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCIS 480 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~ 480 (627)
..++|||-+.|.=|...|... ...+++.....+..||+.||.|||.++ |+|+||||+|||+... -++|||
T Consensus 637 rvFVVMEKl~GDMLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSE----KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred eEEEEehhhcchHHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeec
Confidence 999999999665455555433 356888888889999999999999999 9999999999999765 468999
Q ss_pred ecccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 481 DVGLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 481 DfG~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
|||+|+.++.. .+..||+.|+|||++....|...-|+||.||++|--++|..||.+.. ++- ..++..
T Consensus 710 DFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIn-------dQIQNA- 779 (888)
T KOG4236|consen 710 DFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DIN-------DQIQNA- 779 (888)
T ss_pred cccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chh-------HHhhcc-
Confidence 99999998654 45679999999999999999999999999999999999999997532 111 111111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..++.+ ..+.+.....+++|...++..-.+|-|.+..+.
T Consensus 780 -aFMyPp-----~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 780 -AFMYPP-----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -ccccCC-----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111111 122333345566777778888888888876654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=229.71 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=188.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.++||+|.||+||+|+.+ .++.||+|+++..... .....+|+-+++.+ +|.|||++++....+...-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhH
Confidence 378999999999999954 5888999998765332 35678899999999 999999999999999999999999965
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
+|..|..... ..++......++.|+++||.|+|+++ +.|||+||.|.|++.+|+.|++|||+++.++.+
T Consensus 86 -dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 -DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred -HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 7888876543 35888899999999999999999998 999999999999999999999999999988654
Q ss_pred -CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH--h-hhccccc--ccc
Q 006886 492 -TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV--V-REEWTAE--VFD 563 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~--~~d 563 (627)
+....|..|.+|.++.+. -|++..|+||-||++.|+.. |++-|.+.+..+. +.+.++.. . .+.|..- ..|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccccCCC
Confidence 334568999999998764 58999999999999999988 5555665543332 22222211 1 1222111 111
Q ss_pred hhhh-cCC---ChHHHH----HHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 VELL-KYQ---DVEEEM----VQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ~~l~-~~~---~~~~~~----~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.... .++ ...+.. ..-.+++.+.+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1100 000 011111 11234555677789999999998765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=250.56 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=191.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--------CceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--------DEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 406 (627)
..+||+|.||.||+|+.+ .|+.||+|++--. ..-.....+|++++..+ +|+|++.++..|... ...+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceee
Confidence 468999999999999965 5778898875332 12235678899999999 999999998887642 3478
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+++|+. +|...|.... ..++.....+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+++
T Consensus 101 lVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 99999987 8888886532 45888999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCC--------CCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH-HHHhhhc
Q 006886 487 LINFPT--------TATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV-RSVVREE 556 (627)
Q Consensus 487 ~~~~~~--------~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 556 (627)
.+..+. ....|..|.+||.+.+ +.|+++.|||+-|||+.||+|+.+-+++..+....++++.. ..+..+-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 764322 1234789999999865 67999999999999999999999988876544333322221 1111111
Q ss_pred ccccccchh---------hhc--CCChHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 557 WTAEVFDVE---------LLK--YQDVEEEMV------QMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 557 ~~~~~~d~~---------l~~--~~~~~~~~~------~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
|. .+-..+ +.. ....++.++ +..+++..++..||.+|+.+.+++.+---.
T Consensus 253 WP-~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 253 WP-NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CC-CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 11 110000 110 111222233 456777789999999999999998764433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=249.75 Aligned_cols=234 Identities=25% Similarity=0.384 Sum_probs=189.2
Q ss_pred CceeEEEEEec-CCcEEEEEEeccccc-C-HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhh
Q 006886 346 SYGSTYKAILE-DGTTVVVKRLREVAA-T-KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLH 422 (627)
Q Consensus 346 ~~g~Vy~~~~~-~~~~vavK~l~~~~~-~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 422 (627)
+||.||+|... +++.+|+|++..... . .+.+.+|++.++++ +|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999976 489999999875433 2 57899999999999 99999999999999999999999999999999987
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---CCCCCCcc
Q 006886 423 RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---TTATRTIG 499 (627)
Q Consensus 423 ~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---~~~~~t~~ 499 (627)
... .+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....++..
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 542 2889999999999999999999998 999999999999999999999999999877543 33446788
Q ss_pred ccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHH
Q 006886 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQM 579 (627)
Q Consensus 500 y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 579 (627)
|++||......++.++||||||++++++++|..||..... ....... ........ .........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~~~~~~-~~~~~~~~--------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LLELFKK-IGKPKPPF--------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHH-HhccCCCC--------ccccccCCHHH
Confidence 9999999888899999999999999999999999865311 1111111 11110000 00000023467
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 006886 580 LQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 580 ~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 78888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=280.75 Aligned_cols=252 Identities=19% Similarity=0.209 Sum_probs=160.1
Q ss_pred hcccCcCCceeEEEEEec-C----CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeE------EeeCCceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-D----GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY------YYSKDEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~------~~~~~~~~l 407 (627)
.+.||+|+||.||+|++. + +..||+|++...... +.+..+ .+... .+.++..+... .......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEE
Confidence 478999999999999975 4 689999987643211 111111 11111 22222222211 245567899
Q ss_pred EEecCCCCCHHHHhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec
Q 006886 408 VYSYMPAGSLFMLLHRNRSD---------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 472 (627)
|+||+++++|.+++...... ............++.|++.||.|||+.+ |+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence 99999999999998753210 0001123345679999999999999998 99999999999998
Q ss_pred C-CCCeEEeecccccccCCC-----CCCCCCccccCccccCCC----------------------CCCCcchhHHHHHHH
Q 006886 473 Q-DLNGCISDVGLAHLINFP-----TTATRTIGYRAPEVTETR----------------------KASQKSDVYSFGVLL 524 (627)
Q Consensus 473 ~-~~~~ki~DfG~a~~~~~~-----~~~~~t~~y~aPE~~~~~----------------------~~~~~~Dv~S~Gvvl 524 (627)
. ++.+||+|||+|+..... ....+++.|+|||.+... .+..++|||||||++
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 589999999999865322 344578899999965321 234567999999999
Q ss_pred HHHHhCCCCCCCCC-------CCCCCCHHHHHHHHhhhcccccccchhhhc-CCChHHHHHHHHHHHHHcccCCCCCCCC
Q 006886 525 LEMLTGKAPLQHSG-------HDDVVDLPRWVRSVVREEWTAEVFDVELLK-YQDVEEEMVQMLQIALSCVAKVPDSRPK 596 (627)
Q Consensus 525 ~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 596 (627)
|||+++..|++... .....+...|...... ...+.+.. ............+++.+|+..||++|||
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP------RASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc------ccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 99999776653210 0000111111111000 00000000 0000111223457889999999999999
Q ss_pred HHHHHHH
Q 006886 597 MDDVVRM 603 (627)
Q Consensus 597 ~~ev~~~ 603 (627)
+.|++++
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=266.54 Aligned_cols=252 Identities=17% Similarity=0.241 Sum_probs=198.0
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEecCCc-EEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEee
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILEDGT-TVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS 401 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~ 401 (627)
....++++.. ...||-||||+|-.+..++.. .+|+|.+++.. ...+....|-.+|... +.|.||+++..|.+
T Consensus 415 a~v~l~dl~~--iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 415 AQVKLSDLKR--IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD 491 (732)
T ss_pred cccchhhhhh--hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc
Confidence 3455666633 467999999999999877433 48888887542 2345677888898888 89999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 402 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
+...|++||-|-||.|+..++.. ..++......++..+.+|++|||+++ ||+|||||+|.+++.+|-+||.|
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEee
Confidence 99999999999999999999864 35888889999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCC---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 482 VGLAHLINFPT---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 482 fG~a~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
||+|+.+.... +++||+.|.|||++.....+..+|.||+|+++|||++|.+||.+.++-...+ .++..- .
T Consensus 564 FGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn------~ILkGi-d 636 (732)
T KOG0614|consen 564 FGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN------LILKGI-D 636 (732)
T ss_pred hhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------HHHhhh-h
Confidence 99999986643 5679999999999999999999999999999999999999998754321111 111111 0
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRMIE 605 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~L~ 605 (627)
+++ .+....+.-.+++++.++.+|.+|.- ..||.++-+
T Consensus 637 --~i~-------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 637 --KIE-------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred --hhh-------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 000 00111223456777888899999975 666666543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=248.17 Aligned_cols=283 Identities=19% Similarity=0.303 Sum_probs=209.2
Q ss_pred ccCceeeecCCCCCCCHHHHHH-H---HhcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccC
Q 006886 315 EKNKLCFLDGSYFNFDLEDLLR-A---SAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKH 389 (627)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~-~---~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h 389 (627)
++..-.+..+.|..+.+.|... . ..++||.|-|++||++.+. +.+.||+|+.+....-.+....|+++++++..+
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3334445667777777777766 2 2679999999999999954 578899999987766677789999999998643
Q ss_pred C-------CeeeeeeEEee----CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006886 390 S-------NVVPVRAYYYS----KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458 (627)
Q Consensus 390 ~-------niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 458 (627)
. .||+++++|.. ..+.++|+|++ |.+|..++.+... +.++.....+|+.||+.||.|||+++ .
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--g 208 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--G 208 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--C
Confidence 3 69999999975 45789999999 7799999987643 45899999999999999999999987 6
Q ss_pred eeecCCCCCCeEecCC----------------------------------------------------------------
Q 006886 459 FTHGNIKSSNVLLTQD---------------------------------------------------------------- 474 (627)
Q Consensus 459 ivH~Dlk~~NILl~~~---------------------------------------------------------------- 474 (627)
|||.||||+|||+..+
T Consensus 209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l 288 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL 288 (590)
T ss_pred ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence 9999999999998200
Q ss_pred --------------------------------------------------------------------------------
Q 006886 475 -------------------------------------------------------------------------------- 474 (627)
Q Consensus 475 -------------------------------------------------------------------------------- 474 (627)
T Consensus 289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~ 368 (590)
T KOG1290|consen 289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP 368 (590)
T ss_pred cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence
Q ss_pred ----------------------CCeEEeecccccccCCC-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCC
Q 006886 475 ----------------------LNGCISDVGLAHLINFP-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGK 531 (627)
Q Consensus 475 ----------------------~~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~ 531 (627)
-.+||+|||-|...... .....|..|+|||++.+..|++.+||||++|+++||+||.
T Consensus 369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGD 448 (590)
T KOG1290|consen 369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGD 448 (590)
T ss_pred CCccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCc
Confidence 01244444444443221 1223467799999999999999999999999999999999
Q ss_pred CCCCCCCCC----CCCCHHHHHH-------HHhhh-cccccccch------------------hhhcCCChHHHHHHHHH
Q 006886 532 APLQHSGHD----DVVDLPRWVR-------SVVRE-EWTAEVFDV------------------ELLKYQDVEEEMVQMLQ 581 (627)
Q Consensus 532 ~p~~~~~~~----~~~~~~~~~~-------~~~~~-~~~~~~~d~------------------~l~~~~~~~~~~~~l~~ 581 (627)
.-|+....+ +..++...++ .+... ....+.|+. -..++....++..+|.+
T Consensus 449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd 528 (590)
T KOG1290|consen 449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD 528 (590)
T ss_pred eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence 998754322 2222222221 11111 112222221 11235556788899999
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 006886 582 IALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 582 l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
++.-|++.+|++||||.+.+++
T Consensus 529 FL~PmLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 529 FLSPMLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHHHHHhcCccccccHHHHhcC
Confidence 9999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=267.32 Aligned_cols=250 Identities=21% Similarity=0.256 Sum_probs=169.1
Q ss_pred hcccCcCCceeEEEEEe-----------------cCCcEEEEEEeccccc-CH--------------HHHHHHHHHHHHh
Q 006886 339 AEVLGKGSYGSTYKAIL-----------------EDGTTVVVKRLREVAA-TK--------------REFEQQMEVVGTI 386 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~-~~--------------~~~~~e~~~l~~l 386 (627)
.++||+|+||.||+|.. .+++.||||++..... .. +.+..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 47899999999999964 2356799999864321 11 2234466677777
Q ss_pred ccCCC-----eeeeeeEEee--------CCceEEEEecCCCCCHHHHhhhcCCC-------------------CCCCCCH
Q 006886 387 GKHSN-----VVPVRAYYYS--------KDEKLVVYSYMPAGSLFMLLHRNRSD-------------------GGTALDW 434 (627)
Q Consensus 387 ~~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~ 434 (627)
+|.+ +++++++|.. .+..++||||+++|+|.++++..... ....++|
T Consensus 230 -~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 230 -KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred -hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 4444 3667777753 35679999999999999998753210 1123578
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC-----CCCCccccCccccCCC
Q 006886 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT-----ATRTIGYRAPEVTETR 509 (627)
Q Consensus 435 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~-----~~~t~~y~aPE~~~~~ 509 (627)
..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..+++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 889999999999999999998 99999999999999999999999999976533211 1236889999987532
Q ss_pred C--------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCCCCC------CCCHHHHHHHHhhhccccc
Q 006886 510 K--------------------A--SQKSDVYSFGVLLLEMLTGKA-PLQHSGHDD------VVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 510 ~--------------------~--~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 560 (627)
. + ..+.||||+||++|||++|.. ||....... ...+..|.. ... .
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~-----~ 459 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG-----Q 459 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc-----c
Confidence 2 1 134799999999999999875 665321100 001111110 000 0
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVP---DSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~ev~~~ 603 (627)
..+.. .. ........+++.+++..+| .+|+|++|++++
T Consensus 460 ~~~~~--~~---d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDFS--LL---DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCcc--cc---cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 01110 11 1122344566678888765 789999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=239.66 Aligned_cols=238 Identities=20% Similarity=0.315 Sum_probs=185.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
..+||+|+|+.|..++++ ..+.+|+|++++.-. ...-.+.|-.+.....+||.+|-+..+|.....++.|.||.+
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 478999999999999965 578899999876522 222345566677777799999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc----C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI----N 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~----~ 489 (627)
||+|--++++.+ .+++..+..+...|..||.|||+.| |+.||||-+|+|+|.+|++|+.|+|+.+.- +
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999988887654 4888989999999999999999999 999999999999999999999999998754 2
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-CCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH-DDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
..++..||+.|+|||++.+..|...+|+|++||+++||+.|+.||+--.. ....+-..++-+++.+....- ++
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---pr--- 480 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---PR--- 480 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---cc---
Confidence 34567899999999999999999999999999999999999999974221 111222333333333221110 00
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCC
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRP 595 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP 595 (627)
.. ..+...+++.-+.+||.+|.
T Consensus 481 --sl---svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 --SL---SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --ee---ehhhHHHHHHhhcCCcHHhc
Confidence 00 11223455677889999884
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.35 Aligned_cols=239 Identities=24% Similarity=0.365 Sum_probs=181.5
Q ss_pred hcccCcCCcee-EEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGS-TYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+++|.|+.|+ ||+|... |+.||||++-.. ...-..+|+..++.-.+|||||++++.-.++...|+..|.| ..+|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 46799999875 7999996 899999988542 23446788988888779999999998888888899999999 5599
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---C--CCeEEeecccccccCCC-
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---D--LNGCISDVGLAHLINFP- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~--~~~ki~DfG~a~~~~~~- 491 (627)
.+++.....+ .....-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+...
T Consensus 590 ~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999863111 111111445678899999999999988 999999999999976 3 46799999999987543
Q ss_pred ------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG-KAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.+..||-||+|||++....-+..+||||+|||+|+.++| +.||......+. .++.......
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~---- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV---- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee----
Confidence 334578999999999988888999999999999999995 999975432210 1111111111
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
......++ +..++|.+|++++|..||++.+|+.
T Consensus 734 ---~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 ---HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111122 5567888999999999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=253.92 Aligned_cols=193 Identities=25% Similarity=0.369 Sum_probs=164.6
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||-|+||.|++++..| ...||.|.+++... .-....+|..|+... ..+=||+++..|.+++.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCC
Confidence 579999999999998554 55689998876532 234567788888887 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC-----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----- 489 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~----- 489 (627)
|++-.+|-+. ..+.+..+..++.+++.|+++.|..| +|||||||+|||||.+|++||.|||++.-+.
T Consensus 714 GDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 714 GDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999988764 35888889999999999999999999 9999999999999999999999999975431
Q ss_pred ----C-------C------------------------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHH
Q 006886 490 ----F-------P------------------------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528 (627)
Q Consensus 490 ----~-------~------------------------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~ 528 (627)
. + ...+||+.|+|||++....|+..+|+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 0 0 0113688999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCC
Q 006886 529 TGKAPLQHSGHDD 541 (627)
Q Consensus 529 tg~~p~~~~~~~~ 541 (627)
.|+.||......+
T Consensus 866 ~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 866 VGQPPFLADTPGE 878 (1034)
T ss_pred hCCCCccCCCCCc
Confidence 9999998665443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-30 Score=237.80 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=185.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 409 (627)
++.||.|+||.||.+.+. +|+.||.|++..... ..+.+-+|++++..+ +|.|++..++..... .+.|+++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 367999999999999854 799999999865432 456788999999999 999999988876543 2467888
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|.|. .+|...+-. ...++-....-+..||++||.|||+.+ |.||||||.|.|++.|...||||||+++..+
T Consensus 137 ELmQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 8884 477766642 346777778888999999999999998 9999999999999999999999999999876
Q ss_pred CCCCC-----CCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH--------HHHhhh
Q 006886 490 FPTTA-----TRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV--------RSVVRE 555 (627)
Q Consensus 490 ~~~~~-----~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 555 (627)
..... ..|..|.|||++.+ +.|+...||||.||++.|++..+.-|+..+.-...+++... -....+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 54332 34678999999987 56899999999999999999999999865432222211110 000111
Q ss_pred cccccccc-----hhhh---cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 556 EWTAEVFD-----VELL---KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 556 ~~~~~~~d-----~~l~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
+....++. +.+. ........-.+-+.+...++..||+.|.+.++.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111 1110 1111111222344566688899999999988876654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=226.56 Aligned_cols=205 Identities=28% Similarity=0.504 Sum_probs=180.6
Q ss_pred cCcCCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 342 LGKGSYGSTYKAILED-GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 342 lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
||+|++|.||++...+ ++.+++|++..... ..+.+.+|++.+..+ .|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999764 89999999876543 257799999999999 8999999999999989999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCCC----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~~----~~ 493 (627)
+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 9997542 35899999999999999999999998 999999999999999 899999999999876543 22
Q ss_pred CCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+...|++||..... .++.+.|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3466789999999877 888999999999999999
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+.+++..|+..+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246678889999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=226.84 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=188.1
Q ss_pred CCHHHHHHHHhcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeE-EeeCCceE
Q 006886 329 FDLEDLLRASAEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY-YYSKDEKL 406 (627)
Q Consensus 329 ~~~~~l~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~~~ 406 (627)
.+++|.. .+.+.+|+|.||.+-.++++ +.+.+|+|.+.......++|.+|..---.|+.|.||+..++. |+..+.++
T Consensus 20 v~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 20 VDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred cchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4444443 23578999999999999977 467899999998888899999999877778889999987654 55667778
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--CCCeEEeeccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ--DLNGCISDVGL 484 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~ 484 (627)
.++||++.|+|.+-+.. ..+.+....+++.|++.||.|||+++ +||||||.+|||+-+ ...+|+||||.
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccc
Confidence 89999999999888764 34778888999999999999999999 999999999999943 35799999999
Q ss_pred ccccCCCCCC-CCCccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 485 AHLINFPTTA-TRTIGYRAPEVTETR-----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 485 a~~~~~~~~~-~~t~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
++..+..... ..+..|.|||..... ...+.+|||.||++++.++||+.||+..... .....+|.. ......
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~--w~~rk~ 246 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQ--WLKRKN 246 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHH--HhcccC
Confidence 8876543222 245679999987542 3568899999999999999999999843222 222333322 222111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
....+ .+....+ ..+++.++-+..++++|-...++.++.
T Consensus 247 ~~~P~----~F~~fs~---~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPK----KFNPFSE---KALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCch----hhcccCH---HHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11111 1112222 344555588899999995555555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=249.83 Aligned_cols=189 Identities=22% Similarity=0.334 Sum_probs=164.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---------HHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---------KREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~ 406 (627)
.+.+|+|+||.|+.+.++ +...|+||.+.+.+.- ....-.|+.+|..+. .|+||++++.+|++++.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 478999999999999976 4667899988765321 123556899999993 3999999999999999999
Q ss_pred EEEec-CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 407 VVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 407 lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
++||- -++-+|.+++.... .+++.++.-|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+|||.|
T Consensus 646 l~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 99996 46779999998653 5899999999999999999999999 999999999999999999999999999
Q ss_pred cccCC--CCCCCCCccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCC
Q 006886 486 HLINF--PTTATRTIGYRAPEVTETRKAS-QKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 486 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
..... -..+.||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 77643 4677899999999999998884 56899999999999999998885
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=218.67 Aligned_cols=251 Identities=15% Similarity=0.268 Sum_probs=187.0
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~~g 415 (627)
.+++|+|.++.||.|. ..+.+.++||+++.. .++.+.+|++++..+..||||+++++...+.. ...+|+||.++-
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~ 120 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT 120 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence 5789999999999998 557889999999863 46778999999999988999999999987654 567999999988
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCCCCCC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINFPTTA 494 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~~~~~ 494 (627)
+...... .++.......+.+++.||.|+|++| |.|||+||.|+++|.. ...+|+|+|+|.+.......
T Consensus 121 Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 121 DFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred cHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 7766554 3677788889999999999999999 9999999999999964 67899999999998765443
Q ss_pred ---CCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc------cccccch
Q 006886 495 ---TRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW------TAEVFDV 564 (627)
Q Consensus 495 ---~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~ 564 (627)
..+..|--||.+-. ..|+..-|+|||||++..|+..+.||...... ..+++....-.-.++. ..-.+|+
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 34566888998754 56889999999999999999999998653221 1223222211100000 0001222
Q ss_pred hhhc---------------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLK---------------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~---------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+.. .....-...+.++++.+.+..|..+|||++|.+.+
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2110 01111111345667778889999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=245.06 Aligned_cols=273 Identities=18% Similarity=0.271 Sum_probs=209.9
Q ss_pred CCCCCCHHHHHHHH---hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhc-----cCCCeeee
Q 006886 325 SYFNFDLEDLLRAS---AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVVPV 395 (627)
Q Consensus 325 ~~~~~~~~~l~~~~---~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l 395 (627)
.|+.+.+.|++... ....|+|-|++|..|... -|+.||||+++......+.=..|++++.+|. .--|++++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 57778888887654 345789999999999954 4889999999988777788889999999995 23478999
Q ss_pred eeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-
Q 006886 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD- 474 (627)
Q Consensus 396 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~- 474 (627)
+..|...++++||+|-+ ..+|.+.|.+... ...+.......++.|+.-||..|...+ |+|.||||+|||+++.
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 99999999999999988 4489999987643 345778889999999999999999988 9999999999999986
Q ss_pred CCeEEeecccccccCCCCC--CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH---
Q 006886 475 LNGCISDVGLAHLINFPTT--ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV--- 549 (627)
Q Consensus 475 ~~~ki~DfG~a~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~--- 549 (627)
..+||||||.|........ +..+..|.|||++.+-.|+...|+||.||+||||.||+..|.+....++..+.--+
T Consensus 574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 4569999999987755432 22455799999999999999999999999999999999999887665443221111
Q ss_pred --HHHhhhc-ccccccch--------------------------------hhhcCC----ChHHHHHHHHHHHHHcccCC
Q 006886 550 --RSVVREE-WTAEVFDV--------------------------------ELLKYQ----DVEEEMVQMLQIALSCVAKV 590 (627)
Q Consensus 550 --~~~~~~~-~~~~~~d~--------------------------------~l~~~~----~~~~~~~~l~~l~~~Cl~~~ 590 (627)
..+++.+ .....||. .+...+ .......+|.+|+..|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0111110 01111111 111111 12334567788999999999
Q ss_pred CCCCCCHHHHHHH
Q 006886 591 PDSRPKMDDVVRM 603 (627)
Q Consensus 591 p~~RPs~~ev~~~ 603 (627)
|++|.|..+.+++
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=223.15 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=183.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEEE
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVVY 409 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~ 409 (627)
..+|.|.- .|..+.+. .+++||+|++.... ...+...+|...+..+ .|+||++++.++.-. .+.|+||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHH
Confidence 56788887 56666532 58899999986542 2346678899999999 999999999998754 3578999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|+| .++|...+.. .++-.....|..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+..+
T Consensus 101 e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 101 ELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred Hhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 999 4589888873 2566788899999999999999999 9999999999999999999999999998765
Q ss_pred CC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHH---------------
Q 006886 490 FP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS--------------- 551 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~--------------- 551 (627)
.. +....|..|.|||++-+..+.+.+||||.||++.||++|+.-|.+.+ .+.+|...
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHh
Confidence 44 33456778999999988889999999999999999999999987543 22222211
Q ss_pred ------Hhhh--ccccccc-----chhhhc-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 552 ------VVRE--EWTAEVF-----DVELLK-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 552 ------~~~~--~~~~~~~-----d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.++. ......+ |..+.. .....-......+++.+|+..+|++|-++++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1110 0000000 000000 00011122344567889999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=219.33 Aligned_cols=190 Identities=28% Similarity=0.457 Sum_probs=167.6
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.++ +|+|++++++++......++++||++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCC
Confidence 3679999999999999775 88999999876533 467888999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++..... .+++.....++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+......
T Consensus 83 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 83 DLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999986431 1789999999999999999999998 999999999999999999999999999877544
Q ss_pred -CCCCCCccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 006886 492 -TTATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 536 (627)
....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 234466789999998 677788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-27 Score=243.09 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=190.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.+|.|.||.|||++.+ .++..|+|+++... ...+...+|+-+++.- +||||+.++|-|...+..+++|||+.+|+
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 367999999999999954 68899999998653 3455667777777776 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----CCC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPT 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~----~~~ 492 (627)
|.+..+-. .++++.+...++....+|++|||+.+ =+|||||-.||++++.|.+|++|||.+..+. ...
T Consensus 99 lQdiy~~T-----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 99 LQDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred ccceeeec-----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 98877643 57899999999999999999999998 8999999999999999999999999987664 346
Q ss_pred CCCCCccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 493 TATRTIGYRAPEVT---ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 493 ~~~~t~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|...... ..... + ....-+++.-.+
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~l~--L----mTkS~~qpp~lk- 238 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRALF--L----MTKSGFQPPTLK- 238 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHHHH--H----hhccCCCCCccc-
Confidence 67899999999986 356789999999999999999888887543211 10000 0 011122222111
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
+.......|-++++-|+.++|++||+++.++.
T Consensus 239 -Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 -DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11222334556677899999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=206.23 Aligned_cols=170 Identities=21% Similarity=0.258 Sum_probs=128.7
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~ 494 (627)
|+|.++++.. +..++|..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~ 64 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-S 64 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-C
Confidence 6899999753 246999999999999999999999875 999999999999999 99988765433 3
Q ss_pred CCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHH
Q 006886 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574 (627)
Q Consensus 495 ~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 574 (627)
.+++.|+|||++.+..++.++|||||||++|||++|+.||..... ..................+ ......
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~ 134 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADDPRD-----RSNLES 134 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCCccc-----cccHHH
Confidence 678999999999999999999999999999999999999964321 1111111111111000000 001111
Q ss_pred HH--HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 575 EM--VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 575 ~~--~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.. .++.+++.+||..+|++||++.|+++++..+...
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 11 2578899999999999999999999999887544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=220.56 Aligned_cols=187 Identities=25% Similarity=0.430 Sum_probs=159.6
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.++||+|.|++||++.+. ..+.||+|.+.... .-..+..|++++..++.+.||+++.+++..++...+|+||++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 578999999999999854 36789999987643 3455899999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLIN---- 489 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~---- 489 (627)
..-.+++.. ++...+..++..+..||.++|..| ||||||||.|+|.+.. +.-.|+|||+|...+
T Consensus 120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 998888763 678889999999999999999999 9999999999999865 667899999986210
Q ss_pred -------------C----------------C---------------CCCCCCccccCccccC-CCCCCCcchhHHHHHHH
Q 006886 490 -------------F----------------P---------------TTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLL 524 (627)
Q Consensus 490 -------------~----------------~---------------~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl 524 (627)
. + ....||+||.|||++. ....++++||||.||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 0113799999999975 46678999999999999
Q ss_pred HHHHhCCCCCCCC
Q 006886 525 LEMLTGKAPLQHS 537 (627)
Q Consensus 525 ~el~tg~~p~~~~ 537 (627)
+.+++++.||...
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=256.16 Aligned_cols=187 Identities=18% Similarity=0.218 Sum_probs=136.0
Q ss_pred CCeeeeeeEE-------eeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 006886 390 SNVVPVRAYY-------YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHG 462 (627)
Q Consensus 390 ~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 462 (627)
+||+.++++| ......+.++||+ +++|.+++... ...+++..++.++.||++||.|||+++ |+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 5777777776 2234566788887 66999999743 245899999999999999999999998 9999
Q ss_pred CCCCCCeEecC-------------------CCCeEEeecccccccCCC--------------------CCCCCCccccCc
Q 006886 463 NIKSSNVLLTQ-------------------DLNGCISDVGLAHLINFP--------------------TTATRTIGYRAP 503 (627)
Q Consensus 463 Dlk~~NILl~~-------------------~~~~ki~DfG~a~~~~~~--------------------~~~~~t~~y~aP 503 (627)
||||+|||++. ++.+||+|||+++..... ....+|+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 456677777777642110 012367789999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHH
Q 006886 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIA 583 (627)
Q Consensus 504 E~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~ 583 (627)
|++.+..++.++|||||||+||||++|..|+.... ......... .+.+.. ........+++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~~-----~~~~~~------~~~~~~~~~~~ 245 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRHR-----VLPPQI------LLNWPKEASFC 245 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHHh-----hcChhh------hhcCHHHHHHH
Confidence 99999999999999999999999999988865211 011111000 011110 11122345677
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 006886 584 LSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 584 ~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+||.++|.+||+|.|++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHhCCCChhhCcChHHHhhc
Confidence 89999999999999999874
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=205.09 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=191.2
Q ss_pred CCCCHHHHHHHHhcccCcCCceeEEEEEecCCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 327 FNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 327 ~~~~~~~l~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
..+++.++.. ..+|.+...|..|+|++. |..+++|++.-. ....++|..|.-.++-+ .||||.+++|.|....
T Consensus 185 ~gid~~~lnl--~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnspp 260 (448)
T KOG0195|consen 185 TGIDVSSLNL--ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPP 260 (448)
T ss_pred cCcchhhhhh--hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCC
Confidence 3455555532 356888899999999997 566777877533 22456788888777777 9999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
+..++..||+.|+|+..++... +..++-.++.+++.++|+|++|||+.. +-|..--|.+..+++|++.+++|+- +
T Consensus 261 nlv~isq~mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-a 335 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-A 335 (448)
T ss_pred CceEeeeeccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-c
Confidence 9999999999999999999753 356788899999999999999999986 3344457899999999999998751 2
Q ss_pred cccccCCCCCCCCCccccCccccCCCCC---CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 484 LAHLINFPTTATRTIGYRAPEVTETRKA---SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 484 ~a~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
-+++.-........+.||+||.++..+- -..+|+|||++++||+.|...||.+...-+..- ++..++...
T Consensus 336 d~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialeglrv- 408 (448)
T KOG0195|consen 336 DTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEGLRV- 408 (448)
T ss_pred cceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhccccc-
Confidence 1222222233445789999999876543 467999999999999999999998654332211 111111110
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
. -.++ ....+.+++.-|+..||.+||.+..|+-.|++|+
T Consensus 409 ~------ippg---is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 H------IPPG---ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c------CCCC---ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0 1122 2335566777899999999999999999999885
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=241.80 Aligned_cols=185 Identities=36% Similarity=0.649 Sum_probs=139.7
Q ss_pred hhHHHHHHHHHhhCCC--CCCCCCCCCCCCCCCCcceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcc
Q 006886 28 NSDKQALLDFADAVPH--ARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNY 105 (627)
Q Consensus 28 ~~~~~~l~~~~~~~~~--~~~~~W~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~ 105 (627)
+.|..||++||+.+.. ....+|+..+++| .|.||+|+. .++|+.|+|++|+++|.++. .|..+++|+.|+|++|+
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQ 104 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCc
Confidence 4789999999999843 3445897655555 899999985 46899999999999999887 89999999999999999
Q ss_pred cCccCCCCCC-CcccccEEeeecccccccCchhhccccccccccccccccCCccccccccccccccccCCcccccCCCC-
Q 006886 106 LNGTLPSDIT-SISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL- 183 (627)
Q Consensus 106 l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~- 183 (627)
++|.+|..+. .+++|++|+|++|++++.+|.....+|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|..
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 9998998765 88999999999998888777544446677777777776666666666666676666666666655543
Q ss_pred -CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 184 -NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 184 -~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
++++|++|+|++|.+++.+|..++++++|+.+
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHcCcCCccEE
Confidence 56666666666666666666555555555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=186.01 Aligned_cols=251 Identities=18% Similarity=0.239 Sum_probs=192.9
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.++||+|.||+++.|. +-++++||||.-.. ....-+...|...++.|...+.|..++.+-.+..+..||+|.+ |.+|
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 5889999999999999 55789999996432 3344567889999999989999999988888888889999998 8899
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-----CCeEEeecccccccCCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-----LNGCISDVGLAHLINFPT 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~ki~DfG~a~~~~~~~ 492 (627)
.++..-. +..++..+.+.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.+.++.
T Consensus 111 EDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 111 EDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred HHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 8888765 356999999999999999999999998 9999999999999643 457899999999875543
Q ss_pred -----------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 493 -----------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 493 -----------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
...||.+||+-....++.-+.+.|+=|+|-++.+.+.|..||++......- +-..++-.......
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---~kYeKIGe~Kr~T~- 259 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---EKYEKIGETKRSTP- 259 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---HHHHHhccccccCC-
Confidence 335899999999999999999999999999999999999999986543211 11111111111110
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
++ .+ -.+.+++....++.++ ..+-++-|..+-+...+..+.
T Consensus 260 i~-~L--c~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 260 IE-VL--CEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred HH-HH--HhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHH
Confidence 11 01 1235666666677666 467777788877766665553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=200.39 Aligned_cols=152 Identities=18% Similarity=0.236 Sum_probs=118.2
Q ss_pred hcccCcCCceeEEEEEec--CCcEEEEEEecccc------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE--DGTTVVVKRLREVA------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|+.+ +++.||||++.... ...+.|.+|++++..+ +|+|+++.+.. .+..++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---cCCcEEEEE
Confidence 467999999999999864 57778999875321 1245689999999999 89998853322 245799999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEecCCCCeEEeecccccccC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI-KSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|+++++|... .. .. ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+|||+|+...
T Consensus 99 ~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 99 WTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred ccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999622 11 01 1357889999999999998 999999 9999999999999999999998664
Q ss_pred CCC------------CCCCCccccCccccCCC
Q 006886 490 FPT------------TATRTIGYRAPEVTETR 509 (627)
Q Consensus 490 ~~~------------~~~~t~~y~aPE~~~~~ 509 (627)
... +..+++.|+|||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 321 12356789999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-20 Score=189.52 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=186.7
Q ss_pred hcccCcCCceeEEEEEecCC--cEEEEEEecccccC-HHHHHHHHHHHHHhcc---CCCeeeeeeEE-eeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDG--TTVVVKRLREVAAT-KREFEQQMEVVGTIGK---HSNVVPVRAYY-YSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~~---h~niv~l~~~~-~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||.+..... ..+|+|........ ...+..|..++..+.. -+++..++... ......++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 47899999999999997653 47888876654222 1267888888888852 35788888887 467788999998
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-----CCeEEeeccccc
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-----LNGCISDVGLAH 486 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~ki~DfG~a~ 486 (627)
+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+++
T Consensus 103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7 889999876543 357899999999999999999999999 9999999999999865 468999999998
Q ss_pred ccC---C-----------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH
Q 006886 487 LIN---F-----------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 487 ~~~---~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
... . .....||..|.+++...+...+.+.|+||++.++.|+..|..||........ ...+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHH
Confidence 321 1 1123489999999999999999999999999999999999999965432211 1111111
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
........ .....+.+...+.. .+-..+..++|....+...|++.....
T Consensus 253 ~~~~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDR-------FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhcccc-------ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11110000 11122344444444 444589999999999999988875554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-19 Score=185.87 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=189.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+..|++++++...+......+++++++.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 367899999999999987 7899999876532 3567999999999994444899999999777778999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~-- 491 (627)
+++.+++...... ..+.......+..+++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999777654211 25888999999999999999999998 99999999999999998 7999999999755332
Q ss_pred --------CCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 492 --------TTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
....++..|+|||...+ ..+....|+||+|++++++++|..||...... ................
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 34457899999999987 57899999999999999999999997654321 0011111111111111
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........... ......+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 1222456678889999999999999987765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=170.20 Aligned_cols=193 Identities=22% Similarity=0.282 Sum_probs=161.5
Q ss_pred hcccCcCCceeEEEEE-ecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.++||.|+||.+|.|. ..+|..||||.-... ....+...|.+++..++....|..+.-+..+.+...+||+.+ |.+|
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 4789999999999998 668999999976442 234457788889999977788888888888889999999998 8899
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEeecccccccCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfG~a~~~~~~--- 491 (627)
.+...-.. ..++..+.+-+|-|++.-++|+|.++ ++||||||+|+|+.-+ ..+.++|||+|+...+.
T Consensus 98 EdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 98 EDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 98887553 35888899999999999999999999 9999999999999754 45789999999876432
Q ss_pred --------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 492 --------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
....||.+|.+-....+...+.+.|+=|+|.+|.+.-.|..||++....
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 2234788998877777777789999999999999999999999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=211.62 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=176.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecc---cccCHHH----HHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLRE---VAATKRE----FEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~---~~~~~~~----~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+++|.|++|.|+..... .....+.|..+. ....... +..|+.+-..+ .|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhhh
Confidence 578999999977777633 334444443321 1111111 44455555666 99999888877777776666799
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++ +|..++... ..+...++-.++.|+..|+.|+|+.| |.|||+|++|++++.++.+||+|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999999764 24778888999999999999999999 99999999999999999999999999876643
Q ss_pred C--------CCCCCCccccCccccCCCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 491 P--------TTATRTIGYRAPEVTETRKASQ-KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 491 ~--------~~~~~t~~y~aPE~~~~~~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
+ ....|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+... ........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQ 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhccccc
Confidence 2 2345778899999999999875 5899999999999999999997654433211 00000000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
+........-..........++.++++.+|.+|.|+++|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000111222334556888999999999999999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=174.12 Aligned_cols=138 Identities=12% Similarity=0.162 Sum_probs=106.5
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc---C-------H-----------------HHHHHHHHHHHHhccCCCe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---T-------K-----------------REFEQQMEVVGTIGKHSNV 392 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~-------~-----------------~~~~~e~~~l~~l~~h~ni 392 (627)
+.||+|+||.||+|...+|+.||||+++.... . . .....|++.+.++ .++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCCC
Confidence 57999999999999988899999999975421 1 0 1223488889988 66666
Q ss_pred eeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeEe
Q 006886 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI-HSEGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 393 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlk~~NILl 471 (627)
.....+.. ...++||||++++++....... ..+++....+++.|++.+|.|+ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 43332222 2348999999988775443221 3588899999999999999999 6877 9999999999999
Q ss_pred cCCCCeEEeecccccccC
Q 006886 472 TQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~ 489 (627)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=168.91 Aligned_cols=182 Identities=14% Similarity=0.133 Sum_probs=140.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHH-----HHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKR-----EFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
...|++|+||+||.+.- ++.+++.+.+.......+ .+.+|++++.++.+|+++.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997765 578888888766544333 588999999999777889988886 45689999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEecCCCCeEEeecccccccCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI-KSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
|.+|...+.. ....++.|++++|.++|+.| |+|||| ||+|||++.++.++|+|||+|.......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998654321 11346788999999999999 999999 7999999999999999999998654332
Q ss_pred C-----------------CCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 493 T-----------------ATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 493 ~-----------------~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
. ...++.|++|+...- ...-...++++-|.-+|.++|+..+..+..+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 1 013667777775432 22236778999999999999999987665443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=169.03 Aligned_cols=138 Identities=16% Similarity=0.209 Sum_probs=108.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccC---------------------------HHHHHHHHHHHHHhccCCCe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT---------------------------KREFEQQMEVVGTIGKHSNV 392 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~~h~ni 392 (627)
..||+|+||.||+|...+|+.||||+++..... ...+..|.+.+.++ .|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCCC
Confidence 579999999999999878999999998754210 11235678888888 78887
Q ss_pred eeeeeEEeeCCceEEEEecCCCCCHHHH-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeE
Q 006886 393 VPVRAYYYSKDEKLVVYSYMPAGSLFML-LHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVL 470 (627)
Q Consensus 393 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIL 470 (627)
.....+... ..++||||++++++... +.. ..++.....+++.+++.++.++|+ .+ |+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 544444332 34799999998855433 332 246778899999999999999999 88 999999999999
Q ss_pred ecCCCCeEEeecccccccCC
Q 006886 471 LTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 471 l~~~~~~ki~DfG~a~~~~~ 490 (627)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 89999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=200.25 Aligned_cols=133 Identities=33% Similarity=0.619 Sum_probs=100.4
Q ss_pred cCChhHHHHHHHHHhhCCCCCCCCCCCCCCCC----CCCcceEeeCCC----CcEEEEEcCCCCcccccCccccCCCCcc
Q 006886 25 ADLNSDKQALLDFADAVPHARKLNWNAAAPVC----SSWIGVTCNVNR----SRVIGIHLPGIGFTGPIPANSIGKLDAL 96 (627)
Q Consensus 25 ~~~~~~~~~l~~~~~~~~~~~~~~W~~~~~~c----~~w~gv~C~~~~----~~v~~l~l~~~~l~~~~~~~~l~~l~~L 96 (627)
.....|..||+.||..+.....++|+. ++| +.|.||.|.... ..|+.|+|++|++.|.+|. .++.|++|
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~~L 444 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHL 444 (623)
T ss_pred ccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCCCC
Confidence 345679999999999986544458964 345 379999996321 2588999999999999988 78999999
Q ss_pred cEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccccccccCCccccccccccccccccCCcc
Q 006886 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSI 176 (627)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 176 (627)
+.|+|++|.|+|.+|..++.+++|+.|+|++|+++| .+|..+++|++|+.|+|++|+|
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg----------------------~iP~~l~~L~~L~~L~Ls~N~l 502 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG----------------------SIPESLGQLTSLRILNLNGNSL 502 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCC----------------------CCchHHhcCCCCCEEECcCCcc
Confidence 999999999998898888888888877776666665 4555566666666666666666
Q ss_pred cccCCC
Q 006886 177 SGAIPP 182 (627)
Q Consensus 177 ~~~~p~ 182 (627)
+|.+|.
T Consensus 503 ~g~iP~ 508 (623)
T PLN03150 503 SGRVPA 508 (623)
T ss_pred cccCCh
Confidence 665554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=171.76 Aligned_cols=163 Identities=12% Similarity=0.158 Sum_probs=126.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHH----------HHHHHHHHHHhccCCCeeeeeeEEeeC------
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE----------FEQQMEVVGTIGKHSNVVPVRAYYYSK------ 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~~h~niv~l~~~~~~~------ 402 (627)
.+++|.|+||.||.... ++..+|+|.++......+. +++|++.+.++ .|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeeccccccc
Confidence 57899999999999766 5778999999755332222 58888899999 999999998886543
Q ss_pred --CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 403 --DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 403 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
...++||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++ ++|+
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999977632 222 24568999999999999 99999999999999988 9999
Q ss_pred ecccccccCCCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHH
Q 006886 481 DVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEML 528 (627)
Q Consensus 481 DfG~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~ 528 (627)
|||........... ..+.....+..++|+||||+++....
T Consensus 177 Dfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987655321110 01334455678999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.3e-20 Score=200.11 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=172.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccc--ccCHHHHHHHHHHH-HHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREV--AATKREFEQQMEVV-GTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~e~~~l-~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||++.|=+|.+|+.+.|. |+||++-+. ....+.|.++++-+ ..+.+|||.+++.-+-..+...|+|-+|...
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 477999999999999988776 999998543 23445555555433 3445999999988777777777888888854
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC----CC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FP 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~----~~ 491 (627)
+|++.+... ..+...+...|+.|++.|+.-+|..+ |+|||||.+|||++.-.-+.|+||..-+..- .+
T Consensus 106 nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 106 NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 898888754 35788899999999999999999999 9999999999999999999999998654331 11
Q ss_pred -------CCCCCCccccCccccCCC-----------CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 492 -------TTATRTIGYRAPEVTETR-----------KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 492 -------~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
++...-.+|+|||.+-.. ..+++-||||.||++.||++ |++||.-. +.+..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~aY- 247 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLLAY- 247 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHHhH-
Confidence 112233579999987431 14678899999999999988 68887521 11110
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......|++..-.+ . +-..+.+++..|++.||++|-++++.++.
T Consensus 248 ----r~~~~~~~e~~Le~-I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 ----RSGNADDPEQLLEK-I--EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----hccCccCHHHHHHh-C--cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 01111111110000 0 00145678889999999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=184.88 Aligned_cols=210 Identities=22% Similarity=0.381 Sum_probs=160.7
Q ss_pred cCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 006886 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSS 467 (627)
Q Consensus 388 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~ 467 (627)
.|.|+.+++|.+.+....+.|.+|+..|+|.+.+... ...++|.-...+..+++.||.|+|... -..|+.+++.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 8999999999999999999999999999999999863 356899999999999999999999865 2299999999
Q ss_pred CeEecCCCCeEEeecccccccCCC------CCCCCCccccCccccCCC-------CCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 468 NVLLTQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETR-------KASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 468 NILl~~~~~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~-------~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
|.++|....+||+|||+....... .......-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776421 111123459999998653 1467899999999999999999999
Q ss_pred CCCCCCCC-CCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 535 QHSGHDDV-VDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 535 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
+....... ..+...++. .....+.+...... +...++..++.+||..+|++||++++|-..++.+....
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 86433222 122222221 11112222221111 22236788889999999999999999999998886654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=170.21 Aligned_cols=193 Identities=18% Similarity=0.264 Sum_probs=134.3
Q ss_pred ccCCCeeeeeeEEee---------------------------CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHH
Q 006886 387 GKHSNVVPVRAYYYS---------------------------KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK 439 (627)
Q Consensus 387 ~~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 439 (627)
.+|||||.+.++|.+ ....|+||...+. +|.+|+..+ ..+...+.-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHH
Confidence 489999999888753 1246888887744 899999753 356667777
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec--CCCC--eEEeecccccccCC----------CCCCCCCccccCccc
Q 006886 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT--QDLN--GCISDVGLAHLINF----------PTTATRTIGYRAPEV 505 (627)
Q Consensus 440 i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~--~ki~DfG~a~~~~~----------~~~~~~t~~y~aPE~ 505 (627)
|+.|+++|+.|||.+| |.|||+|++|||+. +|+. ..|+|||.+-..+. .....|...-||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 9999999999999999 99999999999984 4443 47899997643321 112234567999999
Q ss_pred cCCCC------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHH
Q 006886 506 TETRK------ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQM 579 (627)
Q Consensus 506 ~~~~~------~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 579 (627)
..... --.|+|.|+.|-+.||+++..-||....+- ..+...+ ++.....+ .+.....+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Y-----qe~qLPal----------p~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTY-----QESQLPAL----------PSRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhh-----hhhhCCCC----------cccCChHH
Confidence 86532 236899999999999999999999863321 1111111 11111111 11122345
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 580 LQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 580 ~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.+++...++.||++|++..-....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 56777888999999999876666544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=189.27 Aligned_cols=186 Identities=25% Similarity=0.371 Sum_probs=157.4
Q ss_pred ccCcCCceeEEEEEe----cCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 341 VLGKGSYGSTYKAIL----EDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+|+|.||.|+.++- ..|..+|.|.+++... .+.....|..++.....||.++.+...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987652 2367788888765422 122455677788888679999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
+|+|...+... ..+++.........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99998888754 34666777777888999999999998 99999999999999999999999999988766555
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~ 536 (627)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 68999999999997 578899999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.5e-19 Score=172.76 Aligned_cols=229 Identities=17% Similarity=0.277 Sum_probs=141.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhcc---------CCCeeeeeeEEe----
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGK---------HSNVVPVRAYYY---- 400 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~---------h~niv~l~~~~~---- 400 (627)
.+.||.|+++.||.+.+. .++.+|+|+...... ..+++.+|.-....+.. |-.++..++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 468999999999999976 489999998754332 23445555433333211 212222222211
Q ss_pred -----eCC--------ceEEEEecCCCCCHHHHhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 006886 401 -----SKD--------EKLVVYSYMPAGSLFMLLHR---NRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI 464 (627)
Q Consensus 401 -----~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 464 (627)
... +.+++|+-+ .+||...+.. ... ....+....++.+..|+++.+++||+.| ++|+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 235677777 5588777543 211 1233556677888899999999999999 999999
Q ss_pred CCCCeEecCCCCeEEeecccccccCCCCC-CCCCccccCccccCC--------CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 006886 465 KSSNVLLTQDLNGCISDVGLAHLINFPTT-ATRTIGYRAPEVTET--------RKASQKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 465 k~~NILl~~~~~~ki~DfG~a~~~~~~~~-~~~t~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
+|+|++++.+|.++|+||+.....+.... ...+..|.+||.... -.++.+.|.|++|+++|.|+.+..||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999999999999999987765544322 334567999997643 247889999999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCC
Q 006886 536 HSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR 594 (627)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 594 (627)
......... . .+..+.+....+..+|..+++.+|++|
T Consensus 252 ~~~~~~~~~-------------------~---~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADPE-------------------W---DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTSG-------------------G---GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCcccccc-------------------c---cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 543221110 0 111222334455567779999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.2e-17 Score=157.31 Aligned_cols=134 Identities=12% Similarity=0.152 Sum_probs=103.3
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccc-ccCHHHHHHHHHHHHHhc----cCCCeeeeeeEEeeCC---ceE-EEE
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREV-AATKREFEQQMEVVGTIG----KHSNVVPVRAYYYSKD---EKL-VVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~---~~~-lv~ 409 (627)
.+.||+|+||.||. .-.++.. +||++... ....+.+.+|+.++..+. .||||++++|+++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 3334444 79987653 234567999999999984 4899999999998874 333 689
Q ss_pred ec--CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeEecC----CCCeEEeec
Q 006886 410 SY--MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI-AFIHSEGGAKFTHGNIKSSNVLLTQ----DLNGCISDV 482 (627)
Q Consensus 410 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~ki~Df 482 (627)
|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 5679999999643 24444 35577778777 9999998 999999999999974 347999994
Q ss_pred ccc
Q 006886 483 GLA 485 (627)
Q Consensus 483 G~a 485 (627)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.3e-18 Score=187.12 Aligned_cols=185 Identities=24% Similarity=0.319 Sum_probs=147.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
...||+|+||.||+|...+|+.||+|+-+....+ +|..-.+++.+|. --+.|..+..++.-.+.-++|+||.+.|+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 4679999999999999888999999987655433 2333334444441 12345555555556777789999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-------CCCCeEEeecccccccC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-------QDLNGCISDVGLAHLIN 489 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-------~~~~~ki~DfG~a~~~~ 489 (627)
|.+++... ..++|.....+..|+++.++.||..+ |||+||||+|+||. +...++|+|||-+-.+.
T Consensus 781 lld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 781 LLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred HHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999843 46999999999999999999999998 99999999999994 24567999999986553
Q ss_pred ---CCCC---CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 006886 490 ---FPTT---ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 490 ---~~~~---~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
.... ..+|-.+-.+|...++.++...|.|.++-+++-|+.|+.-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2212 2356778999999999999999999999999999999753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=153.42 Aligned_cols=133 Identities=19% Similarity=0.351 Sum_probs=112.0
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
+.||+|++|.||+|.. +|..+++|+...... ....+.+|++++..+ .|+++.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEE
Confidence 5699999999999987 577899997653211 124577889999998 88888877777777788899999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|.|||++ ++.++|+|||.++.
T Consensus 80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998642 12 78899999999999999998 99999999999999 78999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=153.51 Aligned_cols=138 Identities=16% Similarity=0.223 Sum_probs=105.5
Q ss_pred hcccCcCCceeEEEEE--ecCCcEEEEEEeccccc-------------------------CHHHHHHHHHHHHHhccCCC
Q 006886 339 AEVLGKGSYGSTYKAI--LEDGTTVVVKRLREVAA-------------------------TKREFEQQMEVVGTIGKHSN 391 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~-------------------------~~~~~~~e~~~l~~l~~h~n 391 (627)
.+.||+|+||.||+|. ..+|+.||+|.++.... ....+..|++.+.++ .+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~~~ 111 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YEAG 111 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 5789999999999998 56899999999864321 012356789999988 4422
Q ss_pred --eeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 006886 392 --VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469 (627)
Q Consensus 392 --iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI 469 (627)
+.+++++ ...++||||+++++|....... ..........++.|++.++.+||+.+ .|+||||||+||
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 3333332 2357999999998886654221 23455667889999999999999986 499999999999
Q ss_pred EecCCCCeEEeecccccccC
Q 006886 470 LLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 470 Ll~~~~~~ki~DfG~a~~~~ 489 (627)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=150.68 Aligned_cols=130 Identities=18% Similarity=0.307 Sum_probs=105.8
Q ss_pred ccCcCCceeEEEEEecCCcEEEEEEecccc--c-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 341 VLGKGSYGSTYKAILEDGTTVVVKRLREVA--A-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.||+|+||.||+|.+ ++..|++|...... . ....+.+|++++..+ .|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999996 47889999864321 1 124577899999999 777766555566667777899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
++|++|.+++.... . .++.+++.+|.+||+.+ ++|||++|.||+++ ++.+++.|||.++..
T Consensus 79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998875421 0 78899999999999998 99999999999999 899999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-16 Score=148.37 Aligned_cols=132 Identities=17% Similarity=0.199 Sum_probs=103.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc-----------------------CHHHHHHHHHHHHHhccCCC--ee
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-----------------------TKREFEQQMEVVGTIGKHSN--VV 393 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~e~~~l~~l~~h~n--iv 393 (627)
.+.||+|+||.||++..++|+.||||++..... ....+..|..++..+ .|++ +.
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~v~ 98 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEGFPVP 98 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcCCCCC
Confidence 578999999999999988899999998654221 112356778888888 6664 33
Q ss_pred eeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 394 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~ 160 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD 160 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence 3333 2455899999999998655321 234578889999999999988 999999999999999
Q ss_pred CCCeEEeecccccccC
Q 006886 474 DLNGCISDVGLAHLIN 489 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~ 489 (627)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=171.10 Aligned_cols=131 Identities=19% Similarity=0.284 Sum_probs=107.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEe-ccccc--------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRL-REVAA--------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l-~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+|.+.+. .+++|+. ..... ..+.+.+|++++..+ +|++++....++......++||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEE
Confidence 47899999999999997644 3444432 21111 124578899999999 8999988877777777889999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998875 24578999999999999998 9999999999999 6789999999998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=137.30 Aligned_cols=135 Identities=18% Similarity=0.122 Sum_probs=112.8
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccC-CCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKH-SNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
+.||+|.++.||++...+ ..+++|....... ...+..|+.++..+.++ .++.+++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 579999999999999864 7899998865433 56789999999999544 68888888887778899999999887764
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
.+ +......++.+++.++.++|......++|+|++|+||++++++.+++.|||.++..
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 32 45667788999999999999864445999999999999999899999999988654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-17 Score=144.96 Aligned_cols=145 Identities=27% Similarity=0.454 Sum_probs=130.5
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-cccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ 146 (627)
..++|.|.|++|.++ .+|+ .++.|.+|+.|++++|+|+ .+|.++.+|++|+.|+++-|++...+-.|+.. .|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhh
Confidence 467999999999999 6777 6999999999999999999 89999999999999999999999888888775 799999
Q ss_pred cccccccc-CCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 147 LSFNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 147 ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++|+++. .+|..|..++.|+.|+|+.|.|.-.+|+. .+++|+.|.+.+|.+- ++|..++.++.|.-++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelh 179 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELH 179 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHh
Confidence 99999864 58999999999999999999998655555 8999999999999998 8999999888877654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-16 Score=159.63 Aligned_cols=118 Identities=25% Similarity=0.375 Sum_probs=103.6
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
..++.|+++...+|.+|+.+.+. ....++...+.++.|++.|+.| ++ .+|||+||.||++..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 46789999999999999975543 3457888999999999999999 66 9999999999999999999999999
Q ss_pred cccccCCCC----------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh
Q 006886 484 LAHLINFPT----------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT 529 (627)
Q Consensus 484 ~a~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t 529 (627)
+........ ...||..||+||.+.+..|+.++||||+|++|+|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987654322 3357899999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.5e-15 Score=140.52 Aligned_cols=135 Identities=20% Similarity=0.230 Sum_probs=96.0
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCH---HH----------------------HHHHHHHHHHhccC-CCee
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATK---RE----------------------FEQQMEVVGTIGKH-SNVV 393 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~----------------------~~~e~~~l~~l~~h-~niv 393 (627)
+.||+|+||.||+|...+++.||||+++...... .. ...|.+.+..+..+ -.+.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5799999999999998889999999886532211 11 13455555555222 1233
Q ss_pred eeeeEEeeCCceEEEEecCCCCCHHH-HhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEe
Q 006886 394 PVRAYYYSKDEKLVVYSYMPAGSLFM-LLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 394 ~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl 471 (627)
+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 33332 24589999999965421 111110 11 5677899999999999999 77 9999999999999
Q ss_pred cCCCCeEEeecccccccC
Q 006886 472 TQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~ 489 (627)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 9999999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-15 Score=167.32 Aligned_cols=196 Identities=20% Similarity=0.313 Sum_probs=129.5
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.|..|+||.||..+++. .+.+|.| +.+.. .+.+. ++... ..|.+| |+-
T Consensus 88 IklisngAygavylvrh~~trqrfa~k-iNkq~----lilRn--ilt~a-~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILRN--ILTFA-GNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhc-ccccc----hhhhc--ccccc-CCccee---------------------chh
Confidence 4789999999999998764 5667774 32211 11110 11111 333333 344
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-------
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF------- 490 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~------- 490 (627)
...++.. ..++. +.+.+++|+|+-+ |+|||+||+|.+|+.-|++|+.|||+++....
T Consensus 139 ~tllk~~-----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 139 ATLLKNI-----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhcccC-----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3334321 11221 2267899999998 99999999999999999999999999876421
Q ss_pred ------------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc-
Q 006886 491 ------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW- 557 (627)
Q Consensus 491 ------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 557 (627)
+....||+.|+|||++....|...+|+|++|+++||.+-|+.||.+...++. +...+.+..
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i~ 276 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDIE 276 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhcc
Confidence 1223579999999999999999999999999999999999999987644322 222222211
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCC
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP 595 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 595 (627)
+.+- |. ..+. +..+++.+.++.+|.+|-
T Consensus 277 wpE~-de------a~p~---Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 WPEE-DE------ALPP---EAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccc-Cc------CCCH---HHHHHHHHHHHhChHhhc
Confidence 1110 11 1123 344455577789998884
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.6e-14 Score=136.02 Aligned_cols=135 Identities=18% Similarity=0.207 Sum_probs=104.0
Q ss_pred hcccC-cCCceeEEEEEecCCcEEEEEEecccc--------------cCHHHHHHHHHHHHHhccCCCe--eeeeeEEee
Q 006886 339 AEVLG-KGSYGSTYKAILEDGTTVVVKRLREVA--------------ATKREFEQQMEVVGTIGKHSNV--VPVRAYYYS 401 (627)
Q Consensus 339 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~ 401 (627)
...|| .||.|+||.+... +..+++|.+.... .....+.+|++++..+ .|+++ ...+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 56788 8999999999886 6788998874311 1234578899999999 77774 566666443
Q ss_pred CCc----eEEEEecCCC-CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC
Q 006886 402 KDE----KLVVYSYMPA-GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN 476 (627)
Q Consensus 402 ~~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 476 (627)
... .++|+||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGK 180 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCC
Confidence 222 2599999997 6898887542 24433 3568899999999999 999999999999999999
Q ss_pred eEEeeccccccc
Q 006886 477 GCISDVGLAHLI 488 (627)
Q Consensus 477 ~ki~DfG~a~~~ 488 (627)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.6e-16 Score=134.49 Aligned_cols=136 Identities=32% Similarity=0.503 Sum_probs=119.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccccccc-Cc-hhhcc-ccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LP-AFRSL-QLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~-~~~~~-~L~~L 145 (627)
.++..|++.+|++. .+|. +++.|++|+.|+++-|++. .+|..|+.++.|+.|||.+|+++.- .| .|+.. .|+.|
T Consensus 56 ~nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 45778999999998 7888 8999999999999999998 8999999999999999999999853 45 45554 79999
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFP 210 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~ 210 (627)
+|++|.|+ .+|..++++++|+.|.+..|.+-. +|.. .+..|++|++.+|+++ .+|..++++.
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 99999999 899999999999999999999974 5543 8999999999999999 7777766543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.7e-15 Score=151.23 Aligned_cols=147 Identities=21% Similarity=0.248 Sum_probs=118.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-c-cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-L-QLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~-~L~~L~ 146 (627)
..+..|+|+.|+++ .+..+.+-+|+.|+.||||+|.|..+.++.+....+|++|+|++|+|+...+..+. + +|+.|+
T Consensus 269 ~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred cccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 56889999999998 55566899999999999999999988899999999999999999999998886443 3 688888
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC-----CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-----NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++|+++..-...|..+++|++|||++|.|+..+.+. ++++|+.|+|.+|+|....-..|..++.|+.++
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld 422 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD 422 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence 8888888655667888888888888888888766542 677788888888888733335667777666654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=5e-13 Score=142.32 Aligned_cols=140 Identities=20% Similarity=0.304 Sum_probs=100.0
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccC-----------------------------------------HHHHHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT-----------------------------------------KREFEQ 378 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 378 (627)
+.||.|++|.||+|++++|+.||||+.+..... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 579999999999999999999999997543100 002444
Q ss_pred HHHHHHHhc----cCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 006886 379 QMEVVGTIG----KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR-GIAFIHS 453 (627)
Q Consensus 379 e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 453 (627)
|.+.+.++. +++++.-..-+.......++||||++|++|.++...... .. .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 555444442 344443333333334567899999999999887653211 12 23456666665 4678898
Q ss_pred cCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 454 ~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
.| ++|+|+||.||+++.++.++++|||++..+.
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 9999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.6e-15 Score=150.94 Aligned_cols=137 Identities=31% Similarity=0.422 Sum_probs=84.3
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccccccc----Cc----------
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV----LP---------- 135 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~----~~---------- 135 (627)
+...|+|++|++. +||...|-+|+.|-.||||+|++. .+|+.+..|..|++|+|++|-+.-. +|
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 4555666666666 666656667777777777777776 6666677777777777777754311 11
Q ss_pred ------------hhhcc-ccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCcccc
Q 006886 136 ------------AFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 136 ------------~~~~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~ 201 (627)
.+-.+ +|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+..--.. .+.+|+.|+|+.|+|+ .
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence 11111 4677788888887 67888888888888888888777421111 4455555555555555 4
Q ss_pred CCCCCCCCC
Q 006886 202 IPDSLQTFP 210 (627)
Q Consensus 202 ~p~~~~~~~ 210 (627)
+|+.+.+++
T Consensus 283 LP~avcKL~ 291 (1255)
T KOG0444|consen 283 LPDAVCKLT 291 (1255)
T ss_pred chHHHhhhH
Confidence 444444333
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.9e-13 Score=130.60 Aligned_cols=202 Identities=22% Similarity=0.321 Sum_probs=140.3
Q ss_pred HHHHhccCCCeeeeeeEEeeCC-----ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006886 382 VVGTIGKHSNVVPVRAYYYSKD-----EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456 (627)
Q Consensus 382 ~l~~l~~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 456 (627)
.+..+ .|.|++++..||.+.. ...+++|||..|++..+|++.+.. +..+......+++.||..||.|||+..
T Consensus 120 nllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 120 NLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34444 7999999999987644 367899999999999999876542 345667777889999999999999976
Q ss_pred CCeeecCCCCCCeEecCCCCeEEeecccccccCC---------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHH
Q 006886 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEM 527 (627)
Q Consensus 457 ~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el 527 (627)
|+|+|+++.-+-|++..++-+||.--- ...... .....+-++|.+||+-.....+..+|||+||....||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999999984211 111100 1122346789999998887888999999999999999
Q ss_pred HhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 528 LTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 528 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
..+..--...... ... .+.....++..+ .+. =...+.+|+...|..||+|++++.+.-.+
T Consensus 276 ailEiq~tnseS~--~~~--------ee~ia~~i~~le--n~l--------qr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 276 AILEIQSTNSESK--VEV--------EENIANVIIGLE--NGL--------QRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHheeccCCCcce--eeh--------hhhhhhheeecc--Ccc--------ccCcCcccccCCCCCCcchhhhhcCceee
Confidence 8876532111100 000 000000011000 000 01356699999999999999998765443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2e-14 Score=157.75 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=175.9
Q ss_pred cccCcCCceeEEEEEecC--CcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILED--GTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+|+.|-...... ...+|+|.+.... ........|..+-..+.+|+|++.+++...+.+..+++.+|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 458999999998877533 4456666654332 12233444666666675699999999999999999999999999
Q ss_pred CCHHHHh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCC-
Q 006886 415 GSLFMLL-HRNRSDGGTALDWNSRMKIALGTARGIAFIH-SEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINF- 490 (627)
Q Consensus 415 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~- 490 (627)
|++..-+ +.. ....+....-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|.....
T Consensus 106 ~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 106 GSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccCC----ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9998887 322 113455666778999999999999 777 99999999999999999 999999999987755
Q ss_pred CC------CCCC-CccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 PT------TATR-TIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ~~------~~~~-t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ...| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+.. ...|.... ..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-------~~~ 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-------GRF 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-------ccc
Confidence 21 2346 8899999999874 4568899999999999999999998765443311 11111100 000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+.... ....++..+++..+|+.|.+.+++...
T Consensus 251 --~~~~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 --TQLPWNSIS---DQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --ccCccccCC---hhhhhcccccccCCchhcccccccccc
Confidence 001111112 233456668888999999999988653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-13 Score=136.40 Aligned_cols=66 Identities=21% Similarity=0.306 Sum_probs=57.4
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec-ccccccC
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN-NYFSGVL 134 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~ 134 (627)
+...++|+|..|+|+ .||++.|+.+++|+.||||+|+|+-+-|..|..|.+|..|-+.+ |+|+.++
T Consensus 66 P~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~ 132 (498)
T KOG4237|consen 66 PPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP 132 (498)
T ss_pred CCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence 457899999999999 89999999999999999999999988899999998887776655 7776543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-13 Score=141.98 Aligned_cols=145 Identities=23% Similarity=0.416 Sum_probs=105.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCC-CCCcccccEEeeecccccccCchhhcc-cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ 146 (627)
..++.|||++|+|. ..|. .+.+-+++-.|+||+|+|. .||.. |-+|+.|-+||||+|++...+|....+ .|++|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~-~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPT-NLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcch-hhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhh
Confidence 35788888888888 6777 6888888888888888888 66664 457888888888888888888876664 677788
Q ss_pred ccccccc-------------------------cCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcc
Q 006886 147 LSFNAFT-------------------------GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLN 199 (627)
Q Consensus 147 ls~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~ 199 (627)
||+|.+. ..+|.++..|.+|..+|+|.|++. .+|.. ++++|+.|+|++|+|+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 8777542 246777777888888888888887 34543 7888888888888887
Q ss_pred ccCC---CCCCCCCCCcccCCC
Q 006886 200 GSIP---DSLQTFPNSSFVGNS 218 (627)
Q Consensus 200 ~~~p---~~~~~~~~l~~~~n~ 218 (627)
. +. +.+.++..|....|.
T Consensus 259 e-L~~~~~~W~~lEtLNlSrNQ 279 (1255)
T KOG0444|consen 259 E-LNMTEGEWENLETLNLSRNQ 279 (1255)
T ss_pred e-eeccHHHHhhhhhhccccch
Confidence 3 33 234444444444443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-11 Score=114.40 Aligned_cols=130 Identities=15% Similarity=0.114 Sum_probs=95.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCee-eeeeEEeeCCceEEEEecCCCCCHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVV-PVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
+.++.|.++.||++... +..|++|...........+..|++++..+. +.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAA-EAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHH-HhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56889999999999876 778999987654333345788888888884 33443 344332 33457999999998775
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG--GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
.. . .....++.++++++..||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~-~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-D------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-c------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 32 0 011245678999999999986 22369999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.8e-12 Score=132.31 Aligned_cols=146 Identities=23% Similarity=0.215 Sum_probs=106.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
..+..|||++|.|...-+. .|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+.+-..... ..|+.||
T Consensus 78 ~~t~~LdlsnNkl~~id~~-~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFE-FFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred cceeeeeccccccccCcHH-HHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 4577899999999865555 7899999999999999998 8887666667799999999988877654333 3678888
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
||.|.|+...-..|..-.+|++|+|++|.|+..-... .+.+|..|.|+.|+++...+..|.++++|+.++
T Consensus 156 LSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~Ld 227 (873)
T KOG4194|consen 156 LSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLD 227 (873)
T ss_pred hhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhh
Confidence 8888887433335555567888888888877433322 666777777888887755556677777776664
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-13 Score=136.22 Aligned_cols=139 Identities=22% Similarity=0.377 Sum_probs=88.2
Q ss_pred EEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccc
Q 006886 71 VIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSF 149 (627)
Q Consensus 71 v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~ 149 (627)
+..++..+|+++ ++|+ .+.++.+|..|++.+|++. .+|+..-+++.|+.||...|.+..+||..... +|.-|+|.+
T Consensus 139 l~dl~~~~N~i~-slp~-~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPE-DMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhccccccc-cCch-HHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhh
Confidence 455666667766 5665 5666777777777777776 33333434777777777777777666666554 566666677
Q ss_pred cccccCCccccccccccccccccCCcccccCCCC---CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|+|. .+| .|.+|..|++|+++.|+|. .+|.. .+++|..|||++|+++ ..|+.+..+.+|+++|
T Consensus 216 Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLD 281 (565)
T KOG0472|consen 216 NKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLD 281 (565)
T ss_pred cccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhc
Confidence 7666 566 5666666666666666665 34433 5666666666666666 5666666666665554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.5e-10 Score=121.12 Aligned_cols=140 Identities=20% Similarity=0.219 Sum_probs=88.3
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEecccccC-----------------------------------H------HHHH
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAAT-----------------------------------K------REFE 377 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-----------------------------------~------~~~~ 377 (627)
+.||+|++|.||+|++++ |+.||||+.+..... . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 999999998643100 0 1234
Q ss_pred HHHHHHHHhc---cCCCeeeeeeEE-eeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHH-HHHHHHH
Q 006886 378 QQMEVVGTIG---KHSNVVPVRAYY-YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA-RGIAFIH 452 (627)
Q Consensus 378 ~e~~~l~~l~---~h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia-~~l~~LH 452 (627)
+|+..+.++. .+.+.+.+-..+ .-....++||||++|+.+.++-.-.. ...+.. .++...+ .-+.-++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~----~g~d~~---~la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA----AGTDMK---LLAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh----cCCCHH---HHHHHHHHHHHHHHH
Confidence 4444444442 233323322222 22556789999999999977422111 112211 1221111 1123344
Q ss_pred hcCCCCeeecCCCCCCeEecCCC----CeEEeecccccccC
Q 006886 453 SEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAHLIN 489 (627)
Q Consensus 453 ~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~~~~ 489 (627)
..| ++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 566 99999999999999988 89999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-11 Score=130.12 Aligned_cols=239 Identities=19% Similarity=0.178 Sum_probs=171.1
Q ss_pred HhcccCc--CCceeEEEEEe---cCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 338 SAEVLGK--GSYGSTYKAIL---EDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 338 ~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
+.+-+|. |.+|.||.+.. .++..+|+|+-+... .....-.+|...-..+..|+|.++....+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3567899 99999999986 367889999843321 222333456666667778999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeeccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR----GIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGL 484 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~ 484 (627)
|++ +.+|..+.+... ..++....+.+..+..+ |+.++|+.. ++|-|+||.||+..++ ...+++|||+
T Consensus 198 E~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 198 ELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 988 468888876532 23566667777777777 999999988 9999999999999999 8899999999
Q ss_pred ccccCCCC---------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh
Q 006886 485 AHLINFPT---------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555 (627)
Q Consensus 485 a~~~~~~~---------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 555 (627)
...+.... ...+...|++||...+ .++...|+|++|.+..+..++..+...........+..+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 87775432 1135567999998865 7789999999999999999987765433222221111110
Q ss_pred cccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 556 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
...+.. ..-..++...+..+++.+|..|++.+.+..
T Consensus 343 -ip~e~~----------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 -IPLEFC----------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -Cchhhh----------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 001112333667889999999999887654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-12 Score=127.97 Aligned_cols=141 Identities=28% Similarity=0.470 Sum_probs=109.5
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccE-EEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKI-LSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l 147 (627)
-|+.++++.|++. ++|. .+..++.+.+ +.+++|.+. -+|..+..+++|..|+|++|-+..+|-+++.. .|+.||+
T Consensus 389 ~Vt~VnfskNqL~-elPk-~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~Lnl 465 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPK-RLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNL 465 (565)
T ss_pred ceEEEecccchHh-hhhh-hhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecc
Confidence 4999999999998 7887 5666666644 455566655 77778888888888888888888887777665 6888888
Q ss_pred cccccccCCccccccccccccccccCCcccccCCC-C-CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-L-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
|.|+|. .+|..+-.+..|+.+-.++|++....|. . ++.+|+.|||.+|.+. .+|..+++++++..+
T Consensus 466 S~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hL 533 (565)
T KOG0472|consen 466 SFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHL 533 (565)
T ss_pred cccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEE
Confidence 888888 6888777777778888888888754444 2 7888888888888887 788888888877654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-10 Score=130.46 Aligned_cols=108 Identities=38% Similarity=0.674 Sum_probs=90.0
Q ss_pred cccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccccccccCCccccccccccccccccCC
Q 006886 95 ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN 174 (627)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 174 (627)
.++.|+|++|.++|.+|..|+.|++|+.|+|++|+ |+|.+|..++.+++|+.|+|++|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~----------------------l~g~iP~~~~~l~~L~~LdLs~N 476 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS----------------------IRGNIPPSLGSITSLEVLDLSYN 476 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCc----------------------ccCcCChHHhCCCCCCEEECCCC
Confidence 47788888888888888888888887776665555 44578888999999999999999
Q ss_pred cccccCCCC--CCCccceeeccCCCccccCCCCCCCC----CCCcccCCCcCCCCC
Q 006886 175 SISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTF----PNSSFVGNSMLCGLP 224 (627)
Q Consensus 175 ~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~----~~l~~~~n~~~~~~~ 224 (627)
+|+|.+|.. .+++|+.|+|++|+++|.+|..+... ..+.+.+|+.+|+.|
T Consensus 477 ~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999975 89999999999999999999887653 345667899999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-11 Score=113.15 Aligned_cols=126 Identities=26% Similarity=0.376 Sum_probs=42.7
Q ss_pred cCCCCcccEEEccCcccCccCCCCCC-CcccccEEeeecccccccCchhhccccccccccccccccCCcccc-ccccccc
Q 006886 90 IGKLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGF-QNLTRLH 167 (627)
Q Consensus 90 l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~-~~l~~L~ 167 (627)
+.+...++.|+|++|.|+ .+ +.++ .+.+|+.|+|++|.|+.+..-....+|++|++++|+|+ .+++.+ ..+++|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ 91 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence 444445666777777766 33 2454 46667777777777765533222236777777777777 344444 3577888
Q ss_pred cccccCCcccccCCC---CCCCccceeeccCCCccccCCC----CCCCCCCCcccCCCc
Q 006886 168 LLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPD----SLQTFPNSSFVGNSM 219 (627)
Q Consensus 168 ~L~l~~N~l~~~~p~---~~~~~L~~L~l~~N~l~~~~p~----~~~~~~~l~~~~n~~ 219 (627)
.|++++|+|...-.- ..+++|+.|+|.+|+++.. +. .+..+|+|+++|...
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~~ 149 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQD 149 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTEE
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCEE
Confidence 888888887642211 1678888888888888733 33 255678888887543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-12 Score=132.16 Aligned_cols=137 Identities=27% Similarity=0.383 Sum_probs=85.8
Q ss_pred EEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccc
Q 006886 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNA 151 (627)
Q Consensus 73 ~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~ 151 (627)
.+.|.+|.+. .||. .+.+|..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++..++.+... .|..||.+.|.
T Consensus 102 ~liLy~n~~r-~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~ne 177 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNE 177 (722)
T ss_pred HHHHHhccce-ecch-hhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhh
Confidence 3344444444 4444 5566666666666666665 5555555443 566666666666655554432 56666666666
Q ss_pred cccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 152 FTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 152 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+. .+|..++++.+|+.|.+..|++...++....-.|..||++.|+++ .||-.|.+|..|.++
T Consensus 178 i~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l 239 (722)
T KOG0532|consen 178 IQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVL 239 (722)
T ss_pred hh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheee
Confidence 66 566666677777777777777664444434445778888888888 888888888888764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.3e-09 Score=102.04 Aligned_cols=137 Identities=13% Similarity=0.122 Sum_probs=96.2
Q ss_pred cccCcCCceeEEEEEecC-------CcEEEEEEecccc-----------------------cCHHHH----HHHHHHHHH
Q 006886 340 EVLGKGSYGSTYKAILED-------GTTVVVKRLREVA-----------------------ATKREF----EQQMEVVGT 385 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-----------------------~~~~~~----~~e~~~l~~ 385 (627)
..||.|--+.||.|...+ +..+|||+.+... ...+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999863210 001222 378888888
Q ss_pred hccC-CCeeeeeeEEeeCCceEEEEecCCCCCHHH-HhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeec
Q 006886 386 IGKH-SNVVPVRAYYYSKDEKLVVYSYMPAGSLFM-LLHRNRSDGGTALDWNSRMKIALGTARGIAFI-HSEGGAKFTHG 462 (627)
Q Consensus 386 l~~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~ 462 (627)
+... -++...+++ ...++||||+.++.+.. .+.. ..++..+..++..+++.+|..| |..+ +||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 7433 344455543 46679999997654321 2221 1244455667889999999999 7887 9999
Q ss_pred CCCCCCeEecCCCCeEEeecccccccCC
Q 006886 463 NIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 463 Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
||++.||+++ ++.+.|+|||.+...+.
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999998876643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.4e-10 Score=107.67 Aligned_cols=143 Identities=22% Similarity=0.210 Sum_probs=107.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccC-CCeeeeeeEEeeCC---ceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKH-SNVVPVRAYYYSKD---EKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~---~~~lv~e~~~ 413 (627)
+.|+.|..+.||++...+|..+++|....... ....+..|++++..+..+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998765432 356788999999998432 34566666665532 5689999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG-------------------------------------- 455 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 455 (627)
|.++...+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9887665421 23666777778888888888888531
Q ss_pred ---------------CCCeeecCCCCCCeEecC--CCCeEEeeccccccc
Q 006886 456 ---------------GAKFTHGNIKSSNVLLTQ--DLNGCISDVGLAHLI 488 (627)
Q Consensus 456 ---------------~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~a~~~ 488 (627)
...++|+|+++.||+++. ++.+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999998 566889999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.9e-11 Score=123.37 Aligned_cols=240 Identities=17% Similarity=0.204 Sum_probs=171.4
Q ss_pred cccCcCCceeEEEEEec--CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE--DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
..||.|.|+.|++...+ ++..|++|.+...... +..-..|+.+...+..|.+++.....|......++--||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 67999999999998744 5788999987655322 222345677777777899999988888888888888899999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCCCC-
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~~~- 492 (627)
+++.....- ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..+....
T Consensus 351 ~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 351 GSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred cchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence 988766632 234777888999999999999999988 9999999999999886 788999999987543322
Q ss_pred CCCCCcccc--CccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 TATRTIGYR--APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 ~~~~t~~y~--aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+.-++. +++......+..+.|+||||..+.|.+++..--..... | ..+.........
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~----------~~i~~~~~p~~~ 484 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S----------LTIRSGDTPNLP 484 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c----------eeeecccccCCC
Confidence 222333444 45555666788999999999999999998653221110 0 000000011111
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
... .++..+...+...++..||.+.++..+.+...
T Consensus 485 ~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 485 GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred chH---HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 112 34445556777899999999999887766544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.4e-11 Score=108.29 Aligned_cols=119 Identities=26% Similarity=0.403 Sum_probs=51.0
Q ss_pred CcEEEEEcCCCCcccccCccccC-CCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIG-KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR--SLQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~L~~L 145 (627)
.++++|+|++|.++ .|. .++ .+.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+.+.+.+. ..+|+.|
T Consensus 19 ~~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-ccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 46899999999998 454 366 6899999999999999 454 58889999999999999998866543 2489999
Q ss_pred cccccccccCC-ccccccccccccccccCCcccccCCCC------CCCccceeec
Q 006886 146 DLSFNAFTGNI-PPGFQNLTRLHLLNLQNNSISGAIPPL------NLPRLKILNF 193 (627)
Q Consensus 146 ~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~------~~~~L~~L~l 193 (627)
+|++|+|...- =..+..+++|+.|+|.+|.++.. +.- .+|+|+.||-
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 99999998421 13577899999999999999854 431 7889998875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-10 Score=129.92 Aligned_cols=91 Identities=24% Similarity=0.285 Sum_probs=64.8
Q ss_pred cccEEeeecccccccCchh------------------hccccccccccccccccCCccccccccccccccccCCcccccC
Q 006886 119 SLQYVYLQNNYFSGVLPAF------------------RSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI 180 (627)
Q Consensus 119 ~L~~L~l~~N~l~~~~~~~------------------~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 180 (627)
+|++|+|++|+|+++++.. ...+|+.|+|++|+|++ +|... ++|+.|++++|+|++ +
T Consensus 343 ~Lq~LdLS~N~Ls~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-I 417 (788)
T PRK15387 343 GLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-L 417 (788)
T ss_pred ccceEecCCCccCCCCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-C
Confidence 5666666666666543210 01257788888888884 66533 578899999999985 5
Q ss_pred CCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 181 p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|.. +.+|+.|++++|+|+ .+|..+.+++.|..++
T Consensus 418 P~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~Ld 451 (788)
T PRK15387 418 PML-PSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 451 (788)
T ss_pred Ccc-hhhhhhhhhccCccc-ccChHHhhccCCCeEE
Confidence 543 457899999999998 7899888888877653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.3e-11 Score=130.88 Aligned_cols=148 Identities=28% Similarity=0.427 Sum_probs=109.4
Q ss_pred CcEEEEEcCCCCcccccCcccc-------------------------CCCCcccEEEccCcccCccCCCCCCCcccccEE
Q 006886 69 SRVIGIHLPGIGFTGPIPANSI-------------------------GKLDALKILSLRSNYLNGTLPSDITSISSLQYV 123 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l-------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 123 (627)
..+..|+|..|+|. .+|+..| ..++.|+.|+|.+|.|+...-+.|.+..+|+.|
T Consensus 310 ~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred ceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 35888999888876 4444222 235557888888888887666678888999999
Q ss_pred eeecccccccCchhhc-c-ccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccc
Q 006886 124 YLQNNYFSGVLPAFRS-L-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 124 ~l~~N~l~~~~~~~~~-~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~ 200 (627)
+|++|+|..++..... + .|+.|+||+|+++ .+|..+.++..|++|...+|+|.. .|.. .++.|+.+|++.|+|+.
T Consensus 389 hLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~-fPe~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 389 HLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLS-FPELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred eecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceee-chhhhhcCcceEEecccchhhh
Confidence 9999999887765544 2 6899999999999 788889999999999999999884 4554 88899999999998874
Q ss_pred c-CCCCCC--CCCCCcccCCCc
Q 006886 201 S-IPDSLQ--TFPNSSFVGNSM 219 (627)
Q Consensus 201 ~-~p~~~~--~~~~l~~~~n~~ 219 (627)
. +|.... ++..|.+.||.+
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhhCCCcccceeeccCCcc
Confidence 3 343332 333444445654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-10 Score=129.10 Aligned_cols=118 Identities=25% Similarity=0.457 Sum_probs=56.3
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~ 149 (627)
+.+.|+|++++++ .+|. .+. ++|+.|+|++|+|+ .+|..+. .+|++|+|++|+|++++..+ ..+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l-~~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATL-PDTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhh-hccccEEECcC
Confidence 3455666666655 3444 221 34555556655555 3444432 35555555555555433222 22455555555
Q ss_pred cccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~ 199 (627)
|+++ .+|..+. ++|+.|++++|+|+. +|..-.++|+.|++++|+|+
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELRYLSVYDNSIR 296 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCcEEECCCCccc
Confidence 5555 3444332 245555555555542 33322234555555555544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-09 Score=111.97 Aligned_cols=161 Identities=14% Similarity=0.199 Sum_probs=120.8
Q ss_pred ecCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCC
Q 006886 355 LEDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALD 433 (627)
Q Consensus 355 ~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~ 433 (627)
..++.+|.|...+.... ......+-++.++.+ +||||++++..++..+..|+|+|.+. -|..++.+. .
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------G 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------H
Confidence 44688888888765432 123456667888888 99999999999999999999999874 366666542 2
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCC---C-CccccCccccCCC
Q 006886 434 WNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT---R-TIGYRAPEVTETR 509 (627)
Q Consensus 434 ~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~---~-t~~y~aPE~~~~~ 509 (627)
.......+.||+.||.|||..+ .++|++|.-..|+++..|.-||++|-............ . -..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 3455667899999999999776 59999999999999999999999998775443221111 1 1236666654322
Q ss_pred CCCCcchhHHHHHHHHHHHhC
Q 006886 510 KASQKSDVYSFGVLLLEMLTG 530 (627)
Q Consensus 510 ~~~~~~Dv~S~Gvvl~el~tg 530 (627)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 457999999999999999
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.7e-10 Score=126.78 Aligned_cols=137 Identities=22% Similarity=0.343 Sum_probs=107.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
..++.|+|++|+++ .+|.. + .++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++..++.. ...+|+.|+|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~-l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~-l~s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILDNNELK-SLPEN-L--QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPER-LPSALQSLDLF 270 (754)
T ss_pred cCCcEEEecCCCCC-cCChh-h--ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChh-HhCCCCEEECc
Confidence 57999999999999 68873 3 258999999999999 6787664 5899999999999966444 34589999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCC-CCCCCCCcccCCC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDS-LQTFPNSSFVGNS 218 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~~n~ 218 (627)
+|+|+ .+|..+. ++|+.|++++|+|++ +|..-.++|+.|++++|.|+. +|.. ..++..|...+|.
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~ 336 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLTA-LPETLPPGLKTLEAGENA 336 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCcccc-CCccccccceeccccCCc
Confidence 99999 5887665 489999999999996 454334589999999999994 5543 3344555444443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.1e-10 Score=123.41 Aligned_cols=94 Identities=21% Similarity=0.258 Sum_probs=59.1
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~ 149 (627)
+++.|+|.+|+|+ .+|. .+++|+.|+|++|+|+ .+|.. +++|+.|+|++|.|+.+++ ...+|+.|+|++
T Consensus 223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~Lp~--lp~~L~~L~Ls~ 291 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLTHLPA--LPSGLCKLWIFG 291 (788)
T ss_pred CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchhhhhh--chhhcCEEECcC
Confidence 4666667666666 3554 1456677777777776 44532 3566667777776665443 113567777777
Q ss_pred cccccCCccccccccccccccccCCcccc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 178 (627)
|+|+ .+|.. .++|+.|++++|+|++
T Consensus 292 N~Lt-~LP~~---p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 292 NQLT-SLPVL---PPGLQELSVSDNQLAS 316 (788)
T ss_pred Cccc-ccccc---ccccceeECCCCcccc
Confidence 7777 45542 3568888888888875
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.4e-11 Score=129.30 Aligned_cols=126 Identities=25% Similarity=0.382 Sum_probs=109.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCC-CCCCcccccEEeeecccccccCchhhcc-cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPS-DITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ 146 (627)
..+..|.|.+|.|+...-+ .|.++++|++|+|++|+|. .+|. .+.++..|++|+||+|+++.++...... .|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHh
Confidence 4688899999999988666 7999999999999999998 6776 5678999999999999999988655554 799999
Q ss_pred ccccccccCCccccccccccccccccCCcccccC-CCC-CCCccceeeccCCCc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI-PPL-NLPRLKILNFSNNNL 198 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~-~~~~L~~L~l~~N~l 198 (627)
..+|++. ..| .+..+++|+.+|+|.|+|+... |.. ..++|++|||++|.-
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 788 8999999999999999998633 433 458999999999984
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.1e-11 Score=112.74 Aligned_cols=107 Identities=23% Similarity=0.225 Sum_probs=46.3
Q ss_pred CCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccccccccCCcccccccccccccc
Q 006886 91 GKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLN 170 (627)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 170 (627)
...+.|+.||||+|.|+ .+.++..-+++++.|++|+|.|..+-.-....+|+.||||+|.++ .+-.+-..|.++++|.
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 33444445555555544 344444444455555555555443332111124455555555444 2333333344444555
Q ss_pred ccCCcccccCCCCCCCccceeeccCCCcc
Q 006886 171 LQNNSISGAIPPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 171 l~~N~l~~~~p~~~~~~L~~L~l~~N~l~ 199 (627)
|+.|.|.....--.+-+|.+||+++|++.
T Consensus 359 La~N~iE~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 359 LAQNKIETLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhhHhhhhhhHhhhhheeccccccchh
Confidence 55554442111113444445555555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.6e-08 Score=91.39 Aligned_cols=131 Identities=20% Similarity=0.323 Sum_probs=97.5
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEE-eccccc--------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKR-LREVAA--------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~-l~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
..+++|+-+.+|.+.+. |.++++|. +.+... ....-..|+.++.++ +--.|....-+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999875 44566664 222111 123456788888887 44455555556677788889999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|++|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999998888753 2346666777788899999 99999999999998765 899999998754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=91.69 Aligned_cols=141 Identities=16% Similarity=0.285 Sum_probs=102.6
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEe-----ccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRL-----REV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l-----~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
+++-+|+-+.|+++.+. |+...||.= +.+ ....+.-.+|++.+.+. +.-.|.-..-++.+.....++||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEE
Confidence 56889999999999986 777777642 211 12356677888888887 44455544555666677789999
Q ss_pred cCCC-CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeeccccc
Q 006886 411 YMPA-GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLAH 486 (627)
Q Consensus 411 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a~ 486 (627)
|++| .++.+++...-.+ .........++..+-+.+.-||..+ |+|+||..+||++..++. +.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 9977 4788888764322 1222233678888889999999998 999999999999976543 4799999975
Q ss_pred cc
Q 006886 487 LI 488 (627)
Q Consensus 487 ~~ 488 (627)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 44
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-10 Score=108.98 Aligned_cols=127 Identities=27% Similarity=0.380 Sum_probs=100.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l 147 (627)
..+++|||++|.++ .+.+ +..-++.++.|+||+|.|. .+- .+..|++|+.||||+|.++....--..+ +++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhh-hhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeeh
Confidence 34788999999988 5655 7888999999999999998 443 4888999999999999988765432222 7899999
Q ss_pred cccccccCCccccccccccccccccCCcccccCC--CC-CCCccceeeccCCCcccc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP--PL-NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~-~~~~L~~L~l~~N~l~~~ 201 (627)
+.|.|.. + +.+..|-+|..||+++|+|...-. .. ++|-|+.|.|.+|++.+.
T Consensus 360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 9999883 3 457888889999999999975322 22 788899999999999843
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.2e-08 Score=95.63 Aligned_cols=140 Identities=16% Similarity=0.114 Sum_probs=98.1
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc------------CHHHHHHHHHHHHHhccCCCe--eeeeeEEee----
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA------------TKREFEQQMEVVGTIGKHSNV--VPVRAYYYS---- 401 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~---- 401 (627)
+.+-+-....|++..+ +|+.|.||+...... ....+.+|...+.++. ..+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCC
Confidence 4444444455777766 478899997643220 1124778888887773 2232 334445443
Q ss_pred -CCceEEEEecCCCC-CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC------
Q 006886 402 -KDEKLVVYSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ------ 473 (627)
Q Consensus 402 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~------ 473 (627)
....++|+|++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCC
Confidence 23467999999886 8988885321 123455677789999999999999999 999999999999985
Q ss_pred -CCCeEEeecccccc
Q 006886 474 -DLNGCISDVGLAHL 487 (627)
Q Consensus 474 -~~~~ki~DfG~a~~ 487 (627)
+..+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.1e-11 Score=122.44 Aligned_cols=138 Identities=26% Similarity=0.392 Sum_probs=124.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
...+..||+.|++. ++|. .+..+..|+.|.|..|.|. .+|..+++|..|.+|||+.|+++..++.++.+.|+.|-++
T Consensus 75 tdt~~aDlsrNR~~-elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~s 151 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVS 151 (722)
T ss_pred cchhhhhccccccc-cCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEe
Confidence 34667899999998 8888 7899999999999999999 8999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPN 211 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~ 211 (627)
+|+++ .+|..++.+..|..||.+.|++...++.. .+.+|+.|++..|++. .+|+.+..++-
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpL 213 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPL 213 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCce
Confidence 99999 79999999999999999999999655554 8999999999999998 77877776653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-08 Score=122.34 Aligned_cols=142 Identities=20% Similarity=0.235 Sum_probs=97.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
..++.|++.++.+. .+|. .| .+.+|+.|+|++|++. .+|..+..+++|++|+|++|...+.+|.+.. .+|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEe
Confidence 34666777666665 5665 34 4678888888888887 6777778888888888887765555565443 37888888
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~ 214 (627)
++|..-..+|..++++++|+.|++++|..-+.+|.. ++++|+.|++++|...+.+|....++..|..
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L 732 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDL 732 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeec
Confidence 887655578888888888888888876544455543 7778888888877666566655444444433
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.8e-09 Score=79.70 Aligned_cols=60 Identities=28% Similarity=0.488 Sum_probs=49.4
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYF 130 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 130 (627)
+++.|+|++|+++ .+|++.|.++++|+.|+|++|.|+...|..|..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5778888888888 66766888888888888888888877777888888888888888875
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=95.31 Aligned_cols=262 Identities=13% Similarity=0.172 Sum_probs=152.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeE----Ee--eCC-ceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY----YY--SKD-EKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~----~~--~~~-~~~lv~e~ 411 (627)
...||+|+.+.+|..-.- ...+.|+........ -.+.++.+.....||-+..-+.+ .. +.. -..++|..
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~--~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA--QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchH--HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 356999999999975422 123456665432211 12233445555566654331111 11 111 14466666
Q ss_pred CCCCC-HHHHhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 412 MPAGS-LFMLLH-RNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 412 ~~~g~-L~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
+++.. +..++. ..+.++-...+|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+.+++.+.+.|=..-....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence 65532 222221 122333456899999999999999999999999 8889999999999999999998854332222
Q ss_pred CC---CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCC-C-HHHHHHH-H---hh
Q 006886 490 FP---TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTG-KAPLQHSGHDDVV-D-LPRWVRS-V---VR 554 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~-~-~~~~~~~-~---~~ 554 (627)
.. ....|...|.+||... +-.-+...|-|.+||++++++.| +.||.+....... . ....+.. . ..
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeech
Confidence 22 1234677899999764 33457789999999999999886 9999864321110 0 0000000 0 00
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHhhccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKV--PDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~--p~~RPs~~ev~~~L~~~~~~ 610 (627)
+......-.+.-..+...+...+. +..+|+... +.-|||++-.+..|..+.+.
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqA---lF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQA---LFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHH---HHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000000000000111122333333 444787654 46899999999888877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.4e-07 Score=95.66 Aligned_cols=170 Identities=25% Similarity=0.358 Sum_probs=127.0
Q ss_pred ceeEEEEEec-CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecCCC-CCHHH
Q 006886 347 YGSTYKAILE-DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYMPA-GSLFM 419 (627)
Q Consensus 347 ~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 419 (627)
-.+.||+..+ ||..|+.|++...+. .......-+++++++ .|.|+|++...+.. +...++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578999844 899999999944322 112234557788888 99999999888763 4467899999887 56766
Q ss_pred HhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 420 LLHRNRS----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 420 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
+...... ..+...++...+.++.|++.||.++|+.| +.-+-|.+.+|+++.+..++|+..|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5543221 12334677899999999999999999999 8889999999999999999999888877665
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
...+ |-+ .-..+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~----------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4331 111 123467888999999999999653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.6e-08 Score=121.26 Aligned_cols=65 Identities=25% Similarity=0.303 Sum_probs=33.4
Q ss_pred CcceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 59 WIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 59 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
|.|+.+- .+++.|+|++++..+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|+|++|
T Consensus 627 ~~~~~~l---~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 627 WDGVHSL---TGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred ccccccC---CCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 5555332 4456666665544444443 555555555555554433355555555555555555543
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.6e-09 Score=111.74 Aligned_cols=142 Identities=33% Similarity=0.472 Sum_probs=94.1
Q ss_pred cEEEEEcCCCCcccccCccccCCCC-cccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchh-hccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLD-ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF-RSLQLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~L~~L~l 147 (627)
.++.|++.+|+++ .+|+ ....++ +|+.|++++|.+. .+|..+..+++|+.|++++|+++.+++.. ....|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheec
Confidence 5777777777777 5655 455664 7777777777777 66666777777777777777777777665 4456777777
Q ss_pred cccccccCCccccccccccccccccCCcccccCCC-CCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|+++ .+|.....+..|++|++++|++...+.. ..+.++..|.+.+|++. .++..++.++.++.++
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~ 261 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceec
Confidence 777777 5666655566677777777743323332 26666666667777665 3355555555555443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.9e-08 Score=90.64 Aligned_cols=126 Identities=21% Similarity=0.264 Sum_probs=79.8
Q ss_pred eEEEEEecCCcEEEEEEecccc-----------------------c----CHHHHHHHHHHHHHhccC-CCeeeeeeEEe
Q 006886 349 STYKAILEDGTTVVVKRLREVA-----------------------A----TKREFEQQMEVVGTIGKH-SNVVPVRAYYY 400 (627)
Q Consensus 349 ~Vy~~~~~~~~~vavK~l~~~~-----------------------~----~~~~~~~e~~~l~~l~~h-~niv~l~~~~~ 400 (627)
.||.|...+|..+|+|..+... . ......+|.+.|.++... -++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999889999999863210 0 123467788999988433 244555533
Q ss_pred eCCceEEEEecCC--CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 401 SKDEKLVVYSYMP--AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF-IHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 401 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
....+||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+|+.+.||+++++ .+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 24569999998 54444333211 1123445667777775555 57887 9999999999999988 99
Q ss_pred EEeecccccccC
Q 006886 478 CISDVGLAHLIN 489 (627)
Q Consensus 478 ki~DfG~a~~~~ 489 (627)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.3e-09 Score=110.70 Aligned_cols=141 Identities=29% Similarity=0.388 Sum_probs=118.4
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-ccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLS 148 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls 148 (627)
+++.|++++|.+. .+|. .++.+++|+.|++++|.++ .+|...+.+++|+.|++++|++..+++.... ..|++|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~-~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPS-PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhh-hhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhc
Confidence 7999999999998 6664 6899999999999999999 7887777899999999999999999887544 469999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCC-CCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP-PLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+|.+. .++..+.++.++..|.+++|++...+. ...+++|++|++++|.++ .++. ++.+..+..++
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~ 283 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELD 283 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEe
Confidence 99655 477889999999999999999986322 237888999999999998 5554 66666666654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=5.5e-09 Score=103.73 Aligned_cols=148 Identities=25% Similarity=0.367 Sum_probs=112.4
Q ss_pred EEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhcc-ccc-ccccccc
Q 006886 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRSL-QLN-ALDLSFN 150 (627)
Q Consensus 74 l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~-~L~-~L~ls~N 150 (627)
++-++-+|+ .+|.+ + -+....|+|..|+|+.+.|..|+.+++|+.||||+|+|+.+-|. |.++ +|. .++.++|
T Consensus 51 VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred EEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 344555665 45541 2 12467899999999977777999999999999999999999886 4444 554 4555669
Q ss_pred ccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCC-CCCCCCCCccc---CCCcCCCCC
Q 006886 151 AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPD-SLQTFPNSSFV---GNSMLCGLP 224 (627)
Q Consensus 151 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~-~~~~~~~l~~~---~n~~~~~~~ 224 (627)
+|+......|++|..|+.|.+.-|++.-..... .+++|..|.+.+|.+. .++. .|..+..++.+ -|+..|+|.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence 999544558999999999999999998544443 8999999999999998 5554 77777777655 466677665
Q ss_pred CC
Q 006886 225 LT 226 (627)
Q Consensus 225 ~~ 226 (627)
+.
T Consensus 206 L~ 207 (498)
T KOG4237|consen 206 LP 207 (498)
T ss_pred cc
Confidence 53
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-08 Score=113.21 Aligned_cols=191 Identities=22% Similarity=0.261 Sum_probs=133.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+-+-+|.++.++-+.-. .|...++|...... ...+....+-.+.... ++|-++....-+......++|++|..+
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhhHHhcc
Confidence 46778999988877633 23333343332211 0112222222222222 456666555444556778899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF---- 490 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~---- 490 (627)
++|...++... ..+..........+.++++|||... +.|+|++|.|++...++..+++|||.......
T Consensus 889 ~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 889 GDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred CCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999988643 2444444555666788899999876 89999999999999999999999984322100
Q ss_pred -------------------------------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 006886 491 -------------------------------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539 (627)
Q Consensus 491 -------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 539 (627)
.....+|+.|.+||...+......+|+|+.|++++|.++|..||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0112357889999999999999999999999999999999999986543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.4e-09 Score=110.39 Aligned_cols=131 Identities=22% Similarity=0.301 Sum_probs=76.2
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCc---ccEEEccCcccCc----cCCCCCCCc-ccccEEeeecccccccCch----
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDA---LKILSLRSNYLNG----TLPSDITSI-SSLQYVYLQNNYFSGVLPA---- 136 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~~~~---- 136 (627)
.+++.|+|++|.+.+..+. .+..+.+ |+.|+|++|.+++ .+...+..+ ++|+.|+|++|.+++....
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 4677777777777644433 3444444 7777777777662 222334455 6777777777777643221
Q ss_pred hhc--cccccccccccccccC----CccccccccccccccccCCcccccCCC------CCCCccceeeccCCCccc
Q 006886 137 FRS--LQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAIPP------LNLPRLKILNFSNNNLNG 200 (627)
Q Consensus 137 ~~~--~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~------~~~~~L~~L~l~~N~l~~ 200 (627)
... .+|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.... ..+++|+.|++++|++++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 111 2577777777777632 233344455777777777776532211 145677777777777663
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.7e-09 Score=110.01 Aligned_cols=147 Identities=22% Similarity=0.212 Sum_probs=102.3
Q ss_pred CcEEEEEcCCCCccc------ccCccccCCCCcccEEEccCcccCccCCCCCCCccc---ccEEeeecccccccCch---
Q 006886 69 SRVIGIHLPGIGFTG------PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISS---LQYVYLQNNYFSGVLPA--- 136 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~~~~~--- 136 (627)
..++.|+++++.+.+ .++. .+.++++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++....
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~-~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQ-GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHH-HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 457788888877762 2233 5777889999999999998666666666655 99999999998742211
Q ss_pred --hhc--cccccccccccccccC----CccccccccccccccccCCcccccC----CC--CCCCccceeeccCCCcccc-
Q 006886 137 --FRS--LQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAI----PP--LNLPRLKILNFSNNNLNGS- 201 (627)
Q Consensus 137 --~~~--~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----p~--~~~~~L~~L~l~~N~l~~~- 201 (627)
+.. .+|+.|+|++|.+++. ++..+..+++|++|++++|.+++.. +. ..+++|+.|++++|.+++.
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence 111 3789999999998843 3345666778999999999988521 11 1456899999999988743
Q ss_pred ---CCCCCCCCCCCcccC
Q 006886 202 ---IPDSLQTFPNSSFVG 216 (627)
Q Consensus 202 ---~p~~~~~~~~l~~~~ 216 (627)
++..+..+++|+.++
T Consensus 210 ~~~l~~~~~~~~~L~~L~ 227 (319)
T cd00116 210 ASALAETLASLKSLEVLN 227 (319)
T ss_pred HHHHHHHhcccCCCCEEe
Confidence 334455566666664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.9e-07 Score=86.85 Aligned_cols=136 Identities=24% Similarity=0.264 Sum_probs=95.5
Q ss_pred HHhcccCcCCceeEEEEEecCCcEEEEEEecccc-----------------------cCHHHHHHHHHHHHHhccC-CCe
Q 006886 337 ASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVA-----------------------ATKREFEQQMEVVGTIGKH-SNV 392 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~e~~~l~~l~~h-~ni 392 (627)
+..+.||-|--+.||.|....|.++|||.=+... ......++|.++|.++..+ -.+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578899999999999999999999999632110 0123467888899988333 245
Q ss_pred eeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec
Q 006886 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472 (627)
Q Consensus 393 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 472 (627)
.+.+++ +...+||||++|-.|...= ++-...-.++..|+.-+.-+-..| |||+|+.+-||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 554443 4567999999886553221 122233344555555555555667 99999999999999
Q ss_pred CCCCeEEeecccccccC
Q 006886 473 QDLNGCISDVGLAHLIN 489 (627)
Q Consensus 473 ~~~~~ki~DfG~a~~~~ 489 (627)
+||.+.++||--+...+
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999998776544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-08 Score=75.30 Aligned_cols=57 Identities=47% Similarity=0.694 Sum_probs=30.0
Q ss_pred cccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCc
Q 006886 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNL 198 (627)
Q Consensus 142 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l 198 (627)
|+.|++++|+|+...+..|.++++|++|++++|+|+...|.. ++++|++|++++|+|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 445555555555333345555555555555555555444432 555555666655553
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9e-07 Score=95.11 Aligned_cols=140 Identities=16% Similarity=0.280 Sum_probs=93.9
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc----------------------C-------------------HHHHHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA----------------------T-------------------KREFEQ 378 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~----------------------~-------------------~~~~~~ 378 (627)
+.|+.++-|.||+|++++|+.||||+.+.... . +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56789999999999999999999999643110 0 002334
Q ss_pred HHHHHHHhc----cCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 006886 379 QMEVVGTIG----KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG-IAFIHS 453 (627)
Q Consensus 379 e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~ 453 (627)
|...+.++. ..+++.--.-|++-.....++|||++|-.+.+...... ..++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 444443332 44555444445555677889999999988877743221 1244 23333333332 333334
Q ss_pred cCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 454 ~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
.| +.|.|.+|.||+++.++...+.|||+...+.
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 55 9999999999999999999999999987664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2e-09 Score=114.13 Aligned_cols=124 Identities=25% Similarity=0.281 Sum_probs=99.5
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhcccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRSLQLNALDLS 148 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~L~~L~ls 148 (627)
.+...+++.|.|+ .+.. ++.-++.|+.|||++|+++..- .+..|++|+.|||++|++..++-- ..+.+|+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeec
Confidence 3556677777776 3333 7889999999999999998433 788999999999999999976542 233479999999
Q ss_pred ccccccCCccccccccccccccccCCcccccC---CCCCCCccceeeccCCCcc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI---PPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---p~~~~~~L~~L~l~~N~l~ 199 (627)
+|.++. + ..+.+|.+|+.||+++|-|.+.- |-..+..|+.|+|.+|++-
T Consensus 241 nN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999983 3 46889999999999999998733 3337888999999999985
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.2e-06 Score=80.66 Aligned_cols=140 Identities=14% Similarity=0.180 Sum_probs=84.9
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCC-eeeeeeEEeeCCceEEEEecCCCCC-H
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN-VVPVRAYYYSKDEKLVVYSYMPAGS-L 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~-L 417 (627)
..||+|..+.||+. .+..+++|.... ........+|.+++..+....- +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 67999999999984 245677887754 3345567889999988843322 4566777666777789999998863 1
Q ss_pred HHH---------------------hhhcCCCCCCCCCHHHHHH-HHH----------HHH-HHHHHHHhc-CCCCeeecC
Q 006886 418 FML---------------------LHRNRSDGGTALDWNSRMK-IAL----------GTA-RGIAFIHSE-GGAKFTHGN 463 (627)
Q Consensus 418 ~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia-~~l~~LH~~-~~~~ivH~D 463 (627)
... +|..... ......... +.. .+. ....+|... ..+.++|+|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 111 1111000 111111000 000 011 112233221 124578999
Q ss_pred CCCCCeEecCCCCeEEeecccccc
Q 006886 464 IKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 464 lk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.1e-06 Score=81.14 Aligned_cols=108 Identities=20% Similarity=0.257 Sum_probs=81.8
Q ss_pred HHHHHHHHHHHHHhcc-CCCeeeeeeEEeeCC----ceEEEEecCCCC-CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 006886 373 KREFEQQMEVVGTIGK-HSNVVPVRAYYYSKD----EKLVVYSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446 (627)
Q Consensus 373 ~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 446 (627)
.....+|...+..+.+ .-.+...+++.+... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 3457778777776632 223445556655432 347999999884 7999887532 1455677889999999
Q ss_pred HHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEeeccccccc
Q 006886 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCISDVGLAHLI 488 (627)
Q Consensus 447 ~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfG~a~~~ 488 (627)
.+.-||+.| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999 99999999999999887 7899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.3e-07 Score=95.52 Aligned_cols=132 Identities=27% Similarity=0.304 Sum_probs=97.1
Q ss_pred CCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCcc-CCCCCCCcccccEEeeecccccccCc--hhhccccc
Q 006886 67 NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGT-LPSDITSISSLQYVYLQNNYFSGVLP--AFRSLQLN 143 (627)
Q Consensus 67 ~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~~L~ 143 (627)
+-++++.|+|+.|.+.-......-..+++|+.|.|+.+.|+-. +-..+..+++|+.|+|..|..-+... .-....|+
T Consensus 170 qLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~ 249 (505)
T KOG3207|consen 170 QLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ 249 (505)
T ss_pred hcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh
Confidence 3478999999999987555443445788999999999998732 11223467999999999996222221 12223799
Q ss_pred cccccccccccCCc--cccccccccccccccCCcccc-cCCC-------CCCCccceeeccCCCcc
Q 006886 144 ALDLSFNAFTGNIP--PGFQNLTRLHLLNLQNNSISG-AIPP-------LNLPRLKILNFSNNNLN 199 (627)
Q Consensus 144 ~L~ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~-~~p~-------~~~~~L~~L~l~~N~l~ 199 (627)
.|||++|.+- ..+ ...+.++.|+.|+++.+.+.. ..|+ ..+++|++|++..|++.
T Consensus 250 ~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 250 ELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 9999999987 355 467889999999999999875 2232 17899999999999995
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-07 Score=101.73 Aligned_cols=144 Identities=22% Similarity=0.326 Sum_probs=95.5
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC-------------CCCCccccCccccCC
Q 006886 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT-------------ATRTIGYRAPEVTET 508 (627)
Q Consensus 442 ~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~-------------~~~t~~y~aPE~~~~ 508 (627)
.+++.|+.|+|.. ..+||++|.|++|.+++++..||+.|+++.....+.. ......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999976 4799999999999999999999999998755433111 012356999999998
Q ss_pred CCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcc
Q 006886 509 RKASQKSDVYSFGVLLLEML-TGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCV 587 (627)
Q Consensus 509 ~~~~~~~Dv~S~Gvvl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl 587 (627)
...+.++|+||+|+++|.+. .|+.-+............ . . ..+...... ..+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~-~-------~~~~~~~~~--s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----R-N-------LLNAGAFGY--SNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----h-c-------ccccccccc--cccCcHHHHHHHHHHh
Confidence 88899999999999999998 466555543222211110 0 0 000000000 0122233444455778
Q ss_pred cCCCCCCCCHHHHH
Q 006886 588 AKVPDSRPKMDDVV 601 (627)
Q Consensus 588 ~~~p~~RPs~~ev~ 601 (627)
..++.-||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 89999999776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=9.1e-06 Score=76.49 Aligned_cols=138 Identities=12% Similarity=0.084 Sum_probs=100.6
Q ss_pred CcCCceeEEEEEecCCcEEEEEEeccc-------ccCHHHHHHHHHHHHHhccC-CCeeeeeeEEe-e----CCceEEEE
Q 006886 343 GKGSYGSTYKAILEDGTTVVVKRLREV-------AATKREFEQQMEVVGTIGKH-SNVVPVRAYYY-S----KDEKLVVY 409 (627)
Q Consensus 343 g~G~~g~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~-~----~~~~~lv~ 409 (627)
|+||-+-|+.-.+. |..+-+|+-... ......|.+|...+.++... -.+.+.. ++. . ....++|+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 57888889997775 457889976411 12567899999998888422 1233333 332 1 12357899
Q ss_pred ecCCC-CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC--eEEeeccccc
Q 006886 410 SYMPA-GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN--GCISDVGLAH 486 (627)
Q Consensus 410 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfG~a~ 486 (627)
|-+++ -+|.+++.... -.+.+...+..+..+++..+.-||+.| +.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888886432 124567778899999999999999999 999999999999987777 8999998765
Q ss_pred cc
Q 006886 487 LI 488 (627)
Q Consensus 487 ~~ 488 (627)
..
T Consensus 179 ~~ 180 (216)
T PRK09902 179 RR 180 (216)
T ss_pred hh
Confidence 43
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-07 Score=81.08 Aligned_cols=88 Identities=23% Similarity=0.316 Sum_probs=51.2
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~l 147 (627)
.+++.++|++|++. .+|+..-..++.++.|+|++|.|+ .+|.++..++.|+.|++++|.|...+..+..+ +|..||.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcC
Confidence 45666666666666 455533344556666666666666 56666666666666666666666555444433 4555555
Q ss_pred cccccccCCccc
Q 006886 148 SFNAFTGNIPPG 159 (627)
Q Consensus 148 s~N~l~~~~p~~ 159 (627)
.+|.+. .+|-.
T Consensus 131 ~~na~~-eid~d 141 (177)
T KOG4579|consen 131 PENARA-EIDVD 141 (177)
T ss_pred CCCccc-cCcHH
Confidence 555555 34443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.7e-07 Score=93.20 Aligned_cols=148 Identities=25% Similarity=0.261 Sum_probs=105.5
Q ss_pred CcEEEEEcCCCCcccccCc-cccCCCCcccEEEccCcccCccCCCCC-CCcccccEEeeecccccccCch---hhccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPA-NSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA---FRSLQLN 143 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~---~~~~~L~ 143 (627)
.+|+.|||++|=+..-.|- .....|++|+.|+|+.|++.-..-+.. ..++.|+.|.|+.+.|+.---. ..-.+|.
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 6899999999987643221 146789999999999999974333322 3579999999999999832111 1124799
Q ss_pred cccccccccccCCccccccccccccccccCCcccccC--CCC-CCCccceeeccCCCcccc-CCCC-----CCCCCCCcc
Q 006886 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAI--PPL-NLPRLKILNFSNNNLNGS-IPDS-----LQTFPNSSF 214 (627)
Q Consensus 144 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~-~~~~L~~L~l~~N~l~~~-~p~~-----~~~~~~l~~ 214 (627)
.|+|..|...+.--....-+..|+.|||++|++-... +.. .++.|..|+++.|.++.. +|+. ...+++|++
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 9999999633333344556779999999999997543 222 899999999999999743 3433 345666766
Q ss_pred cC
Q 006886 215 VG 216 (627)
Q Consensus 215 ~~ 216 (627)
+.
T Consensus 306 L~ 307 (505)
T KOG3207|consen 306 LN 307 (505)
T ss_pred ee
Confidence 63
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.7e-08 Score=83.26 Aligned_cols=85 Identities=22% Similarity=0.302 Sum_probs=56.9
Q ss_pred cccccEEeeecccccccCchhhcc--ccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeec
Q 006886 117 ISSLQYVYLQNNYFSGVLPAFRSL--QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNF 193 (627)
Q Consensus 117 l~~L~~L~l~~N~l~~~~~~~~~~--~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l 193 (627)
...|+..+|++|.+...++.+... .++.|+|++|.|+ .+|..+..++.|+.|++++|.|...+-.. .+.+|..|+.
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDS 130 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcC
Confidence 344455566666666666655442 5677777777777 57777888888888888888887433322 5777777777
Q ss_pred cCCCccccCC
Q 006886 194 SNNNLNGSIP 203 (627)
Q Consensus 194 ~~N~l~~~~p 203 (627)
.+|.+. .+|
T Consensus 131 ~~na~~-eid 139 (177)
T KOG4579|consen 131 PENARA-EID 139 (177)
T ss_pred CCCccc-cCc
Confidence 777776 444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.6e-07 Score=98.68 Aligned_cols=125 Identities=26% Similarity=0.299 Sum_probs=89.3
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~ 149 (627)
.+..+++..|.+.- +- +.+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+.+.+-.....|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~-~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-IL-NHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hh-cccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchhhccchhhheecc
Confidence 45556666666663 21 24777888888888888887 34434777888888888888888776644444588888888
Q ss_pred cccccCCccccccccccccccccCCcccccCC--CCCCCccceeeccCCCcc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP--PLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~~L~~L~l~~N~l~ 199 (627)
|.|+. + ..+..+++|+.+++++|+++..-+ ...+.+|+.+++.+|.+.
T Consensus 150 N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 150 NLISD-I-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred Ccchh-c-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 88883 3 345667888888888888886545 257778888888888876
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2e-06 Score=59.38 Aligned_cols=37 Identities=43% Similarity=0.900 Sum_probs=26.4
Q ss_pred hhHHHHHHHHHhhCCC---CCCCCCCCC--CCCCCCCcceEee
Q 006886 28 NSDKQALLDFADAVPH---ARKLNWNAA--APVCSSWIGVTCN 65 (627)
Q Consensus 28 ~~~~~~l~~~~~~~~~---~~~~~W~~~--~~~c~~w~gv~C~ 65 (627)
+.|.+||++||+++.. ..+.+|+.. .++| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 5799999999999964 345699987 4555 89999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.1e-05 Score=73.96 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=89.3
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCH--------------------H-----HHHHHHHHHHHhc-cCCCee
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATK--------------------R-----EFEQQMEVVGTIG-KHSNVV 393 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------------------~-----~~~~e~~~l~~l~-~h~niv 393 (627)
..|.+|.-+.||+|.-.++..+|||+.+...... + -.++|...|.++. .+-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4677888899999998889999999975321110 0 1233444444442 122333
Q ss_pred eeeeEEeeCCceEEEEecCCCC-CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEe
Q 006886 394 PVRAYYYSKDEKLVVYSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 394 ~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl 471 (627)
+.+++. ...+||||+... .-.-.|. ..++...+...+..++++.+.-|-. .+ +||+||..-|||+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~ 200 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILV 200 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEE
Confidence 333332 446999998553 1111111 1223333566777888888888877 55 9999999999999
Q ss_pred cCCCCeEEeecccccccCC
Q 006886 472 TQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~ 490 (627)
. ++.+.|+|||-|.....
T Consensus 201 ~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred E-CCeEEEEECccccccCC
Confidence 9 88999999999876653
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-06 Score=60.61 Aligned_cols=40 Identities=28% Similarity=0.488 Sum_probs=30.5
Q ss_pred CcccEEEccCcccCccCCCCCCCcccccEEeeecccccccC
Q 006886 94 DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVL 134 (627)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 134 (627)
++|+.|+|++|+|+ .+|+.|.+|++|++|+|++|+|+.+.
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCCc
Confidence 46888888888888 56767888888888888888887543
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.8e-05 Score=75.79 Aligned_cols=143 Identities=17% Similarity=0.156 Sum_probs=87.0
Q ss_pred ccCcCCc-eeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHH
Q 006886 341 VLGKGSY-GSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFM 419 (627)
Q Consensus 341 ~lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 419 (627)
.|-.|.. ..||+.... +..+++|+..... ..+..+|++++..+..+--+.+++++....+..++|||+++|.++..
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3455655 789998765 4678888875433 34577899998888666445567777666666789999999977654
Q ss_pred Hh-------------------hhcCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----c
Q 006886 420 LL-------------------HRNRSDGGTALD--WNSRMKIAL--------------------GTARGIAFIHS----E 454 (627)
Q Consensus 420 ~l-------------------~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~----~ 454 (627)
.. +.... ...... ......... .+......|-. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 31 11100 011111 001110000 01111222211 1
Q ss_pred CCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 455 ~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
..+.++|+|+.|.|||++.++...|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987788999997653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=9e-07 Score=94.55 Aligned_cols=105 Identities=23% Similarity=0.263 Sum_probs=84.6
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
..+..|+|.+|++... .. .+..+++|+.|+|++|.|+... .+..++.|+.|++++|.|+.+........|+.++++
T Consensus 95 ~~l~~l~l~~n~i~~i-~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~~~~~~l~~L~~l~l~ 170 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKI-EN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDISGLESLKSLKLLDLS 170 (414)
T ss_pred cceeeeeccccchhhc-cc-chhhhhcchheecccccccccc--chhhccchhhheeccCcchhccCCccchhhhcccCC
Confidence 6789999999999843 32 3788999999999999998543 477788899999999999987554444589999999
Q ss_pred ccccccCCccc-cccccccccccccCCcccc
Q 006886 149 FNAFTGNIPPG-FQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 149 ~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~ 178 (627)
+|.++. ++.. ...+.+|+.+++.+|.+..
T Consensus 171 ~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 171 YNRIVD-IENDELSELISLEELDLGGNSIRE 200 (414)
T ss_pred cchhhh-hhhhhhhhccchHHHhccCCchhc
Confidence 999995 4332 5778889999999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 627 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-83
Identities = 106/291 (36%), Positives = 170/291 (58%), Gaps = 17/291 (5%)
Query: 329 FDLEDLLRA-----SAEVLGKGSYGSTYKAILEDGTTVVVKRLRE--VAATKREFEQQME 381
F L +L A + +LG+G +G YK L DGT V VKRL+E + +F+ ++E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 382 VVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIA 441
++ H N++ +R + + E+L+VY YM GS+ L R + LDW R +IA
Sbjct: 80 MISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIA 137
Query: 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--ATR--- 496
LG+ARG+A++H K H ++K++N+LL ++ + D GLA L+++ T T
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG--HDDVVDLPRWVRSVVR 554
TIG+ APE T K+S+K+DV+ +GV+LLE++TG+ + +DD V L WV+ +++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
E+ + D L+ +EE+ Q++Q+AL C P RPKM +VVRM+E
Sbjct: 258 EKKLEALVD-VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-70
Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 26/297 (8%)
Query: 329 FDLEDLLRA-----SAEVLGKGSYGSTYKAILEDGTTVVVKRL-REVAATKREFEQQMEV 382
L DL A ++G G +G YK +L DG V +KR E + EF + E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF--ETEI 86
Query: 383 VGTIGK--HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
T+ H ++V + + ++E +++Y YM G+L L+ ++ W R++I
Sbjct: 87 -ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEI 144
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA-----T 495
+G ARG+ ++H+ H ++KS N+LL ++ I+D G++ T
Sbjct: 145 CIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK--GTELDQTHLST 199
Query: 496 R---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
T+GY PE + ++KSDVYSFGV+L E+L ++ + S ++V+L W
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
++ D L + E + + A+ C+A + RP M DV+ +E +
Sbjct: 260 HNNGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-70
Identities = 89/297 (29%), Positives = 136/297 (45%), Gaps = 33/297 (11%)
Query: 328 NFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATK-----REFEQQMEV 382
NFD E + +G+G +G YK + + TTV VK+L + ++F E+
Sbjct: 26 NFD-ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF--DQEI 81
Query: 383 VGTIGK--HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
+ K H N+V + + D+ +VY YMP GSL L DG L W+ R KI
Sbjct: 82 -KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC--LDGTPPLSWHMRCKI 138
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA-----T 495
A G A GI F+H H +IKS+N+LL + ISD GLA A +
Sbjct: 139 AQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQTVMTS 193
Query: 496 R---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
R T Y APE + + KSD+YSFGV+LLE++TG + L +
Sbjct: 194 RIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEI 250
Query: 553 VREEWT-AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
EE T + D ++ + M +A C+ + + RP + V ++++++
Sbjct: 251 EDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-58
Identities = 72/314 (22%), Positives = 116/314 (36%), Gaps = 40/314 (12%)
Query: 328 NFDLEDLLRAS-----AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEV 382
+ E+L S EV +G +G +KA L V VK + E ++
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYS 71
Query: 383 VGTIGKHSNVVPVRAY----YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM 438
+ + KH N++ + ++ ++ GSL L N + WN
Sbjct: 72 LPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELC 124
Query: 439 KIALGTARGIAFIHSEGGAKFT-------HGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491
IA ARG+A++H + H +IKS NVLL +L CI+D GLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 492 TTATR------TIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
+A T Y APEV E R A + D+Y+ G++L E+ + +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 541 DVVDLPRWVRSVVREEWTAEVFDVELL-----KYQDVEEEMVQMLQIALSCVAKVPDSRP 595
++ + E EV + Y M + + C ++R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 596 KMDDVVRMIEQIQQ 609
V I Q+Q+
Sbjct: 305 SAGCVGERITQMQR 318
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 63/282 (22%), Positives = 124/282 (43%), Gaps = 26/282 (9%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKH 389
D +++ EV+G+G++G KA V +K++ + ++ F ++ + + H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRV-NH 60
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
N+V + Y + +V Y GSL+ +LH M L ++G+A
Sbjct: 61 PNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVA 116
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFPTTATR-TIGYRAPEVTE 507
++HS H ++K N+LL I D G A I T + + + APEV E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567
S+K DV+S+G++L E++T + P D++ + V +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLIK---- 227
Query: 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
++ + + ++ C +K P RP M+++V+++ + +
Sbjct: 228 ---NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 61/191 (31%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 28 NSDKQALLDFADAVPHARKL-NWNAAAPVCS-SWIGVTCNV--NRSRVIGIHLPGIGFTG 83
DKQALL + + L +W C+ +W+GV C+ RV + L G+
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 84 --PIPANSIGKLDALKILSLRS-NYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF--R 138
PIP+ S+ L L L + N L G +P I ++ L Y+Y+ + SG +P F +
Sbjct: 65 PYPIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRL-KILNFSN 195
L LD S+NA +G +PP +L L + N ISGAIP + +L + S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 196 NNLNGSIPDSL 206
N L G IP +
Sbjct: 184 NRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-46
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 30/178 (16%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL-QYVYLQNNYFSGVLPA-FR 138
+G +P SI L L ++ N ++G +P S S L + + N +G +P F
Sbjct: 137 LSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNN 197
+L L +DLS N G+ F + ++L NS++ + + L L+ NN
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 198 LNGSIPDSL--------------------------QTFPNSSFVGNSMLCGLPLTPCS 229
+ G++P L Q F S++ N LCG PL C+
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 18/74 (24%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG--AIPPL--NLPRLKILNFSN-NN 197
D + G + R++ L+L ++ IP NLP L L NN
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 198 LNGSIPDSLQTFPN 211
L G IP ++
Sbjct: 89 LVGPIPPAIAKLTQ 102
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 67/323 (20%), Positives = 120/323 (37%), Gaps = 50/323 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVP---- 394
E++G+G YG+ YK L D V VK A ++ F + + +H N+
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 395 -VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
R + E L+V Y P GSL L + DW S ++A RG+A++H+
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHT 129
Query: 454 EGGAKFT------HGNIKSSNVLLTQDLNGCISDVGLAHLI------------NFPTTAT 495
E H ++ S NVL+ D ISD GL+ + N +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 496 RTIGYRAPEV-------TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRW 548
TI Y APEV + A ++ D+Y+ G++ E+ L + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA-F 248
Query: 549 VRSVVREEWTAEVFDVELLK---------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599
V ++ + + +++ + + + C + ++R
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308
Query: 600 VVRMIEQIQQPELRNRASSGTES 622
+ ++ RN++ S T
Sbjct: 309 AEERMAELMMIWERNKSVSPTAH 331
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLR-----EVAATKREFEQQMEVVG 384
D +L E++G G +G Y+A G V VK R +++ T Q+ ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
+ KH N++ +R + +V + G L +L R + + + A+
Sbjct: 62 ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQI 114
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--------ISDVGLAHLI--NFPTTA 494
ARG+ ++H E H ++KSSN+L+ Q + I+D GLA +A
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554
+ APEV S+ SDV+S+GVLL E+LTG+ P + +D V
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG------IDGLAVAYGVAM 228
Query: 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ + E ++++ C P SRP +++ + I
Sbjct: 229 NKLALPIPS-------TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 33/288 (11%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTI 386
D + L L + G +K G +VVK L+ R+F ++ +
Sbjct: 8 DFKQLNFL--TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 387 GKHSNVVPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
H NV+PV S ++ +MP GSL+ +LH +D + +K AL
Sbjct: 65 -SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDM 120
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPE 504
ARG+AF+H+ + S +V++ +D+ IS + + APE
Sbjct: 121 ARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PGRMYAPAWVAPE 178
Query: 505 VTETRKA---SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561
+ + + +D++SF VLL E++T + P + V E +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD------LSNMEIGMKVALEGLRPTI 232
Query: 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ + ++++ C+ + P RPK D +V ++E++Q
Sbjct: 233 PP-------GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-43
Identities = 72/298 (24%), Positives = 135/298 (45%), Gaps = 30/298 (10%)
Query: 322 LDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQ 378
+DG + DL E +G GS+G+ ++A G+ V VK L E A EF +
Sbjct: 27 MDGDDMDIPWCDLNIK--EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLR 83
Query: 379 QMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM 438
++ ++ + +H N+V +V Y+ GSL+ LLH++ LD R+
Sbjct: 84 EVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRL 140
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA----HLINFPTTA 494
+A A+G+ ++H+ H N+KS N+L+ + + D GL+ +A
Sbjct: 141 SMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554
T + APEV +++KSDVYSFGV+L E+ T + P + ++ + V +V
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN------LNPAQVVAAVGF 253
Query: 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
+ E+ ++ ++ +++ C P RP ++ ++ + + +
Sbjct: 254 KCKRLEIPR-------NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 53/285 (18%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR--------EVAATKREFEQQMEVVGTIGKHS 390
+ +GKG +G +K ++D + V +K L E+ +EF++++ ++ + H
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
N+V + + +V ++P G L+ L + W+ ++++ L A GI +
Sbjct: 84 NIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEY 137
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC-----ISDVGLAHLINFPTTATR-TIGYRAPE 504
+ ++ H +++S N+ L ++D GL+ + + APE
Sbjct: 138 MQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPE 196
Query: 505 V--TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562
E ++K+D YSF ++L +LTG+ P + + +++ + E +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLRPTIP 252
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ D + +++ C + P RP +V+ + ++
Sbjct: 253 E-------DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 64/313 (20%), Positives = 122/313 (38%), Gaps = 63/313 (20%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVV----P 394
E +GKG +G ++ G V VK +R + ++ E+ T+ +H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + +V Y GSLF L+R + +K+AL TA G+A +H E
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHME 158
Query: 455 -----GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--------FPTTATRTIGYR 501
G H ++KS N+L+ ++ CI+D+GLA + P T Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 502 APEV------TETRKASQKSDVYSFGVLLLEMLTGKAPLQH------------SGHDDVV 543
APEV + ++ +++D+Y+ G++ E+ + V
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 544 DLPRWV-----RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMD 598
++ + V R + W + + M ++++ C +R
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSC----------EALRVMAKIMR---ECWYANGAARLTAL 325
Query: 599 DVVRMIEQIQQPE 611
+ + + Q+ Q E
Sbjct: 326 RIKKTLSQLSQQE 338
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 45/300 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVP---- 394
E +GKG YG ++ G V VK ++ + ++ E+ T+ +H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+S + ++ Y GSL+ L LD S ++I L A G+A +H E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 455 GGAKFT-----HGNIKSSNVLLTQDLNGCISDVGLA--------HLINFPTTATRTIGYR 501
H ++KS N+L+ ++ CI+D+GLA L T Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 502 APEV------TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555
APEV + + ++ D+++FG++L E+ +G + P + V +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS---NGIVEDYKPP-FYDVVPND 240
Query: 556 EWTAEVFDV--------ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
++ V + + + + ++ C + P +R + + + +I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 64/304 (21%), Positives = 122/304 (40%), Gaps = 45/304 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVP---- 394
+ +GKG YG + G V VK + + ++ E+ T+ +H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAA 99
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
S + ++ Y GSL+ L LD S +K+A + G+ +H+E
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 455 GGAKFT-----HGNIKSSNVLLTQDLNGCISDVGLA-------HLINFPTTATR-TIGYR 501
+ H ++KS N+L+ ++ CI+D+GLA + ++ P T Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 502 APEV------TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555
PEV ++ +D+YSFG++L E+ G + LP + V +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS---GGIVEEYQLP-YHDLVPSD 269
Query: 556 EWTAEVFDV--------ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
++ ++ +E + QM ++ C A P SR V + + ++
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 608 QQPE 611
+ +
Sbjct: 330 SESQ 333
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 33/190 (17%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLN--GTLPSDITSISSLQYVYLQNNYFSGVLPA-F 137
G I K N L G + +S+ + + + G F
Sbjct: 570 IAGKRYV-YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 138 RSLQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFS 194
+ + LD+S+N +G IP ++ L +LNL +N ISG+IP +L L IL+ S
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 195 NNNLNGSIPDSL--------------------------QTFPNSSFVGNSMLCGLPLTPC 228
+N L+G IP ++ +TFP + F+ N LCG PL C
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 748
Query: 229 STVSSSPSPS 238
++
Sbjct: 749 DPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-39
Identities = 48/221 (21%), Positives = 79/221 (35%), Gaps = 41/221 (18%)
Query: 19 IFPTVVADLNSDKQALLDFADAVPHARKL-NWNAAAPVCSSWIGVTCNVNRSRVIGIHLP 77
+ L + L+ F D +P L +W++ C+ + GVTC +V I L
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCT-FDGVTCR--DDKVTSIDLS 58
Query: 78 GIG---------------------------FTGPIPANSIGKLDALKILSLRSNYLNGTL 110
G + +L L L N L+G +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS--GFKCSASLTSLDLSRNSLSGPV 116
Query: 111 PSD--ITSISSLQYVYLQNNYFSGV--LPAFRSL-QLNALDLSFNAFTGNIPPGFQ---N 162
+ + S S L+++ + +N + L L LDLS N+ +G G+
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 163 LTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
L L + N ISG + L+ L+ S+NN + IP
Sbjct: 177 CGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 55/152 (36%), Positives = 78/152 (51%), Gaps = 5/152 (3%)
Query: 64 CNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYV 123
C ++ + ++L GFTG IP ++ L L L NYL+GT+PS + S+S L+ +
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPP-TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 124 YLQNNYFSGVLPA--FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP 181
L N G +P L L L FN TG IP G N T L+ ++L NN ++G IP
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 182 PL--NLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L L IL SNN+ +G+IP L +
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 5/136 (3%)
Query: 74 IHLPGIGFTGPIPAN--SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS 131
+ L +G LK L++ N ++G + ++ +L+++ + +N FS
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213
Query: 132 GVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKI 190
+P L LD+S N +G+ T L LLN+ +N G IPPL L L+
Sbjct: 214 TGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY 273
Query: 191 LNFSNNNLNGSIPDSL 206
L+ + N G IPD L
Sbjct: 274 LSLAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-35
Identities = 49/133 (36%), Positives = 69/133 (51%), Gaps = 7/133 (5%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSIS-SLQYVYLQNNYFSGVLPA--- 136
F+G +P +++ K+ LK+L L N +G LP +T++S SL + L +N FSG +
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 137 -FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNF 193
L L L N FTG IPP N + L L+L N +SG IP +L +L+ L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 194 SNNNLNGSIPDSL 206
N L G IP L
Sbjct: 450 WLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 48/139 (34%), Positives = 72/139 (51%), Gaps = 9/139 (6%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV 133
+ + G +G +I LK+L++ SN G +P + SLQY+ L N F+G
Sbjct: 228 LDISGNKLSGDFSR-AISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGE 284
Query: 134 LPAF---RSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPR 187
+P F L LDLS N F G +PP F + + L L L +N+ SG +P L +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 188 LKILNFSNNNLNGSIPDSL 206
LK+L+ S N +G +P+SL
Sbjct: 345 LKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 6/135 (4%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
F+ IP +G AL+ L + N L+G I++ + L+ + + +N F G +P
Sbjct: 212 FSTGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNN 197
L L L+ N FTG IP L L+L N GA+PP + L+ L S+NN
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 198 LNGSIP-DSLQTFPN 211
+G +P D+L
Sbjct: 330 FSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 47/133 (35%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 81 FTGPIPANSIGKLDA-LKILSLRSNYLNGTLPSDI--TSISSLQYVYLQNNYFSGVLPAF 137
F+G +P S+ L A L L L SN +G + ++ ++LQ +YLQNN F+G +P
Sbjct: 355 FSGELP-ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
Query: 138 --RSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNF 193
+L +L LSFN +G IP +L++L L L N + G IP + + L+ L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 194 SNNNLNGSIPDSL 206
N+L G IP L
Sbjct: 474 DFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 47/140 (33%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQNNYFSGVLPA-FR 138
F GPIP L +L+ LSL N G +P ++ + +L + L N+F G +P F
Sbjct: 259 FVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 139 SLQ-LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP--LNL-PRLKILNF 193
S L +L LS N F+G +P + L +L+L N SG +P NL L L+
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 194 SNNNLNGSIPDSLQTFPNSS 213
S+NN +G I +L P ++
Sbjct: 376 SSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 9/142 (6%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS 139
G IP + + L+ L L N L G +PS +++ ++L ++ L NN +G +P
Sbjct: 454 LEGEIP-QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 140 LQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNN 196
L+ L L LS N+F+GNIP + L L+L N +G IP + N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAAN 568
Query: 197 NLNGSIPDSLQTFPNSSFVGNS 218
+ G ++ +
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGA 590
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-28
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 7/135 (5%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
TG IP IG+L+ L IL L +N +G +P+++ SL ++ L N F+G +PA ++
Sbjct: 502 LTGEIP-KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AM 558
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN--SISGAIPP--LNLPRLKILNFSNN 196
+ ++ N G +N + N G L N ++
Sbjct: 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 197 NLNGSIPDSLQTFPN 211
G + +
Sbjct: 619 VYGGHTSPTFDNNGS 633
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 31/132 (23%), Positives = 52/132 (39%), Gaps = 11/132 (8%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF--- 137
F+G IPA +G +L L L +N NGT+P+ + S + N+ +G +
Sbjct: 526 FSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKN 580
Query: 138 -RSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFS 194
+ + F G L+ + N+ + G P N + L+ S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 195 NNNLNGSIPDSL 206
N L+G IP +
Sbjct: 641 YNMLSGYIPKEI 652
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 70/283 (24%), Positives = 130/283 (45%), Gaps = 37/283 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVR 396
+ +G GS+G+ YK V VK L + F+ ++ V+ +H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNIL--L 84
Query: 397 AYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
YS +L +V + SL+ LH + T + + IA TARG+ ++H++
Sbjct: 85 FMGYSTAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------NFPTTATRTIGYRAPEV---T 506
H ++KS+N+ L +D I D GLA + + +I + APEV
Sbjct: 141 ---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566
++ S +SDVY+FG++L E++TG+ P + + D + + V R + ++ V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKV-- 250
Query: 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ + M +++ C+ K D RP ++ IE++ +
Sbjct: 251 --RSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 66/306 (21%), Positives = 116/306 (37%), Gaps = 55/306 (17%)
Query: 329 FDLEDLLRASAEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV-AATKREFEQQMEVVGTI 386
F DL+ EVLGKG +G K E G +V+K L T+R F ++++V+ +
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+H NV+ Y + Y+ G+L ++ + W+ R+ A A
Sbjct: 65 -EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIAS 119
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------------------ 488
G+A++HS H ++ S N L+ ++ N ++D GLA L+
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 489 NFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRW 548
T + APE+ R +K DV+SFG++L E++
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------- 221
Query: 549 VRSVVREEWTAEVFDVELLKYQDVEEEMVQ-----MLQIALSCVAKVPDSRPKMDDVVRM 603
++ D L ++ I + C P+ RP +
Sbjct: 222 -----DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 604 IEQIQQ 609
+E ++
Sbjct: 277 LETLRM 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 58/311 (18%), Positives = 117/311 (37%), Gaps = 55/311 (17%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRLR---EVAATKREFEQQMEVVGTI 386
E L E++GKG +G Y V ++ + + + F++++
Sbjct: 31 PFEQLEIG--ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+H NVV S ++ S +L+ ++ + LD N +IA +
Sbjct: 87 -RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVK 141
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFP---------TTATR 496
G+ ++H++G H ++KS NV D I+D GL +
Sbjct: 142 GMGYLHAKG---ILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 497 TIGYRAPEVTETRKA---------SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547
+ + APE+ S+ SDV++ G + E+ + P + + ++
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-- 254
Query: 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ + ++ L + +E+ +L C A + RP ++ M+E++
Sbjct: 255 -MGTGMKPN----------LSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300
Query: 608 QQPELRNRASS 618
+ RNR S
Sbjct: 301 PK---RNRRLS 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVR 396
+G+GS+ + YK + E V L++ TK E ++ E + +H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV--- 88
Query: 397 AYYYS------KDEKLVVYS-YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+Y S + +V+ + M +G+L L R + + +G+
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQ 143
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTAT--RTIGYRAPEV 505
F+H+ H ++K N+ +T G I D+GLA L T + APE+
Sbjct: 144 FLHTRT-PPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM 201
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
E K + DVY+FG+ +LEM T + P
Sbjct: 202 YE-EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 21/210 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHSNVVPV 395
LG GSYG +K EDG VKR ++ ++ +G+H V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120
Query: 396 RAYYYSKDEKLVVYSYM--PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +E ++Y SL G +L T +A +HS
Sbjct: 121 -RLEQAWEEGGILYLQTELCGPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS 175
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG---YRAPEVTETRK 510
+G H ++K +N+ L + D GL + G Y APE+ +
Sbjct: 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ-GS 231
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
+DV+S G+ +LE+ L H G
Sbjct: 232 YGTAADVFSLGLTILEVACNM-ELPHGGEG 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 35/227 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHSNVVPV 395
E +G G +GS +K + DG +KR ++ A + + +++ +G+HS+VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 396 RAYY--YSKDEKLVVYS-YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
Y+ +++D+ +++ + Y GSL + N + L RG+ +IH
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYIH 132
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC-------------------ISDVGLAHLINFPTT 493
S H +IK SN+ +++ I D+G I+ P
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 494 ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539
+ A EV E K+D+++ + ++ + PL +G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE-PLPRNGD 235
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 32/139 (23%), Positives = 53/139 (38%), Gaps = 8/139 (5%)
Query: 79 IGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--A 136
+ F G S +LK L L N + T+ S+ + L+++ Q++ +
Sbjct: 359 LSFKGCCS-QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 137 FRSLQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILN 192
F SL+ L LD+S F L+ L +L + NS P L L L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 193 FSNNNLNGSIPDSLQTFPN 211
S L P + + +
Sbjct: 477 LSQCQLEQLSPTAFNSLSS 495
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 29/139 (20%), Positives = 46/139 (33%), Gaps = 5/139 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ-L 142
+ + S L++L L + S+S L + L N + AF L L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199
L +L L LN+ +N I P NL L+ L+ S+N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 200 GSIPDSLQTFPNSSFVGNS 218
L+ + S
Sbjct: 163 SIYCTDLRVLHQMPLLNLS 181
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 28/121 (23%), Positives = 44/121 (36%), Gaps = 5/121 (4%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
K L L N L S LQ + L + A++SL L+ L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 154 GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG-SIPDSLQTFP 210
F L+ L L +++ +L LK LN ++N + +P+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 211 N 211
N
Sbjct: 150 N 150
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 9/132 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I + L L L L N + + +SSLQ + + + L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 143 NALDLSFNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKI----LNFSN 195
L+++ N +P F NLT L L+L +N I L ++ + L+ S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 196 NNLNGSIPDSLQ 207
N +N P + +
Sbjct: 187 NPMNFIQPGAFK 198
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 32/150 (21%), Positives = 53/150 (35%), Gaps = 10/150 (6%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRS 139
F + +L L L L L P+ S+SSLQ + + +N F + ++
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 140 L-QLNALDLSFNAFTGNIPPGFQNL-TRLHLLNLQNNSISGAIPPL----NLPRLKILNF 193
L L LD S N + Q+ + L LNL N + + + L
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 194 SNNNLNGSIPDSLQTFPNSSFVGNSMLCGL 223
+ + P Q P S ++ C +
Sbjct: 577 EVERMECATPSDKQGMPVLSL---NITCQM 603
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 37/168 (22%), Positives = 62/168 (36%), Gaps = 14/168 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGT-LPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ- 141
+ IG L LK L++ N + LP +++++L+++ L +N + R L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 142 ----LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFS 194
+LDLS N P F+ + RLH L L+NN S + L L++
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 195 NNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYF 242
L+ F S+ G L + + F
Sbjct: 234 LGEFRNEGN--LEKFDKSALEGLCNLTIEEFR-LAYLDYYLDDIIDLF 278
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 28/148 (18%), Positives = 44/148 (29%), Gaps = 17/148 (11%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYV----YLQNNYFSGVLP- 135
L L+ L L SN + +D+ + + + L N + + P
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 136 AFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISG-----AIPPLNLPRLK 189
AF+ ++L+ L L N + N+ Q L L + L L L
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255
Query: 190 ILNFSNNNLN------GSIPDSLQTFPN 211
L L I D N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 36/184 (19%), Positives = 55/184 (29%), Gaps = 45/184 (24%)
Query: 79 IGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV----L 134
+ + + L + SL S + D + Q++ L N F L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 135 PAFRSLQLN-----------------ALDLSFNA--FTGNIPPGFQNLTRLHLLNLQNNS 175
+ + L LDLS N F G T L L+L N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 176 ISGAIPP--LNLPRLKILNFSNNNLNGSIPDS-----------------LQTFPNSSFVG 216
+ + L L +L+ L+F ++NL S + N F G
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 217 NSML 220
S L
Sbjct: 444 LSSL 447
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 24/158 (15%), Positives = 50/158 (31%), Gaps = 13/158 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSG----------V 133
I + ++ L L+LR+N+ + + I ++ L+ L F
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 134 LPAFRSLQLNALDLS-FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILN 192
L +L + L+ + + +I F LT + +L + +I + L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 193 FSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCST 230
N L++ +F N +
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 8/133 (6%)
Query: 84 PIPANSIGKLDALKILSLRSNYLN---GTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
+++ L L I R YL+ + ++++ L + V +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN- 199
L+L F ++L RL +N A ++LP L+ L+ S N L+
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 200 -GSIPDSLQTFPN 211
G S +
Sbjct: 362 KGCCSQSDFGTTS 374
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 114 ITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQN 173
+ + ++ Y ++ N++ +P LDLSFN F + L +L+L
Sbjct: 4 VEVVPNITYQCMELNFYK--IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 174 NSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPN 211
I +L L L + N + + +
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 39/278 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ LG G +G + A T V VK ++ + + F + V+ T+ +H +V + A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVV 252
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+K+ ++ +M GSL L +SD G+ + + A G+AFI +
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQK 514
H +++++N+L++ L I+D GLA +I R I + APE + K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLKY 569
SDV+SFG+LL+E++T G+ P + +V+ + R E E++++
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEELYNI----- 417
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
M++ C P+ RP + + +++
Sbjct: 418 ---------MMR----CWKNRPEERPTFEYIQSVLDDF 442
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 33/275 (12%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
LG+G +G + T V +K L+ + F Q+ +V+ + +H +V + A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 248
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
S++ +V YM GSL L + + G L + +A A G+A++ +
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQK 514
H +++++N+L+ ++L ++D GLA LI R I + APE + + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
SDV+SFG+LL E+ T G+ P + +V+D V R + +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYR-----------MPCPPECP 407
Query: 574 EEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
E + M Q C K P+ RP + + +E
Sbjct: 408 ESLHDLMCQ----CWRKEPEERPTFEYLQAFLEDY 438
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 60/300 (20%), Positives = 117/300 (39%), Gaps = 53/300 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E++G G +G +KA DG T V+K V + E++++ + + H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAEREVKALAKL-DHVNIVHYNGC 72
Query: 399 YYSKDEKLVVYS----------------YMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
+ D S + G+L + + R G LD +++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFE 129
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG--- 499
+G+ +IHS+ K + ++K SN+ L I D GL + TR+ G
Sbjct: 130 QITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 186
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559
Y +PE ++ ++ D+Y+ G++L E+L + ++ + +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFTDLRDGIISDIFDK 242
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM-IEQIQQPELRNRASS 618
+ LL+ ++L K P+ RP +++R + PE R ++
Sbjct: 243 KEKT--LLQ---------KLLS-------KKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 69/298 (23%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG G YG Y+ + + TV VK L+E EF ++ V+ I KH N+V +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 284
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ ++ +M G+L L R + + +A + + ++ +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQ 513
F H N+ + N L+ ++ ++D GL+ L+ T I + APE K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLK 568
KSDV++FGVLL E+ T G +P V +L + R E +V+++
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVYEL---- 451
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI---------QQPELRNRAS 617
M C P RP ++ + E + + EL R +
Sbjct: 452 ----------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 495
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 33/275 (12%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
LG+G +G + T V +K L+ + F Q+ +V+ + +H +V + A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVV 331
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
S++ +V YM GSL L + + G L + +A A G+A++ +
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQK 514
H +++++N+L+ ++L ++D GLA LI R I + APE + + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
SDV+SFG+LL E+ T G+ P + +V+D V R + +
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYR-----------MPCPPECP 490
Query: 574 EEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
E + M Q C K P+ RP + + +E
Sbjct: 491 ESLHDLMCQ----CWRKEPEERPTFEYLQAFLEDY 521
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 72/283 (25%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY- 398
+ +GKG +G G V VK ++ AT + F + V+ + +HSN+V +
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQL-RHSNLV--QLLG 253
Query: 399 --YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
K +V YM GSL L RS G + L + +K +L + ++
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR--APEVTETRKASQK 514
F H ++ + NVL+++D +SD GL + + + + APE +K S K
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-LPVKWTAPEALREKKFSTK 366
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLKY 569
SDV+SFG+LL E+ + G+ P DVV V + + V+DV
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYDV----- 418
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
M C +RP + +E I+ EL
Sbjct: 419 ---------MKN----CWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-25
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP---AFRSL- 140
I S L L+ L++ N + G + T + +L+Y+ L N++ S F SL
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 141 --QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSN 195
L+ L+L+ N + F L L +L+L N I + L + + S
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 196 NNLNGSIPDSLQTFPN 211
N +S P+
Sbjct: 440 NKYLQLTRNSFALVPS 455
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 31/133 (23%), Positives = 45/133 (33%), Gaps = 6/133 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+ KL LK+L+L+ N L+ ++L ++L +N + F L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP----LNLPRLKILNFSNNNL 198
LDLS N + L L L L NN I LK L S+N +
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 199 NGSIPDSLQTFPN 211
P
Sbjct: 184 KEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 31/138 (22%), Positives = 50/138 (36%), Gaps = 9/138 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL--- 140
I N K L L L N L+ T + +LQ + L NN +
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-----LNLPRLKILNFSN 195
L L+LS N P F + RL L L N + ++ L ++ L+ SN
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231
Query: 196 NNLNGSIPDSLQTFPNSS 213
+ L+ + + ++
Sbjct: 232 SQLSTTSNTTFLGLKWTN 249
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 33/146 (22%), Positives = 52/146 (35%), Gaps = 10/146 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDIT---SISSLQYVYLQNNYFSGVLP-AFRSL 140
+ L L L + L +L + + +S++ + L N+ S F L
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 141 Q---LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSN 195
+ L LDLS+N F L +L L+ N+I L ++ LN
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 196 NNLNGSIPD-SLQTFPNSSFVGNSML 220
+ SI SL + SF L
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 7/146 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I +++ L L++L L N + L + ++ +YL N + + +F +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 142 LNALDLSFNAFTG--NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNN 197
L L L A + P FQ L L +L+L NN+I+ + L +L+IL+ +NN
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 198 LNGSIPDSLQTFPNSSFVGNSMLCGL 223
L + P G S L L
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHIL 541
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 33/133 (24%), Positives = 51/133 (38%), Gaps = 4/133 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+PA + + L L + N ++ P + L+ + LQ+N S + F L
Sbjct: 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNL 99
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG 200
L L N+ F L L+L +N +S L L+ L SNN +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 201 SIPDSLQTFPNSS 213
+ L F NSS
Sbjct: 160 LKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 29/145 (20%), Positives = 50/145 (34%), Gaps = 14/145 (9%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV---LPAF 137
+ L+ + + L N + + SLQ + L+ V F
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 138 RSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS--------GAIPPL--NLP 186
+ L L LDLS N + L +L +L+LQ+N+++ G L
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 187 RLKILNFSNNNLNGSIPDSLQTFPN 211
L ILN +N + + +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFE 561
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 6/135 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRSLQ-L 142
+ + L L L SN + + +L + L +N S L L+ L
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 143 NALDLSFNAFTGNIPPGFQ--NLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNL 198
L LS N + L L L +N I P + RL L +N L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 199 NGSIPDSLQTFPNSS 213
S+ + L ++
Sbjct: 208 GPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 28/141 (19%), Positives = 52/141 (36%), Gaps = 12/141 (8%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS---------GVL 134
+ L L IL L +N + + + L+ + LQ+N + G +
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 135 PAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKIL 191
+ L L+ L+L N F F++L L +++L N+++ + N LK L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 192 NFSNNNLNGSIPDSLQTFPNS 212
N N + +
Sbjct: 590 NLQKNLITSVEKKVFGPAFRN 610
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 31/137 (22%), Positives = 48/137 (35%), Gaps = 9/137 (6%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-----FR 138
I +LK L L SN + P +I L ++L N L
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNL--TRLHLLNLQNNSISGAIPPL--NLPRLKILNFS 194
+ + L LS + + F L T L +L+L N+++ LP+L+
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280
Query: 195 NNNLNGSIPDSLQTFPN 211
NN+ SL N
Sbjct: 281 YNNIQHLFSHSLHGLFN 297
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 37/160 (23%), Positives = 58/160 (36%), Gaps = 20/160 (12%)
Query: 85 IPANSIGKLDALKILSLRSNYLN--------GTLPSDITSISSLQYVYLQNNYFSGVLP- 135
I + + L+ L+IL L+ N L G + +S L + L++N F +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 136 AFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP---PLNLPRLKIL 191
F+ L +L +DL N F N L LNLQ N I+ L L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 192 NFSNNNLNGSIPDSL-------QTFPNSSFVGNSMLCGLP 224
+ N + + +T N + + LC P
Sbjct: 615 DMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 26/120 (21%), Positives = 47/120 (39%), Gaps = 7/120 (5%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
++ L +P D+ + ++ + L +N + F QL +LD+ FN +
Sbjct: 6 HEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 154 GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPN 211
P Q L L +LNLQ+N +S L L+ +N++ + N
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 21/150 (14%)
Query: 85 IPANSIGKLD--ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ 141
+ L L +L L N LN + L+Y +L+ N + + L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 142 ----------LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLK 189
+S + FQ L L LN+++N I G + L LK
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 190 ILNFSNNNLNGSIPDSLQTFPNSSFVGNSM 219
L+ SN+ SL+T N +FV +
Sbjct: 357 YLSLSNSFT------SLRTLTNETFVSLAH 380
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 30/121 (24%), Positives = 45/121 (37%), Gaps = 10/121 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL--Q 141
IP L LKI+ L N LN S + SL+ + LQ N + V F
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 142 LNALDLSFNAFTGNIP--PGFQ---NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNN 196
L LD+ FN F F N T ++ L ++ + P + + F +
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT--PPHYHGFPVRLFDTS 668
Query: 197 N 197
+
Sbjct: 669 S 669
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 39/284 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTT-VVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVR 396
E +G+G++G + L T V VK RE K +F Q+ ++ H N+V +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 178
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
K +V + G L + L + +++ A G+ ++ S+
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR-------APEVTETR 509
H ++ + N L+T+ ISD G++ + G R APE
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYG 290
Query: 510 KASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568
+ S +SDV+SFG+LL E + G +P + + +V R L
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGR-----------LPC 336
Query: 569 YQDVEEEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
+ + + + M Q C A P RP + + ++ I++
Sbjct: 337 PELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 37/280 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ +GKG +G G V VK ++ AT + F + V+ + +HSN+V +
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQLLGVI 83
Query: 400 YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ L +V YM GSL L RS G + L + +K +L + ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IGYRAPEVTETRKASQKSDV 517
F H ++ + NVL+++D +SD GL + + + + APE +K S KSDV
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 518 YSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLKYQDV 572
+SFG+LL E+ + G+ P DVV V + + V++V
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVYEV-------- 246
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
M C RP + +E I+ EL
Sbjct: 247 ------MKN----CWHLDAAMRPSFLQLREQLEHIKTHEL 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 39/255 (15%), Positives = 85/255 (33%), Gaps = 28/255 (10%)
Query: 340 EVLGKGSYGSTYKAI------LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVV 393
+LG+G++ Y+A ++ V+K + + Q+ +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ + ++ ++V G+L ++ ++ + + A+ I +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNG-----------CISDVGLA-HLINFP-----TTATR 496
HG+IK N +L + D+G + + FP T
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556
T G++ E+ + + + D + + ML G + + + R +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM 307
Query: 557 WTAEVFDVELLKYQD 571
W E F V +L D
Sbjct: 308 WN-EFFHV-MLNIPD 320
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 36/219 (16%), Positives = 64/219 (29%), Gaps = 58/219 (26%)
Query: 48 NWNAAAPVCS--SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRS-- 103
NWN + + GV+ N + RV G+ L G G +G +P ++IG+L L++L+L S
Sbjct: 59 NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVP-DAIGQLTELEVLALGSHG 116
Query: 104 --------------------------NYLNGTLPSDIT--SISSLQYVYLQNNYFSGVLP 135
+ T S L + ++ +
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 136 A--FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNL-------- 185
+L+ + N T + LT+L + N+
Sbjct: 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA 235
Query: 186 -------------PRLKILNFSNNNLNGSIPDSLQTFPN 211
L + N +P L+ P
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 20/144 (13%), Positives = 47/144 (32%), Gaps = 14/144 (9%)
Query: 75 HLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVL 134
+ L L + + + LP+ + ++ +Q + + N
Sbjct: 231 NSEYAQQYKTEDL-KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 135 PAFRSL----------QLNALDLSFNAF-TGNIPPGFQNLTRLHLLNLQNNSISGAIPPL 183
++ + + +N T + Q + +L +L N + G +P
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349
Query: 184 -NLPRLKILNFSNNNLNGSIPDSL 206
+ +L LN + N + IP +
Sbjct: 350 GSEIKLASLNLAYNQITE-IPANF 372
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 30/153 (19%), Positives = 51/153 (33%), Gaps = 17/153 (11%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
G +P + G L L+L N + + ++ + +N +P
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDA 398
Query: 141 ----QLNALDLSFNAFTG-------NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPR 187
++A+D S+N + P + +NL NN IS L
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 188 LKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220
L +N N L IP + N +F +L
Sbjct: 459 LSSINLMGNMLTE-IPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 25/136 (18%), Positives = 42/136 (30%), Gaps = 11/136 (8%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDI--TSISSLQYVYLQNNYFSGV------LPAFRS 139
+ L + LR N L L D T++ L + L N FS +
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKG 540
Query: 140 LQL-NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
+ N D N P G L L + +N I + P + +L+ +N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPN 599
Query: 199 NGSIPDSLQTFPNSSF 214
+ + +
Sbjct: 600 ISIDLSYVCPYIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-22
Identities = 32/144 (22%), Positives = 56/144 (38%), Gaps = 24/144 (16%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPS--DITSISSLQYVYLQNNYFSGV-------LP 135
IPAN G + ++ LS N L +P+ D S+S + + N V L
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 136 A--FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---------- 183
F+ + +++++LS N + F + L +NL N ++ IP
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFK 485
Query: 184 NLPRLKILNFSNNNLNGSIPDSLQ 207
N L ++ N L + D +
Sbjct: 486 NTYLLTSIDLRFNKLT-KLSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 21/164 (12%), Positives = 50/164 (30%), Gaps = 9/164 (5%)
Query: 58 SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSI 117
+++ + S +I + I S + SN + + + +
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIK-KSSRITLKDTQIGQLSNNI-TFVSKAVMRL 205
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS 177
+ L+ Y+ N+ F + + + NL L + + N
Sbjct: 206 TKLRQFYMGNSPFVAENI---CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 178 GAIPPL--NLPRLKILNFSNNNLNG--SIPDSLQTFPNSSFVGN 217
+P LP ++++N + N + D Q ++
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 19/115 (16%), Positives = 31/115 (26%), Gaps = 11/115 (9%)
Query: 81 FTGPIPANSIGKLDALKILSLR------SNYLNGTLPSDITSISSLQYVYLQNNYFSGVL 134
F+ P LK +R N P IT SL + + +N V
Sbjct: 525 FSK-FPT-QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVN 582
Query: 135 PAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS--GAIPPLNLPR 187
++ LD+ N + L + L++ R
Sbjct: 583 EKITP-NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 57/284 (20%), Positives = 123/284 (43%), Gaps = 40/284 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAAT----KREFEQQMEVVGTIGKHSNVVP 394
+ +G+G + Y+A L DG V +K+++ + + ++++++ + H NV+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVI- 95
Query: 395 VRAYYYS--KDEKLVVYS-YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
YY S +D +L + AG L ++ + + + K + + +
Sbjct: 96 --KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEHM 152
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVTE 507
HS + H +IK +NV +T + D+GL + TTA + +G Y +PE
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---AEVFDV 564
+ KSD++S G LL EM ++P + D ++L + + + ++ ++ +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265
Query: 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
EL + + + + P+ RP + V + +++
Sbjct: 266 EL---RQL---VNMCIN-------PDPEKRPDVTYVYDVAKRMH 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
E LG G +G + T V VK L++ + + F + ++ + +H +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVV 77
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+++ ++ YM GSL L ++ G L N + +A A G+AFI +
Sbjct: 78 -TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTETRKASQ 513
H +++++N+L++ L+ I+D GLA LI T G + APE +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
KSDV+SFG+LL E++T G+ P + +V+
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 36/266 (13%), Positives = 87/266 (32%), Gaps = 54/266 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK---------------------RLREVAATKREFE 377
VLG+ + +A E G + V RLR + K + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 378 QQMEV-------VGTIGKHSNVVPVRAYYYSKDEKLVVYSYM-PAGSLFMLLH--RNRSD 427
++ + + + ++ VR + Y +L + S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 428 GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487
+L ++R+++ L R +A +H G H ++ +++L Q ++
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 488 INFPTTATRTIGYRAPEVTETR-----------KASQKSDVYSFGVLLLEMLTGKAPLQH 536
++ + G+ PE+ R + D ++ G+++ + P+
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 537 SG--------HDDVVDLPRWVRSVVR 554
++P+ VR+++
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE 341
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/311 (22%), Positives = 120/311 (38%), Gaps = 55/311 (17%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
LG+GS+G Y+ + E T V +K + E A + EF + V+ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHH 89
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSR---MKIALGTAR 446
VV + LV+ M G L ++ R L S +++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR----- 501
G+A++++ KF H ++ + N ++ +D I D G+ I T YR
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY------ETDYYRKGGKG 200
Query: 502 -------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553
+PE + + SDV+SFGV+L E+ T + P Q ++ V+ V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEGG 257
Query: 554 REEWTAEVFDVELLKYQDVEEEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
L K + + + + M C P RP +++ I++ +P
Sbjct: 258 L-----------LDKPDNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 613 RNRASSGTESN 623
R + +E N
Sbjct: 303 REVSFYYSEEN 313
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 60/304 (19%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVV-VKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG G YG Y+ + + + V VK L+E EF ++ V+ I KH N+V +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 77
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ ++ +M G+L L R + + +A + + ++ +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-----------FPTTATRTIGYRAPEVTE 507
F H ++ + N L+ ++ ++D GL+ L+ FP I + APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP------IKWTAPESLA 185
Query: 508 TRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVF 562
K S KSDV++FGVLL E+ T G +P V +L + R E +V+
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVY 242
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI---------QQPELR 613
++ M C P RP ++ + E + + EL
Sbjct: 243 EL--------------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284
Query: 614 NRAS 617
R +
Sbjct: 285 KRGT 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHSNVVPV 395
+ +G+GS+G EDG V+K + + +E E +++ V+ + KH N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQY 88
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
R + +V Y G LF ++ + G + + + + +H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRAPEVTETRKA 511
K H +IKS N+ LT+D + D G+A ++N R IG Y +PE+ E +
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 512 SQKSDVYSFGVLLLEMLTGKAP 533
+ KSD+++ G +L E+ T K
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/298 (19%), Positives = 114/298 (38%), Gaps = 52/298 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-----EVAATKREFEQQMEVVGTIGKHSNVV 393
+ LG+G + L DG +KR+ + +RE + H N++
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNIL 89
Query: 394 PVRAYYYSKDEK----LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+ AY + ++ + G+L+ + D G L + + + LG RG+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR------------- 496
IH++ + H ++K +N+LL + + D+G + +R
Sbjct: 149 AIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 497 TIGYRAPEVTETRK---ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553
TI YRAPE+ + +++DV+S G +L M+ G+ P V V
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAV 260
Query: 554 REEWTAEVFDVELLKY-QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
+ + + ++ + + + M+ P RP + ++ +E +Q P
Sbjct: 261 QNQLSIPQSP----RHSSALWQLLNSMMT-------VDPHQRPHIPLLLSQLEALQPP 307
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 32/265 (12%), Positives = 75/265 (28%), Gaps = 53/265 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQME----------------- 381
VLG+ + +A E G + V +QM+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 382 --------VVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM----PAGSLFMLLH--RNRSD 427
+ K + + + V+ + +L + S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 428 GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487
+L ++R+++ L R +A +H G H ++ +++L Q ++
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 488 INFPTTATRTIGYRAPEV----------TETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537
+ G+ PE + D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 538 G--------HDDVVDLPRWVRSVVR 554
++P+ VR+++
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLE 345
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 46/291 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHSNVVPV 395
+G GSYG K DG +V K L + T+ E + ++ ++ + KH N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 70
Query: 396 RAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGG-----TALDWNSRMKIALGTARGI 448
+ + V Y G L ++ + + L +++ +AL
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL------ 124
Query: 449 AFIHSEGGAKFT--HGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-IG---YRA 502
H T H ++K +NV L N + D GLA ++N T+ +T +G Y +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562
PE ++KSD++S G LL E+ P ++ +
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREG------- 231
Query: 563 DVELLKYQDVEEEMVQMLQ-IALSCVAKVPDSRPKMDDVVR---MIEQIQQ 609
K++ + L I + RP +++++ ++E
Sbjct: 232 -----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 61/283 (21%), Positives = 118/283 (41%), Gaps = 41/283 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ LG G +G + V VK ++E + ++ EF Q+ + + + H +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC 72
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ +V Y+ G L L + L+ + +++ G+AF+ S +F
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTETRKASQ 513
H ++ + N L+ +DL +SD G+ + ++G + APEV K S
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLK 568
KSDV++FG+L+ E+ + GK P + +VV V R + ++ +
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGHRLYRPHLASDTIYQI---- 237
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
M C ++P+ RP ++ IE +++ +
Sbjct: 238 ----------MYS----CWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 57/292 (19%), Positives = 115/292 (39%), Gaps = 51/292 (17%)
Query: 340 EVLGKGSYGSTYKAILEDG-----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+VLG G++G+ YK + V +K LRE +E + V+ ++ + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 393 VPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
R + ++ MP G L + ++ + + + + A+G+ ++
Sbjct: 80 C--RLLGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYL 133
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEV 505
+ H ++ + NVL+ + I+D GLA L+ G + A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAE 560
R + +SDV+S+GV + E++T G P ++ + + R T +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICTID 247
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPE 611
V+ + M + C DSRPK +++ ++ + P+
Sbjct: 248 VYMI--------------MRK----CWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 58/312 (18%), Positives = 115/312 (36%), Gaps = 76/312 (24%)
Query: 340 EVLGKGSYGSTYKAIL--------EDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHS 390
E LG+G++ +K + T V++K L + F + ++ + H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHK 72
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
++V DE ++V ++ GSL L +N++ ++ ++++A A + F
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHF 128
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC--------ISDVGLAHLINFPTTATRTIGYR- 501
+ HGN+ + N+LL ++ + +SD G++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDILQE 179
Query: 502 -----APEVTETRKA-SQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL--------- 545
PE E K + +D +SFG L E+ + G PL +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239
Query: 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
P+ AE+ ++ + C+ PD RP ++R +
Sbjct: 240 PKA----------AELANL--------------INN----CMDYEPDHRPSFRAIIRDLN 271
Query: 606 QIQQPELRNRAS 617
+ P+L R S
Sbjct: 272 SLFTPDLVPRGS 283
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 59/284 (20%), Positives = 118/284 (41%), Gaps = 41/284 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ +G G +G + + V +K +RE A ++ +F ++ EV+ + H +V +
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 72
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ +V +M G L L R + + + L G+A++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTETRKASQ 513
H ++ + N L+ ++ +SD G+ + T + G + +PEV + S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLK 568
KSDV+SFGVL+ E+ + GK P ++ + +VV+ + + R + V+ +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFRLYKPRLASTHVYQI---- 237
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
M C + P+ RP ++R + +I + L
Sbjct: 238 ----------MNH----CWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 60/293 (20%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNV 392
++LG+G +GS + L+ V VK ++ +++RE F + + H NV
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNV 98
Query: 393 VP-----VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-SDGGTALDWNSRMKIALGTAR 446
+ + + +V+ +M G L L +R G + + +K + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR----- 501
G+ ++ + F H ++ + N +L D+ C++D GL+ I + +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 502 -APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559
A E R + KSDV++FGV + E+ T G P + ++ D + R
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLHGHR----- 267
Query: 560 EVFDVELLKYQDVEEEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
L + +D +E+ + M C P RP + +E++ +
Sbjct: 268 ------LKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 60/307 (19%), Positives = 115/307 (37%), Gaps = 50/307 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG-----TTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNV 392
+VLG G +G+ +K + V +K + + + + + M +G++ H+++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHI 77
Query: 393 VPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
V R L +V Y+P GSL + ++R L + + A+G+ ++
Sbjct: 78 V--RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYL 131
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEV 505
H N+ + NVLL ++D G+A L+ + A E
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAE 560
K + +SDV+S+GV + E++T G P +V DL + R + T +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERLAQPQICTID 245
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRASSGT 620
V+ V M++ C + RP ++ ++ + R
Sbjct: 246 VYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDPPRYLVIKRE 287
Query: 621 ESNVQTP 627
P
Sbjct: 288 SGPGIAP 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 71/313 (22%), Positives = 117/313 (37%), Gaps = 74/313 (23%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG+G++G +A TV VK L+E A + R +++++ IG H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 392 VV-----------PVRAYYYSKDEKLVVYSYMPAGSL--FMLLHR---------NRSDGG 429
VV P+ +V+ + G+L ++ R
Sbjct: 93 VVNLLGACTKPGGPL----------MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 430 TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489
L + + A+G+ F+ S K H ++ + N+LL++ I D GLA I
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 490 FPTTATRTIGYR------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDV 542
R R APE R + +SDV+SFGVLL E+ + G +P G
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP--GVKID 257
Query: 543 VDLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMD 598
+ R ++ R + T E++ ML C P RP
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQT--------------MLD----CWHGEPSQRPTFS 299
Query: 599 DVVRMIEQIQQPE 611
++V + + Q
Sbjct: 300 ELVEHLGNLLQAN 312
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 69/310 (22%), Positives = 121/310 (39%), Gaps = 68/310 (21%)
Query: 340 EVLGKGSYGSTYKAIL--------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKH 389
+ LG+G++G A ++ TV VK L++ A + +ME++ IGKH
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHR---------NRSDGGTALDWNSRM 438
N++ + V+ Y G+L ++ R + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
ARG+ ++ S+ K H ++ + NVL+T++ I+D GLA IN
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN------NID 211
Query: 499 GYR------------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
Y+ APE R + +SDV+SFGVL+ E+ T G +P +++ L
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 546 PRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601
++ R T E++ + M C VP RP +V
Sbjct: 272 ---LKEGHRMDKPANCTNELYMM--------------MRD----CWHAVPSQRPTFKQLV 310
Query: 602 RMIEQIQQPE 611
+++I
Sbjct: 311 EDLDRILTLT 320
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 60/294 (20%), Positives = 121/294 (41%), Gaps = 48/294 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG---TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVP 394
+V+G+G++G KA ++ +KR++E A R+F ++EV+ +G H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-----------SDGGTALDWNSRMKIALG 443
+ + + Y P G+L L ++R + + L + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT---IGY 500
ARG+ ++ + +F H ++ + N+L+ ++ I+D GL+ T + +
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----E 555
A E + SDV+S+GVLL E+++ G P ++ + + R
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQGYRLEKPL 264
Query: 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
EV+D+ M Q C + P RP ++ + ++ +
Sbjct: 265 NCDDEVYDL--------------MRQ----CWREKPYERPSFAQILVSLNRMLE 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 54/283 (19%), Positives = 110/283 (38%), Gaps = 41/283 (14%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ LG G +G V +K ++E + ++ EF ++ +V+ + H +V +
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 88
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ ++ YM G L L R +++ + ++ S+ +F
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESK---QF 141
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTETRKASQ 513
H ++ + N L+ +SD GL+ + T ++G + PEV K S
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLK 568
KSD+++FGVL+ E+ + GK P + + + + + +R + +V+ +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRPHLASEKVYTI---- 253
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
M C + D RP ++ I + E
Sbjct: 254 ----------MYS----CWHEKADERPTFKILLSNILDVMDEE 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 340 EVLGKG--SYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIG-KHSNVVP 394
V+GKG + A G V V+R+ A + Q E+ + H N+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 395 VRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
Y + D +L VV S+M GS L+ + DG ++ + I G + + +I
Sbjct: 91 ---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDG---MNELAIAYILQGVLKALDYI 144
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR---------- 501
H G + H ++K+S++L++ D +S + + R +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 502 -APEVTETRKA--SQKSDVYSFGVLLLEMLTGKAPLQH 536
+PEV + KSD+YS G+ E+ G P +
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 69/306 (22%), Positives = 109/306 (35%), Gaps = 62/306 (20%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
LG G++G Y+ + V VK L EV + +F + ++ H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V + ++ M G L F+ R R ++L + +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 450 FIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATRTIGYR----- 501
++ F H +I + N LLT I D G+A I R YR
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RASYYRKGGCA 205
Query: 502 -------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553
PE + K+D +SFGVLL E+ + G P + +V++ V S
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGG 262
Query: 554 R----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-Q 608
R + V+ + M Q C P+ RP ++ IE Q
Sbjct: 263 RMDPPKNCPGPVYRI--------------MTQ----CWQHQPEDRPNFAIILERIEYCTQ 304
Query: 609 QPELRN 614
P++ N
Sbjct: 305 DPDVIN 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--LREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
EV+G G+ A V +KR L + + E ++++ + H N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIV--- 76
Query: 397 AYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL---GTARGIAF 450
+YY + ++L +V + GS+ ++ + G IA G+ +
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG----LAHLINFPTTATRT--IG---YR 501
+H G H ++K+ N+LL +D + I+D G LA + R +G +
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 502 APEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQH 536
APEV E + K+D++SFG+ +E+ TG AP
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 73/303 (24%), Positives = 120/303 (39%), Gaps = 56/303 (18%)
Query: 340 EVLGKGSYGSTYKAIL--------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKH 389
+ LG+G++G A T V VK L+ A + +ME++ IGKH
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHR---------NRSDGGTALDWNSRM 438
N++ + V+ Y G+L ++ R + L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
A ARG+ ++ S+ K H ++ + NVL+T+D I+D GLA I+ +T
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 499 GYR------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRS 551
R APE R + +SDV+SFGVLL E+ T G +P +++ L ++
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---LKE 308
Query: 552 VVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
R T E++ + M C VP RP +V +++I
Sbjct: 309 GHRMDKPSNCTNELYMM--------------MRD----CWHAVPSQRPTFKQLVEDLDRI 350
Query: 608 QQP 610
Sbjct: 351 VAL 353
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 30/208 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+G+GS+G ++ + G VK++R E + + +VP
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL-SSPRIVP---L 115
Query: 399 Y--YSKDEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y + + ++ + GSL L+ + L + + G+ ++H+
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR 170
Query: 456 GAKFTHGNIKSSNVLLTQDLNGC-ISDVGLA-HLINFPTTATR--------TIGYRAPEV 505
HG++K+ NVLL+ D + + D G A L + T + APEV
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ K D++S ++L ML G P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 68/310 (21%)
Query: 340 EVLGKGSYGSTYKAIL--------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKH 389
+ LG+G +G A ++ TV VK L++ A + +ME++ IGKH
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 390 SNVVPVRAYYY---SKDEKL-VVYSYMPAGSL--FMLLHR---------NRSDGGTALDW 434
N++ + ++D L V+ Y G+L ++ R + +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494
+ ARG+ ++ S+ K H ++ + NVL+T++ I+D GLA IN
Sbjct: 203 KDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254
Query: 495 TRTIGYR------------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDD 541
Y+ APE R + +SDV+SFGVL+ E+ T G +P ++
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601
+ L ++ R + K + E + + C VP RP +V
Sbjct: 314 LFKL---LKEGHR-----------MDKPANCTNE---LYMMMRDCWHAVPSQRPTFKQLV 356
Query: 602 RMIEQIQQPE 611
+++I
Sbjct: 357 EDLDRILTLT 366
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 62/309 (20%), Positives = 124/309 (40%), Gaps = 57/309 (18%)
Query: 340 EVLGKGSYGSTYKAILED-----GTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNV 392
LG+G +G + G V VK L+ A + ++Q+++++ T+ H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHI 95
Query: 393 VPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + +V Y+P GSL L R+ L + A G+A+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAY 149
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR--------- 501
+H++ + H ++ + NVLL D I D GLA + YR
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-----PEGHEYYRVREDGDSPV 201
Query: 502 ---APEVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDLPRWVRSVVREE 556
APE + K SDV+SFGV L E+LT + + +++ + + +V
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV---- 257
Query: 557 WTAEVFDVELLKYQDVEEEMVQ-------MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ L + + E + + + + +C RP ++++ +++ + +
Sbjct: 258 -------LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
Query: 610 PELRNRASS 618
+ + +A S
Sbjct: 311 -KYQGQAPS 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 29/236 (12%)
Query: 316 KNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKR 374
KL +++F EDL +G+G+YGS K + G + VKR+R ++
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEK 62
Query: 375 EFEQ-QMEVVGTIGKHSNVVP--VRAY--YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG 429
E +Q M++ + S+ P V+ Y + + + + M + S S
Sbjct: 63 EQKQLLMDL--DVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD 119
Query: 430 TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGL-AH 486
+ KI L T + + + K H +IK SN+LL + +G I D G+
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDR--SGNIKLCDFGISGQ 175
Query: 487 LINFPTTA-TRTIG---YRAPEVTETRKASQ----KSDVYSFGVLLLEMLTGKAPL 534
L++ + A TR G Y APE + + Q +SDV+S G+ L E+ TG+ P
Sbjct: 176 LVD--SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 49/291 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
V+GKG +G Y D +K L + F ++ ++ + H NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVL 85
Query: 394 PVRAYYYSKDE-KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + V+ YM G L + + + + L ARG+ ++
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYLA 141
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRTIGYR------APE 504
+ KF H ++ + N +L + ++D GLA I + + R A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTA 559
+T + + KSDV+SFGVLL E+LT G P +H D+ + R E
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGRRLPQPEYCPD 255
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
++ V M Q C P RP +V +EQI
Sbjct: 256 SLYQV--------------MQQ----CWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 67/310 (21%), Positives = 112/310 (36%), Gaps = 67/310 (21%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG G++G +A + TV VK L+ A + +++V+ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR-------------M 438
+V + LV+ Y G L L R R + + +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI 498
+ A+G+AF+ S+ H ++ + N+LLT I D GLA I
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK------NDS 199
Query: 499 GYR------------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545
Y APE + +SDV+S+G+ L E+ + G +P G
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKF 257
Query: 546 PRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601
+ ++ R E AE++D+ M C P RP +V
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDI--------------MKT----CWDADPLKRPTFKQIV 299
Query: 602 RMIEQIQQPE 611
++IE+
Sbjct: 300 QLIEKQISES 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 44/293 (15%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNV 392
+LGKG +GS +A L+ V VK L+ + F ++ + H +V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHV 87
Query: 393 VPV------RAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-SDGGTALDWNSRMKIALGTA 445
+ +V+ +M G L L +R + L + ++ + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR---- 501
G+ ++ S F H ++ + N +L +D+ C++D GL+ I + +
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 502 --APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558
A E + SDV++FGV + E++T G+ P + ++ + + R
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---LIGGNR---- 257
Query: 559 AEVFDVELLKYQDVEEEMVQ-MLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
L + + EE+ M Q C + P RP + +E I
Sbjct: 258 -------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGH 299
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 70/306 (22%), Positives = 110/306 (35%), Gaps = 62/306 (20%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
LG G++G Y+ + V VK L EV + +F + ++ H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 135
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
+V + ++ M G L F+ R R ++L + +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNG---CISDVGLAHLINFPTTATRTIGYR----- 501
++ F H +I + N LLT G I D G+A I R YR
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY------RAGYYRKGGCA 246
Query: 502 -------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553
PE + K+D +SFGVLL E+ + G P + +V++ V S
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGG 303
Query: 554 R----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-Q 608
R + V+ + M Q C P+ RP ++ IE Q
Sbjct: 304 RMDPPKNCPGPVYRI--------------MTQ----CWQHQPEDRPNFAIILERIEYCTQ 345
Query: 609 QPELRN 614
P++ N
Sbjct: 346 DPDVIN 351
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 49/291 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
EV+G+G +G Y L D VK L + +F + ++ H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 89
Query: 394 PVRAYYYSKDEK-LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + LVV YM G L + + + L A+G+ ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLA 145
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRTIGYR------APE 504
S+ KF H ++ + N +L + ++D GLA + + G + A E
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTA 559
+T+K + KSDV+SFGVLL E++T G P D+ + R E
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPD 259
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
+++V ML+ C + RP ++V I I
Sbjct: 260 PLYEV--------------MLK----CWHPKAEMRPSFSELVSRISAIFST 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-REFEQQMEVVGTIGKHSNVVPVRA 397
VLGKG+YG Y L + + +K + E + + +++ + + KH N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83
Query: 398 YY--YSKDEKLVVY-SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA---RGIAFI 451
Y +S++ + ++ +P GSL LL RS G D + I T G+ ++
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKD--NEQTIGFYTKQILEGLKYL 138
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTI-G---YRAPEV 505
H H +IK NVL+ +G + SD G + + T T G Y APE+
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 194
Query: 506 --TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539
R + +D++S G ++EM TGK P G
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 57/292 (19%), Positives = 116/292 (39%), Gaps = 51/292 (17%)
Query: 340 EVLGKGSYGSTYKAILEDG-----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+VLG G++G+ YK + V +K LRE +E + V+ ++ + +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 393 VPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
R + ++ MP G L + ++ + + + + A+G+ ++
Sbjct: 80 C--RLLGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYL 133
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEV 505
+ H ++ + NVL+ + I+D GLA L+ G + A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAE 560
R + +SDV+S+GV + E++T G P ++ + + R T +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICTID 247
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPE 611
V+ + M++ C DSRPK +++ ++ + P+
Sbjct: 248 VYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 21/147 (14%), Positives = 41/147 (27%), Gaps = 18/147 (12%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV 133
+ S L L + L + LP + + LQ + + N
Sbjct: 472 ANSDYAKQYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 134 LPAFRSL-----------QLNALDLSFNAFTGNIPP--GFQNLTRLHLLNLQNNSISGAI 180
++ + +N P Q + +L LL+ +N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 181 PPL-NLPRLKILNFSNNNLNGSIPDSL 206
+L L N + IP+
Sbjct: 589 EAFGTNVKLTDLKLDYNQIE-EIPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 27/154 (17%), Positives = 48/154 (31%), Gaps = 16/154 (10%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDI--TSISSLQYVYLQNNYFSGV------LPAFRS 139
+ L + LR N L +L D T++ L + + N FS ++
Sbjct: 722 GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKA 780
Query: 140 LQLNA-LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
+ D N P G L L + +N I + P+L IL+ ++N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNPN 839
Query: 199 -NGSIPDSLQTFPNSSFV----GNSMLCGLPLTP 227
+ + +V + G
Sbjct: 840 ISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 31/158 (19%), Positives = 57/158 (36%), Gaps = 16/158 (10%)
Query: 65 NVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVY 124
+N S ++ + PI +S L +I +L +N + + I ++ LQ +Y
Sbjct: 397 RLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL-TNRI-TFISKAIQRLTKLQIIY 454
Query: 125 LQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL- 183
N+ F+ ++ + + N + NL L + L N +P
Sbjct: 455 FANSPFTYDNI---AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 184 -NLPRLKILNFSNNNLNG---------SIPDSLQTFPN 211
+LP L+ LN + N + D T P
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 44/180 (24%), Positives = 67/180 (37%), Gaps = 17/180 (9%)
Query: 48 NWNAAAPVCS--SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNY 105
NWN + GV + N RV G+ L G G G +P ++IG+L LK+LS ++
Sbjct: 301 NWNFNKELDMWGDQPGVDLD-NNGRVTGLSLAGFGAKGRVP-DAIGQLTELKVLSFGTHS 358
Query: 106 LNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSLQ-LNALDLSFNAFTGN-----IP 157
+ + + + Q LN DL +A N I
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
Query: 158 PG-FQNLTRLHLLNLQNN--SISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214
+L + NL N IS AI L +L+I+ F+N+ NS +
Sbjct: 419 KDSRISLKDTQIGNLTNRITFISKAIQ--RLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 22/142 (15%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSD--ITSISSLQYVYLQNNYFSGV-------LP 135
IP + D ++ L N L +P+ S+ + V N +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 136 AFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP----------LNL 185
++ + + + LS+N F + + + L NN ++ +IP N
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727
Query: 186 PRLKILNFSNNNLNGSIPDSLQ 207
L ++ N L S+ D +
Sbjct: 728 YLLTTIDLRFNKLT-SLSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 5e-17
Identities = 21/140 (15%), Positives = 44/140 (31%), Gaps = 22/140 (15%)
Query: 86 PANSIGKLDALKILSLRSNYLNGTLPSDITS------ISSLQYVYLQNNYFSGVLP-AFR 138
+ + + + N + +I+ + V L N F
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 139 SL-QLNALDLSFNAFT-------GNIPPGFQNLTRLHLLNLQNNSISGAIPP----LNLP 186
+ ++ + LS N T ++N L ++L+ N ++ + LP
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLP 753
Query: 187 RLKILNFSNNNLNGSIPDSL 206
L ++ S N + S P
Sbjct: 754 YLSNMDVSYNCFS-SFPTQP 772
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 14/93 (15%), Positives = 31/93 (33%), Gaps = 6/93 (6%)
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRL--KILNFSNNNL 198
++ L L+ G +P LT L +L+ +S + + L + + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 199 NGSIP----DSLQTFPNSSFVGNSMLCGLPLTP 227
D Q S + +++ + P
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 54/295 (18%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 340 EVLGKGSYGSTYKAILE-----DGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNV 392
LG+G +G + G V VK L+ + + ++++E++ + H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENI 85
Query: 393 VPVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V + ++ ++P+GSL L +N++ ++ ++K A+ +G+ +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDY 141
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAP 503
+ S ++ H ++ + NVL+ + I D GL I + + AP
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLT--GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561
E K SDV+SFGV L E+LT + ++ +V
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--------- 249
Query: 562 FDVELLKYQDVEEEM-------VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
L+ + + ++ Q+ C P +R +++ E + +
Sbjct: 250 --TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 4/135 (2%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ-L 142
I + +L L L L + S L + L N + A + L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG 200
L + N L L L +N IS P +LK+L+F NN ++
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 201 SIPDSLQTFPNSSFV 215
+ + + ++ +
Sbjct: 168 LSKEDMSSLQQATNL 182
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 8/135 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSGVLP---AFRSL 140
+ S +L LS++ N L + + ++ +L+ + L ++ R+L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 141 -QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L +L+LS+N F+ +L LL+L + NL LK+LN S++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 197 NLNGSIPDSLQTFPN 211
L+ S P
Sbjct: 436 LLDISSEQLFDGLPA 450
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 8/136 (5%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+ L L+ L+L N L+ + L F++L
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-----NLPRLKILNFSN 195
L L+LS + + F L L LNLQ N L RL+IL S
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 196 NNLNGSIPDSLQTFPN 211
+L+ + +
Sbjct: 486 CDLSSIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 24/120 (20%), Positives = 46/120 (38%), Gaps = 5/120 (4%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTG 154
++ ++L+ +Y + S LQ + L + S + L L L LS N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN 315
Query: 155 NIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
N L L+++ N+ + NL L+ L+ S++++ + N
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 32/158 (20%), Positives = 51/158 (32%), Gaps = 26/158 (16%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-QLNA 144
+ + L LK L L +N ++ SL ++ ++ N L +L L
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 145 LDLSFNAFT--GNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199
LDLS + +NL+ L LNL N + P+L++L+ + L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLK 413
Query: 200 GSIPDS-----------------LQTFPNSSFVGNSML 220
S L F G L
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 32/151 (21%), Positives = 64/151 (42%), Gaps = 11/151 (7%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV----LPA 136
+ L LK+L+L + L+ + + +LQ++ LQ N+F +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 137 FRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLK--ILNF 193
++L +L L LSF + F +L ++ ++L +N ++ L LK LN
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNL 530
Query: 194 SNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221
++N+++ +P L + N + C
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 4/120 (3%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
+ L N L + + + +L ++ L + F+S +L+ L L+ N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 154 GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L L IS N L+ L +N+++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 30/129 (23%), Positives = 50/129 (38%), Gaps = 7/129 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRSLQ-L 142
+ ++ ALK L ++ + + +L+ +YL +N+ S + LP + L
Sbjct: 96 MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL 155
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHL--LNLQNNSISGAIPP--LNLPRLKILNFSNNNL 198
LD NA +L + LNL N I+G I P + + LNF
Sbjct: 156 KVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQN 214
Query: 199 NGSIPDSLQ 207
I L+
Sbjct: 215 LLVIFKGLK 223
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-19
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 9/137 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA----FRSL 140
I + L+ L L SN+++ L+ + QNN + +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP----LNLPRLKILNFSNN 196
+L+L+ N G I PG + LN I + L + F +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 197 NLNGSIPDSLQTFPNSS 213
+ P + S
Sbjct: 239 DDEDISPAVFEGLCEMS 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 24/119 (20%), Positives = 37/119 (31%), Gaps = 7/119 (5%)
Query: 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTG 154
K + + LN +P + + S + + N + F L L LDL+
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 155 NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPN 211
FQ+ RL L L N + LK L F ++ L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 24/133 (18%), Positives = 47/133 (35%), Gaps = 7/133 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I ++ L L L +N L + ++ +L++++ S + + L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS----GAIPPLNLPRLKILNFSNNNL 198
+L L N + P +L +L+ QNN+I + L LN + N++
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 199 NGSIPDSLQTFPN 211
I
Sbjct: 192 -AGIEPGAFDSAV 203
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 22/131 (16%), Positives = 42/131 (32%), Gaps = 9/131 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDI--TSISSLQYVYLQNNYFS----GVLPAFRSLQL 142
+ L+ + + ++I SL ++ V + +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNG 200
+++L + F F + L L+L +S +P + L LK L S N
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 201 SIPDSLQTFPN 211
S FP+
Sbjct: 316 LCQISASNFPS 326
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 32/124 (25%), Positives = 56/124 (45%), Gaps = 8/124 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGT---LPSDITSISSLQYVYLQNNYFSGVLP-AFRSL 140
L AL+ L+L+ N+ + + ++ L+ + L S + AF SL
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 141 -QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNN 197
+N +DLS N T + +L ++L NL +N IS +P L L + + +N N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 198 LNGS 201
L+ +
Sbjct: 559 LDCT 562
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 26/230 (11%), Positives = 56/230 (24%), Gaps = 41/230 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR--------EVAATKREFEQQMEV-------- 382
E L G + +E +K E+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 383 -----------VGTIGKHSNVVPVRAYY--YSKDEKLVVYSYMPAGSLFMLLHR--NRSD 427
+ + Y+ L++ + L +L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYV 186
Query: 428 GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487
+ + R A + S+G HG+ N+ + D + DV
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 488 IN--FPTTATRTIGYRAPEVTETRKA--SQKSDVYSFGVLLLEMLTGKAP 533
+ P ++ + Y E A + + + G+ + + P
Sbjct: 244 VGTRGPASSV-PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 63/310 (20%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG G++G +A + V VK L+ A K +++++ +G+H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR---------SDGGTALDWNSRMKIAL 442
+V + LV+ Y G L L R + + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR- 501
A+G+AF+ S+ H ++ + NVLLT I D GLA I Y
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM------NDSNYIV 222
Query: 502 -----------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWV 549
APE + +SDV+S+G+LL E+ + G P G + V
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP--GILVNSKFYKLV 280
Query: 550 RSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
+ + ++ + M C A P RP + ++
Sbjct: 281 KDGYQMAQPAFAPKNIYSI--------------MQA----CWALEPTHRPTFQQICSFLQ 322
Query: 606 QIQQPELRNR 615
+ Q + R R
Sbjct: 323 EQAQEDRRER 332
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 62/302 (20%)
Query: 340 EVLGKGSYGSTYKAILED---GTTVVVKRLREVAATKREFEQ--QMEVVGTIG-KHSNVV 393
+ LG G + Y A ED V +K + K E + + EV + H N+V
Sbjct: 17 DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 394 PVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ +++ V Y+ +L + + L ++ + GI
Sbjct: 75 SM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHA 127
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT---IG---YRAPEV 505
H H +IK N+L+ + I D G+A ++ T+ T+T +G Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQ 183
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP----------LQHSGHDDVVDLPRWVRSVVRE 555
+ + +D+YS G++L EML G+ P ++H D V ++ VR +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIP- 241
Query: 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNR 615
Q + + L K +R K + M + + NR
Sbjct: 242 --------------QSLSN-------VILRATEKDKANRYK--TIQEMKDDLSSVLHENR 278
Query: 616 AS 617
A+
Sbjct: 279 AN 280
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 27/137 (19%), Positives = 44/137 (32%), Gaps = 7/137 (5%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFR 138
++ L+ L L + ++SL + + N F F
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 139 SL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFS 194
+ L LDLS F L RL LLN+ +N++ + L L L+ S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCS 529
Query: 195 NNNLNGSIPDSLQTFPN 211
N + S +
Sbjct: 530 FNRIETSKGILQHFPKS 546
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 26/135 (19%), Positives = 40/135 (29%), Gaps = 5/135 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+ + S L+ L L + + L + L N P +F L L
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL 106
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199
L L L LN+ +N I P NL L ++ S N +
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 200 GSIPDSLQTFPNSSF 214
+ LQ +
Sbjct: 167 TITVNDLQFLRENPQ 181
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 30/131 (22%), Positives = 49/131 (37%), Gaps = 7/131 (5%)
Query: 87 ANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSLQ-LN 143
+ S ++L+ L L N + ++ + LQ++ Q++ V AF SL+ L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNG 200
LD+S+ + F LT L+ L + NS N L L+ S L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 201 SIPDSLQTFPN 211
T
Sbjct: 488 ISWGVFDTLHR 498
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 33/134 (24%), Positives = 51/134 (38%), Gaps = 8/134 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLP-SDITSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + + L+ L+ L + + L S S+ L Y+ + F L
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
LN L ++ N+F N F N T L L+L + I L RL++LN S+NN
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNN 508
Query: 198 LNGSIPDSLQTFPN 211
L +
Sbjct: 509 LLFLDSSHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 28/121 (23%), Positives = 44/121 (36%), Gaps = 5/121 (4%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ-LNALDLSFNAFT 153
K + L N L ++ S LQ++ L + A+ L L+ L L+ N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 154 GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG-SIPDSLQTFP 210
P F LT L L ++ L LK LN ++N ++ +P
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 211 N 211
N
Sbjct: 154 N 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 24/127 (18%), Positives = 45/127 (35%), Gaps = 6/127 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
L +L L + N S++ + ++L ++ L + F +L +
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLN 199
L L++S N + L L L+ N I + L L N +NN++
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
Query: 200 GSIPDSL 206
I +
Sbjct: 559 -CICEHQ 564
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 25/131 (19%), Positives = 43/131 (32%), Gaps = 10/131 (7%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-Q 141
S L +L+ L L I + +L+ + + +N+ F +L
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHL----LNLQNNSISGAIPP--LNLPRLKILNFSN 195
L +DLS+N Q L L++ N I I +L L
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRG 213
Query: 196 NNLNGSIPDSL 206
N + +I +
Sbjct: 214 NFNSSNIMKTC 224
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 24/131 (18%), Positives = 43/131 (32%), Gaps = 5/131 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGT--LPSDITSISSLQYVYLQNNYFSGVLPAFRSLQL 142
+ + L + I R Y N ++++ + L + + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
+L + P +L L L L N S + + LP L L+ S N L+ S
Sbjct: 310 QSLSIIRCQLK-QFP--TLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366
Query: 203 PDSLQTFPNSS 213
S +S
Sbjct: 367 CCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 19/137 (13%), Positives = 42/137 (30%), Gaps = 18/137 (13%)
Query: 88 NSIGKLDA-------LKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSG------- 132
N I + L L+LR N+ + + + +++ L L F
Sbjct: 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 133 ---VLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLK 189
++ + ++ L++ + F L + ++L SI + +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQ 310
Query: 190 ILNFSNNNLNGSIPDSL 206
L+ L L
Sbjct: 311 SLSIIRCQLKQFPTLDL 327
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-14
Identities = 22/99 (22%), Positives = 34/99 (34%), Gaps = 2/99 (2%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRS 139
F +N L L L L ++ LQ + + +N + +
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 140 L-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS 177
L L+ LD SFN + L NL NNS++
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 31/154 (20%), Positives = 54/154 (35%), Gaps = 25/154 (16%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ K + LS+ L P+ + L+ + L N S + +L L+ LD
Sbjct: 301 EDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS-ISFKKVALPSLSYLD 356
Query: 147 LSFNAFTGNIPPGFQNL--TRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
LS NA + + + +L L L+L N L L+ L+F ++ L
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 204 DS-----------------LQTFPNSSFVGNSML 220
S + + F+G + L
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 25/147 (17%), Positives = 41/147 (27%), Gaps = 16/147 (10%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYV----YLQNNYFSGVLP- 135
L L + L NY+ +D+ + V + N +
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199
Query: 136 AFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISG----------AIPPLN 184
AF+ ++L+ L L N + NI QNL LH+ L + L
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPN 211
+ + N N
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLAN 286
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 21/93 (22%), Positives = 29/93 (31%), Gaps = 7/93 (7%)
Query: 123 VYLQNNYFSGVLPA-FRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP 181
+ S V S + +DLSFN F N + L L+L I I
Sbjct: 16 YQCMDQKLSKVPDDIPSSTK--NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IE 72
Query: 182 P---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L L L + N + P S +
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 340 EVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVV 393
LGKG++GS G V VK+L+ +R+F+++++++ + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 394 PVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
R Y + +V Y+P+G L L R+R+ LD + + + +G+ ++
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYL 143
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF------PTTATRT-IGYRAPE 504
S + H ++ + N+L+ + + I+D GLA L+ ++ I + APE
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
S++SDV+SFGV+L E+ T P +
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS----------PSAEFLRMMGCERDVPAL 250
Query: 564 VELLKYQDVEEEM-------VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
LL+ + + + ++ ++ C A P RP + ++ +
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G+G+ G+ Y A+ + G V ++++ K+E +V K+ N+V Y
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV---NY 82
Query: 399 Y--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y ++L VV Y+ GSL ++ +D + + + F+HS
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETC------MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRK 510
H +IKS N+LL D + ++D G I P + R+ +G + APEV +
Sbjct: 137 V---IHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPL 534
K D++S G++ +EM+ G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 49/291 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
EV+G+G +G Y L D VK L + +F + ++ H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 153
Query: 394 PVRAYYYSKDEK-LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + LVV YM G L + + + L A+G+ F+
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA 209
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRTIG-----YRAPE 504
S+ KF H ++ + N +L + ++D GLA + F + +T + A E
Sbjct: 210 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTA 559
+T+K + KSDV+SFGVLL E++T G P D+ + R E
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEYCPD 323
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
+++V ML+ C + RP ++V I I
Sbjct: 324 PLYEV--------------MLK----CWHPKAEMRPSFSELVSRISAIFST 356
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 47/244 (19%), Positives = 98/244 (40%), Gaps = 32/244 (13%)
Query: 308 GSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRL 366
GS ++ + G + ++ DL +G G+ G +K + G + VK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 367 REVAATKREFEQ-QME--VVGTIGKHSNVVPVRAYY--YSKDEKL-VVYSYMPAGSLFML 420
R + K E ++ M+ VV +V + + + + + M + +
Sbjct: 59 R-RSGNKEENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLK 114
Query: 421 LHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480
L K+ + + + ++ + H ++K SN+LL + +
Sbjct: 115 KRMQGPIPERIL-----GKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLC 167
Query: 481 DVGL-AHLINFPTTA-TRTIG---YRAPEVTETRKASQ-----KSDVYSFGVLLLEMLTG 530
D G+ L++ A R+ G Y APE + ++ ++DV+S G+ L+E+ TG
Sbjct: 168 DFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 531 KAPL 534
+ P
Sbjct: 226 QFPY 229
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 36/230 (15%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHSN 391
LGKG +G+ Y A + + +K + +RE E Q + +H N
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPN 70
Query: 392 VVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
++ R Y Y D V + Y P G+++ L + + + I A ++
Sbjct: 71 IL--RLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITE-LANALS 123
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--TIGYRAPEVTE 507
+ HS+ H +IK N+LL I+D G + T+ Y PE+ E
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--------VDLPRWV 549
R +K D++S GVL E L GK P + + + + P +V
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 60/292 (20%), Positives = 125/292 (42%), Gaps = 38/292 (13%)
Query: 340 EVLGKGSYGSTYKAILE-----DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVV 393
+ LGKG++GS + G V VK+L+ R+FE+++E++ ++ +H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 74
Query: 394 PVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ YS + ++ Y+P GSL L +++ +D ++ +G+ ++
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 130
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPE 504
++ ++ H ++ + N+L+ + I D GL ++ + I + APE
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
K S SDV+SFGV+L E+ T ++R + ++ ++
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTY-------IEKSKSPPAEFMRMIGNDKQ-GQMIVF 239
Query: 565 ELLKYQDVEEEM-------VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
L++ + ++ I C + RP D+ ++QI+
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 54/290 (18%), Positives = 114/290 (39%), Gaps = 49/290 (16%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
+G+G +G ++ I V +K + + + +F Q+ + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 79
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ ++ G L L + LD S + A + +A++ S
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLES 134
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTE 507
+ +F H +I + NVL++ + + D GL+ + +T + + APE
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 190
Query: 508 TRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVF 562
R+ + SDV+ FGV + E+L G P Q ++DV+ + + R ++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLY 247
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPE 611
+ M + C A P RP+ ++ + I ++ +
Sbjct: 248 SL--------------MTK----CWAYDPSRRPRFTELKAQLSTILEEEK 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 62/309 (20%), Positives = 127/309 (41%), Gaps = 53/309 (17%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVV 393
+V+G G +G L + +V +K L+ +R+F + ++G H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ ++V YM GSL L ++ + + + G A G+ ++
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSD 165
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-PTTATRTIGYR------APEVT 506
G + H ++ + N+L+ +L +SD GL ++ P A T G + +PE
Sbjct: 166 MG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD-------LPRWVRSVVREEWT 558
RK + SDV+S+G++L E+++ G+ P + DV+ LP +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCP 276
Query: 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRASS 618
A ++ + ML C K ++RPK + +V +++++ + + +
Sbjct: 277 AALYQL--------------MLD----CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
Query: 619 GTESNVQTP 627
+
Sbjct: 319 SAAARPSNL 327
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 60/292 (20%), Positives = 125/292 (42%), Gaps = 38/292 (13%)
Query: 340 EVLGKGSYGSTYKAILE-----DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVV 393
+ LGKG++GS + G V VK+L+ R+FE+++E++ ++ +H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 105
Query: 394 PVRAYYYSKDEK--LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+ YS + ++ Y+P GSL L +++ +D ++ +G+ ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL 161
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPE 504
++ ++ H ++ + N+L+ + I D GL ++ + I + APE
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 218
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
K S SDV+SFGV+L E+ T ++R + ++ ++
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTY-------IEKSKSPPAEFMRMIGNDKQ-GQMIVF 270
Query: 565 ELLKYQDVEEEM-------VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
L++ + ++ I C + RP D+ ++QI+
Sbjct: 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 54/313 (17%), Positives = 105/313 (33%), Gaps = 51/313 (16%)
Query: 323 DGSYFNFDLEDLLRASAEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQ-QM 380
+D + LG G+ G +K G + K + + Q
Sbjct: 24 KQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIR 80
Query: 381 EV-VGTIGKHSNVVPVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNS 436
E+ V +V +Y + D ++ + +M GSL +L + L
Sbjct: 81 ELQVLHECNSPYIV---GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---- 133
Query: 437 RMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTAT 495
K+++ +G+ ++ + K H ++K SN+L+ + D G++ LI+ + A
Sbjct: 134 -GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMAN 188
Query: 496 RTIG---YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
+G Y +PE + S +SD++S G+ L+EM G+ P+ ++ +
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIAL--------------------------SC 586
E + + M L C
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 587 VAKVPDSRPKMDD 599
+ K P R +
Sbjct: 309 LIKNPAERADLKQ 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 40/211 (18%), Positives = 80/211 (37%), Gaps = 29/211 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRL--REVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
+VLG G+ G+ + D V VKR+ + RE ++++ +H NV+
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFC 85
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
+ + + +L + + A + + T G+A +HS
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN-- 138
Query: 458 KFTHGNIKSSNVLLTQ-----DLNGCISDVGLA-------HLINFPTTATRTIGYRAPEV 505
H ++K N+L++ + ISD GL H + + T G+ APE+
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 506 ---TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ D++S G + +++ +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 34/161 (21%), Positives = 58/161 (36%), Gaps = 27/161 (16%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSLQ 141
+ S +LK L L N + T+ S+ + L+++ Q++ + F SL+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 142 -LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L LD+S G F L+ L +L + NS P L L L+ S
Sbjct: 422 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 197 NLNGSIPDS-----------------LQTFPNSSFVGNSML 220
L + + L++ P+ F + L
Sbjct: 481 QLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 29/139 (20%), Positives = 46/139 (33%), Gaps = 5/139 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+ + S L++L L + S+S L + L N + AF L L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLN 199
L +L L LN+ +N I P NL L+ L+ S+N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 200 GSIPDSLQTFPNSSFVGNS 218
L+ + S
Sbjct: 163 SIYCTDLRVLHQMPLLNLS 181
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 9/123 (7%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
K L L N L S LQ + L + A++SL L+ L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLN-GSIPDSLQT 208
++ G F L+ L L +++ + +L LK LN ++N + +P+
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 209 FPN 211
N
Sbjct: 148 LTN 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 37/146 (25%), Positives = 59/146 (40%), Gaps = 13/146 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLN-GTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ- 141
+ IG L LK L++ N + LP +++++L+++ L +N + R L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 142 ----LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFS 194
+LDLS N I PG RLH L L+NN S + L L++
Sbjct: 175 MPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 195 NNNLNGSIPDSLQTFPNSSFVGNSML 220
+L+ F S+ G L
Sbjct: 234 LGEFRNE--GNLEKFDKSALEGLCNL 257
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 5/97 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
L +L++L + N DI T + +L ++ L + P AF SL
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSIS 177
L L+++ N ++P G F LT L + L N
Sbjct: 496 LQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 31/148 (20%), Positives = 51/148 (34%), Gaps = 29/148 (19%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFT- 153
+ L L + P+ + SL+ + +N + L L LDLS N +
Sbjct: 306 WQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSF 361
Query: 154 -GNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDS----- 205
G T L L+L N + + L L +L+ L+F ++NL + +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
Query: 206 -------------LQTFPNSSFVGNSML 220
+ N F G S L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSL 447
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 30/141 (21%), Positives = 49/141 (34%), Gaps = 14/141 (9%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSI----SSLQYVYLQNNYFSGVLPAFRS 139
+++ L L I R YL+ DI + +++ L + V +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLD-YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 140 LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
L+L F P L L L +N A ++LP L+ L+ S N L
Sbjct: 304 FGWQHLELVNCKFG-QFP--TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL- 359
Query: 200 GSIPDSLQTFPNSSFVGNSML 220
S + + S G + L
Sbjct: 360 -----SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 23/101 (22%), Positives = 32/101 (31%), Gaps = 13/101 (12%)
Query: 123 VYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP 182
F + P LDLSFN F + L +L+L I I
Sbjct: 12 YQCMELNFYKI-PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED 69
Query: 183 ---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220
+L L L + N +Q+ +F G S L
Sbjct: 70 GAYQSLSHLSTLILTGNP--------IQSLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 26/162 (16%), Positives = 54/162 (33%), Gaps = 24/162 (14%)
Query: 88 NSIGKLDA-------LKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYF--------- 130
N + + L L+LR+N+ + + I ++ L+ L F
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 131 -SGVLPAFRSLQLNALDLS-FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL----N 184
L +L + L+ + + +I F LT + +L + +I +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFG 305
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLT 226
L+++N SL+ +S G + + L
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 21/145 (14%), Positives = 39/145 (26%), Gaps = 13/145 (8%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV 133
+ L + + I L L++ L ++ L N
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--GNLEKFDKSALEGLCNLTIE-- 260
Query: 134 LPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNF 193
+L LD + +I F LT + +L + +I + L
Sbjct: 261 -----EFRLAYLDYYLD----DIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 194 SNNNLNGSIPDSLQTFPNSSFVGNS 218
N L++ +F N
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNK 336
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 2/79 (2%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRS 139
F + +L L L L L P+ S+SSLQ + + +N V F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 140 L-QLNALDLSFNAFTGNIP 157
L L + L N + + P
Sbjct: 517 LTSLQKIWLHTNPWDCSCP 535
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 59/311 (18%), Positives = 106/311 (34%), Gaps = 72/311 (23%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+VLG G++G A V VK L+E A + + +++++ +G H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSR------------ 437
+V + +++ Y G L ++ R + N +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 438 ----MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493
+ A A+G+ F+ H ++ + NVL+T I D GLA I
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM---- 223
Query: 494 ATRTIGYR------------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHD 540
Y APE + KSDV+S+G+LL E+ + G P G
Sbjct: 224 --SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP--GIP 279
Query: 541 DVVDLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK 596
+ + +++ + T E++ + M C A RP
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYII--------------MQS----CWAFDSRKRPS 321
Query: 597 MDDVVRMIEQI 607
++ +
Sbjct: 322 FPNLTSFLGCQ 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 43/223 (19%), Positives = 77/223 (34%), Gaps = 41/223 (18%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-KHSNVVPVRA 397
+ LG+G +G ++A D +KR+R + EV +H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV---R 67
Query: 398 YYYSKDEKLVVYS---------------YMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
Y+ + EK +L ++ + + + I L
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFL 125
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG--- 499
A + F+HS+ H ++K SN+ T D + D GL ++ +
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 500 -------------YRAPEVTETRKASQKSDVYSFGVLLLEMLT 529
Y +PE S K D++S G++L E+L
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 55/299 (18%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAAT-KREFEQQMEVVGTIGKHSNV 392
LG+G++G + A +D V VK L+E + + +++F+++ E++ + +H ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHI 105
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR----------MKIAL 442
V L+V+ YM G L L + D + +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR- 501
A G+ ++ F H ++ + N L+ Q L I D G++ I + T R G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTM 221
Query: 502 ------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554
PE RK + +SDV+SFGV+L E+ T GK P + + +D +
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC---ITQGRE 278
Query: 555 ----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
EV+ + M C + P R + DV ++ + Q
Sbjct: 279 LERPRACPPEVYAI--------------MRG----CWQREPQQRHSIKDVHARLQALAQ 319
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 28/255 (10%)
Query: 289 RQGSGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYG 348
SGV G + Q ++ G D LL S +G+GS G
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG-----DPRLLLD-SYVKIGEGSTG 59
Query: 349 STYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY--YSKDEK 405
A G V VK + +RE V+ +H NVV Y Y E+
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV---EMYKSYLVGEE 116
Query: 406 L-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI 464
L V+ ++ G+L ++ + R L+ + + +A++H++G H +I
Sbjct: 117 LWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQALAYLHAQGVI---HRDI 167
Query: 465 KSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRKASQKSDVYS 519
KS ++LLT D +SD G I+ R +G + APEV + + D++S
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 520 FGVLLLEMLTGKAPL 534
G++++EM+ G+ P
Sbjct: 227 LGIMVIEMVDGEPPY 241
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--LREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
E +GKGS+G +K I V +K L E + +Q++ V+ V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVT--- 83
Query: 397 AYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
YY Y KD KL ++ Y+ GS LL LD I +G+ ++HS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 137
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTET 508
E H +IK++NVLL++ ++D G+A + T R +G + APEV +
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPL 534
K+D++S G+ +E+ G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPH 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIG 387
DLE + LG+G+YG K + G + VKR+R +E ++ M++ I
Sbjct: 8 DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDL--DIS 59
Query: 388 KHSNVVP--VRAY--YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALG 443
+ P V Y + + + + M SL + G T + + KIA+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQT-IPEDILGKIAVS 117
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGL-AHLINFPTTATRT-IG 499
+ + +HS+ H ++K SNVL+ G + D G+ +L++ A G
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVD--DVAKDIDAG 171
Query: 500 ---YRAPEVTETRKA----SQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
Y APE S KSD++S G+ ++E+ + P G
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 54/303 (17%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVV 393
+++G G G L + V +K L+ +R+F + ++G H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNII 113
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ ++V YM GSL L R+ G + + G G+ ++
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQ-FTIMQLVGMLRGVGAGMRYLSD 169
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPEVT 506
G + H ++ + NVL+ +L +SD GL+ ++ A T I + APE
Sbjct: 170 LG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD-------LPRWVRSVVREEWT 558
R S SDV+SFGV++ E+L G+ P + + DV+ LP
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------PMGCP 280
Query: 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPELRNRAS 617
+ + ML C K RP+ +V +++ + + PE +
Sbjct: 281 HALHQL--------------MLD----CWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322
Query: 618 SGT 620
+ +
Sbjct: 323 TVS 325
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 47/227 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
VLG+G++G KA D +K++R ++ ++ ++ H VV Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVV---RY 67
Query: 399 YYSKDEKLVVYS----------------YMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
Y + E+ Y G+L+ L+H + ++
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFR 123
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT--------- 493
+++IHS+G H ++K N+ + + N I D GLA ++
Sbjct: 124 QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 494 ------ATRTIG---YRAPEVTETRKA-SQKSDVYSFGVLLLEMLTG 530
T IG Y A EV + ++K D+YS G++ EM+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 55/296 (18%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
E LG+ +G YK L E V +K L++ A + EF + + +H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA-RLQHPN 73
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR-----------MKI 440
VV + +++SY G L L + R + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGY 500
A G+ ++ S H ++ + NVL+ LN ISD+GL +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 501 R------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVV 553
APE K S SD++S+GV+L E+ + G P + DVV++ +R+
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM---IRNRQ 247
Query: 554 R----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
++ A V+ + M++ C + P RP+ D+ +
Sbjct: 248 VLPCPDDCPAWVYAL--------------MIE----CWNEFPSRRPRFKDIHSRLR 285
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 68/310 (21%), Positives = 128/310 (41%), Gaps = 76/310 (24%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNV 392
LG+G++G + A +D V VK L++ A +++F+++ E++ + +H ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 79
Query: 393 V----------PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR----- 437
V P+ ++V+ YM G L L + D +D R
Sbjct: 80 VKFYGVCGDGDPL----------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 438 ------MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491
+ IA A G+ ++ S+ F H ++ + N L+ +L I D G++ + +
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YS 185
Query: 492 TTATRTIGYR-------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVV 543
T R G+ PE RK + +SDV+SFGV+L E+ T GK P + +V+
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 544 DLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599
+ + EV+DV ML C + P R + +
Sbjct: 246 EC---ITQGRVLERPRVCPKEVYDV--------------MLG----CWQREPQQRLNIKE 284
Query: 600 VVRMIEQIQQ 609
+ +++ + +
Sbjct: 285 IYKILHALGK 294
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 55/293 (18%), Positives = 116/293 (39%), Gaps = 51/293 (17%)
Query: 340 EVLGKGSYGSTYKAILEDG----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
+G+G +G ++ I V +K + + + +F Q+ + H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 454
Query: 394 PVRAY-YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ +++ ++ G L L + LD S + A + +A++
Sbjct: 455 --KLIGVITENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE 508
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVT 506
S+ +F H +I + NVL++ + + D GL+ + +T + + APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESI 564
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEV 561
R+ + SDV+ FGV + E+L G P Q ++DV+ + + R +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTL 621
Query: 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPELR 613
+ + M + C A P RP+ ++ + I ++ +L+
Sbjct: 622 YSL--------------MTK----CWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 45/220 (20%), Positives = 81/220 (36%), Gaps = 35/220 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNVVPVR 396
+ +G G ++ + E +K + A + + ++ + + + + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 92
Query: 397 AY-YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y Y D+ + + L L + +S +D R + IH G
Sbjct: 93 LYDYEITDQYIYMVMECGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHG 147
Query: 456 GAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTATR------TIGYRAPEV-- 505
H ++K +N L+ +G + D G+A+ + TT+ T+ Y PE
Sbjct: 148 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 506 ---------TETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
K S KSDV+S G +L M GK P Q
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 55/292 (18%), Positives = 111/292 (38%), Gaps = 54/292 (18%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
+LG+G +G Y+ + + V VK ++ K +F + ++ + H ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIV 76
Query: 394 PVRAYYY---SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ ++ ++ P G L L RN++ L + + +L + +A+
Sbjct: 77 KL----IGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAY 128
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APE 504
+ S H +I N+L+ + D GL+ I + R +PE
Sbjct: 129 LESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPE 184
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTA 559
R+ + SDV+ F V + E+L+ GK P + DV+ + + R +
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKPDLCPP 241
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
++ + M + C P RP+ ++V + + Q E
Sbjct: 242 VLYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 60/310 (19%), Positives = 127/310 (40%), Gaps = 54/310 (17%)
Query: 340 EVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNV 392
+V+G G +G YK +L + V +K L+ + +F + ++G H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 108
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +++ YM G+L L + + + G A G+ ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA 164
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-NFPTTATRTIGYR------APEV 505
+ + H ++ + N+L+ +L +SD GL+ ++ + P T G + APE
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 506 TETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD-------LPRWVRSVVREEW 557
RK + SDV+SFG+++ E++T G+ P + +V+ LP +
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------PMDC 275
Query: 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRAS 617
+ ++ + M+Q C + RPK D+V +++++ + +
Sbjct: 276 PSAIYQL--------------MMQ----CWQQERARRPKFADIVSILDKLIRAPDSLKTL 317
Query: 618 SGTESNVQTP 627
+ + V
Sbjct: 318 ADFDPRVSIR 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 45/220 (20%), Positives = 81/220 (36%), Gaps = 35/220 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNVVPVR 396
+ +G G ++ + E +K + A + + ++ + + + + +R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 73
Query: 397 AY-YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y Y D+ + + L L + +S +D R + IH G
Sbjct: 74 LYDYEITDQYIYMVMECGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHG 128
Query: 456 GAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTATR------TIGYRAPEV-- 505
H ++K +N L+ +G + D G+A+ + TT+ T+ Y PE
Sbjct: 129 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 506 ---------TETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
K S KSDV+S G +L M GK P Q
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 10/130 (7%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+ S +LK L L N + T+ S+ + L+++ Q++ + F SL
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L LD+S G F L+ L +L + NS P L L L+ S
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 197 NLNGSIPDSL 206
L + +
Sbjct: 186 QLE-QLSPTA 194
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 27/130 (20%), Positives = 48/130 (36%), Gaps = 18/130 (13%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV---LPAFRSL- 140
IP++ L L SN L ++ L + L +N S +
Sbjct: 26 IPSS-------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL----NLPRLKILNFSNN 196
L LDLSFN + F L +L L+ Q++++ + +L L L+ S+
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 197 NLNGSIPDSL 206
+ + +
Sbjct: 137 HTR-VAFNGI 145
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 15/153 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
L +L++L + N DI T + +L ++ L + P AF SL
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPR-LKILNFSNN 196
L L++S N F ++ ++ L L +L+ N I + P L LN + N
Sbjct: 201 LQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
Query: 197 NLN-----GSIPDSLQTFPNSSFVGNSMLCGLP 224
+ S ++ M C P
Sbjct: 259 DFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 32/233 (13%)
Query: 341 VLGKGSYGSTYKAI-LEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHSN 391
LGKG +G+ Y A ++ + +K + +RE E Q + +H N
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-----RHPN 75
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
++ + Y++ + ++ + P G L+ L ++ G + S + A + +
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEE-LADALHYC 130
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--TIGYRAPEVTETR 509
H H +IK N+L+ I+D G + T T+ Y PE+ E +
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGK 187
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--------VDLPRWVRSVVR 554
+K D++ GVL E L G P H + + P ++ +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 30/125 (24%), Positives = 56/125 (44%), Gaps = 8/125 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L +L + N + + + +++ L + + NN + L +L QL L++
Sbjct: 194 PLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEI 250
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSL 206
N + ++LT+L +LN+ +N IS I L NL +L L +NN L + +
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 207 QTFPN 211
N
Sbjct: 308 GGLTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 29/117 (24%), Positives = 54/117 (46%), Gaps = 7/117 (5%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L + L+L +N+ + S +++++ L Y+ + + + +L L +L L
Sbjct: 127 PLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSL 184
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
++N +I P +LT LH N I+ I P+ N+ RL L NN + P
Sbjct: 185 NYNQIE-DISP-LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 27/113 (23%), Positives = 52/113 (46%), Gaps = 6/113 (5%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ + L L L + +N + + + + ++ L+ + + +N S + +L QLN+L
Sbjct: 237 SPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLF 293
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
L+ N LT L L L N I+ I PL +L ++ +F+N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 9/125 (7%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ +L+++ L + + I +++L+Y+ L N + + +L +L L +
Sbjct: 39 TQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYI 95
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSL 206
N T QNLT L L L ++IS I PL NL ++ LN N+ S L
Sbjct: 96 GTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN-LSDLSPL 151
Query: 207 QTFPN 211
Sbjct: 152 SNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 26/118 (22%), Positives = 50/118 (42%), Gaps = 8/118 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ + L L + +N + P + ++S L ++ + N S + A + L +L L++
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNV 272
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203
N + NL++L+ L L NN + + L L L S N++ P
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNAL 145
N++ L LK+L++ SN ++ S + ++S L ++L NN L L L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS 177
LS N T +I P +L+++ + N I
Sbjct: 317 FLSQNHIT-DIRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 12/70 (17%), Positives = 21/70 (30%), Gaps = 4/70 (5%)
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGS 201
L I P +L LQ S++ + L + L + + S
Sbjct: 2 AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-S 58
Query: 202 IPDSLQTFPN 211
I ++ N
Sbjct: 59 IQG-IEYLTN 67
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 68/315 (21%), Positives = 113/315 (35%), Gaps = 59/315 (18%)
Query: 312 QEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDG---TTVVVKRLRE 368
E + K +LD LL + LG G++G+ K + TV VK L+
Sbjct: 3 LEEIRPKEVYLD--------RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN 54
Query: 369 VA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRN 424
A A K E + V+ + + +V R + E +V G L L +N
Sbjct: 55 EANDPALKDELLAEANVMQQL-DNPYIV--RMIGICEAESWMLVMEMAELGPLNKYLQQN 111
Query: 425 RSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484
R + + +++ + G+ ++ F H ++ + NVLL ISD GL
Sbjct: 112 RH-----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 485 AHLINF-PTTATRTIGYR------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQH 536
+ + + APE K S KSDV+SFGVL+ E + G+ P +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
Query: 537 SGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPD 592
+V + + R E++D+ M C +
Sbjct: 224 MKGSEVTAM---LEKGERMGCPAGCPREMYDL--------------MNL----CWTYDVE 262
Query: 593 SRPKMDDVVRMIEQI 607
+RP V +
Sbjct: 263 NRPGFAAVELRLRNY 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 61/324 (18%), Positives = 122/324 (37%), Gaps = 95/324 (29%)
Query: 340 EVLGKGSYGSTYKAILEDG------TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+G+G++G ++A T V VK L+E A + +F+++ ++ + N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 111
Query: 392 VV----------PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR---- 437
+V P+ +++ YM G L L +L +
Sbjct: 112 IVKLLGVCAVGKPM----------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 438 ---------------MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482
+ IA A G+A++ KF H ++ + N L+ +++ I+D
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADF 218
Query: 483 GLAHLINFPTTATRTIGYR------------APEVTETRKASQKSDVYSFGVLLLEMLT- 529
GL+ I Y+ PE + + +SDV+++GV+L E+ +
Sbjct: 219 GLSRNIY------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 530 GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALS 585
G P H++V+ VR E E++++ M
Sbjct: 273 GLQPYYGMAHEEVIYY---VRDGNILACPENCPLELYNL--------------MRL---- 311
Query: 586 CVAKVPDSRPKMDDVVRMIEQIQQ 609
C +K+P RP + R+++++ +
Sbjct: 312 CWSKLPADRPSFCSIHRILQRMCE 335
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 44/220 (20%), Positives = 80/220 (36%), Gaps = 35/220 (15%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNVVPVR 396
+ +G G ++ + E +K + A + + ++ + + + + +R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 120
Query: 397 AY-YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y Y D+ + + L L + +S +D R + IH G
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKS-----IDPWERKSYWKNMLEAVHTIHQHG 175
Query: 456 GAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTATR------TIGYRAPEV-- 505
H ++K +N L+ +G + D G+A+ + TT+ + Y PE
Sbjct: 176 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 506 ---------TETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
K S KSDV+S G +L M GK P Q
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 67/301 (22%), Positives = 113/301 (37%), Gaps = 63/301 (20%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLRE----VAATKREFEQQMEVVGTIGKHSN 391
E LG GS+G + +V VK L+ +F +++ + ++ H N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 82
Query: 392 VVPVRAYYYSKDEKL-VVYSYMPAGSL--FMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
++ R Y + +V P GSL + H+ GT + A+ A G+
Sbjct: 83 LI--RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGM 134
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-PTTATRTIGYR------ 501
++ S+ F H ++ + N+LL I D GL + +
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD--------LPRWVRSV 552
APE +TR S SD + FGV L EM T G+ P ++ LPR
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR----- 246
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
E+ ++++V M+Q C A P+ RP + + + Q ++
Sbjct: 247 -PEDCPQDIYNV--------------MVQ----CWAHKPEDRPTFVALRDFLLEAQPTDM 287
Query: 613 R 613
R
Sbjct: 288 R 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 66/316 (20%), Positives = 118/316 (37%), Gaps = 75/316 (23%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG+G +G KA TTV VK L+E A + R+ + V+ + H +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPH 87
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSL--FMLLHRNRSDGGTALDWNSR------------ 437
V+ + L++ Y GSL F+ R G +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 438 -----MKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492
+ A ++G+ ++ K H ++ + N+L+ + ISD GL+ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201
Query: 493 TATRTIGYR------------APEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGH 539
Y A E + +SDV+SFGVLL E++T G P
Sbjct: 202 ---EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 540 DDVVDLPRWVRSVVR----EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP 595
+ + +L +++ R + + E++ + MLQ C + PD RP
Sbjct: 259 ERLFNL---LKTGHRMERPDNCSEEMYRL--------------MLQ----CWKQEPDKRP 297
Query: 596 KMDDVVRMIEQIQQPE 611
D+ + +E++
Sbjct: 298 VFADISKDLEKMMVKR 313
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E++G G+YG YK ++ G +K + + E +Q++ ++ H N+ Y
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA---TY 86
Query: 399 Y--------YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449
Y D++L +V + AGS+ L+ + G L I RG++
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLS 143
Query: 450 FIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR-------- 501
+H K H +IK NVLLT++ + D G++ + RT+G R
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTPY 194
Query: 502 --APEVTETRKASQ-----KSDVYSFGVLLLEMLTGKAPL 534
APEV + KSD++S G+ +EM G PL
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 28/145 (19%), Positives = 54/145 (37%), Gaps = 8/145 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNG-TLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QL 142
+ G ++ L L+ N ++ S +L+++ LQ N+ + +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLN- 199
LDLS N + P FQ+ + ++L+NN + I L+ + N +
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 200 GSIPDSLQTFPNSSFVGNSMLCGLP 224
G++ D V + L
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 25/128 (19%), Positives = 43/128 (33%), Gaps = 8/128 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN 143
A+ +K L L N L+ +D+ + L+ + L +N SL L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLR 83
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
LDL+ N + + L+ NN+IS + K + +NN +
Sbjct: 84 TLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRD 137
Query: 204 DSLQTFPN 211
Sbjct: 138 LDEGCRSR 145
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 24/128 (18%), Positives = 46/128 (35%), Gaps = 11/128 (8%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALD 146
+ +++ L +N ++ + + +YL NN + + ++ LD
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 147 LSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
L N + + L LNLQ N I + +LK L+ S+N L +
Sbjct: 151 LKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMG 207
Query: 204 DSLQTFPN 211
Q+
Sbjct: 208 PEFQSAAG 215
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 26/121 (21%), Positives = 49/121 (40%), Gaps = 10/121 (8%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFN 150
+ KI + + L L S S +++ + L N S + +L L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 151 AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFP 210
++L+ L L+L NN + + P ++ L+ +NNN++ + S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNIS-RVSCS--RGQ 120
Query: 211 N 211
Sbjct: 121 G 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 9/105 (8%)
Query: 110 LPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNIPPG-FQNLTRL 166
+ + + + + ++ L +S + LDLS N + I T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60
Query: 167 HLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPD--SLQT 208
LLNL +N + L +L L+ L+ +NN + + S++T
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 5/113 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS-GVLPAFRSLQLN 143
+ + +SLR+N L + + +L++ L+ N F G L F S
Sbjct: 206 MGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFS 194
++ + T L + P L L +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 28/145 (19%), Positives = 54/145 (37%), Gaps = 8/145 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNG-TLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QL 142
+ G ++ L L+ N ++ S +L+++ LQ N+ + +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLN- 199
LDLS N + P FQ+ + ++L+NN + I L+ + N +
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 200 GSIPDSLQTFPNSSFVGNSMLCGLP 224
G++ D V + L
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLT 276
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 25/128 (19%), Positives = 43/128 (33%), Gaps = 8/128 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN 143
A+ +K L L N L+ +D+ + L+ + L +N SL L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLR 83
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
LDL+ N + + L+ NN+IS + K + +NN +
Sbjct: 84 TLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRD 137
Query: 204 DSLQTFPN 211
Sbjct: 138 LDEGCRSR 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 24/129 (18%), Positives = 47/129 (36%), Gaps = 11/129 (8%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNAL 145
+ +++ L +N ++ + + +YL NN + + ++ L
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 146 DLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPP-LNLPRLKILNFSNNNLNGSI 202
DL N + + L LNLQ N I + + +LK L+ S+N L +
Sbjct: 150 DLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FM 206
Query: 203 PDSLQTFPN 211
Q+
Sbjct: 207 GPEFQSAAG 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 26/121 (21%), Positives = 49/121 (40%), Gaps = 10/121 (8%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFN 150
+ KI + + L L S S +++ + L N S + +L L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 151 AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFP 210
++L+ L L+L NN + + P ++ L+ +NNN++ + S
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNIS-RVSCS--RGQ 120
Query: 211 N 211
Sbjct: 121 G 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 20/138 (14%), Positives = 47/138 (34%), Gaps = 5/138 (3%)
Query: 86 PANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNA 144
A D L+ L+L+ N++ + + + L+ + L +N + + P F+S +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTW 218
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS-GAIPPLNLPRLKILNFSNNNLNGSIP 203
+ L N I + L +L+ N G + ++ + +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 204 DSLQTFPNSSFVGNSMLC 221
+ + + C
Sbjct: 278 QNEEECTVPTLGHYGAYC 295
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 5/103 (4%)
Query: 110 LPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLH 167
+ + + + + ++ L +S + LDLS N + T+L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 168 LLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD--SLQT 208
LLNL +N + + +L L+ L+ +NN + + S++T
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET 103
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 20/135 (14%), Positives = 37/135 (27%), Gaps = 4/135 (2%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS-GVLPAFRSLQLN 143
+ + +SLR+N L + + +L++ L+ N F G L F S
Sbjct: 206 MGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
++ + T L + +P RL L + L
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQG 322
Query: 204 DSLQTFPNSSFVGNS 218
+
Sbjct: 323 SETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 7/129 (5%), Positives = 23/129 (17%), Gaps = 9/129 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSI-----SSLQYVYLQNNYFSGV-LPAFR 138
+ + + + + + + Q + +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
+ +D + I L + ++ + R
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS---NGRRAHAELDGTLQ 391
Query: 199 NGSIPDSLQ 207
LQ
Sbjct: 392 QAVGQIELQ 400
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 46/245 (18%)
Query: 340 EVLGKGSYGSTYKAILED---GTTVVVKRLREVAATKREFEQQME----VVGTIGKHSNV 392
++G+G G Y+A ED V +K + E ++ F +M+ G + + +V
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHV 96
Query: 393 VPVRAYYYSKDEKL--VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
VP+ + + + + V + L +L R L + I +
Sbjct: 97 VPI--HDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDA 149
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT---IG---YRAPE 504
H+ G TH ++K N+L++ D + D G+A T+ +G Y APE
Sbjct: 150 AHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPE 205
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAP---------LQHSGHDDVV-------DLPRW 548
A+ ++D+Y+ +L E LTG P H + + +P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVA 264
Query: 549 VRSVV 553
+V+
Sbjct: 265 FDAVI 269
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 49/284 (17%)
Query: 342 LGKGSYGSTYKAILEDG---TTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNVVPVR 396
LG G++GS + + V +K L++ A E ++ +++ + + +V R
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIV--R 74
Query: 397 AYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ E L +V G L L R + + ++ ++ + G+ ++ +
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN 130
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------IGYRAPEVTET 508
F H ++ + NVLL ISD GL+ + + + + APE
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 509 RKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFD 563
RK S +SDV+S+GV + E L+ G+ P + +V+ + R E E++
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPPELYA 244
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ M C + RP V + +
Sbjct: 245 L--------------MSD----CWIYKWEDRPDFLTVEQRMRAC 270
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E LG+GSYGS YKAI E G V +K++ V + +E +++ ++ +VV Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQC-DSPHVV---KY 89
Query: 399 Y--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y Y K+ L +V Y AGS+ ++ L + I T +G+ ++H
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETRK 510
H +IK+ N+LL + + ++D G+A + T A R IG + APEV +
Sbjct: 146 K---IHRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQEIG 201
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPL 534
+ +D++S G+ +EM GK P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPY 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 60/299 (20%), Positives = 106/299 (35%), Gaps = 67/299 (22%)
Query: 340 EVLGKGSYGSTYKA---ILEDGTTVVVKRLREVAATKREFEQ--QMEVVGTIG-KHSNVV 393
E+LG G + A V VK LR A F + E H +V
Sbjct: 18 EILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 394 PVRAYYYSKDE---KLVVY---SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG 447
V Y + E + Y Y+ +L ++H + +++ +
Sbjct: 76 AV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQA 128
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH-LINFPTTATRT---IG---Y 500
+ F H G H ++K +N++++ + D G+A + + + T+T IG Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP----------LQHSGHDDVVDLPRWVR 550
+PE +SDVYS G +L E+LTG+ P QH +D +
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHE 244
Query: 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ D++ + L +AK P++R + M + +
Sbjct: 245 GLS----------------ADLDA-------VVLKALAKNPENRYQ--TAAEMRADLVR 278
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 12/128 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+PA S L IL L SN L + + T ++ L+ + L +N + F L
Sbjct: 47 VPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
+L+ L L + PG F+ L L L LQ+N++ A+P +L L L N
Sbjct: 106 RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGN 163
Query: 197 NLNGSIPD 204
++ S+P+
Sbjct: 164 RIS-SVPE 170
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 8/115 (6%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
+ + L N ++ + + +L ++L +N + + AF L L LDLS NA
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPD 204
++ P F L RLH L+L + + P L L+ L +N L ++PD
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPD 146
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 10/122 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
+ L AL+ L L+ N L LP D + +L +++L N S V AFR L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
L+ L L N ++ P F++L RL L L N++S A+P L L+ L ++N
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236
Query: 198 LN 199
Sbjct: 237 WV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 29/114 (25%), Positives = 42/114 (36%), Gaps = 17/114 (14%)
Query: 109 TLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNIPPG-FQNLTR 165
+P I + + Q ++L N S V +FR+ L L L N I F L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 166 LHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216
L L+L +N+ ++ P L RL L+ LQ F G
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG--------LQELGPGLFRG 127
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-EVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
LG G++G YKA E G K + + ++ ++E++ T H +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIV---K 80
Query: 398 YY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
Y D KL ++ + P G++ ++ + L + + F+HS+
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT--IG---YRAPEVTETR 509
H ++K+ NVL+T + + ++D G++ T R IG + APEV
Sbjct: 137 R---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 510 KASQ-----KSDVYSFGVLLLEMLTGKAPL 534
K+D++S G+ L+EM + P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 30/134 (22%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
+PA + +++L+L + + + ++Q +Y+ N + P F+++
Sbjct: 60 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 118
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
L L L N + ++P G F N +L L++ NN++ I L+ L S+N
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 176
Query: 198 LNGSIPDSLQTFPN 211
L + SL P+
Sbjct: 177 LT-HVDLSL--IPS 187
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 28/127 (22%), Positives = 51/127 (40%), Gaps = 8/127 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + ++ L + N + LP + ++ L + L+ N S + F + +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200
L L +S N I FQ T L L L +N ++ + +P L N S N L+
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS- 199
Query: 201 SIPDSLQ 207
++ +
Sbjct: 200 TLAIPIA 206
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 6/139 (4%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFRSLQ-LNALD 146
+ L + L N L + + L+ +Y+ NN + + + L LD
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 301
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG-SIPDS 205
LS N ++ RL L L +NSI + LK L S+N+ + S+
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRAL 359
Query: 206 LQTFPNSSFVGNSMLCGLP 224
+ + C +
Sbjct: 360 FRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 93 LDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSF 149
L+ KI++ +++ + LP+ + S ++ + L + + AF + L + F
Sbjct: 44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 150 NAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDS 205
NA +PP FQN+ L +L L+ N +S ++P N P+L L+ SNNNL I D
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 206 L 206
Sbjct: 160 T 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 24/142 (16%), Positives = 49/142 (34%), Gaps = 17/142 (11%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I +N + + + + + ++++ + V +N+ + S Q+
Sbjct: 13 IDSN-LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 143 NALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNL 198
L+L+ I F + L + N+I +PP N+P L +L N+
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND- 128
Query: 199 NGSIPDSLQTFPNSSFVGNSML 220
L + P F L
Sbjct: 129 -------LSSLPRGIFHNTPKL 143
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 37/161 (22%), Positives = 57/161 (35%), Gaps = 33/161 (20%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGV-LPAFRSLQ- 141
+P L LS+ +N L + D + +SLQ + L +N + V L SL
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFH 190
Query: 142 ----------------LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLN 184
+ LD S N+ + LT L LQ+N+++ LN
Sbjct: 191 ANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNVELTIL---KLQHNNLTDTAWLLN 246
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPL 225
P L ++ S N L+ FV L L +
Sbjct: 247 YPGLVEVDLSYNE--------LEKIMYHPFVKMQRLERLYI 279
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 2e-17
Identities = 30/134 (22%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
+PA + +++L+L + + + ++Q +Y+ N + P F+++
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
L L L N + ++P G F N +L L++ NN++ I L+ L S+N
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNR 182
Query: 198 LNGSIPDSLQTFPN 211
L + SL P+
Sbjct: 183 LT-HVDLSL--IPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 9e-17
Identities = 30/154 (19%), Positives = 52/154 (33%), Gaps = 6/154 (3%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ L + L N L + + L+ +Y+ NN + + + L LD
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLD 307
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG-SIPDS 205
LS N ++ RL L L +NSI + LK L S+N+ + S+
Sbjct: 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLRAL 365
Query: 206 LQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSP 239
+ + C + + S P
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 1e-16
Identities = 28/127 (22%), Positives = 51/127 (40%), Gaps = 8/127 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + ++ L + N + LP + ++ L + L+ N S + F + +
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200
L L +S N I FQ T L L L +N ++ + +P L N S N L+
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS- 205
Query: 201 SIPDSLQ 207
++ +
Sbjct: 206 TLAIPIA 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 4e-15
Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 93 LDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSF 149
L+ KI++ +++ + LP+ + S ++ + L + + AF + L + F
Sbjct: 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 150 NAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDS 205
NA +PP FQN+ L +L L+ N +S ++P N P+L L+ SNNNL I D
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165
Query: 206 L 206
Sbjct: 166 T 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 30/147 (20%), Positives = 55/147 (37%), Gaps = 26/147 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLN----GTLPS---------DITSIS---SLQYVYLQNN 128
I ++ +L+ L L SN L +PS +++++ +++ + +N
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221
Query: 129 YFSGVLP-AFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LN 184
+ V L + L L N T N L ++L N + I +
Sbjct: 222 SINVVRGPVNVELTI--LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVK 276
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPN 211
+ RL+ L SNN L ++ Q P
Sbjct: 277 MQRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 22/128 (17%), Positives = 45/128 (35%), Gaps = 16/128 (12%)
Query: 99 LSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNI 156
+ + + + ++++ + V +N+ + S Q+ L+L+ I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 157 PPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNS 212
F + L + N+I +PP N+P L +L N+ L + P
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND--------LSSLPRG 141
Query: 213 SFVGNSML 220
F L
Sbjct: 142 IFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 10/81 (12%), Positives = 32/81 (39%), Gaps = 14/81 (17%)
Query: 145 LDLSFNAFTGNIPPGFQ--NLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199
D+ + T ++ GF+ L ++ +N+++ +P + ++++LN ++ +
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88
Query: 200 GSIPDSLQTFPNSSFVGNSML 220
+F +
Sbjct: 89 --------EIDTYAFAYAHTI 101
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 3e-17
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 49/294 (16%)
Query: 332 EDLLRASAEVLGKGSYGSTYKAILEDG---TTVVVKRLRE--VAATKREFEQQMEVVGTI 386
D L + LG G++GS + + V +K L++ A E ++ +++ +
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 387 GKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
+ +V R + E L +V G L L R + + ++ ++ +
Sbjct: 394 -DNPYIV--RLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVS 446
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-------I 498
G+ ++ + F H N+ + NVLL ISD GL+ + + +
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR--- 554
+ APE RK S +SDV+S+GV + E L+ G+ P + +V+ + R
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMEC 560
Query: 555 -EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
E E++ + M C + RP V + +
Sbjct: 561 PPECPPELYAL--------------MSD----CWIYKWEDRPDFLTVEQRMRAC 596
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 30/134 (22%), Positives = 53/134 (39%), Gaps = 12/134 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYL-NGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSLQ 141
+ + L+ + ++ L +N L + + + + L Y+ + + + + SL
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT 195
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
L L N T + + L L L L NSIS A+ N P L+ L+ +NN
Sbjct: 196 --ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNK 251
Query: 198 LNGSIPDSLQTFPN 211
L +P L
Sbjct: 252 LV-KVPGGLADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 36/162 (22%), Positives = 57/162 (35%), Gaps = 26/162 (16%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I + L L+ L L N L LP + +LQ + + N + V F L Q+
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 143 NALDLSFNAFT-GNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200
++L N I G FQ + +L + + + +I+ IP P L L+ N +
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKIT- 205
Query: 201 SIPD-----------------SLQTFPNSSFVGNSMLCGLPL 225
+ S+ N S L L L
Sbjct: 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 12/133 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRSLQLN 143
I L L L L +N ++ P + L+ +YL N + ++LQ
Sbjct: 67 IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQE- 125
Query: 144 ALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI-SGAIPP---LNLPRLKILNFSNNNL 198
L + N T + F L ++ ++ L N + S I + +L + ++ N+
Sbjct: 126 -LRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
Query: 199 NGSIPDSLQTFPN 211
+IP L P+
Sbjct: 184 T-TIPQGL--PPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 27/156 (17%), Positives = 49/156 (31%), Gaps = 33/156 (21%)
Query: 82 TGPIPANSIGKLDALKILSLRSNYL----NGTLPS---------DITSIS--------SL 120
+ I + + L + + + G PS IT + +L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 218
Query: 121 QYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS- 177
+ L N S V + + L L L+ N +P G + + ++ L NN+IS
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277
Query: 178 ---GAIPPL----NLPRLKILNFSNNNLN-GSIPDS 205
P ++ +N + I S
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 20/124 (16%), Positives = 39/124 (31%), Gaps = 13/124 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN 143
+ A S+ L+ L L L N ++ + + L+ ++L NN V +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 266
Query: 144 ALDLSFNAFTGNIPPG-------FQNLTRLHLLNLQNNSIS-GAIPP---LNLPRLKILN 192
+ L N + I ++L +N + I P + +
Sbjct: 267 VVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325
Query: 193 FSNN 196
N
Sbjct: 326 LGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 28/114 (24%), Positives = 47/114 (41%), Gaps = 9/114 (7%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
L+++ L +P D+ + LQNN + + F++L L+ L L N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSL 206
I PG F L +L L L N + +P L+ L N + + S+
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEIT-KVRKSV 140
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 61/323 (18%), Positives = 112/323 (34%), Gaps = 67/323 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL-----REVAATKREFEQQMEVVGTIGKHSNVV 393
VL +G + Y+A + G +KRL + A +E + + + H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE----VCFMKKLSGHPNIV 89
Query: 394 PVRAYYYSKDEK-------LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
+ E+ ++ + + G L L + S G L ++ +KI T R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCR 147
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---------- 496
+ +H + H ++K N+LL+ + D G A I+ +
Sbjct: 148 AVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 497 ------TIGYRAPEVTETRK---ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV---- 543
T YR PE+ + +K D+++ G +L + + P + +V
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266
Query: 544 DLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
+P +Y + MLQ P+ R + +VV
Sbjct: 267 SIPPHDT-----------------QYTVFHSLIRAMLQ-------VNPEERLSIAEVVHQ 302
Query: 604 IEQIQQPELRNRASSGTESNVQT 626
+++I N S TE Q
Sbjct: 303 LQEIAAARNVNPKSPITELLEQN 325
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-17
Identities = 32/137 (23%), Positives = 49/137 (35%), Gaps = 9/137 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP---AFRSL- 140
I + L L+IL L S+ + P + L + L S + FR+L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 141 QLNALDLSFNAFTG-NIPPGFQNLTRLHLLNLQNNSIS----GAIPPLNLPRLKILNFSN 195
L LDLS N + P F L L ++ +N I + PL L + +
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 196 NNLNGSIPDSLQTFPNS 212
N+L + N
Sbjct: 184 NSLYSRVSVDWGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 8e-17
Identities = 34/138 (24%), Positives = 60/138 (43%), Gaps = 8/138 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSLQ- 141
+ A+S L+ L++L L S Y T+ + ++ +L+ + L ++ + P AF+ L
Sbjct: 39 VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFH 98
Query: 142 LNALDLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
L L L F + + F+NL L L+L N I L LK ++FS+N
Sbjct: 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158
Query: 197 NLNGSIPDSLQTFPNSSF 214
+ L+ +
Sbjct: 159 QIFLVCEHELEPLQGKTL 176
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 47/237 (19%), Positives = 76/237 (32%), Gaps = 27/237 (11%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSG 132
IHL + ++ L+IL L N + + SL+ ++L N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 133 VLP------AFRSL-QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLN 184
F L L L L+ N ++PPG F +LT L L+L +N ++
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLT----------------PC 228
L+IL+ S N L PD + N +C L+ P
Sbjct: 525 PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPA 584
Query: 229 STVSSSPSP-SPSYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFFLCCL 284
P S ++S + L S V + L+ + +
Sbjct: 585 DIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKF 641
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 35/136 (25%), Positives = 52/136 (38%), Gaps = 14/136 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-Q 141
+P L+ + L L NY+ S + LQ + L + Y + AFR+L
Sbjct: 19 VPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP----LNLPRLKILNFSNN 196
L LDL + + P FQ L L L L +S A+ NL L L+ S N
Sbjct: 75 LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 197 NLNG-SIPDSLQTFPN 211
+ + S +
Sbjct: 134 QIRSLYLHPSFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 8/110 (7%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ-LNALDLSFNAFT 153
++ L L ++ ++ L+ + L N + + AF L L L+LS+N
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLN 199
+ F L ++ ++LQ N I+ I L +L+ L+ +N L
Sbjct: 328 -ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 24/124 (19%), Positives = 40/124 (32%), Gaps = 10/124 (8%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS----GVLPAFRSLQLNALDLSFNA 151
+ I SN ++ + + + + + LDLS
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 152 FTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQ 207
++ F+ L L +LNL N I+ I L L++LN S N L +
Sbjct: 278 VF-SLNSRVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335
Query: 208 TFPN 211
P
Sbjct: 336 GLPK 339
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 22/107 (20%), Positives = 37/107 (34%), Gaps = 15/107 (14%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI 176
+ + + + V + + L LSFN + F L +L LL L +
Sbjct: 4 FDGRIAFYRFCNLTQVPQVLNTTE--RLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYT 60
Query: 177 SGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220
I NLP L+IL+ ++ + +F G L
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSK--------IYFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 24/156 (15%), Positives = 45/156 (28%), Gaps = 25/156 (16%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNG-TLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ 141
+ L AL L L N + L ++SL+ + +N V LQ
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 142 ---LNALDLSFNAFTGNIPPGFQNL------TRLHLLNLQNNSISGAIPPL--------- 183
L+ L+ N+ + + L +L++ N + I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 184 -----NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214
+ F +N+ ++ SS
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 20/148 (13%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQ-L 142
I + LD L++L+L N L S+ + + Y+ LQ N+ + + F+ L+ L
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 143 NALDLSFNAFT------------------GNIPPGFQNLTRLHLLNLQNNSISGAIPPLN 184
LDL NA T +P +HL + ++ L
Sbjct: 365 QTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLR 424
Query: 185 LPRLKILNFSNNNLNGSIPDSLQTFPNS 212
+P L+IL + N + D + S
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPS 452
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 27/157 (17%), Positives = 53/157 (33%), Gaps = 26/157 (16%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSIS--SLQYVYLQNNY--------F 130
S GKL++LK + SN + ++ + +L + L N +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 131 SGVLPAFRSLQLNALDLSFNAFTGNIPPGFQN------------LTRLHLLNLQNNSIS- 177
+ FR++ L LD+S N +T +I F N + ++I
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 178 ---GAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L ++ L+ S+ + +T +
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-17
Identities = 30/116 (25%), Positives = 49/116 (42%), Gaps = 6/116 (5%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L L+ L + SN ++ S + +++L+ + NN S + L L+ L L
Sbjct: 172 PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSL 228
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
+ N +LT L L+L NN IS P L +L L N ++ P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 8/140 (5%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L AL L L N L S I+++ +L Y+ L N S + SL +L L
Sbjct: 282 PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRLFF 338
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQ 207
N + NLT ++ L+ +N IS P NL R+ L ++ + +
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 208 TFPNSSFVGNSMLCGLPLTP 227
+ V N + G + P
Sbjct: 397 NVSIPNTVKN--VTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 8/118 (6%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ + KL L+ L +N ++ P + +++L + L N + SL L LD
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLD 249
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
L+ N + P LT+L L L N IS I PL L L L + N L P
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 38/117 (32%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+G L L LSL N L + S+++L + L NN S L L +L L L
Sbjct: 216 PLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKL 272
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
N + NI P LT L L L N + I P+ NL L L NN++ P
Sbjct: 273 GANQIS-NISP-LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 29/117 (24%), Positives = 55/117 (47%), Gaps = 9/117 (7%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
++ L +L+ LS N + P + ++++L+ + + +N S + L L +L
Sbjct: 151 ALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIA 206
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
+ N + +I P LT L L+L N + I L +L L L+ +NN ++ P
Sbjct: 207 TNNQIS-DITP-LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 8/124 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
S LD + L + + +++L + NN + + ++L +L + +
Sbjct: 41 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILM 97
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQ 207
+ N NLT L L L NN I+ P NL L L S+N ++ +L
Sbjct: 98 NNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALS 153
Query: 208 TFPN 211
+
Sbjct: 154 GLTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 31/119 (26%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L L L+L +N + + ++++L + L +N S + A L L L
Sbjct: 107 PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSF 163
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDS 205
N T P NLT L L++ +N +S I L L L+ L +NN ++ P
Sbjct: 164 G-NQVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITPLG 218
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 26/116 (22%), Positives = 42/116 (36%), Gaps = 6/116 (5%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ L L + T+ T + + + + L L ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINF 75
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
S N T +I P +NLT+L + + NN I+ P NL L L NN + P
Sbjct: 76 SNNQLT-DITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 18/132 (13%), Positives = 50/132 (37%), Gaps = 5/132 (3%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ + L L+ L +N ++ S + +++++ ++ +N S L +L ++ L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLG 381
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSL 206
L+ A+T N++ + + ++ + + + N + +
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVS 440
Query: 207 QTFPNSSFVGNS 218
TF +G
Sbjct: 441 YTFSQPVTIGKG 452
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 18/104 (17%), Positives = 33/104 (31%), Gaps = 5/104 (4%)
Query: 103 SNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG 159
+ T + I + + L + + Q+ L G
Sbjct: 6 ATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK--SIDG 63
Query: 160 FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
+ L L +N NN ++ P NL +L + +NN + P
Sbjct: 64 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP 107
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 8e-17
Identities = 53/272 (19%), Positives = 97/272 (35%), Gaps = 35/272 (12%)
Query: 340 EVLGKGSYGSTYKA--ILEDGTTVVVKRLREV--AATKREFEQQMEVVGTIGKHSNVVPV 395
+ G G Y A +G VV+K L A + + + + + H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQI 144
Query: 396 RAY--YYSKDEKLVVY---SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + + V Y Y+ SL + L + L +++
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSY 197
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLINFPTTATRTIGYRAPEVTETR 509
+HS G + ++K N++LT++ + D+G IN T G++APE+ T
Sbjct: 198 LHSIG---LVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTG 252
Query: 510 KASQKSDVYSFGVLLLEMLTGKAP-----LQHSGHDD-VVDLPRWVRSVVREEWTAEVFD 563
+ +D+Y+ G L + + DD V+ ++R A D
Sbjct: 253 -PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLR---RAIDPD 308
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRP 595
++ EEM L L V P
Sbjct: 309 PR-QRFTTA-EEMSAQLTGVLREVVAQDTGVP 338
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 49/277 (17%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM--EV-VGTIGKHSNVVPVRA 397
LGKGS+ Y+A + G V +K + + A K Q++ EV + KH +++ +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
Y+ + +V G + L + +R + G+ ++HS G
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMH-QIITGMLYLHSHG-- 132
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI-G---YRAPEVTETRKASQ 513
H ++ SN+LLT+++N I+D GLA + P T+ G Y +PE+
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDD--------VVDLPRWVRSVVREEWTAEVFDVE 565
+SDV+S G + +L G+ P + ++P ++ + +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK----------D 241
Query: 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
L+ Q+L+ + P R + V+
Sbjct: 242 LIH---------QLLR-------RNPADRLSLSSVLD 262
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 25/116 (21%), Positives = 53/116 (45%), Gaps = 5/116 (4%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRSL-QLNAL 145
N I L L+ L + + +++ ++SL + + ++ L +L ++N++
Sbjct: 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNG 200
DLS+N +I P + L L LN+Q + + + + P+L L + + G
Sbjct: 142 DLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 24/129 (18%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNA 144
+ ++++L ++L + + +D+T I +++ + + N + + L L
Sbjct: 39 TEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTINNIHATN-YNPISGLSNLER 92
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA-IPPL-NLPRLKILNFSNNNLNGSI 202
L + T + P LT L LL++ +++ + + + LP++ ++ S N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 203 PDSLQTFPN 211
L+T P
Sbjct: 153 -MPLKTLPE 160
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 14/95 (14%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN 143
++ L +L +L + + + ++ + I ++ + + L N + ++L +L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELK 162
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG 178
+L++ F+ + ++ +L+ L + +I G
Sbjct: 163 SLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 29/147 (19%), Positives = 60/147 (40%), Gaps = 14/147 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I + L++L+ L+L L ++ + L + L++ + + +F+ L +L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLN 199
L++S + + P L L++ + +++ A+P L +L L+ LN S N
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNP-- 259
Query: 200 GSIPDSLQTFPNSSFVGNSMLCGLPLT 226
+ T S L + L
Sbjct: 260 ------ISTIEGSMLHELLRLQEIQLV 280
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 10/134 (7%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
IP L L L + N + L + + +L+ + + +N + AF L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
L L L T +IP +L L +L L++ +I+ AI L RLK+L S+
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWP 211
Query: 198 LNGSIPDSLQTFPN 211
++ + N
Sbjct: 212 YLDTMTPNCLYGLN 225
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 35/131 (26%), Positives = 52/131 (39%), Gaps = 16/131 (12%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
++L L N + + S L+ + L N S V P AF +L L L L N
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPDSLQTF 209
IP G F L+ L L++ N I + +L LK L +N+ L
Sbjct: 94 -LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDND--------LVYI 143
Query: 210 PNSSFVGNSML 220
+ +F G + L
Sbjct: 144 SHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 30/144 (20%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I S +L LK+L + T+ + +L + + + + V A R L L
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
Query: 143 NALDLSFN--------AFTG---------------NIPPG-FQNLTRLHLLNLQNNSISG 178
L+LS+N + P F+ L L +LN+ N ++
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT- 309
Query: 179 AIPP---LNLPRLKILNFSNNNLN 199
+ ++ L+ L +N L
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 27/107 (25%), Positives = 37/107 (34%), Gaps = 15/107 (14%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI 176
+ + V F V P + LDL N + F + L L L N +
Sbjct: 11 AQDRAVLCHRKRFVAV-PEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV 68
Query: 177 SGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220
S A+ P NL L+ L +N L+ P F G S L
Sbjct: 69 S-AVEPGAFNNLFNLRTLGLRSNR--------LKLIPLGVFTGLSNL 106
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 8/134 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + L++L L+S+ +N T+ D S+ SL+++ L +N+ S + F L
Sbjct: 41 IGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
L L+L N + F NLT L L + N I L L L +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 198 LNGSIPDSLQTFPN 211
L SL++ +
Sbjct: 160 LRNYQSQSLKSIRD 173
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 27/135 (20%), Positives = 51/135 (37%), Gaps = 10/135 (7%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSGVLP--AFRSL- 140
I ++ L +L+ L L N+L+ +L S +SSL+Y+ L N + + F +L
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L L + I F LT L+ L ++ S+ ++ + L +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLS 182
Query: 197 NLNGSIPDSLQTFPN 211
+ +
Sbjct: 183 ESAFLLEIFADILSS 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 10/129 (7%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTL---PSDITSISSLQYVYLQNNYFS---GVLPAFR 138
+P + L +L+ L L N + + + SLQ + L N+
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 139 SL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNN 197
+L L +LD+S N F +P Q ++ LNL + I + L++L+ SNNN
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNN 442
Query: 198 LNGSIPDSL 206
L+ S L
Sbjct: 443 LD-SFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 21/130 (16%), Positives = 42/130 (32%), Gaps = 10/130 (7%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQL 142
+ L L L + N + +P ++++ L + V ++L++
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEV 435
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-LNLPRLKILNFSNNNLNGS 201
LD+S N + L L + N + +P P L ++ S N L
Sbjct: 436 --LDVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDASLFPVLLVMKISRNQLKSV 488
Query: 202 IPDSLQTFPN 211
+
Sbjct: 489 PDGIFDRLTS 498
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 10/153 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNG-TLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+ ++ G L +LK L+L N + S ++++LQ + + N + F L
Sbjct: 89 LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
LN L++ + N +++ +H L L + + + + L ++ L +
Sbjct: 149 SLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDT 206
Query: 197 NLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCS 229
NL L SS + G LT S
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 30/164 (18%), Positives = 60/164 (36%), Gaps = 17/164 (10%)
Query: 63 TCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNG-----TLPSDITSI 117
++ L G+G P ++ + +L ++ +++R ++ L + + +
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 118 SSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFTGNIPPG---FQNLTRLHLLNLQ 172
++ + ++N+ V + L L LDLS N L L L
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 173 NNSISGAIPP-----LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
N + ++ L L L L+ S N + +PDS Q
Sbjct: 370 QNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 24/138 (17%), Positives = 50/138 (36%), Gaps = 18/138 (13%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS--------SLQYVYLQNNYFSGVLP-AFR 138
I +L ++ N L PS+ +S +++ +++ Y L +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 139 SL-QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL-----NLPRLKIL 191
L ++ + + + +P Q+L L L+L N + P L+ L
Sbjct: 308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 192 NFSNNNLNGSIPDSLQTF 209
S N+L S+ + +
Sbjct: 367 VLSQNHLR-SMQKTGEIL 383
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 22/142 (15%), Positives = 48/142 (33%), Gaps = 24/142 (16%)
Query: 92 KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-------------LPAFR 138
K A + L N L + I L V + +G+ L
Sbjct: 226 KKLAFRGSVLTDESFNE-LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSN 195
++ + L + ++ + L ++ + ++N+ + +P +L L+ L+ S
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSE 343
Query: 196 NNLNGSIPDSLQTFPNSSFVGN 217
N + + NS+ G
Sbjct: 344 NLM------VEEYLKNSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI 176
+ ++ F+ + P+ + + +LDLSFN T I G + L +L L+++ I
Sbjct: 5 DASGVCDGRSRSFTSI-PSGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI 62
Query: 177 SGAIPP---LNLPRLKILNFSNNNLNGSIPDSL 206
+ I +L L+ L+ S+N+L+ S+ S
Sbjct: 63 N-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 17/150 (11%), Positives = 43/150 (28%), Gaps = 24/150 (16%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-------LPAF 137
+ S+ + + L+L + L +SS++Y+ L++ +
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 138 RSLQLNAL------DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG----------AIP 181
++ A D SFN + L+ + + N + +
Sbjct: 223 SPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 182 PLNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
+ ++ L+ L +
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 91 GKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFN 150
L++L + +N L+ + + LQ +Y+ N + A L + +S N
Sbjct: 428 CIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKTLPDASLFPVLLVMKISRN 483
Query: 151 AFTGNIPPG-FQNLTRLHLLNLQNNSI 176
++P G F LT L + L N
Sbjct: 484 QLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 50/279 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM--EV-VGTIGKHSNVVPV 395
LGKG + ++ + K + + K ++M E+ + H +VV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
++ D VV SL L R + +R G ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEAR-YYLRQIVLGCQYLHRNR 161
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI-G---YRAPEVTETRKA 511
H ++K N+ L +DL I D GLA + + + + G Y APEV +
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDD--------VVDLPRWVRSVVREEWTAEVFD 563
S + DV+S G ++ +L GK P + S + +P+ + V
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA--------- 269
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
L++ +MLQ P +RP +++++
Sbjct: 270 -SLIQ---------KMLQ-------TDPTARPTINELLN 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVV 393
+G GS+G+ Y A + + V +K++ + + + Q +++ + +H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQ-DIIKEVRFLQKLRHPNTI 117
Query: 394 PVRAYY--YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
Y Y ++ +V Y GS LL ++ L + G +G+A+
Sbjct: 118 ---QYRGCYLREHTAWLVMEYC-LGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAY 169
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRK 510
+HS H ++K+ N+LL++ + D G A ++ + T + APEV
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMD 226
Query: 511 ASQ---KSDVYSFGVLLLEMLTGKAPL 534
Q K DV+S G+ +E+ K PL
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 45/243 (18%), Positives = 86/243 (35%), Gaps = 41/243 (16%)
Query: 323 DGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTTVVVKRL--REVAATKREFEQQM 380
+ F L++L+ S ++LG GS G+ G V VKR+ E +
Sbjct: 5 NIPNFEQSLKNLVV-SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----I 59
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLL--HRNRSDGGTALDWNSRM 438
+++ H NV+ + + +L L+ + + +
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-------------ISDVGLA 485
+ A G+A +HS H ++K N+L++ ISD GL
Sbjct: 119 SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 486 HLIN--------FPTTATRTIGYRAPEV-------TETRKASQKSDVYSFGVLLLEMLTG 530
++ + T G+RAPE+ R+ ++ D++S G + +L+
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 531 KAP 533
Sbjct: 236 GKH 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 50/279 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM--EV-VGTIGKHSNVVPV 395
LGKG + ++ + K + + K ++M E+ + H +VV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
++ D VV SL L R + +R G ++H
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEAR-YYLRQIVLGCQYLHRNR 135
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI-G---YRAPEVTETRKA 511
H ++K N+ L +DL I D GLA + + + + G Y APEV +
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDD--------VVDLPRWVRSVVREEWTAEVFD 563
S + DV+S G ++ +L GK P + S + +P+ + V
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA--------- 243
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
L++ +MLQ P +RP +++++
Sbjct: 244 -SLIQ---------KMLQ-------TDPTARPTINELLN 265
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 37/130 (28%), Positives = 55/130 (42%), Gaps = 14/130 (10%)
Query: 91 GKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-QLNALDL 147
G L L L L N L +LP ++ +L + + N + LP A R L +L L L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 148 SFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIP 203
N +PPG +L L+L NN+++ +P L L L N+L +IP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 204 DSLQTFPNSS 213
F +
Sbjct: 189 KG--FFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 30/126 (23%), Positives = 50/126 (39%), Gaps = 15/126 (11%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN 143
+P + IL L N L + + + L + L + L +L L
Sbjct: 29 LPKD-------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLG 80
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
LDLS N ++P Q L L +L++ N ++ ++P L L+ L N L
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137
Query: 201 SIPDSL 206
++P L
Sbjct: 138 TLPPGL 143
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 34/119 (28%), Positives = 45/119 (37%), Gaps = 12/119 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL- 140
+P L AL +L + N L +LP + LQ +YL+ N LP
Sbjct: 92 LPL-LGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNN 196
+L L L+ N T +P G L L L LQ NS+ IP L N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 25/97 (25%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 118 SSLQYVYLQNNYFSGVLPA--FRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNN 174
+S V + + P + L LS N TRL LNL
Sbjct: 10 ASHLEVNCDKRNLTAL-PPDLPKDTT--ILHLSENLLY-TFSLATLMPYTRLTQLNLDRA 65
Query: 175 SISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
++ LP L L+ S+N L S+P QT P
Sbjct: 66 ELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 32/150 (21%), Positives = 52/150 (34%), Gaps = 13/150 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
I +S L +L+ L L NYL L S +SSL ++ L N + + F L
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
+L L + I F LT L L + + + + P ++ + L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMK 208
Query: 197 NLNGSIPDSLQTFPNSSFVGNSMLCGLPLT 226
+ + +S V L L
Sbjct: 209 QHI-LLLEIF--VDVTSSVECLELRDTDLD 235
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 34/150 (22%), Positives = 54/150 (36%), Gaps = 18/150 (12%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFN 150
D I S LN ++PS +T +++ + L NN + + + L AL L+ N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 151 AFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSL 206
I F +L L L+L N +S + L L LN N ++
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLG--- 140
Query: 207 QTFPNSSFVGNSMLCGLPLTPCSTVSSSPS 236
S F + L L + T +
Sbjct: 141 ---ETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 24/134 (17%), Positives = 45/134 (33%), Gaps = 14/134 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I L L+ L + ++ L P + SI ++ ++ L +L +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 143 NALDLSFNAFTGN----IPPG----FQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILN 192
L+L + G + + + S+ + L + L L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 193 FSNNNLNGSIPDSL 206
FS N L S+PD +
Sbjct: 284 FSRNQLK-SVPDGI 296
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 17/129 (13%), Positives = 37/129 (28%), Gaps = 17/129 (13%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGV----LP--AF 137
S+ + + L L L SS++ + L++ L
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 138 RSL----QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKI 190
SL + ++ + + ++ L L N + +P L L+
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQK 305
Query: 191 LNFSNNNLN 199
+ N +
Sbjct: 306 IWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 10/135 (7%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + + + L+ L L SN +N T+ D +S+ SL+++ L NY S + F+ L
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSS 125
Query: 142 LNALDLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L L+L N + + F +LT+L +L + N I L L+ L +
Sbjct: 126 LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 197 NLNGSIPDSLQTFPN 211
+L P SL++ N
Sbjct: 185 DLQSYEPKSLKSIQN 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 36/224 (16%), Positives = 67/224 (29%), Gaps = 41/224 (18%)
Query: 341 VLGKGSYGSTYKAILEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIG----- 387
L +G + +D +K + R+ + +
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 388 ----KHSNVVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIA 441
K+ + + V +Y YM S+ LD N I
Sbjct: 97 ITDIKNEYCL--TCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-----LDKNYTCFIP 149
Query: 442 LGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493
+ + ++IH+E H ++K SN+L+ ++ +SD G + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 494 ATR--TIGYRAPEVTETRK--ASQKSDVYSFGVLLLEMLTGKAP 533
T + PE K D++S G+ L M P
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 36/232 (15%)
Query: 333 DLLRASAEVLGKGSYGSTYKAILEDGTTV---------VVKRLREVAATKREFEQQMEVV 383
+ R ++G+G +G Y D + +K + E + M +
Sbjct: 192 SVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE--RIMLSL 245
Query: 384 GTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK---- 439
+ G +V + +++ D+ + M G L L ++ + M+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS------EADMRFYAA 299
Query: 440 -IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-- 496
I LG + +H+ + ++K +N+LL + + ISD+GLA +
Sbjct: 300 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 497 TIGYRAPEVTETRKASQKS-DVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547
T GY APEV + A S D +S G +L ++L G +P + D ++ R
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 52/222 (23%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATK-REFE--QQMEVVGTIGKHSNVVPV 395
+V+G GS+G Y+A L + G V +K++ + K RE + +++ H N+V +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-------DHCNIVRL 112
Query: 396 RAYYYSKDEKL------VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALG------ 443
R ++YS EK +V Y+P ++R SR K L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP-----ETVYR-------VARHYSRAKQTLPVIYVKL 160
Query: 444 ----TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLI--NFPTT--- 493
R +A+IHS G H +IK N+LL D + D G A + P
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 494 ATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+R YRAPE+ + DV+S G +L E+L G+ P+
Sbjct: 218 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 48/223 (21%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATK-REFEQQMEVVGTIGKHSNVVPVRA 397
+ G+G++G+ G +V +K++ + + RE Q M+ + + H N+V +++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVL-HHPNIVQLQS 86
Query: 398 YYYSKDEK-------LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALG------- 443
Y+Y+ E+ VV Y+P LHR R ++A
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVP-----DTLHR-------CCRNYYRRQVAPPPILIKVF 134
Query: 444 ---TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI--NFPTT-- 493
R I +H H +IK NVL+ + + D G A + + P
Sbjct: 135 LFQLIRSIGCLHLP-SVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 494 -ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+R YRAPE+ + + D++S G + EM+ G+ P+
Sbjct: 192 ICSRY--YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 30/132 (22%), Positives = 58/132 (43%), Gaps = 16/132 (12%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA----------F 137
+++ + L+ L+L N L LP+ I S++ L+ + ++ LP
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 138 RSLQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFS 194
+ L L +L L + ++P NL L L ++N+ +S A+ P +LP+L+ L+
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 195 NNNLNGSIPDSL 206
+ P
Sbjct: 238 GCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 27/131 (20%), Positives = 51/131 (38%), Gaps = 15/131 (11%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ-LNALD 146
+ +L L+ +++ + L LP + + L+ + L N + + SL L L
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELS 156
Query: 147 LS-FNAFT--------GNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSN 195
+ T + Q L L L L+ I ++P NL LK L N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 196 NNLNGSIPDSL 206
+ L+ ++ ++
Sbjct: 216 SPLS-ALGPAI 225
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 20/134 (14%), Positives = 39/134 (29%), Gaps = 8/134 (5%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISS--LQYVYLQNNYFSGVLPAFRSL-QLNAL 145
+ +I + L + + + L++ L L +
Sbjct: 51 RQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHM 109
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIP 203
+ +P Q L L L N + A+P +L RL+ L+ +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 204 DSLQTFPNSSFVGN 217
+ L + S
Sbjct: 168 EPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 21/125 (16%), Positives = 36/125 (28%), Gaps = 24/125 (19%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDL 147
+I L L+ L LR P + L+ + L++
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------------- 263
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDS 205
+ +P LT+L L+L+ +P L LP I+ +
Sbjct: 264 --SNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
Query: 206 LQTFP 210
P
Sbjct: 321 PVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 14/143 (9%), Positives = 34/143 (23%), Gaps = 28/143 (19%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA---- 144
+ L + + ++ + + + Q+
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 145 -------------------LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--L 183
L+L P L+ L + + + +P
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 184 NLPRLKILNFSNNNLNGSIPDSL 206
L+ L + N L ++P S+
Sbjct: 125 QFAGLETLTLARNPLR-ALPASI 146
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 45/269 (16%), Positives = 79/269 (29%), Gaps = 80/269 (29%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR-------------LREVAATKR----------- 374
+ +G+G +G ++A D +KR +REV A +
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 375 -------------------------------EFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403
V +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 404 EKLVVY---SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFT 460
K+ +Y +L ++R + + I + A + F+HS+G
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCLHIFIQIAEAVEFLHSKG---LM 186
Query: 461 HGNIKSSNVLLTQDLNGCISDVGLA-------------HLINFPTTATRTIG---YRAPE 504
H ++K SN+ T D + D GL + T T +G Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAP 533
S K D++S G++L E+L +
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATK-REFEQQMEVVGTIGKHSNVVPVRAY 398
+V+G GS+G ++A L + V +K++ + K RE Q M +V KH NVV ++A+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-QIMRIV----KHPNVVDLKAF 100
Query: 399 YYSKDEKL------VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA------- 445
+YS +K +V Y+P ++R A +++K +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVP-----ETVYR-------ASRHYAKLKQTMPMLLIKLYMY 148
Query: 446 ---RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLA-HLINFPTT----ATR 496
R +A+IHS G H +IK N+LL + D G A LI +R
Sbjct: 149 QLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 497 TIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ + D++S G ++ E++ G+ PL
Sbjct: 206 Y--YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 11/127 (8%)
Query: 79 IGFTGPIPANSIGKLDALKILSLRSNYLN---GTLPSDITSISSLQYVYLQNNYFSGVLP 135
+G G I A K L++L+LR+ + G + + LQ + L +N
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 136 AFRSL---QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKIL 191
A QLN+L+LSF +P G L+ L +L N + P LP++ L
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVL---DLSYNRLDRNPSPDELPQVGNL 301
Query: 192 NFSNNNL 198
+ N
Sbjct: 302 SLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 29/133 (21%), Positives = 45/133 (33%), Gaps = 12/133 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDIT----SISSLQYVYLQNNYFSGVLPAFRSL 140
+ AL L L N G +LQ + L+N +L
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 141 -----QLNALDLSFNAFTGNIPP-GFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFS 194
QL LDLS N+ ++L+ LNL + +P +L +L+ S
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLS 282
Query: 195 NNNLNGSIPDSLQ 207
N L+ P +
Sbjct: 283 YNRLD-RNPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 28/144 (19%), Positives = 50/144 (34%), Gaps = 19/144 (13%)
Query: 96 LKILSLRSNYLNGTLPSDITSIS--SLQYVYLQNN------YFSGVLPAFRSLQLNALDL 147
L+ L+L + + GT P + + L + L+N + L + L L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISG------AIPPLNLPRLKILNFSNNNLNGS 201
+ + L L+L +N G A+ PL P L++L N +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME-- 214
Query: 202 IPDSLQTFPNSSFVGNSMLCGLPL 225
+ ++ L GL L
Sbjct: 215 ---TPSGVCSALAAARVQLQGLDL 235
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 27/126 (21%), Positives = 43/126 (34%), Gaps = 13/126 (10%)
Query: 99 LSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS-----GVLPAFRSLQLNALDLSFNAFT 153
L + +DI SL+ + ++ G L L L L T
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 154 GNIPPGFQNLTRLHL--LNLQNNSISG------AIPPLNLPRLKILNFSNNNLNGSIPDS 205
G PP T L LNL+N S + + P LK+L+ + + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 206 LQTFPN 211
++ FP
Sbjct: 169 VRVFPA 174
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 15/74 (20%), Positives = 21/74 (28%), Gaps = 3/74 (4%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
A S L L+L L +P + + L + L N
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRNPSPDELP 296
Query: 141 QLNALDLSFNAFTG 154
Q+ L L N F
Sbjct: 297 QVGNLSLKGNPFLD 310
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 26/123 (21%), Positives = 49/123 (39%), Gaps = 16/123 (13%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+PA+ + + L N + + + + LQ++ ++ V+ FR L
Sbjct: 27 ELPAH-------VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI-SGAIPP---LNLPRLKILNFSN 195
L L L +N F + G F L L +L L ++ + L L++L +
Sbjct: 80 SLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 196 NNL 198
NN+
Sbjct: 139 NNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 35/152 (23%), Positives = 54/152 (35%), Gaps = 13/152 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYF-SGVLP--AFRSL 140
I N+ L +L IL L N L + +++L+ + L VL F+ L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 141 -QLNALDLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSIS----GAIPPLNLPRLKILNF 193
L L L N I P F N+ R H+L+L N + + +L
Sbjct: 129 TSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 194 SNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPL 225
S+ L L + N+ + L L
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 10/122 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
+ + L+ L+L N +N + + ++ L + L N+ + F +L +
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
L LDLS+N + F L L L L N + ++P L L+ + N
Sbjct: 349 LEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 406
Query: 198 LN 199
+
Sbjct: 407 WD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 27/153 (17%), Positives = 48/153 (31%), Gaps = 20/153 (13%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFS----GVLPAFR 138
+ N L +L++L LR N + P+ ++ + L N L F+
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 139 SLQLNALDLSFN--------AFTGNIPPGFQNLTRLHLLNLQNNSISGAIP-----PLNL 185
L LS T + L+L N ++ +
Sbjct: 179 GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238
Query: 186 PRLKILNFSNNNLNGSIPDS--LQTFPNSSFVG 216
+++ L SN+ GS + N +F G
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 17/80 (21%), Positives = 25/80 (31%), Gaps = 13/80 (16%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
+DLS N+ + F L L L ++ + I L L IL N
Sbjct: 35 VDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ--- 90
Query: 201 SIPDSLQTFPNSSFVGNSML 220
+F G + L
Sbjct: 91 -----FLQLETGAFNGLANL 105
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 21/134 (15%), Positives = 45/134 (33%), Gaps = 24/134 (17%)
Query: 92 KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP----------AFRSLQ 141
+L ++ + + +L + +S+ + L N F + +SL
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 142 LN-----ALDLSFNAFTGNIPPG-FQNL--TRLHLLNLQNNSISGAIPP---LNLPRLKI 190
L+ F + F+ L + + +L + I A+ + L+
Sbjct: 246 LSNSYNMGSSFGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQ 303
Query: 191 LNFSNNNLNGSIPD 204
L + N +N I D
Sbjct: 304 LTLAQNEIN-KIDD 316
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 15/127 (11%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
++L+L N + + + L+ + L N+ + AF L LN L+L N T
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTF 209
IP G F L++L L L+NN I +IP +P L+ L+ L
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK-------RLSYI 176
Query: 210 PNSSFVG 216
+F G
Sbjct: 177 SEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 10/121 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I + L L+ L+L L +P ++T + L + L N+ S + P +F+ L L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 143 NALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNL 198
L + + I F NL L +NL +N+++ +P L L+ ++ +N
Sbjct: 234 QKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
Query: 199 N 199
N
Sbjct: 292 N 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 39/149 (26%), Positives = 58/149 (38%), Gaps = 19/149 (12%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
IP + L LK L LR+N + ++PS I SL+ + L + AF L
Sbjct: 127 IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
L L+L+ IP L +L L+L N +S AI P L L+ L +
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ 242
Query: 198 LNGSIPDSLQTFPNSSFVGNSMLCGLPLT 226
+Q ++F L + L
Sbjct: 243 --------IQVIERNAFDNLQSLVEINLA 263
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 30/112 (26%), Positives = 37/112 (33%), Gaps = 15/112 (13%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI 176
+ V V P S L+L N I F++L L +L L N I
Sbjct: 43 NQFSKVICVRKNLREV-PDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI 100
Query: 177 SGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPL 225
I L L L +N L T PN +FV S L L L
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNR--------LTTIPNGAFVYLSKLKELWL 143
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 33/210 (15%)
Query: 341 VLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIG--------KHSN 391
VLGKG +G + G K+L K+ +++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE-----KKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-----IALGTAR 446
VV + Y +KD +V + M G L ++ G +R I G
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----EARAVFYAAEICCG--- 298
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR--TIGYRAP 503
+ +H E + ++K N+LL + ISD+GLA H+ T R T+GY AP
Sbjct: 299 -LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
EV + + + D ++ G LL EM+ G++P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 34/147 (23%), Positives = 58/147 (39%), Gaps = 26/147 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDIT--SISSLQYVYLQNNYFSGVLP-AFRSL- 140
+P+ +L L N L L ++ T +++L + L +N+ + + AF +
Sbjct: 37 LPSY-------TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L LDLS N + F +L L +L L NN I + ++ +L+ L S N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 197 NLNGSIPDSLQTFPNSSFVGNSMLCGL 223
+ FP + L L
Sbjct: 147 Q--------ISRFPVELIKDGNKLPKL 165
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 13/130 (10%)
Query: 92 KLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL-QLNALDL 147
+L L L L N+LN + S+ + +L+Y+ L +N+ L F L L L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 148 SFNAFTGNIPPG-FQNLTRLHLLNLQNNSIS----GAIPPL-NLPRLKILNFSNNNLNGS 201
N + F+++ +L L L N IS I LP+L +L+ S+N L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 202 IPDSLQTFPN 211
LQ P
Sbjct: 179 PLTDLQKLPA 188
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 13/126 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + + + L+ L L SN+L+ TL + + + +L+ + L NN+ V AF + Q
Sbjct: 79 ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ 137
Query: 142 LNALDLSFNAFTGNIPPG----FQNLTRLHLLNLQNNSIS----GAIPPLNLPRLKILNF 193
L L LS N + P L +L LL+L +N + + L L
Sbjct: 138 LQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 194 SNNNLN 199
NN L
Sbjct: 197 HNNPLE 202
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 37/176 (21%), Positives = 55/176 (31%), Gaps = 52/176 (29%)
Query: 85 IPANSIGKLDALKILSLRSNYL----NGTLPS---------DITSIS--------SLQYV 123
I + L L+ L + N+L S I + ++ +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 124 YLQNN-YFSGVLP--AFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHL----------- 168
+ N + AF L+LN L +S T IP + L LHL
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELE 211
Query: 169 ----------LNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L L +N I I LP L+ L+ NN L+ +P L
Sbjct: 212 DLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 25/132 (18%), Positives = 46/132 (34%), Gaps = 15/132 (11%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
IP + + L L L N + D+ S L + L +N + + L L
Sbjct: 187 IPKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS--------GAIPPLNLPRLKILNFS 194
L L N + +P G +L L ++ L N+I+ + ++
Sbjct: 244 RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 195 NNNL-NGSIPDS 205
NN + + +
Sbjct: 303 NNPVPYWEVQPA 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 22/125 (17%), Positives = 42/125 (33%), Gaps = 15/125 (12%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFRSL-QL 142
I + + L L L N + + + + + +L+ ++L NN S V L L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLL 266
Query: 143 NALDLSFNAFTGNIPPG-------FQNLTRLHLLNLQNNSIS-GAIPP---LNLPRLKIL 191
+ L N T + + ++L NN + + P + +
Sbjct: 267 QVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 192 NFSNN 196
F N
Sbjct: 326 QFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 28/116 (24%), Positives = 44/116 (37%), Gaps = 12/116 (10%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
+L L++N ++ D + L + L NN S + AF L +L L +S N
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNL-NGSIPD 204
IPP +L L + +N I +P L + + N L N
Sbjct: 116 -EIPPNLPSSLVELR---IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 28/97 (28%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 119 SLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSIS 177
L+ V + V P S LDL N + + F+ L L+ L L NN IS
Sbjct: 34 HLRVVQCSDLGLKAV-PKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS 91
Query: 178 GAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
I L +L+ L S N+L IP +L +
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSS 124
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 34/127 (26%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QLNALDLSFNAFT 153
+ L+L N + + L+ + L N + AF L LN L+L N T
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 154 GNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTF 209
IP G F+ L++L L L+NN I +IP +P L L+ L+
Sbjct: 137 -VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK-------KLEYI 187
Query: 210 PNSSFVG 216
+F G
Sbjct: 188 SEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 10/121 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
I + L LK L+L + +P ++T + L+ + + N+F + P +F L L
Sbjct: 187 ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 143 NALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNL 198
L + + + I F L L LNL +N++S ++P L L L+ +N
Sbjct: 245 KKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
Query: 199 N 199
N
Sbjct: 303 N 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 26/107 (24%), Positives = 34/107 (31%), Gaps = 15/107 (14%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSI 176
+ V S V P L+L N I F++L L +L L NSI
Sbjct: 54 NQFSKVVCTRRGLSEV-PQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI 111
Query: 177 SGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220
I L L L +N L P+ +F S L
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNW--------LTVIPSGAFEYLSKL 149
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 50/222 (22%), Positives = 79/222 (35%), Gaps = 41/222 (18%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR------EVAATKREFEQQMEVVGTIGKHSNV 392
E LG G +G + I + G V +K+ R E + ++ H NV
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-----NHPNV 74
Query: 393 VPVRAY--------YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG----TALDWNSRMKI 440
V A D L+ Y G L L++ + G S +
Sbjct: 75 V--SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI-- 130
Query: 441 ALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI---NFPTTA 494
+ + ++H H ++K N++L I D+G A + T
Sbjct: 131 ----SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 495 TRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQH 536
T+ Y APE+ E +K + D +SFG L E +TG P
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 22/157 (14%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP---AFRSL- 140
+ K+ L +N L T+ + ++ L+ + LQ N + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
L LD+S N+ + + G L LN+ +N ++ I PR+K+L+ +N +
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 200 GSIPDS----------------LQTFPNSSFVGNSML 220
SIP L++ P+ F + L
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 17/129 (13%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+ IL++ NY++ SDI S+S L+ + + +N + F+ +L
Sbjct: 19 LSQK-------TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL----NLPRLKILNFSNNNL 198
LDLS N I L L+L N+ A+P N+ +LK L S +L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 199 NGSIPDSLQ 207
S +
Sbjct: 128 EKSSVLPIA 136
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 28/158 (17%), Positives = 52/158 (32%), Gaps = 12/158 (7%)
Query: 58 SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIG----KLDALKILSLRSNYLNGTLPSD 113
S+I + V + V + + G + L AL I + S+
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 114 ITSISSLQYVYLQNNYFSGV-LPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNL 171
S++ + V + + LD S N T + +LT L L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 172 QNNSISGAIPPL-----NLPRLKILNFSNNNLNGSIPD 204
Q N + + + + L+ L+ S N+++
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 22/120 (18%), Positives = 46/120 (38%), Gaps = 6/120 (5%)
Query: 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFRSLQL 142
A ++ +L+ L + N ++ + SL + + +N + + ++
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199
LDL N +IP L L LN+ +N + ++P L L+ + N +
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 19/139 (13%), Positives = 39/139 (28%), Gaps = 6/139 (4%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS--GVLPAFRSL-Q 141
+ + L+ L L N L + +L+++ L N F + F ++ Q
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGS 201
L L LS + +L +L + + P L +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 202 IPDSLQTFPNSSFVGNSML 220
+ + +
Sbjct: 177 EFHFILDVSVKTVANLELS 195
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 20/135 (14%), Positives = 46/135 (34%), Gaps = 12/135 (8%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDIT---SISSLQYVYLQNNYFSGVLP------AFRS 139
+ L L+L + I +++ Y + N G L + S
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274
Query: 140 LQ-LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG--AIPPLNLPRLKILNFSNN 196
L+ L+ + + F ++ + +++ N + + P + L+FSNN
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 197 NLNGSIPDSLQTFPN 211
L ++ ++
Sbjct: 335 LLTDTVFENCGHLTE 349
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 36/219 (16%)
Query: 333 DLLRASAEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIG---- 387
R VLG+G +G + ++ G K+L K+ +++ G +
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLN-----KKRLKKRKGYQGAMVEKKI 238
Query: 388 ----KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK---- 439
+V + + +K + +V + M G + ++ D + R
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE--PRAIFYTA 296
Query: 440 -IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTATR 496
I G + +H + ++K NVLL D N ISD+GLA T
Sbjct: 297 QIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 497 --TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
T G+ APE+ + D ++ GV L EM+ + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 44/218 (20%), Positives = 80/218 (36%), Gaps = 34/218 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL------REVAATKREFEQQMEVVGTIGKHSNV 392
++LG+G+ + ++ + G +K R V REFE ++ H N+
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNI 69
Query: 393 VPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V + A + + + P GSL+ +L + G L + + + G+
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNH 127
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC----ISDVGLAHLI---NFPTTATRTIGYRAP 503
+ G H NIK N++ +G ++D G A + + T Y P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 504 EV--------TETRKASQKSDVYSFGVLLLEMLTGKAP 533
++ +K D++S GV TG P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 24/217 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIGKHSNVVPV 395
+ LG G+YG +K +R+ + + +++ V+ + H N++ +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKL 101
Query: 396 RAYYYSKDEKLVVYSYMPAGSLF--MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
++ K +V G LF ++ ++ A +K L G+ ++H
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA----VIIKQVLS---GVTYLHK 154
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI---NFPTTATRTIGYRAPEVTE 507
H ++K N+LL I D GL+ + T Y APEV
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
+K +K DV+S GV+L +L G P +++
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 28/159 (17%), Positives = 55/159 (34%), Gaps = 28/159 (17%)
Query: 55 VCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDI 114
C + I P + P + + L L +L T+PS
Sbjct: 9 ECHQEEDFRVTCKDIQRI----PSL------PPS-------TQTLKLIETHLR-TIPSHA 50
Query: 115 -TSISSLQYVYLQNNYFSGVLP--AFRSL-QLNALDLSFNAFTGNIPPG-FQNLTRLHLL 169
+++ ++ +Y+ + L +F +L ++ +++ I P + L L L
Sbjct: 51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 170 NLQNNSISGAIPPL----NLPRLKILNFSNNNLNGSIPD 204
+ N + P L + IL ++N SIP
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 25/140 (17%), Positives = 51/140 (36%), Gaps = 16/140 (11%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGV--LPAFRSLQ 141
+ ++S L + + +R+ + D + L+++ + N L S
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTD 130
Query: 142 LN-ALDLSFNAFTGNIPPG-FQNLTR-LHLLNLQNNSISGAIPP--LNLPRLKILNFSNN 196
+ L+++ N + +IP FQ L L L NN + ++ N +L + + N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
Query: 197 NLNGSIPDSLQTFPNSSFVG 216
L +F G
Sbjct: 190 KY-------LTVIDKDAFGG 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 29/118 (24%), Positives = 50/118 (42%), Gaps = 7/118 (5%)
Query: 85 IPANS-IGKLDALKILSLRSNYLNGTLPSDITS--ISSLQYVYLQNNYFSGVLP-AFRSL 140
P + + D IL + N ++P + + + L NN F+ V AF
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGT 179
Query: 141 QLNALDLSFNAFTGNIPPG-FQNL-TRLHLLNLQNNSISGAIPPLNLPRLKILNFSNN 196
+L+A+ L+ N + I F + + LL++ S++ A+P L LK L N
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 8/95 (8%)
Query: 85 IPANSIGKLDA-LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSLQ 141
IP N+ L L L +N ++ + + L VYL N + V+ AF +
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 142 --LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQN 173
+ LD+S + T +P ++L L N
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 25/207 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM----EVVGTIGKHSNVVP 394
VLGKGS+G G VK + + ++ ++ + +++ + H N++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMK 90
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLF--MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ ++ K +V G LF ++ + S+ A ++ L GI ++H
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----RIIRQVLS---GITYMH 143
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI---NFPTTATRTIGYRAPEVT 506
H ++K N+LL I D GL+ T Y APEV
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAP 533
+K DV+S GV+L +L+G P
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 51/305 (16%), Positives = 101/305 (33%), Gaps = 45/305 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL------REVAATKREFEQQMEVVGTIGKHSNV 392
++LG+G+ + ++ + G +K R V REFE ++ H N+
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNI 69
Query: 393 VPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V + A + + + P GSL+ +L + G L + + + G+
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG--LPESEFLIVLRDVVGGMNH 127
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC----ISDVGLAHLIN---FPTTATRTIGYRAP 503
+ G H NIK N++ +G ++D G A + + T Y P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 504 EV--------TETRKASQKSDVYSFGVLLLEMLTGKAP-LQHSGHDDVVDL--------- 545
++ +K D++S GV TG P G ++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKV-PDSRPKMDDVVRMI 604
+ V + E + ++ + + +L L+ + + + D
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 605 EQIQQ 609
I
Sbjct: 305 SDILH 309
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 30/114 (26%), Positives = 45/114 (39%), Gaps = 13/114 (11%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
L+ LS+ N L +LP+ S L ++ NN + + LQ L +S N
Sbjct: 140 PPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTSLPMLPSGLQ--ELSVSDNQL 193
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSL 206
++P L +L N + S+ P LK L S N L S+P
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTSL-----PALPSGLKELIVSGNRLT-SLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 27/123 (21%), Positives = 42/123 (34%), Gaps = 17/123 (13%)
Query: 88 NSIGKLDA----LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLN 143
N++ L A L+ L + N L +LP + L + + L
Sbjct: 71 NNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-----GLC 124
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
L + N T ++P L L + + Q S+ P L L NN L S+P
Sbjct: 125 KLWIFGNQLT-SLPVLPPGLQELSVSDNQLASL-----PALPSELCKLWAYNNQLT-SLP 177
Query: 204 DSL 206
Sbjct: 178 MLP 180
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 12/114 (10%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
+ +L++ + L TLP + + + + + +N + + L+ L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTSLPALPPELR--TLEVSGNQL 93
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSL 206
T ++P L L + + + P L L N L S+P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHL-----PALPSGLCKLWIFGNQLT-SLPVLP 140
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 28/175 (16%), Positives = 62/175 (35%), Gaps = 18/175 (10%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDL 147
+L L +N L +LP+ S L+ + + N + LP S +L L +
Sbjct: 198 TLPSEL---YKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LPVLPS-ELKELMV 248
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDS 205
S N T ++P L L ++ N ++ +P ++L +N N L+ +
Sbjct: 249 SGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303
Query: 206 LQTFPNSSFVGNSML--CGLPLTPCSTVSSSPSPSPSYFPTISPHKNASRKKLNS 258
L+ ++ ++ + + + + + A + +
Sbjct: 304 LREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHM 358
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 11/116 (9%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
+L+ + +N L ++ ++ L +Y NN + SL+ L++ N
Sbjct: 214 PLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEA--LNVRDNYL 269
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQT 208
T ++P Q+LT L + + + P L LN S+N + S+ D +
Sbjct: 270 T-DLPELPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIR-SLCDLPPS 318
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 31/120 (25%), Positives = 51/120 (42%), Gaps = 13/120 (10%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDL 147
+ L L + +N L TLP SL+ + +++NY + + +SL LD+
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLT--FLDV 284
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQ 207
S N F+ + NL L+ + + S+ P L+ LN SNN L +P
Sbjct: 285 SENIFS-GLSELPPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLI-ELPALPP 337
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 26/148 (17%), Positives = 43/148 (29%), Gaps = 34/148 (22%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITS-------------ISSLQYVYLQNNYFSGVLP 135
+ + + P + L N S +
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88
Query: 136 AFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL------------ 183
L+ +L S N+ T +P Q+L L + N ++S P L
Sbjct: 89 LPPHLE--SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK 145
Query: 184 -----NLPRLKILNFSNNNLNGSIPDSL 206
N LKI++ NN+L +PD
Sbjct: 146 LPELQNSSFLKIIDVDNNSLK-KLPDLP 172
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 11/125 (8%)
Query: 88 NSIGKL-DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALD 146
++ L L+ L + +N L LP ++ + S L+ + + NN + SL+ +
Sbjct: 124 KALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLE--FIA 179
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSL 206
N P QNL L + NNS+ +P L L+ + NN L L
Sbjct: 180 AGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDL-PLSLESIVAGNNIL--EELPEL 233
Query: 207 QTFPN 211
Q P
Sbjct: 234 QNLPF 238
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 17/107 (15%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
LK L + N L P S+ L+ N++ + V ++L+ L + N
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDLR----MNSHLAEVPELPQNLK--QLHVETNPL 408
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
P +++ L + + + +L+ F +++ +
Sbjct: 409 R-EFPDIPESVEDLRMNSERVVDPY-EFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 22/130 (16%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
L L+ SN + +L SL+ + + NN + L+ L SFN
Sbjct: 296 PPNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIELPALPPRLE--RLIASFNHL 349
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIP--------------PLNLPRLKILNFSNNNL 198
+P QNL +LH+ P LK L+ N L
Sbjct: 350 A-EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408
Query: 199 NGSIPDSLQT 208
PD ++
Sbjct: 409 R-EFPDIPES 417
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 37/295 (12%), Positives = 72/295 (24%), Gaps = 77/295 (26%)
Query: 340 EVLGKGSYGSTYKAILED---GTTVVVKRLREVAAT----KREFEQQMEVVGTIGKHSNV 392
G ++A D V + + +E + + I V
Sbjct: 37 IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGV 93
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V +++ LVV ++ GSL + + ++ A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH 146
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKAS 512
G S V ++ D G L A+
Sbjct: 147 RAG---VALSIDHPSRVRVSID--------GDVVLAYP--------ATMPD-------AN 180
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL-----------PRWVRSVVREEWTAEV 561
+ D+ G L +L + PL +G + P + + + +A
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA-- 238
Query: 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRA 616
+A V R ++ +++Q R
Sbjct: 239 --------------------VAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 45/242 (18%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
+ L+ +LGKG++G K IL G +K L+ EVA T E
Sbjct: 151 EYLK----LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR--- 200
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMK 439
V +H + ++ + + D V Y G LF L R R A + + +
Sbjct: 201 --VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTATR- 496
AL ++HSE + ++K N++L +D + I+D GL + + T T
Sbjct: 259 SALD------YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 497 -TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--------VDLPR 547
T Y APEV E + D + GV++ EM+ G+ P + H+ + + PR
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 370
Query: 548 WV 549
+
Sbjct: 371 TL 372
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 20/214 (9%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK 388
+ D + S +VLG G G + G +K L + ++E + + G
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---- 80
Query: 389 HSNVVPVRAYY----YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
++V + Y + K L++ M G LF + T + M+
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT- 139
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATR--TIG 499
I F+HS A H ++K N+L T +D ++D G A T T
Sbjct: 140 --AIQFLHSHNIA---HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY 194
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
Y APEV K + D++S GV++ +L G P
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 47/244 (19%), Positives = 87/244 (35%), Gaps = 64/244 (26%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-REFE--QQMEVVGTIGKHSNVVPV 395
+ LG GS+G + +E G +K++ + K RE + + + H N++ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL-------DHVNIIKL 65
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTA------------------------ 431
Y+Y+ ++ P + N +
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 432 --LDWNSRMKIALG----------TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC- 478
L R ++ R + FIHS H +IK N+L+ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV--NSKDNT 180
Query: 479 --ISDVGLAHLI--NFPTT---ATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTG 530
+ D G A + + P+ +R YRAPE+ + + D++S G + E++ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 531 KAPL 534
K PL
Sbjct: 239 K-PL 241
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 8/111 (7%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLS 148
+ L+ L L L+ N + T + + +++ + + L N + A L + LDL+
Sbjct: 59 VQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLT 115
Query: 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
T ++ P L+ L +L L N I+ I PL L L+ L+ N +
Sbjct: 116 STQIT-DVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 35/145 (24%), Positives = 61/145 (42%), Gaps = 16/145 (11%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLN 143
+ L L++L L N + ++I+ ++ +LQY+ + N S L +L +L
Sbjct: 123 TPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLT 176
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSI 202
L N + +I P +L L ++L+NN IS + PL N L I+ +N +
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTITNQP 233
Query: 203 PDSLQTFPNSSFVGNSMLCGLPLTP 227
+ V G P+ P
Sbjct: 234 VFYNNNLVVPNVVKGPS--GAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 30/115 (26%), Positives = 54/115 (46%), Gaps = 12/115 (10%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLN 143
++I L ++K L L S + +D+T ++ +LQ +YL N + + L L
Sbjct: 101 SAIAGLQSIKTLDLTSTQI-----TDVTPLAGLSNLQVLYLDLNQIT-NISPLAGLTNLQ 154
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
L + + ++ P NL++L L +N IS P +LP L ++ NN +
Sbjct: 155 YLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 25/121 (20%), Positives = 47/121 (38%), Gaps = 13/121 (10%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNA 144
+ L L+ LS+ + + SD+T ++ L + +N S + SL L
Sbjct: 146 PLAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIE 199
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204
+ L N + ++ P N + L ++ L N +I+ P L + N I
Sbjct: 200 VHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITN-QPVFYNNNLVVPNVVKGPSGAPIAP 256
Query: 205 S 205
+
Sbjct: 257 A 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 10/96 (10%)
Query: 111 PSDITSIS------SLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLT 164
P+ I I + + + + + + L T I G Q L
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLN 63
Query: 165 RLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLN 199
L L L++N I+ + PL NL ++ L S N L
Sbjct: 64 NLIGLELKDNQITD-LAPLKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 24/123 (19%), Positives = 47/123 (38%), Gaps = 13/123 (10%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSLQLNAL 145
+ L L L N + SDI+ ++ +L V+L+NN S V P + L +
Sbjct: 168 PLANLSKLTTLKADDNKI-----SDISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIV 222
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDS 205
L+ T NL +++ + + I P + +++ NL ++
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAP---IAPATISDN--GTYASPNLTWNLTSF 277
Query: 206 LQT 208
+
Sbjct: 278 INN 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR--------------EVAATKREFEQQMEVVG 384
LG G+YG + +K ++ + E ++ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIAL 442
++ H N++ + + K +V + G LF +++R++ + A + MK L
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----NIMKQIL 156
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLI---NFPTTATR 496
GI ++H H +IK N+LL LN I D GL+
Sbjct: 157 S---GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
T Y APEV + +K ++K DV+S GV++ +L G P
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 28/138 (20%), Positives = 53/138 (38%), Gaps = 24/138 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
IP L L +N + I + L+ + NN + + AF
Sbjct: 30 IPQY-------TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
+N + L+ N N+ F+ L L L L++N I+ + + L +++L+ +N
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 198 LNGSIPD-------SLQT 208
+ ++ SL T
Sbjct: 141 IT-TVAPGAFDTLHSLST 157
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 29/121 (23%), Positives = 48/121 (39%), Gaps = 13/121 (10%)
Query: 85 IPANSI-GKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL 140
+ A I KL L+ ++ +N + + S + + L +N + F+ L
Sbjct: 47 LEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGL 104
Query: 141 -QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSN 195
L L L N T + F L+ + LL+L +N I+ + P L L LN
Sbjct: 105 ESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162
Query: 196 N 196
N
Sbjct: 163 N 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 18/76 (23%), Positives = 29/76 (38%), Gaps = 13/76 (17%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
L L+ N FT G F+ L +L +N NN I+ I + + ++N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR--- 92
Query: 201 SIPDSLQTFPNSSFVG 216
L+ + F G
Sbjct: 93 -----LENVQHKMFKG 103
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 18/126 (14%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-Q 141
+P + K L L N L S LQ + L + A++SL
Sbjct: 26 LPFS-------TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
L+ L L+ N ++ G F L+ L L +++ ++ +L LK LN ++N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 198 LNGSIP 203
+ S
Sbjct: 136 IQ-SFK 140
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 37/169 (21%), Positives = 61/169 (36%), Gaps = 30/169 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSL-Q 141
I + L L L L N + +L + +SSLQ + + + L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKI----LNF 193
L L+++ N P F NLT L L+L +N I +I L ++ + L+
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184
Query: 194 SNNNLNGSIPD----------------SLQTFPNSSFVGNSMLCGLPLT 226
S N +N I L++ P+ F + L + L
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 9/90 (10%)
Query: 92 KLDALKILSLRSNYLNGTLPSDI-TSISSLQYV----YLQNNYFSGVLP-AFRSLQLNAL 145
L L+ L L SN + ++ + + + L N + + P AF+ ++L L
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKEL 205
Query: 146 DLSFNAFTGNIPPG-FQNLTRLHLLNLQNN 174
L N ++P G F LT L + L N
Sbjct: 206 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 22/88 (25%), Positives = 32/88 (36%), Gaps = 14/88 (15%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
LDLSFN ++ F + L +L+L I I +L L L + N
Sbjct: 33 LDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP--- 87
Query: 201 SIPDSLQTFPNSSFVGNSMLCGLPLTPC 228
+Q+ +F G S L L
Sbjct: 88 -----IQSLALGAFSGLSSLQKLVAVET 110
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 24/140 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-Q 141
+P N L L + L+ + + N V+ F +L +
Sbjct: 28 LPRN-------AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 142 LNALDLS-FNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
L+ + + N I P FQNL L L + N I +P + + + +L+ +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 197 NLNGSIPDSLQTFPNSSFVG 216
++ T +SFVG
Sbjct: 139 I-------NIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 29/166 (17%), Positives = 51/166 (30%), Gaps = 30/166 (18%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
I + L L+ L + + + LP + +Q+N + +F L
Sbjct: 95 INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 141 -QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSN 195
+ L L+ N I F L NN++ +P IL+ S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 196 NNLNGSIPD---------------SLQTFPNSSFVGNSMLCGLPLT 226
++ S+P +L+ P + L LT
Sbjct: 212 TRIH-SLPSYGLENLKKLRARSTYNLKKLP--TLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 11/118 (9%)
Query: 85 IPANSIGKLDA-LKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP-AFRSLQ 141
I NS L IL L N + + + + NN + F
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 142 -LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNN 196
LD+S ++P +NL +L + N +P L L L + +
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 18/125 (14%), Positives = 34/125 (27%), Gaps = 27/125 (21%)
Query: 119 SLQYVYLQNNYFSGVLPA--FRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNS 175
S + Q + + + P+ R+ L I G F L + + N
Sbjct: 10 SNRVFLCQESKVTEI-PSDLPRNAIE--LRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65
Query: 176 ISGAIPP---LNLPRLKILNFSNNNLNGSIPDS-----------------LQTFPNSSFV 215
+ I NLP+L + N I ++ P+ +
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 216 GNSML 220
+
Sbjct: 126 HSLQK 130
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 59/249 (23%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
+ L VLGKGS+G K +L VK L+ +V T E
Sbjct: 344 NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----K 392
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
V+ GK + + + + + D V Y+ G L + + +
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-------------RF 439
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINF 490
A G+ F+ S+G + ++K NV+L + + I+D G+ ++ +
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 491 PTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------ 542
TT T T Y APE+ + + D ++FGVLL EML G+AP + D++
Sbjct: 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
Query: 543 --VDLPRWV 549
V P+ +
Sbjct: 557 HNVAYPKSM 565
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 16/126 (12%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSL-QL 142
+P + + L N + P + L+ + L NN S + P AF+ L L
Sbjct: 30 LPET-------ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 143 NALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNL 198
N+L L N T +P F+ L L LL L N I+ + +L L +L+ +N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
Query: 199 NGSIPD 204
+I
Sbjct: 141 Q-TIAK 145
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 30/120 (25%), Positives = 51/120 (42%), Gaps = 12/120 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL- 140
IP + L+ + L +N ++ L D + SL + L N + LP F L
Sbjct: 47 IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLF 104
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
L L L+ N + FQ+L L+LL+L +N + I L ++ ++ + N
Sbjct: 105 SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 21/66 (31%), Positives = 28/66 (42%), Gaps = 7/66 (10%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
+ L N IPPG F +L ++L NN IS + P L L L N +
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 201 SIPDSL 206
+P SL
Sbjct: 94 ELPKSL 99
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 60/230 (26%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAA--TKREFE--QQMEVVGTIGKHSNVVP 394
LG+G Y ++AI + + VVVK L+ V KRE + + + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR------GGPNIIT 95
Query: 395 ---VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA------ 445
+ S+ LV D+ + L
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNT------------------DFKQLYQ-TLTDYDIRFYM 136
Query: 446 ----RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLA---HLINFPTT-- 493
+ + + HS G H ++K NV++ D + D GLA H
Sbjct: 137 YEILKALDYCHSMG---IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 494 ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV 542
A+R ++ PE+ + + D++S G +L M+ K P H GHD+
Sbjct: 192 ASRY--FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNY 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 59/249 (23%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
+ +R VLGKGS+G K +L E G VK L+ +V T E
Sbjct: 26 EFIR----VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----K 74
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
++ H + + + + D V ++ G L + ++R +
Sbjct: 75 RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-------------RF 121
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINF 490
AR + F+H +G + ++K NVLL + + ++D G+ + N
Sbjct: 122 DEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178
Query: 491 PTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------ 542
TTAT T Y APE+ + D ++ GVLL EML G AP + DD+
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
Query: 543 --VDLPRWV 549
V P W+
Sbjct: 239 DEVVYPTWL 247
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 24/217 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E +G GSY + I VK + + +KR+ +++E++ G+H N++ ++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 399 YYSKDEKLVVYSYMPAGSLF--MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
Y VV M G L +L + S+ + + + + ++H++G
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-------AVLFTITKTVEYLHAQG- 136
Query: 457 AKFTHGNIKSSNVLLTQDLNGC----ISDVGLAHLINFPTTATRTI----GYRAPEVTET 508
H ++K SN+L + I D G A + T + APEV E
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
+ D++S GVLL MLTG P + D ++
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 8/106 (7%)
Query: 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ-LNALDLSFNAFTGN 155
++L L L T+ + + + ++ L +N + PA +L+ L L S NA N
Sbjct: 444 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-N 500
Query: 156 IPPGFQNLTRLHLLNLQNNSISG--AIPPL-NLPRLKILNFSNNNL 198
+ G NL RL L L NN + AI PL + PRL +LN N+L
Sbjct: 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 28/136 (20%), Positives = 49/136 (36%), Gaps = 16/136 (11%)
Query: 88 NSIGKLDALKIL--------SLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS 139
++ LK + + + ++ ++L + + VL
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQ 461
Query: 140 L-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNN 197
L + LDLS N +PP L L +L +N++ + + NLPRL+ L NN
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNR 519
Query: 198 LNGSIPD--SLQTFPN 211
L L + P
Sbjct: 520 LQ-QSAAIQPLVSCPR 534
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 25/111 (22%), Positives = 40/111 (36%), Gaps = 11/111 (9%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ-LNALDL 147
+ +L + L L N L LP + ++ L+ + +N + +L L L L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLL 515
Query: 148 SFNAFTGNIP--PGFQNLTRLHLLNLQNNSISGAIPPLN-----LPRLKIL 191
N + RL LLNLQ NS+ LP + +
Sbjct: 516 CNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 23/123 (18%), Positives = 47/123 (38%), Gaps = 4/123 (3%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149
+ L+ L + + T+ + ++ L Y YFS L A ++ LD
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST-LKAVDPMRAAYLDDLR 426
Query: 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQT 208
+ F + +L+L + ++ + L L + L+ S+N L ++P +L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 209 FPN 211
Sbjct: 485 LRC 487
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 49/222 (22%), Positives = 80/222 (36%), Gaps = 34/222 (15%)
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
S+ + + S L + + A+G+ F+ S K
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKC 214
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYR------APEVTETRKASQ 513
H ++ + N+LL++ I D GLA I R R APE R +
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 514 KSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR----EEWTAEVFDVELLK 568
+SDV+SFGVLL E+ + G +P + G + R ++ R + T E++
Sbjct: 275 QSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT---- 328
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610
ML C P RP ++V + + Q
Sbjct: 329 ----------MLD----CWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG+G++G +A TV VK L+E A + R +++++ IG H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 392 VVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNR 425
VV + L V+ + G+L L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 26/207 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK---HSNVVP 394
+LGKGS+G K VK + + +A ++ EV + K H N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV--ELLKKLDHPNIMK 85
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLF--MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ +V G LF ++ + S+ A +K GI ++H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----RIIKQVFS---GITYMH 138
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI---NFPTTATRTIGYRAPEVT 506
H ++K N+LL C I D GL+ T Y APEV
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAP 533
+K DV+S GV+L +L+G P
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 335 LRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRL--REVAATKREFEQQMEVVGTIGKHSN 391
L + LG+GS+ K + + VK + R A T++E + + H N
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPN 67
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAF 450
+V + ++ + +V + G LF R + + + + M+ + ++
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVS---AVSH 121
Query: 451 IHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATRTI----GYRAP 503
+H G H ++K N+L T +L I D G A L +T Y AP
Sbjct: 122 MHDVGVV---HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
E+ + D++S GV+L ML+G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 59/249 (23%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
+ L VLGKGS+G K +L VK L+ +V T E
Sbjct: 23 NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----K 71
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
V+ GK + + + + + D V Y+ G L + + +
Sbjct: 72 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-------------RF 118
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINF 490
A G+ F+ S+G + ++K NV+L + + I+D G+ ++ +
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 491 PTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------ 542
TT T T Y APE+ + + D ++FGVLL EML G+AP + D++
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
Query: 543 --VDLPRWV 549
V P+ +
Sbjct: 236 HNVAYPKSM 244
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 43/232 (18%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQM---EVVG 384
DLLR V+G+GSY K +L + +K ++ E+ + + V
Sbjct: 12 DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
H +V + + + ++ V Y+ G L + R R K+
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-------------KLPEEH 111
Query: 445 AR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPTTA 494
AR + ++H G + ++K NVLL + + ++D G+ L TT+
Sbjct: 112 ARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168
Query: 495 TR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
T T Y APE+ D ++ GVL+ EM+ G++P G D D
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 40/214 (18%)
Query: 341 VLGKGSYGSTYKAILEDGTTV---------VVKRLREVAATKREFEQQMEVVGTIGKHSN 391
+LG+GS+ + A + + + +V RE +V+ + H
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRL-DHPF 91
Query: 392 VVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-----IALGTA 445
V + + + DEKL SY G L + + S D + + I
Sbjct: 92 FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FD-ETCTRFYTAEIVSA-- 142
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR------TIG 499
+ ++H +G H ++K N+LL +D++ I+D G A +++ + R T
Sbjct: 143 --LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
Y +PE+ + A + SD+++ G ++ +++ G P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 35/218 (16%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKRE---FEQQMEVVGTIG--------K 388
+ GSYG+ + +G V +KR+ + R +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 389 HSNVVP----VRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-IAL 442
H N++ + KL +V M L + D + ++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-----LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTT---ATRT 497
G+ +H A H ++ N+LL + + I D LA + T R
Sbjct: 142 HILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 498 IGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ + + ++ D++S G ++ EM K L
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 11/125 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNG--TLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQL 142
A+ D + +L N +L + I+ + L S LP Q+
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDNLPPQI 82
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
L+++ NA ++P +L L + + +++ P LK L+ NN L +
Sbjct: 83 TVLEITQNALI-SLPELPASLEYLDACDNRLSTL-----PELPASLKHLDVDNNQLT-ML 135
Query: 203 PDSLQ 207
P+
Sbjct: 136 PELPA 140
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 14/118 (11%)
Query: 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGN 155
L+ ++ +N L LP +SL+ + ++NN + + SL+ ALD+S N +
Sbjct: 142 LEYINADNNQLT-MLPE---LPTSLEVLSVRNNQLTFLPELPESLE--ALDVSTNLLE-S 194
Query: 156 IPPGFQNLTRL----HLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDSLQ 207
+P + N I+ IP L+L + +N L+ I +SL
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 17/102 (16%), Positives = 31/102 (30%), Gaps = 6/102 (5%)
Query: 85 IPANSIGKLDALK----ILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
+PA + + R N + +P +I S+ + L++N S + S
Sbjct: 195 LPA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP 182
Q D ++ G QN L +
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 36/230 (15%)
Query: 333 DLLRASAEVLGKGSYGSTYKAILEDGTTV---------VVKRLREVAATKREFEQQMEVV 383
++LR +GKGS+G D + EV +E Q M+ +
Sbjct: 18 EILR----AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE-LQIMQGL 72
Query: 384 GTIGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIA 441
+H +V + Y + +E + +V + G L L +N T + + +A
Sbjct: 73 ----EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 442 LGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TI 498
L ++ ++ H ++K N+LL + + I+D +A ++ T T T
Sbjct: 128 LD------YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK 178
Query: 499 GYRAPEVTETRKASQ--KS-DVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545
Y APE+ +RK + + D +S GV E+L G+ P ++
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 44/220 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----------RLREVAATKREFEQQMEVVGTIG 387
+LGKG +G+ + L D V +K L + E + VG G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV-ALLWKVGAGG 95
Query: 388 KHSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR 446
H V+ + ++ +++ ++V +PA LF + + +R
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-----------PLGEGP--SR 142
Query: 447 --------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLI---NFPTTA 494
I HS G H +IK N+L+ + D G L+ +
Sbjct: 143 CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD 199
Query: 495 TRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
T Y PE + + + V+S G+LL +M+ G P
Sbjct: 200 G-TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 51/236 (21%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
DLLR V+G+GSY K +L + ++ ++ ++ + E
Sbjct: 55 DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE----K 103
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
V H +V + + + ++ V Y+ G L + R R K+
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-------------KL 150
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINF 490
AR + ++H G + ++K NVLL + + ++D G+ L
Sbjct: 151 PEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207
Query: 491 PTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD 544
TT+T T Y APE+ D ++ GVL+ EM+ G++P G D D
Sbjct: 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 16/127 (12%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNAL 145
I L + L L N L +DI ++ +L +++L N L + + L +L +L
Sbjct: 61 IQYLPNVTKLFLNGNKL-----TDIKPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSL 114
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPD 204
L N + +I +L +L L L NN I+ I L L +L L+ +N ++ I
Sbjct: 115 SLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIV- 169
Query: 205 SLQTFPN 211
L
Sbjct: 170 PLAGLTK 176
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 14/114 (12%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNAL 145
+ L L L L N + D++S+ L+ + L++N S + L QL +L
Sbjct: 83 LTNLKNLGWLFLDENKI-----KDLSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESL 136
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
L N T +I LT+L L+L++N IS I PL L +L+ L S N++
Sbjct: 137 YLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 26/134 (19%), Positives = 45/134 (33%), Gaps = 10/134 (7%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNA 144
+ +L L LSL N + SDI ++ LQ +YL N+ S L A L L+
Sbjct: 148 VLSRLTKLDTLSLEDNQI-----SDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDV 201
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204
L+L NL + + + S+ + + N + +
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
Query: 205 SLQTFPNSSFVGNS 218
S + +
Sbjct: 262 SFIFYQPVTIGKAK 275
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 9e-08
Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 7/103 (6%)
Query: 101 LRSNYLNGTLPSDITSISSL---QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIP 157
+ T I + L+ + + ++ + + + ++
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQ 59
Query: 158 PGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLN 199
G Q L + L L N ++ I PL NL L L N +
Sbjct: 60 -GIQYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIK 100
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 42/245 (17%), Positives = 70/245 (28%), Gaps = 52/245 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKRE-FEQQMEVVGTIGKHSNV 392
+G+GSYG AI + +K ++R++ E + ++ ++ + H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNI 90
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLF--------MLLHRNRSDGGTALDWNSRMKIALGT 444
+ Y + +V G L + D
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 445 ARGIAFIHSEGGAKFT------------------------HGNIKSSNVLLTQDLNGC-- 478
I H +IK N L + + +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 479 ISDVGLAHLINFPTTATR--------TIGYRAPEV--TETRKASQKSDVYSFGVLLLEML 528
+ D GL+ T + APEV T K D +S GVLL +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 529 TGKAP 533
G P
Sbjct: 271 MGAVP 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 40/204 (19%), Positives = 88/204 (43%), Gaps = 21/204 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE-FEQQMEVVGTIGKHSNVVPVRA 397
E LG G++G ++ G K + + +E ++++ + + +H +V +
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 221
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFIHSEG 455
+ +E +++Y +M G LF + + + + M+ G+ +H
Sbjct: 222 AFEDDNEMVMIYEFMSGGELF---EKVADEHNKMSEDEAVEYMRQVCK---GLCHMHENN 275
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTI----GYRAPEVTETR 509
+ H ++K N++ T + + D GL ++ P + + + APEV E +
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGK 331
Query: 510 KASQKSDVYSFGVLLLEMLTGKAP 533
+D++S GVL +L+G +P
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 29/146 (19%), Positives = 50/146 (34%), Gaps = 10/146 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA 144
I + L L N + L D++ L + N + L +++QL
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-EL--DVSQNKLLNRLNCDTNNITK-LDLNQNIQLTF 216
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204
LD S N T I LT+L + N ++ + L +L L+ +L I
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL-EIDL 271
Query: 205 S-LQTFPNSSFVGNSMLCGLPLTPCS 229
+ G + L +T +
Sbjct: 272 THNTQLIYFQAEGCRKIKELDVTHNT 297
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 7/115 (6%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA 144
S +L L L ++ + + I ++ L + +N + L ++ L
Sbjct: 33 TDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT-LDLSQNTNLTY 89
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
L N T N+ LT+L LN N ++ + P L LN + N L
Sbjct: 90 LACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148
+ + L L+ N L + D++ + L + N L QL LD S
Sbjct: 122 DVSQNPLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178
Query: 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
FN T + L+ LN N+I+ + +L L+ S+N L I
Sbjct: 179 FNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLT-EID 228
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 24/110 (21%), Positives = 43/110 (39%), Gaps = 7/110 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148
+ + L L+ SN L L +T ++ L Y+ N + L ++ L L+ +
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LDVSQNPLLTYLNCA 135
Query: 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
N T I + T+L L+ N + +L L+ S N +
Sbjct: 136 RNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 23/124 (18%), Positives = 45/124 (36%), Gaps = 9/124 (7%)
Query: 88 NSIGKLDALKILSLRSNYLNG---TLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA 144
N++ ++D L + D+T + L + N + L ++ LN
Sbjct: 137 NTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LDVSQNKLLNR 195
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204
L+ N T + +L L+ +N ++ I L +L + S N L +
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPLT-ELDV 250
Query: 205 SLQT 208
S +
Sbjct: 251 STLS 254
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 22/137 (16%), Positives = 44/137 (32%), Gaps = 9/137 (6%)
Query: 88 NSIGKLDALKILSLRSNYLNG---TLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA 144
+ ++D L G D+T + L + Q + L ++ +L
Sbjct: 264 TDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE-LDLSQNPKLVY 322
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIP 203
L L+ T + + T+L L+ N I + +P L +
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPK 378
Query: 204 DSLQTFPNSSFVGNSML 220
++L + V +L
Sbjct: 379 ETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 18/110 (16%), Positives = 35/110 (31%), Gaps = 7/110 (6%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148
+ + L L SN L + D+T ++ L Y N + L +L L
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCI 262
Query: 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
I + T+L + + + +L +L+ +
Sbjct: 263 QTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 18/128 (14%), Positives = 39/128 (30%), Gaps = 7/128 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNA 144
I + L +L ++ + L D++ L Y+YL N + L + +L +
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT-ELDVSHNTKLKS 343
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204
L + + L+ +P L + + +L +
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGN 400
Query: 205 SLQTFPNS 212
+ P
Sbjct: 401 PMNIEPGD 408
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 23/150 (15%), Positives = 46/150 (30%), Gaps = 22/150 (14%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDL 147
+ + L L L + L L D++ + L+ + N + + + LN
Sbjct: 313 DLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFE 368
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQ 207
+ + L NNS++ A+ P +L+ N +N D
Sbjct: 369 AEG-----------QTITMPKETLTNNSLTIAVSP------DLLDQFGNPMNIEPGDGGV 411
Query: 208 TFPNSSFVGNSMLCGLPLTPCSTVSSSPSP 237
++ + L T +S
Sbjct: 412 YDQATNTITWENLSTDNPAVTYTFTSENGA 441
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 30/160 (18%)
Query: 55 VCSSWIGVTCNVNRSRVIGIHLPGIGFT---GPIPANSIGKLDALKILSLRSNYLNGTLP 111
VC +CN N++ V T IPA+ K L L+SN L+
Sbjct: 11 VC------SCNNNKNSV---DCSSKKLTAIPSNIPAD-------TKKLDLQSNKLSSLPS 54
Query: 112 SDITSISSLQYVYLQNNYFSGVLPA--FRSL-QLNALDLSFNAFTGNIPPG-FQNLTRLH 167
++ L+ +YL +N LPA F+ L L L ++ N +P G F L L
Sbjct: 55 KAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLA 112
Query: 168 LLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPD 204
L L N + ++PP +L +L L+ N L S+P
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 38/120 (31%), Positives = 51/120 (42%), Gaps = 12/120 (10%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+P +L L L L N L +LP + S++ L Y+ L N LP F L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
L L L N +P G F LT L L L NN + +P +L +LK+L N
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 38/203 (18%), Positives = 85/203 (41%), Gaps = 20/203 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E LG+G +G ++ + T + K ++ + ++++ ++ H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHES 69
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFIHSEGG 456
+ S +E ++++ ++ +F R + + S + + F+HS
Sbjct: 70 FESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCE---ALQFLHSHN- 122
Query: 457 AKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTATRTI----GYRAPEVTETRK 510
H +I+ N++ + I + G A + P R + Y APEV +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 511 ASQKSDVYSFGVLLLEMLTGKAP 533
S +D++S G L+ +L+G P
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINP 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 67/253 (26%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR--------EVAATKREFEQQM 380
L + +LGKGS+G K L + +K L+ +V T E
Sbjct: 20 ILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE----K 68
Query: 381 EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
V+ +H + + + +K+ V Y+ G L + K
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-------------KF 115
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNI----KSSNVLLTQDLNGCISDVGLA--H 486
L A G+ F+HS G + K N+LL +D + I+D G+ +
Sbjct: 116 DLSRATFYAAEIILGLQFLHS-------KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168
Query: 487 LINFPTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-- 542
++ T T T Y APE+ +K + D +SFGVLL EML G++P +++
Sbjct: 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 543 ------VDLPRWV 549
PRW+
Sbjct: 229 SIRMDNPFYPRWL 241
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 14/114 (12%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNAL 145
I L + L L N L +DI ++ +L +++L N L + + L +L +L
Sbjct: 64 IQYLPNVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSL 117
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
L N + +I +L +L L L NN I+ I L L +L L+ +N +
Sbjct: 118 SLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 35/115 (30%), Positives = 50/115 (43%), Gaps = 14/115 (12%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNA 144
S+ L LK LSL N + SDI + L+ +YL NN + + L +L+
Sbjct: 107 SLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDT 160
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
L L N + +I P LT+L L L N IS + L L L +L +
Sbjct: 161 LSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 14/119 (11%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLN 143
N + L L+ L L +N + +DIT +S L + L++N S + L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQ 181
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
L LS N + ++ L L +L L + P + L + N + N +GS+
Sbjct: 182 NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLN-KPINHQSNLVVPN-TVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 12/98 (12%)
Query: 109 TLPSDITSIS------SLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQ 161
T+P+ I I L+ + + L ++ + + + ++ G Q
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIK-SVQ-GIQ 65
Query: 162 NLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
L + L L N ++ I PL NL L L N +
Sbjct: 66 YLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKV 102
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 10/115 (8%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLNA 144
+ +L L LSL N + SDI ++ LQ +YL N+ S L A L L+
Sbjct: 151 VLSRLTKLDTLSLEDNQI-----SDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDV 204
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
L+L NL + + + S+ + + N +
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 34/217 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK----------RLREVAATKREFEQQMEVVGTIGK 388
E+LG+G + I VK EV + ++++++ +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTAR 446
H N++ ++ Y + +V+ M G LF L + S+ T M+ L
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR----KIMRALLE--- 135
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRA 502
I +H H ++K N+LL D+N ++D G + ++ P R + Y A
Sbjct: 136 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLA 191
Query: 503 PEV------TETRKASQKSDVYSFGVLLLEMLTGKAP 533
PE+ ++ D++S GV++ +L G P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL--REVAATKREFEQQMEVVGTIGKHSNVVPVR 396
LG G++G + G V+K + + E ++EV+ ++ H N++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIF 86
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFIHSE 454
+ +V G L + ++ G + MK + +A+ HS+
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHSQ 143
Query: 455 GGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLI---NFPTTATRTIGYRAPEVTET 508
H ++K N+L I D GLA L T A T Y APEV +
Sbjct: 144 H---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAP 533
R + K D++S GV++ +LTG P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 56/225 (24%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQ-------MEVVGTI 386
LG G++G + A+ E VVVK ++ E + + + V
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV--- 86
Query: 387 GKHSNVVPV------RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
+H+N++ V + ++ LV+ + LF +D + R+
Sbjct: 87 -EHANIIKVLDIFENQGFFQ-----LVMEKHGSGLDLF-----------AFIDRHPRLDE 129
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---N 489
L A + ++ + H +IK N+++ +D + D G A +
Sbjct: 130 PL--ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 490 FPTTATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
T TI Y APEV + +++S GV L ++ + P
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 43/216 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-------REFE--QQMEVVGTIGKH 389
+G G+YGS AI G V +K+L ++ RE + M +H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-------QH 82
Query: 390 SNVVPVR-----AYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-IAL 442
NV+ + A +V +M L ++ S+ +++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSE--------EKIQYLVY 133
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---ATRTIG 499
+G+ +IHS A H ++K N+ + +D I D GLA + T TR
Sbjct: 134 QMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPEV +Q D++S G ++ EMLTGK L
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 20/111 (18%), Positives = 33/111 (29%), Gaps = 8/111 (7%)
Query: 118 SSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNS 175
+ + L L L + ++ + L L L + +
Sbjct: 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 176 ISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV--GNSMLC 221
+ + P PRL LN S N L ++Q V GN + C
Sbjct: 68 LR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 9e-10
Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 12/99 (12%)
Query: 109 TLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL-QLNALDLSFNAFTGNIPPG-FQNLT 164
+ +L +Y++N L R L +L L + + + P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 165 RLHLLNLQNNSIS----GAIPPLNLPRLKILNFSNNNLN 199
RL LNL N++ + L+L L + S N L+
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVL---SGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 11/75 (14%), Positives = 20/75 (26%), Gaps = 11/75 (14%)
Query: 155 NIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
+ L L ++N + L L+ L + L+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG--------LRFVAP 73
Query: 212 SSFVGNSMLCGLPLT 226
+F L L L+
Sbjct: 74 DAFHFTPRLSRLNLS 88
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 28/129 (21%), Positives = 47/129 (36%), Gaps = 11/129 (8%)
Query: 88 NSIGKLDALKILS-LRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QL 142
I ++ L+ L +D+ S +Q N+ L + L
Sbjct: 7 TPINQVFPDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNL 65
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
L LS N + ++ P ++LT+L L++ N + + + L L NN L
Sbjct: 66 KELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNEL--RD 120
Query: 203 PDSLQTFPN 211
DSL N
Sbjct: 121 TDSLIHLKN 129
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 25/119 (21%), Positives = 46/119 (38%), Gaps = 9/119 (7%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSL-QLN 143
N + L+ + L +L+ D S+ +L+ + ++NN + L +L
Sbjct: 95 NRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLE 153
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
LDL N T N L +++ ++L P P L I N + + +G
Sbjct: 154 VLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCV-NEPVKYQPELYITN-TVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 23/112 (20%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSIS--SLQYVYLQNNYFSGVLPAFRSL-QLNALD 146
+ L L+ LS+ N L ++ I L ++L NN + L L L
Sbjct: 81 LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILS 134
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
+ N +I L++L +L+L N I+ L ++ ++ +
Sbjct: 135 IRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 19/114 (16%), Positives = 34/114 (29%), Gaps = 8/114 (7%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS---SLQYVYLQNNYFSGVLPAFRSLQLNAL 145
S+ L L+ILS+R+N L I + L+ + L N + R ++N +
Sbjct: 123 SLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWI 177
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
DL+ L + + + N
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 44/217 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-------REFE--QQMEVVGTIGKH 389
+ +G G+ G A V +K+L + RE + + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NH 120
Query: 390 SNVVPVR-----AYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL- 442
N++ + + + + +V M A +L ++ RM L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH--------ERMSYLLY 171
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTT---ATRT 497
GI +HS A H ++K SN+++ D I D GLA +F T TR
Sbjct: 172 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPEV + D++S G ++ EM+ K L
Sbjct: 229 --YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-IL 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 60/249 (24%), Positives = 96/249 (38%), Gaps = 60/249 (24%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATKREFEQQMEVVGTIG- 387
D L+ +LGKG++G K IL G +K LR K + EV T+
Sbjct: 8 DYLK----LLGKGTFG---KVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTE 55
Query: 388 -------KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKI 440
+H + ++ + + D V Y G LF L R R
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-------------VF 102
Query: 441 ALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINF 490
AR + ++HS + +IK N++L +D + I+D GL + +
Sbjct: 103 TEERARFYGAEIVSALEYLHSRDVV---YRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 491 PTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------ 542
T T T Y APEV E + D + GV++ EM+ G+ P + H+ +
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 543 --VDLPRWV 549
+ PR +
Sbjct: 220 EEIRFPRTL 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 41/208 (19%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVVGTIGKHSNVV 393
E LG G++G ++ + G V K + K E + ++ + H ++
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE----ISIMNQL-HHPKLI 111
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFI 451
+ + K E +++ ++ G LF R ++ + + + M+ A G+ +
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACE---GLKHM 165
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTI----GYRAPEV 505
H H +IK N++ + D GLA +N P + + APE+
Sbjct: 166 HEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEI 221
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ +D+++ GVL +L+G +P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR-------------LREVAATKREFEQQMEVVGT 385
E LG G+Y + YK + G V +K +RE++ K
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE----------- 59
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLL-HRNRSDGGTALDWNSRMKIALGT 444
KH N+V + +++++ +V+ +M L + R + L+ N
Sbjct: 60 -LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPT-TATR---TI 498
+G+AF H H ++K N+L+ + G + D GLA P T + T+
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 499 GYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
YRAP+V +R S D++S G +L EM+TGK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 47/234 (20%), Positives = 78/234 (33%), Gaps = 57/234 (24%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVVGTIG-------- 387
+GKGSYG A D T +K +L A R + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 388 -------------KHSNVV--------PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS 426
H NVV P + Y +V+ + G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY------MVFELVNQGPVMEVPTLKPL 134
Query: 427 DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486
A + + I GI ++H + H +IK SN+L+ +D + I+D G+++
Sbjct: 135 SEDQARFY-FQDLIK-----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 487 LINFPTTATRTI----GYRAPEVTETRKAS---QKSDVYSFGVLLLEMLTGKAP 533
+ APE + + DV++ GV L + G+ P
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFE-QQMEVVGTIG-----KHSNVVPV 395
+G+G+YG YKA +DG ++ A + E M I KH NV+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDD-----KDYALKQIEGTGISMSACREIALLRELKHPNVISL 83
Query: 396 RAYYYSKDEKLV--VYSYMP---AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + S ++ V ++ Y + + L + GI +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLN--GC--ISDVGLAHLINFP----TTATR---TIG 499
+H+ H ++K +N+L+ + G I+D+G A L N P T
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ R ++ D+++ G + E+LT + P+
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/217 (23%), Positives = 80/217 (36%), Gaps = 44/217 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK-------REFE--QQMEVVGTIGKH 389
+ +G G+ G A V +K+L + RE + + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NH 83
Query: 390 SNVVPVRAYYYSKDEKL------VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL- 442
N++ + + + +V M A +L ++ RM L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDH--------ERMSYLLY 134
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTT---ATRT 497
GI +HS A H ++K SN+++ D I D GLA +F T TR
Sbjct: 135 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 498 IGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPEV + D++S G ++ EM+ G L
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 43/217 (19%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKR--------------LREVAATKREFEQQMEVVGT 385
E +G+G+YG YKA G V +KR +RE++ K
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE----------- 75
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
H N+V + +S+ +V+ +M L + + T L +
Sbjct: 76 -LHHPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTIG 499
RG+A H H ++K N+L+ D G ++D GLA P T T+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
YRAP+V ++K S D++S G + EM+TGK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 43/211 (20%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-------RLREVAATKREFEQQMEVVGTIGKHSN 391
E LG G + K G K R ++ E E+++ ++ + H N
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHN 76
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAF 450
V+ + Y ++ + +++ + G LF + + S +K L G+ +
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 451 IHSEGGAKFTHGNIKSSNVLL-TQDLNGC---ISDVGLAHLINFPTTATRTI----GYRA 502
+H++ H ++K N++L +++ + D GLAH I + I + A
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVA 186
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PE+ ++D++S GV+ +L+G +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 47/222 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK---------RLREVAATKREFEQQMEVVGTIGKH 389
+ LG G+ G A + V ++ A E ++E++ + H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NH 199
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDW-NSRMKIALGTAR-- 446
++ ++ ++ ++D +V+ M G LF D ++ T +
Sbjct: 200 PCIIKIKNFFDAEDYYIVL-ELMEGGELF--------------DKVVGNKRLKEATCKLY 244
Query: 447 ------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI---NFPTTA 494
+ ++H G H ++K NVLL+ C I+D G + ++ + T
Sbjct: 245 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 495 TRTIGYRAPEV---TETRKASQKSDVYSFGVLLLEMLTGKAP 533
T Y APEV T ++ D +S GV+L L+G P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 42/211 (19%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-------RLREVAATKREFEQQMEVVGTIGKHSN 391
E LG G + K G K ++ E E+++ ++ I +H N
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPN 69
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAF 450
++ + + +K + +++ + G LF T + +K L G+ +
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILD---GVHY 123
Query: 451 IHSEGGAKFTHGNIKSSNVLL-TQDLNGC---ISDVGLAHLINFPTTATRTI----GYRA 502
+HS+ H ++K N++L +++ + D G+AH I + I + A
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPEFVA 179
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PE+ ++D++S GV+ +L+G +P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 33/211 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG----------K 388
++G+GSYG K + G V +K+ E ++V I +
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--------SDDDKMVKKIAMREIKLLKQLR 82
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H N+V + K +V+ ++ + + LD+ K GI
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPE 504
F HS H +IK N+L++Q + D G A + P T YRAPE
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 505 V-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+ K + DV++ G L+ EM G+ PL
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE-PL 224
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 59/256 (23%), Positives = 98/256 (38%), Gaps = 70/256 (27%)
Query: 333 DLLRASAEVLGKGSYGSTY--KAILEDGT-----------TVVVKRLREVAATKRE---F 376
+LLR VLGKG YG + + + T ++V+ ++ A TK E
Sbjct: 20 ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 377 EQQMEVVGTIGKHSNVVPVRAYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALD 433
E+ KH +V + Y+ KL ++ Y+ G LFM L R
Sbjct: 76 EE--------VKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLEREG-------- 116
Query: 434 WNSRMKIALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485
TA + +H +G + ++K N++L + ++D GL
Sbjct: 117 -----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168
Query: 486 --HLINFPTTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541
+ + T T TI Y APE+ ++ D +S G L+ +MLTG P
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
Query: 542 V--------VDLPRWV 549
++LP ++
Sbjct: 229 TIDKILKCKLNLPPYL 244
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 53/247 (21%), Positives = 103/247 (41%), Gaps = 54/247 (21%)
Query: 333 DLLRASAEVLGKGSYG----STYKAILEDGTTVVVKRLR-EVAATKREFEQQME--VVGT 385
+LL+ VLG+GS+G + + +K L+ + +ME ++
Sbjct: 27 ELLK----VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 386 IGKHSNVVPVRAYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
+ H +V + +Y+ + KL ++ ++ G LF L +
Sbjct: 83 V-NHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-------------MFTE 125
Query: 443 GTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFPT 492
+ + +HS G + ++K N+LL ++ + ++D GL+ + +
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 493 TATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-------- 542
+ T+ Y APEV R +Q +D +SFGVL+ EMLTG P Q +
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
Query: 543 VDLPRWV 549
+ +P+++
Sbjct: 243 LGMPQFL 249
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 56 CSSWIGVTCNVNRSRVIGIHLPGIGFTG-P--IPANSIGKLDALKILSLRSNYLNGTLPS 112
C + G TCN + V G P IPA++ + L L+S L +
Sbjct: 4 CETVTGCTCNEGKKEV---DCQGKSLDSVPSGIPADT-------EKLDLQSTGLATLSDA 53
Query: 113 DITSISSLQYVYLQNNYFSGVLPA--FRSL-QLNALDLSFNAFTGNIPPG-FQNLTRLHL 168
++ L ++ L N L A F L +L L L+ N ++P G F +LT+L
Sbjct: 54 TFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDK 111
Query: 169 LNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPD 204
L L N + ++P L +LK L + N L SIP
Sbjct: 112 LYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLP--AFRSL- 140
+ A L L L L +N L +LP + ++ L +YL N LP F L
Sbjct: 74 LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLT 131
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
+L L L+ N +IP G F LT L L+L N + ++P L +L+ + N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
Query: 197 NLNGSIPDSL 206
+ S + L
Sbjct: 190 QFDCSRCEIL 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 42/211 (19%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-------RLREVAATKREFEQQMEVVGTIGKHSN 391
E LG G + K G K R + E E+++ ++ + H N
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPN 76
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAF 450
++ + Y ++ + +++ + G LF + + S +K L G+ +
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 451 IHSEGGAKFTHGNIKSSNVLL-TQDLNGC---ISDVGLAHLINFPTTATRTI----GYRA 502
+H++ H ++K N++L +++ + D GLAH I + I + A
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVA 186
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PE+ ++D++S GV+ +L+G +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 21/205 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+VLG G G + +K L++ +RE +E+ + ++V +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDV 123
Query: 399 Y----YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
Y + L+V + G LF + T + + MK I ++HS
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSI 180
Query: 455 GGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLI---NFPTTATRTIGYRAPEVTET 508
A H ++K N+L T + ++D G A N TT T Y APEV
Sbjct: 181 NIA---HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 237
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAP 533
K + D++S GV++ +L G P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 42/215 (19%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRL---REVAATKREFEQQMEVVGT 385
+ + +++ LG+G + + I G K L R + E ++ V+
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
V+ + Y + E +++ Y G +F L ++ + D +K L
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-- 142
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLINFPTTATRTI---- 498
G+ ++H H ++K N+LL+ I D G++ I R I
Sbjct: 143 -GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTP 197
Query: 499 GYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
Y APE+ + +D+++ G++ +LT +P
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 48/271 (17%), Positives = 88/271 (32%), Gaps = 86/271 (31%)
Query: 413 PAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471
G L + ++ G L KI +G+ ++H++ + H +IK N+LL
Sbjct: 126 VLGHHLLKWIIKSNYQG---LPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILL 180
Query: 472 T-------------------------------------------------QDLNGCISDV 482
+ + L I+D+
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240
Query: 483 GLAHLIN-FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ-HSGHD 540
G A ++ T +T YR+ EV + +D++S + E+ TG + HSG +
Sbjct: 241 GNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
Query: 541 DVVD-------------LPR--WVRSVVREE--------------WTAEVFDVELLKYQD 571
D +PR V +E +F+V + KY+
Sbjct: 301 YTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+EE L + +P+ R + +R
Sbjct: 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 78/297 (26%)
Query: 270 AVLFLLLALFFLCCLKKLDRQGSGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNF 329
+L +L+ L+ C L R+ K E + + ++ +L D F
Sbjct: 29 TLLDILICLYDECNNSPLRRE-------KNILEYLEWAKPFTSKVKQMRLHRED-----F 76
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATKREFEQQMEVVGT 385
++ L+ V+G+G++G + + +K L K E ++ E
Sbjct: 77 EI---LK----VIGRGAFG---EVAVVKLKNADKVFAMKILN-----KWEMLKRAETACF 121
Query: 386 I--------GKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNS 436
G + + Y + D L +V Y G L LL +
Sbjct: 122 REERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFED---------- 170
Query: 437 RMKIALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG--CISDVGLA- 485
++ AR I +H + H +IK N+L+ D+NG ++D G
Sbjct: 171 --RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM--DMNGHIRLADFGSCL 223
Query: 486 HLINFPTTATR----TIGYRAPEVTETRKASQKS-----DVYSFGVLLLEMLTGKAP 533
L+ T + T Y +PE+ + + + D +S GV + EML G+ P
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLRE------VAATK-REFEQQMEVVGTIGKHSN 391
+G+GSYG +K + G V +K+ E + RE ++ KH N
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-----KHPN 63
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
+V + + K +V+ Y ++ L R + + I T + + F
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFC 118
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT------ATRTIGYRAPEV 505
H H ++K N+L+T+ + D G A L+ P+ ATR YR+PE+
Sbjct: 119 HK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW--YRSPEL 173
Query: 506 -TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
+ DV++ G + E+L+G PL
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV-PL 202
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 91 GKLDALKILSLRSNYLNGTLPSDITSI-----SSLQYVYLQNNYF-SGVLPAFRSL--QL 142
+ L LN +L S S+ + L +N V FR L ++
Sbjct: 397 LMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKV 452
Query: 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNN 197
LDL N +IP +L L LN+ +N + ++P L L+ + +N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 7/123 (5%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFRSLQLN 143
+ I L L++L L N + +L + L+Y+ + +N + L
Sbjct: 67 LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISCCPMASLR 124
Query: 144 ALDLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGS 201
LDLSFN F +P F NLT+L L L + L + L + + ++
Sbjct: 125 HLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYH 182
Query: 202 IPD 204
I
Sbjct: 183 IKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 26/152 (17%), Positives = 57/152 (37%), Gaps = 24/152 (15%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV-LPAFRSLQLN 143
I + L+ N ++ +++ LQ + LQ N A + ++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 144 ALDLSFNAFTGNIPPG-----FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNL 198
+L+ + ++ + +LNL +N ++G++ P++K+L+ NN +
Sbjct: 404 SLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462
Query: 199 NGSIPD----------------SLQTFPNSSF 214
SIP L++ P+ F
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLKSVPDGVF 493
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 28/146 (19%), Positives = 53/146 (36%), Gaps = 9/146 (6%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV 133
+ + S L +L I +++ + + + + + L + +
Sbjct: 286 LTITERIDREE-FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPF 343
Query: 134 LPA--FRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS----GAIPPLNLP 186
+ S L+ + N FT ++ G L RL L LQ N + A+ N+
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403
Query: 187 RLKILNFSNNNLNGSIPDSLQTFPNS 212
L+ L+ S N+LN D + S
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAES 429
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 32/150 (21%), Positives = 50/150 (33%), Gaps = 19/150 (12%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSL-Q 141
+P K LSL N ++ DI+ +S L+ + L +N L F
Sbjct: 50 LPPR-------TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP----LNLPRLKILNFSNNN 197
L LD+S N NI + L L+L N +P NL +L L S
Sbjct: 102 LEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 198 LNGSIPDSLQTFPNSSFVGNSMLCGLPLTP 227
+ S + + + +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGE 187
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 54/286 (18%), Positives = 103/286 (36%), Gaps = 58/286 (20%)
Query: 272 LFLLLALFFLCCLKKLDRQGSGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDL 331
L LLL + +L + K A+ + V ++ +L D F++
Sbjct: 18 LDLLLGVHQELGASELAQD-------KYVADFLQWAEPIVVRLKEVRLQRDD-----FEI 65
Query: 332 EDLLRASAEVLGKGSYGSTYKAILEDGTTVV-VKRLREVAATKREFEQQMEVVGTI---- 386
L+ V+G+G++ ++ V +K + K + ++ EV
Sbjct: 66 ---LK----VIGRGAFSEVAVVKMKQTGQVYAMKIMN-----KWDMLKRGEVSCFREERD 113
Query: 387 ----GKHSNVVPVRAYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK 439
G + + +++ + L +V Y G L LL ++ + +R
Sbjct: 114 VLVNGDRRWITQL---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-ARFY 167
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATR-- 496
+A I +H G + H +IK N+LL + + ++D G L T +
Sbjct: 168 LA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 497 --TIGYRAPEVTETRKASQKSDVY-------SFGVLLLEMLTGKAP 533
T Y +PE+ + + Y + GV EM G+ P
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 57/280 (20%)
Query: 275 LLALFFLCCLKKLDRQGSGVLKGKGTAEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDL 334
L AL + L + K + + + ++ D +++
Sbjct: 29 LDALVYDLDFPALRKN-------KNIDNFLSRYKDTINKIRDLRMKAED-----YEV--- 73
Query: 335 LRASAEVLGKGSYGSTYKAILEDGTTV---------VVKRLREVAATKREFEQQMEVVGT 385
++ V+G+G++G + V + + + A E + +
Sbjct: 74 VK----VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD-----IMA 124
Query: 386 IGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
VV + Y + D L +V YMP G L L+ A + + + +AL
Sbjct: 125 FANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD- 182
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG--CISDVGLA-HLINFPTTATR----T 497
IHS G F H ++K N+LL D +G ++D G + T
Sbjct: 183 -----AIHSMG---FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 498 IGYRAPEVTETRKASQK----SDVYSFGVLLLEMLTGKAP 533
Y +PEV +++ D +S GV L EML G P
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 45/221 (20%)
Query: 340 EVLGKGSYGSTYKA--ILEDGTTVVVKR--------------LREVAATKREFEQQMEVV 383
+G+G+YG +KA + G V +KR +REVA + +E
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR-----HLET- 70
Query: 384 GTIGKHSNVVP----VRAYYYSKDEKLV-VYSYMPAGSLFMLLHRNRSDGGTALDWNSRM 438
+H NVV ++ KL V+ ++ L L + G M
Sbjct: 71 ---FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTTATR 496
L RG+ F+HS H ++K N+L+T +G ++D GLA + +F T
Sbjct: 127 FQLL---RGLDFLHSHR---VVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTS 178
Query: 497 ---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+ YRAPEV + D++S G + EM K PL
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PL 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 4e-10
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 43/217 (19%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKR--------------LREVAATKREFEQQMEVVGT 385
E +G+G+YG YKA G T +K+ +RE++ K
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKE----------- 56
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
KHSN+V + ++K ++V+ ++ L + L+ + L
Sbjct: 57 -LKHSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTIG 499
GIA+ H H ++K N+L+ + G I+D GLA P T T+
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
YRAP+V ++K S D++S G + EM+ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 50/224 (22%), Positives = 81/224 (36%), Gaps = 49/224 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGT------------I 386
+G G+YG+ YKA G V +K +R + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR----VPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFM-----------LLHRNRSDGGTALDWN 435
+H NVV + + + + L + G A
Sbjct: 71 FEHPNVVRLM-------DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 436 SRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFPTT 493
M+ L RG+ F+H+ H ++K N+L+T G ++D GLA + ++
Sbjct: 124 DLMRQFL---RGLDFLHANC---IVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMA 175
Query: 494 ATR---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T T+ YRAPEV + D++S G + EM K PL
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PL 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---ATRTIGYRA 502
RG+ +IHS A H ++K SN+ + +D I D GLA T ATR YRA
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--YRA 197
Query: 503 PEV-TETRKASQKSDVYSFGVLLLEMLTGKA 532
PE+ +Q D++S G ++ E+LTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 52/260 (20%), Positives = 90/260 (34%), Gaps = 43/260 (16%)
Query: 330 DLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVV 383
ED+ + +VLG+G++ I L VK + RE +E++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE----VEML 64
Query: 384 GTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIAL 442
H NV+ + ++ +D +V+ M GS+ L+ + ++
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVA 121
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATR--- 496
+ F+H++G A H ++K N+L Q I D L I +
Sbjct: 122 S---ALDFLHNKGIA---HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 497 --------TIGYRAPEVTETRKASQKS-----DVYSFGVLLLEMLTGKAPLQHSGHDDVV 543
+ Y APEV E D++S GV+L +L+G P
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF----VGRCG 231
Query: 544 DLPRWVRSVVREEWTAEVFD 563
W R +F+
Sbjct: 232 SDCGWDRGEACPACQNMLFE 251
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVG 384
E +G+G+YG+ +KA E V +KR LRE+ K
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKE---------- 57
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
KH N+V + +S + +V+ + L + LD
Sbjct: 58 --LKHKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTI 498
+G+ F HS H ++K N+L+ + NG +++ GLA P + T+
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 499 GYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YR P+V + S D++S G + E+ PL
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 59/248 (23%), Positives = 97/248 (39%), Gaps = 57/248 (22%)
Query: 333 DLLRASAEVLGKGSYGSTYKAIL----EDGTTVVVKRLR-EVAATKREFEQQM---EVVG 384
L+ V+GKGS+G K +L + VK L+ + K+E + M V+
Sbjct: 41 HFLK----VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 385 TIGKHSNVVPVRAYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIA 441
KH +V + ++S +KL V Y+ G LF L R R
Sbjct: 94 KNVKHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQRER-------------CFL 137
Query: 442 LGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA--HLINFP 491
AR + ++HS + ++K N+LL + ++D GL ++ +
Sbjct: 138 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194
Query: 492 TTATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV------- 542
TT+T T Y APEV + + D + G +L EML G P ++
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
Query: 543 -VDLPRWV 549
+ L +
Sbjct: 255 PLQLKPNI 262
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 24/206 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE---QQMEVVGTIGKHSNVVPV 395
+LGKGS+G K VK + + +A ++ +++E++ + H N++ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKL 86
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAFIHSE 454
+V G LF + D +K GI ++H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFS---GITYMHKH 140
Query: 455 GGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATRTI----GYRAPEVTE 507
H ++K N+LL +D + I D GL+ T + Y APEV
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLR 196
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAP 533
+K DV+S GV+L +L+G P
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-------RLREVAATKREFEQQMEVVGTIGKHSN 391
E LG G + K G K + ++ + E+++ ++ I +H N
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 75
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAF 450
V+ + Y +K + +++ + G LF T + +K L G+ +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILN---GVYY 129
Query: 451 IHSEGGAKFTHGNIKSSNVLL-TQDLNGC---ISDVGLAHLINFPTTATRTI----GYRA 502
+HS H ++K N++L +++ I D GLAH I+ + I + A
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVA 185
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533
PE+ ++D++S GV+ +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 28/207 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVVGTIGKHSNVV 393
+G+GS+G A+ K + +V K+E +E++ ++ H N++
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQE----IEIMKSL-DHPNII 69
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAFIH 452
+ + + +V G LF R D MK L +A+ H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLS---AVAYCH 123
Query: 453 SEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLI---NFPTTATRTIGYRAPEVT 506
H ++K N L D + D GLA T T Y +P+V
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 507 ETRKASQKSDVYSFGVLLLEMLTGKAP 533
E + D +S GV++ +L G P
Sbjct: 181 E-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---ATRTIGYRA 502
+G+ +IH+ A H ++K N+ + +D I D GLA + T TR YRA
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--YRA 193
Query: 503 PEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
PEV + +Q D++S G ++ EM+TGK L
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 54/238 (22%), Positives = 87/238 (36%), Gaps = 48/238 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVVGTIGK----- 388
+LG G +GS Y I + D V +K R+ + MEVV + K
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV--LLKKVSSG 106
Query: 389 HSNVVPVRAYYYSKDEKLVVYSY-MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR- 446
S V+ + ++ D +++ P LF + ++ L AR
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----------ALQEEL--ARS 153
Query: 447 -------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLI--NFPTTA 494
+ H+ G H +IK N+L+ DLN + D G L+ T
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDF 208
Query: 495 TRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSG--HDDVVDLPRWV 549
T Y PE + + + V+S G+LL +M+ G P +H V + V
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE-FEQQMEVVGTIGKHSNVVPVRA 397
EVLG G++ + G +K +++ A + E ++ V+ I KH N+V +
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLED 73
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-TALDWNSRMKIALGTARGIAFIHSEGG 456
Y S +V + G LF R G T D + ++ L + ++H G
Sbjct: 74 IYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLS---AVKYLHENG- 126
Query: 457 AKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATR--TIGYRAPEVTETRKA 511
H ++K N+L ++ I+D GL+ + +T T GY APEV +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 512 SQKSDVYSFGVLLLEMLTGKAP 533
S+ D +S GV+ +L G P
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 42/215 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
+ LG G++G G V VK L V KRE Q +++ +H
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLF----RHP 71
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR---- 446
+++ + + + +V Y+ G LF + ++ R++ AR
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-----------RVEEM--EARRLFQ 118
Query: 447 ----GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRTIG 499
+ + H H ++K NVLL +N I+D GL++++ F T+ +
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175
Query: 500 YRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
Y APEV R A + D++S GV+L +L G P
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 44/216 (20%), Positives = 88/216 (40%), Gaps = 33/216 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL---------REVAATKREFEQQMEVVGTIGKH 389
+V+G+G + + G VK + ++ + ++ ++ + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTARG 447
+++ + Y S +V+ M G LF L + S+ T S M+ L
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----SIMRSLLE---A 212
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYRAP 503
++F+H+ H ++K N+LL ++ +SD G + + P R + GY AP
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAP 268
Query: 504 EV------TETRKASQKSDVYSFGVLLLEMLTGKAP 533
E+ ++ D+++ GV+L +L G P
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 58/232 (25%)
Query: 333 DLLRASAEVLGKGSYGSTY--KAILEDGT-----------TVVVKRLREVAATKREFEQQ 379
+LL+ VLG G+YG + + I T +V++ + T+ E
Sbjct: 57 ELLK----VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---- 108
Query: 380 MEVVGTIGKHSNVVPVRAYYYS--KDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNS 436
+V+ I + +V + +Y+ + KL ++ Y+ G LF L +
Sbjct: 109 RQVLEHIRQSPFLVTL---HYAFQTETKLHLILDYINGGELFTHLSQRE----------- 154
Query: 437 RMKIALGTAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL- 487
+ + + +H G + +IK N+LL + + ++D GL+
Sbjct: 155 --RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 488 INFPTTATR----TIGYRAPEV-TETRKASQKS-DVYSFGVLLLEMLTGKAP 533
+ T TI Y AP++ K+ D +S GVL+ E+LTG +P
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKREFEQQMEVVGTIGKHSNVV 393
E+LG G +G +K G + K +++ K E + V+ + H+N++
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE----ISVMNQL-DHANLI 149
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG--TALDWNSRMKIALGTARGIAFI 451
+ + SK++ ++V Y+ G LF R + T LD MK GI +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELF---DRIIDESYNLTELDTILFMKQICE---GIRHM 203
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTI----GYRAPEV 505
H H ++K N+L I D GLA P + + APEV
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEV 259
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
S +D++S GV+ +L+G +P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 50/221 (22%), Positives = 79/221 (35%), Gaps = 46/221 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVG 384
LG+G+YG YKAI TV +KR +REV+ K
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE---------- 89
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGT 444
+H N++ +++ + +++ Y L + +N +
Sbjct: 90 --LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD-----VSMRVIKSFLYQL 141
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-----ISDVGLAHLINFPT-TATR-- 496
G+ F HS H ++K N+LL+ I D GLA P T
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 497 -TIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
T+ YR PE+ +R S D++S + EML
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 72/542 (13%), Positives = 142/542 (26%), Gaps = 172/542 (31%)
Query: 170 NLQNNSISGAIPPLNLPRLK--------ILNFSNNN---LNG------SI--------PD 204
L N++ N+ RL+ +L ++G +
Sbjct: 118 RLYNDNQV--FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK 175
Query: 205 SLQTFPNSSF---VGNS--------MLCGLPLTPCSTVSSSPSPSPSYFPTISPHKNASR 253
F + N ML L + + + + I ++ +
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQKL----LYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 254 KKLNSGSIIAIAVGGCAVLFL-------LLALFFLCCLKKL----DRQGSGVLKGKGTAE 302
+L ++ +L L F L C K L +Q + L T
Sbjct: 232 AELR--RLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-KILLTTRFKQVTDFLSAATTTH 288
Query: 303 KP-KDFGSGVQEAEKNKLC--FLDGS---------------------------------- 325
+ E L +LD
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 326 YFNFD-LEDLLRASAEVLGKGSYGSTYK--AILEDGTTVVVKRLREVAATKREFEQQMEV 382
+ N D L ++ +S VL Y + ++ + L + M V
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVV 407
Query: 383 VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
V + K+S V K K S S+++ L + + AL
Sbjct: 408 VNKLHKYSLV--------EKQPKESTISIP---SIYLELKVKLEN-----------EYAL 445
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRA 502
H + N+ T D + I + + IG+
Sbjct: 446 ---------H----RSI----VDHYNIPKTFDSDDLIPPYLDQYFYSH-------IGHHL 481
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGH---------DDVVDLPRWVRSVV 553
+ + + V+ L L K ++H + + L + +
Sbjct: 482 KNIEHPERMTLFRMVF----LDFRFLEQK--IRHDSTAWNASGSILNTLQQLKFYKPYIC 535
Query: 554 REEWTAEVFDVELLKY-QDVEEEMVQ-----MLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ E +L + +EE ++ +L+IAL + ++ + Q+
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM-----AEDEAIFEEAHK---QV 587
Query: 608 QQ 609
Q+
Sbjct: 588 QR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 9e-08
Identities = 51/390 (13%), Positives = 104/390 (26%), Gaps = 136/390 (34%)
Query: 306 DFGSGVQEAEKNKLC--FLDGSYFNFD---LEDLLRA---SAEV---------------- 341
DF +G + + + F D NFD ++D+ ++ E+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 342 ----LGKGSYGSTYKAILEDG--------TTVVVKRLREVAATKREFEQQMEVVGTIGKH 389
L K + +E+ + + R+ + R + +Q + + +
Sbjct: 68 FWTLLSKQE--EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL-----Y 120
Query: 390 SNVVPVRAYYYSKDEKL-----VVYSYMPAGSLFMLLHRNRSDGG---TALDWNSRMKIA 441
++ Y S+ + + PA +L+ G T + A
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAK--NVLID---GVLGSGKTWV--------A 167
Query: 442 LGTARGIAFIHSEGGAKF--THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG 499
L F N S +L L + I+ T+
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK-------LLYQIDPNWTSRSDHS 220
Query: 500 YRAPEVTETRKAS----QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555
+ +A KS Y +L+L +V
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVL--------------LNV-----Q------N 255
Query: 556 EWTAEVFDVE---LL--KYQDV----------------------EEEMVQMLQIALSCVA 588
F++ LL +++ V +E+ +L L C
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC-- 313
Query: 589 KVPDSRPKMDD----VVRMI-EQIQQPELR 613
+ D ++ + +I E I+
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 8e-07
Identities = 73/574 (12%), Positives = 156/574 (27%), Gaps = 202/574 (35%)
Query: 115 TSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN 174
QY Y + S AF + ++ Q++ + L + +
Sbjct: 9 FETGEHQYQY--KDILSVFEDAFVD------NFDCK----DV----QDMPKSILSKEEID 52
Query: 175 SISGAIPPLNLPRL---KILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPCSTV 231
I + ++ +L+ + + + L+ N F+ ++P T
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLR--INYKFL---------MSPIKTE 101
Query: 232 SSSPSPSPSYF-----------PTISPHKNASRKKLNSGSIIAIAVGGCAVLFLLLALFF 280
PS + + + N SR + + +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQP----YLKLRQ-------------- 142
Query: 281 LCCLKKLDRQGSGVLKGKGTAEKPKDFGSG----VQEAEKNK--LCFLDGSYF--NF--- 329
L +L + ++ G GSG + + C +D F N
Sbjct: 143 --ALLELRPAKNVLIDGVL--------GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 330 -DLEDLLRASAEVLGKGSY--GSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTI 386
E +L E+L K Y + + D ++ + R+ + A R +
Sbjct: 193 NSPETVL----EMLQKLLYQIDPNWTS-RSDHSSNIKLRIHSIQAELRRLLKSK------ 241
Query: 387 GKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGT--ALDWNSRMKIALGT 444
+ N L +L N + A + + ++ L T
Sbjct: 242 -PYEN------------------------CLLVL--LNVQNAKAWNAFNLSCKI---LLT 271
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---------LNGCISD------------VG 483
R A TH ++ ++ LT D L+ D +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 484 L--AHLINFPTTATRTIGYRAPEVTETRKAS---QKSDVY-----SFGVLLLEMLTGKAP 533
+ + + T ++T ++S + Y V P
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF---------P 382
Query: 534 LQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVP-- 591
+P + S++ W + DV + ++ + S V K P
Sbjct: 383 ------PSA-HIPTILLSLI---WFD-------VIKSDVMVVVNKLHK--YSLVEKQPKE 423
Query: 592 ----------DSRPKMDDVV----RMIEQIQQPE 611
+ + K+++ +++ P+
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 61/426 (14%), Positives = 121/426 (28%), Gaps = 144/426 (33%)
Query: 26 DLNSDKQALLDFADAVPHARKL----NWNAAAPVCSSWI----GVTCNV----------- 66
++S + L + P+ L N V ++ ++C +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLN------VQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 67 -----NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLN---GTLPSDITSIS 118
+ + H T P SL YL+ LP ++ + +
Sbjct: 280 FLSAATTTHISLDHHSM-TLT---PDEV---------KSLLLKYLDCRPQDLPREVLTTN 326
Query: 119 SL-----------------QYVYLQNNYFSGVLPAFRSLQLNALDLS-----FNAFT--- 153
+ ++ + + ++ + LN L+ + F+ +
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS----LNVLEPAEYRKMFDRLSVFP 382
Query: 154 --GNIPPG--------------FQNLTRLH---LLNLQNNSISGAIPPLNLPRLKILNFS 194
+IP + +LH L+ Q + +IP + L LK+ +
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-ELKVKLEN 441
Query: 195 NNNLNGSIPDS---LQTFPNSSFVGNSMLCGLPLTPCSTVSSSPSPSPSYFPT-ISPH-K 249
L+ SI D +TF + P YF + I H K
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDL-------------------IPPYLDQYFYSHIGHHLK 482
Query: 250 NASRKKLNSGSIIAIAVGGCAVLF--LLLALFFLCCLKKLDRQGSGVLKGKGTAEKPKDF 307
N + + LF + L FL +K+ + +
Sbjct: 483 NIEHPERMT-------------LFRMVFLDFRFL--EQKIRHDSTAWNASGSILNTLQQL 527
Query: 308 GSGVQEAEKNKLCFLDGSYFNF--DLEDLLRASAEVLGKGSYGSTYK-AILEDGTTVVVK 364
+ K +C D Y + D L E L Y + A++ + + +
Sbjct: 528 -----KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582
Query: 365 RLREVA 370
++V
Sbjct: 583 AHKQVQ 588
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 30/111 (27%), Positives = 44/111 (39%), Gaps = 8/111 (7%)
Query: 92 KLDALKILSLRSNYLN-GTLPSDITSISSLQYVYLQNNYFSGV--LPAFRSLQLNALDLS 148
+K L L ++ N G L L+++ N + + LP L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKK--LELS 72
Query: 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSIS--GAIPPL-NLPRLKILNFSNN 196
N +G + + L LNL N I I PL L LK L+ N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 26/104 (25%), Positives = 42/104 (40%), Gaps = 12/104 (11%)
Query: 116 SISSLQYVYLQNNYFS-----GVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLN 170
+ S ++ + L N+ + G+ F L+ L T +I L +L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELE--FLSTINVGLT-SIA-NLPKLNKLKKLE 70
Query: 171 LQNNSISGAIPPL--NLPRLKILNFSNNNLNG-SIPDSLQTFPN 211
L +N +SG + L P L LN S N + S + L+ N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN 114
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 31/124 (25%), Positives = 57/124 (45%), Gaps = 15/124 (12%)
Query: 92 KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFN 150
+L+++ + ++ + ++ I + +++Y+ L N + A + L L L L+ N
Sbjct: 39 ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-ISALKELTNLTYLILTGN 95
Query: 151 AFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIP--- 203
++P G F LT L L L N + ++P L L LN ++N L S+P
Sbjct: 96 QLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGV 152
Query: 204 -DSL 206
D L
Sbjct: 153 FDKL 156
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 34/95 (35%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL- 140
+P KL LK L L N L +LP + +++L Y+ L +N LP F L
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLT 157
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNN 174
L LDLS+N ++P G F LT+L L L N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 43/217 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR-------------LREVAATKREFEQQMEVVGT 385
+ LG+G+Y + YK V +K +REV+ K
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----------- 56
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
KH+N+V + +++ +V+ Y+ L + D G ++ ++
Sbjct: 57 -LKHANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTIG 499
RG+A+ H K H ++K N+L+ + G ++D GLA + P T+
Sbjct: 111 RGLAYCHR---QKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
YR P++ + S + D++ G + EM TG+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 56/230 (24%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKR--------------LREVAATKREFEQQMEVVG 384
+G+G++G +KA + G V +K+ LRE+ +
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL---------- 72
Query: 385 TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFML----------LHRNRSDGGTALDW 434
KH NVV + +K GS++++ L N T +
Sbjct: 73 --LKHENVVNLIEICRTKASP----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494
M++ L G+ +IH H ++K++NVL+T+D ++D GLA + +
Sbjct: 127 KRVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 495 TR--------TIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
T+ YR PE+ R D++ G ++ EM T +Q
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 43/209 (20%), Positives = 75/209 (35%), Gaps = 21/209 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVV 393
EV+GKG + + I E G VK + T ++ KH ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNRSDGG-TALDWNSRMKIALGTARGIAFI 451
+ Y S +V+ +M L ++ R + + + M+ L + +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALRYC 146
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLINFPTTATRTI----GYRAPE 504
H H ++K VLL N + G+A + + APE
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAP 533
V + + DV+ GV+L +L+G P
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 8/110 (7%)
Query: 93 LDALKILSLRSNYLN-GTLPSDITSISSLQYVYLQNNYFSGV--LPAFRSLQLNALDLSF 149
A++ L L + N G + +L+++ L N V LP L+ L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLK--KLELSE 80
Query: 150 NAFTGNIPPGFQNLTRLHLLNLQNNSIS--GAIPPL-NLPRLKILNFSNN 196
N G + + L L LNL N + + PL L LK L+ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 27/129 (20%), Positives = 44/129 (34%), Gaps = 13/129 (10%)
Query: 87 ANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALD 146
++ +D + + L P+ + + L + G+ F +L+ L
Sbjct: 2 SSGSSGMDMKRRIHLELRNRT---PAAVRELV-LDNCKSNDGKIEGLTAEFVNLE--FLS 55
Query: 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPD 204
L ++ L +L L L N I G + L LP L LN S N L I
Sbjct: 56 LINVGLI-SVS-NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DIST 112
Query: 205 --SLQTFPN 211
L+
Sbjct: 113 LEPLKKLEC 121
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 26/208 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK---HSNVVP 394
E LGKG++ + + + G + + R+ ++ + E I + H N+V
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA--RICRLLKHPNIVR 74
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +++ + G LF ++ R S+ + ++ L + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----HCIQQILE---AVLHCH 127
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNG---CISDVGLAHLINFPTTATRTI----GYRAPEV 505
G H N+K N+LL L G ++D GLA + A GY +PEV
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ D+++ GV+L +L G P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 16/114 (14%)
Query: 92 KLDALKILSLRSNYLNGTLPSDITSISS----LQYVYLQNNYFSGV--LPAFRSLQLNAL 145
+ L LR + I ++ + + +N + P R L+ L
Sbjct: 17 NAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLK--TL 69
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS--GAIPPL-NLPRLKILNFSNN 196
++ N Q L L L L NNS+ G + PL +L L L N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 16/73 (21%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 140 LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNL 198
++ LDL I L + ++ +N I + L RLK L +NN +
Sbjct: 19 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRI 76
Query: 199 NGSIPDSLQTFPN 211
Q P+
Sbjct: 77 CRIGEGLDQALPD 89
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 56/226 (24%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAAT----KREFEQQMEVVGTIGKH 389
++LG+GSYG + + E VK +LR + K+E Q + + +H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-QLLRRL----RH 65
Query: 390 SNVVPVRAY----YYSKDEKLVVYSYMPAGS--LFMLLHRNRSDGGTALDWNSRMKIALG 443
NV+ + K + +V Y G + D + +
Sbjct: 66 KNVI--QLVDVLYNEEKQKMYMVMEYCVCGMQEML--------------DSVPEKRFPVC 109
Query: 444 TAR--------GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI------N 489
A G+ ++HS+G H +IK N+LLT IS +G+A + +
Sbjct: 110 QAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 490 FPTTATRTIGYRAPEVTETRK--ASQKSDVYSFGVLLLEMLTGKAP 533
T+ + ++ PE+ + K D++S GV L + TG P
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK---HSNVVP 394
E LGKG++ + + G K + + R+F++ + E I + H N+V
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA--RICRKLQHPNIVR 69
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +V+ + G LF ++ R S+ + ++ L IA+ H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQILE---SIAYCH 122
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLINFPTTATRTI----GYRAPEV 505
S G H N+K N+LL G ++D GLA +N + A GY +PEV
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEV 178
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ S+ D+++ GV+L +L G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 41/212 (19%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVKRL-------REVAATKREFEQQMEVVGTIGKHSNVV 393
+GKG++ A + G V +K + + RE + M+++ H N+V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV-RIMKIL----NHPNIV 77
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR------- 446
+ ++ ++ Y G +F L + RMK AR
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-----------RMKEK--EARSKFRQIV 124
Query: 447 -GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRTIGYRA 502
+ + H + H ++K+ N+LL D+N I+D G ++ Y A
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 503 PEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
PE+ + +K + DV+S GV+L +++G P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 53/227 (23%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR----EVAA--TKRE--FEQQMEVVGTIGKHS 390
+LG+G+YG A G V +K++ + A T RE + KH
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHE 69
Query: 391 NVVPV----RAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-IALGT 444
N++ + R + ++ ++ M LHR S L + ++ T
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVIS--TQMLS-DDHIQYFIYQT 121
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT----------- 493
R + +H + H ++K SN+L+ + + + D GLA +I+
Sbjct: 122 LRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 494 -----ATRTIGYRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
ATR YRAPEV + K S+ DV+S G +L E+ + P+
Sbjct: 179 MVEFVATR--WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR----EVAA--TKREFE--QQMEVVGTIGKHS 390
+G+G+YG A + V +K++ + T RE + + +H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHE 85
Query: 391 NVVPV----RAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK-IALGT 444
N++ + RA + + + +V M L+ LL L N +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH------LS-NDHICYFLYQI 137
Query: 445 ARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---------AT 495
RG+ +IHS A H ++K SN+LL + I D GLA + + AT
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 496 RTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPL 534
R YRAPE+ ++ ++ D++S G +L EML+ + P+
Sbjct: 195 R--WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 20/119 (16%)
Query: 88 NSIGKLDALKILSLRSNYLNGTLPSDITSIS------SLQYVYLQNNYFSGVLPAFRSLQ 141
++ L A K L+L +N +I IS +L+ + L N +
Sbjct: 42 ATLSTLKACKHLALSTN--------NIEKISSLSGMENLRILSLGRNLIKKIENLDAVAD 93
Query: 142 -LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSIS--GAIPPL-NLPRLKILNFSNN 196
L L +S+N ++ G + L L +L + NN I+ G I L L +L+ L + N
Sbjct: 94 TLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 12/61 (19%), Positives = 19/61 (31%), Gaps = 3/61 (4%)
Query: 139 SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNN 197
+ L + L L L N+I I L + L+IL+ N
Sbjct: 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNL 81
Query: 198 L 198
+
Sbjct: 82 I 82
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 14/108 (12%)
Query: 94 DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAF 152
DA++I + ++ + ++ + +L L LS N
Sbjct: 9 DAIRIFEE----RKSVVATEAEKVE----LHGMIPPIEKMDATLSTLKACKHLALSTNNI 60
Query: 153 TGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNL 198
I + L +L+L N I I L L+ L S N +
Sbjct: 61 E-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 55/229 (24%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL--REVAATKREF-E----QQMEVVGTIGKHSN 391
+ LG G G + A+ + V +K++ + + K E +++ H N
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDN 69
Query: 392 VV-------PVRAYYYSKDEKL-------VVYSYMPAGSLFMLLHRNRSDGGTALDWNSR 437
+V P + L +V YM L +L + L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP------LL-EEH 121
Query: 438 MK-IALGTARGIAFIHSEGGAKFTHGNIKSSNVLL-TQDLNGCISDVGLAHLINFPTT-- 493
+ RG+ +IHS A H ++K +N+ + T+DL I D GLA +++ +
Sbjct: 122 ARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 494 -------ATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPL 534
T+ YR+P + ++ D+++ G + EMLTGK L
Sbjct: 179 GHLSEGLVTK--WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQ-QMEVVGTIGK---HSNVVP 394
E LGKG++ + + G K + + R+F++ + E I + H N+V
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA--RICRKLQHPNIVR 92
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +V+ + G LF ++ R S+ + ++ L IA+ H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----HCIQQILE---SIAYCH 145
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLINFPTTATRTI----GYRAPEV 505
S G H N+K N+LL G ++D GLA +N + A GY +PEV
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEV 201
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ S+ D+++ GV+L +L G P
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 51/255 (20%), Positives = 89/255 (34%), Gaps = 59/255 (23%)
Query: 301 AEKPKDFGSGVQEAEKNKLCFLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILEDGTT 360
A+ +DF + +N FD ++ LG GS+G ++
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQ-----FDR---IK----TLGTGSFGRVMLVKHKESGN 67
Query: 361 V---------VVKRLREVAATKREFEQQMEVVGTIGKHSNVVP--VRAYYYSKDEKLV-- 407
V +L+++ T E V P V+ + KD +
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NF----PFLVKLEFSFKDNSNLYM 118
Query: 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR--------GIAFIHSEGGAKF 459
V Y+ G +F L R + + AR ++HS
Sbjct: 119 VMEYVAGGEMFSHLRRIG-------------RFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRTIGYRAPEVTETRKASQKSDVY 518
+ ++K N+L+ Q ++D G A + T T T APE+ ++ ++ D +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 519 SFGVLLLEMLTGKAP 533
+ GVL+ EM G P
Sbjct: 223 ALGVLIYEMAAGYPP 237
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 43/138 (31%), Positives = 57/138 (41%), Gaps = 25/138 (18%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSL-Q 141
IPA + L L +N L ++SL +YL N LP F L
Sbjct: 26 IPAQT-------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNN 197
L L+LS N ++P G F LT+L L L N + ++P L +LK L N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 198 LNGSIPD-------SLQT 208
L S+PD SLQ
Sbjct: 136 LK-SVPDGVFDRLTSLQY 152
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 42/215 (19%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
+ LG G++G G V VK L V +RE Q +++ +H
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI-QNLKLF----RHP 76
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR---- 446
+++ + + + +V Y+ G LF + +N R+ +R
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-----------RLDEK--ESRRLFQ 123
Query: 447 ----GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRTIG 499
G+ + H H ++K NVLL +N I+D GL++++ F T+ +
Sbjct: 124 QILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 180
Query: 500 YRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
Y APEV R A + D++S GV+L +L G P
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 44/232 (18%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAAT-KREFEQQMEVVGTIGKHSNVVP 394
LG+G+YG A+ V VK R + K+E +++ H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKML----NHENVVK 69
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR-------- 446
+ + + + Y G LF R D M A+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF---DRIEPDI--------GMPEP--DAQRFFHQLMA 116
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN------FPTTATRTIGY 500
G+ ++H G TH +IK N+LL + N ISD GLA + T+ Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 501 RAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS 551
APE+ + R+ ++ DV+S G++L ML G+ P D + W
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK 224
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM---EVVGTIGKH-----S 390
+V+GKGS+G KA + V +K +R KR Q ++ + K
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
NV+ + + ++ + + + + +L+ L+ +N+ G K A + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG---FSLPLVRKFAHSILQCLDA 215
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCIS--DVGLA-HLINFPTTATRTIGYRAPEVTE 507
+H + H ++K N+LL Q I D G + + T ++ YRAPEV
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL 272
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
+ D++S G +L E+LTG L G D
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLP--GED 303
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 42/137 (30%), Positives = 55/137 (40%), Gaps = 24/137 (17%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSL-Q 141
IP N+ +IL L N + P S+ +L+ +YL +N LP F SL Q
Sbjct: 38 IPTNA-------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNL 198
L LDL N T +P F L L L + N ++ +P L L L N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 199 NGSIPD-------SLQT 208
SIP SL
Sbjct: 148 K-SIPHGAFDRLSSLTH 163
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 36/119 (30%), Positives = 48/119 (40%), Gaps = 11/119 (9%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL- 140
+ L LK L L SN L LP + S++ L + L N + VLP+ F L
Sbjct: 55 LEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLV 112
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNN 196
L L + N T +P G + LT L L L N + +IP L L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 44/232 (18%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAAT-KREFEQQMEVVGTIGKHSNVVP 394
LG+G+YG A+ V VK R + K+E +++ H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKML----NHENVVK 69
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR-------- 446
+ + + + Y G LF R D M A+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF---DRIEPDI--------GMPEP--DAQRFFHQLMA 116
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN------FPTTATRTIGY 500
G+ ++H G TH +IK N+LL + N ISD GLA + T+ Y
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 501 RAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS 551
APE+ + R+ ++ DV+S G++L ML G+ P D + W
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 8e-08
Identities = 56/252 (22%), Positives = 99/252 (39%), Gaps = 59/252 (23%)
Query: 333 DLLRASAEVLGKGSYGSTYKAILEDGTTV---------VVKRLREVAATKREFEQQMEVV 383
+LR LG GS+G + +V RL++V T E ++
Sbjct: 9 QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE----RLML 60
Query: 384 GTIGKHSNVVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMK--- 439
+ H ++ + + +++ ++ Y+ G LF LL +++ N K
Sbjct: 61 SIV-THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQR-----FP-NPVAKFYA 112
Query: 440 --IALGTARGIAFIHSEGGAKFTHGNI-----KSSNVLLTQDLNGCISDVGLAHLINFPT 492
+ L + ++HS+ +I K N+LL ++ + I+D G A +
Sbjct: 113 AEVCLA----LEYLHSK--------DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-V 159
Query: 493 TATR--TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-------- 542
T T T Y APEV T+ ++ D +SFG+L+ EML G P S
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
Query: 543 VDLPRWVRSVVR 554
+ P + V+
Sbjct: 220 LRFPPFFNEDVK 231
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 14/97 (14%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSL-Q 141
IP + L L N +P ++++ L + L NN S L F ++ Q
Sbjct: 29 IPRDV-------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 142 LNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSIS 177
L L LS+N IPP F L L LL+L N IS
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 22/63 (34%), Positives = 28/63 (44%), Gaps = 6/63 (9%)
Query: 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGS 201
L L N FT +P N L L++L NN IS + N+ +L L S N L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 202 IPD 204
IP
Sbjct: 93 IPP 95
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK----------REFEQQMEVVGTIGK 388
+ LG+G + + YKA V +K+++ ++ RE + E+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----S 70
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H N++ + + K +V+ +M L +++ ++ S T + M + L +G+
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTL---QGL 125
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLINFP----TTATRTIGYRA 502
++H H ++K +N+LL D NG ++D GLA P T T YRA
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 503 PEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
PE+ R D+++ G +L E+L P
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV-PF 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK-----RLREVAATKRE----FEQQMEVVGTIGKH 389
+ LG G+ G A + V +K + +A + + E ++E++ + H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NH 74
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDW---NSRM--KIALGT 444
++ ++ ++ ++D +V+ M G LF D N R+
Sbjct: 75 PCIIKIKNFFDAEDYYIVL-ELMEGGELF--------------DKVVGNKRLKEATCKLY 119
Query: 445 AR----GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC---ISDVGLAHLINFPTTATRT 497
+ ++H G H ++K NVLL+ C I+D G + ++ T+ RT
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT 175
Query: 498 I----GYRAPEV---TETRKASQKSDVYSFGVLLLEMLTGKAP 533
+ Y APEV T ++ D +S GV+L L+G P
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVK--------RLREVAATKREFEQQMEVVGTIGKHS 390
E LG+GS+G A + V +K + +RE ++++ +H
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI-SYLKLL----RHP 69
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR---- 446
+++ + + + ++V Y G LF + + RM R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-----------RMTED--EGRRFFQ 115
Query: 447 ----GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI---NFPTTATRTIG 499
I + H H ++K N+LL +LN I+D GL++++ NF T+ +
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN 172
Query: 500 YRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
Y APEV + A + DV+S G++L ML G+ P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 42/202 (20%), Positives = 74/202 (36%), Gaps = 36/202 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+VLG G G + +K L++ +RE +E+ + ++V +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDV 79
Query: 399 Y----YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
Y + L+V + G LF + T + + MK I ++HS
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSI 136
Query: 455 GGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKA 511
A H ++K N+L T + ++D G A E T K
Sbjct: 137 NIA---HRDVKPENLLYTSKRPNAILKLTDFGF-----------------AKETTG-EKY 175
Query: 512 SQKSDVYSFGVLLLEMLTGKAP 533
+ D++S GV++ +L G P
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPP 197
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 27/206 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRL---REVAATKREFEQQMEVVGTIGKHSNVVPV 395
LG+G+ Y+ +K L + + E + + H N++ +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-----SHPNIIKL 113
Query: 396 RAYYYSKDEKLVVYSYMPAGSLF-MLLHRNR-SDGGTALDWNSRMKIALGTARGIAFIHS 453
+ + + E +V + G LF ++ + S+ A +K L +A++H
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA----DAVKQILE---AVAYLHE 166
Query: 454 EGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFP---TTATRTIGYRAPEVTE 507
G H ++K N+L D I+D GL+ ++ T T GY APE+
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAP 533
+ D++S G++ +L G P
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 46/241 (19%), Positives = 92/241 (38%), Gaps = 44/241 (18%)
Query: 323 DGSYFNFDLEDLLRAS----AEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFE 377
G Y + + + LG G + + + A + + T V +K +R K E
Sbjct: 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTE 60
Query: 378 Q-QMEV-------------VGTIGKHSNVVPVRAYYYSKDEKLV----VYSYMPAGSLFM 419
+ E+ ++G + +++ + ++ K V V+ + +L
Sbjct: 61 AAEDEIKLLQRVNDADNTKEDSMGAN-HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA 118
Query: 420 LLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC- 478
L+ + G + +I+ G+ ++H H +IK NVL+ +
Sbjct: 119 LIKKYEHRG---IPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 173
Query: 479 -----ISDVGLAHLIN---FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG 530
I+D+G A + + TR YR+PEV +D++S L+ E++TG
Sbjct: 174 LIQIKIADLGNACWYDEHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITG 231
Query: 531 K 531
Sbjct: 232 D 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 45/211 (21%), Positives = 71/211 (33%), Gaps = 40/211 (18%)
Query: 342 LGKGSYGSTYKAI-LEDGTTVVVK----RLREVAATKREFEQQMEVVGTIGKHSNVVPVR 396
+G G++G V VK +RE + +H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-INHRSL----RHPNIVRFK 82
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTAR--------GI 448
+ ++ Y G L+ + R AR G+
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG-----------RFSED--EARFFFQQLLSGV 129
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGC--ISDVGLAHLI---NFPTTATRTIGYRAP 503
++ HS H ++K N LL I D G + + P + T Y AP
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186
Query: 504 EVTETRK-ASQKSDVYSFGVLLLEMLTGKAP 533
EV ++ + +DV+S GV L ML G P
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 48/258 (18%), Positives = 84/258 (32%), Gaps = 83/258 (32%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--------KHS 390
++G GSYG +A + V +K++ V FE ++ + H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112
Query: 391 NVVP----VRAYYYSKDEKL-VVYSYMPAGSLFMLLHRN-RSDGGTALDWNSRMKIALGT 444
+VV V K ++L VV + + R+ + L
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD-----FKKLFRT------------PVYLTE 155
Query: 445 A----------RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTA 494
G+ ++HS A H ++K +N L+ QD + + D GLA +++P
Sbjct: 156 LHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 495 TRTIG-------------------------------YRAPEV-TETRKASQKSDVYSFGV 522
+ YRAPE+ ++ DV+S G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 523 LLLEMLTGKAPLQHSGHD 540
+ E+L D
Sbjct: 273 IFAELLNMIKENVAYHAD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 9e-07
Identities = 33/238 (13%), Positives = 63/238 (26%), Gaps = 51/238 (21%)
Query: 342 LGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVG----------------- 384
+G+G +G ++ I D T V +K + Q
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 385 ------TIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRS----------DG 428
++V V+ Y K + GS + G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 429 GTALD--------WNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480
G L+ + I +A + +F H ++ NVLL + +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 481 DVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSD--VYSFGVLLLEMLTGKAPLQH 536
P+ G + + T ++ V+ + ++ TG Q
Sbjct: 205 YTLNGKSSTIPSC-----GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 59/235 (25%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAA-------TKRE--FEQQMEVVGTIGKH 389
+ LGKG+YG +K+I G V VK++ + T RE ++ H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL------SGH 68
Query: 390 SNVVPVRAYYYSKDEKLV--VYSYMPAGSLFMLLHRN-RSDGGTALDWNSRMK-IALGTA 445
N+V + + +++ V V+ YM LH R++ L+ + +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRAN---ILE-PVHKQYVVYQLI 119
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG------ 499
+ I ++HS H ++K SN+LL + + ++D GL+ T I
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 500 -------------------YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPL 534
YRAPE+ + K ++ D++S G +L E+L GK P+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 44/252 (17%), Positives = 76/252 (30%), Gaps = 76/252 (30%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTI--------GKHS 390
++G+GSYG Y A V +K++ + FE ++ + K
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85
Query: 391 NVVPVRAYYYSKDEKL-----VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
++ + D +V + L + + I L
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSD-----LKKL-----------FKTPIFLTEE 129
Query: 446 ----------RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT 495
G FIH + H ++K +N LL QD + + D GLA IN
Sbjct: 130 HIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 496 RTIG--------------------------YRAPEV-TETRKASQKSDVYSFGVLLLEML 528
YRAPE+ ++ D++S G + E+L
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 529 TGKAPLQHSGHD 540
+ +
Sbjct: 247 NMLQSHINDPTN 258
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 34/120 (28%), Positives = 49/120 (40%), Gaps = 18/120 (15%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDIT--SISSLQYVYLQNNYFSGVLP-AFRSL- 140
IP ++ L L N L + SD + L + L+ N +G+ P AF
Sbjct: 27 IPLHT-------TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNN 196
+ L L N I F L +L LNL +N IS + P +L L LN ++N
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 15/64 (23%), Positives = 23/64 (35%), Gaps = 6/64 (9%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200
L L+ N G F L L L L+ N ++ I P ++ L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 201 SIPD 204
I +
Sbjct: 92 EISN 95
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM---EVVGTIGKH-----S 390
++GKGS+G KA + V +K ++ K Q ++ + KH
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+V ++ ++ ++ +V+ + + +L+ LL G + N K A + F
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRG---VSLNLTRKFAQQMCTALLF 172
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCIS--DVGLA-HLINFPTTATRTIGYRAPEVTE 507
+ + H ++K N+LL I D G + L ++ YR+PEV
Sbjct: 173 LATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLL 231
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPL 534
D++S G +L+EM TG+ PL
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTGE-PL 257
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 15/95 (15%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPA--FRSL- 140
IP+++ L L SN L +LP + ++ L + L N LP F L
Sbjct: 26 IPSSA-------TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76
Query: 141 QLNALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNN 174
+L L L N ++P G F LT+L L L N
Sbjct: 77 KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTN 110
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 16/107 (14%), Positives = 35/107 (32%), Gaps = 18/107 (16%)
Query: 91 GKLDALKILSL---RSNYLNGTLPSDITSI------SSLQYVYLQNNYFSG----VLPAF 137
L L+ L L +Y + + +L+++ + + +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 138 RSL-QLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGA 179
L QL +D+S T + + L +N++ N +S
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 42/237 (17%), Positives = 72/237 (30%), Gaps = 54/237 (22%)
Query: 340 EVLGKGSYGSTYKAI--LEDGTTVVVKRLREVAATKREFEQQM---EVVGTIGKH----- 389
LG+G++G + + + V +K +R + E V+ I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENK 81
Query: 390 SNVVPVRAYYYSKD------EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALG 443
V + ++ E L + F L N +A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELL-------GKNTFEFLKENNFQP---YPLPHVRHMAYQ 131
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRTI--G- 499
+ F+H + TH ++K N+L + + + T+ R G
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 500 ----------------YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540
YR PEV +Q DV+S G +L E G Q H+
Sbjct: 189 ATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ--THE 243
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 14/75 (18%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNG 200
L L N T + PG F LT+L L+L NN ++ +P L +L L+ ++N L
Sbjct: 35 LYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK- 91
Query: 201 SIPD-------SLQT 208
SIP SL
Sbjct: 92 SIPRGAFDNLKSLTH 106
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 14/75 (18%)
Query: 145 LDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNG 200
L L+ N T + PG F +L L L +N ++ AIP L +L L+ ++N+L
Sbjct: 38 LWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK- 94
Query: 201 SIPD-------SLQT 208
SIP SL
Sbjct: 95 SIPRGAFDNLKSLTH 109
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.75 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.75 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.73 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.72 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.71 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.7 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.69 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.68 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.68 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.68 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.68 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.67 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.67 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.66 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.65 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.65 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.64 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.64 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.62 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.62 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.62 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.6 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.6 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.59 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.59 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.59 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.59 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.59 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.59 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.58 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.58 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.57 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.57 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.57 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.56 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.55 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.55 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.55 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.55 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.54 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.52 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.52 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.52 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.51 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.5 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.47 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.45 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.42 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.38 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.38 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.35 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.34 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.29 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.28 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.28 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.25 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.22 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.06 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.75 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.5 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.46 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.35 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.2 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.11 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.11 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.17 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.67 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.63 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.55 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.51 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.15 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.91 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.82 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.11 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.02 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.7 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.28 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.63 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.43 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.93 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.57 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=422.77 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=204.1
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.++.++ +|||||+++|+|.+++..++|||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence 478999999999999863 46789999997543 3467899999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 411 YMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
||++|+|.++|...... ....++|..+++|+.|||.||+|||+++ ||||||||+|||+++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEE
Confidence 99999999999754211 1246899999999999999999999998 999999999999999999999
Q ss_pred eecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 552 (627)
+|||+|+..... ....||+.|||||++.++.|+.++|||||||++|||+| |+.||.+... ...+..+
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~~~~i 260 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVEMI 260 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHHHHHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHHHHHH
Confidence 999999865321 23457899999999999999999999999999999999 8999976432 1222222
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
. .+.... ..+++...+.+++.+||+.||++||||.||++.|+.+.
T Consensus 261 ~-~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 R-NRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp H-TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred H-cCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2 211111 11223345778889999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=425.61 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=201.3
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++.++ +|||||+++|+|.+.+..++||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 478999999999999864 47889999997643 2456899999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 412 MPAGSLFMLLHRNRSD----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
|++|+|.++++..... ...+++|.+++.|+.|||.||+|||+.+ ||||||||+|||+++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence 9999999999865321 2346999999999999999999999988 99999999999999999999999
Q ss_pred cccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 482 VGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 482 fG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+|+..... ....||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.+..+..
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~ 275 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCITQ 275 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHHHHHH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc
Confidence 9999876432 23457899999999999999999999999999999999 8999975432 222222222
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.... . ... ....++.+++.+||+.||++||||.||+++|+.+.+.
T Consensus 276 g~~~-~-------~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GREL-E-------RPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCC-C-------CCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCC-C-------Ccc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 0 111 2234567788899999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=422.25 Aligned_cols=250 Identities=23% Similarity=0.424 Sum_probs=203.7
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||+||+|++. ++..||||+++... ...++|.+|+++++++ +|||||+++|+|.+++..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEc
Confidence 478999999999999864 47789999997643 2457899999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 412 MPAGSLFMLLHRNR--------SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 412 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
|++|+|.++|+... ......++|.+++.++.|||.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence 99999999998642 122457999999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 484 LAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 484 ~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
+|+..... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+... .+....+....
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~~~ 247 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGR 247 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHHTC
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC
Confidence 99865332 22347899999999999999999999999999999999 8999976432 22222222221
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.. . .. .....++.+++.+||+.||++||||+||.+.|+++..
T Consensus 248 ~~-~-------~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 248 VL-Q-------RP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CC-C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-C-------CC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 0 11 1223456778889999999999999999999998864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=416.41 Aligned_cols=249 Identities=29% Similarity=0.461 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+++ ..||||+++.... ..+.|.+|+++++++ +|||||+++|++.+ +..++|||||++|
T Consensus 41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iVmEy~~gG 116 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIVTQWCEGS 116 (307)
T ss_dssp EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence 578999999999999976 3699999875432 346799999999999 99999999998764 5689999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.++++..+ ..++|.+++.|+.|||.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999997542 46999999999999999999999998 999999999999999999999999999876431
Q ss_pred --CCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 --TTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.... ..+...+..... .+.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CCCc
Confidence 23468999999999853 46899999999999999999999999754321 112222222111 1111
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.. ....+..++.+++.+||+.+|++||||.||+++|+.++.+
T Consensus 260 ~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 SK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11 0112234567788899999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=419.72 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=197.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC----ceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD----EKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+++ |+.||||++.........++.|+..+.++ +|||||+++++|.+++ ..++||||+++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 478999999999999985 89999999975433233334455555667 9999999999998764 47899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG-----GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
|+|.++++.. .++|..+.+++.|++.||+|||+++ .++|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999853 4899999999999999999999872 2459999999999999999999999999998764
Q ss_pred CCC--------CCCCCccccCccccCCC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC---------CCHH
Q 006886 490 FPT--------TATRTIGYRAPEVTETR------KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV---------VDLP 546 (627)
Q Consensus 490 ~~~--------~~~~t~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~---------~~~~ 546 (627)
... ...||+.|||||++.+. .++.++|||||||++|||+||+.||........ ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 321 23589999999998764 367899999999999999999887754322111 1111
Q ss_pred HHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 547 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.......+. ..++.+.......+....+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus 240 -~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 -EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp -HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 112111111 112222111222456677889999999999999999999999999987653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=411.52 Aligned_cols=239 Identities=20% Similarity=0.351 Sum_probs=199.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++.+ +|||||++++++.+++..|+||||+++|+|
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 67999999999999976 68999999996543 3456688999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
.+++.+. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .+
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999753 4899999999999999999999998 999999999999999999999999999876432 35
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .......+. ...... + ....
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~-~~~~~~-----~---~~~~ 294 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIR-DNLPPR-----L---KNLH 294 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSSCCC-----C---SCGG
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCCCC-----C---Cccc
Confidence 579999999999999999999999999999999999999997532 112222221 111111 1 1111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....++.+++.+||..||++|||++|++++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122355677889999999999999999774
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=398.75 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=193.6
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~ 411 (627)
+.||+|+||+||+|..+ ++..||+|++..... ..+.|.+|+++++++ +|||||+++++|.+ ++..++||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 57999999999999975 588999999975432 345789999999999 99999999999875 3457899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINF 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~ 490 (627)
+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999865 35899999999999999999999986 57999999999999985 79999999999986544
Q ss_pred C--CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 P--TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. .+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.. ........+. .......++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i~-~~~~~~~~~----- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVT-SGVKPASFD----- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHT-TTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHHH-cCCCCCCCC-----
Confidence 3 34569999999999865 69999999999999999999999997532 1112222222 111111111
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... .++.+++.+||..||++|||++|++++
T Consensus 253 -~~~~---~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 -KVAI---PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GCCC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 245678889999999999999999763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=409.71 Aligned_cols=243 Identities=20% Similarity=0.234 Sum_probs=199.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.++||+|+||.||+|+.+ +|+.||||+++.... +.+|+++++.+ +|||||++++++.+++..++||||++||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999975 689999999975432 24688999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCC-----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFP----- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~----- 491 (627)
.+++++. ..+++..+..++.|++.||+|||+++ ||||||||+|||++.++ .+||+|||+|+.....
T Consensus 138 ~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 138 GQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999865 35999999999999999999999998 99999999999999997 6999999999876432
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....||+.|||||++.+..|+.++|||||||++|||++|+.||........ . ..+........ .
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~~~~~------~ 277 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LKIASEPPPIR------E 277 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HHHHHSCCGGG------G
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHcCCCCch------h
Confidence 224689999999999999999999999999999999999999986543322 1 11121111100 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.....+ ..+.+++.+||++||++|||+.|++++|.....
T Consensus 278 ~~~~~s---~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 278 IPPSCA---PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp SCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccCC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 111222 345667789999999999999999999887643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=408.34 Aligned_cols=241 Identities=21% Similarity=0.397 Sum_probs=195.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+.+ +|+.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..|+||||++|
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 689999999975432 346789999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.+++...+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999997543 345799999999999999999999998 999999999999999999999999999877542
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
.+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+ ....+..+....... . ..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~~--~------~~ 247 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSFPP--V------SL 247 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCCC--C------CT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCCCC--C------Cc
Confidence 23459999999999999999999999999999999999999997542 233333333332211 0 11
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+ .++.+++.+||+.||++|||++|++++
T Consensus 248 ~~s---~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 HYS---YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122 345677889999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=412.28 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=204.3
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~ 409 (627)
.+.||+|+||+||+|.+.. ++.||||+++.... ..+.|.+|++++.++.+|||||+++|+|.+. +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 5789999999999998652 35799999976432 3467999999999996679999999999765 5689999
Q ss_pred ecCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 410 SYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
|||++|+|.++|+..+. .....++|..++.++.|||.||+|||+++ ||||||||+|||+++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence 99999999999976432 11346899999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHH
Q 006886 479 ISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRS 551 (627)
Q Consensus 479 i~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 551 (627)
|+|||+|+...... ...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... ..+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------~~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 99999998764432 2347889999999999999999999999999999998 99999764322 11222
Q ss_pred HhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.+.++..... . +....++.+++.+||+.||++||||.||+++|+.+.+.
T Consensus 300 ~i~~g~~~~~-------p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 RLKEGTRMRA-------P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCC-------C---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2222211111 1 11223567788899999999999999999999998654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=396.70 Aligned_cols=249 Identities=16% Similarity=0.300 Sum_probs=205.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +|+.||||++... ....+.+.+|+++++++ +|||||++++++.+++..|+||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 478999999999999965 6899999999653 23467799999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
||+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 116 gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 116 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999865 35999999999999999999999998 999999999999999999999999999876422
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
.+..||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+ .......+...... +.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~~---~p---- 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLEYD---FP---- 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---CC----
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCC---CC----
Confidence 34569999999999999999999999999999999999999997532 22223333322210 11
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
....+ ++.+++.+|+..||++|||++|+...-+-...+-..+
T Consensus 255 --~~~s~---~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 255 --EKFFP---KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp --TTCCH---HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred --cccCH---HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 11222 4567788999999999999999865544444444443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=412.09 Aligned_cols=240 Identities=20% Similarity=0.347 Sum_probs=199.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.+ +|+.||||++.... ...+.+.+|+++++.+ +|||||+++++|.+++..|+|||||+||+
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 367999999999999975 68999999996543 3456689999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.++++.. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 235 L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 235 LTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred HHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999753 4899999999999999999999998 999999999999999999999999999876432 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.. .......+. ..... .+......
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~-~~~~~-----~~~~~~~~ 373 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIR-DNLPP-----RLKNLHKV 373 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH-HSCCC-----CCSCTTSS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCCC-----CCcccccC
Confidence 4568999999999999999999999999999999999999997532 122222221 11111 11111222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ .++.+++.+||..||++|||+.|++++
T Consensus 374 s---~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 374 S---PSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp C---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2 345667789999999999999999774
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=384.20 Aligned_cols=237 Identities=21% Similarity=0.367 Sum_probs=186.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..++||||+
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 478999999999999965 68999999996542 2356799999999999 9999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 96 GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 68999999764 35999999999999999999999998 999999999999999999999999999876442
Q ss_pred -CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+..||+.|||||++.+..+ +.++||||+||++|||++|+.||.+.. .......+...... + .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~---~------p 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT---L------P 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---C------C
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC---C------C
Confidence 34579999999999998876 579999999999999999999997532 22223322222110 0 1
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+ .++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 233 KFLS---PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122 345677889999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=391.49 Aligned_cols=237 Identities=21% Similarity=0.329 Sum_probs=189.3
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||+||+|+.. .++.||||+++... .....+.+|++++.++ +|||||++++++.+++..++||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEc
Confidence 578999999999999853 46789999986542 2334688899999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
++||+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999865 35999999999999999999999998 99999999999999999999999999986532
Q ss_pred ---CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 491 ---PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 ---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
..+..||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+ ..+....+......
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~--------- 244 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAKLG--------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC---------
Confidence 235579999999999999999999999999999999999999997542 22222333222110
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVR 602 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~ 602 (627)
.....+ .++.+++.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 011122 345677889999999999995 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=381.54 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=182.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----------
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE----------- 404 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 404 (627)
.+.||+|+||+||+|+.+ +|+.||||+++.... ..+.+.+|+++++++ +|||||++++++.+.+.
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCc
Confidence 478999999999999965 689999999865432 346789999999999 99999999999876543
Q ss_pred -eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 405 -KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 405 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
.++||||+++|+|.+++..... ....++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence 6899999999999999986432 234677888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCC----------------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH
Q 006886 484 LAHLINFP----------------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547 (627)
Q Consensus 484 ~a~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 547 (627)
+|+..... .+..||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 99876432 12358999999999999999999999999999999996 775310 1011
Q ss_pred HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..... .... +.+ ...+......+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~-~~~~----~p~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDV-RNLK----FPP------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH-HTTC----CCH------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH-hcCC----CCC------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 1110 011 11222334567889999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=374.52 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=192.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee------CCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS------KDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv 408 (627)
.+.||+|+||+||+|+.+ +|+.||||+++.... ..+.+.+|+++++.+ +|||||++++++.. .+..|+|
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEE
Confidence 478999999999999965 699999999975533 235688999999999 99999999998764 3568999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||++ |+|.+++... ..+++..+..++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+
T Consensus 138 mE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 138 LDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99995 6899999754 36999999999999999999999998 999999999999999999999999999875
Q ss_pred CC--------CCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc-
Q 006886 489 NF--------PTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT- 558 (627)
Q Consensus 489 ~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 558 (627)
.. ..+..||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+.. .....+......
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~~g~p 282 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMVLGTP 282 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCCC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 32 2345799999999998775 5699999999999999999999999864321 111111111000
Q ss_pred -ccccc--------h---hhhcC--CChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 -AEVFD--------V---ELLKY--QDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 -~~~~d--------~---~l~~~--~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... . .+... .... ....++.+++.+||..||++|||++|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0 00000 0000 012356678889999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=370.18 Aligned_cols=187 Identities=24% Similarity=0.428 Sum_probs=164.3
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+.+ .++.||||++... .....+.+|++++..+.+||||+++++++.+.+..++||||+++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 478999999999999853 4678999998653 34567889999999997899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~~-- 491 (627)
|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999984 2889999999999999999999999 9999999999999887 79999999999754321
Q ss_pred ------------------------------CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 492 ------------------------------TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 492 ------------------------------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
.+..||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 123589999999998775 5899999999999999999999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=383.24 Aligned_cols=241 Identities=19% Similarity=0.248 Sum_probs=191.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHH---HHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQME---VVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~---~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.++||+|+||+||+|+.+ +|+.||||++.+.. .....+..|.. ++..+ +|||||++++++.+.+..|+|||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEEEEEEe
Confidence 478999999999999976 68999999996532 23344445544 34444 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|++||+|..++.+. ..+++..+..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 273 y~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 273 LMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999865 35999999999999999999999998 99999999999999999999999999987654
Q ss_pred C--CCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 491 P--TTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 ~--~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
. .+..||+.|||||++. +..|+.++||||+||++|||++|+.||.+....+ ............. .
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~~---------~ 412 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMAV---------E 412 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCCC---------C
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCCC---------C
Confidence 3 4567999999999996 4579999999999999999999999997543322 1111121111110 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
-....++ ++.+++.+||..||.+|++ ++||+++
T Consensus 413 ~p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 LPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0112223 4556778999999999998 6888763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.14 Aligned_cols=265 Identities=28% Similarity=0.525 Sum_probs=223.4
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|+.++++.||||++..... ..+.+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 367999999999999988899999999875533 456789999999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC------
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP------ 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~------ 491 (627)
.+++..... ....++|..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 123 KRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp GGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999975432 2346899999999999999999999998 999999999999999999999999999765321
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+......|.............+++.... ..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-cc
Confidence 12347889999999988899999999999999999999999998776666667777665544444444444443322 23
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..+....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 46677889999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.31 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc----eEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE----KLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+.. ++.||||++.........++.|+.++.++ +||||+++++++..... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 478999999999999986 79999999976555556677788888888 89999999999987543 6899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE----------GGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
|+|.++++.. .++|..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999753 489999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCC------CCCCCCccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH------
Q 006886 485 AHLINFP------TTATRTIGYRAPEVTETR-----KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR------ 547 (627)
Q Consensus 485 a~~~~~~------~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~------ 547 (627)
++..... ....+|+.|+|||++.+. .++.++||||||+++|||++|+.||.............
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 9765432 224578999999998763 45678899999999999999999998754433322211
Q ss_pred ----HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 548 ----WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 548 ----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
+........ . .+.+...........++.+++.+||+.||++|||+.|+++.|++++..
T Consensus 258 ~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 258 SLEDMQEVVVHKK-K----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CHHHHHHHHTTSC-C----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhccc-C----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1 111111111224456688899999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=382.78 Aligned_cols=243 Identities=19% Similarity=0.391 Sum_probs=199.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.+ +|+.||+|++.... ...+.+.+|+++++.+ +||||+++++++.+++..++|||||+||+
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 478999999999999975 68999999986543 2456788999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC--CCeEEeecccccccCCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD--LNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfG~a~~~~~~~-- 492 (627)
|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 241 L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 241 LFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp HHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred HHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 99999643 235899999999999999999999998 9999999999999865 899999999999875543
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
+..||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+...... ++.. ....
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~~---~~~~--~~~~ 382 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWN---MDDS--AFSG 382 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC---CCSG--GGTT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCCC---CCcc--cccC
Confidence 34689999999999999999999999999999999999999975432 2222222222111 1100 1112
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.++ ++.+++.+||..||++|||+.|++++
T Consensus 383 ~s~---~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 ISE---DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223 45567789999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.59 Aligned_cols=280 Identities=38% Similarity=0.676 Sum_probs=224.9
Q ss_pred CCCCHHHHHHHH-----hcccCcCCceeEEEEEecCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEE
Q 006886 327 FNFDLEDLLRAS-----AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYY 399 (627)
Q Consensus 327 ~~~~~~~l~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 399 (627)
..+++.++.... .+.||+|+||.||+|+.++++.||||++..... ....+.+|++++..+ +||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEE
Confidence 345555554443 468999999999999988899999999875432 233688999999999 899999999999
Q ss_pred eeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 400 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
...+..++||||+++|+|.+++..... ....++|..+..++.|++.||.|||+...+.|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999986532 3456999999999999999999999992223999999999999999999999
Q ss_pred eecccccccCCC-----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--CCCCCCCHHHHHHHH
Q 006886 480 SDVGLAHLINFP-----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS--GHDDVVDLPRWVRSV 552 (627)
Q Consensus 480 ~DfG~a~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~--~~~~~~~~~~~~~~~ 552 (627)
+|||+++..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||+.. ..........|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999876432 2234789999999998888999999999999999999999999632 122333455565555
Q ss_pred hhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 553 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..........+.... .....++...+.+++.+||+.+|.+|||+.|++++|+....
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 554444444444332 23456778889999999999999999999999999987533
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=346.48 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=203.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 478999999999999975 5899999988653 23456799999999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC----
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT---- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~---- 492 (627)
|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999998642 45899999999999999999999998 9999999999999999999999999998763321
Q ss_pred --------------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC---CHHHHHHHHhhh
Q 006886 493 --------------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV---DLPRWVRSVVRE 555 (627)
Q Consensus 493 --------------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~ 555 (627)
...||+.|+|||++.+..++.++||||||+++|||++|..|+......... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC-- 244 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC--
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC--
Confidence 345889999999999999999999999999999999999998754322211 1111111000
Q ss_pred cccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 556 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. ......+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 245 -------------~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 245 -------------P---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -------------C---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------C---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 11112466788899999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.27 Aligned_cols=248 Identities=22% Similarity=0.403 Sum_probs=207.6
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|...+++.||+|++.......+++.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 478999999999999998899999999987777788899999999999 8999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----CCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-----PTT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-----~~~ 493 (627)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.... ...
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9997542 35899999999999999999999998 99999999999999999999999999986643 233
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+..... ... .
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~~~---~~~-----~--- 229 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR---LYK-----P--- 229 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC---CCC-----C---
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcCcc---CCC-----C---
Confidence 446778999999988899999999999999999999 9999975321 111222111100 000 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
......+.+++.+||+.+|++|||+.|++++|+++.+..
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 111235677888999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=349.64 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=196.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.. ++.||||++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 578999999999999874 889999998765332 35688999999999 8999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 196 (309)
T 3p86_A 120 SLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196 (309)
T ss_dssp BHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------
T ss_pred cHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccccc
Confidence 99999975321 124899999999999999999999986 56999999999999999999999999999765432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ................ .
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~~~~-------~-- 261 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCKRLEI-------P-- 261 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCCCCCC-------C--
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCCCCC-------C--
Confidence 334578999999999999999999999999999999999999975421 1111111111111000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
......+.+++.+||+.+|++|||+.++++.|+.+......+
T Consensus 262 -~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 262 -RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 112235677888999999999999999999999998765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=351.65 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=203.9
Q ss_pred hcccCcCCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|+.. ++..||||+++.... ..+.+.+|++++.++.+||||+++++++...+..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 478999999999999853 355799999976432 3457899999999998899999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 409 YSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence 9999999999999865321 1245899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. .
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~~---~ 316 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---ELF---K 316 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH---H
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---H
Confidence 99999999866432 12235678999999999999999999999999999999 99999764322 111 1
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. +....... ........+.+++.+||..+|++||++.|+++.|+.+...
T Consensus 317 ~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 L-LKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H-HHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-HhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 11111100 0111223567788899999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.92 Aligned_cols=272 Identities=30% Similarity=0.537 Sum_probs=216.5
Q ss_pred CCCCCHHHHHHHHh-----------cccCcCCceeEEEEEecCCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccC
Q 006886 326 YFNFDLEDLLRASA-----------EVLGKGSYGSTYKAILEDGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKH 389 (627)
Q Consensus 326 ~~~~~~~~l~~~~~-----------~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h 389 (627)
...|+++++..++. +.||+|+||.||+|.. +++.||||++.... ...+.+.+|++++..+ +|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CC
Confidence 35577788877762 6799999999999997 48899999986532 2356789999999999 99
Q ss_pred CCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 006886 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNV 469 (627)
Q Consensus 390 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI 469 (627)
|||+++++++...+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999975432 346899999999999999999999998 99999999999
Q ss_pred EecCCCCeEEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 006886 470 LLTQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV 543 (627)
Q Consensus 470 Ll~~~~~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 543 (627)
+++.++.+||+|||+++..... ....+|+.|+|||++.+ .++.++||||||+++|||++|+.||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999999999999866432 23457899999998865 5889999999999999999999999865433322
Q ss_pred CHHHHHHHHhhhc-ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 544 DLPRWVRSVVREE-WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 544 ~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..+........ ...+.++..+ ..........+.+++.+||+.+|.+|||+.+++++|+++..
T Consensus 244 --~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 --LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 12222111111 1111122111 12235566778899999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=340.99 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=198.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..+ +||||+++++++...+..++||||+++|+
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 37899999999999995 46899999998654 34567789999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999753 4899999999999999999999998 999999999999999999999999998776432 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. .. ...
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~-~~--------~~~ 239 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-EL--------QNP 239 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CC--------SCG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-CC--------CCc
Confidence 34589999999999999999999999999999999999999975321 1111111111111 00 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1223356778889999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=332.77 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=206.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|..+++..||+|++.......+++.+|++++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 478999999999999999888999999987777788899999999999 8999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9997642 35899999999999999999999998 9999999999999999999999999998664432 2
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ............ ...+ ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~---~~~~-----~~- 229 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQGHR---LYRP-----HL- 229 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTCC---CCCC-----TT-
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcCCC---CCCC-----Cc-
Confidence 335678999999988889999999999999999999 9999975321 111111111110 0000 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
....+.+++.+||+.+|++|||+.|+++.|+.+++..
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 230 --ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1235677888999999999999999999999997653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.15 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=204.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++..+++..||+|++.......+++.+|++++..+ +||||+++++++.+.+..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 478999999999999999888999999987777788899999999999 8999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----CCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-----PTT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-----~~~ 493 (627)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.... ...
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9997642 35899999999999999999999998 99999999999999999999999999986643 223
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+...... .. .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~~~---~~-----~--- 243 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGLRL---YR-----P--- 243 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTCCC---CC-----C---
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhcccCC---CC-----C---
Confidence 345778999999988899999999999999999998 9999975421 1111111111100 00 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
......+.+++.+||+.+|++|||+.|++++|+++.+.+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111235677888999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=340.78 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHh-ccCCCeeeeeeEEeeC----CceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTI-GKHSNVVPVRAYYYSK----DEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+. +++.||||++... ....+..|.+++... .+||||+++++++... ...++||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 47899999999999998 5899999998653 355666777777763 2899999999987653 45789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH--------SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
+|+|.++++. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999964 25899999999999999999999 766 999999999999999999999999999
Q ss_pred cccCCC--------CCCCCCccccCccccCCC------CCCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 006886 486 HLINFP--------TTATRTIGYRAPEVTETR------KASQKSDVYSFGVLLLEMLTG----------KAPLQHSGHDD 541 (627)
Q Consensus 486 ~~~~~~--------~~~~~t~~y~aPE~~~~~------~~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~ 541 (627)
+..... ....||+.|+|||++.+. .++.++||||||+++|||++| +.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 765432 223689999999999876 445799999999999999999 78886543322
Q ss_pred CCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
. .... ............. .............+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~-~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 P-SFED-MRKVVCVDQQRPN----IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-CHHH-HHHHHTTSCCCCC----CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-chhh-hhHHHhccCCCCC----CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 1111 1111111111111 111111234566788899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=344.06 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=201.3
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|++++..+ +||||+++++++.+.+..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence 478999999999999974 34569999997642 2356789999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999997542 35999999999999999999999998 9999999999999999999999999998764321
Q ss_pred -------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 493 -------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 493 -------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~~~------ 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEGYRL------ 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTCCC------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCCCC------
Confidence 1224668999999988899999999999999999999 9999975421 1112211111100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.........+.+++.+||..||++|||+.|+++.|+.+.....
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0011222456778889999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.32 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=197.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.||+|+||.||+|+.+ +|+.||||++.... ...+.+.+|+.++..+ +||||+++++++...+..++||||+++|+|
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 47999999999999976 79999999987543 3567789999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ..
T Consensus 130 ~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 130 TDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 9998642 4899999999999999999999998 999999999999999999999999998776432 33
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+. ....... ....
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~~~-~~~~~~~--------~~~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLR-DSPPPKL--------KNSH 265 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSSCCCC--------TTGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cCCCCCc--------Cccc
Confidence 4689999999999999999999999999999999999999975321 11121111 1111110 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....+.+++.+||+.||++|||+.|++++-
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1123466788899999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.58 Aligned_cols=238 Identities=18% Similarity=0.315 Sum_probs=197.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 47899999999999997 4799999999976533 245688999999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 99 GEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 9999999765 24899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCCCCccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 TTATRTIGYRAPEVTETRKAS-QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....||+.|+|||++.+..+. .++||||+||++|||++|+.||.... .......+....... ..
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~---------p~ 235 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYRI---------PF 235 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCC---------CT
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCC---------CC
Confidence 345689999999999887775 79999999999999999999997542 222222222221110 00
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ...++.+++.+||..||.+|||++|++++
T Consensus 236 ~---~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 Y---MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp T---SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 12345678889999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.76 Aligned_cols=247 Identities=26% Similarity=0.469 Sum_probs=205.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|.++++..||||+++......+.|.+|++++..+ +||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 478999999999999998889999999987766788999999999999 9999999999986 66789999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
++++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 9997542 135789999999999999999999998 999999999999999999999999999876432 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+++.|+|||++....++.++||||||+++|||++ |+.||..... ......+...... ...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~~-----------~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALERGYRM-----------PRP 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHHTCCC-----------CCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC-----------CCC
Confidence 345678999999988899999999999999999999 9999975421 1112221111110 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.....++.+++.+||+.||++|||+++|++.|+++...
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12234567788899999999999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=353.92 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=203.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-ceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-EKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|++++.++ +||||+++++++...+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 478999999999999986 7899999997644 557799999999999 9999999999987765 78999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-CCCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATR 496 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~ 496 (627)
.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....+
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 348 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence 99998653 234799999999999999999999998 999999999999999999999999999865432 23346
Q ss_pred CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHH
Q 006886 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575 (627)
Q Consensus 497 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 575 (627)
++.|+|||++.+..++.++||||||+++|||++ |+.||......+ +...+ ....... .. ...
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~~~~-------~p---~~~ 411 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMD-------AP---DGC 411 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHH----HTTCCCC-------CC---TTC
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCCCC-------CC---CcC
Confidence 788999999999999999999999999999998 999998654332 21111 1111100 01 122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 576 ~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
...+.+++.+||+.+|++|||+.++++.|+++...++
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 3456778889999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=339.46 Aligned_cols=252 Identities=16% Similarity=0.200 Sum_probs=203.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++..+.+||||+++++++...+..++||||+ +|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 47899999999999996 468999999986542 23468899999999989999999999999999999999999 9999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC-----eEEeecccccccCCC-
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN-----GCISDVGLAHLINFP- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DfG~a~~~~~~- 491 (627)
.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999864 246999999999999999999999998 999999999999999887 999999999865332
Q ss_pred ----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 492 ----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 492 ----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......+.......
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~~~-- 239 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKIGDTKRAT-- 239 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHHHHHHHHHHS--
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHHHHHhhhccC--
Confidence 23458999999999999999999999999999999999999998754332 222222221111000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..... ....+ ++.+++..||+.+|.+||++.+|.+.|+++...
T Consensus 240 -~~~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 240 -PIEVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -CHHHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -CHHHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000 01111 677888899999999999999999999987644
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.48 Aligned_cols=247 Identities=22% Similarity=0.443 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|+.+ ++..||||+++... ...++|.+|++++.++ +||||+++++++...+..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCC
Confidence 478999999999999865 57789999987542 2346799999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.++++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 129 ENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999754 246899999999999999999999998 9999999999999999999999999998764322
Q ss_pred C-------CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 493 T-------ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 493 ~-------~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ..+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~~~~~------ 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDEGYRL------ 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHTTEEC------
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC------
Confidence 1 123567999999998899999999999999999998 9999975421 1111111111100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.........+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 270 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 -----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01112234577888899999999999999999999998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.82 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=206.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++...+++.||+|++.......+.+.+|++++..+ +||||+++++++...+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 478999999999999998889999999987766778899999999999 8999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----CCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-----PTT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-----~~~ 493 (627)
+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.... ...
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9997642 35899999999999999999999998 99999999999999999999999999986643 223
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.... .. .. ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~i~~~~-~~--~~-----~~-- 228 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF-RL--YK-----PR-- 228 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC-CC--CC-----CT--
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC------HHHHHHHHhcCC-cC--CC-----Cc--
Confidence 346778999999988889999999999999999999 899997532 112222211111 00 00 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.....+.+++.+||+.+|++||++.+++++|+++.+..
T Consensus 229 -~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 229 -LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11235677888999999999999999999999997653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.10 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=206.6
Q ss_pred hcccCcCCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|.++. +..||||.++......++|.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 4789999999999999874 88999999987666788999999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~----- 492 (627)
.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99998643 245899999999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .+... +....... ..
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~-------~~-- 441 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYRME-------RP-- 441 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCCCC-------CC--
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCCC-------CC--
Confidence 2234678999999988889999999999999999999 99999764322 11111 11111100 01
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
......+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 442 -~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11224567788899999999999999999999998644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.61 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=205.4
Q ss_pred hcccCcCCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|+.. .+..||||+++.... ..+.+.+|++++.++.+||||+++++++...+..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 478999999999999853 235799999976532 3367889999999998999999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 409 YSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence 9999999999999865421 1245899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------~~~~~~ 304 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFK 304 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence 99999999876432 22335778999999999999999999999999999999 999997542 122222
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.+. ....... . .....++.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 305 ~~~-~~~~~~~-------~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 305 LLK-EGHRMDK-------P---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHH-TTCCCCC-------C---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHH-cCCCCCC-------C---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 211 1111100 0 1122356778889999999999999999999999875543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=339.44 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=196.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHh-ccCCCeeeeeeEEeeC----CceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTI-GKHSNVVPVRAYYYSK----DEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ ++.||||++... ....+..|.+++... .+||||+++++++... ...++||||++
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 578999999999999986 899999998643 334455555555443 2899999999999887 67899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG-----GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+|+|.++++.. .+++..++.++.|++.||.|||+.+ .+.|+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 99999999753 4899999999999999999999981 112999999999999999999999999999765
Q ss_pred CCC--------CCCCCCccccCccccCCCCCCCc------chhHHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006886 489 NFP--------TTATRTIGYRAPEVTETRKASQK------SDVYSFGVLLLEMLTG----------KAPLQHSGHDDVVD 544 (627)
Q Consensus 489 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~------~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~~~~ 544 (627)
... ....||+.|+|||++.+..+..+ +|||||||++|||++| +.||........ .
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-c
Confidence 332 23468999999999987766665 9999999999999999 566654322211 1
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.. ..............+. ......+...++.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 272 ~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 272 YE-DMREIVCIKKLRPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp HH-HHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hh-hhHHHHhhhccCcccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 11 1111111111111111 11112356677889999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=351.34 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=201.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|.++ +++.||||.++.... ..+.|.+|++++..+ +||||+++++++...+..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 478999999999999986 689999999875422 234688999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999998642 35899999999999999999999998 9999999999999999999999999998654321
Q ss_pred ---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 493 ---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 493 ---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .+........... .
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-------~ 336 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP-------C 336 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC-------C
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-------C
Confidence 1224667999999988889999999999999999998 99999754211 1111111111000 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
. ......+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 337 ~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 P---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1 1122356778889999999999999999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=332.56 Aligned_cols=253 Identities=15% Similarity=0.174 Sum_probs=203.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++..+.+|+|++++++++......++||||+ +++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 47899999999999996 478999999986432 33467889999999989999999999999999999999999 9999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC-----eEEeecccccccCCC-
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN-----GCISDVGLAHLINFP- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DfG~a~~~~~~- 491 (627)
.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99998642 35899999999999999999999998 999999999999987776 999999999876432
Q ss_pred ----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 492 ----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 492 ----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..............
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~- 241 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKKQSTP- 241 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH---HHHHHHHHHHHHSC-
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH---HHHHHHHhhccCcc-
Confidence 2335789999999999999999999999999999999999999865433221 11111111110000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.... ... ....+.+++.+||+.+|++||++++|++.|+++...
T Consensus 242 -~~~~--~~~---~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 -LREL--CAG---FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp -HHHH--TTT---SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHHH--Hhh---CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000 011 123567788899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.17 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.++..+ +||||+++++++......++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEE
Confidence 478999999999999953 46689999986542 2345788999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRSD--GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfG~a 485 (627)
|+++|+|.+++...+.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 99999999999875421 2245899999999999999999999998 99999999999999554 5999999999
Q ss_pred cccC------CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLIN------FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+......
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGGRM 305 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC
Confidence 7542 1223446889999999988899999999999999999998 9999975421 1222222211110
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. ........+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 306 -~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 306 -D----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -C----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 0011223567788899999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.06 Aligned_cols=245 Identities=18% Similarity=0.337 Sum_probs=200.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++..+ +++.||+|.+.........+.+|++++..+ +||||+++++++.+.+..++||||+++|+|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 478999999999999976 588999999876555566788999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--CCCeEEeecccccccCCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ--DLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~a~~~~~~~--- 492 (627)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 89 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 161 (321)
T 1tki_A 89 FERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccc
Confidence 9999753 235899999999999999999999998 999999999999997 7899999999998775433
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...... ++... ..
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~---~~~~~--~~-- 228 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT---FDEEA--FK-- 228 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---CCHHH--HT--
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCC---CChhh--hc--
Confidence 23478999999999988899999999999999999999999975321 2222222222111 11100 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
....++.+++.+|+..||++|||+.|++++-.
T Consensus 229 -~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 229 -EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 11235677888999999999999999998543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.04 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=201.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|.++++..||||+++......++|.+|++++.++ +||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 478999999999999998888899999987666778899999999999 99999999999876 6789999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... +..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 9997532 235899999999999999999999998 9999999999999999999999999998764321 2
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... .. ...
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~-~~----------~~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGY-RM----------PCP 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-CC----------CCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC-CC----------CCC
Confidence 235678999999988899999999999999999999 9999975421 11122211111 00 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
......+.+++.+||+.+|++|||++++++.|+.+....
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 122345677888999999999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.76 Aligned_cols=245 Identities=20% Similarity=0.305 Sum_probs=195.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT----KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|+++..... .+.+..|..++.++.+||||+++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 478999999999999976 5788999999765322 23578889999888799999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999865 35899999999999999999999998 99999999999999999999999999986322
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC--CCHHHHHHHHhhhcccccccchhhh
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV--VDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
..+..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .................
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------- 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--------
Confidence 2345689999999999999999999999999999999999999975432211 11111121111111110
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKM------DDVVR 602 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~ev~~ 602 (627)
-.... ..++.+++.+||+.||++||++ +|+++
T Consensus 281 ~p~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 IPRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCTTS---CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCCcC---CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 01111 2345678889999999999996 56655
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.48 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +|+.||+|+++.. ....+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 6899999999753 23456788999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 89 GGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999764 35899999999999999999999998 99999999999999999999999999986432
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
..+..||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... + .
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~---~------p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEIR---F------P 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---C------C
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC---C------C
Confidence 234458999999999999999999999999999999999999997532 12222222221110 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
...+ .++.+++.+||+.||++|| +++|++++
T Consensus 226 ~~~s---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112 3456778899999999999 89999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.49 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=201.4
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-eEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-KLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~ 409 (627)
.+.||+|+||.||+|++. +++.||||+++.... ..+.+.+|++++.++.+||||+++++++.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 478999999999999842 457899999976432 345789999999999889999999999987654 88999
Q ss_pred ecCCCCCHHHHhhhcCCCC-------------------------------------------------------------
Q 006886 410 SYMPAGSLFMLLHRNRSDG------------------------------------------------------------- 428 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~------------------------------------------------------------- 428 (627)
||+++|+|.++++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998653210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC------CCCCCCccccC
Q 006886 429 GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP------TTATRTIGYRA 502 (627)
Q Consensus 429 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~------~~~~~t~~y~a 502 (627)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....+|+.|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 122899999999999999999999998 999999999999999999999999999866332 22346788999
Q ss_pred ccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHH
Q 006886 503 PEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQ 581 (627)
Q Consensus 503 PE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 581 (627)
||++.+..++.++||||||+++|||++ |+.||......+ .+............ . .....++.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~-------~---~~~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA-------P---DYTTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC-------C---TTCCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC-------C---CCCCHHHHH
Confidence 999988899999999999999999998 999997643221 11111111111110 0 111235677
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 582 IALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 582 l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
++.+||+.+|++|||+.|++++|+++.+.
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 88899999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=335.01 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=194.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.++++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~- 103 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK- 103 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence 478999999999999998899999999875432 236788999999999 999999999999999999999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 104 DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 8888887542 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc---chh--
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF---DVE-- 565 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d~~-- 565 (627)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+............. +..
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchh
Confidence 23457899999999876 568999999999999999999999998654332 112221111111100000 000
Q ss_pred ----hh--cCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 566 ----LL--KYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 566 ----l~--~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.. ..... +....++.+++.+|++.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00000 011235678888999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.90 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=189.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... ++.||||+++... ...+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCC
Confidence 478999999999999986 8899999986542 2346789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--------CCCeEEeecccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ--------DLNGCISDVGLA 485 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--------~~~~ki~DfG~a 485 (627)
+++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999999863 35899999999999999999999998556999999999999986 778999999999
Q ss_pred cccCCC--CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 486 HLINFP--TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 486 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
+..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ...............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~--- 234 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLALP--- 234 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCCC---
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCCC---
Confidence 866433 234578999999999888999999999999999999999999975321 111111111111100
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
........+.+++.+||+.+|++|||+.|++++|+++
T Consensus 235 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 -------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111223567788899999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.13 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=180.0
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
+.||+|+||.||++..+ +++.||||++... ....+.+|++++..+.+||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999975 6899999998643 45678899999999966999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEeecccccccCCC----
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCISDVGLAHLINFP---- 491 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfG~a~~~~~~---- 491 (627)
+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 999864 35899999999999999999999998 99999999999998765 7999999999866432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-CCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV-VDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||........ .........+...... +...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~---~~~~----- 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS---FEGE----- 238 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---CCSH-----
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---CCcc-----
Confidence 234578999999999999999999999999999999999999986543221 1222222222211110 0000
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......++.+++.+||..||++|||+.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001123456778889999999999999999653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=340.48 Aligned_cols=241 Identities=19% Similarity=0.358 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+++.+ +|+.||+|++..... ..+.+.+|++++..+ +||||+++++++.+.+..++|||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEE
Confidence 478999999999999976 689999999875432 357899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC----CeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~ 486 (627)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999753 35899999999999999999999998 99999999999998877 79999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+..... .++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~~---~~~ 238 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVSY---DFD 238 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC---CCC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCC---CCC
Confidence 76543 345689999999999998999999999999999999999999975321 122222221111 011
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
... .... ...+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~--~~~~---s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEF--FSQT---SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHH--HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chh--ccCC---CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 0111 234567888999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.44 Aligned_cols=246 Identities=22% Similarity=0.404 Sum_probs=195.2
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|++. +++ .||+|.+.... ...+++.+|++++.++ +||||+++++++... ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-SEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-CeEEEEEe
Confidence 478999999999999964 344 35888875432 3567899999999999 999999999999875 47799999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999998653 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... +.. .......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~------ 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER------ 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCC------
Confidence 2 2235778999999999999999999999999999999 999997643221 111 1111110
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..........+.+++.+||+.+|++||++.|++++|+.+...
T Consensus 238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 001112234577888899999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.63 Aligned_cols=264 Identities=17% Similarity=0.260 Sum_probs=206.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++.... ..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCC
Confidence 478999999999999976 48999999997543 3467788999999999 8999999999988765 6789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----cCCCCeEEeecccccccC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL----TQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfG~a~~~~ 489 (627)
+|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp TCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999986532 234899999999999999999999998 9999999999999 788889999999998765
Q ss_pred CCC---CCCCCccccCccccC--------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 490 FPT---TATRTIGYRAPEVTE--------TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 490 ~~~---~~~~t~~y~aPE~~~--------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
... ...+|+.|+|||++. +..++.++||||||+++|||++|+.||....... ........+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPS 245 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCT
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCc
Confidence 432 345889999999875 5678999999999999999999999997543221 112222222222111
Q ss_pred c---cc-------c--chhhh-cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 559 A---EV-------F--DVELL-KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 559 ~---~~-------~--d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
. .. + ...+. ...........+.+++.+||+.||++|||++|++++..+-...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 0 00 0 00000 1112245556778899999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.01 Aligned_cols=254 Identities=23% Similarity=0.401 Sum_probs=196.8
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e 410 (627)
.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEE
Confidence 47899999999999984 2588999999875432 346789999999999 899999999998653 45899999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999998653 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC--------CCC-CHHHHHHHHhh
Q 006886 491 PT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD--------DVV-DLPRWVRSVVR 554 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~--------~~~-~~~~~~~~~~~ 554 (627)
.. ...++..|+|||++.+..++.++||||||+++|||++|..|+...... ... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 21 223566799999999889999999999999999999999998642100 000 00000001111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
... ..........++.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 247 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 247 NNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 100 0011122234677788899999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.76 Aligned_cols=252 Identities=19% Similarity=0.295 Sum_probs=200.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 94 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIE 94 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCC
Confidence 478999999999999965 688999999854322 245788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 95 g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 95 GPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp SCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999865 25899999999999999999999998 999999999999999999999999999876432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. ......
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~----~~~~~~ 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVP----NVTTDV 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCC----CHHHHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCC----Ccchhc
Confidence 223579999999999999999999999999999999999999975421 1111111111110 100001
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhccccc
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRP-KMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~ev~~~L~~~~~~~~ 612 (627)
.... ...+.+++.+|++.||++|| +++++.+.|+.+.....
T Consensus 237 ~~~~---~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 RKDI---PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CTTS---CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ccCC---CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1112 23566788899999999998 99999999998865543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=337.10 Aligned_cols=242 Identities=21% Similarity=0.374 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||++..+ +++.||+|++..... ..+.+.+|++++..+ +||||+++++++...+..++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEE
Confidence 578999999999999976 589999999865421 367899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC----CeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~ 486 (627)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 95 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999753 35899999999999999999999998 99999999999999887 79999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... .+.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~---~~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNY---EFE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTCC---CCC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcCC---CcC
Confidence 76432 344589999999999999999999999999999999999999975321 111111111110 011
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... . .....+.+++.+||..||++|||+.|++++
T Consensus 238 ~~~~--~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEYF--S---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHH--T---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccc--c---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 1 112356678889999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.13 Aligned_cols=247 Identities=21% Similarity=0.440 Sum_probs=196.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--C------HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--T------KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+|+.. +++.||+|++..... . .+.+.+|++++.++ +||||+++++++.+.. ++||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~ 100 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVM 100 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEE
Confidence 478999999999999974 789999999864322 1 16789999999999 8999999999986554 6999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC-----eEEeeccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN-----GCISDVGL 484 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~ki~DfG~ 484 (627)
||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++. +||+|||+
T Consensus 101 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 101 EFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp ECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 999999999988754 246999999999999999999999986 56999999999999988876 99999999
Q ss_pred ccccCCC-CCCCCCccccCcccc--CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 485 AHLINFP-TTATRTIGYRAPEVT--ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 485 a~~~~~~-~~~~~t~~y~aPE~~--~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
++..... ....+|+.|+|||++ ....++.++||||||+++|||++|+.||....... ...............
T Consensus 176 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~- 250 (287)
T 4f0f_A 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPT- 250 (287)
T ss_dssp CBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCC-
T ss_pred cccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCC-
Confidence 9865443 335688999999998 44567899999999999999999999997543321 111222111111111
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
+ .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 251 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 I---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 011223567788899999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=341.35 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||||+++.. ....+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 5899999999754 23456688899999988789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 999999998653 5899999999999999999999998 99999999999999999999999999986432
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
..+..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... + .
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---~------p 244 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV---Y------P 244 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---C------C
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC---C------C
Confidence 2345689999999999888899999999999999999999999975421 2222222222110 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM------DDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~ev~~ 602 (627)
.. ....+.+++.+|+..+|++||++ +|+++
T Consensus 245 ~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 12345678889999999999998 77765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.03 Aligned_cols=252 Identities=22% Similarity=0.389 Sum_probs=202.2
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++..+ +||||+++++++...+..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEe
Confidence 478999999999999975 347899999975432 346789999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 006886 411 YMPAGSLFMLLHRNRSD-------------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 471 (627)
|+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEE
Confidence 99999999999864311 1256899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecccccccCC------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006886 472 TQDLNGCISDVGLAHLINF------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 544 (627)
+.++.+||+|||+++.... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 282 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----- 282 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-----
Confidence 9999999999999876532 223446788999999988899999999999999999999 9999975321
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
......+.... .... . ......+.+++.+||+.+|++||++.++++.|+++.+..
T Consensus 283 -~~~~~~~~~~~-~~~~-------~---~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 -EEVIYYVRDGN-ILAC-------P---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -HHHHHHHHTTC-CCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -HHHHHHHhCCC-cCCC-------C---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11122111111 1000 0 112235677888999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.38 Aligned_cols=266 Identities=25% Similarity=0.373 Sum_probs=194.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHH--HhccCCCeeeeeeEEee-----CCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVG--TIGKHSNVVPVRAYYYS-----KDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~--~l~~h~niv~l~~~~~~-----~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|+. +++.||||++.... ...+..|.++.. .+ +||||+++++.+.. ....++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEEEEEec
Confidence 47899999999999987 48999999986533 344455554443 35 99999999986543 2256899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE---------GGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+++|+|.+++... ..++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 94 ~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 94 YPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCC
T ss_pred CCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeec
Confidence 9999999999754 358999999999999999999998 6 999999999999999999999999
Q ss_pred ccccccCCC------------CCCCCCccccCccccCC-------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 006886 483 GLAHLINFP------------TTATRTIGYRAPEVTET-------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV 543 (627)
Q Consensus 483 G~a~~~~~~------------~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~ 543 (627)
|+++..... ....||+.|+|||++.+ ..++.++||||||+++|||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999765321 13358899999999976 35567899999999999999997776543221111
Q ss_pred -CH----------HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 544 -DL----------PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 544 -~~----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.. ................+.. ...........+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 10 0001111111111111111 111223355578889999999999999999999999999998888
Q ss_pred ccCCCCCC
Q 006886 613 RNRASSGT 620 (627)
Q Consensus 613 ~~~~~~~~ 620 (627)
++.+.+.+
T Consensus 322 ~~~~~~~~ 329 (336)
T 3g2f_A 322 RNKSVSPT 329 (336)
T ss_dssp C-------
T ss_pred hcccCCCc
Confidence 77765543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.09 Aligned_cols=252 Identities=22% Similarity=0.381 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEecC-C-------cEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILED-G-------TTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+|..+. + ..||+|++.... ...+.+.+|++++..+ +||||+++++++...+..++||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEE
Confidence 4789999999999998653 3 479999986543 4567899999999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC--------eEEee
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN--------GCISD 481 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~ki~D 481 (627)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999998642 34899999999999999999999998 999999999999998887 99999
Q ss_pred cccccccCCCCCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 482 VGLAHLINFPTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 482 fG~a~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
||++..........+++.|+|||++.+ ..++.++||||||+++|||++|..|+.... .................
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKLQFYEDRHQLPA 239 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHHHHHHTTCCCCC
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHHHHhhccCCCCC
Confidence 999987655545557889999999977 678999999999999999999655543221 11111111111000000
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccccCC
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRA 616 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~~ 616 (627)
. ...++.+++.+||+.||++|||+.|+++.|+++..+......
T Consensus 240 ----------~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 240 ----------P---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp ----------C---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred ----------C---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence 0 012466788899999999999999999999999887665443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.17 Aligned_cols=239 Identities=20% Similarity=0.311 Sum_probs=195.6
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|.. .+++.||+|++... ......+.+|+++++.+ +||||+++++++...+..++||||+
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 47899999999999996 46899999998653 22345789999999999 8999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 92 ~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 92 GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 78999998764 35899999999999999999999998 999999999999999999999999999876443
Q ss_pred -CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......... .+........
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~~~~~~p 228 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNSCVYVMP 228 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCSSCCCCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHcCCCCCc
Confidence 34568999999999988776 689999999999999999999997643322111 0000000001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.. ....+.+++.+|+..||.+|||++|++++-.
T Consensus 229 ~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 229 DF---LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp TT---SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred cc---CCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 11 1234567888999999999999999988533
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=335.14 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=204.7
Q ss_pred hcccCcCCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|+. .+++.||+|++..... ..+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 47899999999999985 2467899999975432 346789999999999899999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 411 YMPAGSLFMLLHRNRS-------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence 9999999999986532 11235899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||+++...... ...+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHH
Confidence 999999998765432 2235678999999988899999999999999999999 999997643221 111
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.......... .. ......+.+++.+||+.||.+|||+.|++++|+++....
T Consensus 259 ~~~~~~~~~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 259 KMIKEGFRML-------SP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHTCCCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCCC-------Cc---ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111111100 00 112235677888999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.99 Aligned_cols=246 Identities=19% Similarity=0.281 Sum_probs=191.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+++.+ +++.||||++.......+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 478999999999999976 689999999987666667889999999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC--eEEeecccccccCC---CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN--GCISDVGLAHLINF---PT 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfG~a~~~~~---~~ 492 (627)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.... ..
T Consensus 104 ~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 104 YERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 9999764 25899999999999999999999998 999999999999988765 99999999975432 23
Q ss_pred CCCCCccccCccccCCCCCCCc-chhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQK-SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~-~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... ............... + .....
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~---~----~~~~~ 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYS---I----PDDIR 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCC---C----CTTSC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCC---C----CCcCC
Confidence 4568999999999988777655 899999999999999999998643322 222322222221110 0 00111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
. ...+.+++.+||..+|++|||+.|++++-.
T Consensus 247 ~---s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 247 I---SPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp C---CHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 1 234567888999999999999999998633
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.59 Aligned_cols=245 Identities=20% Similarity=0.303 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|++..... ..+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 588999999976432 234577889999888789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 94 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999864 25899999999999999999999998 99999999999999999999999999986422
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--CHHHHHHHHhhhcccccccchhhh
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV--DLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ................ +
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--~----- 238 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--I----- 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--C-----
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--C-----
Confidence 23456899999999999999999999999999999999999999753322111 1111111111111100 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKM------DDVVR 602 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~ev~~ 602 (627)
... ...++.+++.+||..||++||++ .|+++
T Consensus 239 -p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 -PRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CTT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 011 12346678889999999999996 56665
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.84 Aligned_cols=240 Identities=19% Similarity=0.278 Sum_probs=195.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++..+ +++.||+|++... ....+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 478999999999999966 5889999998653 23457788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999754 35899999999999999999999998 999999999999999999999999999876433
Q ss_pred -CCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 -TTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ............ .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~~-~--------- 237 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETTV-V--------- 237 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHCC-C---------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhcc-c---------
Confidence 34568999999999864 458999999999999999999999997543322 122221111110 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPK-MDDVVR 602 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~ev~~ 602 (627)
.........+.+++.+||..+|.+||+ ++++.+
T Consensus 238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000112235677888999999999998 676654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=326.76 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=193.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||++... ++.||||++... ...+.+.+|++++.++ +||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 478999999999999986 788999998643 3456789999999999 9999999999876 4578999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC-eEEeecccccccCCC-CCCCC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN-GCISDVGLAHLINFP-TTATR 496 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-~ki~DfG~a~~~~~~-~~~~~ 496 (627)
+++..... ...+++..++.++.|+++||.|||+.+...|+||||||+||+++.++. +||+|||++...... ....|
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~g 165 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG 165 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------C
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCC
Confidence 99985421 234788999999999999999999932223999999999999998887 799999999766443 33458
Q ss_pred CccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHH
Q 006886 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEM 576 (627)
Q Consensus 497 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 576 (627)
|+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .... .....
T Consensus 166 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~----------~~~~~ 230 (307)
T 2eva_A 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGT-RPPL----------IKNLP 230 (307)
T ss_dssp CTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTC-CCCC----------BTTCC
T ss_pred CCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCC-CCCc----------ccccC
Confidence 99999999999999999999999999999999999999754321 111111111111 1100 01112
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 577 VQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 577 ~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
..+.+++.+||+.+|++|||+.|+++.|+.+...-
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 35667888999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.02 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=198.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +|+.||+|+++... ...+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 478999999999999975 68999999997542 3456788899999998 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 90 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 90 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999999864 35899999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... + ....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---~------p~~~ 226 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---F------PPFF 226 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---C------CTTS
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---C------CCCC
Confidence 4568999999999999999999999999999999999999997532 12222222222110 0 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
+ .++.+++.+|+..||++|| +++|++++
T Consensus 227 ~---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 227 N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 2 3456778899999999999 89998863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.20 Aligned_cols=240 Identities=21% Similarity=0.340 Sum_probs=191.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----------
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE----------- 404 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 404 (627)
.+.||+|+||.||+|+.+ +++.||||+++... ...+.+.+|++++.++ +||||+++++++.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 478999999999999976 78999999987443 2457799999999999 89999999999865432
Q ss_pred ----------------------------------------------eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHH
Q 006886 405 ----------------------------------------------KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRM 438 (627)
Q Consensus 405 ----------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~ 438 (627)
.++||||+++|+|.+++..... ....++..++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence 7899999999999999986532 3456788899
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----------------CCCCCCccccC
Q 006886 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----------------TTATRTIGYRA 502 (627)
Q Consensus 439 ~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----------------~~~~~t~~y~a 502 (627)
.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 99999999999999998 999999999999999999999999999876432 22357899999
Q ss_pred ccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHH
Q 006886 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQI 582 (627)
Q Consensus 503 PE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l 582 (627)
||++.+..++.++||||||+++|||++|..|+... ...... ..... .. .........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~-~~~~~----~~------~~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITD-VRNLK----FP------LLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHH-HHTTC----CC------HHHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHH-hhccC----CC------cccccCChhHHHH
Confidence 99999999999999999999999999987764210 000110 10100 00 0112333456788
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 006886 583 ALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 583 ~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.+||+.||++|||+.|++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=336.57 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=193.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++..+ +||||+++++++.+.+..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 478999999999999976 78999999986432 2346688999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999998653 35899999999999999999999998 999999999999999999999999999765321
Q ss_pred --CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 --TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . .......... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~~~~~~~~~~---~~----- 229 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKKTY---LN----- 229 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----HHHHHTTCTT---ST-----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHHhccccc---CC-----
Confidence 24568999999999977665 7789999999999999999999976432211 1 1111111000 00
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
........+.+++.+||..||++|||+.|++++-
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0111223456788899999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=345.35 Aligned_cols=242 Identities=18% Similarity=0.297 Sum_probs=195.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++... +|+.||+|++..... ..+.+.+|++++..+ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 578999999999999864 689999999865432 345688999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec---CCCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 95 g~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 95 GELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999864 35899999999999999999999998 99999999999998 4678999999999876543
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+..... +....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----~~~~~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAY-----DFPSP 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-----CCCTT
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCC-----CCCcc
Confidence 234689999999999998999999999999999999999999975321 122222221111 10001
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+ .++.+++.+||..||++|||+.|++++
T Consensus 236 ~~~~~s---~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDTVT---PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCC---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111222 345677889999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.11 Aligned_cols=245 Identities=18% Similarity=0.306 Sum_probs=197.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|..+ +++.||||++.... ...+.+.+|++++..+ +||||+++++++.+++..++||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeC
Confidence 578999999999999965 68999999986431 2467899999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeeccccccc
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLAHLI 488 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a~~~ 488 (627)
+++|+|.+++..... .+..+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999988865421 1345899999999999999999999998 999999999999987655 999999999876
Q ss_pred CCC----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 489 NFP----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 489 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+...... +++
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~~ 253 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MNP 253 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CCH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CCc
Confidence 543 23458999999999999899999999999999999999999997531 1112222211110 111
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ... ...++.+++.+||..||++|||+.|++++
T Consensus 254 ~~--~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 254 RQ--WSH---ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HH--HTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc--ccc---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 011 12356678889999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.48 Aligned_cols=238 Identities=23% Similarity=0.351 Sum_probs=195.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||+|+++.. ....+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999976 5889999999754 23456778889988887799999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999864 24899999999999999999999998 99999999999999999999999999986432
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..... .+.
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~---~~p------ 238 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDNP---FYP------ 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC---CCC------
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCC---CCC------
Confidence 2345689999999999999999999999999999999999999975421 122222221110 000
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMD-DVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~~ 602 (627)
... ..++.+++.+||..+|++||++. |+++
T Consensus 239 ~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccc---CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111 23456788899999999999998 6653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.69 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=190.6
Q ss_pred hcccCcCCceeEEEEEecCCc----EEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce------
Q 006886 339 AEVLGKGSYGSTYKAILEDGT----TVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK------ 405 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~----~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------ 405 (627)
.+.||+|+||.||+|...... .||||+++... ...+.+.+|++++.++ +||||+++++++......
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCcc
Confidence 578999999999999966432 79999987542 2356789999999999 999999999999877655
Q ss_pred EEEEecCCCCCHHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSD-GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
++|+||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccc
Confidence 8999999999999999764321 1235899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 485 AHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 485 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
++...... ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ + .........
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---~~~~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I---YNYLIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHHHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H---HHHHhcCCC
Confidence 98764322 2235678999999998899999999999999999999 999997643221 1 111111111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
. .........+.+++.+||+.||++|||+.++++.|+++....-
T Consensus 258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 0 0111222456788889999999999999999999999865543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.59 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=200.6
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 578999999999999962 35689999997542 2346789999999999889999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec
Q 006886 411 YMPAGSLFMLLHRNRSD------------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 472 (627)
|+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence 99999999999864321 1134899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006886 473 QDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545 (627)
Q Consensus 473 ~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~ 545 (627)
.++.+||+|||++....... ...+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 282 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 282 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----
Confidence 99999999999998764332 2235678999999988899999999999999999998 999997643221
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
............. ........+.+++.+||..||.+|||+.|++++|+.+....-
T Consensus 283 --~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 283 --NFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp --HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred --HHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 1112222211110 001112356778889999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=326.98 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=205.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|..+ ++..||+|++.......+.+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 478999999999999976 488899999987666678899999999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT----- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~----- 492 (627)
.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99998643 346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+ ...... ..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~~~~----------~~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDYRM----------ER 233 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCCC----------CC
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hccCCC----------CC
Confidence 1234678999999988899999999999999999999 99999754322 111111 111000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.......+.+++.+|+..+|.+|||+.|+++.|+.+...
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111223567788899999999999999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.75 Aligned_cols=254 Identities=17% Similarity=0.218 Sum_probs=192.1
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEecccccCHHHHHHHHHHHHHhc--------------cCCCeeeeeeE
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAATKREFEQQMEVVGTIG--------------KHSNVVPVRAY 398 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------------~h~niv~l~~~ 398 (627)
.+.||+|+||.||+|.+++ ++.||||++.... ..+..|++++.++. +||||++++++
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 4789999999999999764 4789999986532 23334444433332 69999999999
Q ss_pred EeeC----CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec--
Q 006886 399 YYSK----DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-- 472 (627)
Q Consensus 399 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-- 472 (627)
+... ...++||||+ +|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 8865 3478999999 99999999864 246999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 006886 473 QDLNGCISDVGLAHLINFP-----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541 (627)
Q Consensus 473 ~~~~~ki~DfG~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~ 541 (627)
.++.+||+|||+++..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999765321 22338999999999999999999999999999999999999998533221
Q ss_pred CCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
............ .....++..+. .... ..++.+++..||..+|++||++.++++.|+++...
T Consensus 269 --~~~~~~~~~~~~-~~~~~~~~~~~-~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 --KYVRDSKIRYRE-NIASLMDKCFP-AANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp --HHHHHHHHHHHH-CHHHHHHHHSC-TTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHhhh-hHHHHHHHhcc-cccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 111111111111 11112221111 0111 23566788899999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.29 Aligned_cols=237 Identities=19% Similarity=0.227 Sum_probs=188.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+.. +++.||||++...... ...+..|+..+.++.+||||+++++++.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 478999999999999976 7899999998654332 3345566666666669999999999999999999999999 7
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 79999987652 46999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+ .++.++||||||+++|||++|..|+.... . ... +... ...+...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~-~~~-~~~~----~~~~~~~---- 274 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------G-WQQ-LRQG----YLPPEFT---- 274 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------H-HHH-HTTT----CCCHHHH----
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------H-HHH-Hhcc----CCCcccc----
Confidence 23458999999999876 78999999999999999999977764311 0 111 1111 1111111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+||+.||++|||+.|++++
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0112456778889999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.43 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=202.2
Q ss_pred hcccCcCCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++..+ +||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEe
Confidence 47899999999999986 2357899999975432 346788999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 006886 411 YMPAGSLFMLLHRNRSD-------------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 471 (627)
|+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEE
Confidence 99999999999865321 1234899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006886 472 TQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVD 544 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~ 544 (627)
+.++.+||+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 260 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999866432 22345778999999988889999999999999999999 999997543221
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
+.. ......... ........+.+++.+||+.||++||++.|+++.|+++...
T Consensus 261 ~~~----~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 261 LFN----LLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHH----HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH----HhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 111111100 0011223567788899999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.67 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=204.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|.++++..||||+++......++|.+|++++.++ +||||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 578999999999999998888899999987666778899999999999 99999999999876 6789999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 9997532 235899999999999999999999998 999999999999999999999999999876431 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+. ...... ..
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~-~~~~~~----------~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVE-RGYRMP----------CP 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHH-TTCCCC----------CC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-cCCCCC----------CC
Confidence 345778999999988899999999999999999999 9999975421 11122111 111000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
......+.+++.+||+.+|++|||+++|++.|+.+...
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12234567788899999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.13 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ ++.||||++..... ..+.+.+|++++.++ +||||+++++++... +..++||||++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccC
Confidence 478999999999999986 88999999875432 345688999999999 899999999999877 67899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
+|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++.++|+|||++..... ..
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~ 167 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PG 167 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TT
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-cC
Confidence 999999998642 235899999999999999999999975 5699999999999999999999999998765433 34
Q ss_pred CCCCccccCccccCCCCCCC---cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTETRKASQ---KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~---~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..+|+.|+|||++.+..++. ++||||||+++|||++|+.||..... ................ .
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-------~- 233 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPTI-------P- 233 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCCC-------C-
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCCC-------C-
Confidence 56789999999997765544 79999999999999999999975321 1111222211111110 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
......+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 234 --~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 --PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1122356778889999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.71 Aligned_cols=246 Identities=22% Similarity=0.396 Sum_probs=194.7
Q ss_pred hcccCcCCceeEEEEEec-CCcE----EEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTT----VVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|.+. +++. ||+|.+.... ...+.+.+|+.++..+ +||||+++++++. ++..++|+||
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEe
Confidence 478999999999999965 3443 7888775432 2335677899999999 9999999999886 5668899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++...+ ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999997542 36889999999999999999999998 999999999999999999999999999876433
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...++..|+|||++.+..++.++||||||+++|||++ |+.||....... +... ........ .+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~--~~ 239 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKGERLA--QP 239 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTTCBCC--CC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcCCCCC--CC
Confidence 2 2335678999999998899999999999999999999 999998643221 1111 11111000 00
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
......+.+++.+||..+|++||++.|++++|+.+...
T Consensus 240 --------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 --------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112456788899999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=340.19 Aligned_cols=246 Identities=19% Similarity=0.278 Sum_probs=190.6
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++..+ +++.||||+++. ...+.+|++++.++.+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999975 688999999863 34577888888777799999999999875 5568999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999997542 246899999999999999999999998 999999999999998 789999999999876432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-CHHHHHHHHhhhcccccccchhhh
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV-DLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+ ...... ... .
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~~~--~~~---~ 289 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQYE--FPN---P 289 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTCCC--CCT---T
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCccc--CCC---c
Confidence 3445799999999999999999999999999999999999999865433221 111111 111100 000 0
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
... ....++.+++.+||..||++|||+.|++++-.-
T Consensus 290 ~~~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 290 EWS---EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 111 122356678889999999999999999986443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.14 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=192.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 67999999999999965 68999999987543 3456799999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe--cCCCCeEEeecccccccCCC---C
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL--TQDLNGCISDVGLAHLINFP---T 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl--~~~~~~ki~DfG~a~~~~~~---~ 492 (627)
.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..... .
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99987542 35899999999999999999999998 9999999999999 56788999999999876543 2
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....+... .. .....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~--~~---~~~~~ 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN------DAETLNNILACRWDLE--DE---EFQDI 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCCSC--SG---GGTTS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhccCCCC--hh---hhccC
Confidence 3458999999999998899999999999999999999999997542 1222233332221110 00 01112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..++.+++.+||..||.+|||+.|+++
T Consensus 316 ---~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 ---SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 235667888999999999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.41 Aligned_cols=239 Identities=21% Similarity=0.315 Sum_probs=187.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---------------------------CHHHHHHHHHHHHHhccCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------------------------TKREFEQQMEVVGTIGKHS 390 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~~h~ 390 (627)
.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++.++ +||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 96 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHP 96 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-CCT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-CCC
Confidence 478999999999999965 688999999864321 124688999999999 999
Q ss_pred CeeeeeeEEee--CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 006886 391 NVVPVRAYYYS--KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSN 468 (627)
Q Consensus 391 niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 468 (627)
||+++++++.. .+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN 167 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99999999986 5678999999999999876532 35899999999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeecccccccCCC----CCCCCCccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 006886 469 VLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEVTETRK---ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDD 541 (627)
Q Consensus 469 ILl~~~~~~ki~DfG~a~~~~~~----~~~~~t~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~ 541 (627)
||++.++.+||+|||+++..... ....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--- 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence 99999999999999999876543 2346899999999997655 3788999999999999999999997532
Q ss_pred CCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.......+...... ....... ..++.+++.+||+.||++|||+.|++++
T Consensus 245 ---~~~~~~~~~~~~~~-------~~~~~~~---~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 ---IMCLHSKIKSQALE-------FPDQPDI---AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ---HHHHHHHHHHCCCC-------CCSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ---HHHHHHHHhcccCC-------CCCcccc---CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11222211111100 0001112 2356678889999999999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.61 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=196.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++..+ +++.||+|++..... ..+.+.+|++++..+ +||||+++++++.+.+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999975 689999999975432 235688999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++......
T Consensus 113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999998753 35899999999999999999999998 99999999999998654 5999999999877543
Q ss_pred C---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 T---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. ...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+........ .+ .
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~~~--~~---~ 253 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDYP--SP---E 253 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--TT---G
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCCC--cc---c
Confidence 2 34689999999999998999999999999999999999999975321 122222221111000 00 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .....++.+++.+||..||++|||+.|++++
T Consensus 254 ~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 W---DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp G---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c---cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 1112356678889999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.23 Aligned_cols=192 Identities=21% Similarity=0.342 Sum_probs=171.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhc----cCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG----KHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||||+++......+.+..|++++..+. .||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 478999999999999974 6889999999765555667888999999984 4999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--------------------
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-------------------- 473 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-------------------- 473 (627)
+++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 9999999986532 35899999999999999999999998 999999999999975
Q ss_pred -----CCCeEEeecccccccCC-CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 474 -----DLNGCISDVGLAHLINF-PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 474 -----~~~~ki~DfG~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
++.+||+|||+++.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78999999999987644 34456899999999999999999999999999999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.81 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=203.2
Q ss_pred hcccCcCCceeEEEEEec--------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|... ++..||||++..... ..+.+.+|++++.++.+||||+++++++...+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 478999999999999863 467899999975432 3457889999999998999999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 409 YSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence 9999999999999865321 1234899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||+++..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------HHHHHH
Confidence 99999999876432 22335778999999988889999999999999999999 999997542 112222
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.+.... ... ........+.+++.+||..+|.+|||+.|+++.|+.+.....
T Consensus 271 ~~~~~~-~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 271 LLKEGH-RMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHTC-CCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHhcCC-CCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111 100 001122356778889999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=323.15 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=202.8
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|..+++..||+|++.......+.+.+|++++..+ +||||+++++++. .+..++||||+++|+|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 478999999999999998888999999987666788899999999999 9999999999976 45688999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-----C
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-----T 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-----~ 493 (627)
+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9997532 125899999999999999999999998 9999999999999999999999999998764322 2
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... .......... .... ...
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~-~~~~-------~~~-- 233 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG-YRMV-------RPD-- 233 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT-CCCC-------CCT--
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhcc-cCCC-------Ccc--
Confidence 335678999999988889999999999999999999 9999975321 1112211111 1000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.....+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 234 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 234 -NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1123567788899999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=325.70 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=189.8
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|.... +..||+|++..... ..+.+.+|+.++..+ +||||+++++++. ++..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cCccEEEEecC
Confidence 4789999999999999653 45799999875422 346788999999999 9999999999974 56788999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999997642 35899999999999999999999998 9999999999999999999999999998764432
Q ss_pred -----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 -----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ . ...+...... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~---~~~i~~~~~~-~------ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V---IGRIENGERL-P------ 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHHHTTCCC-C------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---H---HHHHHcCCCC-C------
Confidence 2235678999999988899999999999999999997 999997643221 1 1111111100 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
........+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0011223566788899999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.90 Aligned_cols=253 Identities=17% Similarity=0.202 Sum_probs=198.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEE-eeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY-YSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~-~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++..+ +|++++..+.++ ...+..++||||+ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 47899999999999996 578999999986543 335688999999999 666655555544 5667789999999 999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~-- 491 (627)
|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999997542 35899999999999999999999998 9999999999999 48899999999999876432
Q ss_pred ---------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 ---------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 ---------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch----
Confidence 2345789999999999999999999999999999999999999875544333332222111100000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
..+ ... ...++.+++.+||+.+|++|||+.++++.|+++....
T Consensus 240 -~~~--~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 -EVL--CKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -HHH--TTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHH--Hhh---CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000 011 1235677888999999999999999999999986554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.69 Aligned_cols=241 Identities=21% Similarity=0.300 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 478999999999999976 58899999986532 2334578899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999753 3899999999999999999999998 999999999999999999999999999876543
Q ss_pred ---CCCCCCccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 ---TTATRTIGYRAPEVTETRK----ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~----~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.+..||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+........
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~---- 293 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIMNHKNSLT---- 293 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTHHHHCC----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHHHhcccccc----
Confidence 3566899999999987654 7899999999999999999999997532 2222222222110000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDS--RPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~ 603 (627)
.......+ .++.+++.+|+..+|.+ ||+++||+++
T Consensus 294 -~p~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 -FPDDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCTTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -CCCccccc---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00111122 34566777999999988 9999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.47 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence 46799999999999996 4789999999865422 235688999999999 99999999999999999999999997
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 68888886542 46899999999999999999999998 99999999999999999999999999988877667
Q ss_pred CCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..||+.|+|||++. ...++.++||||||+++|||++|+.||.... .............. .. ...
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~-~~------~~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-AL------QSG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CC------CCT
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC-CC------CCC
Confidence 78999999999983 5678999999999999999999999997532 12222222222111 00 011
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
..+ ..+.+++.+||+.+|++|||+++++++..-
T Consensus 277 ~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 277 HWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp TSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCC---HHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 112 345678889999999999999999876443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=332.56 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=201.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHh-ccCCCeeeeeeEEeeCC----ceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTI-GKHSNVVPVRAYYYSKD----EKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. ++.||||++... ..+.+.+|.+++..+ .+||||+++++++.... ..++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 578999999999999985 899999998643 456778888888873 28999999999998776 7899999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH--------SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
+|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||++
T Consensus 124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999753 4899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCC--------CCCCCCccccCccccCCCC------CCCcchhHHHHHHHHHHHhC----------CCCCCCCCCCC
Q 006886 486 HLINFP--------TTATRTIGYRAPEVTETRK------ASQKSDVYSFGVLLLEMLTG----------KAPLQHSGHDD 541 (627)
Q Consensus 486 ~~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg----------~~p~~~~~~~~ 541 (627)
+..... ....+|+.|+|||++.+.. ++.++||||||+++|||++| +.||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 766432 2345789999999987652 33689999999999999999 77876543221
Q ss_pred CCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 542 VVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.....+............ +. ......+....+.+++.+||+.+|++|||+.|++++|+++.+..
T Consensus 275 -~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 -PSVEEMRKVVCEQKLRPN-IP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp -CCHHHHHHHHTTSCCCCC-CC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -ccHHHHHHHHHHHHhCCC-Cc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 122222222221111111 11 11112355667888999999999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=336.00 Aligned_cols=245 Identities=14% Similarity=0.183 Sum_probs=198.0
Q ss_pred hcccCcCCceeEEEEE------ecCCcEEEEEEecccccCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAI------LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|. ..+++.||||++.. ....++..|++++..+. .|+||+.+++++...+..++|||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 4789999999999994 44688999999864 34667888888888883 28999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-----------CCCeEE
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-----------DLNGCI 479 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----------~~~~ki 479 (627)
|+++|+|.+++...+......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEE
Confidence 999999999998654434567999999999999999999999998 999999999999998 899999
Q ss_pred eecccccccCC------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh
Q 006886 480 SDVGLAHLINF------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553 (627)
Q Consensus 480 ~DfG~a~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 553 (627)
+|||+++.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----------- 293 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----------- 293 (365)
T ss_dssp CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----------
T ss_pred eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----------
Confidence 99999975431 1344589999999999999999999999999999999999999864321100
Q ss_pred hhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhccc
Q 006886 554 REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR-PKMDDVVRMIEQIQQP 610 (627)
Q Consensus 554 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~ev~~~L~~~~~~ 610 (627)
.....+... ...+ .+.+++..|++.+|.+| |+++++.+.|+++...
T Consensus 294 -------~~~~~~~~~-~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -------KPEGLFRRL-PHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------EECSCCTTC-SSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------eechhcccc-CcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 001111111 1123 34456678999999998 6888888888887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.45 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=192.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 47899999999999999889999999986542 2346788999999999 899999999999999999999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 85 DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9999887542 35899999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc--------ccc
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA--------EVF 562 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 562 (627)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+.......... ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhccccc
Confidence 23457899999999876 458999999999999999999999997542111 111111111000000 000
Q ss_pred chhhhcCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQ------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
++...... .......++.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11100000 001122356678889999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.19 Aligned_cols=253 Identities=17% Similarity=0.199 Sum_probs=196.9
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeE-EeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY-YYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~-~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+. .+++.||||++.... ....+..|++++..+ +|++++..+.. +...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHh-cCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 47899999999999996 468899999865432 224578899999999 56665555544 46677789999999 999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~-- 491 (627)
|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999997542 35899999999999999999999998 9999999999999 78999999999999876432
Q ss_pred ---------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 ---------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 ---------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----
Confidence 2345789999999999999999999999999999999999999876544433332222111100000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
... .... ...+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 240 -~~~--~~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 240 -EVL--CKGY---PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -HHH--TTTS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -hhh--hccC---CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 0111 235677888999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=323.28 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=202.2
Q ss_pred cccCcCCceeEEEEEec---CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE---DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++..+ +||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 48999999999999854 57789999997642 2356789999999999 999999999998 55678999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 94 GPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999743 245899999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+.... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~i~~~~-~~~------ 233 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGK-RME------ 233 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTC-CCC------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHhcCC-cCC------
Confidence 12235788999999988889999999999999999998 99999754321 1111111111 000
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccccC
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNR 615 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~~ 615 (627)
........+.+++.+||..+|++||++.+++++|+++....-.+.
T Consensus 234 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 234 ----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 001122356778889999999999999999999999976655443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.90 Aligned_cols=247 Identities=21% Similarity=0.431 Sum_probs=195.4
Q ss_pred hcccCcCCceeEEEEEecC-----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED-----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|..+. +..||||+++.... ....+.+|++++..+ +||||+++++++...+..++||||
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeC
Confidence 4789999999999998653 23599999875432 345688999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 128 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 128 MENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred CCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999999764 245899999999999999999999998 999999999999999999999999999876432
Q ss_pred C-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 T-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
. ...+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~~~~---- 270 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFRLP---- 270 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCCCcCC----
Confidence 1 1224678999999998899999999999999999999 9999975321 11111111111000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
........+.+++.+||+.+|++||++.++++.|+++...
T Consensus 271 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111223567788899999999999999999999998644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=332.37 Aligned_cols=238 Identities=18% Similarity=0.223 Sum_probs=198.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +|+.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 478999999999999976 68999999986542 3456788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 125 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 999999998652 4899999999999999999999998 999999999999999999999999999876543 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... + ...
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~---~------p~~- 260 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKVR---F------PSH- 260 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---C------CTT-
T ss_pred cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCCCC---C------CCC-
Confidence 4568999999999999999999999999999999999999997532 12222222221110 0 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
....+.+++.+||+.||.+||+ ++|++++
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1234667888999999999998 8888764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.97 Aligned_cols=193 Identities=26% Similarity=0.407 Sum_probs=169.6
Q ss_pred hcccCcC--CceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKG--SYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+| +||.||+|+.+ +++.||||++...... .+.+.+|+++++.+ +||||+++++++...+..++||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEcc
Confidence 4789999 99999999976 6899999999765332 35678899999999 8999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC---
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--- 489 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~--- 489 (627)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999998653 235899999999999999999999998 9999999999999999999999999876431
Q ss_pred --------CCCCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 490 --------FPTTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 490 --------~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1123357889999999987 678999999999999999999999997644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=333.04 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=196.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||+|+++.. ....+.+..|..++..+.+||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 478999999999999976 4788999999754 23456788899998888789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999998642 4899999999999999999999998 99999999999999999999999999986422
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... + .
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~---~------p 241 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNVA---Y------P 241 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---C------C
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCCC---C------C
Confidence 234568999999999999999999999999999999999999997532 12222222221110 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
... ..++.+++.+||..+|.+||+ ++|++++
T Consensus 242 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 KSM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TTS---CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 235667888999999999995 5777654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.50 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|++++..+ +||||+++++++... ...++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEE
Confidence 47899999999999984 368899999987542 3457899999999999 899999999999876 6689999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CCCCCCHHHHHHHHhh
Q 006886 490 FPT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG--------HDDVVDLPRWVRSVVR 554 (627)
Q Consensus 490 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~ 554 (627)
... ...+|..|+|||++.+..++.++||||||+++|||++|+.|+.... ................
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 432 3346778999999988889999999999999999999999864321 0000000000000010
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
... ...........+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 258 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 00011122345778888999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.10 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=192.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999954 68999999997543 34678999999999976899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeecccccccCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLAHLINFP--- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a~~~~~~--- 491 (627)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++......
T Consensus 99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999865 35899999999999999999999998 999999999999998776 999999998765321
Q ss_pred --------CCCCCCccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCH--------HHHHH
Q 006886 492 --------TTATRTIGYRAPEVTET-----RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL--------PRWVR 550 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~--------~~~~~ 550 (627)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 12347899999999864 4578999999999999999999999986543321100 00011
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........ ...+... . .....+.+++.+||..||++|||+.|++++
T Consensus 251 ~~i~~~~~-~~~~~~~---~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKY-EFPDKDW---A---HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCC-CCCHHHH---T---TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCc-ccCchhc---c---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111100 0000000 0 112356778889999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.62 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=198.2
Q ss_pred hcccCcCCceeEEEEEecC-C---cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce-EEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED-G---TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK-LVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~-~lv~e~ 411 (627)
.+.||+|+||.||+|.+.+ + ..||+|++..... ..+.+.+|++++..+ +||||+++++++.+.+.. ++|+||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEec
Confidence 4789999999999998542 2 3799999875432 346788999999999 999999999999876665 899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 105 MCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999753 246899999999999999999999998 99999999999999999999999999975532
Q ss_pred -------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 491 -------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 491 -------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
.....+++.|+|||.+.+..++.++||||||+++|||++|..|+..... ...+.... . ......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~---~-~~~~~~--- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFL---A-QGRRLP--- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHH---H-TTCCCC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHh---h-cCCCCC---
Confidence 1223467889999999999999999999999999999996665443211 11111111 1 111000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
.. ......+.+++.+||+.+|.+|||+.++++.|+++...-...
T Consensus 249 ----~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 ----QP---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----CC---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 00 111235677888999999999999999999999987664443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.74 Aligned_cols=247 Identities=21% Similarity=0.394 Sum_probs=193.7
Q ss_pred hcccCcCCceeEEEEEec-CCcE----EEEEEeccc--ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTT----VVVKRLREV--AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~----vavK~l~~~--~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|+.. +++. ||+|.+... ....+.+.+|++++..+ +||||+++++++.... .++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEEEEe
Confidence 478999999999999964 4443 577777543 23567899999999999 8999999999998654 7899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999998653 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... +.. ........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~~----- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL----- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC-----
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC-----
Confidence 1 2235678999999999999999999999999999999 999997643221 111 11111100
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
........++.+++.+||..+|.+||++.|+++.|+++....
T Consensus 239 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 239 -----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 001112235677888999999999999999999999987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=356.60 Aligned_cols=244 Identities=20% Similarity=0.324 Sum_probs=198.0
Q ss_pred ccCcCCceeEEEEEec---CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILE---DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||.||+|.++ ++..||||+++... ...+++.+|++++..+ +||||+++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999864 45679999997643 3567899999999999 99999999999876 5689999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~--- 492 (627)
+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 421 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999754 246999999999999999999999998 9999999999999999999999999998764321
Q ss_pred ----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 ----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 ----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+. ......
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~-~~~~~~------- 559 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIE-QGKRME------- 559 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHHHH-TTCCCC-------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHH-cCCCCC-------
Confidence 1224578999999998899999999999999999998 99999864322 1111111 111100
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.......++.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 560 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0112234677788899999999999999999999998644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.24 Aligned_cols=243 Identities=20% Similarity=0.360 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|..+ +++.||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||+++|+
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 478999999999999975 68899999986543 2345788999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--CCCeEEeecccccccCCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ--DLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~a~~~~~~~-- 492 (627)
|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 135 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99998753 235899999999999999999999998 999999999999974 4779999999998775432
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....+. ++.. ...
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~i~~~~~~---~~~~--~~~- 275 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKRCDWE---FDED--AFS- 275 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHCCCC---CCSS--TTT-
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---CCcc--ccc-
Confidence 2358999999999999999999999999999999999999997532 11222222221111 0100 011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....++.+++.+||..||++|||+.|++++
T Consensus 276 --~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 --SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 122356678889999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=335.38 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=192.2
Q ss_pred hcccCcCCceeEEEEEecC--C--cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED--G--TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|.+.+ + ..||||.++.... ..+.+.+|++++.++ +||||+++++++.. ++..++||||
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4689999999999998642 2 3689999865432 346789999999999 89999999998765 4577899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 173 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 173 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999754 235889999999999999999999998 999999999999999999999999999865322
Q ss_pred --------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 --------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+++.|+|||++.+..++.++||||||+++|||++ |.+||...... +....+ ..... ..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~---~~~~~---~~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL---LQGRR---LL 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHH---HTTCC---CC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHH---HcCCC---CC
Confidence 12235678999999998999999999999999999999 67777654332 222111 11110 00
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
. .. .....+.+++.+||+.+|++|||+.|+++.|+++...-...
T Consensus 317 ~-----p~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 317 Q-----PE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp C-----CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C-----CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 0 11 12235677888999999999999999999999987655444
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.52 Aligned_cols=242 Identities=19% Similarity=0.316 Sum_probs=182.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|+.+ +++.||||+++... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 478999999999999976 57899999987543 456688999999999 899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~--- 491 (627)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 136 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 136 FDRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp HHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 9999753 35899999999999999999999998 999999999999976 899999999999876443
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+...... ...+ .
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~~--~~~~------~ 274 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEYY--FISP------W 274 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCCC--CCTT------T
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCCc--cCCc------h
Confidence 2445899999999999999999999999999999999999999753221 1111222211110 0000 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......++.+++.+||..||++|||+.|++++
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122356678889999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=321.77 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|..+ +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence 478999999999999975 689999999975432 246788999999999 899999999999999999999999976
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 -~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 86 -DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp -EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 6666665432 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred -CCCCCCccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh---ccccc---ccc
Q 006886 492 -TTATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---EWTAE---VFD 563 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~d 563 (627)
....+|+.|+|||++.+.. ++.++||||||+++|||++|..||.... ........+... ..... ...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----CHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 3345789999999987765 7999999999999999999988864322 111222221110 00000 000
Q ss_pred -h----------hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 -V----------ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 -~----------~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ ........+.....+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000000011123456678889999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.15 Aligned_cols=238 Identities=20% Similarity=0.327 Sum_probs=187.8
Q ss_pred hcccCcCCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL----EDGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+++. .+++.||+|+++... .....+.+|++++..+ +||||+++++++...+..++||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEE
Confidence 47899999999999996 478999999987542 2345678899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 101 EYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred eCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999764 35889999999999999999999998 9999999999999999999999999997643
Q ss_pred C----CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 490 F----PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 490 ~----~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... +
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~---~--- 240 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN------RKKTIDKILKCKLN---L--- 240 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCC---C---
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCC---C---
Confidence 2 234468999999999999899999999999999999999999997532 11222222221100 0
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
... ....+.+++.+||..+|++|| ++.|++++
T Consensus 241 ---p~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 241 ---PPY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CTT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011 123566788899999999999 77788763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=326.98 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=192.5
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc------cCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCC-----c
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA------ATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKD-----E 404 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~-----~ 404 (627)
.+.||+|+||+||+|+. .+++.||||++.... .....+.+|++++..+. +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 47899999999999996 468999999986432 12356778888887774 4999999999998765 4
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
.++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 789999997 59999998653 234899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh----hcc
Q 006886 485 AHLINFPT---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR----EEW 557 (627)
Q Consensus 485 a~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 557 (627)
++...... ...+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..... ..+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCTTTS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhc
Confidence 98765432 3457899999999988899999999999999999999999997543211 1111111110 000
Q ss_pred ccccc--chhhhc--CCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAEVF--DVELLK--YQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~~~--d~~l~~--~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ...+.. ... .++....+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 000000 000 01122456778889999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.99 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=198.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +|+.||+|++... ......+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 378999999999999975 6899999999653 23456788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 268 GGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp SCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 999999997542 235899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +......... .+. .
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~-i~~~i~~~~~--~~p------~ 410 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREE-VERLVKEVPE--EYS------E 410 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHH-HHHHHHHCCC--CCC------T
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHH-HHHHhhcccc--cCC------c
Confidence 23468999999999999899999999999999999999999998643321 1111 1111111100 000 1
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
.. ..++.+++.+||..||.+|| +++|++++
T Consensus 411 ~~---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 RF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cC---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 23566788899999999999 78888764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.82 Aligned_cols=267 Identities=16% Similarity=0.248 Sum_probs=208.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 478999999999999976 48999999997543 3467788999999999 8999999999998765 6799999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----cCCCCeEEeecccccccC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL----TQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfG~a~~~~ 489 (627)
+|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999976432 234899999999999999999999998 9999999999999 778889999999998764
Q ss_pred CC---CCCCCCccccCccccCC--------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 490 FP---TTATRTIGYRAPEVTET--------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~~--------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
.. ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .......+......
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCc
Confidence 43 23458999999999864 4677899999999999999999999975433221 12222222222111
Q ss_pred ccc---c---------chhhh-cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccc
Q 006886 559 AEV---F---------DVELL-KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELR 613 (627)
Q Consensus 559 ~~~---~---------d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 613 (627)
... . ..... ...........+.+++.+||+.||++||++.|+++.++++....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~~ 313 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVI 313 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEEE
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceEE
Confidence 000 0 00000 0112245556777899999999999999999999999998776543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=327.93 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=202.1
Q ss_pred hcccCcCCceeEEEEEe------cCCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 409 (627)
.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|++++.++.+||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 47899999999999984 2467899999976432 34578899999999988999999999988755 489999
Q ss_pred ecCCCCCHHHHhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 410 SYMPAGSLFMLLHRNRSDG-----------GTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
||+++|+|.+++....... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence 9999999999998653210 123889999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHH
Q 006886 479 ISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRS 551 (627)
Q Consensus 479 i~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 551 (627)
|+|||+++...... ...+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence 99999998764332 2235778999999988899999999999999999998 999997543221 1111
Q ss_pred HhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
.......... . ......+.+++.+||+.+|.+|||+.|++++|+.+.+..
T Consensus 263 ~~~~~~~~~~-------~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 263 RLKEGTRMRA-------P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhccCccCCC-------C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111100 0 111235677888999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.04 Aligned_cols=241 Identities=18% Similarity=0.286 Sum_probs=191.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhcc-CCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGK-HSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++...+++.||||++..... ..+.+.+|++++..+.. ||||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 478999999999999988899999999865432 34678999999999954 6999999999999999999999 568
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 140 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 8999999864 25889999999999999999999998 99999999999995 589999999999876432
Q ss_pred ---CCCCCCccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 492 ---TTATRTIGYRAPEVTET-----------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 285 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTS
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccc
Confidence 23458999999999864 468899999999999999999999997432 11222222221111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.... .... ..++.+++.+||..||++|||+.|++++-
T Consensus 286 ~~~~-------~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 286 EIEF-------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCC-------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCC-------Cccc---hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1000 0111 23566788899999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=356.80 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=196.7
Q ss_pred cccCcCCceeEEEEEec---CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILE---DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++.++ +||||+++++++. .+..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 47999999999999753 467899999976432 357899999999999 8999999999986 456889999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 453 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 453 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999754 35899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 493 ------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ... ..+.......
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~-~~i~~~~~~~----- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVT-AMLEKGERMG----- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHH-HHHHTTCCCC-----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCCCC-----
Confidence 1235678999999998899999999999999999998 99999764321 111 1111111110
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.......++.+++.+||+.||++||++.+|++.|+++..
T Consensus 593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223457778889999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.75 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=202.6
Q ss_pred hcccCcCCceeEEEEEecC------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.... ...||+|.+..... ..+.+.+|++++..+.+||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 4789999999999999652 24799999876432 346789999999999889999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 411 YMPAGSLFMLLHRNRS---------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
|+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence 9999999999975421 01235799999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 482 VGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 482 fG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
||+++...... ...+|+.|+|||++.+..++.++||||||+++|||++ |..||....... .......
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~ 281 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYKLVK 281 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHHHHh
Confidence 99998654322 2235678999999988899999999999999999999 999997543221 1112222
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
...... ... .....+.+++.+||+.+|.+|||+.|+++.|+++....
T Consensus 282 ~~~~~~-------~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 282 DGYQMA-------QPA---FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCC-------CCC---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 211100 001 11235677888999999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.32 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=188.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|..+ +++.||+|+++... ...+.+.+|++++..+ +||||+++++++..++..++||||++ |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 478999999999999965 68999999986542 2346788999999999 99999999999999999999999998 5
Q ss_pred CHHHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 416 SLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 416 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99999875432 12245899999999999999999999998 999999999999999999999999999876432
Q ss_pred -CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc---ccccc-----
Q 006886 492 -TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE---WTAEV----- 561 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----- 561 (627)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+....... .....
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhhhhh
Confidence 23457899999999876 468999999999999999999999997543211 111111111000 00000
Q ss_pred cchhhhc--CCCh---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 FDVELLK--YQDV---------EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~--~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.+.... .... .....++.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 0000 0112357788889999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.39 Aligned_cols=254 Identities=17% Similarity=0.246 Sum_probs=189.3
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEeccccc------------CHHHHHHHHHHHHHhccCCCeeeeeeEEee-
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAA------------TKREFEQQMEVVGTIGKHSNVVPVRAYYYS- 401 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 401 (627)
.+.||+|+||.||+|... ++..||+|++..... ....+.+|+..+..+ +||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEE
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccc
Confidence 478999999999999975 578899999865321 122355667777777 99999999999988
Q ss_pred ---CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC--C
Q 006886 402 ---KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL--N 476 (627)
Q Consensus 402 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~--~ 476 (627)
....++||||+ +++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 67789999999 999999997642 6899999999999999999999998 99999999999999887 9
Q ss_pred eEEeecccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006886 477 GCISDVGLAHLINFP-----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545 (627)
Q Consensus 477 ~ki~DfG~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 545 (627)
+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VA 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HH
Confidence 999999999765321 23357899999999999899999999999999999999999996422111 01
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
............ ...............++.+++.+||..+|++||++++|++.|+++.-
T Consensus 270 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLDEL-----PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHTT-----THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhcccc-----cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111110 10000000000122356778889999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=332.83 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=193.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++..+ +++.||||++..... ...+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 478999999999999976 588999999975432 3456888888887899999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-C---CeEEeecccccccCCC--
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-L---NGCISDVGLAHLINFP-- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~---~~ki~DfG~a~~~~~~-- 491 (627)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+.++ + .+||+|||+++.....
T Consensus 104 ~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 104 LDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9999754 35899999999999999999999998 9999999999998543 3 4999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+..+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+...... +.. ...
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~~~---~~~--~~~ 247 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSGKFS---LSG--GYW 247 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHCCCC---CCS--TTT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccCCcc---cCc--ccc
Confidence 3446789999999998877899999999999999999999999753222 222222222221111 000 001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
...+ .++.+++.+||..||++||++.|++++-.
T Consensus 248 ~~~s---~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 248 NSVS---DTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp TTSC---HHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCC---HHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 1122 34567788999999999999999988544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.23 Aligned_cols=248 Identities=28% Similarity=0.446 Sum_probs=188.6
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.. ..||+|+++..... .+.+.+|++++..+ +||||+++++++ .....++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 478999999999999865 35999998754332 45688999999999 899999999965 556788999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 105 SLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999754 246899999999999999999999998 999999999999999999999999999765421
Q ss_pred --CCCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 --TTATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....+|+.|+|||++. +..++.++||||||+++|||++|+.||...... .. +............ .
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~~~~~----~ 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQ-IIEMVGRGSLSPD----L 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----HH-HHHHHHHTSCCCC----T
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhcccccCcc----h
Confidence 2235789999999986 567888999999999999999999999754321 11 1111211111110 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.. ........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 248 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 011223467788889999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=327.78 Aligned_cols=242 Identities=19% Similarity=0.289 Sum_probs=189.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccC---HHHHHHHHHHHHHhccC-CCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKH-SNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++...+++.||||++...... .+.+.+|++++..+.+| +||+++++++...+..++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 4789999999999999888999999998754332 36788999999999433 999999999999999999999 568
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 8999999864 35899999999999999999999998 99999999999997 678999999999876432
Q ss_pred ---CCCCCCccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 492 ---TTATRTIGYRAPEVTET-----------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..............
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTS
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCc
Confidence 23458999999999854 678999999999999999999999997432 11122222221111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.... .... ..++.+++.+||..||.+|||+.|++++-.
T Consensus 239 ~~~~-------~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 239 EIEF-------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CCCC-------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCC-------cccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1000 0111 135667888999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.49 Aligned_cols=242 Identities=21% Similarity=0.404 Sum_probs=197.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----------------
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS---------------- 401 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~---------------- 401 (627)
.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++..+ +||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccC
Confidence 478999999999999976 78999999986532 4577899999999 99999999998864
Q ss_pred CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 402 KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 402 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECc
Confidence 345789999999999999997643 246899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 482 VGLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 482 fG~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
||++...... ....+++.|+|||++.+..++.++||||||+++|||++|..|+... ...... ......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~-~~~~~~ 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD-LRDGII 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH-HHTTCC
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH-hhcccc
Confidence 9999876543 3345789999999999889999999999999999999999887421 111111 111111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.. .. ...+.+++.+||..||++|||+.|++++|+.++...-
T Consensus 237 ~~----------~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 237 SD----------IF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CT----------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cc----------cC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 11 1245678889999999999999999999999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.50 Aligned_cols=189 Identities=27% Similarity=0.432 Sum_probs=155.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e~~ 412 (627)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.++..+..||||+++++++...+ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 478999999999999965 689999999865422 34567789999999966999999999997544 689999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
+ |+|..++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7 5899998753 4899999999999999999999998 99999999999999999999999999976532
Q ss_pred -----------------------CCCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 491 -----------------------PTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 491 -----------------------~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122357899999999876 67899999999999999999999999764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=320.92 Aligned_cols=252 Identities=20% Similarity=0.290 Sum_probs=193.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++..++..++|+||++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 478999999999999975 688999999875432 236788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 118 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 118 GVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999864 35899999999999999999999998 999999999999999999999999998766432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... ............. .+. ..
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~----~~~-~~ 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGAHINQAIP----RPS-TV 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHHHHHSCCC----CGG-GT
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHHHhccCCC----Ccc-cc
Confidence 23457889999999999899999999999999999999999997532 1111111111110 000 00
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhccccccc
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRP-KMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~ev~~~L~~~~~~~~~~ 614 (627)
.... ...+.+++.+||+.+|++|| +++++++.|+++.......
T Consensus 258 ~~~~---~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 258 RPGI---PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp STTC---CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCC---CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 1111 22466788899999999999 9999999999986655433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.33 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=194.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.++||+|+||+||+|+.+ +++.||+|++.... ...+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 478999999999999976 47889999996532 1233488899999998 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 158 gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 158 GGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999763 235899999999999999999999998 999999999999999999999999999766432
Q ss_pred ---CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 ---TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+........ +.
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~-~p 303 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ-FP 303 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTHHHHCC-CC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHhhhhcccccc-CC
Confidence 2356899999999986 5678999999999999999999999997542 1222222221110000 00
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDS--RPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~ 603 (627)
. .....++ ++.+++.+|+..+|++ ||+++|++++
T Consensus 304 ~---~~~~~s~---~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 T---QVTDVSE---NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp S---SCCCSCH---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c---ccccCCH---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 0011223 4556777999888887 9999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.64 Aligned_cols=239 Identities=23% Similarity=0.404 Sum_probs=177.1
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++|+||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCC
Confidence 47899999999999996 478999999986532 2346789999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 95 NGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp TEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999999754 246899999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||......... ..... . +.. ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~----~---~~~--~~ 232 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL----A---DYE--MP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS----S---CCC--CC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh----c---ccC--Cc
Confidence 2345789999999999888999999999999999999999999764332211 00000 0 000 01
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ...++.+++.+||+.||++|||+.+++++
T Consensus 233 ~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 233 SF---LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc---cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 12356678889999999999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.44 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=200.1
Q ss_pred hcccCcCCceeEEEEEec-----CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-----DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 409 (627)
.+.||+|+||.||++.++ +++.||||++.... ...+.+.+|+++++++ +||||+++++++.+. ...++||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEE
Confidence 478999999999998753 57899999997643 2346789999999999 899999999999874 5678999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999753 3899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC-----CCCC-HHH--HHHHHhh
Q 006886 490 FPT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD-----DVVD-LPR--WVRSVVR 554 (627)
Q Consensus 490 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~-----~~~~-~~~--~~~~~~~ 554 (627)
... ...++..|+|||++.+..++.++||||||+++|||++|+.||...... .... ... .......
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 234677899999998888999999999999999999999998642110 0000 000 0000000
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
... ...........+.+++.+||+.||++|||+.|+++.|+.+.+.-.
T Consensus 266 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 000 001112223467788889999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.95 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=198.7
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEe--eCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYY--SKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lv~e 410 (627)
.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++.++ +||||+++++++. .....++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEe
Confidence 47899999999999984 3588999999875432 346689999999999 9999999999987 4456889999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999998643 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC--------CCCCHHHHHHHHhhh
Q 006886 491 PT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD--------DVVDLPRWVRSVVRE 555 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 555 (627)
.. ...+|..|+|||++.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 234677899999998888999999999999999999999998642110 000000111111111
Q ss_pred cccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 556 EWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 556 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
... ..........+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 260 ~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 260 GQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 100 01112223456788889999999999999999999999866544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.27 Aligned_cols=253 Identities=20% Similarity=0.357 Sum_probs=201.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+++.+ +++.||+|.+..... ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEe
Confidence 478999999999999976 689999999865421 367899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC----CeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~ 486 (627)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999764 35899999999999999999999998 99999999999999877 89999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.... ...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~---~~~~ 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVN---YDFD 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC---CCCC
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhcc---cCCc
Confidence 76443 234578999999999999999999999999999999999999975321 11111111110 0011
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhccccccc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR--MIEQIQQPELRN 614 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~--~L~~~~~~~~~~ 614 (627)
.... . .....+.+++.+||..+|++|||+.|+++ .++.+.....+.
T Consensus 232 ~~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 279 (283)
T 3bhy_A 232 EEYF--S---NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279 (283)
T ss_dssp HHHH--T---TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC--
T ss_pred chhc--c---cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhhc
Confidence 1110 0 11235677888999999999999999998 566665554433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=339.23 Aligned_cols=243 Identities=17% Similarity=0.247 Sum_probs=193.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +|+.||+|++.... ...+.+.+|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 478999999999999975 68999999996532 1223478899999988 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999998642 35899999999999999999999998 999999999999999999999999999876443
Q ss_pred ---CCCCCCccccCccccC-------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 492 ---TTATRTIGYRAPEVTE-------TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~-------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYGKIVHYKEHLSL 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHCCC
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhcccCcCC
Confidence 2346899999999986 45789999999999999999999999975421 1222222211100000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSR---PKMDDVVRM 603 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~ev~~~ 603 (627)
+.. ....+ .++.+++.+|+. +|++| |+++|++++
T Consensus 292 --p~~--~~~~s---~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 --PLV--DEGVP---EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --C------CCC---HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --Ccc--ccCCC---HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000 01122 345677789998 99998 699999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=320.79 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=195.1
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|...+ ...||+|.+..... ..+.+.+|+++++++ +||||+++++++.. ++..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeC
Confidence 4789999999999998643 23589999875432 346788999999999 89999999998654 5577899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 109 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999753 245899999999999999999999998 999999999999999999999999999865332
Q ss_pred --------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 --------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ .... ....... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~~~~---~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRRL---L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTTCCC---C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcCCCC---C
Confidence 22345678999999998899999999999999999999 555665433221 1111 1111100 0
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
. ... ....+.+++.+||+.+|++|||+.|+++.|+++...-
T Consensus 253 ~-----~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 Q-----PEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp C-----CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred C-----Ccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 011 1235677888999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.99 Aligned_cols=238 Identities=22% Similarity=0.388 Sum_probs=197.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+++++.+ +||||+++++++...+..++||||++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 478999999999999976 78999999996542 2456789999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 100 GGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp SEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999753 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+..||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p 236 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIFY---------TP 236 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCCC---------CC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCcC---------CC
Confidence 34568999999999988765 6899999999999999999999975321 2222222221110 00
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+ .++.+++.+||..||++|||+.|++++
T Consensus 237 ~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 237 QYLN---PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TTCC---HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ccCC---HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111 346678889999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.12 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=183.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEe--------eCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYY--------SKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------~~~~~~lv 408 (627)
.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++.++.+||||+++++++. .....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 478999999999999965 68999999985543 235678899999999966999999999984 23347899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+. |+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 188 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188 (337)
T ss_dssp EECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred EEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceec
Confidence 99995 799999876332 246999999999999999999999975 56999999999999999999999999999876
Q ss_pred CCCC----------------CCCCCccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH
Q 006886 489 NFPT----------------TATRTIGYRAPEVT---ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 489 ~~~~----------------~~~~t~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 549 (627)
.... ...+|+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------- 261 (337)
T 3ll6_A 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI------- 261 (337)
T ss_dssp SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-------
Confidence 4321 23478899999998 566789999999999999999999999975322110
Q ss_pred HHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 550 RSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 550 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
....... .. ... ....+.+++.+||+.+|++|||+.|++++|+.+....
T Consensus 262 ---~~~~~~~---~~----~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 ---VNGKYSI---PP----HDT---QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------CCC---CT----TCC---SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---hcCcccC---Cc----ccc---cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0000000 00 000 1123567888999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=315.35 Aligned_cols=240 Identities=23% Similarity=0.390 Sum_probs=194.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|..+ ++..||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCC
Confidence 478999999999999866 57799999986532 3456788999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 93 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999999765 24899999999999999999999998 999999999999999999999999998665432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... + .
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---~------~-- 227 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEFT---F------P-- 227 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCC---C------C--
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCCCC---C------C--
Confidence 34467899999999999999999999999999999999999997532 11111111111100 0 0
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
......+.+++.+||+.+|++|||+.|++++-.
T Consensus 228 -~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 228 -DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 111234567888999999999999999998643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.90 Aligned_cols=246 Identities=21% Similarity=0.364 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|...+ +..||+|.+.... ...+.+.+|++++..+ +||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCCEEEEecC
Confidence 4789999999999998643 2369999987542 2456789999999999 99999999999764 4568999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999997653 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+ ...... .
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~---~~~~~~-~------ 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL---EKGDRL-P------ 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH---HHTCCC-C------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH---hcCCCC-C------
Confidence 22345778999999988899999999999999999998 999997543221 11111 111100 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
... .....+.+++.+||..+|++|||+.|+++.|+++.+.
T Consensus 235 -~~~---~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 -KPD---LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC---CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 001 1123567788899999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.67 Aligned_cols=242 Identities=19% Similarity=0.352 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+++.+ +|+.||+|++..... ..+.+.+|++++..+ +||||+++++++.+.+..++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEE
Confidence 578999999999999976 689999999865422 367899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC----CeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~ 486 (627)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||+++
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999753 35899999999999999999999998 99999999999999988 79999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... .++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~---~~~ 238 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY---DFD 238 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC---CCC
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc---ccC
Confidence 76543 234588999999999999999999999999999999999999975321 112222111110 011
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... . .....+.+++.+|+..||++|||+.|++++
T Consensus 239 ~~~~--~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFF--S---HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHH--T---TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhh--c---ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 0 112356678889999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=316.82 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=191.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++..+ ++..||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 578999999999999965 68899999987653 3467899999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCC-
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~- 491 (627)
+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99999865321 1246899999999999999999999998 9999999999999 45688999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+|+.|+|||++. ..++.++||||||+++|||++|+.||..... .............. ... .
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~---~~~---~ 248 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNY---AVE---C 248 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---CC-----
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCccc---ccc---c
Confidence 3345789999999986 4689999999999999999999999975421 11111111111000 000 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.. ...++.+++.+|++.||++|||+.|+++
T Consensus 249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 1235667888999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.65 Aligned_cols=245 Identities=10% Similarity=0.025 Sum_probs=178.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhc-cCCCeeeee-------eEEeeC---
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIG-KHSNVVPVR-------AYYYSK--- 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-~h~niv~l~-------~~~~~~--- 402 (627)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++..+. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 478999999999999965 789999999986432 3456778877777774 599988754 444332
Q ss_pred --------------CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeeec
Q 006886 403 --------------DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSR------MKIALGTARGIAFIHSEGGAKFTHG 462 (627)
Q Consensus 403 --------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ivH~ 462 (627)
...++||||++ |+|.+++.... ..+.+..+ ..++.|++.||+|||+++ |+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 23799999998 89999998642 23455555 788899999999999998 9999
Q ss_pred CCCCCCeEecCCCCeEEeecccccccCCCC-CCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 006886 463 NIKSSNVLLTQDLNGCISDVGLAHLINFPT-TATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGH 539 (627)
Q Consensus 463 Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~ 539 (627)
||||+|||++.++.+||+|||+++...... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776544 4557799999999987 6799999999999999999999999986533
Q ss_pred CCCCCHHHHHHHHhhhcccccc--cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 540 DDVVDLPRWVRSVVREEWTAEV--FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
...... ........ .......... ....+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSW--------KRPSLRVPGTDSLAFGSCTP---LPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCC--------CBCCTTSCCCCSCCCTTSSC---CCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccch--------hhhhhhhccccccchhhccC---CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211100 00000000 0000111112 2335667888999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.67 Aligned_cols=250 Identities=23% Similarity=0.411 Sum_probs=191.0
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----eE
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-----KL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~ 406 (627)
.+.||+|+||.||+|... .+..||+|++...... .+.+.+|++++.++ +||||+++++++...+. .+
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCcccE
Confidence 578999999999999864 2458999998754332 35688999999999 89999999999987553 48
Q ss_pred EEEecCCCCCHHHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRS-DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
+|+||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999964322 23456999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+..... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... . ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~~~~~~ 268 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M---YDYLLHGHRL 268 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---HHHHHTTCCC
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHHHcCCCC
Confidence 876432 22335778999999999999999999999999999999 889987543221 1 1111111100
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.........+.+++.+||..+|++|||+.+++++|+++..
T Consensus 269 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 269 -----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0011122457788889999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.84 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=200.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|+. .+++.||||++.... ...++..|++++..+.+|+++..+..++...+..++||||+ +++|
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 47899999999999996 468999999876433 23458899999999966677777777778888899999999 9999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCCC--
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99997542 35999999999999999999999998 9999999999999 688999999999998764322
Q ss_pred ---------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 493 ---------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 493 ---------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+..+...... ....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK---QKYEKISEKKVA-TSIE 238 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH---HHHHHHHHHHHH-SCHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH---HHHHHHhhcccc-ccHH
Confidence 345789999999999999999999999999999999999999875443221 111111111100 0000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.+. .. ...++.+++..||+.+|++||++.+|++.|+++..
T Consensus 239 -~l~--~~---~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 -ALC--RG---YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -HHH--TT---SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHh--cC---CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000 01 12367788889999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.99 Aligned_cols=244 Identities=18% Similarity=0.309 Sum_probs=196.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
+.||+|+||.||+|..+ +++.||+|++.... .....+.+|+.++..+..||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999976 68999999987542 346789999999999988899999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC-
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~- 491 (627)
+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 9999986432 346899999999999999999999998 999999999999998 789999999999876543
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...... .. ....
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~---~~--~~~~ 257 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNISQVNVD---YS--EETF 257 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC---CC--TTTT
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHhcccc---cC--chhh
Confidence 234589999999999999999999999999999999999999975421 1111111111100 00 0001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+||+.+|++|||++|++++
T Consensus 258 ---~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 258 ---SSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ---cccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1122356678889999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=326.94 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=191.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|... +|+.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCC
Confidence 478999999999999976 5899999998654332 45678899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 87 TVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred chHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999988754 35899999999999999999999998 999999999999999999999999999876532
Q ss_pred -CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh------------cc
Q 006886 492 -TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE------------EW 557 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 557 (627)
....+|..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+...... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccccccc
Confidence 23457889999999865 6789999999999999999999999976432111 1111111100 00
Q ss_pred ccc--ccchh-----hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAE--VFDVE-----LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~--~~d~~-----l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ..++. ..... .....+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFP---NISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcc---cccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000 00001 122356788889999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=315.15 Aligned_cols=241 Identities=19% Similarity=0.291 Sum_probs=195.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|..+ ++..||+|++... ....+.+.+|++++..+ +||||+++++++.+.+..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 478999999999999976 4778999998765 34567899999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~-- 491 (627)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 93 LFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99998764 34899999999999999999999998 9999999999999 78899999999999876433
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....+|+.|+|||++.+ .++.++||||||+++|||++|+.||..... ......+...... ...... .
T Consensus 165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~--~~~~~~---~ 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIREGTFT--FPEKDW---L 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC--CCHHHH---T
T ss_pred hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC--CCchhh---h
Confidence 34458899999999876 489999999999999999999999975321 1111111111110 000000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 233 ---NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112456778889999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=321.59 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||++..+ |+.||||+++.. ...+.+.+|++++..+ +||||+++++++... +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecch-hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 478999999999999886 889999998754 3556789999999999 899999999997654 468999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-CCCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATR 496 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~ 496 (627)
.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ....+
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 176 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence 99997642 124789999999999999999999998 999999999999999999999999999766443 23456
Q ss_pred CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHH
Q 006886 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575 (627)
Q Consensus 497 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 575 (627)
++.|+|||++.+..++.++||||||+++|||++ |+.||...... .. .... ....... .....
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~---~~~~-~~~~~~~----------~~~~~ 239 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV---VPRV-EKGYKMD----------APDGC 239 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GH---HHHH-TTTCCCC----------CCTTC
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHH-hcCCCCC----------CcccC
Confidence 788999999988899999999999999999998 99999754321 11 1111 1111000 01112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 576 ~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
...+.+++.+||+.+|++|||+.|+++.|++++..+.
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 2356778889999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.64 Aligned_cols=232 Identities=20% Similarity=0.325 Sum_probs=192.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++..+ +||||+++++++.+.+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999954 688999999875431 233577899999999 999999999999999999999
Q ss_pred EecCCCC-CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 409 YSYMPAG-SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 409 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|||+.+| +|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999777 999999764 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCC---CCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 488 INFPT---TATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 488 ~~~~~---~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... ...||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ......
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~~~~ 242 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEAAIH 242 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTTCCC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------HhhccC
Confidence 65432 3458999999999988776 78999999999999999999999642110 000000
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ..++.+++.+||+.+|++|||+.|++++
T Consensus 243 ----~~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 ----PPYLV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----CCccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 2346678889999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.95 Aligned_cols=256 Identities=22% Similarity=0.390 Sum_probs=198.2
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~ 412 (627)
.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++..+ +||||+++++++.. ....++|+||+
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 47899999999999996 478999999886532 3456788999999999 99999999999873 34678999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999986432 2356899999999999999999999998 9999999999999999999999999987653211
Q ss_pred -------------CCCCCccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc
Q 006886 493 -------------TATRTIGYRAPEVTETRK---ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556 (627)
Q Consensus 493 -------------~~~~t~~y~aPE~~~~~~---~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 556 (627)
...+|+.|+|||++.+.. ++.++||||||+++|||++|+.||....... ...... ....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~~~ 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA----VQNQ 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----HHCC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----hhcc
Confidence 123588999999987654 6899999999999999999999996321111 011110 1110
Q ss_pred ccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 557 ~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
. ...........+.+++.+||+.||.+|||+.++++.|+.++......
T Consensus 264 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 264 L----------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred C----------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 0 00001112235777888999999999999999999999998765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=317.15 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +++.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 89 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 89 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence 478999999999999965 5889999998765432 35678899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a~~~~~~ 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++......
T Consensus 90 ~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 90 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999998765 35899999999999999999999998 999999999999987665 999999999776543
Q ss_pred C---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 T---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. ...+|+.|+|||++.+..++.++||||||+++|+|++|+.||..... .............. ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~-----~~~~ 230 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY-----PSPE 230 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC-----CTTT
T ss_pred ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhccccC-----Cchh
Confidence 2 34578999999999999999999999999999999999999975321 11122211111100 0001
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.... ..++.+++.+|++.+|++|||+.|++++-.
T Consensus 231 ~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 231 WDTV---TPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp TTTS---CHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred hccc---CHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 1111 234667888999999999999999988533
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=324.64 Aligned_cols=254 Identities=23% Similarity=0.433 Sum_probs=200.3
Q ss_pred hcccCcCCceeEEEEEec-CCcE--EEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTT--VVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~--vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ ++.. ||+|.+.... ...+.+.+|++++.++.+||||+++++++...+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 478999999999999965 4554 4999886532 2445788999999999889999999999999999999999999
Q ss_pred CCCHHHHhhhcC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 414 AGSLFMLLHRNR-----------SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 414 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+|+|.+++.... ......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence 999999997643 012346899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCC---CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 483 GLAHLINF---PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 483 G~a~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
|+++.... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.. ...
T Consensus 187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~-~~~ 259 (327)
T 1fvr_A 187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQ-GYR 259 (327)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGGG-TCC
T ss_pred CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc------HHHHHHHhhc-CCC
Confidence 99875432 223345788999999988889999999999999999998 999997542 1111221111 100
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.. .... ....+.+++.+||..+|++|||+.|+++.|+++.....
T Consensus 260 ~~-------~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 260 LE-------KPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CC-------CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC-------CCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0111 12356778889999999999999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=320.33 Aligned_cols=255 Identities=20% Similarity=0.331 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 478999999999999964 78999999987532 2346788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999999975321 1346899999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ............... ... .
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~~~------~ 260 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDYP-PLP------S 260 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCSC-CCC------T
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccCC-CCc------c
Confidence 233578899999999999999999999999999999999999975321 222222222211111 000 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
.. ...++.+++.+||+.||++|||+.++++.|++++...-
T Consensus 261 ~~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DH---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 12356678889999999999999999999999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.71 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=196.5
Q ss_pred ccCcCCceeEEEEEec---CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 341 VLGKGSYGSTYKAILE---DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.||+|+||.||+|.+. +++.||||+++.... ..+++.+|++++..+ +||||+++++++ ..+..++||||+++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 8999999999999643 467899999875432 256789999999999 899999999998 56778999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 102 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999864 34899999999999999999999998 9999999999999999999999999998764332
Q ss_pred -----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 -----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ..........
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~~------ 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVT-AMLEKGERMG------ 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHH-HHHHTTCCCC------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCCCC------
Confidence 1234678999999988889999999999999999999 99999754211 111 1111111100
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
........+.+++.+||+.||++||++.++++.|+++....-
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 001122356778889999999999999999999999865543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.04 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=191.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc------ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV------AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|..+ ++..||+|++... ....+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeC
Confidence 578999999999999965 6889999998653 12346789999999999 899999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006886 412 MPAGSLFMLLHRNRSD-----------------------------------GGTALDWNSRMKIALGTARGIAFIHSEGG 456 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 456 (627)
+++|+|.+++...... ....+++..++.++.|++.||.|||+.+
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 188 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG- 188 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999998632110 0112457778899999999999999998
Q ss_pred CCeeecCCCCCCeEecCCC--CeEEeecccccccCC--------CCCCCCCccccCccccCC--CCCCCcchhHHHHHHH
Q 006886 457 AKFTHGNIKSSNVLLTQDL--NGCISDVGLAHLINF--------PTTATRTIGYRAPEVTET--RKASQKSDVYSFGVLL 524 (627)
Q Consensus 457 ~~ivH~Dlk~~NILl~~~~--~~ki~DfG~a~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl 524 (627)
|+||||||+||+++.++ .+||+|||+++.... .....+|+.|+|||++.+ ..++.++||||||+++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999998776 899999999986532 123457899999999865 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 525 LEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 525 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
|||++|+.||..... ............... .+. .......+.+++.+||+.+|.+||++.|++++
T Consensus 267 ~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 267 HLLLMGAVPFPGVND------ADTISQVLNKKLCFE--NPN------YNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHSSCSSCCSSH------HHHHHHHHHCCCCTT--SGG------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCCh------HHHHHHHHhcccccC--Ccc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999975421 122222222111100 010 01122356678889999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.51 Aligned_cols=258 Identities=17% Similarity=0.276 Sum_probs=199.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhcc-------CCCeeeeeeEEe----eCCceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGK-------HSNVVPVRAYYY----SKDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~-------h~niv~l~~~~~----~~~~~~ 406 (627)
.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++..+.+ |+||+++++++. .....+
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 478999999999999864 68899999997655556778899999999842 888999999987 455789
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCC----------
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDL---------- 475 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~---------- 475 (627)
+||||+ +|+|.+++.... ...+++..++.++.|++.||.|||++ + |+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 999999 667777665432 24589999999999999999999998 7 99999999999999775
Q ss_pred ---------------------------------------CeEEeecccccccCCC-CCCCCCccccCccccCCCCCCCcc
Q 006886 476 ---------------------------------------NGCISDVGLAHLINFP-TTATRTIGYRAPEVTETRKASQKS 515 (627)
Q Consensus 476 ---------------------------------------~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~ 515 (627)
.+||+|||+++..... ....+|+.|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 8999999999876543 345689999999999998999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---h---------cccccccch------------------h
Q 006886 516 DVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR---E---------EWTAEVFDV------------------E 565 (627)
Q Consensus 516 Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d~------------------~ 565 (627)
|||||||++|||++|+.||......+..........+.. . ......+.. -
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999986554332211111111110 0 000000000 0
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+....+.+++.+||+.||++|||+.|++++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01112235566788899999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.22 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=203.7
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++..+ +||||+++++++.+.+..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEE
Confidence 478999999999999864 367899999875432 345688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRS-----DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
|+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999975321 11235789999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVMEGGLL 259 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHHTTCCC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------HHHHHHHHHcCCcC
Confidence 865332 12235778999999988899999999999999999999 899987532 11222222111110
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
. .. ......+.+++.+||+.+|++|||+.|+++.|+++.......
T Consensus 260 -~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 260 -D-------KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp -C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred -C-------CC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 0 00 112235677888999999999999999999999987665543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.45 Aligned_cols=234 Identities=23% Similarity=0.316 Sum_probs=183.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHH-HHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVV-GTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l-~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+++.+ +++.||+|+++.... ..+.+..|..++ ..+ +||||+++++++.+.+..++||||+
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 478999999999999976 588999999976532 233455566553 445 8999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
++|+|..++.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999998643 5889999999999999999999998 99999999999999999999999999986422
Q ss_pred --CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 --PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 --~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... +
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~---~------ 258 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPLQ---L------ 258 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSCCC---C------
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcccC---C------
Confidence 234568999999999999999999999999999999999999997532 12222222221100 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDD 599 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 599 (627)
....+ ..+.+++.+||+.||.+||++.+
T Consensus 259 ~~~~~---~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 259 KPNIT---NSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CSSSC---HHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCC---HHHHHHHHHHcccCHHhCCCCCC
Confidence 11122 34567788999999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.07 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=189.1
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce----EEEE
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK----LVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~----~lv~ 409 (627)
.+.||+|+||.||+++. .+++.||||++..... ....+.+|++++..+ +||||+++++++...... ++||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEE
Confidence 47899999999999996 4789999999976432 234678899998888 999999999998765543 8999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 96 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 999999999999864 25899999999999999999999998 9999999999999999999999999998664
Q ss_pred CC-------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FP-------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~---- 237 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI---- 237 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCC----
Confidence 32 123478999999999999999999999999999999999999975321 1112222211111
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHhhc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV-RMIEQIQ 608 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~-~~L~~~~ 608 (627)
.+.. .... ...++.+++.+||+.||++||++.+++ ..+.++.
T Consensus 238 ~~~~-~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 PPSA-RHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHH-HSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Cccc-ccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1100 0111 123566788899999999999766655 4555543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.40 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=195.3
Q ss_pred hcccCcCCceeEEEEEe----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAIL----EDGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+++. .+++.||||+++... ...+.+.+|++++..+.+||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 47899999999999997 368999999986532 234567789999999978999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 999999999999864 25899999999999999999999998 9999999999999999999999999997653
Q ss_pred CC-----CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 FP-----TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~~-----~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..............
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~----- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP----- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCCC-----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccCC-----
Confidence 21 23458999999999975 347899999999999999999999997543322 22222222221110
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRMI 604 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~L 604 (627)
....+....+.+++.+||..||++|| +++|++++.
T Consensus 284 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00011223466788899999999999 999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=340.16 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=197.9
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+++.+ +|+.||+|++.... ...+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 67999999999999975 68999999996542 3456788999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
|+|..++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999999976432 2346899999999999999999999998 999999999999999999999999999876443
Q ss_pred -CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 492 -TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+...... + ..
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~~~~~---~------p~ 414 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLEQAVT---Y------PD 414 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHHCCCC---C------CT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhhcccC---C------Cc
Confidence 2346899999999999999999999999999999999999999865322 1222222222211100 0 01
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVR 602 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~ 602 (627)
.. ...+.+++.+||..||++||++ +++++
T Consensus 415 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 KF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 2345677889999999999975 66664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.17 Aligned_cols=237 Identities=21% Similarity=0.321 Sum_probs=188.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +|+.||||++.... .....+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 478999999999999965 68999999997542 2335677888888888 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF-- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~-- 490 (627)
+|+|..++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 232 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 232 GGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp SCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 99999999765 358999999999999999999998 77 99999999999999999999999999986432
Q ss_pred --CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 --PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 --~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... +
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---~------ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR---F------ 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---C------
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC---C------
Confidence 2345689999999999999999999999999999999999999975321 2222222221110 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRP-----KMDDVVR 602 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 602 (627)
.... ..++.+++.+||+.||.+|| +++|+++
T Consensus 369 p~~~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTL---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccC---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111 23566788899999999999 9999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=316.58 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=194.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|... +++.||+|++.... ....++.+|+..+..+.+||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 478999999999999976 78999999987542 23567888999998888999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-------------------C
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-------------------L 475 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-------------------~ 475 (627)
|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ .
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999976421 1235899999999999999999999998 9999999999999844 4
Q ss_pred CeEEeecccccccCCCCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh
Q 006886 476 NGCISDVGLAHLINFPTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR 554 (627)
Q Consensus 476 ~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 554 (627)
.+||+|||.+..........+|+.|+|||++.+. .++.++||||||+++|||++|..|+.... . .....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~-~~~~~- 241 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------Q-WHEIR- 241 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------H-HHHHH-
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------H-HHHHH-
Confidence 7899999999988777777799999999999765 56689999999999999999988764321 0 11111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... .... ...+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~-------~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 QGRLPRI-------PQVL---SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCCC-------SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCCCCC-------Cccc---CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111110 0111 2356678889999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.70 Aligned_cols=193 Identities=23% Similarity=0.326 Sum_probs=170.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhc-----cCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG-----KHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|... +++.||||+++......+.+..|++++..+. .|+||+++++++...+..++||||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 478999999999999865 5889999999765555677888998888874 5779999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC--eEEeecccccccCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN--GCISDVGLAHLINF 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~ki~DfG~a~~~~~ 490 (627)
. ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 182 ~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 182 S-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp C-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 6 699999986532 35899999999999999999999998 999999999999999987 99999999977654
Q ss_pred C-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 491 P-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 491 ~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
. .+..+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 3 35568999999999999899999999999999999999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=338.60 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=186.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+++++.+ +||||+++++++... ...++|
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEE
Confidence 478999999999999865 688999999975432 345788999999999 999999999999754 356999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 999976 56666642 3899999999999999999999998 999999999999999999999999999877
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH---------------
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR--------------- 550 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~--------------- 550 (627)
... ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+ .+...+.
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHHHcch
Confidence 543 34568999999999999999999999999999999999999997643211 0000000
Q ss_pred ---HHhhhccc-c-----cccchhhhcCC--ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 551 ---SVVREEWT-A-----EVFDVELLKYQ--DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 551 ---~~~~~~~~-~-----~~~d~~l~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........ . ..+...+.... .......++.+++.+||..||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0 00000000000 011124567889999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.59 Aligned_cols=255 Identities=13% Similarity=0.157 Sum_probs=197.3
Q ss_pred hcccCcCCceeEEEEEecC---------CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeee---------------
Q 006886 339 AEVLGKGSYGSTYKAILED---------GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVP--------------- 394 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~--------------- 394 (627)
.+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++.++ +||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhccCCccCccc
Confidence 4789999999999999763 789999998643 4688999999999 8999887
Q ss_pred eeeEEee-CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC
Q 006886 395 VRAYYYS-KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 395 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~ 473 (627)
+++++.. +...++||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDP 194 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEET
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcC
Confidence 5677766 67789999999 999999998642 246999999999999999999999998 999999999999999
Q ss_pred CC--CeEEeecccccccCCC-----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 006886 474 DL--NGCISDVGLAHLINFP-----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHD 540 (627)
Q Consensus 474 ~~--~~ki~DfG~a~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~ 540 (627)
++ .+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999765321 2235789999999999999999999999999999999999999754321
Q ss_pred CCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccc
Q 006886 541 DVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612 (627)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~ 612 (627)
. ..+....... ... .....+.. ...... ..++.+++.+||..||++|||+.++++.|+++.....
T Consensus 275 ~-~~~~~~~~~~-~~~-~~~~~~~~-~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 275 T-EDIMKQKQKF-VDK-PGPFVGPC-GHWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp H-HHHHHHHHHH-HHS-CCCEECTT-SCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-HHHHHHHHhc-cCC-hhhhhhhc-cccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 1 1111111111 111 11111100 000111 2356678889999999999999999999999875543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.45 Aligned_cols=242 Identities=24% Similarity=0.388 Sum_probs=192.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e 410 (627)
.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++++..+ +||||+++++++.. ....++|||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEE
Confidence 367999999999999965 578899999875433 345688999999999 99999999999875 345789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccccccC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLAHLIN 489 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a~~~~ 489 (627)
|+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||||+||+++ .++.+||+|||++....
T Consensus 110 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 110 LMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999864 35899999999999999999999986 4699999999999998 78999999999997654
Q ss_pred CCC--CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 490 FPT--TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 490 ~~~--~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
... ...+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.... ............. ....++
T Consensus 184 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~-~~~~~~---- 252 (290)
T 1t4h_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGV-KPASFD---- 252 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTC-CCGGGG----
T ss_pred ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccC-CccccC----
Confidence 432 3457899999998864 58999999999999999999999997532 1122222211111 111111
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+||+.+|++|||+.|++++
T Consensus 253 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0111356788889999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.55 Aligned_cols=242 Identities=19% Similarity=0.371 Sum_probs=194.9
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
+.||+|+||.||+|+.+ +|+.||||++..... ..+.+.+|+.++..+.+||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 78999999999999976 699999999865431 13567889999999978999999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999764 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred CC---CCCCCCccccCccccCC------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc
Q 006886 490 FP---TTATRTIGYRAPEVTET------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560 (627)
Q Consensus 490 ~~---~~~~~t~~y~aPE~~~~------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (627)
.. ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+......
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~-- 323 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILMLRMIMEGQYQ-- 323 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC--
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCC--
Confidence 43 33468999999999853 357899999999999999999999997532 11111111111100
Q ss_pred ccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+.. . .....+.+++.+||..||++|||+.|++++
T Consensus 324 ~~~~~~---~---~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 FSSPEW---D---DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCHHHH---S---SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCccc---c---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000000 1 112356778889999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=313.52 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++|+||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 478999999999999976 68999999986543 2356789999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----- 490 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----- 490 (627)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999998643 35899999999999999999999998 99999999999999999999999999976532
Q ss_pred -CCCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 -PTTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....+++.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+ ...... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~~~~---~~----- 229 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKKTY---LN----- 229 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----HTTCTT---ST-----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----hhcccc---cC-----
Confidence 233457899999999987665 7789999999999999999999976432211 11111 111000 00
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........+.+++.+||..+|++|||+.|++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001112356678889999999999999999763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.53 Aligned_cols=254 Identities=23% Similarity=0.406 Sum_probs=198.5
Q ss_pred hcccCcCCceeEEEEEe-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--ceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD--EKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~e 410 (627)
.+.||+|+||.||++++ .+++.||||++..... ..+.+.+|++++..+ +||||+++++++...+ ..++|+|
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEE
Confidence 47899999999999984 3688999999876432 346789999999999 8999999999987654 6789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999998652 35899999999999999999999998 99999999999999999999999999987644
Q ss_pred CC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CCCC-CCHHHHHHHHhh
Q 006886 491 PT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG--------HDDV-VDLPRWVRSVVR 554 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~--------~~~~-~~~~~~~~~~~~ 554 (627)
.. ...++..|+|||++.+..++.++||||||+++|||++|..|+.... .... ......+...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 2235677999999988889999999999999999999999876321 0000 000000011111
Q ss_pred hcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 555 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.... .........++.+++.+||+.+|++|||+.|+++.|++++..
T Consensus 278 ~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 278 NNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1000 001112234577788899999999999999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.18 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|++. ++..||||++.... .....+.+|+.++.++ +||||+++++++...+..++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEe
Confidence 478999999999999842 46789999986432 2345788999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNRSD--GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a 485 (627)
|+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999875421 1245899999999999999999999998 999999999999994 456999999998
Q ss_pred cccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGGRM 264 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCC
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHHHhcCCCC
Confidence 754322 23346789999999988899999999999999999998 9999975321 1112211111110
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
. .. ......+.+++.+||+.+|.+||++.|++++|+.+....
T Consensus 265 -~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 265 -D-------PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -C-------CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -C-------CC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0 00 112235677888999999999999999999999986554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=326.73 Aligned_cols=190 Identities=22% Similarity=0.359 Sum_probs=168.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++..++..++||||+++|
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 468999999999999976 68999999987542 2346788999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccC--CCC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--FPT 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~--~~~ 492 (627)
+|.+++.... .+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++.... ...
T Consensus 117 ~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (360)
T 3eqc_A 117 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188 (360)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999998653 489999999999999999999996 7 9999999999999999999999999987553 233
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
...+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 456899999999999999999999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=334.92 Aligned_cols=241 Identities=21% Similarity=0.312 Sum_probs=196.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc---ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV---AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+++.+ +++.||||++... ......+.+|++++.++ +||||+++++++......++|+||+++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 578999999999999975 6899999998643 23567899999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec---CCCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 106 GELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999998765 35899999999999999999999998 99999999999995 4567999999999876543
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+........ ...
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~-----~~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAFD-----LPQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSC-----SGG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCC-----Ccc
Confidence 24468999999999876 599999999999999999999999975421 122222222111110 001
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ....++.+++.+||..+|.+|||+.|++++
T Consensus 246 ~~---~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 WR---TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG---GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cC---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112346678889999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.52 Aligned_cols=238 Identities=21% Similarity=0.342 Sum_probs=196.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 478999999999999976 5788999998643 23456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999998652 4899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..... . ....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-------~--~~~~ 234 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDL-------K--FPPF 234 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------C--CCTT
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcccc-------C--CCCc
Confidence 344678999999999998999999999999999999999999975321 111111111110 0 0011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ...+.+++.+|++.+|.+||++.|++++
T Consensus 235 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 235 L---SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred C---CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1 2346678889999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.11 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=190.0
Q ss_pred hcccCcCCceeEEEEEec--CCc--EEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE--DGT--TVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--~~~--~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.+. +++ .||||+++... ...+.+.+|++++..+ +||||+++++++.... .++|+|
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEe
Confidence 478999999999999853 233 68999986542 2346788999999999 8999999999988654 789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999998642 35899999999999999999999998 99999999999999999999999999987643
Q ss_pred CC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 PT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ...++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL--- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC---
Confidence 22 2335778999999988889999999999999999999 9999975421 22222222111110
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
.........+.+++.+||..+|++|||+.++++.|+++.....+.
T Consensus 245 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 289 (291)
T 1u46_A 245 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred -------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhh
Confidence 001122345677888999999999999999999999998766543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.80 Aligned_cols=250 Identities=18% Similarity=0.276 Sum_probs=192.3
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+. .+++.||||++.. ...+.+.+|++++..+..||||+++++++.. ....++||||++++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 47899999999999986 4689999999864 3467899999999999669999999999987 56789999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFP--- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~--- 491 (627)
+|.+++.. +++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 99998852 788999999999999999999998 99999999999999777 8999999999876433
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccc-------ccc
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE-------VFD 563 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~d 563 (627)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ...+..... ........+ ..+
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~-~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAK-VLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHH-HHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHH-hcCCchhhhHHHHhccccc
Confidence 33457889999999876 67899999999999999999999999643211 001111000 000000000 000
Q ss_pred hh---------------hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VE---------------LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~---------------l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+. ............++.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00001111123467788889999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=332.41 Aligned_cols=194 Identities=23% Similarity=0.425 Sum_probs=153.5
Q ss_pred hcccCcCCceeEEEEEec---CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE---DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~~ 413 (627)
.++||+|+||.||+|+.+ +++.||||++.... ....+.+|++++..+ +||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 467999999999999965 47889999997543 345688999999999 89999999999964 667899999996
Q ss_pred CCCHHHHhhhcCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----cCCCCeEEeecccc
Q 006886 414 AGSLFMLLHRNRS----DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL----TQDLNGCISDVGLA 485 (627)
Q Consensus 414 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~ki~DfG~a 485 (627)
|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 588888764321 11235899999999999999999999998 9999999999999 77899999999999
Q ss_pred cccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 486 HLINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 486 ~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
+..... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 876432 23457899999999877 458999999999999999999999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.87 Aligned_cols=242 Identities=21% Similarity=0.370 Sum_probs=194.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+++.. +|+.||+|+++.... ..+.+.+|++++..+ +||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 578999999999999975 689999999975432 345688999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCCCC-
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~~~- 492 (627)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 93 LFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 99999764 25899999999999999999999998 9999999999999 788999999999997654322
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
...+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...... +... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~---~~~~--~~-- 231 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEGYYE---FESP--FW-- 231 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHCCCC---CCTT--TT--
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCC---CCcc--cc--
Confidence 23478999999999999999999999999999999999999975321 1122222111110 0000 00
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......+.+++.+|+..||++|||+.|++++
T Consensus 232 -~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 -DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122356778889999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.81 Aligned_cols=238 Identities=23% Similarity=0.329 Sum_probs=196.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +++.||||+++.. ....+.+..|.+++..+.+||+|+.+++++.+.+..++||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 478999999999999976 5788999999753 23446678889999888789999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC---
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--- 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--- 490 (627)
+|+|..++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999998652 5899999999999999999999998 99999999999999999999999999986422
Q ss_pred -CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 491 -PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
..+..||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......+...... + .
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~---~------p 562 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA---Y------P 562 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCCC---C------C
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---C------C
Confidence 2345689999999999999999999999999999999999999975421 2222222221110 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKM-----DDVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~ev~~ 602 (627)
... ..++.+++.+||+.||++||++ +||++
T Consensus 563 ~~~---s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KSM---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TTS---CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ccC---CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 2346678889999999999998 67765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.65 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=197.6
Q ss_pred hcccCcCCceeEEEEEe-c-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCC------CeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAIL-E-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS------NVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~------niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|.. + +++.||||+++......+.+.+|++++..+ +|+ +++++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 47899999999999986 3 688999999976555567788999999888 444 59999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-----------------
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ----------------- 473 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~----------------- 473 (627)
|+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99 889999997653 246899999999999999999999998 999999999999987
Q ss_pred --CCCeEEeecccccccCCC-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006886 474 --DLNGCISDVGLAHLINFP-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 474 --~~~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 550 (627)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH
Confidence 678999999999876543 34568999999999999999999999999999999999999997543211 111111
Q ss_pred HHhhh--------ccccccc---------------------chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006886 551 SVVRE--------EWTAEVF---------------------DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601 (627)
Q Consensus 551 ~~~~~--------~~~~~~~---------------------d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 601 (627)
..... ......+ .+.............++.+++.+||+.||++|||+.|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 11100 0000000 000000111234456788899999999999999999997
Q ss_pred HH
Q 006886 602 RM 603 (627)
Q Consensus 602 ~~ 603 (627)
++
T Consensus 328 ~h 329 (339)
T 1z57_A 328 KH 329 (339)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.00 Aligned_cols=237 Identities=14% Similarity=0.179 Sum_probs=183.0
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHHhc--cCCCeeeee-------eEEeeCC-
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREV----AATKREFEQQMEVVGTIG--KHSNVVPVR-------AYYYSKD- 403 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~--~h~niv~l~-------~~~~~~~- 403 (627)
.+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|++++..+. +||||++++ +++...+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 47899999999999996 46899999998743 223567889995555443 899999998 6655443
Q ss_pred ----------------ceEEEEecCCCCCHHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 006886 404 ----------------EKLVVYSYMPAGSLFMLLHRNRS--DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIK 465 (627)
Q Consensus 404 ----------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 465 (627)
..++||||+ +|+|.+++..... .....+++..++.++.|++.||+|||+++ |+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 278999999 6899999986421 11234557888999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeecccccccCCC-CCCCCCccccCccccCCC-----------CCCCcchhHHHHHHHHHHHhCCCC
Q 006886 466 SSNVLLTQDLNGCISDVGLAHLINFP-TTATRTIGYRAPEVTETR-----------KASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 466 ~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
|+|||++.++.+||+|||+++..... ....| +.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999875443 23446 899999999877 899999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 534 LQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
|.......... .+. ......+ .++.+++.+||..||++|||+.|+++
T Consensus 313 f~~~~~~~~~~---------------~~~----~~~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 313 ITKDAALGGSE---------------WIF----RSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp C------CCSG---------------GGG----SSCCCCC---HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred Ccccccccchh---------------hhh----hhccCCC---HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 97543322111 000 0111222 34667888999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.29 Aligned_cols=181 Identities=27% Similarity=0.431 Sum_probs=147.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 409 (627)
.+.||+|+||.||+|+.+ +++.||||++..... ..+.+.+|++++..+ +||||+++++++... ...++||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEE
Confidence 478999999999999965 689999999865432 346788999999999 999999999998543 5689999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+ +|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 137 EIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred ecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 998 57999998753 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CC-------------------------------CCCCCCccccCcccc-CCCCCCCcchhHHHHHHHHHHHh
Q 006886 490 FP-------------------------------TTATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLT 529 (627)
Q Consensus 490 ~~-------------------------------~~~~~t~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~t 529 (627)
.. ....||+.|+|||++ ....++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 21 123468899999986 56679999999999999999999
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.20 Aligned_cols=253 Identities=18% Similarity=0.306 Sum_probs=188.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCH--HHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~--~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|+.. +++.||+|++....... ..+.+|++++..+ +||||+++++++...+..++||||++ |
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 478999999999999976 68999999986543221 2355789999999 89999999999999999999999997 5
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++... +..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 85 DLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999998764 246899999999999999999999998 999999999999999999999999999866432
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc---cccccc-hhh
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW---TAEVFD-VEL 566 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d-~~l 566 (627)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+........ ...... ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23357899999999876 56899999999999999999999999764321 11111111111100 000000 000
Q ss_pred hc-------CCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LK-------YQD----VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~-------~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ... .+....++.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000 00112356678889999999999999999883
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.80 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=184.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|..+ +++.||||++..... ....+.+|++++.++ +||||+++++++. .+..++|
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEE
Confidence 478999999999999965 578999999865321 122478999999999 9999999999975 4567899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEeecccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCISDVGLA 485 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfG~a 485 (627)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999988653 35899999999999999999999998 9999999999999754 45999999999
Q ss_pred cccCCC---CCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc
Q 006886 486 HLINFP---TTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559 (627)
Q Consensus 486 ~~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (627)
+..... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+...+ ......
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i----~~~~~~ 363 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI----TSGKYN 363 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHH----HTTCCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHH----hcCCCC
Confidence 877543 24458999999999853 67788999999999999999999999754322 1221111 111100
Q ss_pred cccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 560 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+.+.. . ......+.+++.+||..||++|||+.|++++
T Consensus 364 --~~~~~--~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 --FIPEV--W---AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --CCHHH--H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCchh--h---cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0 0112356778889999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.72 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=198.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++..+ +||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 478999999999999864 68899999986542 3467899999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 106 SALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999864 35899999999999999999999998 999999999999999999999999999776432
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ........ +. ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~-~~------~~ 242 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFL-IPKNNPPT-LE------GN 242 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCC-CC------SS
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHH-hhcCCCCC-Cc------cc
Confidence 234578899999999999999999999999999999999999975321 111111 11111110 00 11
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 606 (627)
....+.+++.+||+.+|++|||+.|++++..-
T Consensus 243 ---~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 243 ---YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp ---CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred ---cCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 12346778889999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=325.41 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=191.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--------CceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--------DEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 406 (627)
.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++++..+ +||||+++++++... +..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEE
Confidence 478999999999999974 78999999986442 2345788999999999 899999999999873 4578
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+||||+++ +|...+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 99999975 7777776432 35899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCC--------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 487 LINFP--------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 487 ~~~~~--------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
..... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~- 248 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSI- 248 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-
Confidence 65421 23357899999999876 458999999999999999999999998643211 111111111100
Q ss_pred ccccc----chhh--------hcCCChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAEVF----DVEL--------LKYQDVEEE------MVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~~~----d~~l--------~~~~~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+.. .... .......+. ...+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 0000 001111121 1346789999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.28 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=189.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|++++..+ +||||+++++++.... ..++|
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 108 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 108 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEE
Confidence 478999999999999974 689999999865432 245688999999999 8999999999997653 45999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 109 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 9999 88999999753 4899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc-cc-c----c
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE-WT-A----E 560 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~----~ 560 (627)
... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.. ..+..+.... .. . .
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHT
T ss_pred ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCCCHHHHHH
Confidence 543 34568999999999876 68999999999999999999999999764321 1111111100 00 0 0
Q ss_pred c---------------cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhc
Q 006886 561 V---------------FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQ 608 (627)
Q Consensus 561 ~---------------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~ 608 (627)
+ ....+.. ........+.+++.+|+..||++|||++|++++ ++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHH--HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 0000000 001122456778889999999999999999884 44443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=323.58 Aligned_cols=238 Identities=21% Similarity=0.354 Sum_probs=196.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..+ +||||+++++++.+.+..++||||++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCC
Confidence 478999999999999976 47899999986542 2346788899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 125 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 99999998764 35899999999999999999999998 999999999999999999999999999876422
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... + .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~---~------~ 261 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEYS---I------P 261 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCC---C------C
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCCCC---C------C
Confidence 23457899999999988889999999999999999999999997532 11111111111100 0 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ...+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~---~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 KHI---NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 2345678889999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.21 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+.. +++.||||++...... .+.+.+|++++..+ +||||+++++++...+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 478999999999999976 5899999998654332 45678899999999 899999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 109 TILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred chHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9998886643 35899999999999999999999998 999999999999999999999999999775432
Q ss_pred -CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH----------HHhhh-ccc
Q 006886 492 -TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR----------SVVRE-EWT 558 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~-~~~ 558 (627)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||......+ .+..... ..... ...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhcccc
Confidence 334578999999998775 78999999999999999999999997543211 0000000 00000 000
Q ss_pred ccccchhhhcCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLKYQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+........ +.....+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000 1123457788889999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.33 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=193.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|..+ +|+.||+|.+.... ..+.+.+|++++..+ +||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 478999999999999976 58999999987543 456789999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TT 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~~ 493 (627)
.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 9999743 235899999999999999999999998 999999999999999999999999999766432 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..+++.|+|||++.+..++.++||||||+++|||++|+.||..... ........ ........ ...
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~--------~~~ 249 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIP-TNPPPTFR--------KPE 249 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCCCCCS--------SGG
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHh-cCCCcccC--------Ccc
Confidence 4578899999999998999999999999999999999999975321 11111111 11111100 011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....+.+++.+||..||.+|||+.+++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112356778889999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=317.15 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=191.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee------CCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS------KDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++.++.+||||+++++++.. .+..++||||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 478999999999999974 689999999976666678899999999999889999999999987 4578999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999998643 246899999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 ----TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+++.|+|||++. +..++.++||||||+++|||++|+.||..... ........... .....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 255 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPRNP-APRLK 255 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCS
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc-cccCC
Confidence 2345789999999986 56789999999999999999999999965321 11111111111 11100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... ...+.+++.+||..||++||++.+++++
T Consensus 256 ------~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 256 ------SKKW---SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ------CSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------cccc---CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111 2356678889999999999999999883
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.62 Aligned_cols=241 Identities=20% Similarity=0.335 Sum_probs=191.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc-ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV-AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++..+ +||||+++++++...+..++||||+++++
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 478999999999999976 5889999998654 34567899999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc----CCCC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI----NFPT 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~----~~~~ 492 (627)
|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++... ....
T Consensus 103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999987642 35899999999999999999999998 999999999999999999999999987543 1233
Q ss_pred CCCCCccccCcccc-----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 TATRTIGYRAPEVT-----ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 ~~~~t~~y~aPE~~-----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
...+++.|+|||++ .+..++.++||||||+++|||++|+.||.... .............. ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~~~---- 244 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSDPP-TLLT---- 244 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CCSS----
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccCCc-ccCC----
Confidence 45688999999998 46778999999999999999999999997532 11222222211111 1000
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 245 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 ----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112235677888999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=307.20 Aligned_cols=238 Identities=19% Similarity=0.346 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|..+ +++.||||++.... ...+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccC
Confidence 478999999999999976 68999999986532 3456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 95 GGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999997652 4899999999999999999999998 999999999999999999999999999876543
Q ss_pred -CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 -TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+++.|+|||++.+..+ +.++||||||+++|||++|+.||.... .......+. .... .+ .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~-~~~~--~~------~ 231 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIR-GGVF--YI------P 231 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH-HCCC--CC------C
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhh-cCcc--cC------c
Confidence 23457889999999987765 689999999999999999999997532 112121111 1100 00 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .....+.+++.+|++.||++|||+.|++++
T Consensus 232 ~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 E---YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h---hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 112346678889999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=314.63 Aligned_cols=239 Identities=21% Similarity=0.344 Sum_probs=196.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCC
Confidence 478999999999999976 57899999986542 2345688899999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 99 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999998764 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .............. ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---------~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEYS---------IP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCCC---------CC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhccCC---------Cc
Confidence 23457889999999998889999999999999999999999997532 11111111111100 00
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
... ...+.+++.+||+.||++|||+.|++++-
T Consensus 236 ~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 236 KHI---NPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ccc---CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111 23466788899999999999999998853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.05 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=192.2
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
..||+|+||.||+|... +++.||||.+.... ...+.+.+|+.++..+ +||||+++++++...+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 57999999999999964 68899999987643 3456789999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-CCCeEEeecccccccCC----CC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINF----PT 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~~~~----~~ 492 (627)
.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.... ..
T Consensus 107 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 107 SALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 999986432 345778999999999999999999998 999999999999988 89999999999987643 23
Q ss_pred CCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 493 TATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
...+++.|+|||++.+. .++.++||||||+++|||++|+.||...... ............... +
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-----~---- 247 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----QAAMFKVGMFKVHPE-----I---- 247 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----HHHHHHHHHHCCCCC-----C----
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----hHHHHhhcccccccc-----c----
Confidence 44578999999998654 3789999999999999999999999643211 110111000000000 0
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
......++.+++.+||..||++||++.|++++
T Consensus 248 -~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 -PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01122356678889999999999999999763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.32 Aligned_cols=258 Identities=19% Similarity=0.295 Sum_probs=195.7
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhc----------cCCCeeeeeeEEeeCC----
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIG----------KHSNVVPVRAYYYSKD---- 403 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~~---- 403 (627)
.+.||+|+||.||+|+. .+++.||||++.......+.+.+|++++.++. .|+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 47899999999999996 46899999999765555677889999988874 2899999999998654
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEec------CCCC
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLT------QDLN 476 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~------~~~~ 476 (627)
..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++ + |+||||||+|||++ .++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence 678999999 899999998643 23589999999999999999999998 8 99999999999995 3457
Q ss_pred eEEeecccccccCCC-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh
Q 006886 477 GCISDVGLAHLINFP-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555 (627)
Q Consensus 477 ~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 555 (627)
+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||.................+...
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999999999876543 3456899999999999989999999999999999999999999865432222111111111110
Q ss_pred --cccc----------ccc------------------chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 --EWTA----------EVF------------------DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 --~~~~----------~~~------------------d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... ..+ +..............++.+++.+||+.||++|||+.|++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0000 000 00001112234566788899999999999999999999884
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.91 Aligned_cols=194 Identities=22% Similarity=0.331 Sum_probs=167.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCC-----eeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN-----VVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-----iv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|... +++.||||+++.......++..|++++..+..|++ ++++.+++...+..++||||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 478999999999999965 67899999997654455678889999988866764 899999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec--CCCCeEEeecccccccCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT--QDLNGCISDVGLAHLINF 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DfG~a~~~~~ 490 (627)
+ |+|.+++..... ..+++..+..++.|++.||.|||++. ..|+||||||+|||++ .++.+||+|||+++....
T Consensus 139 ~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 139 S-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp C-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6 599999986532 35899999999999999999999531 2399999999999995 478899999999987754
Q ss_pred C-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 006886 491 P-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHS 537 (627)
Q Consensus 491 ~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~ 537 (627)
. ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3 3456899999999999999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.74 Aligned_cols=241 Identities=21% Similarity=0.354 Sum_probs=193.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--------------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--------------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
.+.||+|+||+||+|..+ +++.||+|++.... ...+.+.+|++++..+ +||||+++++++.+..
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCC
Confidence 478999999999999976 57899999986542 2356789999999999 8999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC---CeEEe
Q 006886 404 EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL---NGCIS 480 (627)
Q Consensus 404 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ki~ 480 (627)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999764 34899999999999999999999998 99999999999999876 69999
Q ss_pred ecccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 481 DVGLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 481 DfG~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
|||+++..... ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+.....
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~ 264 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIKKVEKGKY 264 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 99999876543 34468999999999874 689999999999999999999999975421 222222222111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ++.. .+... ..++.+++.+|+..||.+|||+.|++++
T Consensus 265 ~---~~~~--~~~~~---s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 Y---FDFN--DWKNI---SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C---CCHH--HHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C---CCcc--ccCCC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 1100 01111 2356678889999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.13 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=196.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+++.+ +++.||||++... ....+.+.+|++++.++ +||||+++++++...+..++|+||++
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 478999999999999976 7899999998643 23567899999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---cCCCCeEEeecccccccCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL---TQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~ki~DfG~a~~~~~ 490 (627)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 110 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 110 GGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp SCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999754 35899999999999999999999998 9999999999999 5678999999999987654
Q ss_pred CC---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 491 PT---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 491 ~~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
.. ...||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+........ ..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~-----~~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKYTFE-----LP 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCC-----SG
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCCC-----Cc
Confidence 43 2358999999999876 689999999999999999999999975421 122222222111110 00
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... .....+.+++.+||..+|.+|||+.|++++
T Consensus 250 ~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 250 QWK---KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp GGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 111 122346678889999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.86 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=196.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~ 412 (627)
.+.||+|+||.||++..+ +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.. ....++||||+
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 89 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 89 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCC
Confidence 478999999999999975 689999999875432 345688999999999 89999999998854 56789999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG--GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~ 168 (279)
T 2w5a_A 90 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168 (279)
T ss_dssp TTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred CCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence 99999999976432 1345899999999999999999999986 23499999999999999999999999999987654
Q ss_pred CC----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 491 PT----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 491 ~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
.. ...+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+. ...... +.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~-~~~~~~-~~--- 237 (279)
T 2w5a_A 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIR-EGKFRR-IP--- 237 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCCCC-CC---
T ss_pred ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHh-hccccc-CC---
Confidence 32 23478899999999888999999999999999999999999975421 11111111 111111 00
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.....++.+++.+||+.+|++||++.|+++++.....
T Consensus 238 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 238 ------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1112356678889999999999999999987655443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.12 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=185.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++..+ +||||+++++++...+..++||||++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~- 116 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAE- 116 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCC-
Confidence 478999999999999955 688999999865432 235678899999999 99999999999999999999999997
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-----CCCCeEEeecccccccC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-----QDLNGCISDVGLAHLIN 489 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-----~~~~~ki~DfG~a~~~~ 489 (627)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 117 NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 59999998653 4899999999999999999999998 99999999999994 45559999999998764
Q ss_pred CC----CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc-cccc-cc
Q 006886 490 FP----TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE-WTAE-VF 562 (627)
Q Consensus 490 ~~----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~ 562 (627)
.. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... .... ..
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE------IDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH------HHHHHHHHHHhCCCchhhh
Confidence 32 234568999999998774 489999999999999999999999975421 11111111100 0000 00
Q ss_pred ---------chhhh--cCCChHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 ---------DVELL--KYQDVEE-----EMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 ---------d~~l~--~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..... ....... ...++.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 0000111 1245678888999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.62 Aligned_cols=242 Identities=19% Similarity=0.335 Sum_probs=195.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
.+.||+|+||.||+|..+ +++.||||++.... ...+.+.+|++++.++.+||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 478999999999999975 68899999986432 1235678899999999669999999999999999999
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999864 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC---CCCCCCccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 488 INFP---TTATRTIGYRAPEVTE------TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 488 ~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
.... ....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ......+......
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~ 247 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ 247 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCcc
Confidence 6443 2345789999999874 45688999999999999999999999975321 1112222211111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
. .. .........+.+++.+||..||++|||+.|+++
T Consensus 248 ~--~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 F--GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C--CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c--Cc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 00 011122345678888999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.48 Aligned_cols=251 Identities=20% Similarity=0.289 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT------KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|... +|+.||||++...... .+.+.+|++++..+ +||||+++++++...+..++||||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEc
Confidence 478999999999999975 5899999998653221 24678999999999 899999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++ +|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 94 MET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred CCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 976 898888753 245888999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc---ccccccc
Q 006886 492 ----TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE---WTAEVFD 563 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 563 (627)
....+|+.|+|||++.+. .++.++||||||+++|||++|..||..... ......+.... ......+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCCChhhhhh
Confidence 234578999999998654 589999999999999999999999875421 11111111110 0000000
Q ss_pred ----hhh---hcCCCh------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 564 ----VEL---LKYQDV------EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 564 ----~~l---~~~~~~------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
+.. ...... .....++.+++.+|+..||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 000000 11224677888899999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.06 Aligned_cols=241 Identities=20% Similarity=0.342 Sum_probs=191.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|+.+ ++..||+|++.... .....+.+|++++..+ +||||+++++++.+....++||||+++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999976 68899999987542 2356789999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 121 g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 121 GELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999988764 35899999999999999999999998 9999999999999764 55999999999876543
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+........ .+ .
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~--~~---~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKYTFD--SP---E 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCCC--SG---G
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCC--ch---h
Confidence 3446899999999986 4689999999999999999999999975421 222222222211100 01 1
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+...+ ..+.+++.+||..+|.+|||+.|++++
T Consensus 261 ~~~~s---~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 WKNVS---EGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cccCC---HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11122 345677889999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.23 Aligned_cols=250 Identities=19% Similarity=0.273 Sum_probs=185.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccC------------HHHHHHHHHHHHHhccCCCeeeeeeEEeeC----
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT------------KREFEQQMEVVGTIGKHSNVVPVRAYYYSK---- 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~---- 402 (627)
.+.||+|+||.||+|...+|+.||||++...... .+.+.+|++++.++ +||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTT
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccCCC
Confidence 4789999999999999888999999998653221 26789999999999 899999999998543
Q ss_pred -CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEee
Q 006886 403 -DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISD 481 (627)
Q Consensus 403 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~D 481 (627)
...++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEe
Confidence 35789999997 6888888743 246899999999999999999999998 99999999999999999999999
Q ss_pred cccccccCCC---CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 482 VGLAHLINFP---TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 482 fG~a~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
||+++..... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY------NQLNKIVEVVG 251 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHcC
Confidence 9999765432 23457889999999876 67899999999999999999999999754311 11111111000
Q ss_pred ccc--------------ccchhhhc--CCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAE--------------VFDVELLK--YQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~--------------~~d~~l~~--~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... .+...... .... +.....+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000 00000000 0000 1112356788899999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.52 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=184.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+++++.+ +||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEE
Confidence 478999999999999965 688999999875432 245688999999999 9999999999997654 67999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+++ +|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 109 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999974 78888752 3889999999999999999999998 999999999999999999999999999876
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh----------
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE---------- 555 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 555 (627)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .....+...
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCCCHHHHT
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHHHHH
Confidence 543 2346789999999999999999999999999999999999999764311 111111100
Q ss_pred ------------ccc--cc----ccchhhhcCC--ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 ------------EWT--AE----VFDVELLKYQ--DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 ------------~~~--~~----~~d~~l~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... .. .+........ .......++.+++.+||..||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00 0000000000 011224567889999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.30 Aligned_cols=187 Identities=25% Similarity=0.371 Sum_probs=160.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 409 (627)
.+.||+|+||.||+|+.+ +++.||||++..... ..+.+.+|++++..+ +||||+++++++... ...++||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 478999999999999965 578899999975432 346788999999999 899999999999776 5689999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||++ |+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp ECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred ecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9986 5999999753 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CC--------------------------CCCCCCccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 006886 490 FP--------------------------TTATRTIGYRAPEVT-ETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 490 ~~--------------------------~~~~~t~~y~aPE~~-~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
.. ....||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32 334578999999986 56679999999999999999998655543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=318.86 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=178.6
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|... +++.||||++.... ...+++.+|++++..+ +||||+++++++...+..++||||+++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 478999999999999954 68999999986542 2356788899998888 8999999999999999999999999999
Q ss_pred CHHHHhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 416 SLFMLLHRNR---SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 416 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
+|.+++.... ......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999987521 112346899999999999999999999998 999999999999999999999999998765321
Q ss_pred --------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 --------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....... . ......... ...
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~~~~-~~~- 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---V---LMLTLQNDP-PSL- 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHTSSC-CCT-
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---H---HHHHhccCC-Ccc-
Confidence 22357889999999865 568999999999999999999999997543211 1 111111110 000
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
................+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000111235677888999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=311.12 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=177.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC--HHHHHHHHHH-HHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT--KREFEQQMEV-VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+++.. +++.||+|++...... ..++..|... +..+ +||||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~- 89 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWICMELMD- 89 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEEEEehhc-
Confidence 478999999999999964 6899999999754322 2333344444 4444 99999999999999999999999997
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
|+|.+++..... ....+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 90 TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 588888765321 134699999999999999999999998 8 999999999999999999999999999876443
Q ss_pred -CCCCCCccccCcccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 -TTATRTIGYRAPEVT----ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....+|+.|+|||++ .+..++.++||||||+++|||++|+.||..... ............... ..
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~~---- 235 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQ-LP---- 235 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCC-CC----
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCC-cc----
Confidence 233588999999996 566789999999999999999999999974321 111122222111110 00
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .....++.+++.+|++.+|++|||+.|++++
T Consensus 236 --~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 236 --A---DKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --c---ccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0 1122356778889999999999999999873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.51 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=188.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|..+ +++.||||++.... .....+.+|++++..+ +||||+++++++...+ .++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEE
Confidence 578999999999999975 57899999986432 1223588999999999 9999999999987654 8999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeecccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLA 485 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a 485 (627)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999998753 35899999999999999999999998 999999999999987664 999999999
Q ss_pred cccCCCC---CCCCCccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc
Q 006886 486 HLINFPT---TATRTIGYRAPEVT---ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559 (627)
Q Consensus 486 ~~~~~~~---~~~~t~~y~aPE~~---~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 559 (627)
+...... ...+|+.|+|||++ ....++.++||||||+++|||++|+.||...... ..+...+. .....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~----~~~~~ 238 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQIT----SGKYN 238 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHH----HTCCC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHH----hCccc
Confidence 8765432 23478999999996 3567899999999999999999999999754322 12222111 11100
Q ss_pred cccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 560 ~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+... ......+.+++.+||..||++||++.|+++
T Consensus 239 --~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchhh-----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 001100 011245678888999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.79 Aligned_cols=252 Identities=17% Similarity=0.246 Sum_probs=196.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccC------------------HHHHHHHHHHHHHhccCCCeeeeeeEEe
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAAT------------------KREFEQQMEVVGTIGKHSNVVPVRAYYY 400 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------------------~~~~~~e~~~l~~l~~h~niv~l~~~~~ 400 (627)
.+.||+|+||.||+|.. +++.||+|++...... .+.+.+|++++.++ +||||+++++++.
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 113 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCCSEEEE
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence 47899999999999999 8999999998654221 17899999999999 8999999999999
Q ss_pred eCCceEEEEecCCCCCHHHH------hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecC
Q 006886 401 SKDEKLVVYSYMPAGSLFML------LHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQ 473 (627)
Q Consensus 401 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~ 473 (627)
+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ .+ |+||||||+||+++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999998 4432 13579999999999999999999999 88 999999999999999
Q ss_pred CCCeEEeecccccccCCC--CCCCCCccccCccccCCC-CCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHH
Q 006886 474 DLNGCISDVGLAHLINFP--TTATRTIGYRAPEVTETR-KASQ-KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWV 549 (627)
Q Consensus 474 ~~~~ki~DfG~a~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~-~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 549 (627)
++.+||+|||.+...... ....++..|+|||++.+. .++. ++||||||+++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHH
Confidence 999999999999876432 345678999999999877 5666 999999999999999999999754321 1112
Q ss_pred HHHhhhcccccc----cchhhhc---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 550 RSVVREEWTAEV----FDVELLK---YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 550 ~~~~~~~~~~~~----~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+......... ....... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222111110000 0000000 00001223456788889999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.49 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=190.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|..++ .||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++|+||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCC
Confidence 4789999999999999864 49999986532 2235577889999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----- 490 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----- 490 (627)
+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||+++....
T Consensus 115 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 115 TLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999754 245899999999999999999999998 99999999999998 68999999999876531
Q ss_pred ----CCCCCCCccccCccccCC---------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 491 ----PTTATRTIGYRAPEVTET---------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 491 ----~~~~~~t~~y~aPE~~~~---------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
.....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .......... .
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMGTG-M 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHHTT-C
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhccC-C
Confidence 112347889999999864 4578899999999999999999999975321 1111111111 1
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccc
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELR 613 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 613 (627)
...... .. ...++.+++.+||..+|++|||+.++++.|+++.....+
T Consensus 260 ~~~~~~------~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 260 KPNLSQ------IG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCCCC------SS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCCc------CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111100 01 112466788899999999999999999999999876543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=329.63 Aligned_cols=245 Identities=21% Similarity=0.297 Sum_probs=184.2
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++..+.+||||+++++++.+.+..++||||++ |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 3679999999998777678999999998653 345678899999887789999999999999999999999995 6999
Q ss_pred HHhhhcCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-------------CCeEEeecc
Q 006886 419 MLLHRNRSDGG--TALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-------------LNGCISDVG 483 (627)
Q Consensus 419 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ki~DfG 483 (627)
+++........ ...++..++.++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99986432111 11234456789999999999999998 9999999999999754 489999999
Q ss_pred cccccCCCC--------CCCCCccccCccccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHH
Q 006886 484 LAHLINFPT--------TATRTIGYRAPEVTET-------RKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPR 547 (627)
Q Consensus 484 ~a~~~~~~~--------~~~~t~~y~aPE~~~~-------~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~ 547 (627)
+++...... ...||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------ 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------ 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------
Confidence 998765421 2358899999999865 678999999999999999999 999996432110
Q ss_pred HHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 548 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+.......... ..........++.+++.+||+.||++|||+.|+++
T Consensus 248 --~~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111110000 11112344557788899999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=343.28 Aligned_cols=246 Identities=21% Similarity=0.356 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.++..+ +||||+++++++. ++..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCceEEEEEcC
Confidence 5789999999999999742 45799999865432 346789999999999 9999999999985 45689999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999998542 35899999999999999999999998 9999999999999999999999999998765432
Q ss_pred -----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 493 -----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 493 -----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
...+++.|+|||++.+..++.++||||||+++|||++ |..||..... ......+...... .
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~~~~-~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGERL-P------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHTCCC-C------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCCCC-C------
Confidence 2235678999999988899999999999999999997 9999975421 1112222111110 0
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
........+.+++.+||..||++|||+.|+++.|+++.+.
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0011223567788899999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.31 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=181.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-------eEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-------KLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-------~~lv~e 410 (627)
.+.||+|+||.||+|+.. +++.||||++.........+.++++.+..+ +||||+++++++...+. .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEee
Confidence 467999999999999975 689999999876554455667788888888 99999999999976443 789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCeEecC-CCCeEEeecccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH--SEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHL 487 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~Dlk~~NILl~~-~~~~ki~DfG~a~~ 487 (627)
|+++ +|...+.... .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 107 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred cccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 9986 5554443211 12346899999999999999999999 877 999999999999997 89999999999987
Q ss_pred cCCC---CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc------
Q 006886 488 INFP---TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW------ 557 (627)
Q Consensus 488 ~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 557 (627)
.... ....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+.....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA------GQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHH
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH------HHHHHHHHHcCCCCHHH
Confidence 6543 234578999999998654 4899999999999999999999999764321 11111111000
Q ss_pred ----cccccchhhhc----------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhcc
Q 006886 558 ----TAEVFDVELLK----------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQ 609 (627)
Q Consensus 558 ----~~~~~d~~l~~----------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~ 609 (627)
.....+..... .........++.+++.+||+.||.+|||+.|++++ +.++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00000000000 00001134567788899999999999999999874 444443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.83 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=194.6
Q ss_pred hcccCcCCceeEEEEEec-CC-cEEEEEEecccccCHHHHHHHHHHHHHhccCCC------eeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DG-TTVVVKRLREVAATKREFEQQMEVVGTIGKHSN------VVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n------iv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|... ++ +.||+|+++......+.+.+|++++..+ +|++ ++.+.+++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 478999999999999965 34 6899999976555567788899999988 5554 8899999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-------------------
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL------------------- 471 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl------------------- 471 (627)
|+ ++++.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccc
Confidence 99 667777776542 246899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecccccccCCC-CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHH
Q 006886 472 TQDLNGCISDVGLAHLINFP-TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 550 (627)
+.++.+||+|||+++..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 67889999999999876443 34568999999999999999999999999999999999999997543211 111111
Q ss_pred HHhhhc--------ccccccch---------------------hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 006886 551 SVVREE--------WTAEVFDV---------------------ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVV 601 (627)
Q Consensus 551 ~~~~~~--------~~~~~~d~---------------------~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 601 (627)
...... .....+.. ..........+..++.+++.+||+.||++|||+.|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 111000 00000000 0000011123345788899999999999999999998
Q ss_pred HH
Q 006886 602 RM 603 (627)
Q Consensus 602 ~~ 603 (627)
++
T Consensus 333 ~h 334 (355)
T 2eu9_A 333 LH 334 (355)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.71 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=188.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCce------EEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEK------LVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------~lv 408 (627)
.+.||+|+||.||+|... +|+.||||++...... .+.+.+|++++..+ +||||+++++++...+.. ++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEE
Confidence 478999999999999965 6899999999764332 46788999999999 899999999999877654 999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+. |+|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99997 688887742 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc------ccc
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW------TAE 560 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 560 (627)
... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+..... ...
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCcHHHHHH
Confidence 543 34567999999999877 7889999999999999999999999975431 111111111000 000
Q ss_pred ccch-------hhhc--CCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDV-------ELLK--YQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~-------~l~~--~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+. .... .... +.....+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000 0000 1113467788889999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=319.20 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=174.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|++++..+ +||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEE
Confidence 478999999999999954 689999999865432 345788999999999 899999999998754 557899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 113 THLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999 7899888864 25899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc---ccccccc
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE---WTAEVFD 563 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 563 (627)
... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ ....+....... ....+..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHTTCCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHHhhh
Confidence 543 34568999999999876 678999999999999999999999997643211 111111111000 0000000
Q ss_pred h-------hhhc--CCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 V-------ELLK--YQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~-------~l~~--~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. .+.. ..... .....+.+++.+||..||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000 00000 112356788889999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=320.93 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=191.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e 410 (627)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++.++ +||||+++++++... ...++|+|
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEc
Confidence 478999999999999965 688899999875332 336788999999999 899999999999765 36799999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|++ |+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 997 5999998753 4899999999999999999999998 99999999999999999999999999986642
Q ss_pred C-------CCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc---c
Q 006886 491 P-------TTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---A 559 (627)
Q Consensus 491 ~-------~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 559 (627)
. ....||+.|+|||++. +..++.++||||||+++|||++|+.||......+ ....+......... .
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHH
Confidence 2 2346899999999864 4558999999999999999999999997653222 11111111100000 0
Q ss_pred cccch-------hhhc--CCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 560 EVFDV-------ELLK--YQDV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 560 ~~~d~-------~l~~--~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+. .... .... +....++.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000 0000 1112456788889999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.56 Aligned_cols=245 Identities=21% Similarity=0.293 Sum_probs=167.3
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||+|..+ +++.||||++... ....+|+..+.+..+||||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 56999999999999976 6899999998653 2233444444444499999999999876 3457899999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.....
T Consensus 111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999998642 246999999999999999999999998 999999999999986 455999999999866433
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... ......... .........
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~ 257 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLG----QYGFPNPEW 257 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTTS
T ss_pred ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcc----ccccCchhh
Confidence 34457899999999988889999999999999999999999997543322110 000000000 000000001
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....++.+++.+||+.||++|||+.|++++-
T Consensus 258 ---~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 258 ---SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ---ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 11233566788899999999999999999843
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.15 Aligned_cols=242 Identities=19% Similarity=0.283 Sum_probs=189.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---CHHHHHHHHHHHHHhcc-CCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---TKREFEQQMEVVGTIGK-HSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||++...+++.||||++..... ..+.+.+|++++.++.. |+||+++++++...+..++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 478999999999999988899999999865432 34678899999999954 7999999999999999999999 568
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 112 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 112 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence 8999999864 35899999999999999999999998 99999999999996 489999999999876432
Q ss_pred ---CCCCCCccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc
Q 006886 492 ---TTATRTIGYRAPEVTET-----------RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW 557 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 557 (627)
....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .............
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~ 257 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNH 257 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTS
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhccc
Confidence 23357899999999865 4688899999999999999999999974321 1112222221111
Q ss_pred cccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 558 TAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.... .... ...+.+++.+||+.||++||++.|++++-.
T Consensus 258 ~~~~-------~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 258 EIEF-------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCCC-------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCC-------cccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1000 0111 235667888999999999999999988543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=323.33 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=188.5
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc------eEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE------KLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv~e~~ 412 (627)
.+.||+|+||.||+|+...+..||+|++..... ...+|+++++.+ +||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 478999999999999988777899998864322 224688999999 99999999999975443 78999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccccccCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a~~~~~- 490 (627)
+++.+........ ....+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 8754443332221 1246899999999999999999999998 99999999999999 799999999999987643
Q ss_pred --CCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcc-------ccc
Q 006886 491 --PTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEW-------TAE 560 (627)
Q Consensus 491 --~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 560 (627)
.....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+. ...... ...
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPSREQIKTMNPN 272 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCGG
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHHHhhChh
Confidence 2345678999999998764 58999999999999999999999997643211 1111111 000000 000
Q ss_pred ccchhhh--cCCCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccc
Q 006886 561 VFDVELL--KYQDV-----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQP 610 (627)
Q Consensus 561 ~~d~~l~--~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~ 610 (627)
.....+. ..... .....++.+++.+||..||.+|||+.|++++ ++++...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 0000000 00000 0122467788889999999999999999874 4444433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=315.34 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=191.6
Q ss_pred hcccCcCCceeEEEEEe--cCCcEEEEEEeccccc---CHHHHHHHHHHHHHhc--cCCCeeeeeeEEe-----eCCceE
Q 006886 339 AEVLGKGSYGSTYKAIL--EDGTTVVVKRLREVAA---TKREFEQQMEVVGTIG--KHSNVVPVRAYYY-----SKDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~-----~~~~~~ 406 (627)
.+.||+|+||.||+|+. .+++.||+|++..... ....+.+|++++..+. +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 47899999999999997 3678999999865432 2235667887777664 7999999999987 456788
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+|+||++ |+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 9999997 69999998653 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh-------hc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR-------EE 556 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 556 (627)
..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.. ..
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCGGG
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHcCCCCccc
Confidence 76432 334578999999999998999999999999999999999999975432 111111111 00
Q ss_pred ccccccch--hhhc------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WTAEVFDV--ELLK------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~~~~~d~--~l~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+......+ .... ..........+.+++.+||..||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10000000 0000 00001122356678889999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.72 Aligned_cols=241 Identities=21% Similarity=0.324 Sum_probs=194.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++|+||+++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 578999999999999976 68999999986542 3567899999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC---CCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD---LNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~ki~DfG~a~~~~~~ 491 (627)
++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999987642 5899999999999999999999998 9999999999999764 46999999999876543
Q ss_pred C---CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 T---TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ~---~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. ...+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......+....... + ...
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~---~--~~~ 245 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAF---D--LPQ 245 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---C--SGG
T ss_pred CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC---C--chh
Confidence 2 2236788999999876 489999999999999999999999975421 11122221111110 0 001
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... ..++.+++.+|+..+|++|||+.|++++
T Consensus 246 ~~~~---~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 WRTI---SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhc---CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111 2356678889999999999999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.75 Aligned_cols=241 Identities=22% Similarity=0.378 Sum_probs=185.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee-------------CCc
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-------------KDE 404 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-------------~~~ 404 (627)
.+.||+|+||.||+|+.. +++.||||++.......+.+.+|++++..+ +||||+++++++.+ ...
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 478999999999999965 789999999976555567789999999999 89999999998865 345
Q ss_pred eEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccc
Q 006886 405 KLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGL 484 (627)
Q Consensus 405 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~ 484 (627)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcc
Confidence 78999999999999999854 245788999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCC------------------CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCH
Q 006886 485 AHLINFP------------------TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL 545 (627)
Q Consensus 485 a~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 545 (627)
++..... ....+++.|+|||++.+. .++.++||||||+++|||++ ||... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhH
Confidence 9765421 223478899999998764 78999999999999999998 55321 011
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........... ..+.+. ........+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~---~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRSVS---IEFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHSTT---CCCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhccccc---cccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111100 000110 111223356678889999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.96 Aligned_cols=240 Identities=20% Similarity=0.321 Sum_probs=189.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEe--eCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYY--SKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lv~e 410 (627)
.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++. +....++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEE
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 478999999999999965 68899999986542 2356789999999999 8999999999984 4557899999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|++++ |.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99876 777776543 246899999999999999999999998 99999999999999999999999999987643
Q ss_pred C------CCCCCCccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 P------TTATRTIGYRAPEVTETRK--ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ~------~~~~~t~~y~aPE~~~~~~--~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
. ....+++.|+|||++.+.. ++.++||||||+++|||++|+.||.... .......+......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~~~---- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGSYA---- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCCCC----
Confidence 2 2345789999999987644 3789999999999999999999997532 22222221111100
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
... .....+.+++.+||..||++|||+.|++++-
T Consensus 232 -----~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 232 -----IPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -----CCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -----CCC---ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 001 1123566788899999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.64 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=185.1
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC--------------
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-------------- 403 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-------------- 403 (627)
.+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.+ +||||+++++++....
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence 47899999999999996 478999999986542 2234789999999 9999999999985432
Q ss_pred ------------------------ceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006886 404 ------------------------EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459 (627)
Q Consensus 404 ------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 459 (627)
..++||||++ |+|.+.+..... ....+++..+..++.|++.||.|||+.+ |
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i 162 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---I 162 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 3789999998 588877764221 1346899999999999999999999998 9
Q ss_pred eecCCCCCCeEec-CCCCeEEeecccccccCCC---CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 460 THGNIKSSNVLLT-QDLNGCISDVGLAHLINFP---TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 460 vH~Dlk~~NILl~-~~~~~ki~DfG~a~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
+||||||+|||++ .++.+||+|||+++..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999998 6889999999999876432 344578899999998764 4899999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhhhccccccc--chh-----h--hcCCCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 006886 535 QHSGHDDVVDLPRWVRSVVREEWTAEVF--DVE-----L--LKYQDV-----EEEMVQMLQIALSCVAKVPDSRPKMDDV 600 (627)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~-----l--~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 600 (627)
.+....+ .+...+. .........+. ++. . ...... .....++.+++.+||..+|++|||+.|+
T Consensus 243 ~~~~~~~--~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 243 SGETSID--QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CCSSHHH--HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCChHH--HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 7643211 1111111 00000000000 000 0 000000 1122356788889999999999999999
Q ss_pred HH
Q 006886 601 VR 602 (627)
Q Consensus 601 ~~ 602 (627)
++
T Consensus 320 l~ 321 (383)
T 3eb0_A 320 MA 321 (383)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.98 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=185.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~e~ 411 (627)
.+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++..+ +||||+++++++.... ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 478999999999999975 58999999986532 2234789999999 9999999999986421 25689999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccccCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHLINF 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~~~~ 490 (627)
+++ ++.+.+..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 976 66666543211 1346899999999999999999999998 9999999999999965 5689999999987643
Q ss_pred C---CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh-------hh--cc
Q 006886 491 P---TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV-------RE--EW 557 (627)
Q Consensus 491 ~---~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~--~~ 557 (627)
. ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+...+...- .. ..
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhhChh
Confidence 2 345678999999998764 7899999999999999999999999764311 11111111100 00 00
Q ss_pred cccccchhhhcCCCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 558 TAEVFDVELLKYQDV-----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 558 ~~~~~d~~l~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+...+.. ..... .....++.+++.+||..||++|||+.|++++
T Consensus 288 ~~~~~~p~~-~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 288 YTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCC-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhccCcc-CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000 00000 1112457788889999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.43 Aligned_cols=251 Identities=19% Similarity=0.286 Sum_probs=189.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~e 410 (627)
.+.||+|+||.||+|... +|+.||||++..... ....+.+|++++..+ +||||+++++++... ...++|+|
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEe
Confidence 478999999999999976 688999999864322 345678999999999 899999999988754 67899999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+. |+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 997 6999998753 4899999999999999999999998 99999999999999999999999999987642
Q ss_pred C--------------CCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh
Q 006886 491 P--------------TTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE 555 (627)
Q Consensus 491 ~--------------~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 555 (627)
. ....||+.|+|||++. +..++.++||||||+++|||++|+.||......+ ....+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Confidence 1 1235788999999875 4778999999999999999999999997643110 00000000000
Q ss_pred cc----cccccch-------hhhcCC--Ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 EW----TAEVFDV-------ELLKYQ--DV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 ~~----~~~~~d~-------~l~~~~--~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.. ....... .+.... .. +....++.+++.+||..||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0000000 000000 00 1122456778889999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=318.19 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=187.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc------eEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE------KLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv 408 (627)
.+.||+|+||.||+|..+ +|+.||||++...... .+.+.+|+.++..+ +||||+++++++..... .++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEE
Confidence 478999999999999975 6899999999754332 45688999999999 89999999999987654 4899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||++ |+|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99997 588777642 3899999999999999999999998 999999999999999999999999999876
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhc------cccc
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE------WTAE 560 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 560 (627)
... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.... ....
T Consensus 177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH------HHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHH
Confidence 543 33467899999999876 6789999999999999999999999975431 11111111100 0000
Q ss_pred ccch-------hh-----hc-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 561 VFDV-------EL-----LK-YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 561 ~~d~-------~l-----~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..+. .+ .. ....+.....+.+++.+|+..||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00 00 00011223466778889999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.62 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=172.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||.||+|..+ +++.||||++..... ...++..|+..+.+..+||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 478999999999999975 689999999975432 2345566666444444999999999999999999999999975
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
+|.+++..........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 888877643222235689999999999999999999998 8 999999999999999999999999999876433
Q ss_pred CCCCCCccccCcccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 TTATRTIGYRAPEVT----ETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~----~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....+|+.|+|||++ .+..++.++||||||+++|||++|+.||........ ........ .. +.+.
T Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~-~~-----~~~~ 251 (327)
T 3aln_A 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVKG-DP-----PQLS 251 (327)
T ss_dssp -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS-CC-----CCCC
T ss_pred ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhcC-CC-----CCCC
Confidence 223578899999998 456789999999999999999999999975321100 00000000 00 0000
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..........+.+++.+||..||++|||+.|++++
T Consensus 252 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 252 -NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00001122356778889999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=313.52 Aligned_cols=233 Identities=21% Similarity=0.372 Sum_probs=190.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhc-cCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIG-KHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||+|... +++.||||++..... ..+.+..|++++.++. .|+||+++++++...+..++|+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 478999999999999864 688999999875432 2245778999999995 3799999999999999999999
Q ss_pred ecCCC-CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccccc
Q 006886 410 SYMPA-GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLAHL 487 (627)
Q Consensus 410 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a~~ 487 (627)
|++.+ ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99976 8999999864 35899999999999999999999998 99999999999999 789999999999987
Q ss_pred cCCC--CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 488 INFP--TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 488 ~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.... ....+|+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ....... .+
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~---~~-- 262 (320)
T 3a99_A 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FF-- 262 (320)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CC--
T ss_pred cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc---cc--
Confidence 6543 23458899999999876665 688999999999999999999996421 0111100 00
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....+ .++.+++.+||+.||++|||+.|++++
T Consensus 263 ----~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 ----RQRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112 346678889999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=307.03 Aligned_cols=242 Identities=19% Similarity=0.303 Sum_probs=171.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC--HHHHHHHH-HHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT--KREFEQQM-EVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~-~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||.||+|..+ +|+.||||++...... ..++..|. .++..+ +||||+++++++...+..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecc-C
Confidence 478999999999999975 6899999999754322 22333344 445555 9999999999999999999999999 5
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+.+..+.... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 5565555432 23589999999999999999999995 7 999999999999999999999999999766432
Q ss_pred -CCCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 492 -TTATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ...............
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~------ 249 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEPPL------ 249 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCCCC------
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCCCC------
Confidence 2345789999999984 45788999999999999999999999975321 122222222221110
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... ..++.+++.+||+.||.+||++.|++++
T Consensus 250 ~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 LPGHMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCccCCC---CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0001111 2346678889999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.34 Aligned_cols=248 Identities=19% Similarity=0.275 Sum_probs=182.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEe--------------eC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYY--------------SK 402 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------------~~ 402 (627)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++..+ +||||+++++++. ..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccccccc
Confidence 478999999999999976 48999999986543 2346788999999999 9999999999874 34
Q ss_pred CceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEee
Q 006886 403 DEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISD 481 (627)
Q Consensus 403 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~D 481 (627)
...++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||+|
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECC
T ss_pred CceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEcc
Confidence 57789999997 699999864 25899999999999999999999998 99999999999997 567999999
Q ss_pred cccccccCCC-------CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHh
Q 006886 482 VGLAHLINFP-------TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553 (627)
Q Consensus 482 fG~a~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 553 (627)
||+++..... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE------LEQMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 9999876432 22335788999998754 6789999999999999999999999975431 11111111
Q ss_pred hhccc-------------ccccchhhhcCC-Ch----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 554 REEWT-------------AEVFDVELLKYQ-DV----EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 554 ~~~~~-------------~~~~d~~l~~~~-~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
..... ............ .. .....++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11000 000000000000 00 0123456788889999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.84 Aligned_cols=239 Identities=20% Similarity=0.301 Sum_probs=180.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||+||.....+++.||||++..... ..+.+|++++..+.+||||+++++++.+....++||||++ |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 478999999997665566799999999865322 2356789999998789999999999999999999999996 6999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-----CCCeEEeecccccccCCC--
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-----DLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DfG~a~~~~~~-- 491 (627)
+++..... ...+..++.++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 99986532 2444456789999999999999998 999999999999953 346789999999876432
Q ss_pred -----CCCCCCccccCccccC---CCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 492 -----TTATRTIGYRAPEVTE---TRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 492 -----~~~~~t~~y~aPE~~~---~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
....||+.|+|||++. ...++.++|||||||++|||++ |..||...... ...... ........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~-~~~~~~~~ 250 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILL-GACSLDCL 250 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHT-TCCCCTTS
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHh-ccCCcccc
Confidence 2345899999999997 4567889999999999999999 99998643211 111111 11111110
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
. ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 H-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 11122334667888999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.50 Aligned_cols=233 Identities=21% Similarity=0.365 Sum_probs=184.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhc---cCCCeeeeeeEEeeCCceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIG---KHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~---~h~niv~l~~~~~~~~~~~l 407 (627)
.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++++.++. +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 478999999999999864 688999999865432 2234567888888885 79999999999999999999
Q ss_pred EEec-CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccc
Q 006886 408 VYSY-MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLA 485 (627)
Q Consensus 408 v~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a 485 (627)
|+|| +.+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++
T Consensus 116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999 7899999999864 25899999999999999999999998 99999999999999 8899999999999
Q ss_pred cccCCC--CCCCCCccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 486 HLINFP--TTATRTIGYRAPEVTETRKAS-QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 486 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~-~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
+..... ....++..|+|||++.+..+. .++||||||+++|||++|+.||.... ...... . .+
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~-~--~~ 252 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAE-L--HF 252 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTC-C--CC
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhc-c--CC
Confidence 876543 334578999999998766654 58999999999999999999996421 011100 0 00
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ....+.+++.+||+.+|++|||+.|++++
T Consensus 253 ------~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 253 ------PAH---VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------CTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------ccc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 12356678889999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=294.29 Aligned_cols=230 Identities=15% Similarity=0.118 Sum_probs=177.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC----HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT----KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.. +++.||||++...... .+.+.+|++.+..+ +||||+++++++...+..++||||++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 114 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIR 114 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecC
Confidence 378999999999999976 4899999999765332 36788999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
+++|.+++... ....++.+++.|++.||.|||+++ |+||||||+|||++.++.+||+++|
T Consensus 115 g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 115 GGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred CCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999532 345578899999999999999998 9999999999999999999998543
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
|++ .++.++||||||+++|||++|+.||........... ...........+. ......+
T Consensus 175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~ 233 (286)
T 3uqc_A 175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------AERDTAGQPIEPA-DIDRDIP 233 (286)
T ss_dssp ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-------CCBCTTSCBCCHH-HHCTTSC
T ss_pred ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-------HHHHhccCCCChh-hcccCCC
Confidence 443 378999999999999999999999986543321100 0000000000000 0011122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
.++.+++.+||+.||++| |+.|+++.|+++.......
T Consensus 234 ---~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 234 ---FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp ---HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred ---HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 346678889999999999 9999999999988765543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=328.29 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=200.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEee------CCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS------KDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~ 409 (627)
.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEE
Confidence 478999999999999964 68999999987542 2346788999999999 99999999998765 66779999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCC---eEEeeccccc
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLN---GCISDVGLAH 486 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~ki~DfG~a~ 486 (627)
||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999986432 235888999999999999999999998 999999999999997765 8999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---------
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR--------- 554 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 554 (627)
..... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ...|......
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhh
Confidence 76543 234678999999999999999999999999999999999999965310 0011000000
Q ss_pred hccccc-ccchhhhcC-CChHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHhhcccccccCC
Q 006886 555 EEWTAE-VFDVELLKY-QDVEEEMVQMLQIALSCVAKVPDSRPKMDD-----VVRMIEQIQQPELRNRA 616 (627)
Q Consensus 555 ~~~~~~-~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e-----v~~~L~~~~~~~~~~~~ 616 (627)
+..... .+....... .........+.+++.+|+..||++|||+.| ..+.++.+....+....
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f 316 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVM 316 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccc
Confidence 000000 000000000 011224456778888999999999999988 56778887776654433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=334.33 Aligned_cols=233 Identities=18% Similarity=0.265 Sum_probs=188.6
Q ss_pred hcccCcCCceeEEEEEec--CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc-----eEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE--DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE-----KLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~ 409 (627)
.+.||+|+||.||++++. +++.||||++.... ...+.+.+|++++..+ +||||+++++++...+. .++||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 478999999999999975 58999999986532 2345688999999999 89999999999987665 69999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++++|.+++.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ .+||+|||+++...
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999887653 4899999999999999999999998 9999999999999986 89999999999887
Q ss_pred CCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 490 FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 490 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
......||++|+|||++.+. ++.++|||||||++|||++|..||.......... .
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~------------------------~ 287 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE------------------------D 287 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT------------------------T
T ss_pred cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccc------------------------c
Confidence 76677799999999998764 4899999999999999999998886432111100 0
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHhhc
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPK-MDDVVRMIEQIQ 608 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~ev~~~L~~~~ 608 (627)
.........+.+++.+||+.||++||+ ++++...|..+.
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000112245678889999999999995 666666666653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=293.23 Aligned_cols=227 Identities=17% Similarity=0.281 Sum_probs=175.1
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~ 414 (627)
+.||+|+||.||++... +++.||+|+++. ...+.+|++++.++.+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 67999999999999964 689999999864 34577888888777699999999999887 6678999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999998643 246899999999999999999999998 999999999999998 7899999999986543
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
+..++.++||||||+++|||++|+.||.......... ..................
T Consensus 172 ----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-- 226 (299)
T 3m2w_A 172 ----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRMGQYEFPNPEW-- 226 (299)
T ss_dssp ----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCCSSCTTCCSSCHHHH--
T ss_pred ----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHHHHhhccccCCchhc--
Confidence 2457889999999999999999999997543221100 000000000000000000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMI 604 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 604 (627)
.....++.+++.+||+.||++|||+.|++++-
T Consensus 227 -~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 227 -SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -ccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 11234567788899999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.43 Aligned_cols=236 Identities=12% Similarity=0.123 Sum_probs=173.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhccC-CCeeee---------e-------
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIGKH-SNVVPV---------R------- 396 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h-~niv~l---------~------- 396 (627)
.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.++..+ .| +|.... .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhcccCC
Confidence 368999999999999954 68999999987332 2346788999888888 44 322111 1
Q ss_pred -----eEEee-----CCceEEEEecCCCCCHHHHhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 006886 397 -----AYYYS-----KDEKLVVYSYMPAGSLFMLLHRNR--SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNI 464 (627)
Q Consensus 397 -----~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 464 (627)
.++.. ....+++|+++ +|+|.+++.... ......+++..++.++.|++.||.|||+++ |+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 11111 12346666665 689999885321 112346889999999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeecccccccCCC-CCCCCCccccCcccc----------CCCCCCCcchhHHHHHHHHHHHhCCCC
Q 006886 465 KSSNVLLTQDLNGCISDVGLAHLINFP-TTATRTIGYRAPEVT----------ETRKASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 465 k~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~t~~y~aPE~~----------~~~~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
||+|||++.++.+||+|||+++..... ....| +.|+|||++ .+..++.++|||||||++|||++|+.|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998876543 33456 999999998 566688999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 534 LQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
|......... +..+......+ ..+.+++.+||+.||++||++.|+++
T Consensus 317 f~~~~~~~~~-------------------~~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 317 NTDDAALGGS-------------------EWIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCTTGGGSCS-------------------GGGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchhhhH-------------------HHHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9754322111 11111111222 35667888999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.35 Aligned_cols=238 Identities=14% Similarity=0.164 Sum_probs=178.9
Q ss_pred HHhcccCcCCceeEEEEEecCCcEEEEEEecccc---------cCHHHHHHHHHHHHHhc--------cCCCeeeeeeEE
Q 006886 337 ASAEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---------ATKREFEQQMEVVGTIG--------KHSNVVPVRAYY 399 (627)
Q Consensus 337 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~e~~~l~~l~--------~h~niv~l~~~~ 399 (627)
...+.||+|+||+||+|+. +|+.||||++.... ...+.+.+|+++++.+. .||||+++.+.+
T Consensus 23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 3468999999999999998 58999999997542 13478999999999885 477777766654
Q ss_pred e-----------------e-------------CCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 006886 400 Y-----------------S-------------KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA 449 (627)
Q Consensus 400 ~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~ 449 (627)
. + .+..++||||+++|++.+.+.+ ..+++..+..++.|++.||.
T Consensus 102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHH
T ss_pred EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHH
Confidence 2 2 6789999999999987666643 34899999999999999999
Q ss_pred HHH-hcCCCCeeecCCCCCCeEecCCC--------------------CeEEeecccccccCCCCCCCCCccccCccccCC
Q 006886 450 FIH-SEGGAKFTHGNIKSSNVLLTQDL--------------------NGCISDVGLAHLINFPTTATRTIGYRAPEVTET 508 (627)
Q Consensus 450 ~LH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~ 508 (627)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCC
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcC
Confidence 999 888 99999999999999887 8999999999877543 4478999999999987
Q ss_pred CCCCCcchhHHHHHH-HHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcc
Q 006886 509 RKASQKSDVYSFGVL-LLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCV 587 (627)
Q Consensus 509 ~~~~~~~Dv~S~Gvv-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl 587 (627)
.. +.++||||++++ .+++++|..||.. ..|................ ............++.+++.+||
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKT-KCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSS-CCCSHHHHHHHHHHHHHHHHGG
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCc-ccchhhhhhcCHHHHHHHHHHh
Confidence 66 899999998777 7778889988842 1121111110000000000 0001112345567888999999
Q ss_pred cCCCCCCCCHHHHH
Q 006886 588 AKVPDSRPKMDDVV 601 (627)
Q Consensus 588 ~~~p~~RPs~~ev~ 601 (627)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=274.69 Aligned_cols=181 Identities=15% Similarity=0.069 Sum_probs=127.8
Q ss_pred ccCcCCceeEEEEE-ecCCcEEEEEEecccc-----------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 341 VLGKGSYGSTYKAI-LEDGTTVVVKRLREVA-----------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
..+.|++|.+..++ .--|+.+++|.+.... ...++|.+|++++.++..|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666666666554 2247889999986431 12357999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||++|++|.+++... .+++.. +|+.||+.||+|+|++| ||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999864 245543 58999999999999999 999999999999999999999999999877
Q ss_pred CCCC----CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 006886 489 NFPT----TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 489 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
.... +..||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 5432 2347899999999976 567889999999998877655433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=236.10 Aligned_cols=189 Identities=32% Similarity=0.638 Sum_probs=166.7
Q ss_pred cCChhHHHHHHHHHhhCCCC-CCCCCCCCCCCCCC--CcceEeeCCC--CcEEEEEcCCCCccc--ccCccccCCCCccc
Q 006886 25 ADLNSDKQALLDFADAVPHA-RKLNWNAAAPVCSS--WIGVTCNVNR--SRVIGIHLPGIGFTG--PIPANSIGKLDALK 97 (627)
Q Consensus 25 ~~~~~~~~~l~~~~~~~~~~-~~~~W~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~~l~~l~~L~ 97 (627)
.|.+.|..||++||+++..+ ...+|+.+.++| . |.||+|+... ++|+.|+|++|+++| .+|. .|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 46778999999999999544 345898766666 5 9999998654 799999999999999 8998 899999999
Q ss_pred EEEccC-cccCccCCCCCCCcccccEEeeecccccccCchh-hc-cccccccccccccccCCccccccccccccccccCC
Q 006886 98 ILSLRS-NYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF-RS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN 174 (627)
Q Consensus 98 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 174 (627)
.|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|.. .. .+|++|+|++|.+++.+|..|.++++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999888864 33 38999999999999999999999999999999999
Q ss_pred cccccCCCC--CCC-ccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 175 SISGAIPPL--NLP-RLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 175 ~l~~~~p~~--~~~-~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++++.+|.. .++ +|+.|++++|++++.+|..+..++ |+.++
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~ 203 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD 203 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence 999888864 676 999999999999999999888776 66554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-26 Score=247.26 Aligned_cols=177 Identities=16% Similarity=0.211 Sum_probs=144.6
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||.||++... ++.+++|+...... ..+.+.+|++++.++ +||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEE
Confidence 468999999999999654 78899998643211 134589999999999 9999997777777888889999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999874 4579999999999999998 999999999999999 99999999999875
Q ss_pred CC-----------CCCCCCccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 006886 490 FP-----------TTATRTIGYRAPEVTET--RKASQKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 490 ~~-----------~~~~~t~~y~aPE~~~~--~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
.. ....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 42 13457899999999976 568888999999999999888877764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=244.85 Aligned_cols=192 Identities=24% Similarity=0.358 Sum_probs=153.0
Q ss_pred cccccCChhHHHHHHHHHhhCCCC-CCCCCCCCCCCCCCCcceEeeCCCCcEEEEEcCCCCcccc---cCc---------
Q 006886 21 PTVVADLNSDKQALLDFADAVPHA-RKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGP---IPA--------- 87 (627)
Q Consensus 21 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~W~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~~--------- 87 (627)
+++..+.+.|++||++||+++.++ ...+|+.+++|| .|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 344455678999999999998543 455898555555 89999998 48999999999999987 543
Q ss_pred -------------cccCCCCcccEEEccCcccCccCCC--CCCCcccccEEeeecccccccCchhh--c-cccccccccc
Q 006886 88 -------------NSIGKLDALKILSLRSNYLNGTLPS--DITSISSLQYVYLQNNYFSGVLPAFR--S-LQLNALDLSF 149 (627)
Q Consensus 88 -------------~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~--~-~~L~~L~ls~ 149 (627)
..|+++++|+.|+|++|.++|.+|. .|+++++|++|+|++|.+.+..|... . .+|++|+|++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 2688889999999999999988888 89999999999999999988877532 2 3789999999
Q ss_pred cccccCCccc---cccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 150 NAFTGNIPPG---FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 150 N~l~~~~p~~---~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++++..|.. +.++++|++|++++|++++.+|...+++|++|++++|.+++.+|. ++++++|+.++
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~ 229 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence 9998877776 778888888888888888777766788888888888888877776 77777776653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-24 Score=246.25 Aligned_cols=185 Identities=26% Similarity=0.435 Sum_probs=159.4
Q ss_pred CChhHHHHHHHHHhhCCCCCCCCCCCCC-----CC-CCCC------------cceEeeCCCCcEEEEEcCCCCcccccCc
Q 006886 26 DLNSDKQALLDFADAVPHARKLNWNAAA-----PV-CSSW------------IGVTCNVNRSRVIGIHLPGIGFTGPIPA 87 (627)
Q Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~W~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~~~~~~ 87 (627)
+...|..||++||+++..+ +|+.++ ++ ||+| .||+|+. .++|+.|+|++|++.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 3457999999999999544 787544 44 2589 9999986 58999999999999999998
Q ss_pred cccCCCCcccEEEc-cCcccCcc---------------------------------------------------------
Q 006886 88 NSIGKLDALKILSL-RSNYLNGT--------------------------------------------------------- 109 (627)
Q Consensus 88 ~~l~~l~~L~~L~L-~~N~l~~~--------------------------------------------------------- 109 (627)
.|++|++|+.|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 8999999999999 77766554
Q ss_pred -------------------CCCCCCCcccccEEeeecccccc------------------cCchhh--c-cccccccccc
Q 006886 110 -------------------LPSDITSISSLQYVYLQNNYFSG------------------VLPAFR--S-LQLNALDLSF 149 (627)
Q Consensus 110 -------------------~p~~~~~l~~L~~L~l~~N~l~~------------------~~~~~~--~-~~L~~L~ls~ 149 (627)
+|..|++|++|++|+|++|+|++ +++.+. . .+|+.|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 88889999999999999999999 444443 4 4899999999
Q ss_pred cccccCCccccccccccccccccCCc-ccc-cCCCC---------CCCccceeeccCCCccccCCC--CCCCCCCCcccC
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNS-ISG-AIPPL---------NLPRLKILNFSNNNLNGSIPD--SLQTFPNSSFVG 216 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~---------~~~~L~~L~l~~N~l~~~~p~--~~~~~~~l~~~~ 216 (627)
|.+.+.+|..|+++++|+.|+|++|+ |+| .+|.. .+++|+.|+|++|.++ .+|. .+.++++|+.++
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~ 579 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLD 579 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEE
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEE
Confidence 99999999999999999999999998 998 66642 4569999999999999 8998 899998888764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-24 Score=240.08 Aligned_cols=184 Identities=27% Similarity=0.454 Sum_probs=159.2
Q ss_pred hhHHHHHHHHHhhCCCCCC----------CCCCCCCCCCCCC---cceEeeCCCCcEEEEEcCCCCcccccCccccCCCC
Q 006886 28 NSDKQALLDFADAVPHARK----------LNWNAAAPVCSSW---IGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLD 94 (627)
Q Consensus 28 ~~~~~~l~~~~~~~~~~~~----------~~W~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~ 94 (627)
..|+.||.+|++++..... .+|+...++| .| .||+|+.. ++|+.|+|+++++.|.+|+ .|++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcCc
Confidence 4699999999999853321 2698665555 79 99999865 8999999999999999998 899999
Q ss_pred cccEEEccCc----------------------------------------------------------------------
Q 006886 95 ALKILSLRSN---------------------------------------------------------------------- 104 (627)
Q Consensus 95 ~L~~L~L~~N---------------------------------------------------------------------- 104 (627)
+|+.|+|++|
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 9999999998
Q ss_pred --------ccCccCCCCCCCcccccEEeeecccccc------------------cCchhh--c-cccccccccccccccC
Q 006886 105 --------YLNGTLPSDITSISSLQYVYLQNNYFSG------------------VLPAFR--S-LQLNALDLSFNAFTGN 155 (627)
Q Consensus 105 --------~l~~~~p~~~~~l~~L~~L~l~~N~l~~------------------~~~~~~--~-~~L~~L~ls~N~l~~~ 155 (627)
+|+| +|..|+++++|++|+|++|++++ +++.+. . .+|++|+|++|.+.|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 4455 88899999999999999999999 444555 4 3899999999999999
Q ss_pred CccccccccccccccccCCc-ccc-cCCCC--CC------CccceeeccCCCccccCCC--CCCCCCCCcccC
Q 006886 156 IPPGFQNLTRLHLLNLQNNS-ISG-AIPPL--NL------PRLKILNFSNNNLNGSIPD--SLQTFPNSSFVG 216 (627)
Q Consensus 156 ~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~--~~------~~L~~L~l~~N~l~~~~p~--~~~~~~~l~~~~ 216 (627)
+|..|+++++|++|++++|+ ++| .+|.. .+ ++|+.|++++|+++ .+|. .++++++|+.++
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~ 336 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLE 336 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEE
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEe
Confidence 99999999999999999998 998 77753 44 89999999999999 8998 899888888764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-22 Score=198.30 Aligned_cols=138 Identities=17% Similarity=0.193 Sum_probs=112.5
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHHhccCCCeeeeeeEEe
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-------------------TKREFEQQMEVVGTIGKHSNVVPVRAYYY 400 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 400 (627)
+.||+|+||.||+|...+|+.||+|.++.... ....+.+|++++.++. | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCcCeEEe
Confidence 78999999999999997799999999864321 2356889999999994 4 56666554
Q ss_pred eCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEe
Q 006886 401 SKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCIS 480 (627)
Q Consensus 401 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~ 480 (627)
. +..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++.+||+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEEC
T ss_pred c-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEE
Confidence 3 55689999999999987 421 124469999999999999998 99999999999999 9999999
Q ss_pred ecccccccCCCCCCCCCccccCccccC
Q 006886 481 DVGLAHLINFPTTATRTIGYRAPEVTE 507 (627)
Q Consensus 481 DfG~a~~~~~~~~~~~t~~y~aPE~~~ 507 (627)
|||+++.. ..|+|||++.
T Consensus 235 DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET---------TSTTHHHHHH
T ss_pred ECCCCeEC---------CCCCHHHHHH
Confidence 99998754 3468888774
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-22 Score=205.05 Aligned_cols=186 Identities=18% Similarity=0.312 Sum_probs=147.2
Q ss_pred cCChhHHHHHHHHHhhCC---CCCCCCCC---C-CCCCCCCCcceEeeC--------CCCcEEEEEcCCCCcccccCccc
Q 006886 25 ADLNSDKQALLDFADAVP---HARKLNWN---A-AAPVCSSWIGVTCNV--------NRSRVIGIHLPGIGFTGPIPANS 89 (627)
Q Consensus 25 ~~~~~~~~~l~~~~~~~~---~~~~~~W~---~-~~~~c~~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~~ 89 (627)
.++..+..||++||..+. .....+|. . ..++| .|.|+.|.. ...+|+.|+|++|+++ .+|+ .
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~-~ 99 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-Q 99 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS-C
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh-h
Confidence 456679999999999772 22234684 2 33455 799999952 3478999999999998 8888 6
Q ss_pred cCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCCcccccc------
Q 006886 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQN------ 162 (627)
Q Consensus 90 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~------ 162 (627)
+.++++|+.|+|++|.|+ .+|..|+.+++|++|+|++|+++.+++.+... +|+.|+|++|++.+.+|..+..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 888999999999999999 89999999999999999999999665555554 7899999998888888877654
Q ss_pred ---ccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 163 ---LTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 163 ---l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+++|++|++++|+|+ .+|.. .+++|+.|+|++|+++ .+|..+..+++|+.++
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEE
T ss_pred hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEE
Confidence 888888888888888 55543 7788888888888888 4666677777777654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=222.71 Aligned_cols=114 Identities=36% Similarity=0.663 Sum_probs=90.7
Q ss_pred cccccEEeeecccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceee
Q 006886 117 ISSLQYVYLQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILN 192 (627)
Q Consensus 117 l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~ 192 (627)
+++|++|||++|+++|.+|.... .+|+.|+|++|+|+|.+|..|+++++|+.|||++|+++|.+|.. .+++|++|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 45666777777777776665333 26888888888888888888888888888888888888888865 788888888
Q ss_pred ccCCCccccCCCC--CCCCCCCcccCCCcCCCCCCCCCCC
Q 006886 193 FSNNNLNGSIPDS--LQTFPNSSFVGNSMLCGLPLTPCST 230 (627)
Q Consensus 193 l~~N~l~~~~p~~--~~~~~~l~~~~n~~~~~~~~~~c~~ 230 (627)
+++|+|+|.+|.. +..++.+.|.||+.+||.|+.+|..
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 8888888888864 6677888899999999999888875
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=184.96 Aligned_cols=153 Identities=22% Similarity=0.260 Sum_probs=128.5
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
..++.|+|++|++++..+. .|.++++|+.|+|++|.|++..|..|..+++|++|+|++|++++.++..+. .+|+.|+
T Consensus 35 ~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDA-TFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TTCCEEECTTSCCCCCCTT-TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEccCCCcCccCHh-HhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 4588899999999865554 799999999999999999988888899999999999999999988876543 3899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~ 221 (627)
|++|+|++..+..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++++..+..+..+++|+.+ +|+..|
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 9999999766667889999999999999999766643 78999999999999997777778877777655 566655
Q ss_pred C
Q 006886 222 G 222 (627)
Q Consensus 222 ~ 222 (627)
.
T Consensus 194 ~ 194 (251)
T 3m19_A 194 S 194 (251)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=175.36 Aligned_cols=151 Identities=23% Similarity=0.225 Sum_probs=102.2
Q ss_pred CCCCCCCCCCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCccc
Q 006886 49 WNAAAPVCSSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISS 119 (627)
Q Consensus 49 W~~~~~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 119 (627)
|......| +|.+|.|+.. ..+++.|+|++|++++..|. .|.++++|+.|+|++|+|++..+..|..+++
T Consensus 12 ~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 89 (229)
T 3e6j_A 12 ACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89 (229)
T ss_dssp CCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred cCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence 44455566 7999999752 24567777777777755454 6777777777777777776444455677777
Q ss_pred ccEEeeecccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccC
Q 006886 120 LQYVYLQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSN 195 (627)
Q Consensus 120 L~~L~l~~N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~ 195 (627)
|++|+|++|+|+++++..+. .+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.. .+++|+.|+|++
T Consensus 90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 168 (229)
T 3e6j_A 90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168 (229)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 77777777777776665432 36777777777777 56777777777777777777777544432 567777777777
Q ss_pred CCccccC
Q 006886 196 NNLNGSI 202 (627)
Q Consensus 196 N~l~~~~ 202 (627)
|++++..
T Consensus 169 N~~~c~c 175 (229)
T 3e6j_A 169 NPWDCEC 175 (229)
T ss_dssp SCBCTTB
T ss_pred CCccCCc
Confidence 7776543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.79 E-value=6.2e-20 Score=187.39 Aligned_cols=143 Identities=22% Similarity=0.368 Sum_probs=95.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcc-cccEEeeecccccccCchh-hcccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSIS-SLQYVYLQNNYFSGVLPAF-RSLQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~-~~~~L~~L~ 146 (627)
.+++.|+|++|.+++.+|. .+..+++|+.|+|++|.+++.+|..+..++ +|++|+|++|++++.+|.. ...+|+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 5688888888888888877 788888888888888888888888888887 8888888888888766643 333567777
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNS 212 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l 212 (627)
|++|.+++.+|..|..+++|+.|++++|++++.+|.. .+++|++|++++|++++.+|..+..+++|
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 270 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTC
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCC
Confidence 7777666666666666655555555555555444432 34444444444444444444444333333
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.9e-19 Score=169.89 Aligned_cols=149 Identities=19% Similarity=0.261 Sum_probs=104.8
Q ss_pred EEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC-CCCCCcccccEEeeecccccccCch-hhc-cccccccccc
Q 006886 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP-SDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALDLSF 149 (627)
Q Consensus 73 ~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ls~ 149 (627)
.+++++|+++ .+|. .+ .+.++.|+|++|.|++..| ..|..+++|++|+|++|+|+++++. +.. .+|+.|+|++
T Consensus 15 ~l~~s~n~l~-~iP~-~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPE-HI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCS-CC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCcc-CC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 5677777776 4665 33 2345778888888876644 3467778888888888888877764 333 3688888888
Q ss_pred cccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCCCCC
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLCGLP 224 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~~~~ 224 (627)
|+|++..|..|.++++|++|+|++|+|++..|.. .+++|+.|+|++|+|++..|..|..+++|+.+ +|++.|+++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 8887666667777888888888888887766643 67778888888888877777777776666543 566767655
Q ss_pred C
Q 006886 225 L 225 (627)
Q Consensus 225 ~ 225 (627)
+
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=173.15 Aligned_cols=146 Identities=20% Similarity=0.294 Sum_probs=101.2
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~l 147 (627)
.++.|+|++|++++ +++..|.++++|+.|+|++|.|+...+..|..+++|++|+|++|++++.++..+. .+|+.|+|
T Consensus 38 ~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 38 DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TCSEEECCSSCCSC-CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCEEECcCCCCCe-eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 46677777777763 4443677777777777777777754444557777777777777777777665432 36777777
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|.+++..|..|.++++|++|+|++|+|++..+.. .+++|+.|++++|++++..+..|..+++|+.++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 777777666666777777777777777777654432 677777777777777765555676677666654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=165.14 Aligned_cols=146 Identities=22% Similarity=0.279 Sum_probs=119.7
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|.+|.|... ..+++.|+|++|++++ +++..|..+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 7 C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 7 CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKS-LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCc-CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 47999999752 2468899999999984 5554788999999999999999966666678899999999999
Q ss_pred ccccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 128 NYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 128 N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|++++.++..+ . .+|+.|+|++|+|++..+..|.++++|+.|++++|+|++..+.. .+++|+.|++++|++++..|
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 99998887643 3 38999999999999766667888999999999999999766643 78899999999998875443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-18 Score=164.47 Aligned_cols=147 Identities=22% Similarity=0.228 Sum_probs=130.4
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|..+.|+.. ...++.|+|++|++++..+...|..+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 47999999753 235789999999999776665799999999999999999988888999999999999999
Q ss_pred ccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 128 NYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 128 N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|+|+++++..+. .+|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999987443 48999999999999888999999999999999999999887754 89999999999999986644
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=171.09 Aligned_cols=133 Identities=16% Similarity=0.170 Sum_probs=102.3
Q ss_pred hcccCcCCceeEEEEEe-cCCcE--EEEEEecccccC-------------------------HHHHHHHHHHHHHhccCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTT--VVVKRLREVAAT-------------------------KREFEQQMEVVGTIGKHS 390 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~~h~ 390 (627)
.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|++++.++ .|+
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 130 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-KEA 130 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-HHT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-HhC
Confidence 36799999999999997 67888 999987543111 13578899999999 676
Q ss_pred Ce--eeeeeEEeeCCceEEEEecCCC-C----CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeec
Q 006886 391 NV--VPVRAYYYSKDEKLVVYSYMPA-G----SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH-SEGGAKFTHG 462 (627)
Q Consensus 391 ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~ 462 (627)
++ ...+.. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 54 223322 356899999942 4 67665432 223456789999999999999 888 9999
Q ss_pred CCCCCCeEecCCCCeEEeecccccccC
Q 006886 463 NIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 463 Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||||+|||++. .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=167.02 Aligned_cols=146 Identities=24% Similarity=0.323 Sum_probs=80.3
Q ss_pred EEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccc
Q 006886 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNA 151 (627)
Q Consensus 74 l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~ 151 (627)
+++++++++ .+|. .+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|+++.|..+ . .+|+.|+|++|+
T Consensus 16 v~c~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 16 VDCRGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EECTTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEcCCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 444455555 4444 222 456666666666665555556666666666666666666555322 2 256666666666
Q ss_pred cccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCCCC
Q 006886 152 FTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLCGL 223 (627)
Q Consensus 152 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~~~ 223 (627)
|+...+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+..|..+++|+.+ +|++.|++
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 66433334555666666666666666554432 55666666666666665555555555544432 45555544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6e-18 Score=163.26 Aligned_cols=144 Identities=20% Similarity=0.257 Sum_probs=128.0
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|..|.|... ...++.|+|++|++++ +++..|..+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 47999999752 2479999999999995 5555899999999999999999988899999999999999999
Q ss_pred ccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcccc
Q 006886 128 NYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 128 N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~ 201 (627)
|+|+++++..+. .+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++...
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999998887543 48999999999999888899999999999999999999877653 799999999999999753
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.9e-18 Score=168.56 Aligned_cols=153 Identities=22% Similarity=0.278 Sum_probs=133.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
.+++.|+|++|++++ ++ .+..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++.++..+. .+|+.|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 679999999999986 33 699999999999999999987777889999999999999999999887433 4899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~ 221 (627)
|++|++++..|..|.++++|+.|++++|++++..+.. .+++|+.|++++|++++..|..+..+++|+.+ +|+..|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999777777899999999999999999876653 79999999999999998888778888887765 566666
Q ss_pred CCC
Q 006886 222 GLP 224 (627)
Q Consensus 222 ~~~ 224 (627)
.++
T Consensus 220 ~~~ 222 (272)
T 3rfs_A 220 TCP 222 (272)
T ss_dssp CTT
T ss_pred cCc
Confidence 543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.9e-18 Score=167.54 Aligned_cols=155 Identities=21% Similarity=0.268 Sum_probs=133.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
.+++.|+|++|+++ .+|...|.++++|+.|+|++|.+++..+..|..+++|++|+|++|++++.++..+. .+|+.|+
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 67999999999998 67766789999999999999999977777889999999999999999999886543 4899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~ 221 (627)
|++|.|++..+..|..+++|+.|+|++|++++..+.. .+++|+.|+|++|++++..+..+..+++|+.+ +|++.|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 9999999766667999999999999999999866643 78999999999999997666667777776654 677777
Q ss_pred CCC
Q 006886 222 GLP 224 (627)
Q Consensus 222 ~~~ 224 (627)
++.
T Consensus 220 ~c~ 222 (270)
T 2o6q_A 220 TCN 222 (270)
T ss_dssp SSS
T ss_pred CCc
Confidence 653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=161.46 Aligned_cols=156 Identities=22% Similarity=0.287 Sum_probs=130.9
Q ss_pred CcceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh
Q 006886 59 WIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR 138 (627)
Q Consensus 59 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 138 (627)
|..-.|+. +.++.++++++ .+|. .+ .++|+.|+|++|.|++..|..|..+++|++|+|++|+|+++++..+
T Consensus 14 ~~~~~Cs~-----~~v~c~~~~l~-~ip~-~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 14 PSQCSCSG-----TTVDCRSKRHA-SVPA-GI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp CTTCEEET-----TEEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCCCEEeC-----CEeEccCCCcC-ccCC-CC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence 55567763 45889999988 7887 33 3899999999999999889999999999999999999998887654
Q ss_pred c--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcc
Q 006886 139 S--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 139 ~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~ 214 (627)
. .+|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|.. .+++|+.|+|++|+|++..+..+..+++|+.
T Consensus 85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 163 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 3 48999999999999776777899999999999999999 45543 8999999999999999776677887777765
Q ss_pred c---CCCcCCCCC
Q 006886 215 V---GNSMLCGLP 224 (627)
Q Consensus 215 ~---~n~~~~~~~ 224 (627)
+ +|++.|.++
T Consensus 164 L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 164 AYLFGNPWDCECR 176 (229)
T ss_dssp EECTTSCBCTTBG
T ss_pred EEeeCCCccCCcc
Confidence 4 677777653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=176.40 Aligned_cols=145 Identities=21% Similarity=0.309 Sum_probs=127.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCC---------cccccEEeeecccccccCchhhc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITS---------ISSLQYVYLQNNYFSGVLPAFRS 139 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~~~~~~ 139 (627)
.+++.|+|++|.++ .+|. .+.++++|+.|+|++|++.+.+|..+.. +++|++|+|++|+++.++..+..
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcC
Confidence 57999999999999 8887 7999999999999999998899988765 99999999999999966555554
Q ss_pred c-ccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 140 L-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 140 ~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
. +|+.|+|++|.+++ +|..+.++++|+.|++++|++.+.+|.. .+++|+.|+|++|++.+.+|..+.++++|+.++
T Consensus 205 l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~ 283 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLD 283 (328)
T ss_dssp CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEE
T ss_pred CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEe
Confidence 4 79999999999995 7778999999999999999999988865 889999999999999999999998888888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.3e-18 Score=179.42 Aligned_cols=168 Identities=23% Similarity=0.254 Sum_probs=139.4
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccC-CCCcccEEEccCcccCccCCCCCCCcccccEEeee
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIG-KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQ 126 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 126 (627)
|.|..+.|... ...++.|+|++|++++ ++...+. ++++|+.|+|++|+|++..|..|..+++|++|+|+
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 36888888652 2458899999999995 4444787 99999999999999998888889999999999999
Q ss_pred cccccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCC-----CCCCccceeeccCCCcc
Q 006886 127 NNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-----LNLPRLKILNFSNNNLN 199 (627)
Q Consensus 127 ~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-----~~~~~L~~L~l~~N~l~ 199 (627)
+|+|+++++..+ . .+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+. ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999999988643 3 4899999999999988889999999999999999999975443 25899999999999999
Q ss_pred ccCCCCCCCCC-----CCcccCCCcCCCCCC
Q 006886 200 GSIPDSLQTFP-----NSSFVGNSMLCGLPL 225 (627)
Q Consensus 200 ~~~p~~~~~~~-----~l~~~~n~~~~~~~~ 225 (627)
+..+..+..++ .|...+|++.|+|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 55545566554 356678999998753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.4e-17 Score=166.15 Aligned_cols=131 Identities=26% Similarity=0.296 Sum_probs=62.2
Q ss_pred CCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCcccccccccccc
Q 006886 91 GKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHL 168 (627)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 168 (627)
+.+++|+.|+|++|.|+ .+|..+..+++|++|+|++|+|+++++..+ . .+|+.|+|++|+|++..+..|..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 34444444444444444 444445555555555555555555544322 2 24555555555555433344455555555
Q ss_pred ccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcc---cCCCcCCCC
Q 006886 169 LNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF---VGNSMLCGL 223 (627)
Q Consensus 169 L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~---~~n~~~~~~ 223 (627)
|+|++|+|++.++.. .+++|+.|+|++|+|+ .+|..+..+..|.. .+|++.|++
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 555555555333322 3555555555555555 44444444333332 245554443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=168.16 Aligned_cols=147 Identities=20% Similarity=0.175 Sum_probs=108.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcc-cCccCCCCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNY-LNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|+|++|.+++..|. .|..+++|+.|+|++|. ++...|..|..+++|++|+|++|++++.++..+. .+|++|
T Consensus 56 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp TTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 5678888888888755454 67888888888888886 7655577777888888888888888877665433 368888
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+|++|++++..+..|..+++|+.|++++|++++..+.. .+++|+.|++++|.+++..|..+..+++|+.++
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 207 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEee
Confidence 88888887655556777888888888888887655532 677788888888888777777777777776653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=172.10 Aligned_cols=164 Identities=26% Similarity=0.335 Sum_probs=136.0
Q ss_pred CCCCCCCCCCCcceEeeCC-----------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCc
Q 006886 49 WNAAAPVCSSWIGVTCNVN-----------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSI 117 (627)
Q Consensus 49 W~~~~~~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 117 (627)
|......| .|.|+ |+.. ..+++.|+|++|++++ +|...|.++++|+.|+|++|.+++..|..|.++
T Consensus 23 ~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 99 (353)
T 2z80_A 23 SNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL 99 (353)
T ss_dssp ----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence 43344445 78887 7642 2479999999999995 555589999999999999999998888899999
Q ss_pred ccccEEeeecccccccCch-hhc-cccccccccccccccCCcc--ccccccccccccccCCc-ccccCCCC--CCCccce
Q 006886 118 SSLQYVYLQNNYFSGVLPA-FRS-LQLNALDLSFNAFTGNIPP--GFQNLTRLHLLNLQNNS-ISGAIPPL--NLPRLKI 190 (627)
Q Consensus 118 ~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~--~~~~L~~ 190 (627)
++|++|+|++|++++.++. +.. .+|++|+|++|++++ +|. .|.++++|++|++++|+ +++..+.. .+++|+.
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~ 178 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence 9999999999999998886 333 389999999999995 555 79999999999999995 66554543 8999999
Q ss_pred eeccCCCccccCCCCCCCCCCCcccC
Q 006886 191 LNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 191 L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++++|.+++..|..+..+++|+.++
T Consensus 179 L~l~~n~l~~~~~~~l~~l~~L~~L~ 204 (353)
T 2z80_A 179 LEIDASDLQSYEPKSLKSIQNVSHLI 204 (353)
T ss_dssp EEEEETTCCEECTTTTTTCSEEEEEE
T ss_pred EECCCCCcCccCHHHHhccccCCeec
Confidence 99999999999999999999888764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=182.19 Aligned_cols=157 Identities=23% Similarity=0.256 Sum_probs=137.3
Q ss_pred CCcceEeeCC-----------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeee
Q 006886 58 SWIGVTCNVN-----------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQ 126 (627)
Q Consensus 58 ~w~gv~C~~~-----------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 126 (627)
.|.|+ |+.. ..+++.|+|++|++++..|. .|.++++|+.|+|++|++++..|..|..+++|++|+|+
T Consensus 5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 79998 8742 24799999999999976665 89999999999999999998888999999999999999
Q ss_pred cccccccCch-hhcc-cccccccccccccc-CCccccccccccccccccCCcccccCCC-C--CCCccceeeccCCCccc
Q 006886 127 NNYFSGVLPA-FRSL-QLNALDLSFNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPP-L--NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 127 ~N~l~~~~~~-~~~~-~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~--~~~~L~~L~l~~N~l~~ 200 (627)
+|++++.+|. +... +|++|+|++|.+++ .+|..|+++++|++|++++|++.+.+|. . .+++|++|++++|.+++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 9999999987 4444 89999999999996 3678899999999999999996666653 2 89999999999999999
Q ss_pred cCCCCCCCCCCCcccC
Q 006886 201 SIPDSLQTFPNSSFVG 216 (627)
Q Consensus 201 ~~p~~~~~~~~l~~~~ 216 (627)
.+|..+..+++|+.++
T Consensus 163 ~~~~~l~~l~~L~~L~ 178 (549)
T 2z81_A 163 YQSQSLKSIRDIHHLT 178 (549)
T ss_dssp ECTTTTTTCSEEEEEE
T ss_pred cChhhhhccccCceEe
Confidence 9999998888776653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=169.63 Aligned_cols=159 Identities=25% Similarity=0.326 Sum_probs=123.8
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCcc--CCCCCCCcccccEEee
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGT--LPSDITSISSLQYVYL 125 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l 125 (627)
|.|.+|.|+.. ..+++.|+|++|+++ .+|...|.++++|+.|+|++|.++.. .|..+..+++|++|+|
T Consensus 7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 48999999862 257999999999998 67776789999999999999999832 3566677888888888
Q ss_pred ecccccccCchhhcc-ccccccccccccccCCc-cccccccccccccccCCcccccCCCC--CCCccceeeccCCCccc-
Q 006886 126 QNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIP-PGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG- 200 (627)
Q Consensus 126 ~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~- 200 (627)
++|.+.+.++.+... +|+.|+|++|++++..+ ..+.++++|++|++++|++++..+.. .+++|+.|++++|.+++
T Consensus 86 s~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp CSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 888888766654443 78888888888885443 46778888888888888887766653 67788888888888876
Q ss_pred cCCCCCCCCCCCcccC
Q 006886 201 SIPDSLQTFPNSSFVG 216 (627)
Q Consensus 201 ~~p~~~~~~~~l~~~~ 216 (627)
.+|..+..+++|+.++
T Consensus 166 ~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 166 FLPDIFTELRNLTFLD 181 (306)
T ss_dssp EECSCCTTCTTCCEEE
T ss_pred cchhHHhhCcCCCEEE
Confidence 5677777777777664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-17 Score=157.04 Aligned_cols=128 Identities=26% Similarity=0.301 Sum_probs=107.5
Q ss_pred EEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCC-CCCCcccccEEeeecccccccCchhh-c-ccccccccc
Q 006886 72 IGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPS-DITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLS 148 (627)
Q Consensus 72 ~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls 148 (627)
+.|++++|+++ .+|. .+.. +|+.|+|++|.|++..|. .|..+++|++|+|++|+|+++.|..+ . .+|+.|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~-~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPR-DIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCS-CCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCcc-CCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 46788888885 7887 3433 899999999999866654 48899999999999999999977543 3 389999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
+|+|++..|..|.++++|++|+|++|+|++.+|.. .+++|++|+|++|++++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999888888999999999999999999887764 78999999999999987655
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.2e-17 Score=161.85 Aligned_cols=148 Identities=24% Similarity=0.239 Sum_probs=129.3
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccc-ccccCchhh-c-ccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNY-FSGVLPAFR-S-LQLNA 144 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~-~-~~L~~ 144 (627)
...++.|+|++|++++ +++..|.++++|+.|+|++|.+++..|..|..+++|++|+|++|. +....+..+ . .+|++
T Consensus 31 ~~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~ 109 (285)
T 1ozn_A 31 PAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (285)
T ss_dssp CTTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CCCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence 3579999999999995 454489999999999999999998889999999999999999997 888766543 3 38999
Q ss_pred ccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 145 L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|+|++|.+++..|..|.++++|++|++++|++++..+.. .+++|+.|++++|++++..+..+..+++|+.++
T Consensus 110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 999999999877889999999999999999999766653 799999999999999977777788888888764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=157.98 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=118.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
.+++.|+|++|++++..+. .|..+++|+.|+|++|.|++..|..|..+++|++|+|++|+|+++++..+. .+|+.|+
T Consensus 59 ~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAG-VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCCCTT-TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccCHh-HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 6799999999999975554 899999999999999999977778899999999999999999999887543 4899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcccc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~ 201 (627)
|++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|++++.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999766668999999999999999999876643 889999999999999865
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.2e-16 Score=149.76 Aligned_cols=155 Identities=23% Similarity=0.305 Sum_probs=127.7
Q ss_pred ceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-
Q 006886 61 GVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS- 139 (627)
Q Consensus 61 gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~- 139 (627)
+..|.. +.+++++++++ .+|. .+ .++|+.|+|++|.+++..+..|..+++|++|+|++|+++++++..+.
T Consensus 4 ~C~C~~-----~~v~c~~~~l~-~~p~-~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (208)
T 2o6s_A 4 RCSCSG-----TTVECYSQGRT-SVPT-GI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74 (208)
T ss_dssp TCEEET-----TEEECCSSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred CCEECC-----CEEEecCCCcc-CCCC-CC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC
Confidence 456643 46888999988 5665 23 56899999999999977777789999999999999999998886543
Q ss_pred -cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc-
Q 006886 140 -LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV- 215 (627)
Q Consensus 140 -~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~- 215 (627)
.+|++|+|++|+|++..+..|.++++|++|++++|+|++..+.. .+++|+.|++++|++++..+..+..+++|+.+
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 48999999999999766667899999999999999999876653 79999999999999997766667877777655
Q ss_pred --CCCcCCCCC
Q 006886 216 --GNSMLCGLP 224 (627)
Q Consensus 216 --~n~~~~~~~ 224 (627)
+|+..|.++
T Consensus 155 l~~N~~~~~~~ 165 (208)
T 2o6s_A 155 LHDNPWDCTCP 165 (208)
T ss_dssp CCSCCBCCCTT
T ss_pred ecCCCeecCCC
Confidence 566666543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-16 Score=159.22 Aligned_cols=155 Identities=22% Similarity=0.261 Sum_probs=83.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 146 (627)
.+++.|+|++|++++ +++..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|++.+..+. +.. .+|+.|+
T Consensus 52 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp TTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred cCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 345555665555553 2222455555555555555555555455555555555555555555554442 222 2455555
Q ss_pred ccccccccC-CccccccccccccccccCCcccc----------------------------cCCCC-CCCccceeeccCC
Q 006886 147 LSFNAFTGN-IPPGFQNLTRLHLLNLQNNSISG----------------------------AIPPL-NLPRLKILNFSNN 196 (627)
Q Consensus 147 ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~----------------------------~~p~~-~~~~L~~L~l~~N 196 (627)
|++|.+++. +|..|.++++|+.|++++|++++ ..+.. ...+|+.|++++|
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n 210 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTN 210 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSS
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCC
Confidence 555555532 35555555555555555555544 33322 3346777888888
Q ss_pred CccccCCCCCCCCCCCcc---cCCCcCCCCC
Q 006886 197 NLNGSIPDSLQTFPNSSF---VGNSMLCGLP 224 (627)
Q Consensus 197 ~l~~~~p~~~~~~~~l~~---~~n~~~~~~~ 224 (627)
++++..+..+..+++|+. .+|+..|+++
T Consensus 211 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 211 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ceeecCHhHhcccccccEEEccCCcccccCC
Confidence 877555555566666554 3566666553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.1e-17 Score=164.57 Aligned_cols=145 Identities=19% Similarity=0.255 Sum_probs=93.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC-CCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP-SDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|+|++|+++ .+|. .+..+++|+.|+|++|.+++..+ ..+..+++|++|+|++|.+.+..+..+. .+|+.|
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp SCCCEEECCSCSEE-EEEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred cccCEEECCCCccc-cChh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 45777777777776 4555 46677777777777777764433 4566677777777777777666654332 366777
Q ss_pred ccccccccc-CCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 146 DLSFNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 146 ~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|++|.+++ .+|..+..+++|+.|++++|++++..|.. .+++|+.|++++|++++..+..+..+++|+.+
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 777777665 45666666777777777777776655543 56667777777777665555556656665554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.1e-17 Score=183.83 Aligned_cols=144 Identities=18% Similarity=0.157 Sum_probs=125.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ 146 (627)
..++.|||++|+|+ .+|+..|.++++|+.|||++|+|++..|..|.+|++|++|+|++|+|+++++..+ . .+|++|+
T Consensus 52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 57999999999999 5666589999999999999999998778889999999999999999999988644 3 3899999
Q ss_pred ccccccccCCccccccccccccccccCCccccc-CCCC--CCCccceeeccCCCccccCCCCCCCCCCCc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA-IPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSS 213 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~ 213 (627)
|++|+|++..+..|+++++|++|++++|++++. +|.. .+++|++|++++|++++..|..+..+.++.
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~ 200 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 200 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhh
Confidence 999999976667899999999999999999864 3443 789999999999999988888776655544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=171.35 Aligned_cols=155 Identities=23% Similarity=0.247 Sum_probs=120.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCC-------------------------CCCcccccEE
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSD-------------------------ITSISSLQYV 123 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-------------------------~~~l~~L~~L 123 (627)
.+++.|+|++|+++ .+|+..|..+++|+.|+|++|.|++..+.. |..+++|++|
T Consensus 123 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 201 (452)
T 3zyi_A 123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201 (452)
T ss_dssp TTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence 57888999999888 455547888888888888888887544434 4455566666
Q ss_pred eeecccccccCchhhc-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccc
Q 006886 124 YLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 124 ~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~ 200 (627)
+|++|++++.+ .+.. .+|+.|+|++|.|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++
T Consensus 202 ~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 202 NLGMCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp ECTTSCCSSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ECCCCcccccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 66666666553 2322 37889999999999888889999999999999999999877754 78999999999999997
Q ss_pred cCCCCCCCCCCCcc---cCCCcCCCCCC
Q 006886 201 SIPDSLQTFPNSSF---VGNSMLCGLPL 225 (627)
Q Consensus 201 ~~p~~~~~~~~l~~---~~n~~~~~~~~ 225 (627)
..+..+..+++|+. .+|++.|+|.+
T Consensus 281 ~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 281 LPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred cChHHhccccCCCEEEccCCCcCCCCCc
Confidence 77777777776654 47899998765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-16 Score=171.09 Aligned_cols=156 Identities=24% Similarity=0.269 Sum_probs=114.7
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcc-------------------------cccE
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSIS-------------------------SLQY 122 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------------------------~L~~ 122 (627)
-.+++.|+|++|+++ .+|+..|..+++|+.|+|++|.|++..+..|..++ +|++
T Consensus 111 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~ 189 (440)
T 3zyj_A 111 LANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRY 189 (440)
T ss_dssp CSSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCE
T ss_pred CccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCe
Confidence 357888899888888 45555788888888888888888755554454444 4555
Q ss_pred EeeecccccccCchhhc-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcc
Q 006886 123 VYLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLN 199 (627)
Q Consensus 123 L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~ 199 (627)
|+|++|+++.++ .+.. .+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|+|+
T Consensus 190 L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 190 LNLAMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp EECTTSCCSSCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred ecCCCCcCcccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 555555555433 2222 36888888888888777888888888999999999888766654 7889999999999999
Q ss_pred ccCCCCCCCCCCCcc---cCCCcCCCCCC
Q 006886 200 GSIPDSLQTFPNSSF---VGNSMLCGLPL 225 (627)
Q Consensus 200 ~~~p~~~~~~~~l~~---~~n~~~~~~~~ 225 (627)
+..+..+..+++|+. .+|++.|+|.+
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred ccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 777777777776654 47888898764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=160.66 Aligned_cols=145 Identities=23% Similarity=0.218 Sum_probs=122.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
..++.|+|++|++++..+. .|.++++|+.|+|++|.|++. |.. ..+++|++|+|++|+++.++..+.. .+|+.|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLA-TLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGG-GGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHH-HhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCCcCchhhccCCCCCEEEC
Confidence 5789999999999865555 899999999999999999954 433 7899999999999999977665544 38999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..+..+..+++|+.++
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 999999777788999999999999999999766653 789999999999999965556678888887764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=157.84 Aligned_cols=136 Identities=24% Similarity=0.309 Sum_probs=120.3
Q ss_pred CCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccc
Q 006886 67 NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNA 144 (627)
Q Consensus 67 ~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~ 144 (627)
...+++.|+|++|++++. ++..|.++++|+.|+|++|.+++..|..|..+++|++|+|++|++++.++..+. .+|+.
T Consensus 83 ~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TCTTCCEEECTTSCCCCC-CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCEEECCCCccCcc-ChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 346899999999999954 444799999999999999999987777899999999999999999999886543 48999
Q ss_pred ccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 145 LDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 145 L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|+|++|++++..|..|..+++|+.|++++|++++.++.. .+++|+.|++++|++++..|
T Consensus 162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 999999999877777899999999999999999877753 89999999999999987654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=150.22 Aligned_cols=154 Identities=20% Similarity=0.236 Sum_probs=119.2
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|..+.|+.. ...++.|+|++|++++..+...|+.+++|+.|+|++|.|++..|..|..+++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 36888888752 237899999999998655544589999999999999999988899999999999999999
Q ss_pred ccccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCCCCCC-ccceeeccCCCccccCCC
Q 006886 128 NYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLP-RLKILNFSNNNLNGSIPD 204 (627)
Q Consensus 128 N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-~L~~L~l~~N~l~~~~p~ 204 (627)
|+|++.++..+ . .+|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+...+. .|+...+..+......|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 99999988643 3 48999999999999888999999999999999999998765532111 133334445555555565
Q ss_pred CCCCCC
Q 006886 205 SLQTFP 210 (627)
Q Consensus 205 ~~~~~~ 210 (627)
.+....
T Consensus 168 ~l~~~~ 173 (192)
T 1w8a_A 168 KVRDVQ 173 (192)
T ss_dssp TTTTSB
T ss_pred HHcCCC
Confidence 555443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=185.66 Aligned_cols=85 Identities=27% Similarity=0.333 Sum_probs=57.9
Q ss_pred ccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccCCCcC
Q 006886 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSML 220 (627)
Q Consensus 141 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~n~~~ 220 (627)
+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++..-.++|+.|+|++|+|++.+|..+.++..+.+.+|++.
T Consensus 481 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~ 560 (844)
T 3j0a_A 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFI 560 (844)
T ss_dssp CEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCC
T ss_pred cccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcc
Confidence 35555555555555555556666666666666666665444443367777777777777777777777777888899999
Q ss_pred CCCCC
Q 006886 221 CGLPL 225 (627)
Q Consensus 221 ~~~~~ 225 (627)
|+|++
T Consensus 561 C~c~~ 565 (844)
T 3j0a_A 561 CECEL 565 (844)
T ss_dssp CSSSC
T ss_pred ccccc
Confidence 98875
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=172.09 Aligned_cols=155 Identities=22% Similarity=0.272 Sum_probs=130.3
Q ss_pred CcEEEEEcCCCCcccccCccccC---------------------------------------CCCcccEEEccCcccCcc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIG---------------------------------------KLDALKILSLRSNYLNGT 109 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~---------------------------------------~l~~L~~L~L~~N~l~~~ 109 (627)
.+++.|+|++|++++.+|. .+. ..++|+.|+|++|.+++.
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~-~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 290 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAK-RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL 290 (455)
T ss_dssp CEEEEEECTTSCCCHHHHH-HHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEE
T ss_pred ceeeeEecCCCcccccchh-hhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcccccc
Confidence 5788999999988765543 221 126899999999999999
Q ss_pred CCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CC
Q 006886 110 LPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NL 185 (627)
Q Consensus 110 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~ 185 (627)
.|..|..+++|++|+|++|++++.+|..+ . .+|+.|+|++|++++..|..|.++++|+.|+|++|++++..|.. .+
T Consensus 291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 370 (455)
T 3v47_A 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccc
Confidence 99999999999999999999999988543 3 48999999999999888889999999999999999999887754 89
Q ss_pred CccceeeccCCCccccCCCCCCCCCCCccc---CCCcCCCCC
Q 006886 186 PRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLCGLP 224 (627)
Q Consensus 186 ~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~~~~ 224 (627)
++|++|++++|++++..+..+..+++|+.+ +|+..|+++
T Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999999997666677777777654 677777765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=172.99 Aligned_cols=158 Identities=18% Similarity=0.163 Sum_probs=135.6
Q ss_pred CCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 58 SWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
.|..|.|... +..++.|+|++|++++..+. .|.++++|+.|+|++|.+++..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQD-EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHh-HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4778888742 35789999999999965555 8999999999999999999888999999999999999999
Q ss_pred cccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCC
Q 006886 129 YFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPD 204 (627)
Q Consensus 129 ~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~ 204 (627)
+++++++..+ . .+|+.|+|++|++++..|..|.++++|+.|++++|++++..+.. .+++|+.|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 9999888643 3 48999999999999888889999999999999999999876653 889999999999999866656
Q ss_pred CCCCCCCCcccC
Q 006886 205 SLQTFPNSSFVG 216 (627)
Q Consensus 205 ~~~~~~~l~~~~ 216 (627)
.+..+++|+.++
T Consensus 171 ~l~~l~~L~~L~ 182 (477)
T 2id5_A 171 ALSHLHGLIVLR 182 (477)
T ss_dssp HHTTCTTCCEEE
T ss_pred HhcccCCCcEEe
Confidence 677777776653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2e-16 Score=169.94 Aligned_cols=157 Identities=19% Similarity=0.183 Sum_probs=112.7
Q ss_pred CCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 58 SWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
.|..|.|... ..+++.|+|++|++++..|. .|.++++|+.|+|++|.|++..|..|.++++|++|+|++|
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQAD-TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHH-HcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 3678888752 35799999999999965555 8999999999999999999888899999999999999999
Q ss_pred cccccCchhhc--cccccccccccccccCCccccccccccc-------------------------cccccCCcccccCC
Q 006886 129 YFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLH-------------------------LLNLQNNSISGAIP 181 (627)
Q Consensus 129 ~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~-------------------------~L~l~~N~l~~~~p 181 (627)
+|+++++..+. .+|++|+|++|+|++..+..|.++++|+ .|+|++|+|++...
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 213 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN 213 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccccc
Confidence 99988886443 3799999999988854444555444444 44444555543211
Q ss_pred CCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 182 PLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 182 ~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
...+++|+.|+|++|++++..|..|.++++|+.+
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 247 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEE
Confidence 1245556666666666665555555555555544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=146.29 Aligned_cols=133 Identities=24% Similarity=0.232 Sum_probs=115.4
Q ss_pred CcEEEEEcCCCCcc-cccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFT-GPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|+|++|+++ +.+|. .+..+++|+.|+|++|.|++. ..|..+++|++|+|++|++++.+|.... .+|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 67999999999998 88887 689999999999999999965 7899999999999999999997776544 489999
Q ss_pred cccccccccCC-ccccccccccccccccCCcccccCC----C-CCCCccceeeccCCCccccCCCC
Q 006886 146 DLSFNAFTGNI-PPGFQNLTRLHLLNLQNNSISGAIP----P-LNLPRLKILNFSNNNLNGSIPDS 205 (627)
Q Consensus 146 ~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p----~-~~~~~L~~L~l~~N~l~~~~p~~ 205 (627)
+|++|.|++.. +..+..+++|+.|++++|++++..+ . ..+++|++|++++|.+. .+|+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999632 2789999999999999999997665 1 28999999999999997 55543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=168.42 Aligned_cols=165 Identities=15% Similarity=0.143 Sum_probs=125.7
Q ss_pred CCCCCCCCCCCCCcceEeeCC-------------------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccC
Q 006886 47 LNWNAAAPVCSSWIGVTCNVN-------------------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLN 107 (627)
Q Consensus 47 ~~W~~~~~~c~~w~gv~C~~~-------------------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~ 107 (627)
.+|....+||+.|.+..|... -.+++.|+++++.++ .+|...|..+++|+.|+|++|.++
T Consensus 4 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ---CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred CCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCccc
Confidence 367766667766555555311 146788999999887 678767899999999999999999
Q ss_pred ccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCccccccccccccccccCCcccccCCCC--
Q 006886 108 GTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-- 183 (627)
Q Consensus 108 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-- 183 (627)
+..|..|..+++|++|+|++|++++.+|..+ . .+|++|+|++|+++...+..|.++++|++|++++|++++..|..
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 8778899999999999999999999988743 3 37999999999999544445789999999999999999877653
Q ss_pred CCCccceeeccCCCccccCCCCCCCCCCC
Q 006886 184 NLPRLKILNFSNNNLNGSIPDSLQTFPNS 212 (627)
Q Consensus 184 ~~~~L~~L~l~~N~l~~~~p~~~~~~~~l 212 (627)
.+++|+.|++++|++++.....+.++..+
T Consensus 163 ~l~~L~~L~l~~n~l~~~~~~~l~~L~~L 191 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHVDLSLIPSLFHA 191 (390)
T ss_dssp SCTTCCEEECCSSCCSBCCGGGCTTCSEE
T ss_pred CCCCCCEEECCCCcCCcccccccccccee
Confidence 88999999999999986533334333333
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-16 Score=177.19 Aligned_cols=144 Identities=16% Similarity=0.169 Sum_probs=120.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ 146 (627)
.+++.|++++|.+. .+|+..|.++++|+.|+|++|.|++..|..|..+++|++|+|++|.+++.+|..+ . .+|++|+
T Consensus 51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 35678889998887 6777678999999999999999998888899999999999999999999988753 3 3899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSS 213 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~ 213 (627)
|++|.|++..+..|+++++|++|+|++|+|++.+|.. .+++|+.|++++|.+++..+..+.++..|.
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~ 198 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN 198 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhh
Confidence 9999999655556799999999999999999877753 899999999999999976444444444433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=155.17 Aligned_cols=157 Identities=13% Similarity=0.159 Sum_probs=121.9
Q ss_pred CCCCCcceE--eeC------CCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcc-cCccCCCCCCCcccccEEee
Q 006886 55 VCSSWIGVT--CNV------NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNY-LNGTLPSDITSISSLQYVYL 125 (627)
Q Consensus 55 ~c~~w~gv~--C~~------~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~l 125 (627)
.|..|.++. |.. -...++.|+|++|++++ +|+..|.++++|+.|+|++|. +++..+..|..+++|++|+|
T Consensus 9 ~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~-i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l 87 (239)
T 2xwt_C 9 ECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87 (239)
T ss_dssp SEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSE-ECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEE
T ss_pred eeCCCCcceeEccCccccCCCCCcccEEEEeCCcceE-ECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEEC
Confidence 343345544 854 23579999999999994 555589999999999999997 88666678999999999999
Q ss_pred ec-ccccccCchhh-c-cccccccccccccccCCccccccccccc---cccccCC-cccccCCCC--CCCccc-eeeccC
Q 006886 126 QN-NYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLH---LLNLQNN-SISGAIPPL--NLPRLK-ILNFSN 195 (627)
Q Consensus 126 ~~-N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~--~~~~L~-~L~l~~ 195 (627)
++ |+++++++..+ . .+|+.|+|++|++++ +|. |..+++|+ .|++++| ++++..+.. .+++|+ .|++++
T Consensus 88 ~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~ 165 (239)
T 2xwt_C 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165 (239)
T ss_dssp EEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred CCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence 98 99998887543 3 389999999999995 776 88888887 9999999 888766543 788899 999999
Q ss_pred CCccccCCCCCCCCCCCccc
Q 006886 196 NNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 196 N~l~~~~p~~~~~~~~l~~~ 215 (627)
|+++ .+|......++|+.+
T Consensus 166 n~l~-~i~~~~~~~~~L~~L 184 (239)
T 2xwt_C 166 NGFT-SVQGYAFNGTKLDAV 184 (239)
T ss_dssp CCCC-EECTTTTTTCEEEEE
T ss_pred CCCc-ccCHhhcCCCCCCEE
Confidence 9998 555543333555544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.3e-16 Score=159.02 Aligned_cols=144 Identities=19% Similarity=0.257 Sum_probs=118.0
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|..+.|... ..+++.|+|++|++++..|. .|.++++|+.|+|++|.+++..|..|..+++|++|+|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKD-DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHh-HhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 47999999752 24789999999999955444 899999999999999999988899999999999999999
Q ss_pred ccccccCchhhccccccccccccccccCCccccccccccccccccCCcccc--cCCCC--CCCccceeeccCCCccccCC
Q 006886 128 NYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG--AIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 128 N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|+++.+++... .+|++|++++|++++..+..|.++++|+.|++++|+++. ..+.. .+ +|+.|++++|.+++ +|
T Consensus 112 n~l~~l~~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~ 188 (332)
T 2ft3_A 112 NHLVEIPPNLP-SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IP 188 (332)
T ss_dssp SCCCSCCSSCC-TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CC
T ss_pred CcCCccCcccc-ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cC
Confidence 99997766554 689999999999997666679999999999999999963 33432 33 67777777777764 44
Q ss_pred C
Q 006886 204 D 204 (627)
Q Consensus 204 ~ 204 (627)
.
T Consensus 189 ~ 189 (332)
T 2ft3_A 189 K 189 (332)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-16 Score=176.82 Aligned_cols=145 Identities=22% Similarity=0.221 Sum_probs=76.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC-CCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP-SDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|+|++|.+++ +|. .+..+++|+.|+|++|.+++..| ..|..+++|++|+|++|++.+.+|..+. .+|+.|
T Consensus 376 ~~L~~L~L~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 376 NSLRHLDLSFNGAII-MSA-NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp SCCCEEECCSCSEEE-ECC-CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CcccEeECCCCcccc-chh-hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 345666666666553 443 45555555555555555555444 3555555555555555555555443222 245555
Q ss_pred ccccccccc-CCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 146 DLSFNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 146 ~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|++|.+++ .+|..|..+++|+.|++++|++++.+|.. .+++|+.|++++|++++.+|..+..+++|+.+
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 555555554 24445555555555555555555544432 45555555555555555445555555444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-16 Score=173.12 Aligned_cols=147 Identities=21% Similarity=0.200 Sum_probs=105.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc---cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS---LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~---~~L~~L 145 (627)
..++.|+|++|.+++..+ ..+++|+.|+|++|.|++..|..|+.+++|++|+|++|.+++.+|..+. .+|+.|
T Consensus 99 ~~L~~L~L~~N~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L 174 (487)
T 3oja_A 99 PSIETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (487)
T ss_dssp TTCCEEECCSSCCCCEEE----CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECcCCcCCCCCc----cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence 567777777777775433 2457788888888888877777788888888888888888887664332 378888
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~ 221 (627)
+|++|.|++. |. +..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|.|++ +|..+..+++|..+ +|+..|
T Consensus 175 ~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred ecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 8888888854 33 335778888888888888765554 67788888888888874 66666666665543 566665
Q ss_pred C
Q 006886 222 G 222 (627)
Q Consensus 222 ~ 222 (627)
+
T Consensus 252 ~ 252 (487)
T 3oja_A 252 G 252 (487)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-16 Score=156.73 Aligned_cols=144 Identities=18% Similarity=0.136 Sum_probs=124.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ 146 (627)
..++.|+|++|++++..+ ..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|++++.++..+ . .+|+.|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECT-TTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCH-hHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 469999999999995544 489999999999999999998778899999999999999999999987643 3 3899999
Q ss_pred ccccccccCCccccccccccccccccCCccccc-CCCC--CCCccceeeccCCCccccCCCCCCCCCCCc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA-IPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSS 213 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~ 213 (627)
+++|.+++..+..+.++++|++|++++|++++. +|.. .+++|+.|++++|++++..+..+..++.+.
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 176 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence 999999977776899999999999999999873 4543 789999999999999987777776665554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=180.49 Aligned_cols=177 Identities=22% Similarity=0.298 Sum_probs=89.4
Q ss_pred ChhHHHHHHHHHhhCCC---CCCCCCCCCCCCCCCCcceEeeCCCCcEEEEEcCCCCcccc-------------------
Q 006886 27 LNSDKQALLDFADAVPH---ARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGP------------------- 84 (627)
Q Consensus 27 ~~~~~~~l~~~~~~~~~---~~~~~W~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~~~------------------- 84 (627)
...+..+|+++...... .....|.....++.+|.++.++. ++++.|+|.+|++...
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 34578899999877622 12235654444555799888865 5566666655554321
Q ss_pred -------cCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCC
Q 006886 85 -------IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNI 156 (627)
Q Consensus 85 -------~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~ 156 (627)
+++..+..+++|+.|+|++|.|. .+|..+..+++|++|+|++|+|+.+++.+..+ +|+.|+|++|+|+ .+
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 22335666777777777777776 66666667777777777777777444444443 6777777777777 56
Q ss_pred ccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCC
Q 006886 157 PPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQT 208 (627)
Q Consensus 157 p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~ 208 (627)
|..|++|++|++|+|++|.|+ .+|.. .+++|+.|+|++|+|++.+|..+..
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 777777777777777777776 34432 6677777777777777666665543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-16 Score=177.11 Aligned_cols=146 Identities=17% Similarity=0.330 Sum_probs=132.3
Q ss_pred CCcEEEEEcCCCCcccc-----------------cCccccC--CCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 68 RSRVIGIHLPGIGFTGP-----------------IPANSIG--KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~-----------------~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
-.+++.|+|++|.++|. +|. .++ ++++|+.|+|++|.+.|.+|..|+++++|++|+|++|
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 36799999999999996 998 788 9999999999999999999999999999999999999
Q ss_pred c-ccc-cCch-hhc-------cccccccccccccccCCcc--ccccccccccccccCCcccccCCCC-CCCccceeeccC
Q 006886 129 Y-FSG-VLPA-FRS-------LQLNALDLSFNAFTGNIPP--GFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSN 195 (627)
Q Consensus 129 ~-l~~-~~~~-~~~-------~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~ 195 (627)
+ ++| .+|. +.. .+|+.|+|++|+++ .+|. .++++++|+.|++++|+++|.+|.. .+++|+.|++++
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 8 998 6664 433 58999999999999 8998 9999999999999999999989854 789999999999
Q ss_pred CCccccCCCCCCCCCC-CcccC
Q 006886 196 NNLNGSIPDSLQTFPN-SSFVG 216 (627)
Q Consensus 196 N~l~~~~p~~~~~~~~-l~~~~ 216 (627)
|+++ .+|..+..+++ |+.++
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~ 383 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLS 383 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEE
T ss_pred Cccc-cccHhhhhhcccCcEEE
Confidence 9999 89988988888 87764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.1e-16 Score=160.43 Aligned_cols=134 Identities=13% Similarity=0.121 Sum_probs=94.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc---------------CHHHH--------HHHHHHHHHhccCCCeeee
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA---------------TKREF--------EQQMEVVGTIGKHSNVVPV 395 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~---------------~~~~~--------~~e~~~l~~l~~h~niv~l 395 (627)
.+.||+|+||.||+|...+|+.||||+++.... ..... .+|...+.++ .+.++...
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTTCSCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcCCCCC
Confidence 468999999999999998999999998753210 11112 3345555555 33333211
Q ss_pred eeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC
Q 006886 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL 475 (627)
Q Consensus 396 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 475 (627)
.-+.. ...++||||++|++|..+... .....++.|++.+|.|||+.| ||||||||.|||+++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 11111 233699999999888654321 123568899999999999998 99999999999999887
Q ss_pred C----------eEEeecccccccC
Q 006886 476 N----------GCISDVGLAHLIN 489 (627)
Q Consensus 476 ~----------~ki~DfG~a~~~~ 489 (627)
. +.|+||+-+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 4 7899999876543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=8.5e-16 Score=165.14 Aligned_cols=135 Identities=21% Similarity=0.249 Sum_probs=122.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
..++.|+|++|++++.+|. .++.+++|+.|+|++|.+++..|..|..+++|++|+|++|++++.+|..+. .+|+.|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKS-VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchh-hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 5799999999999987777 899999999999999999998899999999999999999999999886543 4899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPD 204 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~ 204 (627)
|++|++++..|..|.++++|++|++++|+|++.++.. .+++|+.|++++|++++..|.
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 9999999888999999999999999999999766543 899999999999999988773
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=156.64 Aligned_cols=141 Identities=17% Similarity=0.233 Sum_probs=109.8
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|..+.|... ...++.|+|++|++++. ++..|.++++|+.|+|++|.+++..|..|..+++|++|+|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEI-KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCB-CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEe-ChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 47999999742 35789999999999954 444899999999999999999988899999999999999999
Q ss_pred ccccccCchhhccccccccccccccccCCccccccccccccccccCCcccc--cCCCC--CCCccceeeccCCCcc
Q 006886 128 NYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG--AIPPL--NLPRLKILNFSNNNLN 199 (627)
Q Consensus 128 N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~--~~~~L~~L~l~~N~l~ 199 (627)
|+++.++.... .+|+.|++++|.+++..+..|.++++|+.|++++|+++. ..+.. .+++|+.|++++|.++
T Consensus 110 n~l~~l~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 110 NQLKELPEKMP-KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SCCSBCCSSCC-TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CcCCccChhhc-ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 99997655443 578888888888886666667777777777777777753 33322 5566666666666665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=5e-16 Score=173.34 Aligned_cols=154 Identities=16% Similarity=0.115 Sum_probs=134.2
Q ss_pred CcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccc
Q 006886 59 WIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNY 129 (627)
Q Consensus 59 w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 129 (627)
+..|.|... +..++.|+|++|++++..|. .|+++++|+.|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNT-TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTT-TSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChh-HhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 456777542 35799999999999965555 89999999999999999999899999999999999999999
Q ss_pred ccccCchhh-c-cccccccccccccccCCccccccccccccccccCCccccc-CCCC-CCCccceeeccCCCccccCCCC
Q 006886 130 FSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA-IPPL-NLPRLKILNFSNNNLNGSIPDS 205 (627)
Q Consensus 130 l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~-~~~~L~~L~l~~N~l~~~~p~~ 205 (627)
+.+..|..+ . .+|++|+|++|++++..|..|.++++|++|++++|++++. +|.. .+++|+.|++++|.+++..|..
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 999988544 3 3899999999999976688899999999999999999974 3443 7999999999999999888888
Q ss_pred CCCCCCCc
Q 006886 206 LQTFPNSS 213 (627)
Q Consensus 206 ~~~~~~l~ 213 (627)
+..+++|+
T Consensus 173 ~~~l~~L~ 180 (606)
T 3t6q_A 173 MSSLQQAT 180 (606)
T ss_dssp HHTTTTCC
T ss_pred hhhhcccc
Confidence 88887776
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=139.94 Aligned_cols=126 Identities=22% Similarity=0.247 Sum_probs=103.1
Q ss_pred EEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccc
Q 006886 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNA 151 (627)
Q Consensus 74 l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~ 151 (627)
+++++++++ .+|. . ..++|+.|+|++|++++..+..|..+++|++|+|++|+++++++..+ . .+|+.|+|++|+
T Consensus 12 l~~~~~~l~-~~p~-~--~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 12 IRCNSKGLT-SVPT-G--IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp EECCSSCCS-SCCT-T--CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEecCCCCc-cCCC-C--CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 333445665 4665 2 24789999999999997767778999999999999999998888643 3 389999999999
Q ss_pred cccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 152 FTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 152 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|++..+..|..+++|+.|++++|+|++.++.. .+++|+.|++++|++++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99776677899999999999999999766543 68999999999999987655
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=168.84 Aligned_cols=154 Identities=25% Similarity=0.319 Sum_probs=123.6
Q ss_pred CCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCc--cCCCCCCCcccccEEeeecccccccCc-hhh-c-cc
Q 006886 67 NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNG--TLPSDITSISSLQYVYLQNNYFSGVLP-AFR-S-LQ 141 (627)
Q Consensus 67 ~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~-~-~~ 141 (627)
...+++.|+|++|.+++.+|. .++++++|+.|+|++|++++ .+|..|..+++|++|+|++|++++.+| ..+ . .+
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred CCCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 346799999999999987877 78999999999999999986 335678899999999999999998444 322 2 47
Q ss_pred cccccccccccccCCccccccccccccccccCCcccccCCC-C-CCCccceeeccCCCccccCCCC-CCCCCCCcc---c
Q 006886 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP-L-NLPRLKILNFSNNNLNGSIPDS-LQTFPNSSF---V 215 (627)
Q Consensus 142 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~-~~~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~---~ 215 (627)
|+.|+|++|++++.+|..+. ++|+.|++++|+|+. +|. . .+++|+.|+|++|+|+ .+|.. +..+++|+. .
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEec
Confidence 99999999999887776654 689999999999984 554 3 8899999999999999 56665 777776665 4
Q ss_pred CCCcCCCCCC
Q 006886 216 GNSMLCGLPL 225 (627)
Q Consensus 216 ~n~~~~~~~~ 225 (627)
+|++.|++++
T Consensus 506 ~N~~~c~c~~ 515 (562)
T 3a79_B 506 DNPWDCTCPG 515 (562)
T ss_dssp SCCBCCCHHH
T ss_pred CCCcCCCcch
Confidence 6888887653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=5.4e-16 Score=139.68 Aligned_cols=124 Identities=23% Similarity=0.259 Sum_probs=103.5
Q ss_pred CcEEEEEcCCCCcc-cccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFT-GPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|++++|+++ +.+|. .+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|.... .+|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 57889999999998 78887 789999999999999999865 7788999999999999999997666543 479999
Q ss_pred cccccccccC-CccccccccccccccccCCcccccCC---CC--CCCccceeeccC
Q 006886 146 DLSFNAFTGN-IPPGFQNLTRLHLLNLQNNSISGAIP---PL--NLPRLKILNFSN 195 (627)
Q Consensus 146 ~ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p---~~--~~~~L~~L~l~~ 195 (627)
++++|.+++. .|..+..+++|+.|++++|++++..+ .. .+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999863 34788899999999999999987655 12 788888888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.2e-15 Score=142.00 Aligned_cols=123 Identities=27% Similarity=0.321 Sum_probs=106.0
Q ss_pred EEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccccccc
Q 006886 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFN 150 (627)
Q Consensus 73 ~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N 150 (627)
.+++++++++ .+|. .+ .++|+.|+|++|.|+ .+|..|..+++|++|+|++|+|+++.+..+ . .+|+.|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~-~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPK-GI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCS-CC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCC-CC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 5788888888 7887 33 368999999999998 788999999999999999999999988643 3 38999999999
Q ss_pred ccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccc
Q 006886 151 AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 151 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~ 200 (627)
+|++..|..|.++++|+.|+|++|+|++..+.. .+++|+.|+|++|++..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999877788999999999999999999766543 78999999999999874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=8e-16 Score=156.62 Aligned_cols=143 Identities=17% Similarity=0.176 Sum_probs=98.4
Q ss_pred CcEEEEEcCCCCcccccCc---cccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccccccc---Cchh--hc-
Q 006886 69 SRVIGIHLPGIGFTGPIPA---NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGV---LPAF--RS- 139 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~~~~--~~- 139 (627)
.+++.|+|++|.+++..+. ..+..+++|+.|+|++|.+++..|..|..+++|++|+|++|++.+. ++.. ..
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 5678888888888865541 2445788888888888888877777888888888888888887652 2222 12
Q ss_pred cccccccccccccccCCcc----ccccccccccccccCCcccccCCCC--C---CCccceeeccCCCccccCCCCCCCCC
Q 006886 140 LQLNALDLSFNAFTGNIPP----GFQNLTRLHLLNLQNNSISGAIPPL--N---LPRLKILNFSNNNLNGSIPDSLQTFP 210 (627)
Q Consensus 140 ~~L~~L~ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~p~~--~---~~~L~~L~l~~N~l~~~~p~~~~~~~ 210 (627)
.+|++|+|++|+++ .+|. .+.++++|++|+|++|+|++..|.. . +++|+.|+|++|+|+ .+|..+. +
T Consensus 197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~ 272 (310)
T 4glp_A 197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A 272 (310)
T ss_dssp CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence 36888888888886 3443 2466778888888888888765532 3 368888888888887 5666553 3
Q ss_pred CCccc
Q 006886 211 NSSFV 215 (627)
Q Consensus 211 ~l~~~ 215 (627)
+|+.+
T Consensus 273 ~L~~L 277 (310)
T 4glp_A 273 KLRVL 277 (310)
T ss_dssp CCSCE
T ss_pred CCCEE
Confidence 44443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.6e-16 Score=173.62 Aligned_cols=145 Identities=18% Similarity=0.186 Sum_probs=104.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCC-CCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSD-ITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
.+++.|+|++|.+.+..|. .|..+++|+.|+|++|.+++..|.. |..+++|++|+|++|.+.+.+|..+. .+|+.|
T Consensus 376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 5677888888888765555 6777888888888888877665544 77778888888888887777665332 367777
Q ss_pred cccccccccC---CccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 146 DLSFNAFTGN---IPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 146 ~ls~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|++|.+++. .+..+..+++|+.|++++|++++.+|.. .+++|+.|++++|++++..|..+..++.| .+
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L 528 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence 7777777752 2345777777777777777777766543 67777777777777777777777777766 44
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.9e-16 Score=160.09 Aligned_cols=107 Identities=20% Similarity=0.232 Sum_probs=46.0
Q ss_pred cEEEEEcCCCCcccccCcccc-CCCCcccEEEccCcccCccCCCCCCCc-----ccccEEeeecccccccCchhh-c-cc
Q 006886 70 RVIGIHLPGIGFTGPIPANSI-GKLDALKILSLRSNYLNGTLPSDITSI-----SSLQYVYLQNNYFSGVLPAFR-S-LQ 141 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~~-~-~~ 141 (627)
+++.|+|++|++++.+|...+ ..+++|+.|+|++|.+++. |..+..+ ++|++|+|++|++.+.++..+ . .+
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 344444444444444444211 4444444444444444433 4444433 444444444444444443221 1 14
Q ss_pred cccccccccccccC--Ccccc--ccccccccccccCCccc
Q 006886 142 LNALDLSFNAFTGN--IPPGF--QNLTRLHLLNLQNNSIS 177 (627)
Q Consensus 142 L~~L~ls~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~ 177 (627)
|+.|+|++|++++. +|..+ ..+++|++|++++|+|+
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 44444444444432 12222 44444444444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-15 Score=150.18 Aligned_cols=138 Identities=17% Similarity=0.274 Sum_probs=117.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|++++|+++ .++ .+..+++|+.|+|++|.|++..| +..+++|++|+|++|++++.++... .+|+.|+|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~~~~-~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPS-ACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTTCCC-SSCCEEECC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCcccc-CcccEEEcc
Confidence 57899999999998 566 58999999999999999996544 9999999999999999998765433 789999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+|+|++ +| .+.++++|+.|++++|+|++..+-..+++|+.|++++|++++. ..+..+++|+.++
T Consensus 115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~ 178 (263)
T 1xeu_A 115 NNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178 (263)
T ss_dssp SSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEE
T ss_pred CCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEe
Confidence 999996 44 5999999999999999999754333899999999999999966 6677777777653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-15 Score=170.06 Aligned_cols=157 Identities=22% Similarity=0.274 Sum_probs=134.6
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccccc-ccCchhh-c-cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS-GVLPAFR-S-LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~~~~-~-~~L~~L 145 (627)
..++.+++.+++.....+...+..+++|+.++++.|.+.+..|..+..+++|++|+|++|++. +.+|..+ . .+|+.|
T Consensus 420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L 499 (635)
T 4g8a_A 420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 499 (635)
T ss_dssp TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence 457778888888777777667899999999999999999999999999999999999999854 4555533 3 389999
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCC-CCCcc---cCCCc
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTF-PNSSF---VGNSM 219 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~-~~l~~---~~n~~ 219 (627)
+|++|+|++..|..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..|..+..+ ++|+. -+|++
T Consensus 500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~ 579 (635)
T 4g8a_A 500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence 99999999988999999999999999999999877753 89999999999999999999988776 45554 57999
Q ss_pred CCCCCC
Q 006886 220 LCGLPL 225 (627)
Q Consensus 220 ~~~~~~ 225 (627)
.|+|.+
T Consensus 580 ~C~C~~ 585 (635)
T 4g8a_A 580 ACTCEH 585 (635)
T ss_dssp CCSGGG
T ss_pred cccCCc
Confidence 998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=9.6e-16 Score=177.45 Aligned_cols=149 Identities=22% Similarity=0.225 Sum_probs=123.3
Q ss_pred CCcceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccC-CCCCCCcccccEEeeecccccccCch
Q 006886 58 SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTL-PSDITSISSLQYVYLQNNYFSGVLPA 136 (627)
Q Consensus 58 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~ 136 (627)
+|..|.+ .+.+++.|+|++|.+++..|. .|.++++|+.|+|++|.+.+.+ |..|.++++|++|+|++|++.+..|.
T Consensus 15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 5777777 457899999999999866665 8999999999999999666666 77899999999999999999998775
Q ss_pred hh-cc-ccccccccccccccCCccc--cccccccccccccCCcccccCCC---CCCCccceeeccCCCccccCCCCCCCC
Q 006886 137 FR-SL-QLNALDLSFNAFTGNIPPG--FQNLTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNGSIPDSLQTF 209 (627)
Q Consensus 137 ~~-~~-~L~~L~ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~---~~~~~L~~L~l~~N~l~~~~p~~~~~~ 209 (627)
.+ .. +|++|+|++|.+++.+|.. |.++++|++|+|++|++++..+. .++++|++|+|++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 43 33 8999999999999866665 88999999999999999886653 278999999999999988887776544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=140.94 Aligned_cols=124 Identities=23% Similarity=0.301 Sum_probs=107.2
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|+|.++.|... ...++.|+|++|++++ +|+..|..+++|+.|+|++|.|++..+..|..+++|++|+|++
T Consensus 7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccE-eCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 47999999752 2579999999999994 5554789999999999999999977677789999999999999
Q ss_pred ccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCC
Q 006886 128 NYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP 181 (627)
Q Consensus 128 N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 181 (627)
|+|++.++..+. .+|+.|+|++|+|++..+..|..+++|+.|++++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999999886543 489999999999997666667889999999999999997655
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=160.15 Aligned_cols=156 Identities=21% Similarity=0.214 Sum_probs=100.4
Q ss_pred CCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 58 SWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
.|..|.|... ...++.|+|++|++++..+. .|.++++|+.|+|++|.|++..|..|.++++|++|+|++|
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~-~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVN-SFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTT-TTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHH-HhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 3667888642 24577888888888854444 7888888888888888888766677888888888888888
Q ss_pred cccccCchhh-c-cccccccccccccccCCccccccccccccccc-------------------------cCCcccccCC
Q 006886 129 YFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNL-------------------------QNNSISGAIP 181 (627)
Q Consensus 129 ~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l-------------------------~~N~l~~~~p 181 (627)
+|+++++..+ . .+|+.|+|++|.|++..+..|.++++|+.|++ ++|+|+. +|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc
Confidence 8887776433 2 36777777777776544434444444444444 4444442 22
Q ss_pred CC-CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 182 PL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 182 ~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
.. .+++|+.|+|++|++++..|..|..+++|+.+
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 236 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEE
Confidence 22 45555566666666655555555555555544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=166.97 Aligned_cols=151 Identities=26% Similarity=0.352 Sum_probs=103.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCc--cCCCCCCCcccccEEeeecccccccCc-h-hhc-cccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNG--TLPSDITSISSLQYVYLQNNYFSGVLP-A-FRS-LQLN 143 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~-~~L~ 143 (627)
..++.|+|++|.+++.+|. .++.+++|+.|+|++|++++ .+|..+..+++|++|+|++|++++.+| . +.. .+|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 5677777777777776666 67777777777777777775 455667777777777777777777333 2 222 3677
Q ss_pred cccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCC-CCCCCCCccc---CC
Q 006886 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDS-LQTFPNSSFV---GN 217 (627)
Q Consensus 144 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~---~n 217 (627)
.|+|++|++++.+|..+. ++|+.|++++|+|+ .+|.. .+++|+.|++++|+++ .+|.. +..+++|+.+ +|
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence 777777777766666554 57777788888777 45532 6777888888888887 45554 6666665543 56
Q ss_pred CcCCCCC
Q 006886 218 SMLCGLP 224 (627)
Q Consensus 218 ~~~~~~~ 224 (627)
+..|+++
T Consensus 479 ~~~c~c~ 485 (520)
T 2z7x_B 479 PWDCSCP 485 (520)
T ss_dssp CBCCCHH
T ss_pred CCcccCC
Confidence 6666544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=170.22 Aligned_cols=154 Identities=19% Similarity=0.278 Sum_probs=111.2
Q ss_pred EEEEEcCCCCcc--cccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch---------hhc
Q 006886 71 VIGIHLPGIGFT--GPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA---------FRS 139 (627)
Q Consensus 71 v~~l~l~~~~l~--~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~---------~~~ 139 (627)
++.|++++|.+. +.+|. .|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+. +..
T Consensus 456 L~~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~ 534 (680)
T 1ziw_A 456 LQRLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534 (680)
T ss_dssp CCEEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred cccchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence 444444444443 34555 677888888888888888876667788888888888888888775321 222
Q ss_pred -cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCC----CCCCCC
Q 006886 140 -LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSL----QTFPNS 212 (627)
Q Consensus 140 -~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~----~~~~~l 212 (627)
.+|+.|+|++|+|+...+..|.++++|+.|+|++|+|++.++.. .+++|+.|++++|++++..|..+ .++..+
T Consensus 535 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l 614 (680)
T 1ziw_A 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEE
T ss_pred CCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEE
Confidence 36888888888888433346888889999999999998655543 77889999999999987666543 455556
Q ss_pred cccCCCcCCCCCC
Q 006886 213 SFVGNSMLCGLPL 225 (627)
Q Consensus 213 ~~~~n~~~~~~~~ 225 (627)
...+|++.|+|+.
T Consensus 615 ~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 615 DMRFNPFDCTCES 627 (680)
T ss_dssp ECTTCCCCBCCCC
T ss_pred EccCCCcccCCcc
Confidence 6668899888764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.9e-16 Score=156.79 Aligned_cols=142 Identities=20% Similarity=0.198 Sum_probs=110.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCC-----CcccEEEccCcccCccCCCCCCCcccccEEeeecccccccC---chh--h
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKL-----DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVL---PAF--R 138 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~--~ 138 (627)
.+++.|+|++|++++. |. .++.+ ++|+.|+|++|+|++..|..|+.+++|++|+|++|++.+.. +.+ .
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp CCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 6789999999999876 65 67766 89999999999999877788999999999999999987752 222 2
Q ss_pred c-ccccccccccccccc--CCc-cccccccccccccccCCcccccCCCC---CCCccceeeccCCCccccCCCCCCCCCC
Q 006886 139 S-LQLNALDLSFNAFTG--NIP-PGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPDSLQTFPN 211 (627)
Q Consensus 139 ~-~~L~~L~ls~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~L~~L~l~~N~l~~~~p~~~~~~~~ 211 (627)
. .+|+.|+|++|+|++ .++ ..+.++++|+.|++++|+|++.+|.. .+++|+.|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 2 378999999999883 122 34457788999999999998866432 5788999999999998 7777665 55
Q ss_pred Cccc
Q 006886 212 SSFV 215 (627)
Q Consensus 212 l~~~ 215 (627)
|+.+
T Consensus 276 L~~L 279 (312)
T 1wwl_A 276 LSVL 279 (312)
T ss_dssp EEEE
T ss_pred ceEE
Confidence 5544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=170.42 Aligned_cols=144 Identities=19% Similarity=0.168 Sum_probs=125.0
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchh-hcc-ccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF-RSL-QLNAL 145 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~L~~L 145 (627)
+.+++.|+|++|++++..+. .|.++++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|.. ... +|++|
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 109 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSY-SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109 (606)
T ss_dssp CTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEE
T ss_pred CCCcCEEECCCCCcCEeChh-hccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEE
Confidence 36799999999999965554 8999999999999999999888989999999999999999999997764 333 89999
Q ss_pred cccccccccCCccccccccccccccccCCcccc-cCCCC--CCCccceeeccCCCccccCCCCCCCCCCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG-AIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNS 212 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l 212 (627)
+|++|.+++..|..|+++++|++|++++|++++ .+|.. ++++|++|++++|++++..|..++.+.++
T Consensus 110 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 179 (606)
T 3vq2_A 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179 (606)
T ss_dssp ECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHC
T ss_pred EccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcc
Confidence 999999997777889999999999999999986 55654 89999999999999998888877766544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=166.61 Aligned_cols=153 Identities=20% Similarity=0.286 Sum_probs=93.4
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC-CCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP-SDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
+++.|+|++|.+++ +++ .+..+++|+.|+|++|.+++..| ..+..+++|++|+|++|++.+.+|..+. .+|+.|+
T Consensus 374 ~L~~L~l~~n~l~~-~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 374 SLKYLDLSFNGVIT-MSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp CCCEEECCSCSEEE-EEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred ccCEEECCCCcccc-ccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 45555555555542 333 26666666666666666665544 3566666666677766666666554332 2677777
Q ss_pred ccccccc-cCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcC
Q 006886 147 LSFNAFT-GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSML 220 (627)
Q Consensus 147 ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~ 220 (627)
|++|.++ +.+|..|..+++|+.|++++|++++..|.. .+++|+.|++++|++++..|..+..+++|+.+ +|+..
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 531 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence 7777765 456666777777777777777776655543 56677777777777776666666666555543 45555
Q ss_pred CCCC
Q 006886 221 CGLP 224 (627)
Q Consensus 221 ~~~~ 224 (627)
|.++
T Consensus 532 ~~~~ 535 (570)
T 2z63_A 532 CSCP 535 (570)
T ss_dssp CCTT
T ss_pred CCCc
Confidence 5544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=166.13 Aligned_cols=146 Identities=23% Similarity=0.373 Sum_probs=119.7
Q ss_pred CCCCCCCCCC----CCcce-EeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccE
Q 006886 48 NWNAAAPVCS----SWIGV-TCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQY 122 (627)
Q Consensus 48 ~W~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 122 (627)
+|.....+|. .|.|+ .|.. .+++.|+|++|++++ +|. .+ +++|+.|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~-~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPD-NL--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCS-CC--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCH-hH--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 4655555663 49999 7875 579999999999996 887 34 488999999999999 788 45799999
Q ss_pred EeeecccccccCchhhccccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccC
Q 006886 123 VYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202 (627)
Q Consensus 123 L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~ 202 (627)
|+|++|+|+++++ +. .+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +
T Consensus 105 L~Ls~N~l~~ip~-l~-~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 105 LDACDNRLSTLPE-LP-ASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp EECCSSCCSCCCC-CC-TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-C
T ss_pred EEccCCCCCCcch-hh-cCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCCCCCCC-c
Confidence 9999999999655 43 389999999999996 776 68899999999999997 555 78899999999999986 7
Q ss_pred CCCCCCCCCCccc
Q 006886 203 PDSLQTFPNSSFV 215 (627)
Q Consensus 203 p~~~~~~~~l~~~ 215 (627)
|. +. ++|..+
T Consensus 176 p~-l~--~~L~~L 185 (571)
T 3cvr_A 176 PE-LP--ESLEAL 185 (571)
T ss_dssp CC-CC--TTCCEE
T ss_pred ch-hh--CCCCEE
Confidence 77 54 555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-15 Score=143.55 Aligned_cols=140 Identities=22% Similarity=0.316 Sum_probs=113.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 146 (627)
.+++.|++++|+++ .+| .+..+++|+.|+|++|.++ .+..+..+++|++|+|++|++++..+. +.. .+|+.|+
T Consensus 44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 46889999999998 666 4889999999999999776 334788999999999999999985443 433 3799999
Q ss_pred ccccccccCCccccccccccccccccCCc-ccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNS-ISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++|++++..|..+..+++|++|++++|+ ++ .+|.. .+++|+.|++++|++++ ++ .+..+++|+.++
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~ 187 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLY 187 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEE
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEE
Confidence 99999998788889999999999999998 55 44544 88999999999999985 44 666777766553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.3e-15 Score=153.60 Aligned_cols=125 Identities=22% Similarity=0.317 Sum_probs=75.8
Q ss_pred ccCCCCcccEEEccCcccC--ccCCCCCCCcccccEEeeecccccccCchhhccccccccccccccccCCcccccccccc
Q 006886 89 SIGKLDALKILSLRSNYLN--GTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRL 166 (627)
Q Consensus 89 ~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L 166 (627)
.|.++++|+.|+|++|.++ +..|..+..+ +|++|++++|++++++.... .+|+.|+|++|.+++..|..|.++++|
T Consensus 142 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~-~~L~~L~l~~n~i~~~~~~~l~~l~~L 219 (332)
T 2ft3_A 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP-ETLNELHLDHNKIQAIELEDLLRYSKL 219 (332)
T ss_dssp GGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC-SSCSCCBCCSSCCCCCCTTSSTTCTTC
T ss_pred HhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc-CCCCEEECCCCcCCccCHHHhcCCCCC
Confidence 3444444444444444443 2334444444 44444444444444332222 367777777777776666677777778
Q ss_pred ccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 167 HLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 167 ~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+.|++++|++++..+.. .+++|+.|++++|+++ .+|..+..+++|+.++
T Consensus 220 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 270 (332)
T 2ft3_A 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270 (332)
T ss_dssp SCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred CEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence 88888888777655533 6777888888888877 6777777777776654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-15 Score=154.06 Aligned_cols=144 Identities=21% Similarity=0.271 Sum_probs=113.8
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCc--cCCCCCCCcccccEEeeecccccccCchhhccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNG--TLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l 147 (627)
.++.|++++|.+++ +++..|.++++|+.|+|++|.++. ..|..|..+++|++|++++|+++.++.... .+|+.|+|
T Consensus 122 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~-~~L~~L~l 199 (330)
T 1xku_A 122 TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP-PSLTELHL 199 (330)
T ss_dssp TCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC-TTCSEEEC
T ss_pred cccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc-ccCCEEEC
Confidence 45555555555553 333357788888888888888853 667778888888888888888887655433 67999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|++++..|..|.++++|+.|++++|++++..+.. .+++|+.|++++|+++ .+|..+..+++|+.++
T Consensus 200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 999999877888999999999999999999876643 7889999999999998 8888888888887764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=167.58 Aligned_cols=110 Identities=18% Similarity=0.171 Sum_probs=98.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ 146 (627)
.+++.|+|++|++++..|. .|+.+++|+.|+|++|.|++..|..|+.+++|++|+|++|.|+++++..+ . .+|+.|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTY-AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChH-HhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 4689999999999965555 89999999999999999998888889999999999999999999888753 3 4899999
Q ss_pred ccccccccCCccccccccccccccccCCccccc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA 179 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 179 (627)
|++|.|++..|..|.++++|+.|+|++|+|++.
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 999999988888899999999999999998863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=175.10 Aligned_cols=145 Identities=20% Similarity=0.312 Sum_probs=130.0
Q ss_pred CCcEEEEEcCCCCccc-----------------ccCccccC--CCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 68 RSRVIGIHLPGIGFTG-----------------PIPANSIG--KLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~-----------------~~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
-.+++.|+|++|+++| .+|. .++ ++++|+.|+|++|.+.+.+|..|+++++|++|+|++|
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 3679999999999998 4888 677 9999999999999999999999999999999999999
Q ss_pred c-ccc-cCch-hhcc--------ccccccccccccccCCcc--ccccccccccccccCCcccccCCCC-CCCccceeecc
Q 006886 129 Y-FSG-VLPA-FRSL--------QLNALDLSFNAFTGNIPP--GFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFS 194 (627)
Q Consensus 129 ~-l~~-~~~~-~~~~--------~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~ 194 (627)
+ ++| .+|. +... +|+.|+|++|+|+ .+|. .|+++++|+.|+|++|+|+ .+|.. .+++|+.|+|+
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 8 998 6664 3322 7999999999999 8998 9999999999999999999 67754 89999999999
Q ss_pred CCCccccCCCCCCCCCC-CcccC
Q 006886 195 NNNLNGSIPDSLQTFPN-SSFVG 216 (627)
Q Consensus 195 ~N~l~~~~p~~~~~~~~-l~~~~ 216 (627)
+|+++ .+|..+..+++ |+.++
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~ 625 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLG 625 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEE
T ss_pred CCccc-cchHHHhhccccCCEEE
Confidence 99999 89999988888 87764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.2e-15 Score=138.92 Aligned_cols=126 Identities=23% Similarity=0.366 Sum_probs=107.6
Q ss_pred cEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCCccccccccccccccccCCc
Q 006886 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNS 175 (627)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 175 (627)
+.+++++|.|+ .+|..+. ++|++|+|++|+|+.++..+... +|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 57999999998 7887764 79999999999999777555554 89999999999998777889999999999999999
Q ss_pred ccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCCCCCC
Q 006886 176 ISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLCGLPL 225 (627)
Q Consensus 176 l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~~~~~ 225 (627)
|++..|.. .+++|+.|+|++|+|++..+..|..+++|+.+ +|++.|++.+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 99877753 89999999999999996666678777777654 7888887654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-15 Score=164.73 Aligned_cols=31 Identities=6% Similarity=0.048 Sum_probs=25.8
Q ss_pred CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC
Q 006886 372 TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD 403 (627)
Q Consensus 372 ~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 403 (627)
..++|..|++.+.++ +|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i-~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQA-RQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHH-HHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcc-cccchhhHHHHhcChH
Confidence 367899999999999 9999999999997654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.2e-15 Score=147.18 Aligned_cols=146 Identities=16% Similarity=0.197 Sum_probs=123.8
Q ss_pred CCcEEEEEcCCCC-cccccCccccCCCCcccEEEccC-cccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccc-
Q 006886 68 RSRVIGIHLPGIG-FTGPIPANSIGKLDALKILSLRS-NYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLN- 143 (627)
Q Consensus 68 ~~~v~~l~l~~~~-l~~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~- 143 (627)
-.+++.|+|++|+ ++ .+++..|.++++|+.|+|++ |.|++..+..|..+++|++|+|++|+++++++ +... +|+
T Consensus 54 l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCccccc-ccccccccc
Confidence 3679999999998 66 66666899999999999999 99997777889999999999999999999654 4443 676
Q ss_pred --ccccccc-ccccCCccccccccccc-cccccCCcccccCCCC--CCCccceeeccCCC-ccccCCCCCCCC-CCCccc
Q 006886 144 --ALDLSFN-AFTGNIPPGFQNLTRLH-LLNLQNNSISGAIPPL--NLPRLKILNFSNNN-LNGSIPDSLQTF-PNSSFV 215 (627)
Q Consensus 144 --~L~ls~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~-l~~~~p~~~~~~-~~l~~~ 215 (627)
.|++++| .+++..+..|.++++|+ .|++++|+++ .+|.. ..++|+.|++++|+ +++..+..|..+ ++|+.+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99976666799999999 9999999999 45543 44899999999995 996667788888 888876
Q ss_pred C
Q 006886 216 G 216 (627)
Q Consensus 216 ~ 216 (627)
+
T Consensus 211 ~ 211 (239)
T 2xwt_C 211 D 211 (239)
T ss_dssp E
T ss_pred E
Confidence 5
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.1e-15 Score=163.18 Aligned_cols=148 Identities=20% Similarity=0.185 Sum_probs=130.1
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNAL 145 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L 145 (627)
-.+++.|+|++|.+++..|. .|.++++|+.|+|++|.|++..+..|.++++|++|+|++|++.+.++..+. .+|+.|
T Consensus 55 l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp CTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 36799999999999976666 899999999999999999966666789999999999999999999886443 389999
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCC--CCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+|++|.+++..|..|.++++|+.|++++|++++..+. ..+++|+.|++++|.+++..+..+..+++|+.++
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 206 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEE
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceee
Confidence 9999999988888999999999999999999975543 2899999999999999988888888888887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=9.9e-16 Score=137.97 Aligned_cols=125 Identities=22% Similarity=0.302 Sum_probs=108.1
Q ss_pred CCCCcccEEEccCcccC-ccCCCCCCCcccccEEeeecccccccCchhhc-cccccccccccccccCCcccccccccccc
Q 006886 91 GKLDALKILSLRSNYLN-GTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHL 168 (627)
Q Consensus 91 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 168 (627)
...++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. +.+.. .+|+.|+|++|.+++.+|..+..+++|++
T Consensus 14 ~~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CCGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 34578999999999998 88999999999999999999999998 54444 38999999999999879998989999999
Q ss_pred ccccCCcccccC--CCC-CCCccceeeccCCCccccCC---CCCCCCCCCcccC
Q 006886 169 LNLQNNSISGAI--PPL-NLPRLKILNFSNNNLNGSIP---DSLQTFPNSSFVG 216 (627)
Q Consensus 169 L~l~~N~l~~~~--p~~-~~~~L~~L~l~~N~l~~~~p---~~~~~~~~l~~~~ 216 (627)
|++++|++++.. ... .+++|+.|++++|++++..+ ..+..+++|+.++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 146 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEET
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccccc
Confidence 999999999743 222 89999999999999996655 4688888888775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-15 Score=171.45 Aligned_cols=137 Identities=22% Similarity=0.252 Sum_probs=113.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 146 (627)
.+++.|+|++|++++ +++..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|+++++++. +.. .+|++|+
T Consensus 25 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 578999999999885 4444789999999999999999988888888999999999999999988775 444 3799999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSL 206 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~ 206 (627)
|++|++++..|..|+++++|++|++++|++++..|.. .+++|++|++++|.+++..+..+
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 165 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHH
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHh
Confidence 9999998766678889999999999999998876654 78888888888888887666543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.8e-15 Score=137.89 Aligned_cols=126 Identities=23% Similarity=0.295 Sum_probs=108.6
Q ss_pred CCCCcccEEEccCcccC-ccCCCCCCCcccccEEeeecccccccCchhhc-cccccccccccccccCCcccccccccccc
Q 006886 91 GKLDALKILSLRSNYLN-GTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHL 168 (627)
Q Consensus 91 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 168 (627)
...++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. +.+.. .+|+.|+|++|++++.+|..+.++++|+.
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 34578999999999998 78999999999999999999999988 54444 38999999999999878888888999999
Q ss_pred ccccCCcccccC--CCC-CCCccceeeccCCCccccCC---CCCCCCCCCcccCC
Q 006886 169 LNLQNNSISGAI--PPL-NLPRLKILNFSNNNLNGSIP---DSLQTFPNSSFVGN 217 (627)
Q Consensus 169 L~l~~N~l~~~~--p~~-~~~~L~~L~l~~N~l~~~~p---~~~~~~~~l~~~~n 217 (627)
|++++|+|++.. +.. .+++|+.|++++|++++..+ ..+..+++|+.++-
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 154 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG 154 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETT
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecC
Confidence 999999999743 222 89999999999999995544 47888898888764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.7e-15 Score=165.23 Aligned_cols=149 Identities=18% Similarity=0.242 Sum_probs=99.6
Q ss_pred CcEEEEEcCCCCcccccC-ccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIP-ANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~l 147 (627)
.+++.|+|++|++++..+ ...+..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++++... ..+|+.|+|
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~-~~~L~~L~L 438 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI-PQTLEVLDV 438 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTS-CTTCSEEEC
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchh-cCCceEEEC
Confidence 345555555555542211 023556666666666666666 56666666666666666666666543322 236777777
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcc---cCCCcCCCC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF---VGNSMLCGL 223 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~---~~n~~~~~~ 223 (627)
++|+|++.+ ..+++|++|+|++|+|+ .+|.. .+++|+.|+|++|++++.+|..+..+++|+. .+|++.|++
T Consensus 439 s~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 439 SNNNLDSFS----LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred CCCChhhhc----ccCChhcEEECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 777777532 46888999999999998 45544 7889999999999999888877777776664 467777765
Q ss_pred C
Q 006886 224 P 224 (627)
Q Consensus 224 ~ 224 (627)
+
T Consensus 514 ~ 514 (549)
T 2z81_A 514 P 514 (549)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.6e-14 Score=150.35 Aligned_cols=148 Identities=20% Similarity=0.219 Sum_probs=121.7
Q ss_pred cceEeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCC-CcccccEEeeecccccccCch-h
Q 006886 60 IGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQNNYFSGVLPA-F 137 (627)
Q Consensus 60 ~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~-~ 137 (627)
.+..|.. ..+++++++|+ .+|. .+. +.|+.|+|++|+|++..+..|. .+++|++|+|++|+|+++++. +
T Consensus 14 ~~C~C~~-----~~l~c~~~~l~-~iP~-~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~ 84 (361)
T 2xot_A 14 ANCLCAS-----NILSCSKQQLP-NVPQ-SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF 84 (361)
T ss_dssp TTCEEET-----TEEECCSSCCS-SCCS-SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCEECC-----CEEEeCCCCcC-ccCc-cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc
Confidence 5677763 36899999998 5787 343 4689999999999987777787 999999999999999999886 4
Q ss_pred hc-cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCC---CCCCC
Q 006886 138 RS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSL---QTFPN 211 (627)
Q Consensus 138 ~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~---~~~~~ 211 (627)
.. .+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|.. .+++|+.|+|++|+|++..+..+ ..+++
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~ 164 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK 164 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTT
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc
Confidence 44 38999999999999777778999999999999999999876654 89999999999999995444444 55777
Q ss_pred CcccC
Q 006886 212 SSFVG 216 (627)
Q Consensus 212 l~~~~ 216 (627)
|+.++
T Consensus 165 L~~L~ 169 (361)
T 2xot_A 165 LMLLD 169 (361)
T ss_dssp CCEEE
T ss_pred CCEEE
Confidence 77664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=7.8e-15 Score=154.34 Aligned_cols=109 Identities=18% Similarity=0.175 Sum_probs=80.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ 146 (627)
.+++.|+|++|++++..+ ..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|+++.+++..+ . .+|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccCh-hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 467778888888774333 367888888888888888877667777788888888888888887666543 2 3688888
Q ss_pred ccccccccCCccccccccccccccccCCcccc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 178 (627)
|++|.+++..|..|.++++|+.|++++|++++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 88888876666677777788888888777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=6.4e-16 Score=157.88 Aligned_cols=147 Identities=21% Similarity=0.221 Sum_probs=107.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc---cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS---LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~---~~L~~L 145 (627)
..++.|++++|++++.. ...+++|+.|+|++|.+++..|..+..+++|++|+|++|++++..+.... .+|+.|
T Consensus 99 ~~L~~L~l~~n~l~~~~----~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 174 (317)
T 3o53_A 99 PSIETLHAANNNISRVS----CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174 (317)
T ss_dssp TTCCEEECCSSCCSEEE----ECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred CCcCEEECCCCccCCcC----ccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEE
Confidence 44556666666666432 23467888999999998877777888888999999999988887665332 478888
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLC 221 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~ 221 (627)
+|++|.|++ +|. ...+++|+.|++++|+|++.++.. .+++|+.|++++|+++ .+|..+..+++|+.+ +|+..|
T Consensus 175 ~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 175 NLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp ECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred ECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 888888885 343 334788888888888888755544 7788888888888888 567777777776654 455554
Q ss_pred C
Q 006886 222 G 222 (627)
Q Consensus 222 ~ 222 (627)
+
T Consensus 252 ~ 252 (317)
T 3o53_A 252 G 252 (317)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-14 Score=150.93 Aligned_cols=96 Identities=13% Similarity=0.103 Sum_probs=61.5
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCC-CCCCcccccE-Eee
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPS-DITSISSLQY-VYL 125 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~l 125 (627)
|+|..|.|+.. +..++.|+|++|+|+ .+|++.|.+|++|+.|+|++|.+.+.+|. .|.++++|++ +++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 47899999752 246899999999998 68877899999999999999998655543 3444544432 333
Q ss_pred ecccccccCchhhc--cccccccccccccc
Q 006886 126 QNNYFSGVLPAFRS--LQLNALDLSFNAFT 153 (627)
Q Consensus 126 ~~N~l~~~~~~~~~--~~L~~L~ls~N~l~ 153 (627)
++|++.+++|..+. .+|+.|++++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred cCCcccccCchhhhhccccccccccccccc
Confidence 44444444443221 13444444444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.54 E-value=9.7e-15 Score=147.08 Aligned_cols=138 Identities=27% Similarity=0.379 Sum_probs=104.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++++ +++ +..+++|+.|+|++|.+++ +| .+..+++|++|+|++|++++. +.+.. .+|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEc
Confidence 568888888888875 333 7888888888888888874 34 488888888888888888875 44433 37888888
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|++++. ..+..+++|+.|++++|++++..+-..+++|+.|++++|.+++ +| .+..+++|..++
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~ 206 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLE 206 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEE
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence 88888853 5688888888888888888876664478888888888888874 44 366677766653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-15 Score=152.73 Aligned_cols=146 Identities=18% Similarity=0.120 Sum_probs=117.5
Q ss_pred cEEEEEcCCCCcccccCcccc--CCCCcccEEEccCcccCccCC----CCCCCcccccEEeeecccccccCchhhc--cc
Q 006886 70 RVIGIHLPGIGFTGPIPANSI--GKLDALKILSLRSNYLNGTLP----SDITSISSLQYVYLQNNYFSGVLPAFRS--LQ 141 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~ 141 (627)
+++.|+|++|++++..|. .+ ..+++|+.|+|++|.+++..| ..+..+++|++|+|++|++.+.++..+. .+
T Consensus 92 ~L~~L~l~~n~l~~~~~~-~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPP-LPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp CCCEEEEESCCCBSCCCC-CSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred ceeEEEeeCCEeccchhh-hhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 489999999999988888 55 899999999999999997665 3456789999999999999998876433 38
Q ss_pred cccccccccccccC--Cc--cccccccccccccccCCcccccCCC-----CCCCccceeeccCCCccccCCCCCCCC---
Q 006886 142 LNALDLSFNAFTGN--IP--PGFQNLTRLHLLNLQNNSISGAIPP-----LNLPRLKILNFSNNNLNGSIPDSLQTF--- 209 (627)
Q Consensus 142 L~~L~ls~N~l~~~--~p--~~~~~l~~L~~L~l~~N~l~~~~p~-----~~~~~L~~L~l~~N~l~~~~p~~~~~~--- 209 (627)
|++|+|++|++.+. ++ ..+..+++|++|+|++|+++...+. ..+++|++|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999998753 32 2347889999999999999743221 167899999999999998888877766
Q ss_pred CCCcccC
Q 006886 210 PNSSFVG 216 (627)
Q Consensus 210 ~~l~~~~ 216 (627)
++|+.++
T Consensus 251 ~~L~~L~ 257 (310)
T 4glp_A 251 SALNSLN 257 (310)
T ss_dssp TTCCCEE
T ss_pred CcCCEEE
Confidence 4666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=137.90 Aligned_cols=127 Identities=19% Similarity=0.302 Sum_probs=107.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 146 (627)
.+++.|++++|.++ .++ .+..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..+. +.. .+|+.|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 57999999999765 333 699999999999999999988899999999999999999999986665 333 3899999
Q ss_pred ccccc-cccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccc
Q 006886 147 LSFNA-FTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200 (627)
Q Consensus 147 ls~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~ 200 (627)
|++|. ++ .+| .+..+++|+.|++++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99998 66 576 699999999999999999975433489999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=6.4e-15 Score=162.96 Aligned_cols=144 Identities=18% Similarity=0.136 Sum_probs=121.2
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNAL 145 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L 145 (627)
+.+++.|+|++|++++..+. .|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++.+|..+ . .+|++|
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (570)
T ss_dssp CSSCCEEECCSCCCCEECTT-TTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred cccccEEEccCCccCccChh-HhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccc
Confidence 35789999999999865444 89999999999999999998778889999999999999999999887543 3 389999
Q ss_pred cccccccccCCccccccccccccccccCCcccc-cCCCC--CCCccceeeccCCCccccCCCCCCCCCCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG-AIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNS 212 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l 212 (627)
++++|++++..+..|+++++|++|++++|++++ .+|.. ++++|+.|++++|++++..|..++.+++|
T Consensus 106 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 175 (570)
T 2z63_A 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175 (570)
T ss_dssp ECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTC
T ss_pred cccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhcc
Confidence 999999996555579999999999999999987 35653 78999999999999998777777766665
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=5e-15 Score=162.03 Aligned_cols=139 Identities=23% Similarity=0.291 Sum_probs=121.5
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|++++..|. .|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+++++++. ...+|++|+|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-~l~~L~~L~L~ 98 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTS-DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH-PTVNLKHLDLS 98 (520)
T ss_dssp TTCSEEECCSSCCCCCCHH-HHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC-CCCCCSEEECC
T ss_pred ccccEEECCCCcccccChh-hccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc-ccCCccEEecc
Confidence 6799999999999965544 899999999999999999988899999999999999999999976655 44589999999
Q ss_pred cccccc-CCccccccccccccccccCCcccccCCCCCCCcc--ceeeccCCCc--cccCCCCCCCCC
Q 006886 149 FNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRL--KILNFSNNNL--NGSIPDSLQTFP 210 (627)
Q Consensus 149 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L--~~L~l~~N~l--~~~~p~~~~~~~ 210 (627)
+|.+++ .+|..|+++++|++|++++|+|++. ....+++| +.|++++|.+ ++..|..+..+.
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred CCccccccchhhhccCCcceEEEecCcccchh-hccccccceeeEEEeecccccccccccccccccc
Confidence 999997 4789999999999999999999862 22367777 9999999999 888888887766
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-14 Score=146.72 Aligned_cols=137 Identities=27% Similarity=0.434 Sum_probs=95.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++++ +++ +..+++|+.|+|++|.+++ +| .+..+++|++|+|++|++++..+ +.. .+|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCchh-hcCCCCCCEEEC
Confidence 567888888888774 433 7778888888888888774 33 57777888888888888777544 333 36777888
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
++|.+++. |. +..+++|+.|++++|++++..+-..+++|+.|++++|++++..+ +..+++|+.+
T Consensus 137 ~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L 200 (308)
T 1h6u_A 137 DLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEV 200 (308)
T ss_dssp CSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred CCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcChh--hcCCCCCCEE
Confidence 88877753 33 77777777777777777765443467777777777777774433 5555665554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1e-16 Score=151.97 Aligned_cols=145 Identities=21% Similarity=0.342 Sum_probs=119.6
Q ss_pred CcEEEEEcCCCCcccccCc-----cccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-ccc
Q 006886 69 SRVIGIHLPGIGFTGPIPA-----NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQL 142 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~-----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L 142 (627)
..|+.++++.++++|.+|. ..+..+++|+.|+|++|.|++ +| .+..+++|++|+|++|+++.++..+.. .+|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcC
Confidence 3455666666666666553 268899999999999999996 77 899999999999999999976654444 489
Q ss_pred ccccccccccccCCccccccccccccccccCCcccccCC--C-CCCCccceeeccCCCccccCCCC----------CCCC
Q 006886 143 NALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIP--P-LNLPRLKILNFSNNNLNGSIPDS----------LQTF 209 (627)
Q Consensus 143 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--~-~~~~~L~~L~l~~N~l~~~~p~~----------~~~~ 209 (627)
+.|+|++|+|++ +| .+..+++|+.|++++|++++..+ . ..+++|++|++++|++++.+|.. +..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 999999999996 66 69999999999999999986433 2 38999999999999999887764 7788
Q ss_pred CCCcccCC
Q 006886 210 PNSSFVGN 217 (627)
Q Consensus 210 ~~l~~~~n 217 (627)
++|+.++.
T Consensus 174 ~~L~~Ld~ 181 (198)
T 1ds9_A 174 PNLKKLDG 181 (198)
T ss_dssp SSCSEECC
T ss_pred CCcEEECC
Confidence 88888864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=145.27 Aligned_cols=137 Identities=23% Similarity=0.377 Sum_probs=117.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|++++|++. .++ .+..+++|+.|+|++|.+++..| +..+++|++|+|++|+++++.. +.. .+|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS-LKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGGG-GTTCTTCCEEEC
T ss_pred CcccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCChh-hccCCCCCEEEC
Confidence 56899999999998 454 48999999999999999996554 9999999999999999998544 444 48999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|++++ + +.+..+++|+.|++++|++++. +.. .+++|+.|++++|++++..| +..+++|+.++
T Consensus 120 ~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 9999996 4 4689999999999999999976 433 89999999999999996655 88888887764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.2e-15 Score=150.01 Aligned_cols=142 Identities=19% Similarity=0.156 Sum_probs=116.3
Q ss_pred eCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-ccc
Q 006886 65 NVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQL 142 (627)
Q Consensus 65 ~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L 142 (627)
.....+++.|+|++|++++ ++ ..++|+.|+|++|.+++..+.. +++|++|+|++|++++..+..+ . .+|
T Consensus 76 ~~~l~~L~~L~Ls~n~l~~-l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L 146 (317)
T 3o53_A 76 LESLSTLRTLDLNNNYVQE-LL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV 146 (317)
T ss_dssp ETTCTTCCEEECCSSEEEE-EE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred hhhcCCCCEEECcCCcccc-cc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCC
Confidence 3445789999999999983 33 3489999999999999766544 6789999999999999887533 3 489
Q ss_pred ccccccccccccCCccccc-cccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 143 NALDLSFNAFTGNIPPGFQ-NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 143 ~~L~ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+.|+|++|.+++..|..+. .+++|++|++++|+|++..+...+++|+.|++++|++++ +|..+..+++|+.++
T Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (317)
T ss_dssp EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhcccCcccEEE
Confidence 9999999999987777764 789999999999999977555589999999999999995 555588888887764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.2e-14 Score=145.69 Aligned_cols=122 Identities=25% Similarity=0.397 Sum_probs=58.4
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-ccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLS 148 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls 148 (627)
+++.|++++|+++ .+| .+..+++|+.|+|++|.+++..+ +..+++|++|+|++|++++.. .+.. .+|+.|+|+
T Consensus 42 ~L~~L~l~~~~i~-~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCcc-Cch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCch-hhcCCCCCCEEECC
Confidence 3455555555554 233 24455555555555555553222 555555555555555555432 2222 245555555
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~ 199 (627)
+|++++ +|. +..+++|+.|++++|++++..+-..+++|+.|++++|+++
T Consensus 116 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 116 STQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS 164 (308)
T ss_dssp TSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCC
Confidence 555553 222 4555555555555555554333224455555555555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=159.61 Aligned_cols=139 Identities=23% Similarity=0.260 Sum_probs=117.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|++++. ++..|.++++|+.|+|++|.|++..|..|.++++|++|+|++|+|+.+++. ...+|++|+|+
T Consensus 52 ~~L~~L~Ls~N~i~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-~l~~L~~L~Ls 129 (562)
T 3a79_B 52 PRTKALSLSQNSISEL-RMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC-PMASLRHLDLS 129 (562)
T ss_dssp TTCCEEECCSSCCCCC-CGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC-CCTTCSEEECC
T ss_pred CCcCEEECCCCCcccc-ChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc-ccccCCEEECC
Confidence 6799999999999954 444899999999999999999988899999999999999999999976665 34589999999
Q ss_pred cccccc-CCccccccccccccccccCCcccccCCCCCCCcc--ceeeccCCCc--cccCCCCCCCCC
Q 006886 149 FNAFTG-NIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRL--KILNFSNNNL--NGSIPDSLQTFP 210 (627)
Q Consensus 149 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L--~~L~l~~N~l--~~~~p~~~~~~~ 210 (627)
+|++++ .+|..|+++++|++|++++|++++. ....+++| +.|++++|.+ ++..|..+..+.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccccC-chhhhhhceeeEEEeecccccccccCcccccccC
Confidence 999996 3568999999999999999999862 22355555 9999999999 888888777665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.8e-15 Score=155.58 Aligned_cols=146 Identities=19% Similarity=0.218 Sum_probs=120.8
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCc-h-hhc-ccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-A-FRS-LQLNA 144 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~-~~L~~ 144 (627)
-.+++.|+|++|++++..|. .|.++++|+.|+|++|.|++..+..|..+++|++|+|++|+++++++ . +.. .+|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEED-SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHh-hcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcE
Confidence 36799999999999965555 89999999999999999995444458999999999999999998877 3 333 48999
Q ss_pred cccccc-ccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCC-CCCCCCCCccc
Q 006886 145 LDLSFN-AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPD-SLQTFPNSSFV 215 (627)
Q Consensus 145 L~ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~-~~~~~~~l~~~ 215 (627)
|++++| .+++..|..|.++++|+.|++++|++++..|.. .+++|++|++++|.++ .+|. .+..+++|+.+
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L 227 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEE
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEE
Confidence 999999 577666788999999999999999999887764 8999999999999997 4443 33345555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.2e-15 Score=170.75 Aligned_cols=140 Identities=24% Similarity=0.298 Sum_probs=118.1
Q ss_pred CCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccc
Q 006886 67 NRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNAL 145 (627)
Q Consensus 67 ~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L 145 (627)
....++.|+|++|.+. .+|. .+.++++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+.++..+..+ +|+.|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEE
Confidence 3467999999999998 8888 5679999999999999999 89999999999999999999999765566554 89999
Q ss_pred cccccccccCCccccccccccccccccCCcccccCCCC--CC-CccceeeccCCCccccCCCCCCCCC
Q 006886 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NL-PRLKILNFSNNNLNGSIPDSLQTFP 210 (627)
Q Consensus 146 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~-~~L~~L~l~~N~l~~~~p~~~~~~~ 210 (627)
+|++|.|+ .+|..|++|++|+.|+|++|+|++.+|.. .+ ..+..|+|++|.++|.+|..+..+.
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 99999998 78999999999999999999999988754 12 1223578999999999998776553
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=133.36 Aligned_cols=125 Identities=17% Similarity=0.299 Sum_probs=104.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCC-cccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchh-hc-cccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLD-ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAF-RS-LQLNAL 145 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~-~~L~~L 145 (627)
..++.|+|++|+++ .+|. +..+. +|+.|+|++|.|++. ..|..+++|++|+|++|+|+++++.. .. .+|+.|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 57899999999998 5654 55544 999999999999965 68999999999999999999887765 33 489999
Q ss_pred cccccccccCCcc--ccccccccccccccCCcccccCCC----C-CCCccceeeccCCCcc
Q 006886 146 DLSFNAFTGNIPP--GFQNLTRLHLLNLQNNSISGAIPP----L-NLPRLKILNFSNNNLN 199 (627)
Q Consensus 146 ~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~----~-~~~~L~~L~l~~N~l~ 199 (627)
+|++|+|+ .+|. .+..+++|+.|++++|.++...+. . .+++|+.|++++|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999997 5776 788999999999999999854332 2 7899999999999876
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.7e-14 Score=156.75 Aligned_cols=138 Identities=27% Similarity=0.366 Sum_probs=117.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++++ +++ +..+++|+.|+|++|.|++ +| .|..+++|++|+|++|+|.++ +.+.. .+|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEEC
Confidence 679999999999995 443 8999999999999999985 44 799999999999999999986 44444 48999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|.|++. ..+..+++|+.|+|++|+|++..|...+++|+.|+|++|+|++. | .+..+++|..++
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~ 203 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLE 203 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEE
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEE
Confidence 99999964 67999999999999999999887755899999999999999864 3 577788877654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.1e-14 Score=155.50 Aligned_cols=117 Identities=26% Similarity=0.284 Sum_probs=69.2
Q ss_pred EEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccc
Q 006886 71 VIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSF 149 (627)
Q Consensus 71 v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~ 149 (627)
++.|+|++|+|++ +|. |+.+++|+.|+|++|.|+ .+|..|+.+++|++|+|++|+|++++ .+..+ +|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCC
Confidence 4556666666663 443 666666666666666666 55666666666666666666666633 33332 566666666
Q ss_pred cccccCC-ccccccccccccccccCCcccccCCCC-----CCCccceee
Q 006886 150 NAFTGNI-PPGFQNLTRLHLLNLQNNSISGAIPPL-----NLPRLKILN 192 (627)
Q Consensus 150 N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~-----~~~~L~~L~ 192 (627)
|+|++.. |..|+.+++|+.|+|++|+|++.+|.. .+++|+.|+
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 6666544 666666666666666666666554432 255555554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=148.75 Aligned_cols=138 Identities=27% Similarity=0.373 Sum_probs=92.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|++++ ++ .+..+++|+.|+|++|.+++..| +..+++|++|+|++|++++.++-....+|+.|+|+
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 295 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcC
Confidence 567788888887774 32 47777777777887777775544 77777777777777777776652222367777777
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|++++..| +..+++|+.|++++|++++..|...+++|+.|++++|++++. ..+..+++|+.+
T Consensus 296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 777775333 667777777777777777665544667777777777777653 345566665554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.45 E-value=6.4e-14 Score=154.87 Aligned_cols=137 Identities=23% Similarity=0.386 Sum_probs=118.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++. .++ .+..|++|+.|+|++|.|++..| +..+++|+.|+|++|+|.+++ .+.. .+|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh-hhccCCCCCEEEe
Confidence 56889999999998 455 48999999999999999996555 999999999999999999864 4444 48999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|.|++ + +.+..|++|+.|+|++|+|++. +.. .+++|+.|+|++|.|++..| +..+++|..++
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 9999995 4 4599999999999999999976 433 89999999999999997766 88888887764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.4e-13 Score=125.64 Aligned_cols=104 Identities=24% Similarity=0.297 Sum_probs=82.8
Q ss_pred EEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccc
Q 006886 72 IGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSF 149 (627)
Q Consensus 72 ~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~ 149 (627)
+.+++++|+++ .+|. .+. ++|+.|+|++|.|++..|..|..+++|++|+|++|+|+++++..+ . .+|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 57899999996 7887 443 889999999999998888899999999999999999998777643 3 3788888888
Q ss_pred cccccCCccccccccccccccccCCccccc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGA 179 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 179 (627)
|+|++..+..|..+++|+.|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 888754444577777777777777777643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.4e-13 Score=150.65 Aligned_cols=118 Identities=25% Similarity=0.361 Sum_probs=81.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|+|+ .+| ..+++|+.|+|++|.|++ +|. |.. +|++|+|++|+|+++++ ...+|+.|+|+
T Consensus 80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~--~l~~L~~L~Ls 148 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPE--LPALLEYINAD 148 (571)
T ss_dssp TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCC--CCTTCCEEECC
T ss_pred CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCC--cCccccEEeCC
Confidence 45788888888887 566 346777888888888875 666 554 77777777777777544 33467777777
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPD 204 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~ 204 (627)
+|+|++ +|. .+++|+.|+|++|+|++ +|... ++|+.|+|++|+|+ .+|.
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~-~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELP-ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCC-TTCCEEECCSSCCS-SCCC
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cchhh-CCCCEEECcCCCCC-chhh
Confidence 777774 555 45677777777777776 44333 66777777777776 5555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=126.01 Aligned_cols=104 Identities=23% Similarity=0.278 Sum_probs=80.3
Q ss_pred EEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccc
Q 006886 72 IGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSF 149 (627)
Q Consensus 72 ~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~ 149 (627)
+.|++++|+++ .+|. .+ .++|+.|+|++|.|++..|..|..+++|++|+|++|+|+++++..+ . .+|+.|+|++
T Consensus 12 ~~l~~s~n~l~-~ip~-~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPT-GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCS-SCCS-CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCc-cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 46888888888 5776 34 3889999999999998888889999999999999999988777543 2 3677777777
Q ss_pred cccccCCccccccccccccccccCCccccc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGA 179 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 179 (627)
|+|++..|..|.++++|+.|+|++|.++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 777755555577777777777777777643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=2.2e-13 Score=125.39 Aligned_cols=105 Identities=26% Similarity=0.304 Sum_probs=91.2
Q ss_pred ccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCccccccccccccccccC
Q 006886 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQN 173 (627)
Q Consensus 96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 173 (627)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++++|..+ . .+|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999999 6887774 899999999999999988644 3 3899999999999977677789999999999999
Q ss_pred CcccccCCCC--CCCccceeeccCCCccccCC
Q 006886 174 NSISGAIPPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 174 N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
|+|++..+.. .+++|+.|+|++|+++...+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999877653 89999999999999986543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3.3e-14 Score=152.33 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=77.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccc-------------cEEeeecccccccCc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSL-------------QYVYLQNNYFSGVLP 135 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~l~~N~l~~~~~ 135 (627)
.+++.|++++|++ |.+|+ .+++|++|+.|+|++|.++|.+|..++.+++| ++|++++|.+++++.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 5789999999999 79998 79999999999999999999999999988875 888888888887654
Q ss_pred hhhccccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 136 AFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 136 ~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
...+|+.|++++|.+++ +|..+ ++|+.|++++|++++ +|.. .++|++|++++|++++ +| .++++++|+.+
T Consensus 89 --~~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~-~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L 158 (454)
T 1jl5_A 89 --LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL-PPLLEYLGVSNNQLEK-LP-ELQNSSFLKII 158 (454)
T ss_dssp --CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred --CcCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC-CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEE
Confidence 22467777777777775 56432 556666666666664 2211 1466666666666664 55 35555555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=6.6e-14 Score=129.78 Aligned_cols=125 Identities=18% Similarity=0.143 Sum_probs=103.1
Q ss_pred ccCCCCcccEEEccCcccCccCCCCCCCcc-cccEEeeecccccccCchhhc-cccccccccccccccCCcccccccccc
Q 006886 89 SIGKLDALKILSLRSNYLNGTLPSDITSIS-SLQYVYLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRL 166 (627)
Q Consensus 89 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L 166 (627)
.+.++++|+.|+|++|.++ .+|. +..+. +|++|+|++|+|+++ +.+.. .+|+.|+|++|+|++..|..|..+++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4778899999999999999 4564 66655 999999999999987 55544 389999999999996544556999999
Q ss_pred ccccccCCcccccCC--CC-CCCccceeeccCCCccccCCCC----CCCCCCCcccCC
Q 006886 167 HLLNLQNNSISGAIP--PL-NLPRLKILNFSNNNLNGSIPDS----LQTFPNSSFVGN 217 (627)
Q Consensus 167 ~~L~l~~N~l~~~~p--~~-~~~~L~~L~l~~N~l~~~~p~~----~~~~~~l~~~~n 217 (627)
++|++++|+|+...+ .. .+++|+.|++++|+++ .+|.. +..+++|++++.
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~ 147 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 147 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCC
Confidence 999999999975333 22 7899999999999998 66764 888888888764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=2e-13 Score=135.27 Aligned_cols=124 Identities=21% Similarity=0.318 Sum_probs=106.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++++ +++ +.++++|+.|+|++|++++ +|. +.. ++|++|+|++|++++.. .+.. .+|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCCh-hhcCcccccEEEC
Confidence 679999999999995 444 9999999999999999995 554 333 99999999999999864 4444 48999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcccc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~ 201 (627)
++|+|++ +| .+..+++|+.|++++|+|++...-..+++|+.|++++|++++.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 9999996 55 6999999999999999999872233899999999999999855
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.4e-13 Score=140.39 Aligned_cols=139 Identities=23% Similarity=0.353 Sum_probs=101.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|++++|++.+ ++. +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++..+ +.. .+|+.|++
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEEC
Confidence 578889999888874 433 7778888888888888875444 7778888888888888887766 333 37888888
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|.+++ + +.+..+++|+.|++++|++++. +.. .+++|+.|++++|++++..|..+..+++|+.++
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 317 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEE
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEE
Confidence 8888874 3 3577778888888888887764 332 677888888888888777777777777766553
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.7e-13 Score=123.12 Aligned_cols=102 Identities=24% Similarity=0.326 Sum_probs=88.5
Q ss_pred cEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCccccccccccccccccCC
Q 006886 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN 174 (627)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 174 (627)
+.+++++|.++ .+|..+. ++|++|+|++|+|++++|..+ . .+|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 7888775 899999999999999988644 3 38999999999999765566899999999999999
Q ss_pred cccccCCCC--CCCccceeeccCCCcccc
Q 006886 175 SISGAIPPL--NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 175 ~l~~~~p~~--~~~~L~~L~l~~N~l~~~ 201 (627)
+|++.++.. .+++|+.|+|++|++...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999766653 799999999999999843
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.3e-13 Score=152.64 Aligned_cols=145 Identities=21% Similarity=0.293 Sum_probs=90.3
Q ss_pred CCCCCCCCCCCCcceEe------eCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCccccc
Q 006886 48 NWNAAAPVCSSWIGVTC------NVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQ 121 (627)
Q Consensus 48 ~W~~~~~~c~~w~gv~C------~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 121 (627)
+|....++| .|.|..| .+....++.|++++|+++ .+|. .+. ++|+.|+|++|+|+ .+|. .+++|+
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~ 84 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELR 84 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence 465444444 6865322 112235778888888887 7776 343 67888888888887 5665 467788
Q ss_pred EEeeecccccccCchhhccccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcccc
Q 006886 122 YVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 122 ~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~ 201 (627)
+|+|++|+|+++++ ...+|++|+|++|+|++ +|. .+++|+.|++++|+|++ +|. .+++|++|++++|++++
T Consensus 85 ~L~Ls~N~l~~lp~--~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~-~l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 85 TLEVSGNQLTSLPV--LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPV-LPPGLQELSVSDNQLAS- 155 (622)
T ss_dssp EEEECSCCCSCCCC--CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-
T ss_pred EEEcCCCcCCcCCC--CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCC-CCCCCCEEECcCCcCCC-
Confidence 88888888776555 23467777777777774 444 44566667777776664 332 24666666666666663
Q ss_pred CCCCCCCCC
Q 006886 202 IPDSLQTFP 210 (627)
Q Consensus 202 ~p~~~~~~~ 210 (627)
+|..+.++.
T Consensus 156 l~~~~~~L~ 164 (622)
T 3g06_A 156 LPALPSELC 164 (622)
T ss_dssp CCCCCTTCC
T ss_pred cCCccCCCC
Confidence 344333333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.39 E-value=4.5e-13 Score=144.33 Aligned_cols=138 Identities=25% Similarity=0.350 Sum_probs=104.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|++++|.+++..| ++.+++|+.|+|++|.+++ + +.+..+++|++|+|++|++++..+-....+|+.|+++
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 273 (466)
T 1o6v_A 199 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 273 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEEecCCccccccc---ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECC
Confidence 578888888888885443 6778888888888888874 3 3577888888888888888887762222478888888
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|.+++. |. +..+++|+.|++++|++++..+...+++|+.|++++|++++..| +..+++|+.+
T Consensus 274 ~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 274 ANQISNI-SP-LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp SSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred CCccCcc-cc-ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 8888854 33 78888888888888888876554478888888888888887655 5566666554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.39 E-value=3e-13 Score=139.72 Aligned_cols=139 Identities=20% Similarity=0.288 Sum_probs=116.0
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-ccccccc
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALD 146 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ 146 (627)
...++.|++++|++++.. . +..+++|+.|+|++|.+++..+ +..+++|++|+|++|.+++. +.+.. .+|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~~-~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDIT-P--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLN 271 (347)
T ss_dssp CTTCCEEECCSSCCCCCG-G--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEE
T ss_pred CCccceeecccCCCCCCc-h--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEE
Confidence 367899999999998543 2 8899999999999999995444 89999999999999999986 44433 4899999
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+++|.+++ + +.+..+++|+.|++++|++++..|.. .+++|+.|++++|++++..| +..+++|+.++
T Consensus 272 l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 339 (347)
T 4fmz_A 272 VGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSAD 339 (347)
T ss_dssp CCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEES
T ss_pred ccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceee
Confidence 99999996 4 45889999999999999999877653 89999999999999997766 66677776654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.9e-13 Score=142.22 Aligned_cols=100 Identities=18% Similarity=0.193 Sum_probs=62.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
..++.|++++|+..+.+ .+..+++|+.|+|++|++++ +| +..+++|++|+|++|++++. + +.. .+|+.|+|
T Consensus 148 ~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~-l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL---DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D-LNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC---CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C-CTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc---ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c-cccCCCCCEEEC
Confidence 45667777777655555 25666677777777777764 44 66666666666666666665 1 222 35666666
Q ss_pred cccccccCCccccccccccccccccCCccccc
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA 179 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 179 (627)
++|+|++ +| +..+++|+.|++++|+|++.
T Consensus 220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCSEEECCSSCCSCC
T ss_pred cCCcccc-cC--ccccCCCCEEEeeCCcCCCc
Confidence 6666665 44 56666666666666666653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=9.9e-13 Score=140.98 Aligned_cols=116 Identities=21% Similarity=0.252 Sum_probs=54.1
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-ccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLS 148 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls 148 (627)
+++.|+|++|++++ +| .++.+++|+.|+|++|.|++ +| ++.+++|++|+|++|++++.. +.. .+|++|+|+
T Consensus 43 ~L~~L~Ls~n~l~~-~~--~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITD-MT--GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCC-CT--TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCccc-Ch--hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceee--cCCCCcCCEEECC
Confidence 45555555555553 23 24555555555555555553 22 445555555555555555431 222 245555555
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNN 197 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~ 197 (627)
+|++++ +| ++.+++|++|++++|+|++ ++...+++|++|++++|+
T Consensus 115 ~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 115 TNKLTK-LD--VSQNPLLTYLNCARNTLTE-IDVSHNTQLTELDCHLNK 159 (457)
T ss_dssp SSCCSC-CC--CTTCTTCCEEECTTSCCSC-CCCTTCTTCCEEECTTCS
T ss_pred CCcCCe-ec--CCCCCcCCEEECCCCccce-eccccCCcCCEEECCCCC
Confidence 555553 22 4445555555555555544 222244444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=6.3e-13 Score=146.01 Aligned_cols=104 Identities=29% Similarity=0.363 Sum_probs=69.7
Q ss_pred ccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCCccccccccccccccccCC
Q 006886 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNN 174 (627)
Q Consensus 96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 174 (627)
|+.|+|++|.|++ +|. |+.+++|++|+|++|+|+.+++.+..+ +|+.|+|++|+|++ +| .|+++++|+.|+|++|
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 5567777777774 565 777777777777777777554444443 67777777777774 56 6777777777777777
Q ss_pred cccccC-CCC--CCCccceeeccCCCccccCC
Q 006886 175 SISGAI-PPL--NLPRLKILNFSNNNLNGSIP 203 (627)
Q Consensus 175 ~l~~~~-p~~--~~~~L~~L~l~~N~l~~~~p 203 (627)
+|++.+ |.. .+++|+.|+|++|+|++.+|
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 777654 433 67777777777777775544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=138.23 Aligned_cols=132 Identities=23% Similarity=0.310 Sum_probs=96.3
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~ 149 (627)
.++.|++++|++++ +|. ..++|+.|+|++|.+++ +| .|+.+++|++|++++|++++++... .+|++|++++
T Consensus 112 ~L~~L~l~~n~l~~-l~~----~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~--~~L~~L~L~~ 182 (454)
T 1jl5_A 112 SLKSLLVDNNNLKA-LSD----LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP--PSLEFIAAGN 182 (454)
T ss_dssp TCCEEECCSSCCSC-CCS----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC--TTCCEEECCS
T ss_pred CCcEEECCCCccCc-ccC----CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc--ccccEEECcC
Confidence 45555555555542 222 11578888888888885 77 5888888999999988888754322 3788899999
Q ss_pred cccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|++++ +| .++++++|+.|++++|++++ +|.. .++|+.|++++|.++ .+|+ +..+++|+.++
T Consensus 183 n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~ 243 (454)
T 1jl5_A 183 NQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-PLSLESIVAGNNILE-ELPE-LQNLPFLTTIY 243 (454)
T ss_dssp SCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-cCcccEEECcCCcCC-cccc-cCCCCCCCEEE
Confidence 98886 66 58888889999999998886 3332 358888888888888 6774 77777777664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-14 Score=146.70 Aligned_cols=147 Identities=20% Similarity=0.274 Sum_probs=77.2
Q ss_pred CcEEEEEcCCCCcccc-cCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc-ccccc-Cch-hhc-cccc
Q 006886 69 SRVIGIHLPGIGFTGP-IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN-YFSGV-LPA-FRS-LQLN 143 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~-~~~-~~L~ 143 (627)
.+++.|+|++|.+++. ++. .+..+++|+.|+|++|.+++..|..+..+++|++|+|++| .+++. ++. +.. .+|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 3455555555555443 443 4555555555555555555555555555555555555555 44431 222 211 2566
Q ss_pred ccccccc-ccccC-Ccccccccc-ccccccccCC--ccc-ccCCCC--CCCccceeeccCCC-ccccCCCCCCCCCCCcc
Q 006886 144 ALDLSFN-AFTGN-IPPGFQNLT-RLHLLNLQNN--SIS-GAIPPL--NLPRLKILNFSNNN-LNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 144 ~L~ls~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~--~~~~L~~L~l~~N~-l~~~~p~~~~~~~~l~~ 214 (627)
.|+|++| .+++. ++..+..++ +|++|++++| .++ +.+|.. .+++|+.|++++|. +++..+..+..+++|+.
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 6666666 55543 455555566 6666666666 333 222222 45666666666666 55555555555555555
Q ss_pred cC
Q 006886 215 VG 216 (627)
Q Consensus 215 ~~ 216 (627)
++
T Consensus 252 L~ 253 (336)
T 2ast_B 252 LS 253 (336)
T ss_dssp EE
T ss_pred ee
Confidence 43
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-12 Score=134.64 Aligned_cols=98 Identities=20% Similarity=0.209 Sum_probs=76.6
Q ss_pred CCC-CcccccCccccCCCCcccEEEccC-cccCccCCCCCCCcccccEEeeecccccccCchhhc-c-cccccccccccc
Q 006886 77 PGI-GFTGPIPANSIGKLDALKILSLRS-NYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-L-QLNALDLSFNAF 152 (627)
Q Consensus 77 ~~~-~l~~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~-~L~~L~ls~N~l 152 (627)
+++ +|+ .+|. |..+++|+.|+|++ |.|++..|..|.+|++|++|+|++|+|++++|..+. + +|+.|+|++|+|
T Consensus 16 ~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 92 (347)
T 2ifg_A 16 TRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92 (347)
T ss_dssp CSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred CCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcc
Confidence 344 676 5776 89999999999996 999987778899999999999999999988875433 3 788888888888
Q ss_pred ccCCccccccccccccccccCCcccc
Q 006886 153 TGNIPPGFQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 153 ~~~~p~~~~~l~~L~~L~l~~N~l~~ 178 (627)
++..|..|..++ |+.|+|++|+|..
T Consensus 93 ~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 93 ESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ceeCHHHcccCC-ceEEEeeCCCccC
Confidence 854444555554 8888888887764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-13 Score=144.80 Aligned_cols=148 Identities=22% Similarity=0.307 Sum_probs=101.0
Q ss_pred CcEEEEEcCCC---CcccccCccc------cCCCCcccEEEccCcccCc----cCCCCCCCcccccEEeeecccccccCc
Q 006886 69 SRVIGIHLPGI---GFTGPIPANS------IGKLDALKILSLRSNYLNG----TLPSDITSISSLQYVYLQNNYFSGVLP 135 (627)
Q Consensus 69 ~~v~~l~l~~~---~l~~~~~~~~------l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~ 135 (627)
.+++.|+|++| ++++.+|... |..+++|+.|+|++|.|++ .+|..+..+++|++|+|++|.++...+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 56778888774 4555555521 3677888888888888876 466677778888888888888765443
Q ss_pred hh-hc--------------cccccccccccccc-cCCc---cccccccccccccccCCccc--c---cCC-CC-CCCccc
Q 006886 136 AF-RS--------------LQLNALDLSFNAFT-GNIP---PGFQNLTRLHLLNLQNNSIS--G---AIP-PL-NLPRLK 189 (627)
Q Consensus 136 ~~-~~--------------~~L~~L~ls~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p-~~-~~~~L~ 189 (627)
.. .. .+|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | ..| .. .+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 21 11 36888888888876 3455 35667778888888888877 2 233 22 677888
Q ss_pred eeeccCCCcc----ccCCCCCCCCCCCcccC
Q 006886 190 ILNFSNNNLN----GSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 190 ~L~l~~N~l~----~~~p~~~~~~~~l~~~~ 216 (627)
.|+|++|.++ +.+|..+..+++|+.++
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 8888888875 56676677777766654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.1e-12 Score=139.87 Aligned_cols=134 Identities=25% Similarity=0.310 Sum_probs=71.9
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCC---CCCc--------------ccccEEeeeccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSD---ITSI--------------SSLQYVYLQNNYFS 131 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~---~~~l--------------~~L~~L~l~~N~l~ 131 (627)
..++.|+|++|+++ .+|. . +++|+.|+|++|.|++ +|.. +..| ++|+.|+|++|+|+
T Consensus 121 ~~L~~L~L~~N~l~-~lp~-~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~ 194 (622)
T 3g06_A 121 SGLCKLWIFGNQLT-SLPV-L---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA 194 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC-C---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS
T ss_pred CCcCEEECCCCCCC-cCCC-C---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCC
Confidence 34556666666665 2444 1 3666677777776663 3322 2222 67777777777777
Q ss_pred ccCchhh------------------ccccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeec
Q 006886 132 GVLPAFR------------------SLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNF 193 (627)
Q Consensus 132 ~~~~~~~------------------~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l 193 (627)
++++... ..+|+.|+|++|+|++ +| ..+++|+.|+|++|+|++ +|. .+++|+.|+|
T Consensus 195 ~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~-~~~~L~~L~L 268 (622)
T 3g06_A 195 SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM-LPSGLLSLSV 268 (622)
T ss_dssp CCCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCTTCCEEEC
T ss_pred CCCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc-ccccCcEEeC
Confidence 6543210 0235555555555553 44 233455555555555553 333 4555666666
Q ss_pred cCCCccccCCCCCCCCCCCccc
Q 006886 194 SNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 194 ~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
++|+|+ .+|..+.++++|..+
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTV 289 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEE
T ss_pred CCCCCC-cCCHHHhhccccCEE
Confidence 666665 555555555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.28 E-value=6.1e-14 Score=132.70 Aligned_cols=124 Identities=21% Similarity=0.280 Sum_probs=106.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|++++ +| .+.++++|+.|+|++|.|+ .+|..+..+++|++|+|++|++++++ .+.. .+|+.|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEEC
Confidence 579999999999996 76 6899999999999999999 78888888899999999999999964 4444 48999999
Q ss_pred cccccccCCc-cccccccccccccccCCcccccCCC-----------C-CCCccceeeccCCCcc
Q 006886 148 SFNAFTGNIP-PGFQNLTRLHLLNLQNNSISGAIPP-----------L-NLPRLKILNFSNNNLN 199 (627)
Q Consensus 148 s~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-----------~-~~~~L~~L~l~~N~l~ 199 (627)
++|+|++..+ ..+..+++|++|++++|.+++.+|. . .+++|+.|| +|.++
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 9999995322 4789999999999999999987664 2 688999887 77776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.25 E-value=4.1e-13 Score=138.01 Aligned_cols=147 Identities=18% Similarity=0.197 Sum_probs=117.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCc-ccCcc-CCCCCCCcccccEEeeecc-ccccc-Cch-hhc-c-c
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSN-YLNGT-LPSDITSISSLQYVYLQNN-YFSGV-LPA-FRS-L-Q 141 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~~~-~~~-~-~ 141 (627)
.+++.|+|++|++++..+. .++.+++|+.|+|++| .+++. +|..+..+++|++|+|++| .+++. ++. +.. . +
T Consensus 118 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~ 196 (336)
T 2ast_B 118 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 196 (336)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCCEEeCcCcccCHHHHH-HHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC
Confidence 6799999999999988877 7999999999999999 78863 6777889999999999999 99864 343 222 4 8
Q ss_pred ccccccccc--ccc-cCCccccccccccccccccCCc-ccccCCCC--CCCccceeeccCCC-ccccCCCCCCCCCCCcc
Q 006886 142 LNALDLSFN--AFT-GNIPPGFQNLTRLHLLNLQNNS-ISGAIPPL--NLPRLKILNFSNNN-LNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 142 L~~L~ls~N--~l~-~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~--~~~~L~~L~l~~N~-l~~~~p~~~~~~~~l~~ 214 (627)
|+.|+|++| .++ +.+|..+.++++|+.|++++|. +++..+.. .+++|+.|++++|. ++......+.++++|+.
T Consensus 197 L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~ 276 (336)
T 2ast_B 197 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276 (336)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence 999999999 555 4678888999999999999999 66544433 78999999999996 32221125677777777
Q ss_pred cC
Q 006886 215 VG 216 (627)
Q Consensus 215 ~~ 216 (627)
++
T Consensus 277 L~ 278 (336)
T 2ast_B 277 LQ 278 (336)
T ss_dssp EE
T ss_pred Ee
Confidence 65
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.9e-13 Score=139.03 Aligned_cols=135 Identities=19% Similarity=0.299 Sum_probs=85.9
Q ss_pred CcEEEEEcCCCCcccccCc---cccCCCC-cccEEEccCcccCccCCCCCCCc-----ccccEEeeecccccccCch---
Q 006886 69 SRVIGIHLPGIGFTGPIPA---NSIGKLD-ALKILSLRSNYLNGTLPSDITSI-----SSLQYVYLQNNYFSGVLPA--- 136 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~---~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~--- 136 (627)
..++.|+|++|++++.-+. ..|..++ +|+.|+|++|.|++..+..|..+ ++|++|+|++|++++..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 4477777777777643330 2566677 77777777777776666666654 7777777777777766653
Q ss_pred --hhc--cccccccccccccccCCcccccc-----ccccccccccCCcccccCCC----C--CCC-ccceeeccCCCccc
Q 006886 137 --FRS--LQLNALDLSFNAFTGNIPPGFQN-----LTRLHLLNLQNNSISGAIPP----L--NLP-RLKILNFSNNNLNG 200 (627)
Q Consensus 137 --~~~--~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~p~----~--~~~-~L~~L~l~~N~l~~ 200 (627)
+.. .+|+.|+|++|.|++..+..+.. .++|++|+|++|+|++.... . .++ +|+.|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 111 36777777777777655544433 24777777777777742221 1 333 77777777777765
Q ss_pred cCC
Q 006886 201 SIP 203 (627)
Q Consensus 201 ~~p 203 (627)
..+
T Consensus 182 ~~~ 184 (362)
T 3goz_A 182 KNC 184 (362)
T ss_dssp SCH
T ss_pred hhH
Confidence 544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.2e-11 Score=127.72 Aligned_cols=102 Identities=23% Similarity=0.208 Sum_probs=88.4
Q ss_pred EEEccCc-ccCccCCCCCCCcccccEEeeec-ccccccCchhh-cc-ccccccccccccccCCccccccccccccccccC
Q 006886 98 ILSLRSN-YLNGTLPSDITSISSLQYVYLQN-NYFSGVLPAFR-SL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQN 173 (627)
Q Consensus 98 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~~-~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 173 (627)
.+++++| +|+ .+|. |..+++|++|+|++ |+|+++++..+ .+ +|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4688888 898 6888 99999999999996 99999998644 43 899999999999998888999999999999999
Q ss_pred CcccccCCCC-CCCccceeeccCCCcccc
Q 006886 174 NSISGAIPPL-NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 174 N~l~~~~p~~-~~~~L~~L~l~~N~l~~~ 201 (627)
|+|++.++.. ....|+.|+|++|+|...
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 9999766554 333499999999999853
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-13 Score=143.80 Aligned_cols=147 Identities=20% Similarity=0.316 Sum_probs=98.6
Q ss_pred CcEEEEEcCCCCccc----ccCccccCCCCcccEEEccCcccCccCCCCCC----Cc---------ccccEEeeeccccc
Q 006886 69 SRVIGIHLPGIGFTG----PIPANSIGKLDALKILSLRSNYLNGTLPSDIT----SI---------SSLQYVYLQNNYFS 131 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~----~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~ 131 (627)
.+++.|+|++|.+++ .+|. .+..+++|+.|+|++|.|++..+..+. .+ ++|++|+|++|+++
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~ 172 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred CcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence 578888888888886 3555 677888888888888888644333333 33 78888888888886
Q ss_pred -ccCch----hhc-cccccccccccccc--c---CCccccccccccccccccCCccc----ccCCCC--CCCccceeecc
Q 006886 132 -GVLPA----FRS-LQLNALDLSFNAFT--G---NIPPGFQNLTRLHLLNLQNNSIS----GAIPPL--NLPRLKILNFS 194 (627)
Q Consensus 132 -~~~~~----~~~-~~L~~L~ls~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~--~~~~L~~L~l~ 194 (627)
+..+. +.. .+|+.|+|++|+|+ | .+|..+..+++|+.|+|++|+|+ +.+|.. .+++|+.|+|+
T Consensus 173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~ 252 (386)
T 2ca6_A 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252 (386)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence 33442 112 26888888888877 3 34446777888888888888875 344432 67778888888
Q ss_pred CCCcccc----CCCCC--CCCCCCcccC
Q 006886 195 NNNLNGS----IPDSL--QTFPNSSFVG 216 (627)
Q Consensus 195 ~N~l~~~----~p~~~--~~~~~l~~~~ 216 (627)
+|.+++. +|..+ +.+++|..++
T Consensus 253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 253 DCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred CCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 8887754 45544 2255555543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=7.3e-11 Score=116.62 Aligned_cols=136 Identities=18% Similarity=0.093 Sum_probs=106.3
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
..++.|+.+.||++... ++.+++|+..... .....+.+|++++..+..+..+.++++++...+..++||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677788899999865 6889999986532 234468899999999966778888999998888899999999999987
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG------------------------------------------- 455 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------- 455 (627)
+.+.. ......++.++++++..||+..
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76321 1123467889999999999811
Q ss_pred -------------CCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 456 -------------GAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 456 -------------~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876666799999764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-12 Score=132.22 Aligned_cols=128 Identities=17% Similarity=0.129 Sum_probs=106.2
Q ss_pred EEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC----CCCCCcc-cccEEeeecccccccCch-hhc------c
Q 006886 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP----SDITSIS-SLQYVYLQNNYFSGVLPA-FRS------L 140 (627)
Q Consensus 73 ~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~~~-~~~------~ 140 (627)
..+|++|+++|.+|. .+...++|+.|+|++|.|++..+ ..|..++ +|++|+|++|++++..+. +.. .
T Consensus 2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 367899999999887 77778889999999999997666 6777888 999999999999998664 332 5
Q ss_pred ccccccccccccccCCccccccc-----cccccccccCCcccccCCCC------C-CCccceeeccCCCcccc
Q 006886 141 QLNALDLSFNAFTGNIPPGFQNL-----TRLHLLNLQNNSISGAIPPL------N-LPRLKILNFSNNNLNGS 201 (627)
Q Consensus 141 ~L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~------~-~~~L~~L~l~~N~l~~~ 201 (627)
+|+.|+|++|.+++..+..+... ++|++|+|++|+|++..+.. . .++|++|+|++|.++..
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 79999999999998777755554 89999999999998755432 2 36999999999999853
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.5e-10 Score=117.90 Aligned_cols=148 Identities=15% Similarity=0.061 Sum_probs=117.4
Q ss_pred EEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec-ccccccCchh-hc--ccccccc
Q 006886 71 VIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN-NYFSGVLPAF-RS--LQLNALD 146 (627)
Q Consensus 71 v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~~~-~~--~~L~~L~ 146 (627)
...+.+.+|+++ .++++.|..+++|+.|++++|.|++..+..+....++..|++.+ |++..+++.. .. ..++.|+
T Consensus 82 ~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~ 160 (350)
T 4ay9_X 82 HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160 (350)
T ss_dssp CEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred hhhhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhc
Confidence 345777889998 45555899999999999999999977777778888999999976 6777776643 33 2689999
Q ss_pred ccccccccCCccccccccccccccccC-CcccccCCC-C--CCCccceeeccCCCccccCCCCCCCCCCCcccCCCcCC
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQN-NSISGAIPP-L--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLC 221 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~n~~~~ 221 (627)
|++|+|+ .+|......++|+.|++++ |+++ .+|. . .+++|+.|+|++|+|+...+..+.+++.|..+++..+.
T Consensus 161 L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~~l~ 237 (350)
T 4ay9_X 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237 (350)
T ss_dssp CCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCTTCC
T ss_pred ccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCCCcC
Confidence 9999999 5777666778999999986 5665 5554 2 89999999999999995555678889988888765543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.06 E-value=3.4e-12 Score=137.07 Aligned_cols=148 Identities=15% Similarity=0.094 Sum_probs=114.7
Q ss_pred CcEEEEEcCCCCcccc----cCccccCCCCcccEEEccCcccCcc----CCCCCCCcccccEEeeecccccccCchh-hc
Q 006886 69 SRVIGIHLPGIGFTGP----IPANSIGKLDALKILSLRSNYLNGT----LPSDITSISSLQYVYLQNNYFSGVLPAF-RS 139 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~ 139 (627)
.+++.|+|++|.+++. +.+..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..+.. ..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 6799999999998754 2232445789999999999999864 6777788999999999999997654432 11
Q ss_pred ------cccccccccccccccC----CccccccccccccccccCCcccccCCCC-------CCCccceeeccCCCccc--
Q 006886 140 ------LQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAIPPL-------NLPRLKILNFSNNNLNG-- 200 (627)
Q Consensus 140 ------~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~-------~~~~L~~L~l~~N~l~~-- 200 (627)
.+|+.|+|++|.+++. +|..+..+++|+.|++++|++++..+.. ..++|+.|++++|.+++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 3799999999999865 5667788899999999999998643321 26789999999999986
Q ss_pred --cCCCCCCCCCCCcccC
Q 006886 201 --SIPDSLQTFPNSSFVG 216 (627)
Q Consensus 201 --~~p~~~~~~~~l~~~~ 216 (627)
.+|..+..+++|+.++
T Consensus 387 ~~~l~~~l~~~~~L~~L~ 404 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELD 404 (461)
T ss_dssp HHHHHHHHHHCCCCCEEE
T ss_pred HHHHHHHHHhCCCccEEE
Confidence 6777777777776654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.06 E-value=2.3e-12 Score=138.47 Aligned_cols=135 Identities=21% Similarity=0.200 Sum_probs=104.1
Q ss_pred CcEEEEEcCCCCcccc----cCccccCCCCcccEEEccCcccCccC-----CCCCCCcccccEEeeeccccccc----Cc
Q 006886 69 SRVIGIHLPGIGFTGP----IPANSIGKLDALKILSLRSNYLNGTL-----PSDITSISSLQYVYLQNNYFSGV----LP 135 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~~ 135 (627)
.+++.|+|++|++++. ++. .+..+++|+.|+|++|.+++.. +..+..+++|++|+|++|+++.. ++
T Consensus 199 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 199 CQLEALKLESCGVTSDNCRDLCG-IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCEEECTTSCCBTTHHHHHHH-HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCceEEEccCCCCcHHHHHHHHH-HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 4799999999999863 555 6788999999999999987532 22334689999999999999874 23
Q ss_pred -hhhc-cccccccccccccccCCccccccc-----cccccccccCCcccccC----CCC--CCCccceeeccCCCccccC
Q 006886 136 -AFRS-LQLNALDLSFNAFTGNIPPGFQNL-----TRLHLLNLQNNSISGAI----PPL--NLPRLKILNFSNNNLNGSI 202 (627)
Q Consensus 136 -~~~~-~~L~~L~ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~----p~~--~~~~L~~L~l~~N~l~~~~ 202 (627)
.+.. .+|+.|+|++|.+++..+..+... ++|+.|++++|++++.. +.. .+++|+.|++++|.+++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 2322 479999999999986555555443 69999999999998652 222 6789999999999998654
Q ss_pred CC
Q 006886 203 PD 204 (627)
Q Consensus 203 p~ 204 (627)
+.
T Consensus 358 ~~ 359 (461)
T 1z7x_W 358 VR 359 (461)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=3.4e-10 Score=111.45 Aligned_cols=132 Identities=12% Similarity=0.104 Sum_probs=96.8
Q ss_pred ccC-cCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCC-eeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 341 VLG-KGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN-VVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 341 ~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.++ .|..+.||++...+|+.+++|..... ....+..|+++++.+..+.- +.+++++....+..++||||++|.++.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 45569999998777888999987543 23457889999999855522 455788877777889999999998874
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG------------------------------------------- 455 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------- 455 (627)
... .+ ...++.++++.+..||+..
T Consensus 104 --~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 104 --SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp --TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred --cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 211 11 2256677777788887642
Q ss_pred ------------CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 456 ------------GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 456 ------------~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.8e-09 Score=111.80 Aligned_cols=141 Identities=17% Similarity=0.215 Sum_probs=104.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEec--ccc--cCHHHHHHHHHHHHHhcc-CCCeeeeeeEEeeC---CceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLR--EVA--ATKREFEQQMEVVGTIGK-HSNVVPVRAYYYSK---DEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~---~~~~lv~e~ 411 (627)
+.++.|.++.||+.... +..+++|+.. ... .....+.+|.+++..+.. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56889999999999876 4678888876 332 234578889999999843 34577888887765 347899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG------------------------------------ 455 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 455 (627)
++|..+.+.. ...++...+..++.++++.|..||+..
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9987764311 123677888899999999999999831
Q ss_pred -------------------CCCeeecCCCCCCeEecCCCC--eEEeeccccccc
Q 006886 456 -------------------GAKFTHGNIKSSNVLLTQDLN--GCISDVGLAHLI 488 (627)
Q Consensus 456 -------------------~~~ivH~Dlk~~NILl~~~~~--~ki~DfG~a~~~ 488 (627)
.+.++|+|+++.||+++.++. +.|.||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999998754 589999988653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.4e-12 Score=125.08 Aligned_cols=162 Identities=18% Similarity=0.138 Sum_probs=112.7
Q ss_pred CCCCCcceEeeCCCCcEEEEEcCC---CCcccccCccccCCCCcccEEEccCcccCccCCC-CCCCcccccE--Eeeecc
Q 006886 55 VCSSWIGVTCNVNRSRVIGIHLPG---IGFTGPIPANSIGKLDALKILSLRSNYLNGTLPS-DITSISSLQY--VYLQNN 128 (627)
Q Consensus 55 ~c~~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~--L~l~~N 128 (627)
.| +|.|+.|+.+..+|+.+...+ ..+.+.++++.+..++. .|...+|.-++.++- .|...+.|.. ++++.|
T Consensus 77 l~-~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 77 LK-AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HH-HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HH-hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 45 699999987666777666655 45556666545555544 344555555544432 2666667776 788888
Q ss_pred cccccC---chhh--cccccccccccccccc--CCccccccccccccccccCCcccccCCCCCCC--ccceeeccCCCcc
Q 006886 129 YFSGVL---PAFR--SLQLNALDLSFNAFTG--NIPPGFQNLTRLHLLNLQNNSISGAIPPLNLP--RLKILNFSNNNLN 199 (627)
Q Consensus 129 ~l~~~~---~~~~--~~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--~L~~L~l~~N~l~ 199 (627)
+..... +... ..+|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.-.-..+. +|++|+|++|+++
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTG
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcCc
Confidence 644332 2111 1379999999999997 45677889999999999999999752222333 9999999999999
Q ss_pred ccCCC-------CCCCCCCCcccCCCc
Q 006886 200 GSIPD-------SLQTFPNSSFVGNSM 219 (627)
Q Consensus 200 ~~~p~-------~~~~~~~l~~~~n~~ 219 (627)
+.+|+ .+..+++|..++...
T Consensus 234 ~~~~~~~~y~~~il~~~P~L~~LDg~~ 260 (267)
T 3rw6_A 234 DTFRDQSTYISAIRERFPKLLRLDGHE 260 (267)
T ss_dssp GGCSSHHHHHHHHHHHCTTCCEESSCB
T ss_pred cccCcchhHHHHHHHHCcccCeECCcC
Confidence 88874 367889998887543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=9.2e-10 Score=111.24 Aligned_cols=183 Identities=16% Similarity=0.139 Sum_probs=118.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCe--eeeeeEEeeCC---ceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNV--VPVRAYYYSKD---EKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~~~---~~~lv~e~~~~ 414 (627)
+.++.|....||+.. ..+++|+-... .....+.+|.+++..+..+..+ ..++......+ ..++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458889999999853 45888875432 2346788999999888544433 33343332222 24789999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG--------------------------------------- 455 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------- 455 (627)
.++...... .++..++..++.++++.+..||+..
T Consensus 101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 887653321 2566777788888888888888611
Q ss_pred ----------------CCCeeecCCCCCCeEecC--CCCeEEeecccccccCCCCCCCCCccc---cCccccC------C
Q 006886 456 ----------------GAKFTHGNIKSSNVLLTQ--DLNGCISDVGLAHLINFPTTATRTIGY---RAPEVTE------T 508 (627)
Q Consensus 456 ----------------~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~a~~~~~~~~~~~t~~y---~aPE~~~------~ 508 (627)
.+.++|+|++|.||++++ +..+.|+||+.+..............+ ..|+... +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 135899999999999998 456789999988654321100000000 1121110 0
Q ss_pred --------CCCCCcchhHHHHHHHHHHHhCCCCC
Q 006886 509 --------RKASQKSDVYSFGVLLLEMLTGKAPL 534 (627)
Q Consensus 509 --------~~~~~~~Dv~S~Gvvl~el~tg~~p~ 534 (627)
.+.....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01122368999999999999998765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.86 E-value=3.5e-09 Score=108.22 Aligned_cols=144 Identities=18% Similarity=0.150 Sum_probs=94.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccc----ccc-----------
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYF----SGV----------- 133 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l----~~~----------- 133 (627)
..++.|+|++ +++ .|+...|.++++|+.|+|++|.++...+..|..+.++.++.++.+.. ..+
T Consensus 101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 5688899988 777 67777899999999999999988766666676666666665544211 000
Q ss_pred -----------Cch----------------------------h--hccccccccccccccccCCcccccccccccccccc
Q 006886 134 -----------LPA----------------------------F--RSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQ 172 (627)
Q Consensus 134 -----------~~~----------------------------~--~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 172 (627)
++. + ...+|+.|+|++|+++...+..|.+|++|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 000 0 01367778888877775444567778888888887
Q ss_pred CCcccccCCCC--CCCccc-eeeccCCCccccCCCCCCCCCCCcccC
Q 006886 173 NNSISGAIPPL--NLPRLK-ILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 173 ~N~l~~~~p~~--~~~~L~-~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+| ++...+.. ++++|+ .|++.+ .++..-+..|.++++|+.+.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 77 55322222 677777 777777 66644556777777776653
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=8.8e-11 Score=122.06 Aligned_cols=106 Identities=21% Similarity=0.129 Sum_probs=48.0
Q ss_pred CcccEEEccCcccCccCCCCC-CCcccccEEeeecccccccCchhh-------cccccccccccccccc----CCccccc
Q 006886 94 DALKILSLRSNYLNGTLPSDI-TSISSLQYVYLQNNYFSGVLPAFR-------SLQLNALDLSFNAFTG----NIPPGFQ 161 (627)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~-------~~~L~~L~ls~N~l~~----~~p~~~~ 161 (627)
++|+.|+|++|.|+..-...+ ..+++|++|+|++|+|+....... ..+|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 455555555555543222222 234455555555555543322110 1245555555555542 1223334
Q ss_pred cccccccccccCCcccccC----CC--CCCCccceeeccCCCcc
Q 006886 162 NLTRLHLLNLQNNSISGAI----PP--LNLPRLKILNFSNNNLN 199 (627)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~----p~--~~~~~L~~L~l~~N~l~ 199 (627)
.+++|++|+|++|+|+..- +. ...++|+.|+|++|.|+
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 4555555555555554311 10 12345555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=3.8e-11 Score=124.79 Aligned_cols=133 Identities=16% Similarity=0.178 Sum_probs=100.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCC-----CCcccccEEeeecccccccCch-----hh
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDI-----TSISSLQYVYLQNNYFSGVLPA-----FR 138 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~~~-----~~ 138 (627)
..++.|+|++|+++..-.......+++|+.|+|++|.|+..-...+ ...++|++|+|++|.|+..... +.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 5899999999999754333234457789999999999975443344 2458899999999999763221 12
Q ss_pred -ccccccccccccccccC----CccccccccccccccccCCcccccCC----CC--CCCccceeeccCCCcccc
Q 006886 139 -SLQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAIP----PL--NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 139 -~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~--~~~~L~~L~l~~N~l~~~ 201 (627)
..+|++|+|++|.|+.. ++..+...++|+.|+|++|+|+..-. .. ..++|++|+|++|.|+..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 23799999999999852 35667788899999999999985321 11 568899999999999743
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.75 E-value=4.8e-09 Score=107.22 Aligned_cols=146 Identities=10% Similarity=0.103 Sum_probs=104.9
Q ss_pred CcEEEEEcCCCCcc----------c---------ccCccccCC--------CCcccEEEccCcccCccCCCCCCCccccc
Q 006886 69 SRVIGIHLPGIGFT----------G---------PIPANSIGK--------LDALKILSLRSNYLNGTLPSDITSISSLQ 121 (627)
Q Consensus 69 ~~v~~l~l~~~~l~----------~---------~~~~~~l~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 121 (627)
.+++.|||++|++. . .||...|.+ +++|+.|+|.+ .++.+-+..|.++++|+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~ 127 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK 127 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence 46777777777766 0 467777888 99999999999 88866677899999999
Q ss_pred EEeeecccccccCchhhcc--cccccccccccc----c----------------------cCCccc--------------
Q 006886 122 YVYLQNNYFSGVLPAFRSL--QLNALDLSFNAF----T----------------------GNIPPG-------------- 159 (627)
Q Consensus 122 ~L~l~~N~l~~~~~~~~~~--~L~~L~ls~N~l----~----------------------~~~p~~-------------- 159 (627)
+|+|++|.+..+.+..+.. ++..+.++.+.. . +.+|..
T Consensus 128 ~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l 207 (329)
T 3sb4_A 128 ICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFL 207 (329)
T ss_dssp EEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEE
T ss_pred eEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceE
Confidence 9999999998777754432 344444433211 0 001110
Q ss_pred -------------c-ccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCc-ccC
Q 006886 160 -------------F-QNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSS-FVG 216 (627)
Q Consensus 160 -------------~-~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~-~~~ 216 (627)
+ ..+++|+.|+|++|+++...+.. ++++|+.|+|.+| ++..-+..|.++++|+ .+.
T Consensus 208 ~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~ 280 (329)
T 3sb4_A 208 TIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLE 280 (329)
T ss_dssp EEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred EEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEE
Confidence 0 13789999999999998544433 8999999999998 7755567899999887 554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.50 E-value=3.6e-09 Score=117.23 Aligned_cols=35 Identities=11% Similarity=0.112 Sum_probs=17.4
Q ss_pred CCCcccEEEccCcccCccCCCCCCC-cccccEEeee
Q 006886 92 KLDALKILSLRSNYLNGTLPSDITS-ISSLQYVYLQ 126 (627)
Q Consensus 92 ~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~ 126 (627)
.+++|+.|+|+.|.+++..+..+.. +++|+.|+|+
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 3555555555555555444444433 4555555553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.46 E-value=9.7e-09 Score=113.76 Aligned_cols=142 Identities=12% Similarity=0.040 Sum_probs=91.3
Q ss_pred cEEEEEcCCCC-ccc-ccCccccCCCCcccEEEccCcccCcc----CCCCCCCcccccEEeeecccccccCc----hhhc
Q 006886 70 RVIGIHLPGIG-FTG-PIPANSIGKLDALKILSLRSNYLNGT----LPSDITSISSLQYVYLQNNYFSGVLP----AFRS 139 (627)
Q Consensus 70 ~v~~l~l~~~~-l~~-~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~ 139 (627)
+++.|+|++|. ++. .++. ...++++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++... ....
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 49999999886 221 1222 345789999999999998765 33344578999999999999985433 2222
Q ss_pred --cccccccccccccccCCccccccccccccccccCCccccc---CCC--CCCCccceeeccCCCccccCCCCCCCCCCC
Q 006886 140 --LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGA---IPP--LNLPRLKILNFSNNNLNGSIPDSLQTFPNS 212 (627)
Q Consensus 140 --~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~--~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l 212 (627)
.+|+.|+|++|.+++ +|..+.++++|+.|+++++..... .+. ..+++|+.|+++++.. +.+|..+..+++|
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L 295 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQI 295 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCC
Confidence 479999999999985 778888889999998875332211 111 1445555555555422 2344444444444
Q ss_pred cc
Q 006886 213 SF 214 (627)
Q Consensus 213 ~~ 214 (627)
+.
T Consensus 296 ~~ 297 (592)
T 3ogk_B 296 RK 297 (592)
T ss_dssp CE
T ss_pred cE
Confidence 33
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2e-06 Score=84.83 Aligned_cols=136 Identities=15% Similarity=0.215 Sum_probs=95.9
Q ss_pred ccCcCCce-eEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 341 VLGKGSYG-STYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 341 ~lg~G~~g-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+..|..| .||+.... ++..+++|+-... ...++.+|...+..+..+--+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445554 68988754 4667889976432 34568889999998866655777888888888999999999998876
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG------------------------------------------- 455 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------- 455 (627)
+...... .....++.+++..|.-||+..
T Consensus 109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6543211 122334555555555555421
Q ss_pred ------------CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 456 ------------GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 456 ------------~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877777999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=1.9e-08 Score=93.48 Aligned_cols=111 Identities=11% Similarity=0.138 Sum_probs=68.5
Q ss_pred ccCCCCcccEEEccCc-ccCcc----CCCCCCCcccccEEeeecccccccCc----h-hhc-cccccccccccccccC--
Q 006886 89 SIGKLDALKILSLRSN-YLNGT----LPSDITSISSLQYVYLQNNYFSGVLP----A-FRS-LQLNALDLSFNAFTGN-- 155 (627)
Q Consensus 89 ~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~----~-~~~-~~L~~L~ls~N~l~~~-- 155 (627)
.+...++|+.|+|++| .|... +...+...++|++|+|++|+|...-- . +.. .+|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4566677777777777 66532 22334455677777777777754221 1 111 2577777777777642
Q ss_pred --Cccccccccccccccc--cCCcccccCC----CC--CCCccceeeccCCCcc
Q 006886 156 --IPPGFQNLTRLHLLNL--QNNSISGAIP----PL--NLPRLKILNFSNNNLN 199 (627)
Q Consensus 156 --~p~~~~~l~~L~~L~l--~~N~l~~~~p----~~--~~~~L~~L~l~~N~l~ 199 (627)
+...+...++|++|+| ++|.|...-. .. ..++|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3445666677888888 7787764211 11 4467888888888774
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.35 E-value=1.6e-07 Score=91.95 Aligned_cols=101 Identities=22% Similarity=0.226 Sum_probs=61.3
Q ss_pred cCCCCcccE--EEccCcccC---ccCCCCCCCcccccEEeeecccccccC--chhh-c-cccccccccccccccCCcccc
Q 006886 90 IGKLDALKI--LSLRSNYLN---GTLPSDITSISSLQYVYLQNNYFSGVL--PAFR-S-LQLNALDLSFNAFTGNIPPGF 160 (627)
Q Consensus 90 l~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~-~-~~L~~L~ls~N~l~~~~p~~~ 160 (627)
|...+.|.. ++++.|... +.++....++++|++|+|++|+|+++. |... . .+|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 455555555 666666332 222222245677777777777777743 2322 2 3677777777777753 334
Q ss_pred cccc--ccccccccCCcccccCCC---------CCCCccceee
Q 006886 161 QNLT--RLHLLNLQNNSISGAIPP---------LNLPRLKILN 192 (627)
Q Consensus 161 ~~l~--~L~~L~l~~N~l~~~~p~---------~~~~~L~~L~ 192 (627)
..+. +|+.|+|++|.+++.+|. ..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 4444 788888888888876663 1577777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.9e-06 Score=85.49 Aligned_cols=137 Identities=16% Similarity=0.106 Sum_probs=89.4
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCC--CeeeeeeEEe-eCCceEEEEecCCCCC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS--NVVPVRAYYY-SKDEKLVVYSYMPAGS 416 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~--niv~l~~~~~-~~~~~~lv~e~~~~g~ 416 (627)
+.++.|....||+. +..+++|+-.. ......+..|.+++..+..|- .+.+++.+.. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45778888899987 56688887432 223467889999999995542 2445555553 3455789999999987
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE------------------------------------------ 454 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 454 (627)
+...... .++...+..++.++++.|..||+.
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 7653211 123333344444444444444432
Q ss_pred ---------------CCCCeeecCCCCCCeEecC---CCCe-EEeeccccccc
Q 006886 455 ---------------GGAKFTHGNIKSSNVLLTQ---DLNG-CISDVGLAHLI 488 (627)
Q Consensus 455 ---------------~~~~ivH~Dlk~~NILl~~---~~~~-ki~DfG~a~~~ 488 (627)
..+.++|+|+++.||+++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999997 4554 79999987543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.9e-08 Score=106.88 Aligned_cols=126 Identities=21% Similarity=0.192 Sum_probs=74.0
Q ss_pred CCCCcccEEEccCcccCccCCCCCC-CcccccEEeeecc-ccccc-Cchhh--ccccccccccccccccCCccccc----
Q 006886 91 GKLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQNN-YFSGV-LPAFR--SLQLNALDLSFNAFTGNIPPGFQ---- 161 (627)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N-~l~~~-~~~~~--~~~L~~L~ls~N~l~~~~p~~~~---- 161 (627)
..+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++.+. ..+|++|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3567777777777777766555554 5677777777777 44432 22222 13677777777777654443333
Q ss_pred cccccccccccCCc--cccc-CCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 162 NLTRLHLLNLQNNS--ISGA-IPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 162 ~l~~L~~L~l~~N~--l~~~-~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
.+++|+.|++++|. ++.. ++.. .+++|+.|++++|...+.+|..+.++++|+.++
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 241 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEE
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcc
Confidence 45677777777776 2110 0111 457777777777732223555555555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.15 E-value=4.8e-08 Score=108.13 Aligned_cols=108 Identities=12% Similarity=0.060 Sum_probs=60.3
Q ss_pred CCCcccEEEccCcccCccCCCCCC-CcccccEEeee--c----ccccccCch------hhc-cccccccccccccccCCc
Q 006886 92 KLDALKILSLRSNYLNGTLPSDIT-SISSLQYVYLQ--N----NYFSGVLPA------FRS-LQLNALDLSFNAFTGNIP 157 (627)
Q Consensus 92 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~~~~~------~~~-~~L~~L~ls~N~l~~~~p 157 (627)
.+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.++..+.. +.. .+|+.|+|++ .+++..+
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 366777777777777655444443 46677777777 3 455533221 111 2566677655 4554444
Q ss_pred ccccc-ccccccccccCCcccccCCC---CCCCccceeeccCCCccc
Q 006886 158 PGFQN-LTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLNG 200 (627)
Q Consensus 158 ~~~~~-l~~L~~L~l~~N~l~~~~p~---~~~~~L~~L~l~~N~l~~ 200 (627)
..+.. +++|+.|+|++|.+++.... ..+++|+.|+|++|++++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 44444 56667777776666543221 145666777777776643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=4.6e-06 Score=85.86 Aligned_cols=79 Identities=14% Similarity=0.114 Sum_probs=55.0
Q ss_pred ccc-CcCCceeEEEEEec-------CCcEEEEEEecccc---c-CHHHHHHHHHHHHHhccC--CCeeeeeeEEeeC---
Q 006886 340 EVL-GKGSYGSTYKAILE-------DGTTVVVKRLREVA---A-TKREFEQQMEVVGTIGKH--SNVVPVRAYYYSK--- 402 (627)
Q Consensus 340 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~--- 402 (627)
+.| +.|....+|+.... ++..+++|+-.... . ....+..|.+++..+..+ -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998764 26678898765432 1 234678888888888655 3456677776554
Q ss_pred CceEEEEecCCCCCHH
Q 006886 403 DEKLVVYSYMPAGSLF 418 (627)
Q Consensus 403 ~~~~lv~e~~~~g~L~ 418 (627)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.11 E-value=5.2e-06 Score=86.81 Aligned_cols=77 Identities=16% Similarity=0.145 Sum_probs=44.0
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-cc-ccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-SL-QLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~-~L~~L~l 147 (627)
.++.+.|.. ++. .|+...|.++++|+.++|++|+++..-...|. ..+|+.+.|.+| +..+....+ .. +|+.++|
T Consensus 158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 466777765 554 55655777777777777777777633333333 466666666633 444433322 22 4555555
Q ss_pred ccc
Q 006886 148 SFN 150 (627)
Q Consensus 148 s~N 150 (627)
..|
T Consensus 234 ~~~ 236 (401)
T 4fdw_A 234 PEN 236 (401)
T ss_dssp CTT
T ss_pred CCC
Confidence 543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.11 E-value=2.4e-07 Score=85.96 Aligned_cols=108 Identities=18% Similarity=0.204 Sum_probs=81.6
Q ss_pred CcEEEEEcCCC-Ccccc----cCccccCCCCcccEEEccCcccCcc----CCCCCCCcccccEEeeecccccccCc----
Q 006886 69 SRVIGIHLPGI-GFTGP----IPANSIGKLDALKILSLRSNYLNGT----LPSDITSISSLQYVYLQNNYFSGVLP---- 135 (627)
Q Consensus 69 ~~v~~l~l~~~-~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~---- 135 (627)
..++.|+|++| ++... +.. .+...++|+.|+|++|.|... +...+...++|++|+|++|.|+..--
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 67999999999 88642 333 577789999999999999742 23344556889999999999986421
Q ss_pred -hhhc-cccccccc--cccccccC----CccccccccccccccccCCccc
Q 006886 136 -AFRS-LQLNALDL--SFNAFTGN----IPPGFQNLTRLHLLNLQNNSIS 177 (627)
Q Consensus 136 -~~~~-~~L~~L~l--s~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 177 (627)
.+.. .+|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 1221 36999999 88999753 3345666689999999999986
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=8.1e-07 Score=91.42 Aligned_cols=144 Identities=14% Similarity=0.222 Sum_probs=76.1
Q ss_pred CcEEEEEcCCCCcc---------cccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hh
Q 006886 69 SRVIGIHLPGIGFT---------GPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FR 138 (627)
Q Consensus 69 ~~v~~l~l~~~~l~---------~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~ 138 (627)
++++.|.+..+... +.+.. .+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.+....-. +.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 45666766554321 12323 4566777777777776311 2333 3 367777777777666432211 11
Q ss_pred ---ccccccccccc--cccccC-----Ccccc--ccccccccccccCCcccccCCC-----CCCCccceeeccCCCcccc
Q 006886 139 ---SLQLNALDLSF--NAFTGN-----IPPGF--QNLTRLHLLNLQNNSISGAIPP-----LNLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 139 ---~~~L~~L~ls~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p~-----~~~~~L~~L~l~~N~l~~~ 201 (627)
..+|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+. ..+++|+.|+|+.|.++..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 13677777653 221111 11112 2356777777777777642211 1467777777777777642
Q ss_pred ----CCCCCCCCCCCcccC
Q 006886 202 ----IPDSLQTFPNSSFVG 216 (627)
Q Consensus 202 ----~p~~~~~~~~l~~~~ 216 (627)
++..+..+++|+.++
T Consensus 295 G~~~L~~~L~~l~~L~~L~ 313 (362)
T 2ra8_A 295 GARLLLDHVDKIKHLKFIN 313 (362)
T ss_dssp HHHHHHTTHHHHTTCSEEE
T ss_pred HHHHHHhhcccCCcceEEE
Confidence 344434455555554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.8e-05 Score=78.30 Aligned_cols=143 Identities=15% Similarity=0.221 Sum_probs=80.7
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhcc----CCCeeeee-e--EEeeCCceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK----HSNVVPVR-A--YYYSKDEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~----h~niv~l~-~--~~~~~~~~~lv~e~~ 412 (627)
+.|+.|..+.||+....+| .+++|+... ...+...|.+++..+.. .|.++... | +....+..++|++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677889999987654 588998864 23445556666665532 23333211 1 112456678999999
Q ss_pred CCCCHH--------------HHhhhcCCCC----C-----CCCCHHHHH-------------------------------
Q 006886 413 PAGSLF--------------MLLHRNRSDG----G-----TALDWNSRM------------------------------- 438 (627)
Q Consensus 413 ~~g~L~--------------~~l~~~~~~~----~-----~~l~~~~~~------------------------------- 438 (627)
+|..+. ..+|...... . ..-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986432 1122211100 0 112343211
Q ss_pred HHHHHHHHHHHHHHh--------c--CCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 439 KIALGTARGIAFIHS--------E--GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 439 ~i~~~ia~~l~~LH~--------~--~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
.+...+..++.+|++ . ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666663 1 23569999999999999888899999999764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.96 E-value=1.6e-05 Score=83.02 Aligned_cols=139 Identities=16% Similarity=0.133 Sum_probs=98.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ 146 (627)
..++.+.|+.+ ++ .|+...|.++++|+.++|.+| ++..-...|.+ .+|+.+.| .|.+..+.+. |.. .+|+.++
T Consensus 203 ~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~ 277 (401)
T 4fdw_A 203 AGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVT 277 (401)
T ss_dssp CCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEE
T ss_pred cccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEE
Confidence 46788888744 55 677778999999999999876 55455566766 78999999 4556666554 333 3799999
Q ss_pred ccccccc-----cCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 147 LSFNAFT-----GNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 147 ls~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+.+|.+. ..-+..|.+|++|+.++|.+ .++..-... ++.+|+.|+|.+| ++..-+..|.++ +|+.+
T Consensus 278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l 350 (401)
T 4fdw_A 278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEV 350 (401)
T ss_dssp EESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEE
T ss_pred eCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEE
Confidence 9888765 34456788899999999984 465332222 7788999999655 664445667777 66654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=8.5e-05 Score=77.55 Aligned_cols=74 Identities=14% Similarity=0.170 Sum_probs=48.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccc--------cCHHHHHHHHHHHHHhccC-CCee-eeeeEEeeCCceEEE
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--------ATKREFEQQMEVVGTIGKH-SNVV-PVRAYYYSKDEKLVV 408 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~~h-~niv-~l~~~~~~~~~~~lv 408 (627)
+.+|.|..+.||++... +++.++||...... .....+..|.+++..+..+ +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999754 46889999764321 1234567788888887543 3434 34433 44556899
Q ss_pred EecCCCC
Q 006886 409 YSYMPAG 415 (627)
Q Consensus 409 ~e~~~~g 415 (627)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0001 Score=73.90 Aligned_cols=140 Identities=16% Similarity=0.166 Sum_probs=91.8
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccC--CCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKH--SNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.|+.|....+|+... ++..+++|+-... ....+..|.+.+..+..+ ..+.+++.+....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4678899999999886 4678889986542 356788999999888654 5677788888777889999999998754
Q ss_pred H-----------HHhhhcCCCC--C---------------CCCCHHHHH---HHHHH----------------HHHH-HH
Q 006886 418 F-----------MLLHRNRSDG--G---------------TALDWNSRM---KIALG----------------TARG-IA 449 (627)
Q Consensus 418 ~-----------~~l~~~~~~~--~---------------~~l~~~~~~---~i~~~----------------ia~~-l~ 449 (627)
. ..+|...... + -.-+|.... ++..+ +... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 1 1233321100 0 012565332 11111 1111 22
Q ss_pred HHHh-cCCCCeeecCCCCCCeEecCCCCeEEeecc
Q 006886 450 FIHS-EGGAKFTHGNIKSSNVLLTQDLNGCISDVG 483 (627)
Q Consensus 450 ~LH~-~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG 483 (627)
.|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3322 2246799999999999999887 8888974
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=2.2e-06 Score=88.22 Aligned_cols=147 Identities=12% Similarity=0.146 Sum_probs=94.6
Q ss_pred CCcEEEEEcCCCCccc-cc-------CccccCCCCcccEEEccCcccC---------ccCCCCCCCcccccEEeeecccc
Q 006886 68 RSRVIGIHLPGIGFTG-PI-------PANSIGKLDALKILSLRSNYLN---------GTLPSDITSISSLQYVYLQNNYF 130 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~-~~-------~~~~l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~l~~N~l 130 (627)
..+|+.|.+...+..| +. .. ++.+|++|+.|.+..+... +.++..+..+++|+.|+|++|.-
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~-s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~ 184 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVE-NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN 184 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHT-THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHH-hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC
Confidence 4578899988777653 21 22 4567889999999776432 12333345679999999999842
Q ss_pred cccCchhhccccccccccccccccCCccccc--cccccccccccC--Cccccc---------CCCCCCCccceeeccCCC
Q 006886 131 SGVLPAFRSLQLNALDLSFNAFTGNIPPGFQ--NLTRLHLLNLQN--NSISGA---------IPPLNLPRLKILNFSNNN 197 (627)
Q Consensus 131 ~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~---------~p~~~~~~L~~L~l~~N~ 197 (627)
... +.+...+|+.|+|..|.++...-..+. .+++|+.|+|+. |...+. +....+++|+.|+|++|.
T Consensus 185 l~l-~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 185 LSI-GKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp CBC-CSCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred cee-ccccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 222 333345899999999888754333444 689999999863 332221 111258999999999999
Q ss_pred ccccCCCCC---CCCCCCcccC
Q 006886 198 LNGSIPDSL---QTFPNSSFVG 216 (627)
Q Consensus 198 l~~~~p~~~---~~~~~l~~~~ 216 (627)
++...+..+ ..+++|+.++
T Consensus 264 i~~~~~~~la~a~~~~~L~~Ld 285 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMD 285 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEE
T ss_pred CchHHHHHHHhCccCCCCCEEE
Confidence 875433222 2345555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00046 Score=72.54 Aligned_cols=74 Identities=14% Similarity=0.155 Sum_probs=47.5
Q ss_pred CCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCC-----CCccccCccccCCC---CCCCcchhHHHHHHHHHH
Q 006886 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT-----RTIGYRAPEVTETR---KASQKSDVYSFGVLLLEM 527 (627)
Q Consensus 456 ~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~-----~t~~y~aPE~~~~~---~~~~~~Dv~S~Gvvl~el 527 (627)
.+.++|+|+++.|||++.++ ++|+||+.+.......... -...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 35699999999999999876 9999999887543211000 01246666655321 112235556777788877
Q ss_pred HhC
Q 006886 528 LTG 530 (627)
Q Consensus 528 ~tg 530 (627)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00063 Score=67.46 Aligned_cols=73 Identities=21% Similarity=0.287 Sum_probs=52.8
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCC--eeeeeeEEeeCCceEEEEecCCCCC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSN--VVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
+.+|.|..+.||+.+..||+.|++|+-.... .....|..|.+.++.+.+... +.+++++ . ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 5689999999999999999999999865432 234568899999998854322 3334433 2 3468999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00093 Score=67.48 Aligned_cols=145 Identities=17% Similarity=0.123 Sum_probs=83.7
Q ss_pred ccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCC-CeeeeeeE-----EeeCCceEEEEecCCC
Q 006886 341 VLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS-NVVPVRAY-----YYSKDEKLVVYSYMPA 414 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~-----~~~~~~~~lv~e~~~~ 414 (627)
.++ |....||+....+|+.+++|...........+..|..++..+..+. .+.+++.. ....+..++|++|++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 455 7778899988777778999998644445677888888888875432 13334332 1224456789999987
Q ss_pred CCHH-----H---------HhhhcCCC----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc---
Q 006886 415 GSLF-----M---------LLHRNRSD----GGTALDWNSR----MKI---------------ALGTARGIAFIHSE--- 454 (627)
Q Consensus 415 g~L~-----~---------~l~~~~~~----~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~~--- 454 (627)
..+. . .+|..... .....++... ..+ ...+...+..+.+.
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5431 0 11211100 0112232211 001 11111223333321
Q ss_pred -CCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 455 -GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 455 -~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
....++|+|+++.||+++ + .+.|+||+.+...
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 224589999999999999 4 8899999877543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0012 Score=68.03 Aligned_cols=144 Identities=11% Similarity=0.118 Sum_probs=83.9
Q ss_pred cccCcCCceeEEEEEec--------CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILE--------DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
+.+..|-...+|+.... +++.+++|+..........+.+|.++++.+..+.-..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45666777889998864 247899988643333456677899999888665544566665532 289999
Q ss_pred CCCCCHHH-----------------HhhhcCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHHH--
Q 006886 412 MPAGSLFM-----------------LLHRNRSDGGTALD--WNSRMKIALGTA-------------------RGIAFI-- 451 (627)
Q Consensus 412 ~~~g~L~~-----------------~l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~l~~L-- 451 (627)
++|.+|.. -+|......+.... |.+..++..++. ..+.+|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98854421 11221111112222 334443433321 123333
Q ss_pred --HhcC-CCCeeecCCCCCCeEecCC----CCeEEeecccccc
Q 006886 452 --HSEG-GAKFTHGNIKSSNVLLTQD----LNGCISDVGLAHL 487 (627)
Q Consensus 452 --H~~~-~~~ivH~Dlk~~NILl~~~----~~~ki~DfG~a~~ 487 (627)
.... ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 2358999999999999877 7899999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0025 Score=64.10 Aligned_cols=145 Identities=10% Similarity=0.072 Sum_probs=80.3
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCC-eeeeeeE------EeeCCceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN-VVPVRAY------YYSKDEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~------~~~~~~~~lv~e~~ 412 (627)
+.|+.|....+|+....+| .+++|..... ....++..|.+++..+..+.- +.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 4567788889999987655 6788887652 123356677888777754421 2222211 12235568999999
Q ss_pred CCCCHH--------------HHhhhcCCC--CC-----CCCCHHHHHHH------------HHHHHHHHHHHHhc----C
Q 006886 413 PAGSLF--------------MLLHRNRSD--GG-----TALDWNSRMKI------------ALGTARGIAFIHSE----G 455 (627)
Q Consensus 413 ~~g~L~--------------~~l~~~~~~--~~-----~~l~~~~~~~i------------~~~ia~~l~~LH~~----~ 455 (627)
+|..+. ..+|..... .. ....|.....- ...+...+.++++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 885431 012221110 00 01124331110 11244556666542 1
Q ss_pred CCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 456 ~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2358999999999999987666899999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0012 Score=65.95 Aligned_cols=141 Identities=11% Similarity=-0.027 Sum_probs=74.4
Q ss_pred cccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC-CCCCHH
Q 006886 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM-PAGSLF 418 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~-~~g~L~ 418 (627)
+.|+.|....+|+. ..+++|+-............|.+++..+..+.-..+++++ ..+..++|+||+ ++-++.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 56888889999998 4588887754321111235677777777544322344443 344457899999 554332
Q ss_pred H------------------HhhhcCCCCCCCCCHHHH-HHHHH--------------HHHHHH----HHHHh-cCCCCee
Q 006886 419 M------------------LLHRNRSDGGTALDWNSR-MKIAL--------------GTARGI----AFIHS-EGGAKFT 460 (627)
Q Consensus 419 ~------------------~l~~~~~~~~~~l~~~~~-~~i~~--------------~ia~~l----~~LH~-~~~~~iv 460 (627)
. .+|..........+.... ..+.. .+...+ ..+.. ...+.++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 1 111111100111111111 11100 011111 11211 1224589
Q ss_pred ecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 461 HGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 461 H~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|+|+.+.||+ ..++.+.|+||..+...
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 9999999999 56677899999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=66.59 Aligned_cols=145 Identities=13% Similarity=0.080 Sum_probs=73.5
Q ss_pred cccCcCCcee-EEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCC-CeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGS-TYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS-NVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.|+.|+... +|+....++..+++|...... ..++..|++++..+..+. .+.+++.+... .. +++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g-~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHA-RG-LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETT-TT-EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCC-CC-EEEEeeCCCcch
Confidence 3455554444 667665446777777643321 133456677777775442 23445555332 23 789999977666
Q ss_pred HHHhhhcC---------------------CCCCCCCCHHHHH--------------------HHHHHHHHHHHHHHh---
Q 006886 418 FMLLHRNR---------------------SDGGTALDWNSRM--------------------KIALGTARGIAFIHS--- 453 (627)
Q Consensus 418 ~~~l~~~~---------------------~~~~~~l~~~~~~--------------------~i~~~ia~~l~~LH~--- 453 (627)
.+++.... ......++..... .....+...+..+.+
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54443210 0000111111000 000111222333311
Q ss_pred cCCCCeeecCCCCCCeEecCC----CCeEEeeccccccc
Q 006886 454 EGGAKFTHGNIKSSNVLLTQD----LNGCISDVGLAHLI 488 (627)
Q Consensus 454 ~~~~~ivH~Dlk~~NILl~~~----~~~ki~DfG~a~~~ 488 (627)
.....++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123469999999999999875 67899999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00022 Score=64.57 Aligned_cols=81 Identities=6% Similarity=0.051 Sum_probs=39.4
Q ss_pred cccEEEccCcccCccCCCCCCCcccccEEeeeccc-ccccC-chhhc-----cccccccccccc-cccCCcccccccccc
Q 006886 95 ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNY-FSGVL-PAFRS-----LQLNALDLSFNA-FTGNIPPGFQNLTRL 166 (627)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~-~~~~~-----~~L~~L~ls~N~-l~~~~p~~~~~l~~L 166 (627)
+|+.|||+++.|+..--..+..+++|+.|+|+++. ++..- ..+.. .+|+.|+|+++. +|..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 35555555555543322334556666666666653 33211 11111 146666666653 543211235556666
Q ss_pred ccccccCCc
Q 006886 167 HLLNLQNNS 175 (627)
Q Consensus 167 ~~L~l~~N~ 175 (627)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777666653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0066 Score=63.74 Aligned_cols=72 Identities=8% Similarity=0.113 Sum_probs=49.3
Q ss_pred cccCcCCceeEEEEEecC--------CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILED--------GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
+.|+.|....+|+....+ +..+++|+.... .....+..|..++..+..+.-..++++.+. + .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 467788889999998753 478999987432 222556678888888865544456666543 2 389999
Q ss_pred CCCCC
Q 006886 412 MPAGS 416 (627)
Q Consensus 412 ~~~g~ 416 (627)
++|-+
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 98633
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00067 Score=58.42 Aligned_cols=36 Identities=25% Similarity=0.192 Sum_probs=18.0
Q ss_pred ccccccccccccccCCccccccccccccccccCCcc
Q 006886 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSI 176 (627)
Q Consensus 141 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 176 (627)
+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 344455555555533333455555555555555544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.002 Score=66.24 Aligned_cols=73 Identities=11% Similarity=0.085 Sum_probs=43.5
Q ss_pred cccCcCCceeEEEEEecC---------CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 340 EVLGKGSYGSTYKAILED---------GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
+.++.|....+|+....+ +..+++|+.........+...|.+++..+..+.-..++++.. . -++|+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778888999998654 267888876543221112467788888775553334555443 2 368999
Q ss_pred cCCCCC
Q 006886 411 YMPAGS 416 (627)
Q Consensus 411 ~~~~g~ 416 (627)
|++|-.
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.014 Score=61.66 Aligned_cols=74 Identities=7% Similarity=0.069 Sum_probs=46.8
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
+.|+.|-...+|+....+ +..+++|+........-+...|..++..+..+.-..++++.+. + .+|+||++|-+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 567788889999998765 4778888764322211123578888888855443456666652 2 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0071 Score=61.35 Aligned_cols=32 Identities=25% Similarity=0.257 Sum_probs=27.9
Q ss_pred CCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 457 ~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45899999999999998888999999876543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0056 Score=63.52 Aligned_cols=54 Identities=13% Similarity=0.075 Sum_probs=25.8
Q ss_pred cccccccccccccccCCcccccCCCC---CCCccceeeccCCCccccCCCCCCCCCCCcc
Q 006886 158 PGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 158 ~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~ 214 (627)
..|.++++|+.+.+.++..+ ++.. ++.+|+.+++..| ++..-...|.++..|+.
T Consensus 156 ~aF~~c~~L~~i~l~~~~~~--I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~ 212 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSMET--LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLEN 212 (394)
T ss_dssp TTTTTCTTCCEEECCTTCCE--ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCB
T ss_pred hhhcccCCCcEEecCCccce--eccccccCCCCceEEEcCCC-ceEeCchhhccccccce
Confidence 34566666666666544322 2221 4556666666554 33222334444444443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0032 Score=54.07 Aligned_cols=56 Identities=20% Similarity=0.230 Sum_probs=43.5
Q ss_pred EEEcCCCCcc-cccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeeccccc
Q 006886 73 GIHLPGIGFT-GPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFS 131 (627)
Q Consensus 73 ~l~l~~~~l~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 131 (627)
.++.++++|+ ..+|.+ + -++|+.|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6788888887 467752 2 246889999999999655667788999999999988775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.025 Score=52.47 Aligned_cols=102 Identities=9% Similarity=0.043 Sum_probs=66.5
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCCCC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT 495 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~~~ 495 (627)
+|.+.|... +.++++.+++.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+...+ +.+. .
T Consensus 34 SL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------~ 98 (229)
T 2yle_A 34 SLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------A 98 (229)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------c
Confidence 789999865 4689999999999999998776622110 1 1222346899999999997753 1111 1
Q ss_pred CCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 006886 496 RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAP 533 (627)
Q Consensus 496 ~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p 533 (627)
....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 123467888764 3557888999999999998875544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00014 Score=67.20 Aligned_cols=86 Identities=14% Similarity=0.067 Sum_probs=43.9
Q ss_pred ccCCCCcccEEEccCc-ccCcc----CCCCCCCcccccEEeeecccccccCch----hh--ccccccccccccccccC--
Q 006886 89 SIGKLDALKILSLRSN-YLNGT----LPSDITSISSLQYVYLQNNYFSGVLPA----FR--SLQLNALDLSFNAFTGN-- 155 (627)
Q Consensus 89 ~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~--~~~L~~L~ls~N~l~~~-- 155 (627)
.+.+-+.|+.|+|++| .|... +-..+..=+.|+.|+|++|+|...--. .. ...|+.|+|++|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3445566777777764 55421 122233445677777777776532111 11 12466777777766531
Q ss_pred --CccccccccccccccccCC
Q 006886 156 --IPPGFQNLTRLHLLNLQNN 174 (627)
Q Consensus 156 --~p~~~~~l~~L~~L~l~~N 174 (627)
+-..+..-+.|+.|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 1123333445666666644
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.15 E-value=0.00066 Score=62.64 Aligned_cols=109 Identities=8% Similarity=0.131 Sum_probs=72.1
Q ss_pred CCcEEEEEcCCC-Ccccc----cCccccCCCCcccEEEccCcccCccCCCCCC----CcccccEEeeecccccccCch--
Q 006886 68 RSRVIGIHLPGI-GFTGP----IPANSIGKLDALKILSLRSNYLNGTLPSDIT----SISSLQYVYLQNNYFSGVLPA-- 136 (627)
Q Consensus 68 ~~~v~~l~l~~~-~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~l~~N~l~~~~~~-- 136 (627)
...++.|+|++| ++... +-. .+..=+.|+.|+|++|.|...--..|. .=+.|++|+|++|+|+..--.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 357899999986 66421 222 567778899999999999754333333 347899999999999854221
Q ss_pred ---hh-cccccccccccccc---cc----CCccccccccccccccccCCccc
Q 006886 137 ---FR-SLQLNALDLSFNAF---TG----NIPPGFQNLTRLHLLNLQNNSIS 177 (627)
Q Consensus 137 ---~~-~~~L~~L~ls~N~l---~~----~~p~~~~~l~~L~~L~l~~N~l~ 177 (627)
+. ...|+.|+|++|.. .. .+-..+..-+.|+.|+++.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 11 13599999987643 31 12234455567777877776653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0067 Score=62.95 Aligned_cols=110 Identities=13% Similarity=0.232 Sum_probs=75.1
Q ss_pred cCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh-c-cccccccccccccccCCcccccc
Q 006886 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR-S-LQLNALDLSFNAFTGNIPPGFQN 162 (627)
Q Consensus 85 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~-~~L~~L~ls~N~l~~~~p~~~~~ 162 (627)
+....|.+.++|+.+.+.++..+ .-...|.++++|+.+.+. +.+..+....+ . .+|+.++|..| ++..-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 34446888888888888766554 555677888888888885 45555554433 3 37888888765 55344557888
Q ss_pred ccccccccccCCcccccCCC---CCCCccceeeccCCCcc
Q 006886 163 LTRLHLLNLQNNSISGAIPP---LNLPRLKILNFSNNNLN 199 (627)
Q Consensus 163 l~~L~~L~l~~N~l~~~~p~---~~~~~L~~L~l~~N~l~ 199 (627)
|++|+.+.|..+ ++ .+.. .++.+|+.+++.+|...
T Consensus 333 C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 333 CEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence 888888888654 44 3433 27888888888887653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.019 Score=59.04 Aligned_cols=125 Identities=11% Similarity=0.100 Sum_probs=83.8
Q ss_pred cccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccccccccccccCCccccccccc
Q 006886 88 NSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTR 165 (627)
Q Consensus 88 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~ 165 (627)
..+....+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++.+....+. .+|+.+.+..+ ++..-...|.++++
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 35677788888888765 44355567788888988888765 5544443222 36788887654 44334457888889
Q ss_pred cccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 166 LHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 166 L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
|+.+.+.+|.++..-... ++.+|+.+.|.+| ++..-...|.++.+|+.+.
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 999988888877433332 7788888888655 5533345677777776554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0024 Score=57.69 Aligned_cols=84 Identities=11% Similarity=-0.015 Sum_probs=59.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcc-cCccCCCCCCCc----ccccEEeeeccc-ccccC-chhhc-c
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNY-LNGTLPSDITSI----SSLQYVYLQNNY-FSGVL-PAFRS-L 140 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~-~~~~~-~ 140 (627)
-+++.|||+++.++..=-. .+..+++|+.|+|+++. |+..-=..+..+ ++|++|+|+++. ++..- ..+.. .
T Consensus 61 ~~L~~LDLs~~~Itd~GL~-~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFD-HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGG-GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHH-HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 4799999999998754223 57899999999999984 765332334443 479999999975 66421 12222 4
Q ss_pred ccccccccccc-cc
Q 006886 141 QLNALDLSFNA-FT 153 (627)
Q Consensus 141 ~L~~L~ls~N~-l~ 153 (627)
+|+.|+|+++. ++
T Consensus 140 ~L~~L~L~~c~~It 153 (176)
T 3e4g_A 140 NLKYLFLSDLPGVK 153 (176)
T ss_dssp TCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCC
Confidence 79999999875 44
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.018 Score=59.64 Aligned_cols=116 Identities=12% Similarity=0.130 Sum_probs=69.4
Q ss_pred CcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCc-hhhc-cccccccccccccccCCccccccccccccccc
Q 006886 94 DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNL 171 (627)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 171 (627)
..+..+.+.+ .++..-...|.++.+|+.+.+.++... +.. .+.. ..|+.+.+. +.++..-...|.+|++|+.++|
T Consensus 242 ~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~l 318 (394)
T 4gt6_A 242 REDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDI 318 (394)
T ss_dssp CCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEEC
T ss_pred cccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEe
Confidence 3444454433 333344556778888888888665433 222 2332 367888875 4455344457888888888888
Q ss_pred cCCcccccCCC-C--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 172 QNNSISGAIPP-L--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 172 ~~N~l~~~~p~-~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
..| ++ .+.. . ++.+|+.+.|..+ ++..-...|.++++|+.+
T Consensus 319 p~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i 362 (394)
T 4gt6_A 319 PEG-IT-QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNI 362 (394)
T ss_dssp CTT-CC-EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred CCc-cc-EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence 754 44 2332 2 7788888888654 552333567777777654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.081 Score=55.09 Aligned_cols=74 Identities=5% Similarity=0.082 Sum_probs=47.2
Q ss_pred cccCcCCceeEEEEEecC--------CcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILED--------GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
+.+..|-...+|+....+ +..+++|+........-+..+|.+++..+..+.-..++++.+ . .++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456667778899988753 578899886443222223457888888775554444555433 2 3689999
Q ss_pred CCCCCH
Q 006886 412 MPAGSL 417 (627)
Q Consensus 412 ~~~g~L 417 (627)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.077 Score=54.38 Aligned_cols=30 Identities=13% Similarity=0.125 Sum_probs=13.2
Q ss_pred CCCccceeeccCCCccccCCCCCCCCCCCc
Q 006886 184 NLPRLKILNFSNNNLNGSIPDSLQTFPNSS 213 (627)
Q Consensus 184 ~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~ 213 (627)
++.+|+.+.+.+|.++..-...|.++.+|+
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~ 313 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLS 313 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred cccccccccccccccceehhhhhcCCCCCC
Confidence 444455555544444422233444444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.077 Score=54.80 Aligned_cols=129 Identities=8% Similarity=0.038 Sum_probs=83.8
Q ss_pred ccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch-hhc-cccccccccccccccCCccccc
Q 006886 84 PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA-FRS-LQLNALDLSFNAFTGNIPPGFQ 161 (627)
Q Consensus 84 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~-~~L~~L~ls~N~l~~~~p~~~~ 161 (627)
.|....|.++++|+.+.|.++ ++.+-...|.++++|+.++|.+| +..+... +.. .+|+.+.+..+ ++..-...|.
T Consensus 61 sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~ 137 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK 137 (394)
T ss_dssp EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence 466668999999999999754 77555678999999999999765 5544443 222 36777777655 3324445677
Q ss_pred cccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 162 NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++..++.........-+.-.-.++++|+.+.+.++..+ .-...|.++.+|+.+.
T Consensus 138 ~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~ 191 (394)
T 4fs7_A 138 GCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIK 191 (394)
T ss_dssp TCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCC
T ss_pred cccccccccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEE
Confidence 76555444444433322221227889999999766532 3445677777776654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.021 Score=37.96 Aligned_cols=32 Identities=19% Similarity=0.038 Sum_probs=18.1
Q ss_pred ccceeeeehhhHHHHHHHHHHHHhhhhccccc
Q 006886 258 SGSIIAIAVGGCAVLFLLLALFFLCCLKKLDR 289 (627)
Q Consensus 258 ~~~ii~~~~~~~~~~~~l~~~~~~~~~r~~~~ 289 (627)
...|.+.++++++++++++++++++.+||+++
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34456666666666666665555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.022 Score=37.72 Aligned_cols=32 Identities=22% Similarity=0.240 Sum_probs=18.3
Q ss_pred ccceeeeehhhHHHHHHHHHHHHhhhhccccc
Q 006886 258 SGSIIAIAVGGCAVLFLLLALFFLCCLKKLDR 289 (627)
Q Consensus 258 ~~~ii~~~~~~~~~~~~l~~~~~~~~~r~~~~ 289 (627)
...|.+.+++++++++++++.++++.|||+++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 34466666666666666665555555554443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.15 E-value=0.031 Score=35.98 Aligned_cols=31 Identities=26% Similarity=0.356 Sum_probs=19.5
Q ss_pred ccCccceeeeehhhHHHHHHHHHHHHhhhhc
Q 006886 255 KLNSGSIIAIAVGGCAVLFLLLALFFLCCLK 285 (627)
Q Consensus 255 ~~~~~~ii~~~~~~~~~~~~l~~~~~~~~~r 285 (627)
..+.+.+.+++++.++.+++++++.++++||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 3445667777777776666666666655544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.63 E-value=0.83 Score=47.10 Aligned_cols=29 Identities=21% Similarity=0.398 Sum_probs=24.5
Q ss_pred eeecCCCCCCeEe------cCCCCeEEeecccccc
Q 006886 459 FTHGNIKSSNVLL------TQDLNGCISDVGLAHL 487 (627)
Q Consensus 459 ivH~Dlk~~NILl------~~~~~~ki~DfG~a~~ 487 (627)
++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.43 E-value=0.14 Score=33.89 Aligned_cols=27 Identities=26% Similarity=0.359 Sum_probs=11.6
Q ss_pred ceeeeehhhHHHHHHHHHHHHhhhhccc
Q 006886 260 SIIAIAVGGCAVLFLLLALFFLCCLKKL 287 (627)
Q Consensus 260 ~ii~~~~~~~~~~~~l~~~~~~~~~r~~ 287 (627)
.++++++| +++++++++.++++.|||+
T Consensus 13 ~Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 13 SIISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred chHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 34555555 3333333333344434433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.93 E-value=1.4 Score=40.78 Aligned_cols=116 Identities=11% Similarity=0.120 Sum_probs=77.8
Q ss_pred cCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 006886 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSS 467 (627)
Q Consensus 388 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~ 467 (627)
.||+.+.. ..-.+.+...+.|+.-+.+.=...++ ..+...+++++.+|+....++++ =+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888866 44455566555555543332222232 36788999999999887755554 468889999
Q ss_pred CeEecCCCCeEEeecccccccCCCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 006886 468 NVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 468 NILl~~~~~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
||+++.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764333 221 11222223357788888999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.57 E-value=3 Score=38.65 Aligned_cols=115 Identities=16% Similarity=0.131 Sum_probs=76.3
Q ss_pred cCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCC
Q 006886 388 KHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIA-FIHSEGGAKFTHGNIKS 466 (627)
Q Consensus 388 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~Dlk~ 466 (627)
.||++ -...-.+++...+.|+.-+++.=...++ ..+...+++++.+++.... ++++ -+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 68887 3333356667666677654544444443 2678899999988877555 4443 57888999
Q ss_pred CCeEecCCCCeEEeecccccccCCCCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 006886 467 SNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535 (627)
Q Consensus 467 ~NILl~~~~~~ki~DfG~a~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~ 535 (627)
+||++|.++.++|.-.|+-.. ++|.-+ ++.-=.-.+=+++..++.++..|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~-------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES-------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT-------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCccc-------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999988886433 233211 111123356777888888887764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 627 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 7e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-54
Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 31/274 (11%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
E LG G +G + T V VK L++ + + F + ++ + +H +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYA-V 76
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+++ ++ YM GSL L G L N + +A A G+AFI +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLIN-----FPTTATRTIGYRAPEVTETRKASQK 514
H +++++N+L++ L+ I+D GLA LI A I + APE + K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
SDV+SFG+LL E++T G+ P + +V+ +VR + E
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE------------- 237
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
++ Q+ C + P+ RP D + ++E
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-53
Identities = 51/275 (18%), Positives = 109/275 (39%), Gaps = 29/275 (10%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ +G G +G + + V +K +RE A ++ +F ++ EV+ + H +V +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ +V+ +M G L L R + + + L G+A++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-----TIGYRAPEVTETRKASQK 514
H ++ + N L+ ++ +SD G+ + + + + +PEV + S K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
SDV+SFGVL+ E+ + + + ++ + + R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGFRLY--------------KPRL 226
Query: 575 EMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ QI C + P+ RP ++R + +I +
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATK---REFEQQMEVVGTIGKHSNVVPVR 396
+ +G GS+G+ YK V VK L A T + F+ ++ V+ +H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 70
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
Y + + +V + SL+ LH T + + IA TA+G+ ++H++
Sbjct: 71 GYS-TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRK 510
H ++KS+N+ L +DL I D GLA + + + +I + APEV +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 511 A---SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567
S +SDVY+FG++L E++TG+ P + ++ + +V + +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN------INNRDQIIFMVGRGYLSPDLS---- 232
Query: 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ M ++ C+ K D RP ++ IE + +
Sbjct: 233 --KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-53
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ +GKG +G G V VK ++ AT + F + V+ + +HSN+V +
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQLLGVI 69
Query: 400 YSKDEKL-VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ L +V YM GSL L G + L + +K +L + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-FPTTATRTIGYRAPEVTETRKASQKSDV 517
F H ++ + NVL+++D +SD GL + T + + APE +K S KSDV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 518 YSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEEMV 577
+SFG+LL E+ + + D+ V + +
Sbjct: 184 WSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKGYKMDAPDGCPP-------------- 227
Query: 578 QMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPEL 612
+ ++ +C RP + +E I+ EL
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 35/299 (11%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
E +GKG +G ++ G V VK E ++ + +H N++ A
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 66
Query: 400 YSKDEKLV----VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ V Y GSLF L+R + +K+AL TA G+A +H E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEI 120
Query: 456 GA-----KFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--------FPTTATRTIGYRA 502
H ++KS N+L+ ++ CI+D+GLA + P T Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 503 PEVTETR------KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDV----VDLPRWVRSV 552
PEV + ++ +++D+Y+ G++ E+ + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
+R+ + + E + M +I C +R + + + Q+ Q E
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-51
Identities = 52/274 (18%), Positives = 105/274 (38%), Gaps = 31/274 (11%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+ LG G +G V +K ++E + ++ EF ++ +V+ + H +V +
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
+ ++ YM G L L R +++ + ++ S+ F
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-----TIGYRAPEVTETRKASQK 514
H ++ + N L+ +SD GL+ + + + + PEV K S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 515 SDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
SD+++FGVL+ E+ + GK P + + + + + R +E
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
++ I SC + D RP ++ I +
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 66/295 (22%), Positives = 112/295 (37%), Gaps = 45/295 (15%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+ LG G++G +A + TV VK L+ A + +++V+ +G H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-------------SDGGTALDWNSRM 438
+V + LV+ Y G L L R R D ALD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-- 496
+ A+G+AF+ S+ H ++ + N+LLT I D GLA I +
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 497 ----TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
+ + APE + +SDV+S+G+ L E+ + + + G + ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-PYPGMPVDSKFYKMIKEG 264
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
R E +M I +C P RP +V++IE+
Sbjct: 265 FRML--------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 55/291 (18%), Positives = 115/291 (39%), Gaps = 38/291 (13%)
Query: 340 EVLGKGSYGSTYKAILEDG---TTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVVP 394
+V+G+G++G KA ++ +KR++E A+ R+F ++EV+ +G H N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRN-----------RSDGGTALDWNSRMKIALG 443
+ + + Y P G+L L ++ + + L + A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 444 TARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TIGY 500
ARG+ ++ + F H ++ + N+L+ ++ I+D GL+ T + +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560
A E + SDV+S+GVLL E+++ +L + R E
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYRLEKPLN 250
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
D ++ + C + P RP ++ + ++ +
Sbjct: 251 CDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 3e-48
Identities = 56/303 (18%), Positives = 117/303 (38%), Gaps = 53/303 (17%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
+G+G++G ++A E T V VK L+E A+ +F+++ ++ + N
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 77
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR-------------------SDGGTAL 432
+V + +++ YM G L L S G L
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 433 DWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN--- 489
++ IA A G+A++ F H ++ + N L+ +++ I+D GL+ I
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 490 ---FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLP 546
I + PE + + +SDV+++GV+L E+ + + ++
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG--MAHEEVI 252
Query: 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606
+VR E +++ + C +K+P RP + R++++
Sbjct: 253 YYVRDGNILAC--------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 607 IQQ 609
+ +
Sbjct: 299 MCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-48
Identities = 63/273 (23%), Positives = 111/273 (40%), Gaps = 29/273 (10%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
LG+G +G + T V +K L+ + F Q+ +V+ + +H +V + A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYA-V 80
Query: 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKF 459
S++ +V YM GSL L G L + +A A G+A++ +
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---Y 134
Query: 460 THGNIKSSNVLLTQDLNGCISDVGLAHLIN-----FPTTATRTIGYRAPEVTETRKASQK 514
H +++++N+L+ ++L ++D GLA LI A I + APE + + K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEE 574
SDV+SFG+LL E+ T ++ V R E +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE----------- 241
Query: 575 EMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ + C K P+ RP + + +E
Sbjct: 242 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 2e-47
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 29/276 (10%)
Query: 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG G YG Y+ + + TV VK L+E EF ++ V+ I KH N+V +
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 81
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ ++ +M G+L L + + +A + + ++ +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 459 FTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEVTETRKASQ 513
F H ++ + N L+ ++ ++D GL+ L+ T I + APE K S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
KSDV++FGVLL E+ T D+ + + R E +
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKDYRMERPEGCPE---------- 243
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
++ ++ +C P RP ++ + E + Q
Sbjct: 244 ----KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-47
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 39/289 (13%)
Query: 340 EVLGKGSYGSTYKAILED----GTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVV 393
EV+G+G +G Y L D VK L + +F + ++ H NV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 91
Query: 394 PVRAYYYSKDEK-LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + LVV YM G L + + + L A+G+ F+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA 147
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--------TIGYRAPE 504
S+ F H ++ + N +L + ++D GLA + + + + A E
Sbjct: 148 SKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
+T+K + KSDV+SFGVLL E++T AP + D+ ++ R
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVNTFDITVYLLQGRR---------- 252
Query: 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELR 613
LL+ + + + ++ L C + RP ++V I I +
Sbjct: 253 -LLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 57/298 (19%), Positives = 107/298 (35%), Gaps = 50/298 (16%)
Query: 340 EVLGKGSYGSTYKAILED------GTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSN 391
+VLG G++G A V VK L+E A + + +++++ +G H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR------------------SDGGTALD 433
+V + +++ Y G L L R + L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 434 WNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN---- 489
+ + A A+G+ F+ + H ++ + NVL+T I D GLA I
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 490 --FPTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR 547
A + + APE + KSDV+S+G+LL E+ + + G + +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFYK 278
Query: 548 WVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605
+++ + + + ++ I SC A RP ++ +
Sbjct: 279 LIQNGFKMDQPFYATE--------------EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 54/284 (19%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 340 EVLGKGSYGSTYKAILEDGT-----TVVVKRLRE--VAATKREFEQQMEVVGTIGKHSNV 392
+V+G G +G YK +L+ + V +K L+ + +F + ++G H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 71
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +++ YM G+L L + + + G A G+ ++
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLA 127
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-------TIGYRAPEV 505
+ + H ++ + N+L+ +L +SD GL+ ++ AT I + APE
Sbjct: 128 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565
RK + SDV+SFG+++ E++T + ++ + + R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGFRLPTP------- 235
Query: 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ + Q+ + C + RPK D+V +++++ +
Sbjct: 236 -------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-46
Identities = 49/288 (17%), Positives = 105/288 (36%), Gaps = 18/288 (6%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR--EVAATKREFEQQMEVVGTIGKHSNVVPVR 396
LG G+ G +K G + K + A + + ++++V+ +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFY 70
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+YS E + +M GSL +L + + K+++ +G+ ++ +
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHK 125
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRTIGYRAPEVTETRKASQK 514
H ++K SN+L+ + D G++ + + + T Y +PE + S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV--FDVELLKYQDV 572
SD++S G+ L+EM G+ P+ ++ + E L Y
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKM---DDVVRMIEQIQQPELRNRAS 617
+ + ++ V + P P + + + RA
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 2e-45
Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 41/286 (14%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVV 393
+V+G G +G L + V +K L+ K R+F + ++G H NV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVI 90
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ +M GSL L +N + + G A G+ ++
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLAD 146
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---------TIGYRAPE 504
+ H ++ + N+L+ +L +SD GL+ + T+ I + APE
Sbjct: 147 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
+ RK + SDV+S+G+++ E+++ G+ P + DV++ + R +
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN---AIEQDYRLPPPMDCPS 260
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ Q+ L C K + RPK +V ++++ +
Sbjct: 261 --------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-45
Identities = 54/276 (19%), Positives = 100/276 (36%), Gaps = 33/276 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPV 395
+G GSYG K DG +V K L + T K+ ++ ++ + KH N+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 68
Query: 396 RAYYYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ + V Y G L ++ + + LD +++ + H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHR 127
Query: 454 EG--GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN----FPTTATRTIGYRAPEVTE 507
G H ++K +NV L N + D GLA ++N F T Y +PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD-LPRWVRSVVREEWTAEVFDVEL 566
++KSD++S G LL E+ P ++ + + ++ E+ +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE--- 244
Query: 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
I + RP +++++
Sbjct: 245 ---------------IITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 54/293 (18%), Positives = 113/293 (38%), Gaps = 45/293 (15%)
Query: 328 NFDLEDLLRASAEVLGKGSYGSTYKAIL---EDGTTVVVKRLREVA--ATKREFEQQMEV 382
N + D+ LG G++GS + + + V +K L++ A E ++ ++
Sbjct: 9 NLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 383 VGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIAL 442
+ + + +V + + + ++V G L L R + + ++ ++
Sbjct: 63 MHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLH 116
Query: 443 GTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-------TTAT 495
+ G+ ++ + F H ++ + NVLL ISD GL+ + +
Sbjct: 117 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 496 RTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVR 554
+ + APE RK S +SDV+S+GV + E L+ G+ P + +V+ ++ R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR 230
Query: 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
E E ++ + C + RP V + +
Sbjct: 231 MECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 41/291 (14%)
Query: 322 LDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQM 380
DG + FD +G+GS+ + YK + E V L++ TK E ++
Sbjct: 6 NDGRFLKFD---------IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK 56
Query: 381 EVVGTIGK--HSNVVPVRAYYYS----KDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDW 434
E + H N+V + S K ++V M +G+L L R + +
Sbjct: 57 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKI 111
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLIN--FP 491
+G+ F+H+ H ++K N+ +T I D+GLA L F
Sbjct: 112 KVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170
Query: 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRS 551
T + APE+ E K + DVY+FG+ +LEM T + P +S + + R V S
Sbjct: 171 KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTS 227
Query: 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
V+ +V E+ +I C+ + D R + D++
Sbjct: 228 GVKPASFDKVAIPEV-------------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-44
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 46/297 (15%)
Query: 340 EVLGKGSYGSTYKAIL--------EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKH 389
+ LG+G++G A T V VK L+ A K + +ME++ IGKH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 390 SNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDG-----------GTALDWNSRM 438
N++ + V+ Y G+L L R G L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 439 KIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR-- 496
A ARG+ ++ S+ H ++ + NVL+T+D I+D GLA I+ +
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 497 ----TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV 552
+ + APE R + +SDV+SFGVLL E+ T V +L + ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFKLLKEG 253
Query: 553 VREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
R + + + ++ + C VP RP +V +++I
Sbjct: 254 HRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 3e-44
Identities = 54/271 (19%), Positives = 108/271 (39%), Gaps = 33/271 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE----FEQQMEVVGTIGKHSNVVP 394
+G GS+G+ Y A + + V +K++ E +++ + + +H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
R Y + +V Y + +L + L + G +G+A++HS
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSH 134
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEV---TETRKA 511
H ++K+ N+LL++ + D G A ++ + T + APEV + +
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571
K DV+S G+ +E+ K PL + + + + E A L+
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPA-------LQSGH 238
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
E + SC+ K+P RP + +++
Sbjct: 239 WSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-44
Identities = 59/269 (21%), Positives = 103/269 (38%), Gaps = 32/269 (11%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQM--EV-VGTIGKHSNVVPV 395
LGKG +G+ Y A + + +K L + K E Q+ EV + + +H N++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
Y++ ++ Y P G+++ L + D A +++ HS+
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKR 126
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--TIGYRAPEVTETRKASQ 513
H +IK N+LL I+D G + T T+ Y PE+ E R +
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
K D++S GVL E L GK P + + + + V + T D
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD---------- 233
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+ + P RP + +V+
Sbjct: 234 --------LISRLLKHNPSQRPMLREVLE 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-44
Identities = 65/301 (21%), Positives = 111/301 (36%), Gaps = 49/301 (16%)
Query: 321 FLDGSYFNFDLEDLLRASAEVLGKGSYGSTYKAILED---GTTVVVKRLREVA---ATKR 374
+LD LED + LG G++G+ K + TV VK L+ A A K
Sbjct: 2 YLDRKLLT--LED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 53
Query: 375 EFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDW 434
E + V+ + + +V + + ++V G L L +NR +
Sbjct: 54 ELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-----VKD 106
Query: 435 NSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491
+ +++ + G+ ++ F H ++ + NVLL ISD GL+ +
Sbjct: 107 KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLP 546
T + + APE K S KSDV+SFGVL+ E + G+ P + +V +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM- 222
Query: 547 RWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQ 606
+ R A +M + C ++RP V +
Sbjct: 223 --LEKGERMGCPAGCPR--------------EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
Query: 607 I 607
Sbjct: 267 Y 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 60/303 (19%), Positives = 113/303 (37%), Gaps = 39/303 (12%)
Query: 340 EVLGKGSYGSTYKAIL------EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSN 391
LG+GS+G Y+ + E T V +K + E A+ + EF + V+ +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 84
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGG-----TALDWNSRMKIALGTAR 446
VV + LV+ M G L L R + +++A A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 447 GIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN------FPTTATRTIGY 500
G+A++++ F H ++ + N ++ +D I D G+ I + +
Sbjct: 145 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 501 RAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAE 560
+PE + + SDV+SFGV+L E+ T ++ + R+V +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVMEGGLLDKPDN 259
Query: 561 VFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRASSGT 620
D + ++ C P RP +++ I++ +P R + +
Sbjct: 260 CPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
Query: 621 ESN 623
E N
Sbjct: 306 EEN 308
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-42
Identities = 59/285 (20%), Positives = 112/285 (39%), Gaps = 41/285 (14%)
Query: 340 EVLGKGSYGSTYKAILE----DGTTVVVKRLREVAATK----REFEQQMEVVGTIGKHSN 391
E LG GS+G + + +V VK L+ ++ +F +++ + ++ H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 72
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
++ + + K+V P GSL L +++ + + A+ A G+ ++
Sbjct: 73 LIRLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYL 127
Query: 452 HSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------FPTTATRTIGYRAPE 504
S+ F H ++ + N+LL I D GL + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 505 VTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
+TR S SD + FGV L EM T G+ P ++ + +E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKE-------G 231
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608
L + +D +++ + + C A P+ RP + + + Q
Sbjct: 232 ERLPRPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 44/296 (14%)
Query: 340 EVLGKGSYGSTYKAI------LEDGTTVVVKRLRE--VAATKREFEQQMEVVGTIGKHSN 391
+ LG+G++G +A TV VK L+E + R +++++ IG H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 392 VVPVRAYYYSKDEKL-VVYSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMK 439
VV + L V+ + G+L L R++ L +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 440 IALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR--- 496
+ A+G+ F+ S H ++ + N+LL++ I D GLA I R
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 497 ---TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVV 553
+ + APE R + +SDV+SFGVLL E+ + A + G + R ++
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLKEGT 254
Query: 554 REEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
R + +M Q L C P RP ++V + + Q
Sbjct: 255 RMRA--------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 58/269 (21%), Positives = 108/269 (40%), Gaps = 31/269 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE-FEQQMEVVGTIGKHSNVVPVRA 397
E +G+G+ G+ Y A+ + G V ++++ K+E ++ V+ K+ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
Y DE VV Y+ GSL ++ D + + + F+HS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALEFLHSNQ-- 136
Query: 458 KFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEVTETRKASQ 513
H +IKS N+LL D + ++D G I +T T + APEV +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
K D++S G++ +EM+ G+ P + + + L + EL + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATN----------GTPELQNPEKLS 243
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
L C+ + R ++++
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 50/283 (17%), Positives = 103/283 (36%), Gaps = 36/283 (12%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVV 393
+G+G +G ++ I V +K + + + +F Q+ + H ++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 71
Query: 394 PVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
+ +++ ++ G L L + +LD S + A + +A++ S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES 126
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TTATRTIGYRAPEVTET 508
+ F H +I + NVL++ + + D GL+ + + I + APE
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568
R+ + SDV+ FGV + E+L D+ + + R
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQ--GVKNNDVIGRIENGERLPMPPNCPP----- 236
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611
+ + C A P RP+ ++ + I + E
Sbjct: 237 ---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (381), Expect = 3e-41
Identities = 47/268 (17%), Positives = 111/268 (41%), Gaps = 29/268 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE-FEQQMEVVGTIGKHSNVVPVRA 397
E LG G++G ++ G K + + +E ++++ + + +H +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 90
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
+ +E +++Y +M G LF + + + + ++ +G+ +H
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 458 KFTHGNIKSSNVLLTQDLNGCI--SDVGLAHLINFPTTATRTIG---YRAPEVTETRKAS 512
+ H ++K N++ T + + D GL ++ + T G + APEV E +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572
+D++S GVL +L+G +P D+ +R+V +W ++ + +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN-----MDDSAFSGI 252
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKMDDV 600
E+ ++ + P++R +
Sbjct: 253 SEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-40
Identities = 54/273 (19%), Positives = 104/273 (38%), Gaps = 34/273 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR--EVAATKREFEQQMEVVGTIGKHSNVVPVR 396
+ LG+G+YG A+ V VK + ++++ + + H NVV
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFY 69
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ + + + Y G LF + + + + G+ ++H G
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR------TIGYRAPEVTETRK 510
TH +IK N+LL + N ISD GLA + + T+ Y APE+ + R+
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 511 -ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569
++ DV+S G++L ML G+ D + W +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN-----------PW 229
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+ ++ + +L + + P +R + D+ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 50/286 (17%), Positives = 109/286 (38%), Gaps = 35/286 (12%)
Query: 328 NFDLEDLLRASAEVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE-FEQQMEVVGT 385
+ + ED LG G++G YKA E K + + + E + +++++ +
Sbjct: 7 DLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 65
Query: 386 IGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTA 445
H N+V + +Y ++ ++ + G++ ++ L + + T
Sbjct: 66 C-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTL 120
Query: 446 RGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTI----GYR 501
+ ++H H ++K+ N+L T D + ++D G++ + +
Sbjct: 121 DALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 502 APEV-----TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREE 556
APEV ++ R K+DV+S G+ L+EM + P V + + + E
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE 231
Query: 557 WTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
L + L+ C+ K D+R +++
Sbjct: 232 P------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 57/303 (18%), Positives = 117/303 (38%), Gaps = 41/303 (13%)
Query: 340 EVLGKGSYGSTYKAIL-----EDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNV 392
+VLG G++G+ YK + + V +K LRE + K +E + V+ ++ + +V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 73
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + +L+ MP G L + ++ + + + A+G+ ++
Sbjct: 74 CRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLE 128
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVT 506
H ++ + NVL+ + I+D GLA L+ I + A E
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 507 ETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565
R + +SDV+S+GV + E++T G P ++ + + R
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERLPQPPICTI-- 240
Query: 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI-QQPELRNRASSGTESNV 624
+ I + C DSRPK +++ ++ + P+ ++
Sbjct: 241 ------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 625 QTP 627
+P
Sbjct: 289 PSP 291
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 48/287 (16%), Positives = 115/287 (40%), Gaps = 34/287 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
E LG+G +G ++ + T + K ++ + ++++ ++ +H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
+ S +E ++++ ++ +F ++ + L+ + + F+HS
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN--- 122
Query: 459 FTHGNIKSSNVLLTQDLNG--CISDVGLAHLINFP---TTATRTIGYRAPEVTETRKASQ 513
H +I+ N++ + I + G A + Y APEV + S
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
+D++S G L+ +L+G P + + + +++ E+T FD E K ++
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT---FDEEAFK--EIS 231
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR------MIEQIQQPELRN 614
E + + + K SR + ++ IE++ +R
Sbjct: 232 IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 1e-38
Identities = 45/281 (16%), Positives = 96/281 (34%), Gaps = 42/281 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR----------EVAATKREFEQQMEVVGTIGK 388
E+LG+G + I VK + EV + ++++++ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
H N++ ++ Y + +V+ M G LF L + L KI I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVI 123
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG--------- 499
+H H ++K N+LL D+N ++D G + ++ G
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 500 YRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA 559
++ D++S GV++ +L G P H + +R ++
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIMSGN--- 231
Query: 560 EVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
+ ++ D + + ++ + P R ++
Sbjct: 232 --YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (362), Expect = 2e-38
Identities = 50/270 (18%), Positives = 103/270 (38%), Gaps = 29/270 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-EVAATKREFEQQMEVVGTIGKHSNVVPVRA 397
E LG G++G ++ + G V K + K + ++ ++ + H ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 93
Query: 398 YYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGA 457
+ K E +++ ++ G LF + + + G+ +H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS-- 147
Query: 458 KFTHGNIKSSNVLLTQDLNG--CISDVGLAHLINFPTTA---TRTIGYRAPEVTETRKAS 512
H +IK N++ I D GLA +N T T + APE+ +
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 513 QKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572
+D+++ GVL +L+G +P + +++V R +W FD + + V
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---FDEDA--FSSV 255
Query: 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
E ++ + + K P R + D +
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-38
Identities = 55/286 (19%), Positives = 106/286 (37%), Gaps = 34/286 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+VLG G G + +K L++ +RE E + ++V +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS----QCPHIVRIVDV 73
Query: 399 YYSKDEK----LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
Y + L+V + G LF + G A +I I ++HS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 455 GGAKFTHGNIKSSNVLLTQDLNG---CISDVGLAHLI---NFPTTATRTIGYRAPEVTET 508
H ++K N+L T ++D G A N TT T Y APEV
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568
K + D++S GV++ +L G P + + P + + ++ +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY--SNHGLAISPGMKTRIRMGQ-----YEFPNPE 240
Query: 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR---MIEQIQQPE 611
+ +V EE+ +++ + + P R + + + +++ + P+
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 41/285 (14%), Positives = 100/285 (35%), Gaps = 36/285 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK---HSNVVPV 395
++LG+GS+ + A L +K L + K + + H V +
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ ++ SY G L + + S D + ++H +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLHGK- 127
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT------IGYRAPEVTETR 509
H ++K N+LL +D++ I+D G A +++ + R Y +PE+ +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 510 KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569
A + SD+++ G ++ +++ G P + + + +++ E+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLEYDFP--------- 230
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614
+ + +++ + R +++ P +
Sbjct: 231 EKFFPKARDLVE---KLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 3e-36
Identities = 38/287 (13%), Positives = 85/287 (29%), Gaps = 36/287 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+G+GS+G ++ L + V +K + + + + + + V +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
++V + +L R + A + IH +
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 459 FTHGNIKSSNVLLTQDLNG-----CISDVGLAHLINFPTTATR-----------TIGYRA 502
+ +IK N L+ + + + D G+ P T T Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 503 PEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562
R+ S++ D+ + G + + L G P Q + + E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
EE + + D+ P D + + ++ +
Sbjct: 242 A-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 2e-35
Identities = 50/269 (18%), Positives = 97/269 (36%), Gaps = 26/269 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE--FEQQMEVVGTIGKHSNVVPVR 396
+VLG G++ A V +K + + A +E E ++ V+ I KH N+V +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALD 73
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
Y S ++ + G LF + ++ + ++H G
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLGI 128
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TIGYRAPEVTETRKASQ 513
L +D ISD GL+ + + + + T GY APEV + S+
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 514 KSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573
D +S GV+ +L G P + E+ ++ + + D+
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLF-----------EQILKAEYEFDSPYWDDIS 237
Query: 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVR 602
+ ++ + K P+ R + ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 38/288 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKRE----FEQQMEVVGTIGKHSNVVP 394
++LGKGS+G + A + +K L++ + + V+ +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 395 VRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE 454
+ + +K+ V Y+ G L + D + A G+ F+HS+
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSK 122
Query: 455 GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEVTETRK 510
G + ++K N+LL +D + I+D G+ T T Y APE+ +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 511 ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570
+ D +SFGVLL EML G++P +++ R E D+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL------ 233
Query: 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM---IEQIQQPELRNR 615
+V++ + P+ R + +R +I EL +
Sbjct: 234 -----LVKLFV-------REPEKRLGVRGDIRQHPLFREINWEELERK 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 1e-34
Identities = 45/283 (15%), Positives = 86/283 (30%), Gaps = 34/283 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+G GS+G Y + G V +K V + + ++ + + +R
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 399 YYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAK 458
D ++V + + +R + + +A I +IHS+
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 459 FTHGNIKSSNVLLTQDLNG---CISDVGLAHLINFPTTATR-----------TIGYRAPE 504
F H ++K N L+ G I D GLA T T Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
+ S++ D+ S G +L+ G P Q ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------YERISEKKMSTP 236
Query: 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607
+ + E L C + D +P + ++ +
Sbjct: 237 IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 129 bits (325), Expect = 3e-34
Identities = 54/286 (18%), Positives = 106/286 (37%), Gaps = 40/286 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK----REFEQQMEVVGTIGKHSNVVP 394
E+LG G + A L V VK LR A F ++ + + H +V
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVA 71
Query: 395 VRAYYYSKDEKL----VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V ++ +V Y+ +L ++H + +++ + + F
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNF 126
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-------TTATRTIGYRAP 503
H G H ++K +N++++ + D G+A I T Y +P
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 504 EVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
E +SDVYS G +L E+LTG+ P V VRE+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---- 233
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK-MDDVVRMIEQIQ 608
+++ + ++ ++ +AK P++R + ++ + ++
Sbjct: 234 -PSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 57/298 (19%), Positives = 104/298 (34%), Gaps = 34/298 (11%)
Query: 340 EVLGKGSYGSTYKA--ILEDGTTVVVKRLREVAATKREFEQQMEVVGTI-----GKHSNV 392
+G+G+YG +KA + G V +KR+R + + V + +H NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 393 VPVRAYYYSKDEKLVVYSYMP----AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
V + + L L + G + + + RG+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR---TIGYRAPEV 505
F+HS H ++K N+L+T ++D GLA + +F T T+ YRAPEV
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 506 TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565
+ D++S G + EM K + S D + V + EE +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 566 LLKYQDVEEEMVQMLQIALS---------CVAKVPDSRPKMDDV-----VRMIEQIQQ 609
+ + ++ + C+ P R + +E+ ++
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 128 bits (323), Expect = 3e-33
Identities = 51/280 (18%), Positives = 105/280 (37%), Gaps = 35/280 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTI------GKHSNV 392
++G+G +G Y + G +K L + ++ E + G +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
V + +++ D+ + M G L L ++ A G+ +H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMH 124
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--NFPTTATRTIGYRAPEVTETRK 510
+ + ++K +N+LL + + ISD+GLA P + T GY APEV +
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 511 A-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569
A +D +S G +L ++L G +P + D ++ R ++ E
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------ 229
Query: 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
E+ +L+ + + + R R +++++
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVKE 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 8e-33
Identities = 55/296 (18%), Positives = 110/296 (37%), Gaps = 40/296 (13%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-------EVAATKREFEQQMEVVGTIGKHSN 391
E LG G + K G K ++ ++ + E+++ ++ I +H N
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 74
Query: 392 VVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFI 451
V+ + Y +K + +++ + G LF L S L + G+ ++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYL 129
Query: 452 HSEGGAKFTHGNIKSSNVLLTQD----LNGCISDVGLAHLINFPTTATRTIG---YRAPE 504
HS + H ++K N++L I D GLAH I+F G + APE
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 505 VTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
+ ++D++S GV+ +L+G +P + + V +E+
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239
Query: 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPELRNRASS 618
+ + ++ + K P R + D ++ I+ + + A S
Sbjct: 240 ----FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWS 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 123 bits (310), Expect = 4e-32
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 28/282 (9%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLR---EVAATKREFEQQMEVVGTIGKHSNVVPVR 396
E +G+G+YG YKA G T +K++R E +++ ++ + KHSN+V +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
++K ++V+ ++ +L L+ + L GIA+ H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT----IGYRAPEV-TETRKA 511
H ++K N+L+ ++ I+D GLA P + YRAP+V ++K
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV----------DLPRWVRSVVREEWTAEV 561
S D++S G + EM+ G D + + W ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 562 FDVELLKYQDVEEEM-VQMLQIALSCVAKVPDSRPKMDDVVR 602
E L ++ + + + + + P+ R +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 64/299 (21%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
+V+G GS+G Y+A L + G V +K++ + KR ++++++ + H N+V +R +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKL-DHCNIVRLRYF 81
Query: 399 YYSKDEK------LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+YS EK +V Y+P + H +R+ L R +A+IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIH 139
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLI---NFPTTATRTIGYRAP-EVTE 507
S G H +IK N+LL D + D G A + + + YRAP +
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV------ 561
+ DV+S G +L E+L G+ D + V E E+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 562 FDVELLKYQDVEEEMV-----QMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPELR 613
F +K + + + + + P +R + ++++ P ++
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 57/294 (19%), Positives = 116/294 (39%), Gaps = 32/294 (10%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVR 396
E +G+G+YG YKA G V +K++R T+ + + + + H N+V +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+++++ +V+ ++ + + + +G+AF HS
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----TTATRTIGYRAPEV-TETRKA 511
+ H ++K N+L+ + ++D GLA P T T+ YRAPE+ +
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY-- 569
S D++S G + EM+T +A G ++ L R R++ + + Y
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFP--GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 570 -------QDVEEEMVQMLQIALS----CVAKVPDSRPKMDDVVRM--IEQIQQP 610
QD + + + + S + P+ R + + + +P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 50/287 (17%), Positives = 97/287 (33%), Gaps = 46/287 (16%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR-------EVAATKREFEQQMEVVGTI-GKHS 390
+LG G +GS Y I + D V +K + ++ ++ + S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
V+ + ++ D +++ R AL +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGC-ISDVGLAHLIN--FPTTATRTIGYRAPEVTE 507
H+ G H +IK N+L+ + + D G L+ T T Y PE
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 508 TRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566
+ + + V+S G+LL +M+ G P +H E+ ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEIIRGQV 221
Query: 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPE 611
Q V E +++ C+A P RP +++ ++ + P+
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 54/305 (17%), Positives = 116/305 (38%), Gaps = 46/305 (15%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK--REFEQQMEVVGTIGKHSNVVPVR 396
+G+G+YG A + V +K++ + ++++++ +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGIN 72
Query: 397 AYYYSKDEKLVVYSYM----PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + + Y+ L+ LL L + RG+ +IH
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH 126
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN-------FPTTATRTIGYRAPEV 505
S H ++K SN+LL + I D GLA + + F T T YRAPE+
Sbjct: 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 506 -TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
++ ++ D++S G +L EML+ + + D ++ + +E + ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 565 ELLKYQ----------------DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQ 606
+ Y + + + + +L + P R +++ + +EQ
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 607 IQQPE 611
P
Sbjct: 301 YYDPS 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 3e-30
Identities = 48/230 (20%), Positives = 95/230 (41%), Gaps = 13/230 (5%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQME---VVGTIGKHSNVVPV 395
LG GS+G + +G +K L++ + + + ++ +I H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ + ++ Y+ G LF LL +++ A + ++HS+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSKD 124
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI-NFPTTATRTIGYRAPEVTETRKASQK 514
+ ++K N+LL ++ + I+D G A + + T T Y APEV T+ ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
D +SFG+L+ EML G P S + + +V D+
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 3e-28
Identities = 49/289 (16%), Positives = 108/289 (37%), Gaps = 37/289 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATK------REFEQQMEVVGTIGKHSNV 392
+ LG+G + + YKA V +K+++ ++ R ++++++ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62
Query: 393 VPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIH 452
+ + + K +V+ +M ++ + L + L T +G+ ++H
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLH 117
Query: 453 SEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEV-TE 507
H ++K +N+LL ++ ++D GLA P A T YRAPE+
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV-------------DLPRWVRSVVR 554
R D+++ G +L E+L L D + P
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 555 EEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603
+ + + ++++ ++Q P +R ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 4e-28
Identities = 42/230 (18%), Positives = 82/230 (35%), Gaps = 13/230 (5%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQM--EV-VGTIGKHSNVVPV 395
+ LG GS+G E G +K L + K + + E + +V +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ +V Y+ G +F L R A ++HS
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLD 161
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLA-HLINFPTTATRTIGYRAPEVTETRKASQK 514
+ ++K N+L+ Q ++D G A + T T APE+ ++ ++
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564
D ++ GVL+ EM G P + + + +++++ D+
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 54/292 (18%), Positives = 109/292 (37%), Gaps = 24/292 (8%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVR 396
+ +G G+YG+ A+ G V +K+L ++ ++ + + H NV+ +
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ + + L + + +G+ +IH+ G
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAAG- 141
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATRTIGYRAPEV-TETRKASQK 514
H ++K N+ + +D I D GLA + T T YRAPEV + +Q
Sbjct: 142 --IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQT 199
Query: 515 SDVYSFGVLLLEMLTGKAPLQHSGHDDVVDL---------PRWVRSVVREEWTAEVFDVE 565
D++S G ++ EM+TGK + S H D + +V+ + +E + +
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259
Query: 566 LLKYQDVEEEMVQMLQIAL----SCVAKVPDSRPKMDDVVRM--IEQIQQPE 611
L+ +D + +A+ + + R + + E + E
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 51/278 (18%), Positives = 96/278 (34%), Gaps = 36/278 (12%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK---HSNVVPV 395
++LGKG++G G +K LR+ ++ + + H + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 396 RAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG 455
+ + + D V Y G LF L R R + ++HS
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRD 125
Query: 456 GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATR----TIGYRAPEVTETRKA 511
+ +IK N++L +D + I+D GL + T Y APEV E
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571
+ D + GV++ EM+ G+ P + H+ + +L + E +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL------- 235
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
+ +L+ K P R +++ +
Sbjct: 236 ----LAGLLK-------KDPKQRLGGGP--SDAKEVME 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 1e-27
Identities = 45/286 (15%), Positives = 109/286 (38%), Gaps = 22/286 (7%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAY 398
LG+G Y ++AI + + VVVK L+ V K++ +++++++ + N++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98
Query: 399 YYSKDEKLV--VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+ V+ ++ L L + + + HS G
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG- 149
Query: 457 AKFTHGNIKSSNVLLT-QDLNGCISDVGLAHLINFPTTATRTIG---YRAPEVTETRKA- 511
H ++K NV++ + + D GLA + + ++ PE+ +
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 512 SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571
D++S G +L M+ K P H GHD+ L R + + E+ + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRNRAS 617
+ + + + + + + ++++ + + ++R +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-26
Identities = 52/283 (18%), Positives = 102/283 (36%), Gaps = 28/283 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIG--KHSNVVPVR 396
E +G+G+YG+ +KA E V +KR+R + + + + KH N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 397 AYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGG 456
+S + +V+ + N D +G+ F HS
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTAT----RTIGYRAPEVTETRKA- 511
H ++K N+L+ ++ +++ GLA P T+ YR P+V K
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 512 SQKSDVYSFGVLLLEMLTGKAPL-QHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570
S D++S G + E+ PL + DD + + EE + + K
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 571 DVEEEMVQMLQIA-----------LSCVAKVPDSRPKMDDVVR 602
+ ++ + + + P R ++ ++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 52/286 (18%), Positives = 105/286 (36%), Gaps = 40/286 (13%)
Query: 340 EVLGKGSYGSTYKAIL----EDGTTVVVKRLREVAATKRE-----FEQQMEVVGTIGKHS 390
+VLG G+YG + + G +K L++ ++ + +V+ I +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 391 NVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+V + + ++ + ++ Y+ G LF L + + +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEH 144
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRT-----IGYRAPEV 505
+H G + +IK N+LL + + ++D GL+ T I Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 506 --TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563
+ D +S GVL+ E+LTG +P G + E + +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-----------AEISRRILK 250
Query: 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609
E Q++ ++Q + K P R R ++I++
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 5e-25
Identities = 56/285 (19%), Positives = 107/285 (37%), Gaps = 34/285 (11%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR---EVAATKREFEQQMEVVGTIGKHSNVVPV 395
+G G+YGS A + G V VK+L + + +++ ++ + KH NV+ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL 82
Query: 396 RAYYYSKD-----EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + + +++ L ++ + L + + RG+ +
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKY 136
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATRTIGYRAPEVT-ET 508
IHS H ++K SN+ + +D I D GLA + T T YRAPE+
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 509 RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568
+Q D++S G ++ E+LTG+ + H D + L + E ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 569 YQDVEEEMVQM-------------LQIALSCVAKVPDSRPKMDDV 600
Y +M +M + + + D R
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-24
Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 44/296 (14%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLR---EVAATKREFEQQMEVVGTIGKHSNVVPV 395
+G+G++G +KA + G V +K++ E ++++++ + KH NVV +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 74
Query: 396 RAYYYSKDEK--------LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARG 447
+K +V+ + +L + + ++ G
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQMLLNG 129
Query: 448 IAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI--------NFPTTATRTIG 499
+ +IH H ++K++NVL+T+D ++D GLA N T T+
Sbjct: 130 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 500 YRAPEV-TETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558
YR PE+ R D++ G ++ EM T +Q + + L + + E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 559 AEVFDVELLKYQDVEEEMVQMLQIAL--------------SCVAKVPDSRPKMDDV 600
V + EL + ++ + + ++ L + P R DD
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (243), Expect = 8e-23
Identities = 48/302 (15%), Positives = 96/302 (31%), Gaps = 53/302 (17%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTIGK--HSNVVPVR 396
+ +G G+ G A V +K+L + ++ + + H N++ +
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 397 AYYYSKD------EKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAF 450
+ + + +V M A ++ D + GI
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 451 IHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIG---YRAPEVTE 507
+HS H ++K SN+++ D I D GLA T + YRAPEV
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 508 TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD----------------------- 544
+ D++S G ++ EM+ K + D +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 545 ----LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDV 600
P++ + + +F + + + +L + P R +DD
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDA 308
Query: 601 VR 602
++
Sbjct: 309 LQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 38/214 (17%), Positives = 79/214 (36%), Gaps = 20/214 (9%)
Query: 340 EVLGKGSYGSTYKAI-LEDGTTVVVKRLREVAATKREFEQQMEVVGTI----------GK 388
LG G + + + A + + T V +K +R E +++++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 389 HSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGI 448
++++ + ++ K V + LL + + +I+ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 449 AFIHSEGGAKFTHGNIKSSNVLLTQ-DLNGCISDVGLAHLINFPTTATRTI------GYR 501
++H G H +IK NVL+ D + + +A L N YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 502 APEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQ 535
+PEV +D++S L+ E++TG +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 3e-16
Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 22/85 (25%)
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPD 204
DL N G +P G L LH LN+ N++ G IP NL R + ++NN
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC------ 303
Query: 205 SLQTFPNSSFVGNSMLCGLPLTPCS 229
LCG PL C+
Sbjct: 304 ---------------LCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.2 bits (183), Expect = 2e-15
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 8/179 (4%)
Query: 29 SDKQALLDFADAVPHARKL-NWNAAAPVC-SSWIGVTCNVNRS--RVIGIHLPGIGFTGP 84
DKQALL + + L +W C +W+GV C+ + RV + L G+ P
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 85 IP-ANSIGKLDALKILSLRSNY-LNGTLPSDITSISSLQYVYLQNNYFSGVLP--AFRSL 140
P +S+ L L L + L G +P I ++ L Y+Y+ + SG +P +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
L LD S+NA +G +PP +L L + N ISGAIP K+ + N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 16/58 (27%), Positives = 26/58 (44%), Gaps = 1/58 (1%)
Query: 101 LRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ-LNALDLSFNAFTGNIP 157
LR+N + GTLP +T + L + + N G +P +LQ + + N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 4/83 (4%)
Query: 56 CSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDIT 115
S + + G+ L G +P + +L L L++ N L G +P
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288
Query: 116 SISSLQYVYLQNNYF--SGVLPA 136
++ NN LPA
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPA 311
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 5e-15
Identities = 29/143 (20%), Positives = 49/143 (34%), Gaps = 25/143 (17%)
Query: 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISS-------------- 119
+ L + P + L L L L +N ++ P + +
Sbjct: 246 LDLANNQISNLAP---LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 120 ------LQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQN 173
L Y+ L N S + P +L L + N + NLT ++ L+ +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 174 NSISGAIPPLNLPRLKILNFSNN 196
N IS P NL R+ L ++
Sbjct: 361 NQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 1e-12
Identities = 37/151 (24%), Positives = 54/151 (35%), Gaps = 27/151 (17%)
Query: 81 FTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL 140
+ P + L LSL N L + S+++L + L NN S + P
Sbjct: 209 ISDITPLGILTNL---DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 263
Query: 141 QLNALDLSFNAFTGNIP--------------------PGFQNLTRLHLLNLQNNSISGAI 180
+L L L N + P NL L L L N+IS
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 323
Query: 181 PPLNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
P +L +L+ L F+NN ++ SL N
Sbjct: 324 PVSSLTKLQRLFFANNKVSD--VSSLANLTN 352
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 5e-08
Identities = 16/110 (14%), Positives = 40/110 (36%), Gaps = 5/110 (4%)
Query: 42 PHARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSL 101
P A + ++ N + + L + P + L L+ L
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFF 336
Query: 102 RSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNA 151
+N ++ S + +++++ ++ +N S + P ++ L L+ A
Sbjct: 337 ANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 26/116 (22%), Positives = 37/116 (31%), Gaps = 23/116 (19%)
Query: 82 TGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ 141
T P N I AL L T +D S + L Q
Sbjct: 7 TQDTPINQIFTDTALA--EKMKTVLGKTNVTDTVSQTDLD-------------------Q 45
Query: 142 LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNN 197
+ L +I G + L L +N NN ++ P NL +L + +NN
Sbjct: 46 VTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 17/61 (27%), Positives = 21/61 (34%), Gaps = 4/61 (6%)
Query: 144 ALDLSFNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSI 202
L T + +T L L SI G + L L +NFSNN L
Sbjct: 26 KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-VE--YLNNLTQINFSNNQLTDIT 82
Query: 203 P 203
P
Sbjct: 83 P 83
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-11
Identities = 27/196 (13%), Positives = 63/196 (32%), Gaps = 19/196 (9%)
Query: 340 EVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYY 399
+++G+G + + E VVK + + ++ +++ + G V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRD----YGDLHFSVLAIRSA 61
Query: 400 YSKDEKLV------VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS 453
++ L V +L+ + + + ++ +A +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 454 EGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTTATRTIGYRAPEVTET---RK 510
HG++ NVL++ + I D + + R I R T R
Sbjct: 122 R---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--WREILERDVRNIITYFSRT 175
Query: 511 ASQKSDVYSFGVLLLE 526
+ D+ S +L+
Sbjct: 176 YRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.7 bits (151), Expect = 2e-11
Identities = 39/202 (19%), Positives = 60/202 (29%), Gaps = 39/202 (19%)
Query: 56 CS-SWIGVTCNVNRSRVIGIHLP---------GIGFTGPIPANSIGKLDALKILSLRSNY 105
C V C+ + LP T I L L L L +N
Sbjct: 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNK 66
Query: 106 LNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFT------------ 153
++ P + L+ +YL N LP L L + N T
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 154 --------------GNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
G FQ + +L + + + +I+ IP P L L+ N +
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKIT 184
Query: 200 GSIPDSLQTFPNSSFVGNSMLC 221
SL+ N + +G S
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNS 206
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 29/108 (26%), Positives = 40/108 (37%), Gaps = 4/108 (3%)
Query: 119 SLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG 178
L+ V + V P LDL N T F+NL LH L L NN IS
Sbjct: 11 HLRVVQCSDLGLEKV-PKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 179 AIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLP 224
P L +L+ L S N L +P+ + V + + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVR 116
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 32/207 (15%), Positives = 64/207 (30%), Gaps = 39/207 (18%)
Query: 27 LNSDKQALLDFADAVPHARKLNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIP 86
L K L + + +P + + V +N+ V+ + + +G
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 87 ANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRSLQLNA 144
+ + L + + + T+P + SL ++L N + V A L
Sbjct: 144 -GAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 145 LDLSFNAFTGNI-----------------------PPGFQNLTRLHLLNLQNNSISGAIP 181
L LSFN+ + P G + + ++ L NN+IS I
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA-IG 258
Query: 182 P---------LNLPRLKILNFSNNNLN 199
++ +N +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.0 bits (137), Expect = 1e-10
Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 9/121 (7%)
Query: 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNI 156
++L L L T+ + + + ++ L +N + PA +L+ L +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALR-CLEVLQASDNALEN 57
Query: 157 PPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNL---NGSIPDSLQTFP 210
G NL RL L L NN + + + PRL +LN N+L G + P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 211 N 211
+
Sbjct: 118 S 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 4e-08
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 9/110 (8%)
Query: 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148
+ +L + L L N L P+ + ++ L+ + +N V +L L L
Sbjct: 15 HLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 149 FNAFTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPL------NLPRLKIL 191
N + + RL LLNLQ NS+ + LP + +
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEMLPSVSSI 122
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (141), Expect = 3e-10
Identities = 32/164 (19%), Positives = 51/164 (31%), Gaps = 9/164 (5%)
Query: 47 LNWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYL 106
L+ + + + L + P ++ L L L L N +
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQAL------PDDTFRDLGNLTHLFLHGNRI 165
Query: 107 NGTLPSDITSISSLQYVYLQNNYFSGVLP-AFRSLQLNA-LDLSFNAFTGNIPPGFQNLT 164
+ + SL + L N + V P AFR L L L N + L
Sbjct: 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
Query: 165 RLHLLNLQNNSISGAIPPLNLPR-LKILNFSNNNLNGSIPDSLQ 207
L L L +N L L+ S++ + S+P L
Sbjct: 226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 6e-09
Identities = 18/71 (25%), Positives = 28/71 (39%), Gaps = 7/71 (9%)
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200
L L++S N +P L R L N ++ +P L LK L+ N L
Sbjct: 285 SLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPEL-PQNLKQLHVEYNPLR- 337
Query: 201 SIPDSLQTFPN 211
PD ++ +
Sbjct: 338 EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 3e-08
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 101 LRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGF 160
N + + S SL+ + + NN + L+ L SFN +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE--RLIASFNHLA-EVPELP 323
Query: 161 QNLTRLHLLNLQNNSISGAIP--PLNLPRLKILN 192
QNL +LH ++ N + P P ++ L++ +
Sbjct: 324 QNLKQLH---VEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 1e-06
Identities = 14/78 (17%), Positives = 34/78 (43%), Gaps = 7/78 (8%)
Query: 93 LDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAF 152
+L+ L++ +N L LP+ L+ + N+ + V ++L+ L + +N
Sbjct: 283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEVPELPQNLKQ--LHVEYNPL 336
Query: 153 TGNIPPGFQNLTRLHLLN 170
P +++ L + +
Sbjct: 337 RE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 6/67 (8%)
Query: 162 NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLC 221
L L N +S ++P L P L+ L S N+L +P+ Q+ + N++
Sbjct: 39 QAHEL---ELNNLGLS-SLPEL-PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 222 GLPLTPC 228
L P
Sbjct: 93 LSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 17/60 (28%), Positives = 27/60 (45%), Gaps = 6/60 (10%)
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNG 200
Q + L+L+ + ++P +L L NS++ +P L LK L NNNL
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 5e-08
Identities = 14/79 (17%), Positives = 24/79 (30%), Gaps = 11/79 (13%)
Query: 141 QLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAIP-------PLNLPRLK 189
L L L+ + + + L L+L NN + A L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 190 ILNFSNNNLNGSIPDSLQT 208
L + + + D LQ
Sbjct: 430 QLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 18/95 (18%)
Query: 119 SLQYVYLQNNYFSG-----VLPAFRSLQLNALDLSFNAFTG----NIPPGFQNLTRLHLL 169
+Q + +Q S +LP + Q + L T +I + L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQ--VVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 170 NLQNNSISGAIPPL-------NLPRLKILNFSNNN 197
NL++N + +++ L+ N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 24/156 (15%), Positives = 47/156 (30%), Gaps = 32/156 (20%)
Query: 48 NWNAAAPVCSSWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLN 107
A SS + + ++ L G L++L L ++
Sbjct: 324 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG-SVLRVLWLADCDVS 382
Query: 108 GT----LPSDITSISSLQYVYLQNNYFS--GVLPAFRSLQLNALDLSFNAFTGNIPPGFQ 161
+ L + + + SL+ + L NN G+L S++ Q
Sbjct: 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR-------------------Q 423
Query: 162 NLTRLHLLNLQNNSISGAIPPL------NLPRLKIL 191
L L L + S + + P L+++
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 12/53 (22%), Positives = 21/53 (39%), Gaps = 6/53 (11%)
Query: 160 FQNLTRLHLLNLQNNSISG----AIPPL--NLPRLKILNFSNNNLNGSIPDSL 206
Q + L +L L + +S ++ L+ L+ SNN L + L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 16/55 (29%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSN 195
+L L N + P +L L ++L+NN IS P N L I+ +N
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 111 PSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLL 169
+ + ++S L + +N S + SL L + L N + P N + L ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 170 NLQN 173
L N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 14/47 (29%), Positives = 22/47 (46%)
Query: 157 PPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
NL++L L +N IS P +LP L ++ NN ++ P
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 6/50 (12%), Positives = 18/50 (36%), Gaps = 2/50 (4%)
Query: 162 NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPN 211
L + ++++ + +L + L+ + +I +Q N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNN 64
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 8/60 (13%), Positives = 19/60 (31%), Gaps = 4/60 (6%)
Query: 141 QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLN 199
+ + T + +L + L+ ++ I + L L L +N +
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQIT 76
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 2e-06
Identities = 21/137 (15%), Positives = 45/137 (32%), Gaps = 5/137 (3%)
Query: 158 PGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215
+ N R L+L+ I I L L + ++FS+N + L + V
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70
Query: 216 GNSMLCGLPLTPCSTVSSSPSP--SPSYFPTISPHKNASRKKLNSGSIIAIAVGGCAVLF 273
N+ +C + + + + + + K + I +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 274 LLLALFFLCCLKKLDRQ 290
L ++ + ++ LD Q
Sbjct: 131 RLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 3e-05
Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 1/72 (1%)
Query: 140 LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199
++ LDL I L + ++ +N I L RLK L +NN +
Sbjct: 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRIC 76
Query: 200 GSIPDSLQTFPN 211
Q P+
Sbjct: 77 RIGEGLDQALPD 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 17/76 (22%), Positives = 25/76 (32%), Gaps = 1/76 (1%)
Query: 113 DITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQ 172
+++ ++S V + LP L LS N TRL LNL
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 173 NNSISGAIPPLNLPRL 188
++ LP L
Sbjct: 64 RAELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 13/54 (24%), Positives = 15/54 (27%), Gaps = 3/54 (5%)
Query: 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPP--LNLPRLKILNFSNNNLN 199
+ N T L L L LQ NS+ IP L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 85 IPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYF 130
+PA + L+ L L L+ N L T+P L + +L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 12/53 (22%), Positives = 23/53 (43%), Gaps = 3/53 (5%)
Query: 160 FQNLTRLHLLNLQNNSISGAIPPLNLPR-LKILNFSNNNLNGSIPDSLQTFPN 211
+ +N +++ A+PP +LP+ IL+ S N L +L +
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTR 56
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 17/105 (16%), Positives = 33/105 (31%), Gaps = 4/105 (3%)
Query: 127 NNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--- 183
N V S + A + + F + R+ ++L N+ I +
Sbjct: 10 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILS 68
Query: 184 NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLTPC 228
+L+ L+ L+ I ++L N + S G
Sbjct: 69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL 113
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 14/116 (12%)
Query: 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQ----LNAL 145
+ + +L+ RS+ TL +I L + L NN + +Q L L
Sbjct: 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 146 DLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---------NLPRLKILN 192
+LS N +L L L NS+S P+L L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 23/112 (20%), Positives = 37/112 (33%), Gaps = 10/112 (8%)
Query: 119 SLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG 178
S Q + L+ P + ++ + ++ + +N+ L LNL NN +
Sbjct: 23 SQQALDLKGLRS---DPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYR 79
Query: 179 AIPP----LNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSMLCGLPLT 226
P LKILN S N L + L G L+
Sbjct: 80 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL---WLDGNSLS 128
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.3 bits (83), Expect = 0.004
Identities = 20/75 (26%), Positives = 28/75 (37%), Gaps = 7/75 (9%)
Query: 140 LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISG-AIPPLNLPRLKILNFSNNNL 198
ALDL P +LN +++ + I N+P L LN SNN L
Sbjct: 22 GSQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 199 NG--SIPDSLQTFPN 211
+ +Q PN
Sbjct: 78 YRLDDMSSIVQKAPN 92
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 5e-05
Identities = 11/57 (19%), Positives = 21/57 (36%), Gaps = 3/57 (5%)
Query: 152 FTGNIPPG-FQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQ 207
+P F + +L++ I +P L LK L + +P +L+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNLKKLP-TLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 8e-05
Identities = 11/49 (22%), Positives = 16/49 (32%), Gaps = 4/49 (8%)
Query: 136 AFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL 183
F LD+S G +NL +L + N +P L
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 12/40 (30%), Positives = 16/40 (40%), Gaps = 2/40 (5%)
Query: 157 PPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSN 195
LT+L L L N IS + L L L +L +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 12/78 (15%), Positives = 24/78 (30%), Gaps = 2/78 (2%)
Query: 144 ALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIP 203
+L + T + L + + N+ I LP + L + N L P
Sbjct: 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKP 85
Query: 204 DSLQTFPNSSFVGNSMLC 221
+ F+ + +
Sbjct: 86 LANLKNLGWLFLDENKVK 103
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 12/68 (17%), Positives = 20/68 (29%), Gaps = 9/68 (13%)
Query: 159 GFQNLTRLHLLNLQNNSISGAIPPL-------NLPRLKILNFSNNNLN--GSIPDSLQTF 209
L L LQ N I +P L L + N + + D ++
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 210 PNSSFVGN 217
++ G
Sbjct: 328 FSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 11/70 (15%), Positives = 20/70 (28%), Gaps = 13/70 (18%)
Query: 121 QYVYLQNNYFSG--------VLPAFRSLQLNALDLSFNAFTGNIPPG-----FQNLTRLH 167
+ + L + S ++ L L L +N + + + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 168 LLNLQNNSIS 177
L L N S
Sbjct: 306 FLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 13/84 (15%)
Query: 142 LNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISG----AIPPL--NLPRLKIL 191
+ L +A T + + + L N+I + + L+I
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 192 NFSNN---NLNGSIPDSLQTFPNS 212
FS+ + IP++L+ +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQA 88
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.9 bits (89), Expect = 7e-04
Identities = 15/60 (25%), Positives = 21/60 (35%), Gaps = 8/60 (13%)
Query: 141 QLNALDLSFNAFTGNIPP------GFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNF 193
+ A + G IPP L L L N+I I L + L+IL+
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSL 77
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 9/58 (15%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 162 NLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVGNSM 219
L L +++ + +L ++ L + SI D ++ N + + S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.003
Identities = 10/35 (28%), Positives = 15/35 (42%)
Query: 157 PPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKIL 191
NLT L L++ +N +S L L+ L
Sbjct: 165 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 36.7 bits (83), Expect = 0.003
Identities = 36/177 (20%), Positives = 50/177 (28%), Gaps = 24/177 (13%)
Query: 56 CS-SWIGVTCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDI 114
C V C + I P IP + L L N L +
Sbjct: 6 CHCEGTTVDCTGRGLKEI----PR-----DIPLH-------TTELLLNDNELGRISSDGL 49
Query: 115 TSISSL--QYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPG-FQNLTRLHLLNL 171
+ +N AF I F L +L LNL
Sbjct: 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 172 QNNSISGAIPPL--NLPRLKILNFSNNNLNG--SIPDSLQTFPNSSFVGNSMLCGLP 224
+N IS +P +L L LN ++N N + + S G + CG P
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.65 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.63 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.6 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.59 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.34 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.27 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.2 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.17 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.76 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.69 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.29 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.28 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.19 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.07 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.01 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.59 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.72 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.73 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=399.25 Aligned_cols=247 Identities=22% Similarity=0.386 Sum_probs=198.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||+||+|++++++.||||+++......++|.+|++++.++ +||||++++|+|..++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 478999999999999999889999999987777788999999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
+++.... ..++|..++.++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9987542 46899999999999999999999998 999999999999999999999999999876432 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTG-KAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..||+.|+|||++.+..++.++|||||||++|||+|+ ++||... ........+...... ..+
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~~~---~~p-------- 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFRL---YKP-------- 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHHHHHHTCCC---CCC--------
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHHHHHhcCCC---CCc--------
Confidence 3478899999999999999999999999999999995 5555432 112222222211110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.....++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11223567888899999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=392.86 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=201.7
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||+||+|++++++.||||+++......++|.+|++++.++ +||||+++++++.+ +..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence 478999999999999999889999999987777788999999999999 99999999998754 5678999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
+++.... ...++|..+++++.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9886542 235899999999999999999999998 999999999999999999999999999877532 23
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..+|+.|+|||++.+..++.++|||||||++|||+||..|+.... ........+. ...... .....
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~-~~~~~~-------~p~~~- 235 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLE-RGYRMV-------RPDNC- 235 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHH-TTCCCC-------CCTTC-
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH-hcCCCC-------CcccC-
Confidence 457889999999998899999999999999999999666554321 1111122211 111100 11112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..++.+++.+||+.+|++||||+||++.|+++-.
T Consensus 236 --~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 2356778889999999999999999999998743
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=393.69 Aligned_cols=248 Identities=27% Similarity=0.439 Sum_probs=195.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+++ ..||||+++... ...+.|.+|++++.++ +||||+++++++.+ +..++||||+++|
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVTQWCEGS 88 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence 478999999999999875 369999986542 2356899999999999 99999999998754 5688999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.++++..+ ..+++..++.++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999997542 35999999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 --TTATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.... ..+.......... +.+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~----p~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLS----PDL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCC----CCG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----Ccc
Confidence 23458999999999864 35899999999999999999999999754321 1122222221111 111
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
... ......++.+++.+||+.+|++||||+||+++|+.+..
T Consensus 232 ~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 110 01122456678889999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-49 Score=393.45 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=206.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||+||+|+++ +++.||||+++......++|.+|+++++++ +||||++++++|.+.+..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 478999999999999976 588999999987777788999999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC----
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT---- 493 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~---- 493 (627)
.+++.... ...++|..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 99997643 356999999999999999999999998 99999999999999999999999999987754322
Q ss_pred -CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 -ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 -~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+++.|+|||++.+..++.++|||||||++|||++|..||.... .... +...+....... .....
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~-~~~~i~~~~~~~-------~~~~~ 241 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQ-VYELLEKDYRME-------RPEGC 241 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHH-HHHHHHTTCCCC-------CCTTC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHH-HHHHHhcCCCCC-------CCccc
Confidence 236788999999999999999999999999999999777764321 1111 111222211111 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 242 ---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 23567788899999999999999999999987543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=385.64 Aligned_cols=244 Identities=20% Similarity=0.362 Sum_probs=205.9
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||+||+|++++++.||||+++......++|.+|++++.++ +||||++++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 478999999999999999888999999988777888999999999999 9999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
.++.... ..+++..+.+++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9987543 35899999999999999999999998 999999999999999999999999999866432 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
..+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+....+. .... ...+ ..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~-~~~~--~~~p-----~~- 225 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIA-QGLR--LYRP-----HL- 225 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHH-TTCC--CCCC-----TT-
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHHH-hCCC--CCCc-----cc-
Confidence 447889999999999999999999999999999998 8999975432 12222222 1111 1111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQI 607 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 607 (627)
...++.+++.+||+.||++|||++|++++|.++
T Consensus 226 --~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 --ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 223567888899999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=394.64 Aligned_cols=247 Identities=22% Similarity=0.429 Sum_probs=193.8
Q ss_pred hcccCcCCceeEEEEEecC-C---cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED-G---TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||+||+|+++. + ..||||++..... ..++|.+|+++++++ +|||||+++|++..++..++||||+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEec
Confidence 4789999999999999752 2 2588998865432 346799999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT 492 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~ 492 (627)
++|+|.+++.... ..++|.+++.++.|+|.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 110 ~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 110 ENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp TTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999987542 35999999999999999999999998 9999999999999999999999999998764321
Q ss_pred ---------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 493 ---------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 493 ---------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ......+.......
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~~~~~--- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQDYRLP--- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC---
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCC---
Confidence 1235788999999999999999999999999999998 8999975432 12222222211110
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
...+...++.+++.+||+.+|++||||.||++.|+++.+.
T Consensus 254 --------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 --------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1112234567788899999999999999999999997543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=384.02 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=199.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..++||||+++|+
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 378999999999999964 69999999987543 4567899999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----C
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP----T 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~----~ 492 (627)
|.+++.+. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 104 L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp HHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred HHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99988653 4899999999999999999999998 999999999999999999999999999876432 3
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ............... ...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~~---------~~~ 239 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPEL---------QNP 239 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCCC---------SSG
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCCC---------CCc
Confidence 44589999999999999999999999999999999999999975321 122222222221110 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.....++.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112356678889999999999999999763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=383.26 Aligned_cols=238 Identities=25% Similarity=0.415 Sum_probs=199.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +++.||+|++... ....+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecC
Confidence 478999999999999975 6889999998643 23467889999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 90 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999865 35899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 492 TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... + ...
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~---~------p~~ 226 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEFT---F------PDF 226 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCCC---C------CTT
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC---C------Ccc
Confidence 33468999999999999999999999999999999999999997532 12222222221110 0 111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+ .++.+++.+||+.||++|||++|++++
T Consensus 227 ~s---~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 227 VT---EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp SC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CC---HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 22 345677889999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=387.39 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=193.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..++||||+++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 478999999999999975 68999999986542 2345789999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----- 490 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----- 490 (627)
+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 89 ~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 89 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999643 36999999999999999999999998 99999999999999999999999999987632
Q ss_pred -CCCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 -PTTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 -~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ........... .. .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~~~~~~~~~----~~---~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTY----LN---P 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHHHHHTTCTT----ST---T
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCCC----CC---c
Confidence 234568999999999987776 5789999999999999999999975432211 11111111100 00 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
....+ .++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKID---SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112 34567788999999999999999965
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=386.65 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=200.6
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+.||+|+||.||+|++++++.||||+++......+.|.+|+.+++++ +|||||++++++. ++..++||||+++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 578999999999999999888999999987777788999999999999 9999999999985 45678999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-----CC
Q 006886 419 MLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-----TT 493 (627)
Q Consensus 419 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-----~~ 493 (627)
.++.... ...++|.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 ~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 100 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 9987543 235999999999999999999999998 999999999999999999999999999876432 22
Q ss_pred CCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChH
Q 006886 494 ATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVE 573 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 573 (627)
..+|+.|+|||++..+.++.++|||||||++|||++|..|+.... ........+..... .. .. .
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~~~-~~-------~~---~ 237 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGYR-MP-------CP---P 237 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCC-CC-------CC---T
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCC-CC-------CC---c
Confidence 447899999999999999999999999999999999766654322 12222222222111 01 11 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 574 EEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 574 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
....++.+++.+||+.||++||||++|+++|+.+...
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1223566788899999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=384.50 Aligned_cols=248 Identities=21% Similarity=0.409 Sum_probs=195.2
Q ss_pred hcccCcCCceeEEEEEecCC-----cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDG-----TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.++||+|+||.||+|.+++. ..||||++..... ...+|.+|++++.++ +|||||+++|++.+.+..++||||
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEe
Confidence 47899999999999997642 3699999865432 345789999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+.+|++.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 91 MENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999887542 46999999999999999999999998 999999999999999999999999999876432
Q ss_pred C-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...||+.|+|||++.+..++.++|||||||++|||++|..|+.... ........ +......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~-i~~~~~~----- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKA-INDGFRL----- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH-HHTTCCC-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHHH-HhccCCC-----
Confidence 1 2346889999999999999999999999999999999766654321 11111221 1111110
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
........++.+++.+||+.+|++||||.||++.|+.+.+.
T Consensus 233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112234577888999999999999999999999988653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=385.70 Aligned_cols=243 Identities=20% Similarity=0.334 Sum_probs=197.9
Q ss_pred ccCcCCceeEEEEEec---CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 341 VLGKGSYGSTYKAILE---DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 341 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.||+|+||+||+|.++ ++..||||+++.... ..++|.+|++++.++ +|||||+++|++.. +..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 4999999999999864 355799999975432 346799999999999 99999999999864 5688999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
+|.+++...+ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 94 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred cHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999986542 46999999999999999999999998 999999999999999999999999999876432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +.... +..+...+.
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~-i~~~~~~~~------ 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IEQGKRMEC------ 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHH-HHTTCCCCC------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCCCCC------
Confidence 23347889999999998899999999999999999998 89999864321 11111 112111111
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
... ...++.+++.+||+.+|++||||.+|++.|+.+..
T Consensus 234 -p~~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 -PPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -CTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 22356678889999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=383.79 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=195.0
Q ss_pred cccCcCCceeEEEEEecC---CcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 340 EVLGKGSYGSTYKAILED---GTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
+.||+|+||+||+|.+++ ++.||||+++.... ..++|.+|+++++++ +||||++++++|.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 579999999999998653 46899999965422 246799999999999 99999999999864 56789999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC-
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT- 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~- 492 (627)
+|+|.++++.. ..++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 91 LGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999864 35999999999999999999999998 9999999999999999999999999998764321
Q ss_pred ------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchh
Q 006886 493 ------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVE 565 (627)
Q Consensus 493 ------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 565 (627)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+... .+... .+..+....
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~~-~i~~~~~~~----- 230 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTA-MLEKGERMG----- 230 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-HHHTTCCCC-----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HHHHH-HHHcCCCCC-----
Confidence 2347889999999999899999999999999999998 8999975431 11111 121111111
Q ss_pred hhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 566 LLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 566 l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
.... ...++.+++.+||+.||++|||+++|++.|+..-
T Consensus 231 --~p~~---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 --CPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCcc---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111 2235667888999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=378.47 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=192.7
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~ 411 (627)
+.||+|+||+||+|+.+ +++.||+|++..... ..+.+.+|+++++++ +||||+++++++.+ +...++||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 57999999999999975 588999999876432 345689999999999 89999999999875 3457899999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec-CCCCeEEeecccccccCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT-QDLNGCISDVGLAHLINF 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ki~DfG~a~~~~~ 490 (627)
+++|+|.+++.+. ..+++..+..++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 94 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999865 35899999999999999999999986 5699999999999997 478999999999987644
Q ss_pred C--CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 491 P--TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 491 ~--~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
. .+..||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ........+. .......++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~-~~~~~~~~~----- 235 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVT-SGVKPASFD----- 235 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHT-TTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHH-cCCCCcccC-----
Confidence 3 34568999999999875 69999999999999999999999997432 1111122221 111111111
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.... .++.+++.+||+.||++|||++|++++
T Consensus 236 -~~~~---~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 -KVAI---PEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GCCC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccCC---HHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1112 245678889999999999999999763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=387.06 Aligned_cols=242 Identities=18% Similarity=0.294 Sum_probs=197.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||+||+|+.+ +++.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..++||||+++|+
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 467999999999999975 68899999986543 3446789999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC----CC
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF----PT 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~----~~ 492 (627)
|.+++.+.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.... ..
T Consensus 96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999987542 35999999999999999999999998 99999999999999999999999999976532 24
Q ss_pred CCCCCccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 493 TATRTIGYRAPEVTE-----TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~-----~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
+..||+.|+|||++. ...|+.++|||||||++|||++|+.||.+....+ ....+...... ..
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~-~~------ 235 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPP-TL------ 235 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCC-CC------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCC-CC------
Confidence 567899999999983 4568899999999999999999999997643221 11222222111 10
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........++.+++.+||+.||++|||++|++++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122356678889999999999999999763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=390.21 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=198.3
Q ss_pred hcccCcCCceeEEEEEecC-C-----cEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED-G-----TTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|++.. + ..||||++.... .....+.+|+.++.++.+|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 5789999999999999653 2 369999986542 3346789999999999889999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec
Q 006886 411 YMPAGSLFMLLHRNRSD------------------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT 472 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 472 (627)
|+++|+|.++++..+.. ....++|..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence 99999999999765321 1245899999999999999999999998 99999999999999
Q ss_pred CCCCeEEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCH
Q 006886 473 QDLNGCISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDL 545 (627)
Q Consensus 473 ~~~~~ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~ 545 (627)
.++.+||+|||+|+...... +..+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.....
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---- 274 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998764432 2346889999999999999999999999999999998 899997643221
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIE 605 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 605 (627)
.+..++....... ..... ..++.+++.+||+.||++|||++||+++|.
T Consensus 275 --~~~~~~~~~~~~~-------~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 --NFYKLIQNGFKMD-------QPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --HHHHHHHTTCCCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHhcCCCCC-------CCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1222222221111 11112 235677888999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=391.87 Aligned_cols=191 Identities=21% Similarity=0.346 Sum_probs=170.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.+ +|+.||+|+++... ...+.+.+|+++++.+ +|||||+++++|.+.+..++||||+++|
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 478999999999999965 68999999987542 2356789999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCCeEecCCCCeEEeecccccccCC--CC
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSE-GGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF--PT 492 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~--~~ 492 (627)
+|.+++.+. ..+++..+..++.|++.||.|||++ + |+||||||+|||+++++.+||+|||+|+.... ..
T Consensus 90 ~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 90 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp EHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence 999999865 3589999999999999999999974 7 99999999999999999999999999987632 34
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSG 538 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~ 538 (627)
+..||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5679999999999999999999999999999999999999997643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=379.00 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=187.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEee--CCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYS--KDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~e~~ 412 (627)
.+.||+|+||+||+|+.+ +|+.||||++...... .+.+.+|++++.++ +||||+++++++.+ ++..++||||+
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~ 87 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYC 87 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence 478999999999999965 6899999998765332 35688999999999 99999999999865 45678999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG--GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
++|+|.+++.+... ....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 99999999975421 1346999999999999999999999875 23599999999999999999999999999987644
Q ss_pred C----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 491 P----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 491 ~----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......+.. ......
T Consensus 167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i~~-~~~~~~----- 234 (269)
T d2java1 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIRE-GKFRRI----- 234 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCCCCC-----
T ss_pred CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHHHHc-CCCCCC-----
Confidence 2 345689999999999999999999999999999999999999975321 122222221 111111
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
....+ .++.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~s---~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --PYRYS---DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CcccC---HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01122 34667788999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-47 Score=382.07 Aligned_cols=239 Identities=21% Similarity=0.341 Sum_probs=197.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++++++ +|||||++++++.+++..++||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecC
Confidence 478999999999999965 688999999875432 235688999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCCC
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPTT 493 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~~ 493 (627)
+|+|..++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 99 ~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 99 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99998776543 35999999999999999999999998 99999999999999999999999999998877777
Q ss_pred CCCCccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCC
Q 006886 494 ATRTIGYRAPEVTET---RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQ 570 (627)
Q Consensus 494 ~~~t~~y~aPE~~~~---~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 570 (627)
..||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.. .......+...... ... ..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~~~-~~~------~~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-ALQ------SG 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CCS------CT
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCC-CCC------CC
Confidence 889999999999854 468999999999999999999999997532 11222222222111 110 11
Q ss_pred ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 571 DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+ ..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HWS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122 34667788999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=377.45 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=195.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee-CCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS-KDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|+++++++ +||||++++|+|.+ ++..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 478999999999999986 789999999753 4567899999999999 99999999999865 4567999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-CCCCC
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-TTATR 496 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~~~~~ 496 (627)
.+++.... ...++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ....+
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~ 162 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence 99997642 235899999999999999999999988 999999999999999999999999999876543 34457
Q ss_pred CccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCChHHH
Q 006886 497 TIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDVEEE 575 (627)
Q Consensus 497 t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 575 (627)
+..|+|||++.+..++.++||||||+++|||+| |+.||...... ++..++ ......+. ....
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~~~~----------~~~~ 225 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKMDA----------PDGC 225 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCCCCC----------CTTC
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCCCCC----------CccC
Confidence 889999999998999999999999999999998 68887654322 222221 11111111 1112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 576 MVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 576 ~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
..++.+++.+||+.||++||||.|++++|+++++.+
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 235667888999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=377.84 Aligned_cols=244 Identities=16% Similarity=0.295 Sum_probs=200.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +|+.||||++... ....+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence 478999999999999975 6899999998643 23457799999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 92 NGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999998865 35999999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELL 567 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 567 (627)
.+..||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+...... +.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~~~---~p---- 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIKLEYD---FP---- 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTCCC---CC----
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHcCCCC---CC----
Confidence 23468999999999999999999999999999999999999997532 11222222222110 11
Q ss_pred cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 568 KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
...+ .++.+++.+||+.||++|||++|+++.-.-...
T Consensus 231 --~~~s---~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 231 --EKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp --TTCC---HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred --ccCC---HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 1122 345678889999999999999998665443333
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=383.90 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=197.1
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccccCHHHHHHHHHH--HHHhccCCCeeeeeeEEeeCC----ceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAATKREFEQQMEV--VGTIGKHSNVVPVRAYYYSKD----EKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~--l~~l~~h~niv~l~~~~~~~~----~~~lv~e~~ 412 (627)
.+.||+|+||+||+|+++ |+.||||+++... .+++..|.++ +..+ +||||+++++++...+ ..++||||+
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 467999999999999975 8899999986543 3444445444 4456 8999999999998754 478999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEG-----GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
++|+|.+++++. .++|..+++++.|+|.||+|+|+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 84 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999864 4899999999999999999999741 23599999999999999999999999999987
Q ss_pred cCCC--------CCCCCCccccCccccCCCC------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CH
Q 006886 488 INFP--------TTATRTIGYRAPEVTETRK------ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVV--------DL 545 (627)
Q Consensus 488 ~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~--------~~ 545 (627)
.... ....||+.|+|||++.+.. ++.++|||||||++|||+||..||......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6432 2345899999999987643 567899999999999999999887543221110 11
Q ss_pred HHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 546 PRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 546 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
............ +++.+.......+....+.+++.+||+.||++||||.||++.|+++.+.+
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 122222222111 11111111223455667889999999999999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=380.88 Aligned_cols=242 Identities=23% Similarity=0.380 Sum_probs=184.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.+ +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 478999999999999975 68999999986543 2345688999999999 9999999999999999999999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec---CCCCeEEeecccccccCCC-
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfG~a~~~~~~- 491 (627)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+.....
T Consensus 93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999754 35999999999999999999999998 99999999999995 5789999999999876543
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
.+..||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+....... +.. ..
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~~---~~~--~~ 233 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAEYEF---DSP--YW 233 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTCCCC---CTT--TT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccCCCC---CCc--cc
Confidence 345689999999999999999999999999999999999999975321 12222222221110 100 11
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...+ .++.+++.+||..||++|||++|++++
T Consensus 234 ~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDIS---DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1222 345677889999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=373.55 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred hcccCcCCceeEEEEEecCC----cEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeC-CceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILEDG----TTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSK-DEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~e~ 411 (627)
.++||+|+||+||+|++.++ ..||||+++.... ..++|.+|++++.++ +||||++++|++... ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEE
Confidence 36799999999999997532 2589999975332 346799999999999 899999999998764 578999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++... ...+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999998754 245788999999999999999999998 999999999999999999999999999876432
Q ss_pred --------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 492 --------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .++..++ ...... ..
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~~~---~~ 255 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGRRL---LQ 255 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTCCC---CC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCCCC---CC
Confidence 1234688999999999999999999999999999999988887643211 1222211 111111 01
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccccccc
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELRN 614 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~~ 614 (627)
.... ..++.+++.+||..||++||+|.||+++|+.+...-...
T Consensus 256 -----p~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 256 -----PEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -----CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----cccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 1111 235677888999999999999999999999998664443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=376.77 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=201.0
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+++++++ +||||++++++|...+..++|+|
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEE
Confidence 478999999999999864 357899999875432 346799999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 006886 411 YMPAGSLFMLLHRNRS-------------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLL 471 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 471 (627)
|+++|+|.++++.... .....+++..++.++.|++.||+|||+.+ ||||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEE
Confidence 9999999999975321 12345899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 006886 472 TQDLNGCISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGK-APLQHSGHDDVVD 544 (627)
Q Consensus 472 ~~~~~~ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~ 544 (627)
+.++.+||+|||+|+..... .+..+++.|+|||++.+..++.++|||||||++|||++|. +||....
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~------ 247 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------ 247 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC------
Confidence 99999999999999765321 2345778999999999999999999999999999999986 5676432
Q ss_pred HHHHHHHHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 545 LPRWVRSVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..+....+ ........ . .....++.+++.+||+.+|++||||.||+++|++|.+
T Consensus 248 ~~e~~~~v-~~~~~~~~-------p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 HEEVIYYV-RDGNILAC-------P---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHH-HTTCCCCC-------C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHH-HcCCCCCC-------C---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 12222222 22211111 1 1122356788899999999999999999999999853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-45 Score=379.76 Aligned_cols=243 Identities=19% Similarity=0.372 Sum_probs=199.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.+ +|+.||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 478999999999999975 68999999986543 2356789999999999 89999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC--CCCeEEeecccccccCCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ--DLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~ki~DfG~a~~~~~~~-- 492 (627)
|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+......
T Consensus 110 L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 110 LFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99998643 235999999999999999999999998 999999999999964 6889999999998875433
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
+..||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+ .......+....... +.. ....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~---~~~--~~~~ 251 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCDWNM---DDS--AFSG 251 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCS---CCG--GGGG
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCC---Ccc--cccC
Confidence 3468999999999999999999999999999999999999997542 222233332222111 000 0011
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ..++.+++.+||..||++|||++|++++
T Consensus 252 ~---s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 I---SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C---CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 2345678889999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=374.52 Aligned_cols=253 Identities=22% Similarity=0.415 Sum_probs=200.0
Q ss_pred hcccCcCCceeEEEEEecC-Cc--EEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILED-GT--TVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|++++ |. .||||+++... ...++|.+|++++.++.+||||++++++|.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 5789999999999999764 43 47888876432 2455799999999998789999999999999999999999999
Q ss_pred CCCHHHHhhhcC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeec
Q 006886 414 AGSLFMLLHRNR-----------SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDV 482 (627)
Q Consensus 414 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~Df 482 (627)
+|+|.++++... ......++|..+.+++.|||.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence 999999997542 123457999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 483 GLAHLINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKA-PLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 483 G~a~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
|+++..... ....+|..|+|||.+.+..++.++|||||||++|||++|.. ||.... .......+......
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQGYRL 245 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHGGGTCCC
T ss_pred cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHHHHhcCCC
Confidence 999866432 23457889999999999999999999999999999999764 565432 22222222211111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPE 611 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~ 611 (627)
. .....+ .++.+++.+||+.||++||||.||+++|+++.+..
T Consensus 246 -~-------~~~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 246 -E-------KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -C-------CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -C-------CCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0 111222 35667788999999999999999999999987543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=373.98 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=191.7
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEecccc--cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC-ceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVA--ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD-EKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 409 (627)
.+.||+|+||.||+|++. +++.||||+++... ...+.+..|.+.+.++.+|+||+.+++++...+ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 478999999999999864 24689999987543 235678888899999888999999999987654 578999
Q ss_pred ecCCCCCHHHHhhhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeE
Q 006886 410 SYMPAGSLFMLLHRNRS-----------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGC 478 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 478 (627)
||+++|+|.++++..+. .....+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 99999999999976431 11245899999999999999999999998 99999999999999999999
Q ss_pred EeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHH
Q 006886 479 ISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGK-APLQHSGHDDVVDLPRWVRS 551 (627)
Q Consensus 479 i~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~ 551 (627)
|+|||+|+..... ....||+.|+|||++.+..++.++|||||||++|||++|. .||...... ..+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~------~~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS------HHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9999999865432 2345789999999999999999999999999999999974 577643221 12222
Q ss_pred HhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 552 VVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 552 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.+..+...... .....++.+++.+||+.||++|||++|++++|+.+.+
T Consensus 249 ~~~~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 RLKEGTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCC----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222211111 1122356788889999999999999999999998854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=369.77 Aligned_cols=246 Identities=21% Similarity=0.370 Sum_probs=190.9
Q ss_pred hcccCcCCceeEEEEEecC----CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 339 AEVLGKGSYGSTYKAILED----GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
.+.||+|+||.||+|++.. +..||||.++.... ..+.|.+|+++++++ +||||+++++++. ++..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEec
Confidence 4789999999999998653 34689998865432 346799999999999 9999999999985 56789999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999887542 46899999999999999999999998 999999999999999999999999999876432
Q ss_pred ----CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhh
Q 006886 492 ----TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVEL 566 (627)
Q Consensus 492 ----~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 566 (627)
....+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ++.. .+...... .
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~---~i~~~~~~-~------ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIENGERL-P------ 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---HHHTTCCC-C------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCCC-C------
Confidence 22346889999999999999999999999999999998 89999765332 1211 11111111 1
Q ss_pred hcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 567 LKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 567 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..... ..++.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 230 -~~~~~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 -MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11122 23566788899999999999999999999998654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=373.35 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=190.3
Q ss_pred hcccCcCCceeEEEEEecC--C--cEEEEEEecccc----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILED--G--TTVVVKRLREVA----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|+++. + ..||||+++... ...++|.+|+++++++ +||||++++|++.+ +..++|||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeee
Confidence 4679999999999998642 2 368999986542 2246799999999999 99999999999965 46789999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF 490 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~ 490 (627)
|+++|++.+++.... ..+++..++.++.|+|.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999887643 35999999999999999999999998 99999999999999999999999999998744
Q ss_pred CC-------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 491 PT-------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 491 ~~-------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
.. ...++..|+|||++.+..++.++|||||||++|||+| |+.||.+.+ .......+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~~~~-- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERLP-- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCCCCC--
Confidence 32 2236778999999999999999999999999999998 899997542 2222233332221111
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQ 608 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~ 608 (627)
..... ...+.+++.+||+.||++||||.||.+.|++.+
T Consensus 236 -----~~~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 236 -----RPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -----CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----Ccccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 11112 235677888999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=374.32 Aligned_cols=246 Identities=22% Similarity=0.389 Sum_probs=196.6
Q ss_pred hcccCcCCceeEEEEEec-CCc----EEEEEEeccc--ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGT----TVVVKRLREV--AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||+||+|.+. +|+ .||+|+++.. ....++|.+|++++.++ +||||++++|+|.++ ..++++||
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEEC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CeeEEEEe
Confidence 478999999999999865 343 5899988654 33567899999999999 999999999999764 56788999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+.+|+|.+++... ...+++..+++++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 92 MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred ccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999988764 346999999999999999999999998 999999999999999999999999999876432
Q ss_pred C------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 492 T------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 492 ~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
. ...||+.|+|||++.++.++.++|||||||++|||+| |+.||++.... .+... +..+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~----i~~~~~~~---- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERLP---- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH----HHHTCCCC----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCC----
Confidence 2 2246899999999999999999999999999999999 78888754322 12211 11111000
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
.. +....++.+++.+||..||++|||+.||+++|+.+...
T Consensus 234 ---~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 234 ---QP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11 11224567788899999999999999999999988543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=369.71 Aligned_cols=242 Identities=21% Similarity=0.382 Sum_probs=198.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-------cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-------ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++++ +||||+++++++.+++..++|||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999975 68999999986432 2367899999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC----CeEEeeccccc
Q 006886 411 YMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL----NGCISDVGLAH 486 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~ki~DfG~a~ 486 (627)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+
T Consensus 94 ~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 94 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999865 35999999999999999999999998 99999999999998876 49999999998
Q ss_pred ccCCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc
Q 006886 487 LINFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD 563 (627)
Q Consensus 487 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 563 (627)
..... .+..+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+...... +.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~---~~ 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYE---FE 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCCC---CC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCCC---CC
Confidence 76543 345688999999999999999999999999999999999999975421 1112222211110 01
Q ss_pred hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 564 VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 564 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
... ... ....+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~--~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEY--FSN---TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHH--HTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chh--cCC---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 011 12345678889999999999999999763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-45 Score=377.23 Aligned_cols=243 Identities=20% Similarity=0.368 Sum_probs=198.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGS 416 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 416 (627)
.+.||+|+||.||+|+.+ +|+.||||+++... ...+.+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 478999999999999965 69999999987543 2356788999999999 99999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec--CCCCeEEeecccccccCCCC--
Q 006886 417 LFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT--QDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 417 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~ki~DfG~a~~~~~~~-- 492 (627)
|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+......
T Consensus 113 L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 113 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 99887643 246999999999999999999999998 99999999999998 57899999999998876543
Q ss_pred -CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCC
Q 006886 493 -TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQD 571 (627)
Q Consensus 493 -~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 571 (627)
+..+|+.|+|||++.+..++.++||||+||++|||++|+.||.+... ......+...... +.. .....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~---~~~--~~~~~ 254 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FDE--DAFSS 254 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CCS--STTTT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCc--ccccC
Confidence 34589999999999999999999999999999999999999975321 1222222221111 000 01111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 572 VEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.+ .++.+++.+||+.||.+|||+.|++++
T Consensus 255 ~s---~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 VS---PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SC---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22 345678889999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-45 Score=369.65 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=199.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +|+.||||+++.. ....+.+.+|+.+++.+ +||||+++++++.+.+..++||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecC
Confidence 478999999999999975 6899999999643 23467899999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 88 gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 88 GGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp SCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred Ccccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 99999998865 35788999999999999999999998 999999999999999999999999999887543 4
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+ .......+...... + ....
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---~------p~~~ 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---F------PPFF 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---C------CTTS
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC---C------CCCC
Confidence 5679999999999999999999999999999999999999997542 12222222222110 0 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRP-----KMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 603 (627)
+ .++.+++.+|+..||.+|| |++|++++
T Consensus 225 s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2 3456778899999999996 89999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=370.34 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=198.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +|+.||||++++. ....+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccC
Confidence 478999999999999964 7999999999753 23457789999999999 89999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|..++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999998753 5899999999999999999999998 999999999999999999999999999876432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+. ......+...... -.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~~---------~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR---------FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCCC---------CC
Confidence 245689999999999999999999999999999999999999986432 1222222221110 01
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
...++ ++.+++.+||++||++||+ ++|++++
T Consensus 226 ~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCCH---HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11222 4567788999999999995 8888774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=367.60 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=198.4
Q ss_pred hcccCcCCceeEEEEEecC--------CcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEE
Q 006886 339 AEVLGKGSYGSTYKAILED--------GTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 408 (627)
.+.||+|+||.||+|+... +..||||+++.... ...++.+|...+.++.+||||++++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 4789999999999998542 24799999976543 3467888999999998899999999999999999999
Q ss_pred EecCCCCCHHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 409 YSYMPAGSLFMLLHRNRSD-----------GGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|||+++|+|.+++...+.. ....+++.++++++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence 9999999999999765321 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||+++..... ....+++.|+|||.+.++.|+.++|||||||++|||++ |..||...... .+.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-------~~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------ELF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-------HHH
Confidence 99999999876432 22347889999999999999999999999999999998 68888653321 111
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
..+........ .... ..++.+++.+||+.||++|||+.||++.|+++..
T Consensus 248 ~~i~~~~~~~~-------p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKEGHRMDK-------PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTCCCCC-------CSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC-------Cccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22222211111 1112 2356778889999999999999999999998853
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=370.88 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=202.6
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||.||+|++. +++.||||+++.... ...+|.+|+.++.++.+||||++++++|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 478999999999999853 456899999975432 345789999999999789999999999999999999999
Q ss_pred cCCCCCHHHHhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCe
Q 006886 411 YMPAGSLFMLLHRNRS-------------DGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNG 477 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 477 (627)
|+++|+|.++++.... .....+++..+.+++.||+.||+|||+++ |+||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence 9999999999986532 12346899999999999999999999998 9999999999999999999
Q ss_pred EEeecccccccCCCC------CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCHHHHHH
Q 006886 478 CISDVGLAHLINFPT------TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLT-GKAPLQHSGHDDVVDLPRWVR 550 (627)
Q Consensus 478 ki~DfG~a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~ 550 (627)
||+|||.++...... ...+|+.|+|||++.+..++.++|||||||++|||+| |.+||...... ..+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~------~~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 999999998775432 2346889999999999999999999999999999999 55555443221 1112
Q ss_pred HHhhhcccccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhccc
Q 006886 551 SVVREEWTAEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQP 610 (627)
Q Consensus 551 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~ 610 (627)
..+....... .. .....++.+++.+||+.||++||||.||+++|+++..+
T Consensus 259 ~~i~~~~~~~-------~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGFRML-------SP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTCCCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC-------Cc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222221111 01 11224567788899999999999999999999987544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=370.60 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=192.6
Q ss_pred cccCcCCceeEEEEEe-cCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEee----CCceEEEEecCCC
Q 006886 340 EVLGKGSYGSTYKAIL-EDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYS----KDEKLVVYSYMPA 414 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~e~~~~ 414 (627)
+.||+|+||+||+|+. .+++.||||+++. ...+.+|++++.++.+||||+++++++.+ +...++||||++|
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 5699999999999996 4689999999864 35577899888777689999999999875 3567999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC---CCCeEEeecccccccCCC
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ---DLNGCISDVGLAHLINFP 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~ki~DfG~a~~~~~~ 491 (627)
|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|+.....
T Consensus 94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC
Confidence 99999997532 346999999999999999999999998 999999999999986 467999999999876432
Q ss_pred ---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 ---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+........ ...... ....++ + .
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i----~~~~~~--~-~ 237 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRI----RMGQYE--F-P 237 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC----CSCSSS--C-C
T ss_pred CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHH----hcCCCC--C-C
Confidence 34568999999999999999999999999999999999999997654322111 000000 000000 0 0
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.........++.+++.+||..||++|||+.|++++
T Consensus 238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00112223467788889999999999999999884
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-44 Score=361.78 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=196.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCc----eEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDE----KLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lv~ 409 (627)
.+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++++.+ +||||+++++++...+. .++||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEE
Confidence 478999999999999964 689999999975422 235689999999999 99999999999886543 78999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.++...
T Consensus 91 E~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp ECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred ECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999998765 35999999999999999999999998 9999999999999999999999999987653
Q ss_pred C-------CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 F-------PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC---
Confidence 2 223458999999999999999999999999999999999999997532 122223333222111
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhcc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRP-KMDDVVRMIEQIQQ 609 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~ev~~~L~~~~~ 609 (627)
+ .......+ .++.+++.+|++.||++|| |+++++..|.++++
T Consensus 234 -~-~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 -P-SARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -G-GGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -C-chhccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0 01112222 3456777899999999999 89999999988753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-44 Score=358.34 Aligned_cols=243 Identities=20% Similarity=0.342 Sum_probs=196.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc----------CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA----------TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLV 407 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 407 (627)
.+.||+|+||+||+|+.+ +|+.||||++..... ..+.+.+|+++++++..||||+++++++.+++..++
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 478999999999999964 689999999865421 124588999999999669999999999999999999
Q ss_pred EEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 408 VYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 408 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999764 35999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCC---CCCCCCccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 488 INFP---TTATRTIGYRAPEVTE------TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 488 ~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
.... ....||+.|+|||++. ...++.++||||+||++|||++|+.||.+... ......+......
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~~~~~~ 233 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ 233 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHHhCCCC
Confidence 7543 3455899999999984 24568899999999999999999999985421 1112222222111
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ..+ .....+ .++.+++.+||+.+|++|||++|++++
T Consensus 234 ~--~~~---~~~~~s---~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 F--GSP---EWDDYS---DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--CTT---TGGGSC---HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--CCc---ccccCC---HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 000 111122 356677889999999999999999653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.7e-44 Score=370.03 Aligned_cols=242 Identities=18% Similarity=0.256 Sum_probs=191.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc----cCHHHHHHHHHHHHHhc--cCCCeeeeeeEEeeCCceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA----ATKREFEQQMEVVGTIG--KHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
.+.||+|+||.||+|+.+ +|+.||||++.... .....+.+|...+..+. +||||+++++++.+.+..++||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 478999999999999975 68999999986432 23444555544444332 799999999999999999999999
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP 491 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~ 491 (627)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999865 35889999999999999999999998 999999999999999999999999999876543
Q ss_pred --CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhc
Q 006886 492 --TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLK 568 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 568 (627)
....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+ ........... . ...
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~----~-----~~~ 228 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTM----A-----VEL 228 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSSC----C-----CCC
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccC----C-----CCC
Confidence 34568999999999864 568999999999999999999999998654322 11111111100 0 001
Q ss_pred CCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 006886 569 YQDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVRM 603 (627)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~~ 603 (627)
....+ .++.+++.+||..||++||| ++|++++
T Consensus 229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 229 PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11222 24567788999999999999 6888763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=367.50 Aligned_cols=243 Identities=18% Similarity=0.355 Sum_probs=199.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||+||+|..+ +++.||||+++........+.+|++++..+ +||||+++++++.+++..++||||+++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 478999999999999975 688999999976655566788999999999 999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC--CCeEEeecccccccCCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD--LNGCISDVGLAHLINFPT--- 492 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~ki~DfG~a~~~~~~~--- 492 (627)
.+++.... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99997542 35899999999999999999999998 9999999999999854 589999999998775432
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..+|+.|+|||...+..++.++||||+||++|||++|+.||..... ......+...... ++... ....
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~---~~~~~--~~~~ 230 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT---FDEEA--FKEI 230 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---CCHHH--HTTS
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CChhh--ccCC
Confidence 33578999999999999999999999999999999999999975431 2222222222211 11110 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+ .++.+++.+|+..||++|||++|++++
T Consensus 231 s---~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 S---IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2 345678889999999999999999884
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-44 Score=368.99 Aligned_cols=237 Identities=17% Similarity=0.218 Sum_probs=198.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||.||+|+.+ +|+.||||++... ....+.+.+|+++++.+ +||||+++++++......++|+||+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence 478999999999999975 6999999998643 23456789999999999 99999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-C
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-T 492 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-~ 492 (627)
+|+|..++.+.. .+++..+..++.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+..... .
T Consensus 125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999998653 5899999999999999999999998 999999999999999999999999999887543 4
Q ss_pred CCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcCCCh
Q 006886 493 TATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKYQDV 572 (627)
Q Consensus 493 ~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 572 (627)
+..||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. .......+...... .....
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p~~~ 261 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKVR---------FPSHF 261 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CCTTC
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCCC---------CCccC
Confidence 5568999999999999999999999999999999999999997532 22222222221110 01112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 006886 573 EEEMVQMLQIALSCVAKVPDSRP-----KMDDVVR 602 (627)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 602 (627)
+ .++.+++.+||..||.+|+ |++|+++
T Consensus 262 s---~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 S---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C---HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2 3466788899999999994 8999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=365.31 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=204.6
Q ss_pred hcccCcCCceeEEEEEec------CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEe
Q 006886 339 AEVLGKGSYGSTYKAILE------DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYS 410 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e 410 (627)
.+.||+|+||+||+|.++ +++.||||+++.... ....|.+|+++++++ +||||+++++++..++..++|||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEEe
Confidence 578999999999999864 357899999975432 234689999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccc
Q 006886 411 YMPAGSLFMLLHRNR-----SDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLA 485 (627)
Q Consensus 411 ~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a 485 (627)
|+++|+|.+++...+ ......+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccc
Confidence 999999999987532 112235799999999999999999999998 999999999999999999999999999
Q ss_pred cccCCC------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCHHHHHHHHhhhccc
Q 006886 486 HLINFP------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGK-APLQHSGHDDVVDLPRWVRSVVREEWT 558 (627)
Q Consensus 486 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 558 (627)
+..... ....+|+.|+|||.+.+..++.++||||||+++|||+||. .||... ...+....+.....
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGGL- 253 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTCC-
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhCCC-
Confidence 876432 2234689999999999999999999999999999999985 666543 22333333222211
Q ss_pred ccccchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcccccc
Q 006886 559 AEVFDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQPELR 613 (627)
Q Consensus 559 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~~~~~ 613 (627)
... ... ....+.+++.+||+.+|++||||++|+++|++..++..+
T Consensus 254 ~~~-------p~~---~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 254 LDK-------PDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp CCC-------CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred CCC-------ccc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 110 111 123577788899999999999999999999998776544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=363.65 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=189.6
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccC------HHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT------KREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~ 412 (627)
++||+|+||+||+|+.+ +|+.||||+++..... .+.+.+|+++++++ +||||+++++++..++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhh
Confidence 68999999999999965 6899999998654221 24688999999999 9999999999999999999999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~- 491 (627)
.++++..+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988776665432 45888999999999999999999998 999999999999999999999999999876442
Q ss_pred ---CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccc----
Q 006886 492 ---TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFD---- 563 (627)
Q Consensus 492 ---~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 563 (627)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ....+.............+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence 23458999999999865 467999999999999999999999997543211 1111111110000000000
Q ss_pred ---hhhhcCCC--h----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 564 ---VELLKYQD--V----EEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 564 ---~~l~~~~~--~----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
........ . +....++.+++.+||..||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000 0 011245778888999999999999999965
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=363.79 Aligned_cols=238 Identities=23% Similarity=0.361 Sum_probs=194.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccc----ccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREV----AATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMP 413 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~ 413 (627)
.+.||+|+||+||+|+.+ +++.||||+++.. ....+.+..|..++.+..+||||+++++++.+++..++||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 478999999999999975 6899999999653 23455677787777654499999999999999999999999999
Q ss_pred CCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC--
Q 006886 414 AGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP-- 491 (627)
Q Consensus 414 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~-- 491 (627)
+|+|.++++... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999998653 4899999999999999999999998 999999999999999999999999999865432
Q ss_pred --CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccchhhhcC
Q 006886 492 --TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDVELLKY 569 (627)
Q Consensus 492 --~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 569 (627)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+. ......+.... . .+ .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~-~--~~------p 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN-P--FY------P 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C--CC------C
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-C--CC------C
Confidence 234689999999999999999999999999999999999999975431 11122221111 0 00 1
Q ss_pred CChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 006886 570 QDVEEEMVQMLQIALSCVAKVPDSRPKMD-DVVR 602 (627)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~~ 602 (627)
...+ .++.+++.+||..||++||++. |+++
T Consensus 224 ~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccCC---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122 3456788899999999999996 6754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=353.45 Aligned_cols=233 Identities=21% Similarity=0.376 Sum_probs=189.1
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc-------CHHHHHHHHHHHHHhc-cCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA-------TKREFEQQMEVVGTIG-KHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||+||+|+.. +|+.||||++..... ....+.+|+++++++. .||||+++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 478999999999999965 689999999865321 1234678999999984 3999999999999999999999
Q ss_pred ecCCC-CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCC-CCeEEeecccccc
Q 006886 410 SYMPA-GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQD-LNGCISDVGLAHL 487 (627)
Q Consensus 410 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~ki~DfG~a~~ 487 (627)
||+.+ +++.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence 99976 6888888764 35899999999999999999999998 9999999999999855 7899999999987
Q ss_pred cCCC--CCCCCCccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccccch
Q 006886 488 INFP--TTATRTIGYRAPEVTETRKA-SQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVFDV 564 (627)
Q Consensus 488 ~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 564 (627)
.... .+..||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+..... .+.
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~---~~~- 224 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FFR- 224 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CCS-
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc---CCC-
Confidence 6443 44568999999999977665 577999999999999999999996421 1111110 011
Q ss_pred hhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 565 ELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 565 ~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...++ ++.+++.+||..||++|||++|++++
T Consensus 225 -----~~~s~---~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 -----QRVSS---ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11222 45667789999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=350.92 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=190.3
Q ss_pred hcccCcCCceeEEEEEe-cCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAIL-EDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++++ +||||+++++++.+++..++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCC
Confidence 37899999999999996 468999999996543 2356789999999999 999999999999999999999999976
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC---
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~--- 491 (627)
+ +..++.... ...+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 86 ~-~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 86 D-LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp E-HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred c-hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 4 444544332 246999999999999999999999998 999999999999999999999999999776432
Q ss_pred -CCCCCCccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh--hccccccc-----
Q 006886 492 -TTATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR--EEWTAEVF----- 562 (627)
Q Consensus 492 -~~~~~t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----- 562 (627)
....||+.|+|||++.... ++.++||||+||++|||++|+.||.+.+..+ .+......... +.......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccccc
Confidence 3346899999999876655 5789999999999999999999997542111 01110000000 00000000
Q ss_pred chhhhc--CCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 563 DVELLK--YQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 563 d~~l~~--~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
...... ..... ....++.+++.+|+..||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 00000 112456778889999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.1e-43 Score=351.27 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=192.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.++|+.||||+++... ...+.+.+|+.+++++ +||||+++++++..++..++++||+.++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhh
Confidence 47899999999999999999999999996542 2356899999999999 8999999999999999999999999887
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCC----
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFP---- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~---- 491 (627)
++..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 86 ~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 86 LKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp HHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 776665433 46999999999999999999999998 999999999999999999999999999876542
Q ss_pred CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc---ccc-----c
Q 006886 492 TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT---AEV-----F 562 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~ 562 (627)
....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+ ....... ... .
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~-~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTSTTGGGSTTC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHH-hhCCCChhhccchhhhhhc
Confidence 23457889999999865 456899999999999999999999997543211 0111111 0000000 000 0
Q ss_pred chhhhc------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 563 DVELLK------YQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 563 d~~l~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
+..... ..........+.+++.+||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0001111235677888999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=352.67 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=188.2
Q ss_pred hcccCcCCceeEEEEEec-C-CcEEEEEEeccccc---CHHHHHHHHHHHHHhc--cCCCeeeeeeEEee-----CCceE
Q 006886 339 AEVLGKGSYGSTYKAILE-D-GTTVVVKRLREVAA---TKREFEQQMEVVGTIG--KHSNVVPVRAYYYS-----KDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 406 (627)
.+.||+|+||+||+|+.. + ++.||||+++.... ....+.+|+++++.+. +||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 478999999999999964 4 56799999865422 2335667888877664 79999999999863 24578
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+++||+++|++....... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 999999988776554432 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCC---CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh-------c
Q 006886 487 LINF---PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE-------E 556 (627)
Q Consensus 487 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 556 (627)
.... .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.. .....+... .
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCCCCGGG
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhhCCCchhc
Confidence 6643 24566899999999999999999999999999999999999999754321 111111110 0
Q ss_pred cccccc----------chhhh-cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 557 WTAEVF----------DVELL-KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 557 ~~~~~~----------d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
+..... ..... .....+ ..+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCC---HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 00000 011122 345667889999999999999999774
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=342.50 Aligned_cols=251 Identities=18% Similarity=0.194 Sum_probs=189.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||+||+|++. +|+.||||++.... ..+++..|+++++.+.+|++|+.+.++..+.+..++||||+ +|++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l 89 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 89 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence 478999999999999964 68999999876532 33457889999999954555666666667788889999999 5567
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEec---CCCCeEEeecccccccCCC---
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLT---QDLNGCISDVGLAHLINFP--- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~ki~DfG~a~~~~~~--- 491 (627)
...+... ...+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.....
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 6666543 246899999999999999999999998 99999999999976 3567999999999876432
Q ss_pred --------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHH-HHHHHhhhccccccc
Q 006886 492 --------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPR-WVRSVVREEWTAEVF 562 (627)
Q Consensus 492 --------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 562 (627)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ........ .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~---- 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--P---- 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--C----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--C----
Confidence 23358999999999999999999999999999999999999998654433222111 11110000 0
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
.+.+ ....+ .++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 237 ~~~~--~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVL--CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHH--TTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhHh--ccCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000 11112 356678889999999999999999999988743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-41 Score=338.90 Aligned_cols=252 Identities=15% Similarity=0.180 Sum_probs=199.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCH
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSL 417 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 417 (627)
.+.||+|+||+||+|+.. +|+.||||++.... ....+.+|++.+..+.+|+|++.+++++..+...++||||+ +|+|
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 478999999999999965 68899999885432 33457788999999977799999999999999999999998 7899
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecC-----CCCeEEeecccccccCCC-
Q 006886 418 FMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQ-----DLNGCISDVGLAHLINFP- 491 (627)
Q Consensus 418 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~ki~DfG~a~~~~~~- 491 (627)
.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99987642 35899999999999999999999998 999999999999974 578999999999875321
Q ss_pred ----------CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccccc
Q 006886 492 ----------TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEV 561 (627)
Q Consensus 492 ----------~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (627)
....||+.|+|||++.+..++.++||||||+++|||++|+.||.+....... .....+........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~---~~~~~i~~~~~~~~- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKKQSTP- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH---HHHHHHHHHHHHSC-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH---HHHHHHHhccCCCC-
Confidence 2345899999999999999999999999999999999999999865433221 11111111110000
Q ss_pred cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhcc
Q 006886 562 FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRMIEQIQQ 609 (627)
Q Consensus 562 ~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~~~ 609 (627)
-..+ ....+ .++.+++..|++.+|++||+++.+.+.|+++.+
T Consensus 237 -~~~l--~~~~p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 -LREL--CAGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp -HHHH--TTTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -hHHh--cCCCC---HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0001 11122 346677789999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=347.17 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=189.8
Q ss_pred cccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEEEecC
Q 006886 340 EVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVVYSYM 412 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~e~~ 412 (627)
++||+|+||+||+|+.+ +|+.||||++..... .+.+|+++++++ +||||+++++++... ...++||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 68999999999999975 689999999965432 234789999999 999999999998643 2468999999
Q ss_pred CCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCC-
Q 006886 413 PAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINF- 490 (627)
Q Consensus 413 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~- 490 (627)
++|.+....+... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 8765444333221 1346999999999999999999999998 99999999999999875 899999999987643
Q ss_pred --CCCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHH-------hh---hcc
Q 006886 491 --PTTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSV-------VR---EEW 557 (627)
Q Consensus 491 --~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~---~~~ 557 (627)
..+..||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...++.. .. ...
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCC--
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhhccch
Confidence 334568899999998764 578999999999999999999999997543211 111111000 00 000
Q ss_pred cccccc----hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccccc
Q 006886 558 TAEVFD----VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQPEL 612 (627)
Q Consensus 558 ~~~~~d----~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~~~ 612 (627)
....+. ..... ........++.+++.+||..||++|||+.|++++ ++++.....
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 314 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314 (350)
T ss_dssp -CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCC
Confidence 000000 00000 0001122346678889999999999999999974 666655443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=343.49 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=187.3
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccc---cCHHHHHHHHHHHHHhccCCCeeeeeeEEee--------CCceE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVA---ATKREFEQQMEVVGTIGKHSNVVPVRAYYYS--------KDEKL 406 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~ 406 (627)
.+.||+|+||+||+|+.+ +|+.||||++.... ...+.+.+|+++++++ +|||++++++.+.. .+..+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEE
Confidence 478999999999999964 79999999986442 2356788999999999 99999999998865 34578
Q ss_pred EEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 407 VVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 407 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+||||+.++++..+... ...++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 94 iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 99999988776655433 245888999999999999999999998 9999999999999999999999999997
Q ss_pred ccCC--------CCCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhh--
Q 006886 487 LINF--------PTTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVRE-- 555 (627)
Q Consensus 487 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 555 (627)
.... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..... ....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence 6542 2234589999999998764 68999999999999999999999997532111 11111111100
Q ss_pred -ccccccc--------chhhhcCCChHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 556 -EWTAEVF--------DVELLKYQDVEEE------MVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 556 -~~~~~~~--------d~~l~~~~~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
....... ...........+. ...+.+++.+||..||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 0000001111111 2355678999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=341.31 Aligned_cols=258 Identities=19% Similarity=0.298 Sum_probs=188.8
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc--CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCC----ceEEEEec
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA--TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKD----EKLVVYSY 411 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~e~ 411 (627)
.+.||+|+||+||+|+.+ +|+.||||++..... ..+.+.+|+++++.+ +||||+++++++.... ..+++++|
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEe
Confidence 478999999999999864 799999999975432 345788999999999 9999999999987643 23556667
Q ss_pred CCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCC-
Q 006886 412 MPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINF- 490 (627)
Q Consensus 412 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~- 490 (627)
+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 7799999999753 4899999999999999999999998 99999999999999999999999999976532
Q ss_pred ------CCCCCCCccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhcccc---c
Q 006886 491 ------PTTATRTIGYRAPEVTE-TRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTA---E 560 (627)
Q Consensus 491 ------~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 560 (627)
.....||+.|+|||++. +..++.++||||+||++|||++|+.||......+. .............. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhhhhh
Confidence 23345789999999984 45678999999999999999999999975432111 00000000000000 0
Q ss_pred ccch-------hhh--cCCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhcc
Q 006886 561 VFDV-------ELL--KYQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQ 609 (627)
Q Consensus 561 ~~d~-------~l~--~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~ 609 (627)
.... ... ...... ....++.+++.+|+..||++|||++|++++ +++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0000 000 000000 011256788899999999999999999985 554443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=338.23 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=192.4
Q ss_pred hcccCcCCceeEEEEEec----CCcEEEEEEecccc-----cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE----DGTTVVVKRLREVA-----ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 409 (627)
.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++.++.+||||+++++++.+....++|+
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 478999999999999852 47899999986432 245678899999999965689999999999999999999
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
||+.+|+|.+++.... .++......++.|++.||+|+|+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999998763 4678889999999999999999998 9999999999999999999999999998653
Q ss_pred C-----CCCCCCCccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccccccc
Q 006886 490 F-----PTTATRTIGYRAPEVTETR--KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWTAEVF 562 (627)
Q Consensus 490 ~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (627)
. ..+..+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+.. ........... .
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~~-~---- 253 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-P---- 253 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC-C----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccCC-C----
Confidence 2 2344578999999998654 4688999999999999999999999866443321 11111111110 0
Q ss_pred chhhhcCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 006886 563 DVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPK-----MDDVVR 602 (627)
Q Consensus 563 d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~ 602 (627)
........++.+++.+||..+|++||| ++|+++
T Consensus 254 -------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001122345667788999999999994 788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=339.76 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=187.9
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeCC------ceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSKD------EKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 408 (627)
.+.||+|+||+||+|..+ +|+.||||+++..... .+.+.+|+++++.+ +|||||+++++|...+ ..++|
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEE
Confidence 478999999999999965 6999999999754332 35688999999999 9999999999997654 46899
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+ +++|..+.+.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+|+..
T Consensus 102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 9999 66788777642 4999999999999999999999998 999999999999999999999999999887
Q ss_pred CCC-CCCCCCccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh------hcc---
Q 006886 489 NFP-TTATRTIGYRAPEVTET-RKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR------EEW--- 557 (627)
Q Consensus 489 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------~~~--- 557 (627)
... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+. +......... ...
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHTCSCH
T ss_pred CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHHhhhcch
Confidence 554 34568999999999865 4568999999999999999999999976432110 0000000000 000
Q ss_pred --------cccccchhhh-cCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhccc
Q 006886 558 --------TAEVFDVELL-KYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQQP 610 (627)
Q Consensus 558 --------~~~~~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~~~ 610 (627)
..+.....+. .... ....+.+++.+||..||++|||++|++++ ++.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTN---ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTT---CCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhccCCcccccchHHhccC---CCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000000000 0011 12345678889999999999999999985 6665433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-40 Score=336.12 Aligned_cols=249 Identities=17% Similarity=0.261 Sum_probs=189.2
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeC--CceEEEEecCCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSK--DEKLVVYSYMPAG 415 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~e~~~~g 415 (627)
.+.||+|+||+||+|+.. +|+.||||+++. ...+.+.+|++++..+..||||+++++++... ...++||||+++|
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 478999999999999974 689999999864 34677899999999997799999999998743 4688999999999
Q ss_pred CHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCC-CeEEeecccccccCCC---
Q 006886 416 SLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDL-NGCISDVGLAHLINFP--- 491 (627)
Q Consensus 416 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~ki~DfG~a~~~~~~--- 491 (627)
+|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9876532 4899999999999999999999999 99999999999998765 5899999999876543
Q ss_pred CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---------hcccc--
Q 006886 492 TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR---------EEWTA-- 559 (627)
Q Consensus 492 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~-- 559 (627)
....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...... .+....+..... .....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 344578999999998765 4799999999999999999999999754321 110000100000 00000
Q ss_pred cccc-----------hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 006886 560 EVFD-----------VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVR 602 (627)
Q Consensus 560 ~~~d-----------~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 602 (627)
..+. ..............++.+++.+|+..||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000001111122345678889999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=331.32 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=193.7
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEeccccc---CHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCC
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAA---TKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPA 414 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~ 414 (627)
.+.||+|+||+||+|+.. +++.||||+++.... ..+.+.+|+.+++.+ +||||+++++++.+....++|+|++.+
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccc
Confidence 378999999999999964 789999999865432 356789999999999 999999999999999999999999999
Q ss_pred CCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccCCCC--
Q 006886 415 GSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLINFPT-- 492 (627)
Q Consensus 415 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~~~~-- 492 (627)
+++..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 86 ~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 86 DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9998887654 35889999999999999999999998 9999999999999999999999999998765432
Q ss_pred --CCCCCccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc--ccc------
Q 006886 493 --TATRTIGYRAPEVTETRK-ASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT--AEV------ 561 (627)
Q Consensus 493 --~~~~t~~y~aPE~~~~~~-~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~------ 561 (627)
...++..|+|||++.... ++.++||||+||++|||++|+.||.... +.......+...... ...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-----CHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 234577899999987654 6899999999999999999999975422 112222221110000 000
Q ss_pred ---------cchhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 562 ---------FDVELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 562 ---------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
.................+.+++.+|++.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000111122356678889999999999999999763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=331.71 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=182.5
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeC------CceEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSK------DEKLVV 408 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 408 (627)
.++||+|+||+||+|++. +|+.||||++...... ...+.+|+++++++ +||||+++++++... ...++|
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEE
Confidence 378999999999999976 6999999999755332 34688999999999 899999999999643 578999
Q ss_pred EecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeeccccccc
Q 006886 409 YSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLI 488 (627)
Q Consensus 409 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~ 488 (627)
|||+.++.+ ..+.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++..
T Consensus 101 ~Ey~~~~l~-~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 101 MELMDANLC-QVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EECCSEEHH-HHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EeccchHHH-Hhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 999976544 44432 3899999999999999999999999 999999999999999999999999998876
Q ss_pred CCC---CCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC---------HHH-------HH
Q 006886 489 NFP---TTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVD---------LPR-------WV 549 (627)
Q Consensus 489 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~---------~~~-------~~ 549 (627)
... ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...... ..+ ..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 442 33457899999999999999999999999999999999999997543111000 000 00
Q ss_pred HHHhhhccccc------ccchhhhcCC--ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 550 RSVVREEWTAE------VFDVELLKYQ--DVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 550 ~~~~~~~~~~~------~~d~~l~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
........... .+........ .......++.+++.+|+..||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00001000000 0000000000 112334567889999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=331.16 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=188.4
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccC---HHHHHHHHHHHHHhccCCCeeeeeeEEeeC-----CceEEEE
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAAT---KREFEQQMEVVGTIGKHSNVVPVRAYYYSK-----DEKLVVY 409 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 409 (627)
.+.||+|+||+||+|+.. +|+.||||++...... .+.+.+|+++++.+ +|||++++++++... ...++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEE
Confidence 478999999999999964 7999999999755332 35688999999999 999999999998643 3456778
Q ss_pred ecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEEeecccccccC
Q 006886 410 SYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCISDVGLAHLIN 489 (627)
Q Consensus 410 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~~~ 489 (627)
+|+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++....
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence 888999999998643 4899999999999999999999998 9999999999999999999999999997764
Q ss_pred CC-CCCCCCccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhhhccc--ccc----
Q 006886 490 FP-TTATRTIGYRAPEVTETR-KASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVREEWT--AEV---- 561 (627)
Q Consensus 490 ~~-~~~~~t~~y~aPE~~~~~-~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 561 (627)
.. .+..|++.|+|||+..+. .++.++||||+||++|+|++|+.||.+.+... ....+...... .+.
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~------~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCHHHHTTC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCCCChHHhhhc
Confidence 33 445678899999987665 46899999999999999999999997543111 11111110000 000
Q ss_pred cc-------hhhhc--CCChH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhhc
Q 006886 562 FD-------VELLK--YQDVE----EEMVQMLQIALSCVAKVPDSRPKMDDVVRM--IEQIQ 608 (627)
Q Consensus 562 ~d-------~~l~~--~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~--L~~~~ 608 (627)
.. ..... ..... ....++.+++.+|+..||++|||++|++++ +.++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00 00000 00000 112345678889999999999999999873 44443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-36 Score=310.85 Aligned_cols=260 Identities=19% Similarity=0.263 Sum_probs=187.0
Q ss_pred hcccCcCCceeEEEEEec-CCcEEEEEEecccccCHHHHHHHHHHHHHhc----------cCCCeeeeeeEEeeC--Cce
Q 006886 339 AEVLGKGSYGSTYKAILE-DGTTVVVKRLREVAATKREFEQQMEVVGTIG----------KHSNVVPVRAYYYSK--DEK 405 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~--~~~ 405 (627)
.++||+|+||+||+|+.. +|+.||||+++......+.+.+|+++++.+. .|+||+++++++... ...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 578999999999999964 7999999999865445567888988888773 368899999888653 455
Q ss_pred EEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEecCCCC------eE
Q 006886 406 LVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHS-EGGAKFTHGNIKSSNVLLTQDLN------GC 478 (627)
Q Consensus 406 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~------~k 478 (627)
+++++++..+.......... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++. ++
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence 66666655544333322221 23568899999999999999999998 66 999999999999987654 89
Q ss_pred EeecccccccCC-CCCCCCCccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCHHHHHHHHhh---
Q 006886 479 ISDVGLAHLINF-PTTATRTIGYRAPEVTETRKASQKSDVYSFGVLLLEMLTGKAPLQHSGHDDVVDLPRWVRSVVR--- 554 (627)
Q Consensus 479 i~DfG~a~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 554 (627)
++|||.+..... .....+|+.|+|||++.+..++.++||||+||+++||++|+.||....................
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 999999986643 3455689999999999999999999999999999999999999976443322222111111100
Q ss_pred --------h-cccccccc------------------hhhhcCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 006886 555 --------E-EWTAEVFD------------------VELLKYQDVEEEMVQMLQIALSCVAKVPDSRPKMDDVVRM 603 (627)
Q Consensus 555 --------~-~~~~~~~d------------------~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 603 (627)
. ......++ ..............++.+++.+|+..||.+|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000000 0001222345666788999999999999999999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=4.2e-30 Score=260.65 Aligned_cols=202 Identities=35% Similarity=0.631 Sum_probs=146.9
Q ss_pred CChhHHHHHHHHHhhCCCCC-CCCCCCCCCCCC-CCcceEeeCC--CCcEEEEEcCCCCccc--ccCccccCCCCcccEE
Q 006886 26 DLNSDKQALLDFADAVPHAR-KLNWNAAAPVCS-SWIGVTCNVN--RSRVIGIHLPGIGFTG--PIPANSIGKLDALKIL 99 (627)
Q Consensus 26 ~~~~~~~~l~~~~~~~~~~~-~~~W~~~~~~c~-~w~gv~C~~~--~~~v~~l~l~~~~l~~--~~~~~~l~~l~~L~~L 99 (627)
|.+.|++||++||+++.++. ..+|..++++|. +|.||+|+.. ..||+.|+|++++++| ++|+ .+++|++|+.|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccccc
Confidence 67899999999999996553 458987777773 5999999864 3489999999999998 5777 89999999999
Q ss_pred EccC-cccCccCCCCCCCcccccEEeeecccccccCchhhc--------------------------ccccccccccccc
Q 006886 100 SLRS-NYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--------------------------LQLNALDLSFNAF 152 (627)
Q Consensus 100 ~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--------------------------~~L~~L~ls~N~l 152 (627)
+|++ |+++|.+|..|++|++|++|+|++|++.+.++.... .+|+.+++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 9996 899999999999999999999999998876553111 0233444444443
Q ss_pred ccCCcc-----------------------------------------------------------------------ccc
Q 006886 153 TGNIPP-----------------------------------------------------------------------GFQ 161 (627)
Q Consensus 153 ~~~~p~-----------------------------------------------------------------------~~~ 161 (627)
+|.+|. .++
T Consensus 162 ~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~ 241 (313)
T d1ogqa_ 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241 (313)
T ss_dssp EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 333322 223
Q ss_pred cccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCC--CCCCCCCcccCCCcCCCCCCCCC
Q 006886 162 NLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDS--LQTFPNSSFVGNSMLCGLPLTPC 228 (627)
Q Consensus 162 ~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~--~~~~~~l~~~~n~~~~~~~~~~c 228 (627)
.+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|+. +.++..+.+.+|+.+||.|+++|
T Consensus 242 ~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 3455566677777777766653 6677777777777777777742 23334444556777777777666
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.3e-22 Score=189.26 Aligned_cols=159 Identities=16% Similarity=0.142 Sum_probs=116.0
Q ss_pred hcccCcCCceeEEEEEecCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHHhccCCCeeeeeeEE
Q 006886 339 AEVLGKGSYGSTYKAILEDGTTVVVKRLREVAA-------------------TKREFEQQMEVVGTIGKHSNVVPVRAYY 399 (627)
Q Consensus 339 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~ 399 (627)
.+.||+|+||+||+|...+|+.||||+++.... ....+..|...+.++ .|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~~ 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEEE
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEec
Confidence 578999999999999988899999998753211 012345677788888 888988776553
Q ss_pred eeCCceEEEEecCCCCCHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEecCCCCeEE
Q 006886 400 YSKDEKLVVYSYMPAGSLFMLLHRNRSDGGTALDWNSRMKIALGTARGIAFIHSEGGAKFTHGNIKSSNVLLTQDLNGCI 479 (627)
Q Consensus 400 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ki 479 (627)
..+++|||++++.+.. ++.....+++.|++.++.|||+++ |+||||||+|||++++ .++|
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 2369999998865432 333445678999999999999998 9999999999999965 4899
Q ss_pred eecccccccCCCCCCCCCccccCc------cccCCCCCCCcchhHHHHHH
Q 006886 480 SDVGLAHLINFPTTATRTIGYRAP------EVTETRKASQKSDVYSFGVL 523 (627)
Q Consensus 480 ~DfG~a~~~~~~~~~~~t~~y~aP------E~~~~~~~~~~~Dv~S~Gvv 523 (627)
+|||.|.....+... .|... |. ..+.|..++|+||..--
T Consensus 144 iDFG~a~~~~~~~~~----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 999999766433211 11110 11 13567888999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.8e-18 Score=160.92 Aligned_cols=123 Identities=27% Similarity=0.310 Sum_probs=69.1
Q ss_pred EEcCCCCcccccCccccCCCCcccEEEccCcccCccC-CCCCCCcccccEEeeecccccccCchhhc--ccccccccccc
Q 006886 74 IHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTL-PSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDLSFN 150 (627)
Q Consensus 74 l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ls~N 150 (627)
++.++++|+ .+|. .+ .++++.|+|++|.|++.+ +..|..+++|++|+|++|++.+.++..+. .+|++|+|++|
T Consensus 13 v~Cs~~~L~-~iP~-~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPR-DI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCS-CC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCC-CC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 455555555 4555 22 145566666666665433 33455566666666666666665554332 25666666666
Q ss_pred ccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccc
Q 006886 151 AFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 151 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~ 200 (627)
+|++..|..|.++++|++|+|++|+|++..+.. .+++|++|+|++|++..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 666544555666666666666666666544432 55666666666666553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.8e-17 Score=161.10 Aligned_cols=153 Identities=22% Similarity=0.214 Sum_probs=109.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc---------
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--------- 139 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--------- 139 (627)
..++.|+|++|.++ .+|+..|.++++|+.|+|++|+|+ .+| .++.+++|++|+|++|++++.++.+..
T Consensus 31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccccccccccccccccccccc
Confidence 45778888888877 455546778888888888888877 444 356677777777777777665443222
Q ss_pred ----------------cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcccc
Q 006886 140 ----------------LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGS 201 (627)
Q Consensus 140 ----------------~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~ 201 (627)
.+++.|++++|.++...+..+..+++|+.|++++|+|++..+.. .+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 13566666677777555566777888888888888888766653 6888999999999998 7
Q ss_pred CCCCCCCCCCCcc---cCCCcCCCCCC
Q 006886 202 IPDSLQTFPNSSF---VGNSMLCGLPL 225 (627)
Q Consensus 202 ~p~~~~~~~~l~~---~~n~~~~~~~~ 225 (627)
+|+.+..++.|++ .||++.|+|.+
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCcch
Confidence 8887777776664 47888887643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.65 E-value=2.2e-16 Score=146.58 Aligned_cols=165 Identities=19% Similarity=0.227 Sum_probs=136.0
Q ss_pred CCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc
Q 006886 58 SWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN 128 (627)
Q Consensus 58 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 128 (627)
.|..|.|+.. +..++.|+|++|.|++.++...|.++++|+.|+|++|.+.+..+..|..+++|++|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 7899999752 2578999999999998787778999999999999999999999999999999999999999
Q ss_pred cccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCCC
Q 006886 129 YFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPDS 205 (627)
Q Consensus 129 ~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~~ 205 (627)
+|.++++..+. .+|++|+|++|+|++..|..|..+++|++|+|++|.+....... -...|+.+.+..|.++...|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~~ 168 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK 168 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCChh
Confidence 99999886443 38999999999999877888999999999999999998654432 2234677788889998888877
Q ss_pred CCCCCCCcccCCCcCCC
Q 006886 206 LQTFPNSSFVGNSMLCG 222 (627)
Q Consensus 206 ~~~~~~l~~~~n~~~~~ 222 (627)
+.++.-+..-.|...|.
T Consensus 169 l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 169 VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTSBGGGSCTTTCCCC
T ss_pred hcCCEeeecCHhhCcCC
Confidence 76655444444444453
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=3.5e-16 Score=153.14 Aligned_cols=142 Identities=20% Similarity=0.222 Sum_probs=111.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
....+++.++++|+ .+|+ .+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+.+.+.....+|+.|+|+
T Consensus 10 ~~~~~v~C~~~~L~-~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS 85 (266)
T ss_dssp TTCCEEECTTSCCS-SCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECC
T ss_pred CCCeEEEccCCCCC-eeCc-CcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccccccccc
Confidence 45566799999999 6887 443 5899999999999976677899999999999999999976554333589999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
+|+++ ..|..+.++++|+.|++++|++.+..+.. .+.+++.|++++|.+++..+..+..++.+..+
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l 153 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence 99999 46778999999999999999888654433 66677777777777775555555556655544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.8e-15 Score=149.59 Aligned_cols=147 Identities=24% Similarity=0.233 Sum_probs=112.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccC-------------------------CCCCCCcccccEE
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTL-------------------------PSDITSISSLQYV 123 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-------------------------p~~~~~l~~L~~L 123 (627)
..++.|+|++|+|+ .+|+..|.++++|+.|++++|+|.+.. |..|.++++|++|
T Consensus 32 ~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L 110 (284)
T d1ozna_ 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (284)
T ss_dssp TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEE
Confidence 35789999999998 677768999999999999999886532 3456667788888
Q ss_pred eeecccccccCchhhc--cccccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCcc
Q 006886 124 YLQNNYFSGVLPAFRS--LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLN 199 (627)
Q Consensus 124 ~l~~N~l~~~~~~~~~--~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~ 199 (627)
+|++|.+....+.... .+|+.+++++|.|++..+..|..+++|+.|++++|+|++..+.. ++++|+.+++++|+++
T Consensus 111 ~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence 8888887776654333 36788888888888655667777888888888888887655543 6778888888888888
Q ss_pred ccCCCCCCCCCCCcccC
Q 006886 200 GSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 200 ~~~p~~~~~~~~l~~~~ 216 (627)
+..|..|..++++..++
T Consensus 191 ~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp EECTTTTTTCTTCCEEE
T ss_pred ccChhHhhhhhhccccc
Confidence 77788888777777664
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=9e-16 Score=151.76 Aligned_cols=156 Identities=22% Similarity=0.267 Sum_probs=130.8
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDL 147 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~l 147 (627)
.+..++...++....+++..|.++++|+.|+|++|.+....+..+..+++|+.+++++|+|+++++..+. .+|+.|+|
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence 4455554433333356565899999999999999999977788889999999999999999998886543 37999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc---CCCcCCC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV---GNSMLCG 222 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~---~n~~~~~ 222 (627)
++|+|++..|..|.++++|+.|++++|++++..|.. .+++|++|++++|.+++..|..|.++++|+.+ +|++.|+
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999877889999999999999999999877765 88999999999999998888888887777765 7888887
Q ss_pred CCC
Q 006886 223 LPL 225 (627)
Q Consensus 223 ~~~ 225 (627)
+++
T Consensus 241 C~~ 243 (284)
T d1ozna_ 241 CRA 243 (284)
T ss_dssp GGG
T ss_pred ccc
Confidence 653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.58 E-value=2.8e-15 Score=149.75 Aligned_cols=158 Identities=24% Similarity=0.272 Sum_probs=117.3
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeec
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQN 127 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 127 (627)
|.|.+|.|+.. +..++.|+|++|+++ .+|+..|.++++|+.|++++|.++...|..|..+++|++|+|++
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 47999999752 356999999999998 67776899999999999999999987788999999999999999
Q ss_pred ccccccCchhh------------------------------------------------c-cc-----------------
Q 006886 128 NYFSGVLPAFR------------------------------------------------S-LQ----------------- 141 (627)
Q Consensus 128 N~l~~~~~~~~------------------------------------------------~-~~----------------- 141 (627)
|+++.++.... . .+
T Consensus 89 n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~ 168 (305)
T d1xkua_ 89 NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168 (305)
T ss_dssp SCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred CccCcCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence 98764321100 0 01
Q ss_pred ----cccccccccccccCCccccccccccccccccCCcccccCCCC--CCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 142 ----LNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL--NLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 142 ----L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
|+.|++++|.+++..+..|.+++.++.|++++|++++..+.. .+++|++|+|++|+|+ .+|+.+.++++|+.+
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence 334455555555555566677777777777777777655543 6778888888888887 567777777777766
Q ss_pred C
Q 006886 216 G 216 (627)
Q Consensus 216 ~ 216 (627)
+
T Consensus 248 ~ 248 (305)
T d1xkua_ 248 Y 248 (305)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=1.1e-14 Score=124.26 Aligned_cols=101 Identities=26% Similarity=0.307 Sum_probs=60.4
Q ss_pred EEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccccccc
Q 006886 73 GIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLSFNA 151 (627)
Q Consensus 73 ~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~ 151 (627)
.|+|++|+++ .++. ++.+++|+.|+|++|.|+ .+|+.|+.+++|++|++++|+|++++ .+.. .+|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCc
Confidence 4666777766 4442 666667777777777776 45666666677777777666666543 2333 256666666666
Q ss_pred cccCC-ccccccccccccccccCCcccc
Q 006886 152 FTGNI-PPGFQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 152 l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 178 (627)
|+... ...+..+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 65321 1345556666666666666653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.51 E-value=3.6e-15 Score=149.56 Aligned_cols=132 Identities=33% Similarity=0.481 Sum_probs=103.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcc-cEEEccCcccCc-----------------------cCCCCCCCcccccEEe
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDAL-KILSLRSNYLNG-----------------------TLPSDITSISSLQYVY 124 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L-~~L~L~~N~l~~-----------------------~~p~~~~~l~~L~~L~ 124 (627)
..++.+++++|.+.|.+|. .+..+..+ +.+++++|++++ .+|..+..+++|+.|+
T Consensus 149 ~~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeecccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3456666777766666665 45554443 555555555544 5555566778889999
Q ss_pred eecccccccCchhhc-cccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCC-cccc
Q 006886 125 LQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNN-LNGS 201 (627)
Q Consensus 125 l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~-l~~~ 201 (627)
+++|.+.+.+|.+.. .+|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|.. ++++|+.+++++|+ +.|.
T Consensus 228 ~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 999999888886554 47999999999999999999999999999999999999999976 79999999999998 5554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=8.7e-15 Score=131.25 Aligned_cols=124 Identities=18% Similarity=0.132 Sum_probs=58.3
Q ss_pred cCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccccccccccCCcccccccccccc
Q 006886 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDLSFNAFTGNIPPGFQNLTRLHL 168 (627)
Q Consensus 90 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 168 (627)
+.+...|+.|||++|+|+ .+|..+..+++|+.|+|++|+|+.+ +.+.. .+|++|+|++|+|+...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 334444555555555554 3343334455555555555555443 22222 24555555555555322233344555555
Q ss_pred ccccCCcccccCC--C-CCCCccceeeccCCCccccCCC----CCCCCCCCcccC
Q 006886 169 LNLQNNSISGAIP--P-LNLPRLKILNFSNNNLNGSIPD----SLQTFPNSSFVG 216 (627)
Q Consensus 169 L~l~~N~l~~~~p--~-~~~~~L~~L~l~~N~l~~~~p~----~~~~~~~l~~~~ 216 (627)
|++++|+|+.... . ..+++|++|++++|+++ ..|. .+..+++|++++
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 5555555543111 1 14555666666666554 2332 244555665554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.47 E-value=4.5e-14 Score=132.63 Aligned_cols=139 Identities=27% Similarity=0.362 Sum_probs=98.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|.+++ +++ ++.+++|+.|+|++|+|++ +| .+..+++|+.|++++|.+....+-....+++.++++
T Consensus 68 ~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142 (210)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCCGGGGGCTTCCEEECC
T ss_pred CCCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-cccccccccccccccccccccccccccccccccccc
Confidence 567788888887774 443 6777888888888888773 44 477778888888888877654322222367888888
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
+|.+++ +..+..+++|+.+++++|++++..+-.++++|+.|+|++|+++ .+| .+.++++|++++
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~ 206 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLE 206 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEE
T ss_pred cccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEE
Confidence 888774 2356777888888888888876444447888888888888887 454 477777777654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=3.7e-14 Score=120.88 Aligned_cols=100 Identities=30% Similarity=0.413 Sum_probs=86.5
Q ss_pred cEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCCccccccccccccccccCCc
Q 006886 97 KILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNS 175 (627)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 175 (627)
+.|||++|+|+ .+| .+..+++|++|+|++|+|+.+++.+... +|+.|++++|.|++ +| .+..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 57999999998 566 5999999999999999999887766554 89999999999994 65 49999999999999999
Q ss_pred ccccCCC---CCCCccceeeccCCCccc
Q 006886 176 ISGAIPP---LNLPRLKILNFSNNNLNG 200 (627)
Q Consensus 176 l~~~~p~---~~~~~L~~L~l~~N~l~~ 200 (627)
|+..... ..+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9864432 278999999999999984
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=7e-14 Score=130.11 Aligned_cols=137 Identities=26% Similarity=0.376 Sum_probs=68.6
Q ss_pred cEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccc
Q 006886 70 RVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSF 149 (627)
Q Consensus 70 ~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~ 149 (627)
+++.|++++|+++ .++ .++.+++|+.|+|++|+|++..| +..+++|++|++++|.+....+-....+|+.|++++
T Consensus 41 ~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 115 (199)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCcccccccccccccccccccccccccccccccc
Confidence 4555666666655 232 25556666666666666653322 555666666666666555443311112455555555
Q ss_pred cccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCccc
Q 006886 150 NAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 150 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~ 215 (627)
|.+.. + ..+..+++|+.|++++|++.....-..+++|+.|++.+|++++. + .++++++|+.+
T Consensus 116 ~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L 177 (199)
T d2omxa2 116 NQITD-I-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERL 177 (199)
T ss_dssp SCCCC-C-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEE
T ss_pred ccccc-c-cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC-c-cccCCCCCCEE
Confidence 55553 2 22455555555555555554321122555555555555555532 1 24444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.43 E-value=1.2e-13 Score=128.43 Aligned_cols=137 Identities=25% Similarity=0.368 Sum_probs=114.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|+|++|.+++ +++ ++++++|+.|++++|.+. .+| .+.++++|++|++++|.+....+-....+|+.|+++
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~ 136 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 136 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCcCcCccccccccC-ccc--ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhh
Confidence 689999999999985 443 899999999999999998 454 488999999999999999876543333589999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~ 214 (627)
+|++. .+| .+..+++|+.|++++|++++..+-.++++|+.|++++|+++. ++ .+..+++|+.
T Consensus 137 ~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~ 198 (199)
T d2omxa2 137 SNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLES 198 (199)
T ss_dssp SSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred hhhhc-ccc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence 99998 454 588999999999999999975554589999999999999984 44 4667777654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=8.6e-14 Score=124.62 Aligned_cols=119 Identities=18% Similarity=0.306 Sum_probs=101.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
.++.+|+|++|+++ .++. .+..+++|+.|||++|.|+ .++ .|..+++|++|+|++|+++.+++..+. .+|+.|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 56899999999998 5665 6788999999999999999 454 589999999999999999998886543 4899999
Q ss_pred ccccccccCCc--cccccccccccccccCCcccccCCC------CCCCccceeec
Q 006886 147 LSFNAFTGNIP--PGFQNLTRLHLLNLQNNSISGAIPP------LNLPRLKILNF 193 (627)
Q Consensus 147 ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~------~~~~~L~~L~l 193 (627)
|++|+|+. ++ ..+..+++|++|++++|.++.. |. ..+++|++||.
T Consensus 94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~-~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETT
T ss_pred eccccccc-cccccccccccccchhhcCCCccccc-cchHHHHHHHCCCcCeeCC
Confidence 99999984 54 3688999999999999999854 43 26889998873
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=3.4e-13 Score=126.50 Aligned_cols=138 Identities=21% Similarity=0.336 Sum_probs=114.4
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
..++.|++++|+++. ++ .+..+++|+.|+|++|.|++ ++ .+..+++|++|++++|++++++ .+.. .+|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccccc-ccccccccccccc
Confidence 358899999999984 44 38899999999999999996 44 4789999999999999999865 3443 48999999
Q ss_pred cccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcccC
Q 006886 148 SFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSFVG 216 (627)
Q Consensus 148 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~~ 216 (627)
++|.+. .++ .+..++.|+.+++++|++++......+++|+.+++++|++++ ++ .+.++++|+.++
T Consensus 120 ~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~ 184 (210)
T d1h6ta2 120 EHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY 184 (210)
T ss_dssp TTSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEE
T ss_pred cccccc-ccc-cccccccccccccccccccccccccccccccccccccccccc-cc-cccCCCCCCEEE
Confidence 999998 343 688999999999999999865544589999999999999985 43 377788877654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=7.6e-15 Score=136.38 Aligned_cols=126 Identities=21% Similarity=0.338 Sum_probs=103.8
Q ss_pred ccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-ccccccccccccccCCccccccccccc
Q 006886 89 SIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-QLNALDLSFNAFTGNIPPGFQNLTRLH 167 (627)
Q Consensus 89 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~l~~L~ 167 (627)
.+..|++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+.+++..... +|+.|++++|+|+. ++ .+..+++|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~ 118 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLR 118 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSS
T ss_pred HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccccccc-cc-ccccccccc
Confidence 6889999999999999999 555 5999999999999999999876544333 79999999999994 54 588999999
Q ss_pred cccccCCcccccCC--C-CCCCccceeeccCCCccccCCCC----------CCCCCCCcccCCC
Q 006886 168 LLNLQNNSISGAIP--P-LNLPRLKILNFSNNNLNGSIPDS----------LQTFPNSSFVGNS 218 (627)
Q Consensus 168 ~L~l~~N~l~~~~p--~-~~~~~L~~L~l~~N~l~~~~p~~----------~~~~~~l~~~~n~ 218 (627)
.|++++|+|+.... . ..+++|+.|+|++|+++...+.. +..+++|+.+|..
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD~~ 182 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGM 182 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEESSG
T ss_pred ccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeCCc
Confidence 99999999985322 2 38999999999999998655543 4567888888743
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.6e-12 Score=124.56 Aligned_cols=68 Identities=10% Similarity=0.157 Sum_probs=47.1
Q ss_pred CCCcceEeeCC---------CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCC-CCCCcccccEEee
Q 006886 57 SSWIGVTCNVN---------RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPS-DITSISSLQYVYL 125 (627)
Q Consensus 57 ~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 125 (627)
|....|.|... +..++.|+|++|.++ .+|...|.++++|+.|+|++|.+...+|. .|..++++++|++
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 36778888742 236889999999987 67766789999999999999987654432 3444444444443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.29 E-value=3.7e-12 Score=126.58 Aligned_cols=128 Identities=22% Similarity=0.287 Sum_probs=82.4
Q ss_pred cEEEEEcCCCCccc-ccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc--ccccccc
Q 006886 70 RVIGIHLPGIGFTG-PIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALD 146 (627)
Q Consensus 70 ~v~~l~l~~~~l~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ 146 (627)
....++...+.... ......+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.+.+..+..+. ..++.|+
T Consensus 125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~ 201 (305)
T d1xkua_ 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201 (305)
T ss_dssp TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred cccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccc
Confidence 34455555554321 122225677777777777777776 455443 56777777777777776664333 2577777
Q ss_pred ccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccc
Q 006886 147 LSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 147 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~ 200 (627)
+++|.+++..|..|.++++|++|+|++|+|+..++.. .+++|+.|+|++|+|+.
T Consensus 202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred cccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCc
Confidence 7777777666667777777777777777777432222 67777777777777773
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=2.5e-12 Score=114.11 Aligned_cols=97 Identities=20% Similarity=0.163 Sum_probs=64.3
Q ss_pred CCCCcccccCccccCCCCcccEEEccCc-ccCccCCCCCCCcccccEEeeecccccccCchhhc--cccccccccccccc
Q 006886 77 PGIGFTGPIPANSIGKLDALKILSLRSN-YLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS--LQLNALDLSFNAFT 153 (627)
Q Consensus 77 ~~~~l~~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~~L~~L~ls~N~l~ 153 (627)
.+++++ .+|. .+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+.+.+..+. .+|++|+|++|+|+
T Consensus 16 ~~~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 16 TRDGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp CSSCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred cCCCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence 445555 4555 5788889999999766 48865566788888988888888888877665332 25666666666666
Q ss_pred cCCccccccccccccccccCCcc
Q 006886 154 GNIPPGFQNLTRLHLLNLQNNSI 176 (627)
Q Consensus 154 ~~~p~~~~~l~~L~~L~l~~N~l 176 (627)
.+|.......+|+.|+|++|.+
T Consensus 94 -~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 94 -SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp -CCCSTTTCSCCCCEEECCSSCC
T ss_pred -ccChhhhccccccccccCCCcc
Confidence 3444333333566666666655
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.27 E-value=3.2e-12 Score=131.05 Aligned_cols=138 Identities=24% Similarity=0.355 Sum_probs=91.1
Q ss_pred CCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc-------
Q 006886 68 RSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL------- 140 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------- 140 (627)
..+++.|++++|.++. ++ .+..+++|+.|++++|.+++..| +..+++|++|++++|++++..+.....
T Consensus 218 ~~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~ 292 (384)
T d2omza2 218 LTNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292 (384)
T ss_dssp CTTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred cCCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccc
Confidence 3678899999999884 43 58889999999999999986443 788899999999999988765422212
Q ss_pred ---------------ccccccccccccccCCccccccccccccccccCCcccccCCCC-CCCccceeeccCCCccccCCC
Q 006886 141 ---------------QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL-NLPRLKILNFSNNNLNGSIPD 204 (627)
Q Consensus 141 ---------------~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~L~~L~l~~N~l~~~~p~ 204 (627)
+++.|++++|++++. + .+..+++|++|++++|+|++ ++.. ++++|++|++++|++++..|
T Consensus 293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~- 368 (384)
T d2omza2 293 NENQLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP- 368 (384)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG-
T ss_pred cccccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh-
Confidence 355666666666642 2 25556666666666666654 2222 55666666666666664433
Q ss_pred CCCCCCCCccc
Q 006886 205 SLQTFPNSSFV 215 (627)
Q Consensus 205 ~~~~~~~l~~~ 215 (627)
+.++++|+.+
T Consensus 369 -l~~l~~L~~L 378 (384)
T d2omza2 369 -LANLTRITQL 378 (384)
T ss_dssp -GTTCTTCSEE
T ss_pred -hccCCCCCEe
Confidence 4555555444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.1e-11 Score=117.38 Aligned_cols=124 Identities=23% Similarity=0.360 Sum_probs=67.0
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcc--------
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSL-------- 140 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-------- 140 (627)
.+++.|+|++|.+++ ++ .+..+++|+.|++++|.++ .++ .+..+++|++|++++|...+..+-....
T Consensus 63 ~~L~~L~ls~n~i~~-~~--~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 63 NNLIGLELKDNQITD-LA--PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp TTCCEEECCSSCCCC-CG--GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCcEeecCCceeec-cc--ccccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 567777777777763 22 2677777777777777766 333 4667777777777777766543321111
Q ss_pred --------------ccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcc
Q 006886 141 --------------QLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 141 --------------~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~ 199 (627)
+|+.|++++|.+++. + .+.++++|+.|+|++|++++..+-..+++|++|+|++|+++
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred hhhhchhhhhccccccccccccccccccc-h-hhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCC
Confidence 244445555444421 1 24444555555555555543222124445555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.20 E-value=1.6e-11 Score=116.26 Aligned_cols=122 Identities=27% Similarity=0.437 Sum_probs=87.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCC--------------------CCCCCcccccEEeeecc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLP--------------------SDITSISSLQYVYLQNN 128 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~l~~N 128 (627)
.+++.+++++|.++ .++ .+..+++|+.|++++|.+.+..+ ..+..+++|++|++++|
T Consensus 85 ~~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n 161 (227)
T d1h6ua2 85 TKITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA 161 (227)
T ss_dssp CSCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccccccccc-ccc--cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhcccccccccccccc
Confidence 45556666666555 333 35566666666666655443211 23566788999999999
Q ss_pred cccccCchhhccccccccccccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccC
Q 006886 129 YFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSN 195 (627)
Q Consensus 129 ~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~ 195 (627)
.+....+-....+|+.|+|++|++++ +|. +.++++|++|+|++|+|++..|-.++++|+.|++++
T Consensus 162 ~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 162 QVSDLTPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCCGGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred ccccchhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 98876552222489999999999995 554 899999999999999999765545899999999974
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=9.7e-12 Score=127.41 Aligned_cols=141 Identities=28% Similarity=0.384 Sum_probs=104.7
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.....+++++|.+++..| +...++|+.|++++|.++. +| .+..+++|+.|++++|++++..+-....+|+.|+++
T Consensus 197 ~~~~~l~l~~n~i~~~~~---~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~ 271 (384)
T d2omza2 197 TNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLG 271 (384)
T ss_dssp TTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred cccceeeccCCccCCCCc---ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCcccccccCCEeecc
Confidence 568899999999996433 5678899999999999984 43 688999999999999999998774444689999999
Q ss_pred ccccccCCc--------------------cccccccccccccccCCcccccCCCCCCCccceeeccCCCccccCCCCCCC
Q 006886 149 FNAFTGNIP--------------------PGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQT 208 (627)
Q Consensus 149 ~N~l~~~~p--------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~ 208 (627)
+|++++..| ..+..+++++.|++++|++++..+-..+++|+.|++++|+|++ ++ .+.+
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~ 349 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLAN 349 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGG
T ss_pred CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcC
Confidence 998885332 1245556667777777777664443467777777777777763 33 4666
Q ss_pred CCCCcccC
Q 006886 209 FPNSSFVG 216 (627)
Q Consensus 209 ~~~l~~~~ 216 (627)
+++|+.++
T Consensus 350 l~~L~~L~ 357 (384)
T d2omza2 350 LTNINWLS 357 (384)
T ss_dssp CTTCCEEE
T ss_pred CCCCCEEE
Confidence 67666654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.17 E-value=3.6e-13 Score=124.86 Aligned_cols=123 Identities=21% Similarity=0.284 Sum_probs=100.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhc-cccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRS-LQLNALDL 147 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~~L~~L~l 147 (627)
.+++.|+|++|+++ .++ .|..+++|+.|+|++|.|+ .+|..+..+++|++|++++|+++.+. .+.. .+|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccccc-ccccccccccccc
Confidence 57999999999998 565 4899999999999999998 67766666789999999999999864 3433 48999999
Q ss_pred cccccccCCc--cccccccccccccccCCcccccCCCC------------CCCccceeeccCCCcc
Q 006886 148 SFNAFTGNIP--PGFQNLTRLHLLNLQNNSISGAIPPL------------NLPRLKILNFSNNNLN 199 (627)
Q Consensus 148 s~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~------------~~~~L~~L~l~~N~l~ 199 (627)
++|+|+. ++ ..+..+++|+.|+|++|.+....+.. .+++|+.|| +..++
T Consensus 123 ~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 123 SNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred ccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 9999994 44 46899999999999999998755532 478888876 44554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=4.1e-11 Score=106.05 Aligned_cols=104 Identities=19% Similarity=0.128 Sum_probs=87.0
Q ss_pred cccEEEccCcccCccCCCCCCCcccccEEeeecc-cccccCchh-hc-cccccccccccccccCCccccccccccccccc
Q 006886 95 ALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN-YFSGVLPAF-RS-LQLNALDLSFNAFTGNIPPGFQNLTRLHLLNL 171 (627)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~-~~-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 171 (627)
..+.++.+++++. ..|..+..+++|++|+|++| .|+.+.+.. .. .+|+.|+|++|+|+...|.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3456889999998 68889999999999999766 588887754 33 38999999999999777888999999999999
Q ss_pred cCCcccccCCCC-CCCccceeeccCCCcc
Q 006886 172 QNNSISGAIPPL-NLPRLKILNFSNNNLN 199 (627)
Q Consensus 172 ~~N~l~~~~p~~-~~~~L~~L~l~~N~l~ 199 (627)
++|+|+...+.. ...+|+.|+|++|++.
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCcccChhhhccccccccccCCCccc
Confidence 999999544443 5557999999999985
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.87 E-value=2.3e-09 Score=101.96 Aligned_cols=141 Identities=18% Similarity=0.193 Sum_probs=104.2
Q ss_pred EeeCCCCcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCch--hhc-
Q 006886 63 TCNVNRSRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPA--FRS- 139 (627)
Q Consensus 63 ~C~~~~~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~- 139 (627)
.|++.. +.++.++.+++ .+|+ .+ .++++.|+|++|.|+...+..|.++++|++|+|++|.+...++. +..
T Consensus 5 ~C~C~~---~~i~c~~~~l~-~iP~-~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l 77 (242)
T d1xwdc1 5 ICHCSN---RVFLCQESKVT-EIPS-DL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 77 (242)
T ss_dssp SEEECS---SEEEEESCSCS-SCCS-CS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC
T ss_pred cCCCcC---CEEEEeCCCCC-CcCC-CC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccc
Confidence 455532 35677888888 7887 33 25899999999999955556799999999999999999886553 322
Q ss_pred ccccccccc-ccccccCCccccccccccccccccCCcccccCCCC---CCCccceeeccCCCccccCCCCCCCCC
Q 006886 140 LQLNALDLS-FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPL---NLPRLKILNFSNNNLNGSIPDSLQTFP 210 (627)
Q Consensus 140 ~~L~~L~ls-~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~L~~L~l~~N~l~~~~p~~~~~~~ 210 (627)
.+++.|++. .|.+....+..|.++++|+.|++++|+++...+.. .+..|..+...++.+....+..+..++
T Consensus 78 ~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~ 152 (242)
T d1xwdc1 78 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 152 (242)
T ss_dssp TTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence 378888876 47788777788999999999999999998544433 445556666677777755455555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.76 E-value=1.3e-08 Score=102.04 Aligned_cols=116 Identities=25% Similarity=0.360 Sum_probs=91.1
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhcccccccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLS 148 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls 148 (627)
.+++.|||++++|+ .+|+ . +++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++.+.. ....|++|+++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~~--lp~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALSD--LPPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCCS--CCTTCCEEECC
T ss_pred cCCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhhh--hcccccccccc
Confidence 35789999999998 6886 3 578999999999999 788764 578999999999986642 22369999999
Q ss_pred ccccccCCccccccccccccccccCCcccccCCCCCCCccceeeccCCCcc
Q 006886 149 FNAFTGNIPPGFQNLTRLHLLNLQNNSISGAIPPLNLPRLKILNFSNNNLN 199 (627)
Q Consensus 149 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~L~~L~l~~N~l~ 199 (627)
+|.++ .+|. ++.+++|+.|++++|.++.... ....+..+.+.++...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~--~~~~l~~l~~~~~~~~ 153 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD--LPPSLEFIAAGNNQLE 153 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccccccc--ccccccchhhcccccc
Confidence 99999 5775 6889999999999999975443 3445666666666554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.69 E-value=2.6e-08 Score=99.73 Aligned_cols=110 Identities=21% Similarity=0.186 Sum_probs=84.9
Q ss_pred CcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhhccccccccccccccccCCccccccccccccccccC
Q 006886 94 DALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFRSLQLNALDLSFNAFTGNIPPGFQNLTRLHLLNLQN 173 (627)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 173 (627)
.+|+.|||++|.|+ .+|+. +++|++|+|++|+|+.++... .+|+.|++++|+++ .++... +.|++|++++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~~--~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPELP--QSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCCC--TTCCEEECCSSCCS-CCCSCC---TTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccch--hhhhhhhhhhcccc-hhhhhc---cccccccccc
Confidence 36889999999998 68864 578999999999999765332 37999999999998 455421 3699999999
Q ss_pred CcccccCCCCCCCccceeeccCCCccccCCCCCCCCCCCcc
Q 006886 174 NSISGAIPPLNLPRLKILNFSNNNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 174 N~l~~~~p~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~l~~ 214 (627)
|+++.......+++|+.|++++|.++ ..|.....+..+..
T Consensus 108 n~l~~lp~~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~ 147 (353)
T d1jl5a_ 108 NQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 147 (353)
T ss_dssp SCCSSCCCCTTCTTCCEEECCSSCCS-CCCCCCTTCCEEEC
T ss_pred cccccccchhhhccceeecccccccc-ccccccccccchhh
Confidence 99986443348999999999999997 44555545544433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=1.5e-09 Score=106.16 Aligned_cols=148 Identities=20% Similarity=0.243 Sum_probs=85.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecc-ccccc-Cchhh-c-ccccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNN-YFSGV-LPAFR-S-LQLNA 144 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~-~-~~L~~ 144 (627)
.+++.|||+++.++.......+.++++|+.|+|+++.+++..+..++.+++|++|+|+++ .++.. +.... . .+|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 467888888887765433336778888888888888887777777778888888888874 45421 11111 1 36777
Q ss_pred cccccc-ccccC-Ccccccc-ccccccccccCC--ccccc-CCCC--CCCccceeeccCC-CccccCCCCCCCCCCCccc
Q 006886 145 LDLSFN-AFTGN-IPPGFQN-LTRLHLLNLQNN--SISGA-IPPL--NLPRLKILNFSNN-NLNGSIPDSLQTFPNSSFV 215 (627)
Q Consensus 145 L~ls~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~-~p~~--~~~~L~~L~l~~N-~l~~~~p~~~~~~~~l~~~ 215 (627)
|+|+++ .++.. ++..+.. .++|+.|++++. .++.. +... .+++|++|++++| .+++.....+.++++|+.+
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 777764 34321 2222222 245666666543 23211 1111 4556666666654 3554455555555555554
Q ss_pred C
Q 006886 216 G 216 (627)
Q Consensus 216 ~ 216 (627)
+
T Consensus 206 ~ 206 (284)
T d2astb2 206 S 206 (284)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=7.5e-09 Score=91.78 Aligned_cols=119 Identities=18% Similarity=0.189 Sum_probs=72.1
Q ss_pred ccEEEccCcccCccCCCCCCCcccccEEeeecccccccCchhh--ccccccccccccccccC--Cccccccccccccccc
Q 006886 96 LKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLPAFR--SLQLNALDLSFNAFTGN--IPPGFQNLTRLHLLNL 171 (627)
Q Consensus 96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~l 171 (627)
.+.|+++++... ..+..+..+..|++.+|..... +... ..+|++|+|++|+|+.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~~l-~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAATL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHHHH-HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhhhh-HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 344555554322 2344445555555555544332 2221 13678888888888743 2345677888888888
Q ss_pred cCCcccccCCC--CCCCccceeeccCCCccccCCCC-------CCCCCCCcccCCCc
Q 006886 172 QNNSISGAIPP--LNLPRLKILNFSNNNLNGSIPDS-------LQTFPNSSFVGNSM 219 (627)
Q Consensus 172 ~~N~l~~~~p~--~~~~~L~~L~l~~N~l~~~~p~~-------~~~~~~l~~~~n~~ 219 (627)
++|+|+...+. ....+|+.|++++|+++...... +..+|+|+.+|+..
T Consensus 99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LDg~~ 155 (162)
T d1koha1 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155 (162)
T ss_dssp TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEETTEE
T ss_pred ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEECcCC
Confidence 88888753321 14557888888888887655432 56788888887544
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=4.1e-08 Score=95.62 Aligned_cols=148 Identities=19% Similarity=0.202 Sum_probs=105.8
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccC-cccCcc-CCCCCCCcccccEEeeecc-ccccc-Cch-hh--ccc
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRS-NYLNGT-LPSDITSISSLQYVYLQNN-YFSGV-LPA-FR--SLQ 141 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~-N~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~~~-~~--~~~ 141 (627)
.+++.|+|++|++++..+. .++.+++|+.|+|++ +.++.. +..-+.++++|++|+|+++ .++.. ... .. ..+
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 5799999999999877766 789999999999999 466532 2222356899999999985 45432 111 21 136
Q ss_pred ccccccccc--ccccC-CccccccccccccccccCC-cccccCCCC--CCCccceeeccC-CCccccCCCCCCCCCCCcc
Q 006886 142 LNALDLSFN--AFTGN-IPPGFQNLTRLHLLNLQNN-SISGAIPPL--NLPRLKILNFSN-NNLNGSIPDSLQTFPNSSF 214 (627)
Q Consensus 142 L~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~~--~~~~L~~L~l~~-N~l~~~~p~~~~~~~~l~~ 214 (627)
|+.|++++. .++.. +...+.++++|++|++++| .+++..... .+++|++|++++ +.++......++++++|+.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 999999864 34422 3344567899999999986 466544332 789999999999 4677666667778888887
Q ss_pred cCC
Q 006886 215 VGN 217 (627)
Q Consensus 215 ~~n 217 (627)
++-
T Consensus 230 L~l 232 (284)
T d2astb2 230 LQV 232 (284)
T ss_dssp EEC
T ss_pred Eee
Confidence 754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=1.6e-08 Score=89.58 Aligned_cols=105 Identities=24% Similarity=0.201 Sum_probs=61.0
Q ss_pred cCCCCcccEEEccCcccCccCCCCCCCcccccEEeeecccccccCc--h-hhc-cccccccccccccccCCcc-cccccc
Q 006886 90 IGKLDALKILSLRSNYLNGTLPSDITSISSLQYVYLQNNYFSGVLP--A-FRS-LQLNALDLSFNAFTGNIPP-GFQNLT 164 (627)
Q Consensus 90 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~-~~~-~~L~~L~ls~N~l~~~~p~-~~~~l~ 164 (627)
+..+..+..|++.+|... .++..+..+++|++|+|++|+|+.+.+ . +.. .+|+.|+|++|.|+. +++ .+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~ 115 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGL 115 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhcc
Confidence 333444444444444443 333334456777777777777776543 1 112 367778888888774 333 333445
Q ss_pred ccccccccCCcccccCCC---------CCCCccceeeccCCCc
Q 006886 165 RLHLLNLQNNSISGAIPP---------LNLPRLKILNFSNNNL 198 (627)
Q Consensus 165 ~L~~L~l~~N~l~~~~p~---------~~~~~L~~L~l~~N~l 198 (627)
+|+.|++++|.++..... ..+|+|+.|| ++.+
T Consensus 116 ~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 116 KLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 678888888887765442 1577777765 4444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=4.5e-08 Score=101.52 Aligned_cols=110 Identities=17% Similarity=0.195 Sum_probs=72.3
Q ss_pred CcEEEEEcCCCCcccccCccccCCCCcccEEEccCcccCc----cCCCCCCCcccccEEeeecccccccC----chhh--
Q 006886 69 SRVIGIHLPGIGFTGPIPANSIGKLDALKILSLRSNYLNG----TLPSDITSISSLQYVYLQNNYFSGVL----PAFR-- 138 (627)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~----~~~~-- 138 (627)
..|++||++++++++.--...+..+++|+.|+|++|.|+. .+...+..+++|++|||++|.|+... ....
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3588889988888754212246667888888888888773 23444567788888888888875321 1111
Q ss_pred -ccccccccccccccccC----CccccccccccccccccCCcccc
Q 006886 139 -SLQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISG 178 (627)
Q Consensus 139 -~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 178 (627)
..+|+.|+|++|+++.. ++..+..+++|++|++++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 12577777777777642 34456666777777777777653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=8.5e-06 Score=77.44 Aligned_cols=130 Identities=16% Similarity=0.108 Sum_probs=88.2
Q ss_pred ceeEEEEEecCCcEEEEEEecccc-cCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEecCCCCCHHHHhhhcC
Q 006886 347 YGSTYKAILEDGTTVVVKRLREVA-ATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSYMPAGSLFMLLHRNR 425 (627)
Q Consensus 347 ~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 425 (627)
.+.||+... +++.+++|+..... .....+.+|...+..+..+--+.+++.+...++..++||++++|.++.......
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 468998865 46677888875442 234457888888888866655667778878888889999999998775543211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 006886 426 SDGGTALDWNSRMKIALGTARGIAFIHSEG-------------------------------------------------- 455 (627)
Q Consensus 426 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------------- 455 (627)
-. ..+++.++++.+..||+..
T Consensus 105 ------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 01 1223444444455555311
Q ss_pred ------CCCeeecCCCCCCeEecCCCCeEEeecccccc
Q 006886 456 ------GAKFTHGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 456 ------~~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
.+.++|+|+.|.|||+++++..-|.||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877677999997653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.07 E-value=1.6e-07 Score=93.99 Aligned_cols=131 Identities=19% Similarity=0.172 Sum_probs=81.5
Q ss_pred CcEEEEEcCCCCcc--c--ccCc--------cccCCCCcccEEEccCcccCcc----CCCCCCCcccccEEeeecccccc
Q 006886 69 SRVIGIHLPGIGFT--G--PIPA--------NSIGKLDALKILSLRSNYLNGT----LPSDITSISSLQYVYLQNNYFSG 132 (627)
Q Consensus 69 ~~v~~l~l~~~~l~--~--~~~~--------~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 132 (627)
.+++.|++++|++. + .+.. ......+.|+.|++++|.++.. +...+...++|++|+|++|+++.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 56888888888752 0 0100 0124566788888888877532 22234456778888888888764
Q ss_pred cC-----ch-hhc-cccccccccccccccC----CccccccccccccccccCCcccccCC--------CCCCCccceeec
Q 006886 133 VL-----PA-FRS-LQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGAIP--------PLNLPRLKILNF 193 (627)
Q Consensus 133 ~~-----~~-~~~-~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~~L~~L~l 193 (627)
.- .. +.. .+|+.|+|++|.|+.. +...+..+++|++|+|++|+|++.-. ....+.|+.|++
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 21 11 111 3688888888887532 33456677888888888888764211 113456888888
Q ss_pred cCCCcc
Q 006886 194 SNNNLN 199 (627)
Q Consensus 194 ~~N~l~ 199 (627)
++|+++
T Consensus 281 s~N~i~ 286 (344)
T d2ca6a1 281 QYNEIE 286 (344)
T ss_dssp CSSCCB
T ss_pred CCCcCC
Confidence 888876
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.94 E-value=3.1e-07 Score=91.84 Aligned_cols=148 Identities=21% Similarity=0.260 Sum_probs=85.2
Q ss_pred CCcEEEEEcCCCCcccc---cCc------cccCCCCcccEEEccCcccCcc----CCCCCCCcccccEEeeecccccccC
Q 006886 68 RSRVIGIHLPGIGFTGP---IPA------NSIGKLDALKILSLRSNYLNGT----LPSDITSISSLQYVYLQNNYFSGVL 134 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~---~~~------~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~ 134 (627)
..+++.|+++++.+... .+. ..+...++|+.|+|++|.++.. +...+...++|+.|+|++|.+...-
T Consensus 58 ~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~ 137 (344)
T d2ca6a1 58 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 137 (344)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccc
Confidence 35677777776654311 111 1356677788888888877643 2223345677888888888764321
Q ss_pred ch-----h----------hccccccccccccccccC----CccccccccccccccccCCccccc-----CCC-C-CCCcc
Q 006886 135 PA-----F----------RSLQLNALDLSFNAFTGN----IPPGFQNLTRLHLLNLQNNSISGA-----IPP-L-NLPRL 188 (627)
Q Consensus 135 ~~-----~----------~~~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~-~-~~~~L 188 (627)
.. . ....|+.|++++|.++.. +...+..++.|+.|+|++|+|+.. +.. . ..++|
T Consensus 138 ~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L 217 (344)
T d2ca6a1 138 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 217 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC
T ss_pred cccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhh
Confidence 10 0 012467777777776522 223345566778888888777531 111 1 56677
Q ss_pred ceeeccCCCcccc----CCCCCCCCCCCccc
Q 006886 189 KILNFSNNNLNGS----IPDSLQTFPNSSFV 215 (627)
Q Consensus 189 ~~L~l~~N~l~~~----~p~~~~~~~~l~~~ 215 (627)
+.|+|++|.++.. +...+..+++|+.+
T Consensus 218 ~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 218 KVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred cccccccccccccccccccccccccccchhh
Confidence 7888888877532 33344555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.8e-05 Score=74.78 Aligned_cols=144 Identities=13% Similarity=0.111 Sum_probs=84.2
Q ss_pred ccCcCCc-eeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCC-CeeeeeeEEeeCCceEEEEecCCCCCHH
Q 006886 341 VLGKGSY-GSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHS-NVVPVRAYYYSKDEKLVVYSYMPAGSLF 418 (627)
Q Consensus 341 ~lg~G~~-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~e~~~~g~L~ 418 (627)
.+..|.. +.||+....++..+++|.-.... ...+..|.+.+..+..+. .+.+++.+..+.+..++||++++|-++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3445543 67999998888888999765432 334677788777774432 2455677777778889999999886542
Q ss_pred H--------------Hh---hhcCCCC-CCCCCHHHHHHHHH--------------------HHHHHHHHHHhcC----C
Q 006886 419 M--------------LL---HRNRSDG-GTALDWNSRMKIAL--------------------GTARGIAFIHSEG----G 456 (627)
Q Consensus 419 ~--------------~l---~~~~~~~-~~~l~~~~~~~i~~--------------------~ia~~l~~LH~~~----~ 456 (627)
. .+ |...... +..-.+.....-.. .....+..+.... .
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 2 11 1100000 00001111100000 0122233333321 1
Q ss_pred CCeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 457 AKFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 457 ~~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
+.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 237999999999999988777899999764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.80 E-value=6.5e-07 Score=92.50 Aligned_cols=133 Identities=22% Similarity=0.227 Sum_probs=86.0
Q ss_pred CCcEEEEEcCCCCcccccCc---cccCCCCcccEEEccCcccCccCCCCC-----CCcccccEEeeecccccccCch-h-
Q 006886 68 RSRVIGIHLPGIGFTGPIPA---NSIGKLDALKILSLRSNYLNGTLPSDI-----TSISSLQYVYLQNNYFSGVLPA-F- 137 (627)
Q Consensus 68 ~~~v~~l~l~~~~l~~~~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~~~-~- 137 (627)
...+..+++++|++...... ..+...+.++.+++++|.++......+ .....|+.+++++|.++..... +
T Consensus 254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~ 333 (460)
T d1z7xw1 254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 333 (460)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcc
Confidence 35688899999988643211 135567788888888888763221111 2345788888888887755322 1
Q ss_pred --hc--cccccccccccccccC----Cccccc-cccccccccccCCccccc----CCCC--CCCccceeeccCCCccc
Q 006886 138 --RS--LQLNALDLSFNAFTGN----IPPGFQ-NLTRLHLLNLQNNSISGA----IPPL--NLPRLKILNFSNNNLNG 200 (627)
Q Consensus 138 --~~--~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~--~~~~L~~L~l~~N~l~~ 200 (627)
.. .+|++|+|++|.|+.. ++..+. ..+.|++|+|++|+|+.. +... ..++|++|+|++|+|+.
T Consensus 334 ~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 11 2688888888888642 333333 355688888888888742 1111 46788888888888864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=0.00017 Score=72.49 Aligned_cols=75 Identities=13% Similarity=0.197 Sum_probs=47.2
Q ss_pred cccCcCCceeEEEEEecC-CcEEEEEEeccc--------ccCHHHHHHHHHHHHHhccC-CC-eeeeeeEEeeCCceEEE
Q 006886 340 EVLGKGSYGSTYKAILED-GTTVVVKRLREV--------AATKREFEQQMEVVGTIGKH-SN-VVPVRAYYYSKDEKLVV 408 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~--------~~~~~~~~~e~~~l~~l~~h-~n-iv~l~~~~~~~~~~~lv 408 (627)
+.||.|....||+....+ ++.++||.-... .........|.+.+..+..+ |. +.+++ +.+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~--~~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF--YSDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE--EEETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE--EEcCCCCEEE
Confidence 568999999999998654 678899864321 11223345678888777554 22 33344 3455667899
Q ss_pred EecCCCCC
Q 006886 409 YSYMPAGS 416 (627)
Q Consensus 409 ~e~~~~g~ 416 (627)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=0.0007 Score=66.00 Aligned_cols=138 Identities=15% Similarity=0.090 Sum_probs=81.0
Q ss_pred eeEEEEEecCCcEEEEEEecccccCHHHHHHHHHHHHHhccCCC-eeeee-----eEEeeCCceEEEEecCCCCCHH---
Q 006886 348 GSTYKAILEDGTTVVVKRLREVAATKREFEQQMEVVGTIGKHSN-VVPVR-----AYYYSKDEKLVVYSYMPAGSLF--- 418 (627)
Q Consensus 348 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~-----~~~~~~~~~~lv~e~~~~g~L~--- 418 (627)
-.||++..++|+.|++|+.+......+++..|.+.+..|..+.- ++..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 47999999999999999988766678889999998888853321 11111 1123455678899998763220
Q ss_pred -----------HHhhh----cCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCCee
Q 006886 419 -----------MLLHR----NRSDGGTALDWNS-------------------RMKIALGTARGIAFIHSE----GGAKFT 460 (627)
Q Consensus 419 -----------~~l~~----~~~~~~~~l~~~~-------------------~~~i~~~ia~~l~~LH~~----~~~~iv 460 (627)
..++. .........++.. +..+...+.+.+..+... ....++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 01111 1111111222211 111222223333444332 223589
Q ss_pred ecCCCCCCeEecCCCCeEEeecccccc
Q 006886 461 HGNIKSSNVLLTQDLNGCISDVGLAHL 487 (627)
Q Consensus 461 H~Dlk~~NILl~~~~~~ki~DfG~a~~ 487 (627)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999753 56889998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.01 E-value=4.7e-05 Score=66.84 Aligned_cols=63 Identities=8% Similarity=0.221 Sum_probs=29.0
Q ss_pred CcEEEEEcCCC-Ccccc----cCccccCCCCcccEEEccCcccCccCCCCC----CCcccccEEeeecccccc
Q 006886 69 SRVIGIHLPGI-GFTGP----IPANSIGKLDALKILSLRSNYLNGTLPSDI----TSISSLQYVYLQNNYFSG 132 (627)
Q Consensus 69 ~~v~~l~l~~~-~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~ 132 (627)
+.+++|+|+++ .++.. +-. .+..-++|+.|+|++|.+...-...+ ...+.|++|+|++|.|+.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~-~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHH-HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 44566666543 23321 111 34455556666666665543222222 223455555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.97 E-value=5.5e-05 Score=66.38 Aligned_cols=108 Identities=14% Similarity=0.016 Sum_probs=65.6
Q ss_pred cCCCCcccEEEccCc-ccCcc----CCCCCCCcccccEEeeecccccccCc-h---hh--ccccccccccccccccC---
Q 006886 90 IGKLDALKILSLRSN-YLNGT----LPSDITSISSLQYVYLQNNYFSGVLP-A---FR--SLQLNALDLSFNAFTGN--- 155 (627)
Q Consensus 90 l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~-~---~~--~~~L~~L~ls~N~l~~~--- 155 (627)
..+-++|+.|+|+++ .++.. +-..+...++|++|+|++|.+..... . .. ...|+.|+|++|.|+..
T Consensus 11 ~~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 11 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 345688999999874 46532 22245566789999999988864321 1 11 13688888888887742
Q ss_pred -CccccccccccccccccCCcccccC-------CCC--CCCccceeeccCCC
Q 006886 156 -IPPGFQNLTRLHLLNLQNNSISGAI-------PPL--NLPRLKILNFSNNN 197 (627)
Q Consensus 156 -~p~~~~~l~~L~~L~l~~N~l~~~~-------p~~--~~~~L~~L~l~~N~ 197 (627)
+-..+...++|++|++++|.+...- ... .-++|+.|+++.+.
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 1223555567888888877654210 000 34566777766554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.59 E-value=0.0038 Score=62.34 Aligned_cols=73 Identities=10% Similarity=0.112 Sum_probs=50.0
Q ss_pred cccCcCCceeEEEEEecCC--------cEEEEEEecccccCHHHHHHHHHHHHHhccCCCeeeeeeEEeeCCceEEEEec
Q 006886 340 EVLGKGSYGSTYKAILEDG--------TTVVVKRLREVAATKREFEQQMEVVGTIGKHSNVVPVRAYYYSKDEKLVVYSY 411 (627)
Q Consensus 340 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~e~ 411 (627)
+.|+.|-.-.+|+....++ ..|++++.. .........+|.++++.+..+.-..++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 4677788889999986543 456666654 33445567788999998876654556777653 2589999
Q ss_pred CCCCCH
Q 006886 412 MPAGSL 417 (627)
Q Consensus 412 ~~~g~L 417 (627)
++|-.+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.72 E-value=0.00065 Score=59.10 Aligned_cols=14 Identities=7% Similarity=0.071 Sum_probs=7.4
Q ss_pred CCCccceeeccCCC
Q 006886 184 NLPRLKILNFSNNN 197 (627)
Q Consensus 184 ~~~~L~~L~l~~N~ 197 (627)
..++|+.|+++.|.
T Consensus 130 ~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 130 KNTTLLKFGYHFTQ 143 (166)
T ss_dssp HCSSCCEEECCCSS
T ss_pred hCCCcCEEeCcCCC
Confidence 34455666655443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.29 E-value=0.00085 Score=58.30 Aligned_cols=108 Identities=15% Similarity=0.178 Sum_probs=72.8
Q ss_pred CcEEEEEcCC-CCcccc----cCccccCCCCcccEEEccCcccCccCC----CCCCCcccccEEeeecccccccCc----
Q 006886 69 SRVIGIHLPG-IGFTGP----IPANSIGKLDALKILSLRSNYLNGTLP----SDITSISSLQYVYLQNNYFSGVLP---- 135 (627)
Q Consensus 69 ~~v~~l~l~~-~~l~~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~~---- 135 (627)
+.++.|+|++ ++++.. +-. .+...++|+.|+|++|.++..-- ..+...++|+.|++++|.++...-
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 6788999987 456432 222 46788999999999999875322 234557899999999998874321
Q ss_pred -hhhc-ccccc--cccccccccc----CCccccccccccccccccCCccc
Q 006886 136 -AFRS-LQLNA--LDLSFNAFTG----NIPPGFQNLTRLHLLNLQNNSIS 177 (627)
Q Consensus 136 -~~~~-~~L~~--L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 177 (627)
.+.. .+|+. |++++|.+.. .+...+...++|+.|+++.|...
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 1111 25665 5556777753 24445667889999999887654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.73 E-value=0.028 Score=53.71 Aligned_cols=29 Identities=21% Similarity=0.213 Sum_probs=26.2
Q ss_pred CeeecCCCCCCeEecCCCCeEEeeccccc
Q 006886 458 KFTHGNIKSSNVLLTQDLNGCISDVGLAH 486 (627)
Q Consensus 458 ~ivH~Dlk~~NILl~~~~~~ki~DfG~a~ 486 (627)
.+||+|+.++||+++++...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 48999999999999998877899999874
|